<SEC-DOCUMENT>0001728117-20-000009.txt : 20201110
<SEC-HEADER>0001728117-20-000009.hdr.sgml : 20201110
<ACCEPTANCE-DATETIME>20201110162541
ACCESSION NUMBER:		0001728117-20-000009
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		65
CONFORMED PERIOD OF REPORT:	20200930
FILED AS OF DATE:		20201110
DATE AS OF CHANGE:		20201110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Gossamer Bio, Inc.
		CENTRAL INDEX KEY:			0001728117
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				475461709
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38796
		FILM NUMBER:		201301494

	BUSINESS ADDRESS:	
		STREET 1:		3013 SCIENCE PARK
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		(858) 922-0718

	MAIL ADDRESS:	
		STREET 1:		3013 SCIENCE PARK
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>goss-20200930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:a28f2324-59ee-4208-be3f-ac91f14d0976,g:685f1ccc-55e8-49df-855b-4b6ee836ad79,d:40514bbc3b4c4ca6a3766d45caf8fa76--><html xmlns:goss="http://www.gossamerbio.com/20200930" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>goss-20200930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80L2ZyYWc6OTk4NWQyNTNjZmY2NGZlNWJmYWFhOTEzYjg1ZDNlZjgvdGFibGU6M2I1OWU1YjE5NTY5NDc5ZTljOWM0ZDlhMmVhNzVlYTQvdGFibGVyYW5nZTozYjU5ZTViMTk1Njk0NzllOWM5YzRkOWEyZWE3NWVhNF80LTEtMS0xLTA_d29ce8cc-62d3-4078-b3d4-ef6b96d88f13">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80L2ZyYWc6OTk4NWQyNTNjZmY2NGZlNWJmYWFhOTEzYjg1ZDNlZjgvdGFibGU6M2I1OWU1YjE5NTY5NDc5ZTljOWM0ZDlhMmVhNzVlYTQvdGFibGVyYW5nZTozYjU5ZTViMTk1Njk0NzllOWM5YzRkOWEyZWE3NWVhNF81LTEtMS0xLTA_c1b9b240-6ee5-4f30-9ada-46c639e7e282">September 30, 2020</ix:nonNumeric><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80L2ZyYWc6OTk4NWQyNTNjZmY2NGZlNWJmYWFhOTEzYjg1ZDNlZjgvdGFibGU6M2I1OWU1YjE5NTY5NDc5ZTljOWM0ZDlhMmVhNzVlYTQvdGFibGVyYW5nZTozYjU5ZTViMTk1Njk0NzllOWM5YzRkOWEyZWE3NWVhNF82LTEtMS0xLTA_e6f7d086-0841-4b5a-96c5-bded20aac134">2020</ix:nonNumeric><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80L2ZyYWc6OTk4NWQyNTNjZmY2NGZlNWJmYWFhOTEzYjg1ZDNlZjgvdGFibGU6M2I1OWU1YjE5NTY5NDc5ZTljOWM0ZDlhMmVhNzVlYTQvdGFibGVyYW5nZTozYjU5ZTViMTk1Njk0NzllOWM5YzRkOWEyZWE3NWVhNF83LTEtMS0xLTA_83aacf86-aa52-472d-99a4-ffa533a903e9">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80L2ZyYWc6OTk4NWQyNTNjZmY2NGZlNWJmYWFhOTEzYjg1ZDNlZjgvdGFibGU6M2I1OWU1YjE5NTY5NDc5ZTljOWM0ZDlhMmVhNzVlYTQvdGFibGVyYW5nZTozYjU5ZTViMTk1Njk0NzllOWM5YzRkOWEyZWE3NWVhNF8xMC0xLTEtMS0w_2e6b7c08-dd6c-4be6-a026-e0d20ab8b87c">0001728117</ix:nonNumeric><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80L2ZyYWc6OTk4NWQyNTNjZmY2NGZlNWJmYWFhOTEzYjg1ZDNlZjgvdGFibGU6M2I1OWU1YjE5NTY5NDc5ZTljOWM0ZDlhMmVhNzVlYTQvdGFibGVyYW5nZTozYjU5ZTViMTk1Njk0NzllOWM5YzRkOWEyZWE3NWVhNF8xMS0xLTEtMS0w_2e1b5a07-f506-46b7-9ce2-dd7f9584b6be">12-31</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i5fed8506ec5c42a0b5ad8496948c43b6_D20200521-20200521" decimals="4" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81OC9mcmFnOjlhYjI2NTI0YzAwNzQ0OWI5NDYyYjU2NzZiZjgwMDQ4L3RleHRyZWdpb246OWFiMjY1MjRjMDA3NDQ5Yjk0NjJiNTY3NmJmODAwNDhfMTA5OTUxMTYyNzkxMQ_c7a04677-351b-4ae8-adbe-c53a90c8e53e">0.0616</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="goss-20200930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ie505de77d9a8407ab07995dedcd8776a_I20201105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-11-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i720b6695621443f1bfacd04fd902b4fd_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e476b4d712f41b58c1f9eec52fea678_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf88702e49f34f05a203c305e7218d7c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7379eeb81da423f99c7cf5072cffbc2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie414046cc6c443539a8b1ba823193e96_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6adcea0a3af47708c4c2ce641288ef5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ca596cd49d2414786bbd3a11c836866_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib95b4750602f4fd8bdf1f4408e3bac46_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1caa3930a2594a799b9714a362f1b101_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9700bbf1ee8c490ead9c97fb9c7d5dc7_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93af83044802421987749ef31a183d52_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7d34d11bc09445287a4c15de915761e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idccd09399cdb4afd946bd554abecc76e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fba8fc0709c48be89520d5a63454847_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3af9d2e206e40adaa4e86d644948813_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic17e964b37084a94a4881db7645fa317_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ed5a5578fba4ebc96b685a36facf9c3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c0263dedae046d1bf5c601e9e997bc3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i713b4ee54335442fa90cd348ffab165f_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06c4796c101b42a492b0b4c35e73bbf4_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i179e6d0fae8d486f92313c7f72e868be_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc2769e3ef10494aaf33bceab6b40d73_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i480da23e7ba242298f782217cc12a7de_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc9220fd857749928edaccab2a419a18_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ff593aedcba40a79fd271254329a2e8_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i709889bc20a04f829d4afc37e00775f6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61df284353eb4dd6bd4c5ccba7156006_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbe555fee6524c44a457250b4e5a4021_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31856bc57f6c47a3bf3f5b8adeeb728f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71bc32578df241928d2449da7c53426b_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d810e89f07c449a83b0758c44d745bf_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78bd0f4aff6f43e499d7ce9e3c5b17bb_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i094d4c2753d9481590781ade460fad59_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7edc736569724e8b8c6e523b7a87a15c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3312a4a7c1f41c7bb6ef94d06af70aa_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">goss:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54d8aec85f094dd690dc3a0c548af271_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">goss:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i343a722113ce45f1bf66666c91555acd_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">goss:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97e4156cb4c140a6a6a93b8df92d43a7_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb3c158457d84ea98458e3654e48a62c_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb107b5d59dc4b05a8e01ddcc4874d2f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea07989a2b224869843ff82cca663a29_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b49cacc7d364d80be392cf7b95e4972_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c1117486726474d966d52141c13b867_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d8d3eefe0054e2c89d598ac1a177a07_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i204c4d8a4ae54157a23623329533ce14_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2b24c51d3c14bf39e027c08084d0df0_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">goss:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c6f2d65140a444f9beca064afdc4187_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">goss:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c30e6a7eee0456a8b8e9b7b04d7cc10_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">goss:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88d438efdfcf48699af3cb8a4c151884_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibef492d549a34220b9476308f889a3ad_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ca39df98ce8457d8d865eabaaba7f70_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">goss:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d60975fadce491d9047cc147f13b8af_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">goss:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a1343a170f74a2b85887cc27f953407_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">goss:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa5a9b278e164c2da9b072055d0bc7c3_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i601fef938815423388ebc7b90b509f2c_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if74dcc4469a54a8c98af2792cc68e327_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e47c631459c4f0aa8359cd24d601d03_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4b5355aba354232bb2a9f7d614c0e15_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f9261b47f7c4dedb3e011d185c7d383_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51ad8abfdf85411b98659ee7f825d361_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7688ecc551594d43b36f111047a7deb4_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3cc915869004ddaaa6c21c954b57896_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b9f0d0a440e443ab0d19184e46dc5b1_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i402b84a37c734fd2ada2568ef7353e2b_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41d5abe0dfd841d695c962b1f348472c_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c1183f5df444d8a9dbef8a80208eb1d_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3deb511ea20347b989c9a3668500baf2_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04d13b8492374901b4f4bf2ad46601c5_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibac864d50598406f8c85d4bdd4a64b15_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e10c5e62242441296917276fcd983f2_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76a2221bc96b477d9033dce08a133c47_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3eb22709373e449784bf6abde9e5ef9d_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id84abe36ab124aee9361fd90972e72a9_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d31ff554106438ca11cdde65438f9f1_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a97f2ca2b0143f8bf6974c1fc94e461_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie52349d1207b400e8a20c808e6df36aa_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4575faeae2514742ab2eedb009712d84_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf9016d9d3c54fdcbd742124c1e00da3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandNineteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedadf32f302e470ca02b51105b2ffa9e_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandNineteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia37b4eed12f64ea0ad441fc0ad1e503d_D20190212-20190212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-12</xbrli:startDate><xbrli:endDate>2019-02-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72382ce16b8b49b292e97c0ef7b75dd3_I20190212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47525e97b2e2423db6a765678a6c4fec_D20190212-20190212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">goss:ConversionOfConvertiblePreferredStockIntoCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-12</xbrli:startDate><xbrli:endDate>2019-02-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9eebf838097e49fa93a3a4ab394c7e68_D20171001-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i1fed2bfc69594ec7a6dbcd619a5e2bef_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5780f8c4c24046a9b2f18bb81e280495_D20180104-20180104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AABiopharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-04</xbrli:startDate><xbrli:endDate>2018-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib505254a0d25402398cd90e47386b544_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16119fa6447641b4b0438be989f83724_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85914c244cbc465a8537031c3daf6f1e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d717c27684b4376bc058963cf8edc06_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i628ea545993847d1a0da78338212f66f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65156772da894ffc943654c22ccecde9_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e067eee87aa40508462e122f6750be3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a55d6d56691410aa331d57da9a540d1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8bca8bf3b2f456db5ae73401c2d37be_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76f89fa7250e4a06b29eb2156d416d96_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i260bc0a3e86245f2b8b08107a4dee7bd_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib750f63eb6b944cb98e71a7f0d4cf5f8_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21f9a7a1498e4ac9bff64988b80f1530_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b11b05347a54ecd8d3f69919983392e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d433a516bc643149feff09002c301ba_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51a4aedbde574295bf88fe0261d77059_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8efc8bdaf1074768864d3ed973853b90_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i103f71b1047849e5b84f76f80ae06494_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42449cdc53ba4b89b9cdf57fa83320b0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdf44d92b2ca4b57a02e2892703853f1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if27e640809cf45798d09eb333cf0b6da_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d06d2274931457baab6e055385a4ed4_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1c26254dc044115869b6c29020aa2f9_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd07bdcfbfb94667ac7bec7ea6ef1c07_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i611f783c934a4fb6b3f38212acc720ca_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d68ba3fe6824af092a4888b932d3991_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i835b26655f28493fad355a6322860843_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f0c40e6d7654a0d84a3748e61f8aac5_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17213d559ba7419fab19ce258c60725e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26809f02394e4f7fa0669e5465e107e5_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf0f77fbe2fa411887f11ed7f2f99c11_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">goss:USTreasuryAndAgencySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c3c2ed990164cdf9677553f5b066742_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">goss:USTreasuryAndAgencySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20a2c95edf9e4ccba5c6b16a8d676493_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">goss:USTreasuryAndAgencySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iada21370c53144b09d7b9404f3ee35ff_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">goss:USTreasuryAndAgencySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe176d3a79e745d79ba915619691251d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bda7b8e7dd04e8caccd4a6f241affe0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i345c770504cf47799812979d3f5b302d_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e3869d1f23741b4a71e5a062db9b80c_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i301f52d7e9c04c2491017b8e1843e74a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e014916db25406589a2a5f00d8eb334_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1402b051056b4d9799e3b18f2092e6f0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if59687e3ceb840559fdd247e955190ca_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba100508cf4f4d92b301e065ad6ff443_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7e2d34db3e44a1c82443160f196e896_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81256eb7c9e04561a9015aca0c513258_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42e5b4d69dd14ffea2c2f3c7b25f6034_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc5f664a8d9f42fbae6150714af2998f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">goss:USTreasuryAndAgencySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b301e21a02a4512a5e81e1b78038f75_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">goss:USTreasuryAndAgencySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e20f232351042e2a775afe12f0c8249_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">goss:USTreasuryAndAgencySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i977d5f93f97946efb350e31e78f7b85c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">goss:USTreasuryAndAgencySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i833b6168e6d6460e8cb4fa5a0da5de2e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09e8387031f142ac9019e52d736c6004_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1efadb52eb943fe9951cac243f24a01_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i039111ce7909430b990dd8e90c1779a2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4266b95b8b344eb6960b0767413da8a3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c5f2803efa24a25b712849347cd1cf5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i686c91e5254648cea5586df68b2d908e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5083b3c67e204f679f3a2c11014f24c1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83bde4dee6094380821298b49ab659af_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3101b95085834b9ea5a1dc9f746956db_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice172af8d59747e98811da5f3ed0dfc7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifec2d9641952468d8894861a5747a001_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">goss:USTreasuryAndAgencySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8ff014a368f4ecdbeb3dedc5d6a4ec9_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0a2dd9240654fb5a702e98d4d3f4e28_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5422129c1c59408889a2b99ef392c162_I20190502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70316c2b436540a398e8730c8f3d7325_D20190502-20190502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-02</xbrli:startDate><xbrli:endDate>2019-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="tranche"><xbrli:measure>goss:Tranche</xbrli:measure></xbrli:unit><xbrli:context id="i5007e0fab37a4961ae06a859fbe77235_I20190502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">goss:TrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i667382cf02644ff3a4aefdaf07b9cb60_I20190502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">goss:TrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i049d323be2aa4c3fbc15de6068f993c8_D20190502-20190502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-02</xbrli:startDate><xbrli:endDate>2019-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2111df5e71074410b154ca22ac755a6d_I20190502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d6528bf258548188d528464e3134189_I20190502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">goss:PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd99beac9caf44318e4f61c224f56fa4_I20190502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">goss:FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1aa9b85a36ff422abc868819f1b52110_I20190502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">goss:SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd6482abdd604fa3b4920ae6543e4b2e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">goss:MidCapFinancialTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f195af7643b4ea094fcedba56dc2482_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic984cdc9b0e0482fbb94f5d207f8e3fa_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fbffc547f2d4d6c8b7ed7d9553a691e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fed8506ec5c42a0b5ad8496948c43b6_D20200521-20200521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-21</xbrli:startDate><xbrli:endDate>2020-05-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0fc320a9ff8434485ec70bde2f2d365_I20200521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="day"><xbrli:measure>goss:day</xbrli:measure></xbrli:unit><xbrli:context id="idda6a8263ec542759323ed492c31b7bc_D20200521-20200521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">goss:OneHundredThirtyPercentApplicableConversionPriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-21</xbrli:startDate><xbrli:endDate>2020-05-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dc17920346740a4a7c548c095f7e04c_D20200521-20200521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">goss:OneHundredThirtyPercentApplicableConversionPriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-21</xbrli:startDate><xbrli:endDate>2020-05-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f7d41d10a544ee8bd19cb9b3d404bd3_D20200521-20200521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">goss:NinetyEightPercentApplicableConversionPriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-21</xbrli:startDate><xbrli:endDate>2020-05-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaeecc10913964395b00a41848ddfd5d3_D20200521-20200521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">goss:NinetyEightPercentApplicableConversionPriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-21</xbrli:startDate><xbrli:endDate>2020-05-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7efacb2f1f254242abcd3924f60c15be_D20200521-20200521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-21</xbrli:startDate><xbrli:endDate>2020-05-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65ad3aed5a854b92910ae3dd0bf4a19a_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5bf8c1de2ef4f56b4e73b156372b2a3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48ce1ae69a484b2897d46eda4fe74206_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if94daf002452491ebb4b1b5e305750ce_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if767ec539aa84bdf81a78eff0a4bcd22_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f6ba65eca1c4988aeda7e1649f3720f_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7131a2487c34cb4bd58334ee5055363_D20171002-20171002"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:PulmokineIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">goss:LicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-02</xbrli:startDate><xbrli:endDate>2017-10-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51900b7591e64e51863c94621c055cae_I20171002"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:PulmokineIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">goss:LicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcc05f91f85e4e60b74e1e52f826c49d_D20171001-20171031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:PulmokineIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">goss:LicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2017-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id960de866c1840368aa1b490b1df8a76_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:PulmokineIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">goss:LicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48df4955276f406984e65cbd02fc2753_D20180104-20180104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AABiopharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">goss:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-04</xbrli:startDate><xbrli:endDate>2018-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc437c92dc4d47abbc82d156fe56b94a_D20180104-20180104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AABiopharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-04</xbrli:startDate><xbrli:endDate>2018-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6763b93bb734419aa637f9886d0f8d4_D20180101-20180131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AABiopharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i149440b5575441f1ade1e500f96cffcd_D20180601-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-06-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c1fea39e1c24a86b52512965a113dc8_D20200511-20200511"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">goss:LicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AerpioPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-11</xbrli:startDate><xbrli:endDate>2020-05-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34b002ec88bf4140996fb7ae42f20c25_I20200511"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">goss:LicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AerpioPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i058b2b9596f049bf88bf24e8ef1b88f5_D20180624-20180624"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">goss:LicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AerpioPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-06-24</xbrli:startDate><xbrli:endDate>2018-06-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f2d41e0946a449d9739a4055373fcb5_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">goss:LicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AerpioPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d3bd9ebc0c04c8aac7d80aadda3c812_D20180921-20180921"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AdhaerePharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-21</xbrli:startDate><xbrli:endDate>2018-09-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71ff0fe376bb4ce4a0d344274d60cda5_I20180921"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AdhaerePharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i311895b288e84df99a0fe27ae04661aa_D20180901-20180930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AdhaerePharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-01</xbrli:startDate><xbrli:endDate>2018-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i449c34cb7fd642fc8a19b754af262018_D20190501-20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AdhaerePharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-01</xbrli:startDate><xbrli:endDate>2019-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5f049d5e60d4e86a687f615be004af7_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AdhaerePharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4e0c83f4759440487e347440556bf19_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa29bc841f9e4fb0955d09333da173cf_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0589fce7ead149e3b77ab56902cfd9da_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb792d6d5530491786d139e759d02ca9_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d36daa696204d2a993a2a5386f71366_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica43b072ffa14194a075ee24b8eefd04_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic25495903f344f3badaca483a298b34c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id69f21cf412842c28bbd38e5675710e9_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i785b0d7d87e64989afb260e63ffcaa75_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5877020a64de4daf9c2e9fc19548520c_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dcb3875d02e46f6860a02a7ae51afa3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc960cc1b38e453d8577212588425de5_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e82f42dcfad490d88675b7ce2d18579_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f1eb79d41a7477e8aac7ef9621f779b_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc076cf8ed8c4b60a0160f586d633a9d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6dfed8a74714ce4b52a2b48f1f8bcfe_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29791a3aea134a31a642f180d6f252e1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentOtherProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28e36142d5da400cbe56fb94780d66fe_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentOtherProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i213f70a2c4f54d029f161eb250548f2f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentOtherProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97eeb89fb4f541069f7d7bb71850f31f_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentOtherProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="vote"><xbrli:measure>goss:vote</xbrli:measure></xbrli:unit><xbrli:context id="i32aaefa176c1431b83d26da9efa9e0e0_D20200521-20200521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-21</xbrli:startDate><xbrli:endDate>2020-05-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4903290fc91c4b818ef0419687e6bdb2_I20200521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-05-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9231a57c1ff4550b9a94b3c726cfbfc_D20151203-20151203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">goss:FounderSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-12-03</xbrli:startDate><xbrli:endDate>2015-12-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f6a02fac0054f41ac0a21a7a698dd11_I20151203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">goss:FounderSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-12-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9c4125058a849188d84d6987a2aca5c_I20180104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">goss:FounderSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56b9c2498afd46cea09d67fffcd7f527_D20180104-20180104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">goss:FounderSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-04</xbrli:startDate><xbrli:endDate>2018-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id747bd928ed14565962ba04db245c625_I20180104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">goss:FounderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia05c65f0299b4470b9988c00f268c597_D20180521-20180521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">goss:FounderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-21</xbrli:startDate><xbrli:endDate>2018-05-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44b0b9ab297245a587e455ae0fbdf7e1_I20180521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">goss:FounderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13993408590b4d4aae392dedae7f7168_D20180906-20180906"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">goss:FounderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-06</xbrli:startDate><xbrli:endDate>2018-09-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4232852076fb41578223f9f35c5620ed_I20180906"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">goss:FounderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6361b8d7044547f78137b4ca8e8367ae_D20171101-20171130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">goss:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">goss:StockRestrictionAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-11-01</xbrli:startDate><xbrli:endDate>2017-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id21572d412b64344adae1b7652804401_D20180101-20180131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">goss:StockRestrictionAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i565814101ba9433cabc2aba6a50774be_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icada44f7b33b4bb69194179efb087bf7_I20190206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c8bcc0cc5824acab60dce389cc0e01a_D20190206-20190206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-06</xbrli:startDate><xbrli:endDate>2019-02-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id21248c7f8d1404dbfbcc4790900c1a8_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id682609138d74f299a22b9b828664934_D20190206-20190206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandNineteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-06</xbrli:startDate><xbrli:endDate>2019-02-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55d566fa333348f38fe0698d8122d240_I20190206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandNineteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id82f48c87413404898cd5e95a6f92456_D20190206-20190206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandNineteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-06</xbrli:startDate><xbrli:endDate>2019-02-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib62a29f3d4bd41768f85b8c430ff8ed2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandSeventeenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bca54ddec634c619bb186716592456f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandSeventeenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id60e67dc25ec478c8538a048150413cc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57a7a1c92af444738a26579e9c9b97f4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7cf20b97501468ba190ca44f798aa5c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dde91022b6f4727b6a3442ab07af3f3_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ee46adffb174aab896b0ef706379d9e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i383e88d1480f4707a5e280fb091f49f1_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e99060b0b3445c2ab001b2db044619c_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbd4563ff308475bb9677d83bd6901ed_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5234f8600a24470b93bc826f0087d51f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83e749032dd647eeb7e5730f0d79e71f_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9addd071f2134af4b1c59d6d7647b955_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic44d278160054bb5935c16c50beece12_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief5753da810c4701b357b0ba9f8e7bc1_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4c2928920df49ebaed3b6aed298b48b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib654ba389ce740a5b5698b7efa4bf39b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandNineteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0f9d120e4f34b0e85ac915426783ced_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandNineteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d1e2f5620c948549f4affe56ba4eba6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="goss:LeaseContractualTermAxis">goss:NonCancelableLeaseAgreementEnteredInAugust2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f160954a3ed444fa5812d76c8308a06_D20191101-20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="goss:LeaseContractualTermAxis">goss:AdditionalNonCancelableLeaseAgreementInNov2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia55f355b0bbc4b78be1ab19f707c05ec_D20200601-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="goss:LeaseContractualTermAxis">goss:SubleaseAgreementEnteredInJune2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29f32f74db5543c8a8510694e76a3c8d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="goss:LeaseContractualTermAxis">goss:SubleaseAgreementEnteredInJune2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ac3518affc6454b9e891197f6e12355_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="goss:LeaseContractualTermAxis">goss:SubleaseAgreementEnteredInJune2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ea38ec7e8c7483eb917072f4fe3f12d_I20200729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="goss:LeaseContractualTermAxis">goss:LeaseAssignmentAgreementEnteredInJuly2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c084b288ebf4e26a9b2953bd0afde9a_D20200729-20200729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="goss:LeaseContractualTermAxis">goss:LeaseAssignmentAgreementEnteredInJuly2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-29</xbrli:startDate><xbrli:endDate>2020-07-29</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_1"></div><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">_________________________</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">FORM <ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGV4dHJlZ2lvbjo2N2VkMTBkOWMwZmE0YjkwYTYzMTg1OWE0MjEyMGIxZF8xMDk5NTExNjI5ODU2_54384758-a480-4fb9-ad2f-6b497f07dfc3">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">_________________________</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6OWU5NDUyM2FhYTg1NGE1MTg1MTFjOGZkOGM4YjYyMWEvdGFibGVyYW5nZTo5ZTk0NTIzYWFhODU0YTUxODUxMWM4ZmQ4YzhiNjIxYV8wLTAtMS0xLTU4Ng_86441efe-f11f-453c-99a2-6eaf88b5aed4">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the quarterly period ended September&#160;30, 2020 </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6OWIxYzEyMGUxODE2NDY1N2I0ZDgyMGE1ZWU5MTc4NTcvdGFibGVyYW5nZTo5YjFjMTIwZTE4MTY0NjU3YjRkODIwYTVlZTkxNzg1N18wLTAtMS0xLTU5MA_e9404a11-ba3a-4192-a843-ecea7198a008">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from ________to_________.</span></div><div style="text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGV4dHJlZ2lvbjo2N2VkMTBkOWMwZmE0YjkwYTYzMTg1OWE0MjEyMGIxZF8xMDk5NTExNjI5ODU3_fd3cfa81-f05d-4a77-823a-e0372b3d3bb9">001-38796</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">_________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGV4dHJlZ2lvbjo2N2VkMTBkOWMwZmE0YjkwYTYzMTg1OWE0MjEyMGIxZF8xMDk5NTExNjI5ODU5_2b73939b-5c6c-40a9-b3eb-fd2871209e4d">GOSSAMER BIO, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of Registrant as specified in its charter).</span></div><div style="text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">_________________________</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.093%"><tr><td style="width:1.0%"></td><td style="width:29.029%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.393%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.306%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6NjRlODZhMzc2MDA2NDY2OGEyMTdiNTA2MThkZTU3MDQvdGFibGVyYW5nZTo2NGU4NmEzNzYwMDY0NjY4YTIxN2I1MDYxOGRlNTcwNF8wLTAtMS0xLTYwNw_c74fc985-237f-495f-bf33-b8c408250fa7">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6NjRlODZhMzc2MDA2NDY2OGEyMTdiNTA2MThkZTU3MDQvdGFibGVyYW5nZTo2NGU4NmEzNzYwMDY0NjY4YTIxN2I1MDYxOGRlNTcwNF8wLTEtMS0xLTYxMA_56c1b161-e504-4710-abcf-76b9324db65f">47-5461709</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6NjRlODZhMzc2MDA2NDY2OGEyMTdiNTA2MThkZTU3MDQvdGFibGVyYW5nZTo2NGU4NmEzNzYwMDY0NjY4YTIxN2I1MDYxOGRlNTcwNF8zLTAtMS0xLTc3NQ_df8a262c-66e4-43e3-97da-812ed1986ae3">3013 Science Park Road</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6NjRlODZhMzc2MDA2NDY2OGEyMTdiNTA2MThkZTU3MDQvdGFibGVyYW5nZTo2NGU4NmEzNzYwMDY0NjY4YTIxN2I1MDYxOGRlNTcwNF8zLTEtMS0xLTc3Nw_652fddf5-fe31-4321-9091-1844da30fa91">San Diego</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6NjRlODZhMzc2MDA2NDY2OGEyMTdiNTA2MThkZTU3MDQvdGFibGVyYW5nZTo2NGU4NmEzNzYwMDY0NjY4YTIxN2I1MDYxOGRlNTcwNF8zLTItMS0xLTc3OQ_668956ec-42b4-435c-87cd-1c56d874daa7">California</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6NjRlODZhMzc2MDA2NDY2OGEyMTdiNTA2MThkZTU3MDQvdGFibGVyYW5nZTo2NGU4NmEzNzYwMDY0NjY4YTIxN2I1MDYxOGRlNTcwNF8zLTEtMS0xLTYxOQ_d9865f8f-9c7d-4937-b034-6cd8e0bcfc0b">92121</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGV4dHJlZ2lvbjo2N2VkMTBkOWMwZmE0YjkwYTYzMTg1OWE0MjEyMGIxZF8xMDk5NTExNjI5ODY1_28f00ad7-0b49-48b3-905f-77f446290199">858</ix:nonNumeric>) <ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGV4dHJlZ2lvbjo2N2VkMTBkOWMwZmE0YjkwYTYzMTg1OWE0MjEyMGIxZF8xMDk5NTExNjI5ODY5_acd8a855-c84c-4f79-9610-d570f5b31374">684-1300</ix:nonNumeric></span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.294%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.297%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading<br/>Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6YjQ2Nzg2NTFmNjQzNDE3Zjg3NjVkNzc5MmRiNzc1NDcvdGFibGVyYW5nZTpiNDY3ODY1MWY2NDM0MTdmODc2NWQ3NzkyZGI3NzU0N18xLTAtMS0xLTYzNA_88e056a1-3975-4ba6-aa10-9b6cf9d23db2">Common Stock, $0.0001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6YjQ2Nzg2NTFmNjQzNDE3Zjg3NjVkNzc5MmRiNzc1NDcvdGFibGVyYW5nZTpiNDY3ODY1MWY2NDM0MTdmODc2NWQ3NzkyZGI3NzU0N18xLTItMS0xLTYzNw_20c071bd-36d5-497b-a591-a83494c31836">GOSS</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6YjQ2Nzg2NTFmNjQzNDE3Zjg3NjVkNzc5MmRiNzc1NDcvdGFibGVyYW5nZTpiNDY3ODY1MWY2NDM0MTdmODc2NWQ3NzkyZGI3NzU0N18xLTQtMS0xLTY0MA_314e8f2e-ecb9-4d99-a96b-1bb35b516ff8">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days:&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGV4dHJlZ2lvbjo2N2VkMTBkOWMwZmE0YjkwYTYzMTg1OWE0MjEyMGIxZF8xMDk5NTExNjI5ODcx_c21da7b7-435d-4bca-be6f-08295bdd1102">Yes</ix:nonNumeric>&#160;&#160;&#160;&#160;&#9746;&#160;&#160; &#160;&#160;&#160;&#160;No&#160;&#160;&#160;&#160;&#160;&#9744;</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGV4dHJlZ2lvbjo2N2VkMTBkOWMwZmE0YjkwYTYzMTg1OWE0MjEyMGIxZF8xMDk5NTExNjI5ODcy_5e3f5a07-6b5c-452f-8347-1455171dfb40">Yes</ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;&#160;&#9746; &#160;&#160;&#160;&#160;No&#160;&#160;&#160;&#160;&#160;&#160;&#9744;</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.849%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6MDdjZDI1ZWU0M2EwNGMzMjgyNTBmNDM1MWE0OTQ0MTAvdGFibGVyYW5nZTowN2NkMjVlZTQzYTA0YzMyODI1MGY0MzUxYTQ5NDQxMF8xLTAtMS0xLTc5OA_1d653a17-de9f-4282-b540-896c0e9d95c5">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6MDdjZDI1ZWU0M2EwNGMzMjgyNTBmNDM1MWE0OTQ0MTAvdGFibGVyYW5nZTowN2NkMjVlZTQzYTA0YzMyODI1MGY0MzUxYTQ5NDQxMF8xLTQtMS0xLTY1OA_5ffa652a-e9ee-44f9-9f40-77726c6a87a0">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6MDdjZDI1ZWU0M2EwNGMzMjgyNTBmNDM1MWE0OTQ0MTAvdGFibGVyYW5nZTowN2NkMjVlZTQzYTA0YzMyODI1MGY0MzUxYTQ5NDQxMF8yLTEtMS0xLTY1Ng_7dc8972b-fd5a-48a4-bdab-17ce047b83a8">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGV4dHJlZ2lvbjo2N2VkMTBkOWMwZmE0YjkwYTYzMTg1OWE0MjEyMGIxZF8xMDk5NTExNjI5ODkx_08ac8e3c-4dec-4a8c-a6b2-b600fb2f7ee5">&#9746;</ix:nonNumeric></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;YES <ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGV4dHJlZ2lvbjo2N2VkMTBkOWMwZmE0YjkwYTYzMTg1OWE0MjEyMGIxZF8xMDk5NTExNjI5ODc0_47b75038-6668-43bc-bd4c-2680d0ce5e77">&#9744;</ix:nonNumeric>&#160;&#160;NO&#160;&#9746;</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of November&#160;5, 2020, the registrant had <ix:nonFraction unitRef="shares" contextRef="ie505de77d9a8407ab07995dedcd8776a_I20201105" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGV4dHJlZ2lvbjo2N2VkMTBkOWMwZmE0YjkwYTYzMTg1OWE0MjEyMGIxZF8xMDk5NTExNjI5ODc3_d9bdc7af-4661-48b8-81ec-8a93368d5814">75,927,877</ix:nonFraction> shares of common stock ($0.0001 par value) outstanding.</span></div><div style="margin-bottom:5pt;margin-top:13pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.619%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.849%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_10">PART I. FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_13">Item&#160;1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_13">Condensed Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_16">Condensed Consolidated Balance Sheets as of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_16">Se</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_16">ptember</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_16"> 30, 2020 and December 31, 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_22">Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_22">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_22"> Months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_22">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_22"> 30, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_22">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_25">Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders&#8217; Equity for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_25">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_25"> Months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_25">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_25"> 30, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_25">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_28">Condensed Consolidated Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_28">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_28"> Months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_28">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_28"> 30, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_28">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_34">Notes to Unaudited Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_34">10</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_91">Item&#160;2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_91">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_91">24</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_121">Item&#160;3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_121">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_121">33</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_124">Item&#160;4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_124">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_124">33</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_127">PART II. OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_130">Item&#160;1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_130">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_130">35</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_133">Item&#160;1A</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_133">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_133">35</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_136">Item&#160;2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_136">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_136">36</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_139">Item&#160;3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_139">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_139">36</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_142">Item&#160;4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_142">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_142">36</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_145">Item&#160;5</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_145">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_145">36</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_148">Item&#160;6</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_148">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_148">36</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_151">Exhibit Index</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_151">37</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_154">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_154">38</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I. FINANCIAL INFORMATION</span></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_13"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS (unaudited)</span></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOSSAMER BIO, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and par value amounts)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ASSETS</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMy0xLTEtMS0w_6f85e7a4-760a-4639-bd45-d43763713c06">461,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMy0zLTEtMS0w_05bcf82c-c4fd-4bcb-b1d0-961c0b4d97e4">135,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfNC0xLTEtMS0w_c4413b81-a154-4edf-bd47-059eedaf3024">93,422</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfNC0zLTEtMS0w_564d852a-83c4-4909-a6fa-2a23d5d8dbed">266,740</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfNS0xLTEtMS0w_c3fa9c28-70bc-40d6-92ca-0ac67b5c001c">10,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfNS0zLTEtMS0w_9d7be74c-c4fd-465d-8993-225d4c926e41">7,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total current assets</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfNi0xLTEtMS0w_54339e31-b995-45c9-ae2d-58cbee3e8797">566,206</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfNi0zLTEtMS0w_0c0f98e9-a560-4db7-b3ae-71ac6987aab4">409,317</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfNy0xLTEtMS0w_18e3b731-0c7e-4749-9be0-c1422bffcf63">5,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfNy0zLTEtMS0w_8c4cfb86-2889-4946-9690-dc56c69241cb">5,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfOC0xLTEtMS0w_95c281fa-1f24-4cf8-89da-08be137f459c">11,394</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfOC0zLTEtMS0w_de1e9cea-378b-463e-a6a6-de0bf23db2bc">10,303</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfOS0xLTEtMS0w_8fa347d1-da4c-4963-ab03-f97e122836d4">861</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfOS0zLTEtMS0w_25d28d85-7f67-4e25-aa03-bb8ba1a3bd67">1,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Total assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTAtMS0xLTEtMA_5664c3a0-86c5-409c-8e3d-f378f7f65ec7">584,178</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTAtMy0xLTEtMA_1c531699-0af9-409e-b554-5cbdb21111d4">426,604</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">LIABILITIES, CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS' EQUITY (DEFICIT)</span></div></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTMtMS0xLTEtMA_276fc92d-c3ef-4909-a485-89f5fbd4c8b6">865</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTMtMy0xLTEtMA_9bf404e3-a22f-4efe-b115-3a1d527e9ae9">956</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued research and development expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="goss:AccruedResearchAndDevelopmentExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTQtMS0xLTEtMA_dce934d8-4fee-46b4-af81-3c0fec670d35">12,239</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="goss:AccruedResearchAndDevelopmentExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTQtMy0xLTEtMA_6da45d92-b8b3-43c0-908c-d6e05b063ad7">19,258</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTUtMS0xLTEtMA_a5dbb166-87fe-4409-8306-21be143abc2d">19,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTUtMy0xLTEtMA_a2b7d038-19ca-4623-946f-ff51dba4476f">16,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total current liabilities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTYtMS0xLTEtMA_ecc51a02-38cb-4ea9-9b77-9c9820cfdd5e">32,607</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTYtMy0xLTEtMA_4e7da944-7807-458a-9741-2ebf3d459a4a">36,923</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Long-term convertible senior notes</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="goss:LongTermConvertibleSeniorNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTctMS0xLTEtMA_7999db25-d2a2-4c9e-b2fc-88c5e9c6a911">142,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:zerodash" name="goss:LongTermConvertibleSeniorNotes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTctMy0xLTEtMA_ef9fe763-8537-48a5-afbf-25a0e7ecef22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTgtMS0xLTEtMA_c01b8206-ee64-47aa-85dc-395132e26210">28,665</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTgtMy0xLTEtMA_d7ba595f-4566-4694-865e-64e8ee7a0934">28,459</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities - long-term</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTktMS0xLTEtMA_fd9232f7-88ce-45d6-b54a-de6a54d8ba1e">8,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTktMy0xLTEtMA_d1e78a2d-7860-4c75-a70e-76459a290ff9">8,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Total liabilities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjAtMS0xLTEtMA_2efa6400-7ca0-4995-b454-194953f5187e">212,077</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjAtMy0xLTEtMA_9b839f61-1477-40f8-9bfe-64deba979257">74,119</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjEtMS0xLTEtMA_d0fc8837-749f-4036-b92d-56598ee7fe8a"></ix:nonFraction></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjEtMy0xLTEtMA_1d18c8c5-9ecb-4f57-8462-69c03bae51a8"></ix:nonFraction></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Stockholders' equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjMtMC0xLTEtNTIvdGV4dHJlZ2lvbjphNzQwZjJmYmVkMGM0ZTExOGYyZWNhNjdmZTM5MzJkNF8zMjk4NTM0ODgzNzQw_17fa281f-b65e-49ca-8271-7d9247d655af"><ix:nonFraction unitRef="usdPerShare" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjMtMC0xLTEtNTIvdGV4dHJlZ2lvbjphNzQwZjJmYmVkMGM0ZTExOGYyZWNhNjdmZTM5MzJkNF8zMjk4NTM0ODgzNzQw_f7a7d872-5f86-4787-a4c5-f437ab927e61">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjMtMC0xLTEtNTIvdGV4dHJlZ2lvbjphNzQwZjJmYmVkMGM0ZTExOGYyZWNhNjdmZTM5MzJkNF8zMjk4NTM0ODgzNjE1_082d2be6-ab27-47f1-b5df-9bf2259fc033"><ix:nonFraction unitRef="shares" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjMtMC0xLTEtNTIvdGV4dHJlZ2lvbjphNzQwZjJmYmVkMGM0ZTExOGYyZWNhNjdmZTM5MzJkNF8zMjk4NTM0ODgzNjE1_ac310e83-f7aa-4c83-8648-5a34ad578ed7">700,000,000</ix:nonFraction></ix:nonFraction> shares authorized as of September&#160;30, 2020 and December&#160;31, 2019; <ix:nonFraction unitRef="shares" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjMtMC0xLTEtNTIvdGV4dHJlZ2lvbjphNzQwZjJmYmVkMGM0ZTExOGYyZWNhNjdmZTM5MzJkNF8zMjk4NTM0ODgzNjk1_701facbd-748f-4359-bb75-16c46f865db0">75,907,527</ix:nonFraction> shares issued and</span></div><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjMtMC0xLTEtNTIvdGV4dHJlZ2lvbjphNzQwZjJmYmVkMGM0ZTExOGYyZWNhNjdmZTM5MzJkNF8zMjk4NTM0ODgzNzA3_a49c4714-15d6-4312-ab75-0a218fce813f">72,475,912</ix:nonFraction> shares outstanding as of September&#160;30, 2020, and <ix:nonFraction unitRef="shares" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjMtMC0xLTEtNTIvdGV4dHJlZ2lvbjphNzQwZjJmYmVkMGM0ZTExOGYyZWNhNjdmZTM5MzJkNF8zMjk4NTM0ODgzNzE5_80ba2185-07e2-4a54-9883-ced23b9f1806">66,284,003</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjMtMC0xLTEtNTIvdGV4dHJlZ2lvbjphNzQwZjJmYmVkMGM0ZTExOGYyZWNhNjdmZTM5MzJkNF8zMjk4NTM0ODgzNzMx_dc99d9c0-18a4-42b4-ad55-d307378bdd4e">61,635,477</ix:nonFraction> shares outstanding as of December&#160;31, 2019</span></div></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjMtMS0xLTEtMA_15219eaf-2266-4b48-885b-73803e701ad5">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjMtMy0xLTEtMA_a38c6ea7-de52-4f04-ac82-30fc7776c180">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additional paid-in capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjQtMS0xLTEtMA_c873a9a9-6a2a-4f4b-bd50-3f76504c23d2">884,677</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjQtMy0xLTEtMA_9f63c109-f074-47ce-8321-213e8b456c26">686,390</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjUtMS0xLTEtMA_83d7e870-b536-4dc0-bd30-1f92586f7a11">512,926</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjUtMy0xLTEtMA_8f5811de-3696-406c-9c1f-03652ff053e3">334,170</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accumulated other comprehensive income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjYtMS0xLTEtMA_74b88758-d202-4e35-9c3e-1974109e188f">342</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjYtMy0xLTEtMA_1aec386d-c761-411b-bb71-923dd285cac4">258</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjctMS0xLTEtMA_ef1dd983-f8ea-4731-a81c-d92e985fe946">372,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjctMy0xLTEtMA_c3e1479b-ae48-42d6-95ae-f4062c25fe54">352,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Total liabilities and stockholders' equity</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjgtMS0xLTEtMA_28735692-2897-43b9-89ce-321de0f5bccb">584,178</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjgtMy0xLTEtMA_9de19def-8980-4f42-b08f-d1bedcc75e90">426,604</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOSSAMER BIO, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations and Comprehensive Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share amounts)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMy0xLTEtMS0w_3de6cc00-d35e-4595-acc5-c3fa0644d3f5">41,846</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMy0zLTEtMS0w_fbc4f168-f4c5-49b6-9e98-0a096dd3272a">40,148</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMy01LTEtMS0w_3fdf7f06-e4b9-4515-abc8-59dd1d0fb2bd">121,944</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMy03LTEtMS0w_df6662dd-ef76-4171-bc75-dfeea996fdd2">100,807</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In process research and development</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-3" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNC0xLTEtMS0w_e34463ad-66e5-4f63-b194-5d00902b55d3">275</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNC0zLTEtMS0w_936aa098-1e03-4f47-b4c3-86a9f7f14769">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNC01LTEtMS0w_551e2c16-a6a2-4b77-b705-0e767f990128">18,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNC03LTEtMS0w_9aea5878-d69a-4c78-bd67-5c916d99b304">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNS0xLTEtMS0w_6938dfbf-a25b-4caf-a7b6-5fff2ad61260">11,448</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNS0zLTEtMS0w_12502475-7fbd-4749-90a9-70e0b2f7898b">9,838</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNS01LTEtMS0w_b7ad0bd4-2563-4430-9248-2e8e2df2cf57">33,851</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNS03LTEtMS0w_ca149d28-2d1c-40f1-83ba-3f63712c32ca">27,544</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNi0xLTEtMS0w_c5147846-df1a-4cc8-af59-a28279ca9769">53,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNi0zLTEtMS0w_737a9c98-f937-4d92-b4fa-04946422972a">49,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNi01LTEtMS0w_cad0c176-e289-4b99-910f-f2c7599cbbcf">173,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNi03LTEtMS0w_6a86f80e-e5c6-468a-b156-2bc0a85cda45">130,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss from operations</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNy0xLTEtMS0w_85874649-0b15-4325-9e8f-86221b9781bb">53,569</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNy0zLTEtMS0w_1d808e20-8097-4490-a3da-7164dee7604e">49,986</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNy01LTEtMS0w_a0ecd173-8ba2-416b-8f59-76d6713a3397">173,875</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNy03LTEtMS0w_e79a2c2a-0f00-43f5-93fc-fc5a619bcce4">130,351</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfOC0xLTEtMS0w_f37d737f-602b-4fa7-b25e-d46623ac5906">4,243</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfOC0zLTEtMS0w_32e4c744-194f-4a72-9445-d09a1db71240">1,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfOC01LTEtMS0w_172660e3-6f15-479e-98b7-a1765e8a260e">4,881</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfOC03LTEtMS0w_ca14e983-6584-4ec1-ac87-f795ffcc52ae">4,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net loss</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfOS0xLTEtMS0w_54565f27-eced-4977-ae27-3b0dd4b98282">57,812</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfOS0zLTEtMS0w_20de74cc-67d9-4df1-ad03-10f419613aed">48,500</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfOS01LTEtMS0w_715549d8-85cc-4f13-a19d-c2603229d106">178,756</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfOS03LTEtMS0w_52b5dda8-0d89-4bad-89ed-c72b52bc71b8">125,609</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency translation, net of tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTEtMS0xLTEtMA_0ea3042d-b13e-4033-a842-5980fd9dbd66">68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTEtMy0xLTEtMA_0263841c-8f11-47a7-8064-867c1209d435">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTEtNS0xLTEtMA_cd6a60f9-3296-46eb-9291-fa7173f777eb">59</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTEtNy0xLTEtMA_dfb12522-59c7-4fd8-96c5-b9a9bb9933e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized gain (loss) on marketable securities, net of tax</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTItMS0xLTEtMA_b0820b47-1dcb-4eed-9737-2d754ebd86b9">293</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTItMy0xLTEtMA_5293d8a1-d150-4f46-86d3-815d7512a2a5">168</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTItNS0xLTEtMA_cfcafc2b-861b-4405-b2d7-5bda1ba39d15">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTItNy0xLTEtMA_04715ab4-c00a-45a4-95bd-a4328b7e4de1">389</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss)</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTMtMS0xLTEtMA_7b280451-9281-4a3f-8d1f-dcc812343220">225</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTMtMy0xLTEtMA_7a6af1c3-07a7-451f-bdda-6fc555c0b31a">168</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTMtNS0xLTEtMA_f106fd45-a65a-43cb-b0a7-61229f2d52bb">84</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTMtNy0xLTEtMA_76a8075a-dbc0-441a-b345-efc1ed5dce2b">389</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comprehensive loss</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTQtMS0xLTEtMA_4b6255af-b9ec-4754-b2f3-65867ec6a706">58,037</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTQtMy0xLTEtMA_28a84bc9-bf87-4146-9752-5ebb0fe23cd7">48,668</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTQtNS0xLTEtMA_e69014d8-3377-4c16-beb1-52850d8e2448">178,672</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTQtNy0xLTEtMA_8bfaa6ee-3b8e-46c4-98ff-eee155d4eae0">125,220</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share, basic and diluted</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTUtMS0xLTEtMA_5970dc42-ffc6-46cd-bfce-15fca4d68029">0.80</ix:nonFraction>)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTUtMy0xLTEtMA_b1d62390-e671-4b8a-be60-ca959e9152ae">0.80</ix:nonFraction>)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTUtNS0xLTEtMA_49a3fd4c-bfd9-4462-8a0e-ecc71616089b">2.67</ix:nonFraction>)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTUtNy0xLTEtMA_8c226af6-55d4-4930-86f8-794cf4b26179">2.39</ix:nonFraction>)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average common shares outstanding, basic and diluted</span></td><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTYtMS0xLTEtMA_a59f171f-130a-49a4-bb4c-8e2d8f125952">72,245,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTYtMy0xLTEtMA_f10f7081-19a0-4220-9591-e378d558c8ac">60,755,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTYtNS0xLTEtMA_d8393ecd-fe4d-4c3b-ad2d-a688984457fc">66,931,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTYtNy0xLTEtMA_a07e04e7-1f47-4472-9dda-ed516d510d04">52,535,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOSSAMER BIO, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders&#8217; Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series Seed</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series B</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">convertible<br/>preferred stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">convertible<br/>preferred stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">convertible<br/>preferred stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Accumulated deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf88702e49f34f05a203c305e7218d7c_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMy0xNC0xLTEtMA_88846c87-8f32-46b3-bd2c-56aa561a9959">61,635,477</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf88702e49f34f05a203c305e7218d7c_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMy0xNi0xLTEtMA_02783be0-f1a2-4e3f-8c4a-15eab3b8669b">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7379eeb81da423f99c7cf5072cffbc2_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMy0xOC0xLTEtMA_d3b4b089-2ed3-4d6d-a60c-e3b40ccfe9aa">686,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie414046cc6c443539a8b1ba823193e96_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMy0yMC0xLTEtMA_35fdb9ad-1aac-4ded-87ce-65c298d5bebe">334,170</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6adcea0a3af47708c4c2ce641288ef5_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMy0yMi0xLTEtMA_f812bc07-d251-4bda-bd0e-e14266119d20">258</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMy0yNC0xLTEtMA_55911209-584c-4ed2-85c8-f5033ecc1ff4">352,485</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Vesting of restricted stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9ca596cd49d2414786bbd3a11c836866_D20200101-20200331" decimals="INF" format="ixt:numdotdecimal" name="goss:StockIssuedDuringPeriodSharesVestingOfRestrictedStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfNC0xNC0xLTEtMA_9885cf87-aeae-46ad-a417-4126525b4386">404,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Exercise of stock options</span></div></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9ca596cd49d2414786bbd3a11c836866_D20200101-20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfNS0xNC0xLTEtMA_e8f5f372-c4c4-4f70-a5c0-a4b97ec0bd95">4,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95b4750602f4fd8bdf1f4408e3bac46_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfNS0xOC0xLTEtMA_253aead1-97a6-453a-84f8-bbd6a6b78f27">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1caa3930a2594a799b9714a362f1b101_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfNS0yNC0xLTEtMA_cb88d393-88a6-49b9-9b91-0899fcab6136">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Stock-based compensation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95b4750602f4fd8bdf1f4408e3bac46_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfNi0xOC0xLTEtMA_d7454711-f8cb-4182-aa43-01958d477a31">8,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9700bbf1ee8c490ead9c97fb9c7d5dc7_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfNi0yMC0xLTEtMA_1a6c2d89-48f1-4ae7-94ed-4bcbffc37621">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1caa3930a2594a799b9714a362f1b101_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfNi0yNC0xLTEtMA_bc54e182-fb22-4d98-adab-8d2f56ef1487">8,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Issuance of common stock pursuant to Employee Stock Purchase Plan</span></div></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9ca596cd49d2414786bbd3a11c836866_D20200101-20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfNy0xNC0xLTEtMA_5771ee19-7ab5-449b-823a-14e159931dbf">49,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95b4750602f4fd8bdf1f4408e3bac46_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfNy0xOC0xLTEtMA_c0af3139-0aca-4914-b8c2-417fe11c6071">556</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1caa3930a2594a799b9714a362f1b101_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfNy0yNC0xLTEtMA_76b21fd1-2bc8-4368-bb2a-bc59c097563a">556</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9700bbf1ee8c490ead9c97fb9c7d5dc7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfOC0yMC0xLTEtMA_d63a4439-caa6-4d86-b8f8-2fce5b6a3df4">54,074</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1caa3930a2594a799b9714a362f1b101_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfOC0yNC0xLTEtMA_0d103331-5234-47a1-b070-cabbac8c29af">54,074</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Other comprehensive loss</span></div></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93af83044802421987749ef31a183d52_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfOS0yMi0xLTEtMA_48a5bd7f-65e6-4f84-8206-622a2cf66b3a">763</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1caa3930a2594a799b9714a362f1b101_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfOS0yNC0xLTEtMA_0466b8e9-3d63-49c2-b20e-9b2944b5b71a">763</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of March 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib7d34d11bc09445287a4c15de915761e_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTAtMTQtMS0xLTA_a94e1fd2-447b-4b6c-9e54-dbff9dd36948">62,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7d34d11bc09445287a4c15de915761e_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTAtMTYtMS0xLTA_b2efca44-a83d-44a7-bfe1-7def7331ad09">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idccd09399cdb4afd946bd554abecc76e_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTAtMTgtMS0xLTA_7c610077-83e3-4ba6-9365-c3a8406f0189">695,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fba8fc0709c48be89520d5a63454847_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTAtMjAtMS0xLTA_30ccf0ec-5d8e-4e76-8ca1-566bd25d82d7">388,244</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3af9d2e206e40adaa4e86d644948813_I20200331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTAtMjItMS0xLTA_9533ed5a-121e-47f0-8232-9747d3100c88">505</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic17e964b37084a94a4881db7645fa317_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTAtMjQtMS0xLTA_16afbef7-0a6f-49e3-9d98-b1c30c6fca25">306,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Issuance of common stock in connection with public offering, net of underwriting discounts, commissions, and offering costs</span></div></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ed5a5578fba4ebc96b685a36facf9c3_D20200401-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTEtMTQtMS0xLTA_1fac073c-a29f-4cba-b6dc-42c1153f344a">9,433,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ed5a5578fba4ebc96b685a36facf9c3_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTEtMTYtMS0xLTA_3da3e5fb-ec81-4144-ae58-02e0eaeca432">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0263dedae046d1bf5c601e9e997bc3_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTEtMTgtMS0xLTA_52c20028-bacc-4cd6-b7b8-b8a071a915e9">117,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i713b4ee54335442fa90cd348ffab165f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTEtMjQtMS0xLTA_3e63515b-1a31-44e4-b85e-17d01965215d">117,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Equity component of convertible note issuance</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0263dedae046d1bf5c601e9e997bc3_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="goss:EquityComponentOfConvertibleNoteIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTItMTgtMS0xLTA_8dff300b-a43a-4c80-92a3-cf7464cb3e76">53,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i713b4ee54335442fa90cd348ffab165f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="goss:EquityComponentOfConvertibleNoteIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTItMjQtMS0xLTA_ac106527-8afc-4af6-b449-93d4c79a1b03">53,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Debt issuance costs attributable to convertible feature</span></div></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0263dedae046d1bf5c601e9e997bc3_D20200401-20200630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTMtMTgtMS0xLTA_9ca72998-be9e-44a0-a05a-b1c7580a50c3">109</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i713b4ee54335442fa90cd348ffab165f_D20200401-20200630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTMtMjQtMS0xLTA_ad65c1b1-d441-448d-b273-c0c42f1845d1">109</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Vesting of restricted stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ed5a5578fba4ebc96b685a36facf9c3_D20200401-20200630" decimals="INF" format="ixt:numdotdecimal" name="goss:StockIssuedDuringPeriodSharesVestingOfRestrictedStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTQtMTQtMS0xLTA_b384431e-5709-4491-9a87-7d629d448cdf">404,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Exercise of stock options</span></div></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ed5a5578fba4ebc96b685a36facf9c3_D20200401-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTUtMTQtMS0xLTA_c97e5ff1-707c-45ab-ae5b-13c236d1f4ce">39,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0263dedae046d1bf5c601e9e997bc3_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTUtMTgtMS0xLTA_44585e5d-3599-40e3-88c1-330c3e16a502">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i713b4ee54335442fa90cd348ffab165f_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTUtMjQtMS0xLTA_30de6af2-165b-4c4d-8d23-3df7a2d830dd">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Stock-based compensation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ed5a5578fba4ebc96b685a36facf9c3_D20200401-20200630" decimals="INF" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTYtMTQtMS0xLTA_e1e4d7b2-eb77-4123-8923-3c4aed25489c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0263dedae046d1bf5c601e9e997bc3_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTYtMTgtMS0xLTA_8eea3b93-392a-4294-bb45-f5da4d680e49">8,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i713b4ee54335442fa90cd348ffab165f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTYtMjQtMS0xLTA_446d7a41-660f-4702-89d9-4a6c266e480c">8,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Net loss</span></div></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06c4796c101b42a492b0b4c35e73bbf4_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTctMjAtMS0xLTA_e617c70d-129b-4b5d-84e6-3497dc3fb0f7">66,870</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i713b4ee54335442fa90cd348ffab165f_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTctMjQtMS0xLTA_3ce0c52a-e0f1-48f2-b272-149aa98f2c42">66,870</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Other comprehensive income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i179e6d0fae8d486f92313c7f72e868be_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTgtMjItMS0xLTA_69b2ea34-5fb7-42ad-849f-c8547384c9b8">1,072</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i713b4ee54335442fa90cd348ffab165f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTgtMjQtMS0xLTA_9adfe33b-5979-4158-996b-66e2d2e4386e">1,072</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of June 30,<br/>2020</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idc2769e3ef10494aaf33bceab6b40d73_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTktMTQtMS0xLTA_03dcc46d-110d-47f5-8365-0acabb230b8a">71,972,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc2769e3ef10494aaf33bceab6b40d73_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTktMTYtMS0xLTA_cf576948-1c53-4581-ab2d-397b1aff2df6">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i480da23e7ba242298f782217cc12a7de_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTktMTgtMS0xLTA_5eab939e-4a25-45f3-8546-342140c1a814">874,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc9220fd857749928edaccab2a419a18_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTktMjAtMS0xLTA_b79cb636-34d5-460c-86e7-e86026388ccf">455,114</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ff593aedcba40a79fd271254329a2e8_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTktMjItMS0xLTA_a2b59bec-88cb-47f5-9c40-0e775e08f9d4">567</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i709889bc20a04f829d4afc37e00775f6_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTktMjQtMS0xLTA_d0d5392c-9977-4ca3-b8a8-929839d06bb9">420,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Vesting of restricted stock</span></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61df284353eb4dd6bd4c5ccba7156006_D20200701-20200930" decimals="INF" format="ixt:numdotdecimal" name="goss:StockIssuedDuringPeriodSharesVestingOfRestrictedStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjAtMTQtMS0xLTEyMzM_e82d1d31-fe1c-436a-bcd2-537094872cbf">404,637</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61df284353eb4dd6bd4c5ccba7156006_D20200701-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjEtMTQtMS0xLTEyMzM_38b12b31-0bd5-43c3-93ab-1d801c9f563a">32,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe555fee6524c44a457250b4e5a4021_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjEtMTgtMS0xLTEyMzM_fb42db71-bc06-486e-a1ea-791b92b91652">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjEtMjQtMS0xLTEyMzM_6caea8cc-0ae2-4270-be95-4df00a057a3e">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Stock-based   compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe555fee6524c44a457250b4e5a4021_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjItMTgtMS0xLTEyMzM_31e9daf3-1ccc-4844-9b36-6c43dbe91957">8,923</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31856bc57f6c47a3bf3f5b8adeeb728f_D20200701-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjItMjAtMS0xLTEyMzM_dc21cf98-d643-444f-9e11-4c4072f54cd2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjItMjQtMS0xLTEyMzM_bc6c3d01-9836-4743-bdbd-233e2733eef0">8,923</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Issuance of common stock pursuant to  Employee Stock Purchase Plan</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61df284353eb4dd6bd4c5ccba7156006_D20200701-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjMtMTQtMS0xLTEyMzM_7801e966-3764-4ada-a278-165d1d86be54">63,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe555fee6524c44a457250b4e5a4021_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjMtMTgtMS0xLTEyMzM_9eadb826-67b4-46a4-aef3-48cafa950c94">744</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjMtMjQtMS0xLTEyMzM_4ac21faa-d89b-4995-9e22-9cf1872cdcea">744</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Other additional paid-in   capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe555fee6524c44a457250b4e5a4021_D20200701-20200930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjQtMTgtMS0xLTEyMzM_5658da05-520f-4a00-88ca-4fd7699515a1">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjQtMjQtMS0xLTEyMzM_7a0eb11c-8cd9-436c-99f1-9ab3d62268c1">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31856bc57f6c47a3bf3f5b8adeeb728f_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjUtMjAtMS0xLTIwNzQ_b5ad6e4b-6963-4f2f-a87d-7d07cea40af9">57,812</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjUtMjQtMS0xLTIwNzQ_b6c57019-c52a-46bf-a921-a6c0e384b569">57,812</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71bc32578df241928d2449da7c53426b_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjUtMjItMS0xLTEyMzM_b6853138-c623-4915-bbc7-067c2ac4ac6a">225</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjUtMjQtMS0xLTEyMzM_835ba298-ef17-475c-baf5-4eaa75f1a3b9">225</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of September 30,<br/>2020</span></td><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d810e89f07c449a83b0758c44d745bf_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjYtMTQtMS0xLTEyMzM_13413b54-befb-4aed-b959-04ff4cd03301">72,472,912</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d810e89f07c449a83b0758c44d745bf_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjYtMTYtMS0xLTEyMzM_ac556179-682c-459f-ba39-c09928c7650a">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78bd0f4aff6f43e499d7ce9e3c5b17bb_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjYtMTgtMS0xLTEyMzM_6a5ce5f1-487a-4345-aa9c-d5af6a6c78d4">884,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i094d4c2753d9481590781ade460fad59_I20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjYtMjAtMS0xLTEyMzM_5eb8568f-eac2-46b4-bdce-4a0aebfc5c28">512,926</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7edc736569724e8b8c6e523b7a87a15c_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjYtMjItMS0xLTEyMzM_298144e5-63c8-464d-864c-34d054ffee25">342</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjYtMjQtMS0xLTEyMzM_7826da9d-130f-4a92-8088-b81aa79c4a07">372,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.704%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series Seed</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Series B</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">convertible<br/>preferred stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">convertible<br/>preferred stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">convertible<br/>preferred stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Accumulated deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Amount </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of December 31, 2018</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie3312a4a7c1f41c7bb6ef94d06af70aa_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy0xLTEtMS0w_dd224f7c-ba99-4857-b7ad-3adba33a533c">20,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3312a4a7c1f41c7bb6ef94d06af70aa_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy0zLTEtMS0w_3f73f210-73e8-4e22-83fb-7630ca74b260">29,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i54d8aec85f094dd690dc3a0c548af271_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy01LTEtMS0w_11c445fa-7de4-4657-a443-a3fd2c23a0a8">45,714,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54d8aec85f094dd690dc3a0c548af271_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy03LTEtMS0w_3eb48fc5-a5a5-4a51-9afa-913877bc2b79">79,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i343a722113ce45f1bf66666c91555acd_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy05LTEtMS0w_30580628-874c-4a90-9d4e-f65ad4d082c9">71,506,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343a722113ce45f1bf66666c91555acd_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy0xMS0xLTEtMA_79b2f1bb-f24e-4de4-8c85-31c970e9840f">229,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i97e4156cb4c140a6a6a93b8df92d43a7_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy0xNC0xLTEtMA_171e976a-a7b0-4933-afe4-bd3ae7516e2d">8,051,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97e4156cb4c140a6a6a93b8df92d43a7_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy0xNi0xLTEtMA_480aa907-72e0-4a5c-b202-3c5f4bb35cdf">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb3c158457d84ea98458e3654e48a62c_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy0xOC0xLTEtMA_2b2d241a-7224-4f52-8edf-b89242cc94a9">33,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb107b5d59dc4b05a8e01ddcc4874d2f_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy0yMC0xLTEtMA_ba9ec170-f18d-4cdb-8cc5-7b2f646b07a5">153,863</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea07989a2b224869843ff82cca663a29_I20181231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy0yMi0xLTEtMA_aaf0f7f4-824a-4105-8e7c-2008b74819e8">61</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b49cacc7d364d80be392cf7b95e4972_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy0yNC0xLTEtMA_8e9291bb-4a37-4ae9-b1d4-21bacb05e23d">120,069</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Issuance of common stock in connection with a public offering, net of underwriting discounts, commissions, and offering costs</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4c1117486726474d966d52141c13b867_D20190101-20190331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNC0xNC0xLTEtMA_4330e180-170f-4ea2-a112-33225d86b218">19,837,500</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c1117486726474d966d52141c13b867_D20190101-20190331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNC0xNi0xLTEtMA_d23b8828-3894-48c5-b009-778634d61ef6">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8d3eefe0054e2c89d598ac1a177a07_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNC0xOC0xLTEtMA_5c9f088e-204d-4a6b-a65b-e6058e79e58f">291,342</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204c4d8a4ae54157a23623329533ce14_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNC0yNC0xLTEtMA_e8f4a028-2421-4973-8d08-e9f1a3954589">291,344</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Conversion of convertible preferred stock into common stock</span></div></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib2b24c51d3c14bf39e027c08084d0df0_D20190101-20190331" decimals="INF" format="ixt:numdotdecimal" name="goss:TemporaryEquitySharesConvertedIntoCommonSharesShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNS0xLTEtMS0w_2dea3829-c181-4a73-a60b-9cf0e294ad3f">20,000,000</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib2b24c51d3c14bf39e027c08084d0df0_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="goss:TemporaryEquitySharesConvertedIntoCommonSharesValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNS0zLTEtMS0w_0bb0c3ff-25b4-44ae-93d7-9b94b1fa89cd">29,200</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i7c6f2d65140a444f9beca064afdc4187_D20190101-20190331" decimals="INF" format="ixt:numdotdecimal" name="goss:TemporaryEquitySharesConvertedIntoCommonSharesShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNS01LTEtMS0w_e970bf90-281f-41ec-88a2-70d02eb156a1">45,714,286</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c6f2d65140a444f9beca064afdc4187_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="goss:TemporaryEquitySharesConvertedIntoCommonSharesValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNS03LTEtMS0w_a8693af6-4d18-40ce-a47f-558fabaf6c2e">79,615</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0c30e6a7eee0456a8b8e9b7b04d7cc10_D20190101-20190331" decimals="INF" format="ixt:numdotdecimal" name="goss:TemporaryEquitySharesConvertedIntoCommonSharesShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNS05LTEtMS0w_48f87826-54cf-4ae3-9806-2d4142a45ecd">71,506,513</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c30e6a7eee0456a8b8e9b7b04d7cc10_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="goss:TemporaryEquitySharesConvertedIntoCommonSharesValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNS0xMS0xLTEtMA_d4ff62f4-e33c-4696-8b9c-00113a341d3a">229,552</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4c1117486726474d966d52141c13b867_D20190101-20190331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNS0xNC0xLTEtMA_ac7e6fb1-4532-4194-80fb-0763399b2cb2">30,493,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c1117486726474d966d52141c13b867_D20190101-20190331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNS0xNi0xLTEtMA_fc565d33-ee74-4ea3-8555-88e6f9cfdc84">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8d3eefe0054e2c89d598ac1a177a07_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNS0xOC0xLTEtMA_a1e6ce51-5079-4559-9140-8d788bcc7f87">338,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204c4d8a4ae54157a23623329533ce14_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNS0yNC0xLTEtMA_ef7da098-941b-4f71-a758-5870fb968c55">338,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Vesting of restricted stock</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4c1117486726474d966d52141c13b867_D20190101-20190331" decimals="INF" format="ixt:numdotdecimal" name="goss:StockIssuedDuringPeriodSharesVestingOfRestrictedStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNi0xNC0xLTEtMA_404849c2-f044-4d93-aebc-0dfa16c022a3">1,619,592</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Stock-based compensation</span></div></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4c1117486726474d966d52141c13b867_D20190101-20190331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNy0xNC0xLTEtMA_faa18720-23a1-4103-97ce-70231b930f64">27,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8d3eefe0054e2c89d598ac1a177a07_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNy0xOC0xLTEtMA_2663ada8-90d2-4a79-9bc0-bb7825383db6">3,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204c4d8a4ae54157a23623329533ce14_D20190101-20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNy0yNC0xLTEtMA_788fe5b9-e3ae-4edf-980d-9b704cfdc785">3,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88d438efdfcf48699af3cb8a4c151884_D20190101-20190331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfOC0yMC0xLTEtMA_d88797cf-07f2-4869-a5d4-3a2b3e49b38f">32,611</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i204c4d8a4ae54157a23623329533ce14_D20190101-20190331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfOC0yNC0xLTEtMA_f889765f-1c6b-4e3f-9879-d3aea6b72c70">32,611</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Other comprehensive income</span></div></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibef492d549a34220b9476308f889a3ad_D20190101-20190331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfOS0yMi0xLTEtMA_b245cc49-37d6-43f5-8f09-fab61cea5e2b">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i204c4d8a4ae54157a23623329533ce14_D20190101-20190331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfOS0yNC0xLTEtMA_e5ee698a-cc20-4a6b-b61f-f1d812bb07ea">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of March 31, 2019</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ca39df98ce8457d8d865eabaaba7f70_I20190331" decimals="INF" format="ixt:zerodash" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtMS0xLTEtMA_a6eb8555-8092-4684-9d18-febd9e22e37b">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ca39df98ce8457d8d865eabaaba7f70_I20190331" decimals="-3" format="ixt:zerodash" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtMy0xLTEtMA_e64aee15-a664-4789-8b95-d8fe63f53fee">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d60975fadce491d9047cc147f13b8af_I20190331" decimals="INF" format="ixt:zerodash" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtNS0xLTEtMA_8bea59bb-b8dd-4d42-9ee9-a9e1d73f846e">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d60975fadce491d9047cc147f13b8af_I20190331" decimals="-3" format="ixt:zerodash" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtNy0xLTEtMA_d7cc730d-7657-4950-bc67-f6dd87e1494c">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a1343a170f74a2b85887cc27f953407_I20190331" decimals="INF" format="ixt:zerodash" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtOS0xLTEtMA_ec6225ae-c6a4-4a2f-9330-fc724bf40e66">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a1343a170f74a2b85887cc27f953407_I20190331" decimals="-3" format="ixt:zerodash" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtMTEtMS0xLTA_29cea77e-46f9-489a-a11f-a3c72df8cdca">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa5a9b278e164c2da9b072055d0bc7c3_I20190331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtMTQtMS0xLTA_39992259-ab7b-4ee9-9b43-a0972297c1fd">60,029,470</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa5a9b278e164c2da9b072055d0bc7c3_I20190331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtMTYtMS0xLTA_196d76a0-4cab-4a30-a2a9-8af07d4a9dbb">7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i601fef938815423388ebc7b90b509f2c_I20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtMTgtMS0xLTA_ee74510f-1475-4050-bbea-904e72ca97da">666,648</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if74dcc4469a54a8c98af2792cc68e327_I20190331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtMjAtMS0xLTA_6724db7a-5945-4ca6-ac6a-d633a8218ee1">186,474</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e47c631459c4f0aa8359cd24d601d03_I20190331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtMjItMS0xLTA_3aa50aa9-ee75-4180-becf-a08bf51f39c5">79</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4b5355aba354232bb2a9f7d614c0e15_I20190331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtMjQtMS0xLTA_6b05bab2-4d52-4ac7-b1bb-a55742fee04f">480,260</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Vesting of restricted stock</span></div></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7f9261b47f7c4dedb3e011d185c7d383_D20190401-20190630" decimals="INF" format="ixt:numdotdecimal" name="goss:StockIssuedDuringPeriodSharesVestingOfRestrictedStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTEtMTQtMS0xLTA_049d4dd2-bc46-4095-83c4-e702c941625b">404,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Exercise of stock options</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7f9261b47f7c4dedb3e011d185c7d383_D20190401-20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTItMTQtMS0xLTA_98238bb5-90c6-4b31-8adb-c46cde3f5f21">33,273</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51ad8abfdf85411b98659ee7f825d361_D20190401-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTItMTgtMS0xLTA_76d7d4f6-21fd-4a4b-ae86-29a503153730">86</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7688ecc551594d43b36f111047a7deb4_D20190401-20190630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTItMjQtMS0xLTA_177bc8a3-42e2-4f4c-a6ad-c27804271142">86</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Stock-based compensation</span></div></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51ad8abfdf85411b98659ee7f825d361_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTMtMTgtMS0xLTA_07447b03-960d-4f4c-a189-7a393f73b520">5,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7688ecc551594d43b36f111047a7deb4_D20190401-20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTMtMjQtMS0xLTA_d6b61bcd-0b16-45e9-bf9f-fcabb0656d48">5,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Other additional paid-in capital</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51ad8abfdf85411b98659ee7f825d361_D20190401-20190630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTQtMTgtMS0xLTA_04520a3f-1341-4d24-8bda-42891dc480ce">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7688ecc551594d43b36f111047a7deb4_D20190401-20190630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTQtMjQtMS0xLTA_5bb7fec0-a610-4404-be05-e57a4d61328b">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3cc915869004ddaaa6c21c954b57896_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTUtMjAtMS0xLTA_0a2e3a98-4f01-495c-a804-bb649e64715c">44,498</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7688ecc551594d43b36f111047a7deb4_D20190401-20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTUtMjQtMS0xLTA_48c064b1-ba95-4633-a507-b3d47fc550cc">44,498</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Other comprehensive income</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b9f0d0a440e443ab0d19184e46dc5b1_D20190401-20190630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTYtMjItMS0xLTA_a57c33d4-1730-4ceb-9102-2f9bb6fdbd69">417</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7688ecc551594d43b36f111047a7deb4_D20190401-20190630" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTYtMjQtMS0xLTA_ac4a4151-f786-4495-8981-e8b0d3ad0df8">417</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of June 30,<br/>2019</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i402b84a37c734fd2ada2568ef7353e2b_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTctMTQtMS0xLTA_075c7366-1d17-489d-b37c-d3ca222529a3">60,467,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i402b84a37c734fd2ada2568ef7353e2b_I20190630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTctMTYtMS0xLTA_fd9f987f-8b19-4ea2-8056-c30462e51ff5">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41d5abe0dfd841d695c962b1f348472c_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTctMTgtMS0xLTA_116084e7-1c58-449e-8481-7a8fbee16bca">671,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c1183f5df444d8a9dbef8a80208eb1d_I20190630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTctMjAtMS0xLTA_1848e57d-7622-45bf-88a6-93383acde905">230,972</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3deb511ea20347b989c9a3668500baf2_I20190630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTctMjItMS0xLTA_206a6314-e045-438c-ba51-b49f2ad6b845">496</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04d13b8492374901b4f4bf2ad46601c5_I20190630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTctMjQtMS0xLTA_6dabddc1-c709-485a-a291-feb44313f8dd">441,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Vesting of restricted<br/>stock</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibac864d50598406f8c85d4bdd4a64b15_D20190701-20190930" decimals="INF" format="ixt:numdotdecimal" name="goss:StockIssuedDuringPeriodSharesVestingOfRestrictedStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTgtMTQtMS0xLTEzMDI_bd99d372-9065-48cd-a913-afe6f07816a0">404,639</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibac864d50598406f8c85d4bdd4a64b15_D20190701-20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTktMTQtMS0xLTEzMDI_fd9e3234-4557-4d38-b82d-382ac59663d6">112,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e10c5e62242441296917276fcd983f2_D20190701-20190930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTktMTgtMS0xLTEzMDI_d19ade69-b20f-48ea-b066-6e6d20031fac">369</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTktMjQtMS0xLTEzMDI_64c17183-fd1f-4e6d-95ad-7795733cf00e">369</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Stock-based  compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e10c5e62242441296917276fcd983f2_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjAtMTgtMS0xLTEzMDI_aa8a9a7c-a59f-46b5-ad5c-fd5c644e383c">5,728</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjAtMjQtMS0xLTEzMDI_050f69e5-2628-4d57-903b-d30bdce88795">5,728</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76a2221bc96b477d9033dce08a133c47_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjEtMjAtMS0xLTEzMDI_96a3cea1-ebbf-4b7a-a8b9-6708a38376e3">48,500</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjEtMjQtMS0xLTEzMDI_a4407db2-e10b-429d-b3b9-a8bef445fa7d">48,500</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 9pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3eb22709373e449784bf6abde9e5ef9d_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjItMjItMS0xLTEzMDI_5aed6d9e-6dcd-4cf0-a32f-a3922ec098c5">168</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjItMjQtMS0xLTEzMDI_3a39fc05-712d-4e7d-99ae-d1734c68b597">168</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Balance as of September 30,<br/>2019</span></td><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id84abe36ab124aee9361fd90972e72a9_I20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjMtMTQtMS0xLTEzMDI_9d553154-008e-48d4-85af-f85afb7a4952">60,984,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id84abe36ab124aee9361fd90972e72a9_I20190930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjMtMTYtMS0xLTEzMDI_6775f3b2-85a9-4be4-9d27-3f174e023869">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d31ff554106438ca11cdde65438f9f1_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjMtMTgtMS0xLTEzMDI_b6de1911-64d8-41e3-ae43-365f1959983a">678,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a97f2ca2b0143f8bf6974c1fc94e461_I20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjMtMjAtMS0xLTEzMDI_63829c30-872f-4702-97e0-1bba92d287ad">279,472</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie52349d1207b400e8a20c808e6df36aa_I20190930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjMtMjItMS0xLTEzMDI_e717d185-f802-45b7-9479-27fd3405bc34">328</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4575faeae2514742ab2eedb009712d84_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjMtMjQtMS0xLTEzMDI_934ffefe-7225-4c8b-9ee0-8f20187e3726">398,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOSSAMER BIO, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMy0xLTEtMS0w_496e22b3-e101-4e2a-b092-1b7ec3a64a2c">178,756</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMy0zLTEtMS0w_931b581d-b18e-4a45-8d05-a7faf3fe4141">125,609</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNS0xLTEtMS0w_5ef44bde-778d-424b-9887-19b327afe3ac">1,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNS0zLTEtMS0w_1ecbf891-8c0a-4fb5-9243-36c890876d69">625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNi0xLTEtMS0w_0714abe2-2d34-4b0f-b8fd-1e147fb58e63">26,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNi0zLTEtMS0w_6f19a247-c40d-444f-855c-f1f21f17372b">13,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">In process research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="goss:InProcessResearchAndDevelopmentExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNy0xLTEtMS0w_700ca347-fdb9-4700-afe0-3ed9d876cac4">18,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="goss:InProcessResearchAndDevelopmentExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNy0zLTEtMS0w_ab7fc30a-7865-4ca6-afc0-12be95efe362">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amortization of operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="goss:AmortizationOfOperatingLeaseRightOfUseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfOC0xLTEtMS0w_b574296f-9dba-4e53-ad5a-89a41f25b798">2,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="goss:AmortizationOfOperatingLeaseRightOfUseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfOC0zLTEtMS0w_92fc0edc-5fb9-437e-8fb3-cc05f58f51a6">1,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amortization of debt discount and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfOS0xLTEtMS0w_f0f62cb4-809c-4163-9419-09888f877aad">2,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfOS0zLTEtMS0w_b2565b27-b2a7-4550-ad99-1e58a955ee63">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amortization of premium on investments, net of accretion of discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTAtMS0xLTEtMA_04772627-01d5-4b16-bfdd-2b75d057ca7c">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTAtMy0xLTEtMA_61c37e4a-b7db-43c0-bac0-b68d695b677d">2,296</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net realized gain on investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" name="us-gaap:RealizedInvestmentGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTEtMS0xLTEtMA_6d5ca413-4d4d-41a5-bdd3-b3134748c8f2">256</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" name="us-gaap:RealizedInvestmentGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTEtMy0xLTEtMA_ad6da169-e798-4476-8e54-9c42b48e56f5">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTMtMS0xLTEtMA_147e216e-8f04-4774-b8a7-342f00b3c8bc">3,340</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTMtMy0xLTEtMA_d6538b41-f2aa-436a-8524-252e2464f59a">2,807</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTQtMS0xLTEtMA_ee5de171-9196-41aa-bd80-41d824bde618">698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTQtMy0xLTEtMA_6355ec59-b22c-4525-9e78-3c990632d7a5">2,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="goss:IncreaseDecreaseInOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTUtMS0xLTEtMA_83560ae5-0e89-4b13-adc8-6531ff4bf79b">1,294</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="goss:IncreaseDecreaseInOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTUtMy0xLTEtMA_efab1623-7d5d-43e1-a300-916695f825d9">1,566</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTYtMS0xLTEtMA_86554b51-3bb8-4cec-a52b-c0393998c4a3">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTYtMy0xLTEtMA_632f557f-febe-4a6e-a4f3-ac38bdedbb4b">333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTctMS0xLTEtMA_2bd877e9-ff94-4869-b8bd-ec3261a70f3f">2,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTctMy0xLTEtMA_a1925df5-44d2-4cda-8b2e-8aac0f746143">760</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accrued research and development expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="goss:IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTgtMS0xLTEtMA_4f35470d-6e9f-4390-bd8b-1bd0d6f8c818">7,019</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="goss:IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTgtMy0xLTEtMA_99b15265-59cc-4c70-b35b-ba2dc40bb780">8,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTktMS0xLTEtMA_4454c4e5-a2e2-4d50-8a57-9ee1b5923c0f">1,959</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTktMy0xLTEtMA_1a48cce9-7d08-4a0f-9b8f-c49748fe0a65">2,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjAtMS0xLTEtMA_13ae6101-b63e-410f-960e-c31e77a05283">139,624</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjAtMy0xLTEtMA_42507090-c5cd-40fa-a187-b3053e0ce498">100,694</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Research and development asset acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="goss:PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjItMS0xLTEtMA_a611b42b-48cd-45b9-b82b-0aef5da079fd">18,080</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="goss:PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjItMy0xLTEtMA_0e2e459a-5382-4ba4-bfc2-744729780046">2,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Purchase of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjMtMS0xLTEtMA_67df4da8-14e4-45bf-97ec-ab2bfd37cacb">108,969</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjMtMy0xLTEtMA_fe9c4dcb-00a3-46f2-9453-c98020fc4aad">399,393</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Maturities of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="goss:ProceedsFromMaturityOfMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjQtMS0xLTEtMA_910cc16d-1243-47f3-bfbd-0e3f4164a814">199,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="goss:ProceedsFromMaturityOfMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjQtMy0xLTEtMA_b458d58c-7442-472b-8938-4e1f77fb3db2">205,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Sales of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="goss:ProceedsFromSaleOfMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjUtMS0xLTEtMA_1aba67b5-556a-4c3b-b680-56b3c549ff20">83,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="goss:ProceedsFromSaleOfMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjUtMy0xLTEtMA_f2a62b79-bd90-4a2a-8d95-74c1c177e341">4,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjYtMS0xLTEtMA_40e1dcf3-2143-4df4-b0fd-fa3cd181e40c">1,253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjYtMy0xLTEtMA_23c60bee-ba31-40b0-809f-bd084d8ca470">2,438</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjctMS0xLTEtMA_c39d0490-e771-450c-8277-b287cc377361">154,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjctMy0xLTEtMA_f44102ea-0b06-4c26-9f70-d84a55dffd5e">194,077</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proceeds from issuance of common stock in a public offering, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjktMS0xLTEtMA_39d0a0a1-0af5-44b7-bcf4-042bdb9b0b4f">117,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjktMy0xLTEtMA_c5e73682-f75b-4285-8612-df49b8e17808">291,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proceeds from issuance of convertible debt, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzAtMS0xLTEtMA_9a566b5f-7b5d-4d56-8bc2-003d4c915fa9">193,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzAtMy0xLTEtMA_4a75df31-1d7c-4be8-a52a-880057c48798">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proceeds from the issuance of long-term debt, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzEtMC0xLTEtMTc5L3RleHRyZWdpb246N2EzNjc0NWUwMjI2NDFkYmFmZjUxMDQwMmNlZGEyOTZfMzI5ODUzNDg4MzQxOA_e4329337-ab33-4c37-aa68-377a9f345ccd">1,778</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzEtMS0xLTEtMA_d77697e0-a4ff-4d7f-a525-3d5b394748ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzEtMy0xLTEtMA_23e5adfc-6c38-421d-932a-6a8ea8798f66">28,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Purchase of shares pursuant to Employee Stock Purchase Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icf9016d9d3c54fdcbd742124c1e00da3_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzItMS0xLTEtMA_a8ee77e2-b564-4b27-a013-3c3fe75130a6">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iedadf32f302e470ca02b51105b2ffa9e_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzItMy0xLTEtMA_a2f80365-a25d-42c4-89cd-f10221b8ab14">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 36pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proceeds from the exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzMtMS0xLTEtMA_36ad716a-f373-4289-9ee3-7a2405e1597e">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzMtMy0xLTEtMA_bfb4a988-c075-47ca-afd1-4a6056a0301a">527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzQtMS0xLTEtMA_d7c91979-506e-4b43-b304-ed3bd2dc734d">312,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzQtMy0xLTEtMA_9643a941-8317-46ed-b384-a295987e5f9c">320,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzUtMS0xLTEtMA_1f59aabb-2db7-43aa-aa59-797a74195ac9">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzUtMy0xLTEtMA_867817e8-b2a3-454e-9c3e-b28c6b58c5bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzYtMS0xLTEtMA_9ed26e77-9384-4f1b-90cb-329b4a59d65f">326,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzYtMy0xLTEtMA_5ee635b7-6032-4f02-9611-73c55cd3a1a9">25,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash and cash equivalents, at the beginning of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzctMS0xLTEtMA_a6452310-c7b6-478a-820c-bade75f29962">135,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3b49cacc7d364d80be392cf7b95e4972_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzctMy0xLTEtMA_7a8e2af4-a9b0-4855-8db4-9a3696f051d3">105,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cash and cash equivalents, at the end of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzgtMS0xLTEtMA_3619fcbc-be1a-4333-9857-717b42ba201a">461,956</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4575faeae2514742ab2eedb009712d84_I20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzgtMy0xLTEtMA_56eefad9-765f-4ce6-bb48-8e05d3a70ea9">130,708</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash paid for interest</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNDEtMS0xLTEtMA_211b9a52-0ab3-45b6-b2f7-2f388164716e">1,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNDEtMy0xLTEtMA_6689b76d-33e4-4f7f-8725-0f77840ffd45">854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Supplemental disclosure of noncash investing and financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Right-of-use assets obtained in exchange for lease liabilities</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="goss:RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNDQtMS0xLTEtMA_3d6b1bc4-edda-4dcd-b926-784a31f126fa">3,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="goss:RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNDQtMy0xLTEtMA_8eb68112-fb43-4b3e-928f-a6f2a027f977">12,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Change in unrealized gain on marketable securities, net of tax</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" name="goss:NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNDUtMS0xLTEtMA_64fb25aa-3b9c-4b00-9a15-7890dccaef92">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" name="goss:NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNDUtMy0xLTEtMA_f99d28e7-29a7-4f38-a6cc-8efffbdcfa4d">510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unpaid property and equipment</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNDYtMS0xLTEtMA_16575c1a-b6c0-49ac-ab1c-7df79692c184">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNDYtMy0xLTEtMA_1a57b58a-95e0-446c-961e-6cc2511273a7">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Conversion of convertible preferred stock to common stock</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="goss:NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNDctMS0xLTEtMA_28df855e-226f-46c4-8bf4-7e24914c1b3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="goss:NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNDctMy0xLTEtMA_1bbd6956-e1be-4fd9-a1f6-7f427cf5bc34">338,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOSSAMER BIO, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Condensed Consolidated Financial Statements</span></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_37"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8zNy9mcmFnOjE2ZmIzNGVjY2U5NjQ3ZGM4MTg4YTUwNGZiMmI3ODYzL3RleHRyZWdpb246MTZmYjM0ZWNjZTk2NDdkYzgxODhhNTA0ZmIyYjc4NjNfMTA5OTUxMTYzMjM0Mw_b5795836-9028-4bba-ac53-b959bea79478" continuedAt="i6d2355177f9f475f8620a96c019ae3d3" escape="true">Description of the Business</ix:nonNumeric></span></div><ix:continuation id="i6d2355177f9f475f8620a96c019ae3d3"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gossamer Bio, Inc. (including its subsidiaries, referred to as &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221;, or the &#8220;Company&#8221;) is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. The Company was incorporated in the state of Delaware on October&#160;25, 2015 (originally as FSG Bio, Inc.) and is based in San Diego, California.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of Gossamer Bio, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions among the consolidated entity have been eliminated in consolidation.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Initial Public Offering in February 2019</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 12, 2019, the Company completed its initial public offering (&#8220;IPO&#8221;) with the sale of <ix:nonFraction unitRef="shares" contextRef="ia37b4eed12f64ea0ad441fc0ad1e503d_D20190212-20190212" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8zNy9mcmFnOjE2ZmIzNGVjY2U5NjQ3ZGM4MTg4YTUwNGZiMmI3ODYzL3RleHRyZWdpb246MTZmYjM0ZWNjZTk2NDdkYzgxODhhNTA0ZmIyYjc4NjNfODQ0_eaab2579-ce09-4fa7-86f2-277ebd46cefb">19,837,500</ix:nonFraction> shares of common stock, including shares of common stock issued upon the exercise in full of the underwriters&#8217; option to purchase additional shares, at a public offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i72382ce16b8b49b292e97c0ef7b75dd3_I20190212" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8zNy9mcmFnOjE2ZmIzNGVjY2U5NjQ3ZGM4MTg4YTUwNGZiMmI3ODYzL3RleHRyZWdpb246MTZmYjM0ZWNjZTk2NDdkYzgxODhhNTA0ZmIyYjc4NjNfMTAyNg_c1a96169-81ab-4099-ac88-132546ba0e5d">16.00</ix:nonFraction> per share, resulting in net proceeds of $<ix:nonFraction unitRef="usd" contextRef="ia37b4eed12f64ea0ad441fc0ad1e503d_D20190212-20190212" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8zNy9mcmFnOjE2ZmIzNGVjY2U5NjQ3ZGM4MTg4YTUwNGZiMmI3ODYzL3RleHRyZWdpb246MTZmYjM0ZWNjZTk2NDdkYzgxODhhNTA0ZmIyYjc4NjNfMTA2OQ_89f74412-e896-417e-b9b0-dcdcb323a4ef">291.3</ix:nonFraction> million, after deducting underwriting discounts, commissions, and offering expenses.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in connection with the completion of the IPO, all of the Company&#8217;s outstanding shares of convertible preferred stock were automatically converted into <ix:nonFraction unitRef="shares" contextRef="i47525e97b2e2423db6a765678a6c4fec_D20190212-20190212" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ConversionOfStockSharesIssued1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8zNy9mcmFnOjE2ZmIzNGVjY2U5NjQ3ZGM4MTg4YTUwNGZiMmI3ODYzL3RleHRyZWdpb246MTZmYjM0ZWNjZTk2NDdkYzgxODhhNTA0ZmIyYjc4NjNfMTMxMw_b011d13a-3098-4fdf-aba3-2cd26f9600cf">30,493,460</ix:nonFraction> shares of common stock.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has incurred significant operating losses since its inception. As of September&#160;30, 2020, the Company had an accumulated deficit of  $<ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8zNy9mcmFnOjE2ZmIzNGVjY2U5NjQ3ZGM4MTg4YTUwNGZiMmI3ODYzL3RleHRyZWdpb246MTZmYjM0ZWNjZTk2NDdkYzgxODhhNTA0ZmIyYjc4NjNfMTUwMA_6a1e0401-7f7b-45ce-b20f-e25729de0394">512.9</ix:nonFraction> million. From the Company&#8217;s inception through September&#160;30, 2020, the Company has funded its operations primarily through equity and debt financings. The Company raised $<ix:nonFraction unitRef="usd" contextRef="i9eebf838097e49fa93a3a4ab394c7e68_D20171001-20200930" decimals="-5" format="ixt:numdotdecimal" name="goss:FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8zNy9mcmFnOjE2ZmIzNGVjY2U5NjQ3ZGM4MTg4YTUwNGZiMmI3ODYzL3RleHRyZWdpb246MTZmYjM0ZWNjZTk2NDdkYzgxODhhNTA0ZmIyYjc4NjNfMTcxOQ_39cb4779-e05c-491d-84bc-72c6a14d5000">942.0</ix:nonFraction> million from October 2017 through September&#160;30, 2020 through Series A and Series B convertible preferred stock financings, a convertible note financing, its IPO, its Credit Facility (as defined in Note 5 below), and concurrent underwritten public offerings of its <ix:nonFraction unitRef="number" contextRef="i1fed2bfc69594ec7a6dbcd619a5e2bef_I20200930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8zNy9mcmFnOjE2ZmIzNGVjY2U5NjQ3ZGM4MTg4YTUwNGZiMmI3ODYzL3RleHRyZWdpb246MTZmYjM0ZWNjZTk2NDdkYzgxODhhNTA0ZmIyYjc4NjNfMTk2Mg_4169c611-3c99-4574-81f4-e99e58f9bce9">5.00</ix:nonFraction>% convertible senior notes due 2027 (the &#8220;2027 Notes&#8221;) and common stock in May 2020. See Note 5 for additional information regarding the Credit Facility and the 2027 Notes. In addition, the Company received $<ix:nonFraction unitRef="usd" contextRef="i5780f8c4c24046a9b2f18bb81e280495_D20180104-20180104" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8zNy9mcmFnOjE2ZmIzNGVjY2U5NjQ3ZGM4MTg4YTUwNGZiMmI3ODYzL3RleHRyZWdpb246MTZmYjM0ZWNjZTk2NDdkYzgxODhhNTA0ZmIyYjc4NjNfMjE3MA_3529a8ad-055c-4fc2-919c-6a6f187afee3">12.8</ix:nonFraction> million in cash in connection with the January 2018 acquisition of AA Biopharma Inc.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects to continue to incur significant operating losses for the foreseeable future and may never become profitable. As a result, the Company will need to raise capital through equity offerings, debt financings and other capital sources, including potential collaborations, licenses and other similar arrangements. Management believes that it has sufficient working capital on hand to fund operations through at least the next twelve months from the date these condensed consolidated financial statements were available to be issued. There can be no assurance that the Company will be successful in acquiring additional funding, that the Company&#8217;s projections of its future working capital needs will prove accurate, or that any additional funding would be sufficient to continue operations in future years.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has caused significant business disruption around the globe. The extent of the impact of COVID-19 on the Company&#8217;s operational and financial performance will depend on certain developments, including the duration and spread of the pandemic and the impact on the Company&#8217;s clinical trials, employees and vendors. At this point, the degree to which COVID-19 may impact the Company&#8217;s financial condition or results of operations is uncertain.&#160;&#160;A prolonged pandemic could have a material and adverse impact on financial results and business operations of the Company, including the timing and ability of the Company to complete certain clinical trials and other efforts required to advance the development of its product candidates and raise additional capital. For example, the Company commenced enrolling patients for a Phase 1b clinical trial in pulmonary arterial hypertension ("PAH") in the first quarter of 2020, and because the Company temporarily paused enrollment as a result of the ongoing COVID-19 viral pandemic, the Company now expects to report topline results from this trial in the fourth quarter of 2020. In addition, due to the challenges of enrolling patients posed by the COVID-19 pandemic, the Company may experience delays in the commencement of its Phase 2 clinical trial of GB002 in PAH and enrollment of patients in its Phase 2 clinical trials of GB004 in ulcerative colitis and of GB002 in PAH, as well as delays in reporting data results from its ongoing trials.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_40"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RleHRyZWdpb246NWMyMTcxYTdlZDg2NDYzNDkzZDY4MzAxZTMwMWVhYzhfMTA5OTUxMTYzMzc1Mg_b03ac649-3990-4f4c-8d60-b46a85d36706" continuedAt="icd405be3aa074e80a1c32ca21d2d6d64" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="icd405be3aa074e80a1c32ca21d2d6d64" continuedAt="i8d9f1d6e2f054fdcae068fb3257bce3f"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RleHRyZWdpb246NWMyMTcxYTdlZDg2NDYzNDkzZDY4MzAxZTMwMWVhYzhfNTk3MQ_6199c054-1026-4f0b-a3be-ca450a6cbe1d" continuedAt="i6233ebd5f5974e3cb68bd2bd0414389d" escape="true">Basis of Presentation</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6233ebd5f5974e3cb68bd2bd0414389d">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) for interim financial information and with the instructions of the Securities and Exchange Commission (&#8220;SEC&#8221;) on Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, the condensed consolidated financial statements include all adjustments necessary, which are of a normal and recurring nature, for the fair presentation of the Company&#8217;s financial position and of the results of operations and cash flows for the periods presented. These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December&#160;31, 2019 included in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March 24, 2020. The results of operations for the interim period shown in this report are not necessarily indicative of the results that may be expected for any other interim period or for the full year. The balance sheet at December&#160;31, 2019, has been derived from the audited financial statements at that date.</ix:continuation> </span></div><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RleHRyZWdpb246NWMyMTcxYTdlZDg2NDYzNDkzZDY4MzAxZTMwMWVhYzhfNTk3Mg_fce560f3-5e75-41d4-a907-719e4f91acc7" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting period. The most significant estimates in the Company&#8217;s condensed consolidated financial statements relate to the allocation of the 2027 Notes into liability and equity components, accrued research and development expenses, the valuation of preferred and common stock, the valuation of stock options and the valuation allowance of deferred tax assets resulting from net operating losses. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results could differ from those estimates.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="goss:ConvertibleSeniorNotesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RleHRyZWdpb246NWMyMTcxYTdlZDg2NDYzNDkzZDY4MzAxZTMwMWVhYzhfNTk3Mw_d5ead1a7-35ae-452f-b20f-54392957524a" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accounting for the issuance of the 2027 Notes, the Company separated the 2027 Notes into liability and equity components. The carrying amount of the liability component was calculated by measuring the fair value of similar debt instruments that do not have associated convertible features. The carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the par value of the 2027 Notes. The equity component is not remeasured as long as it continues to meet the condition for equity classification. The excess of the principal amount of the liability component over its carrying amount (&#8220;debt discount&#8221;) is amortized to interest expense over the term of the 2027 Notes.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocated the issuance costs incurred to the liability and equity components of the 2027 Notes based on their relative fair values. Issuance costs attributable to the liability component were recorded as a reduction to the liability portion of the 2027 Notes and are being amortized to interest expense over the term of the 2027 Notes. Issuance costs attributable to the equity component, representing the conversion option, were netted with the equity component in stockholders' equity.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RleHRyZWdpb246NWMyMTcxYTdlZDg2NDYzNDkzZDY4MzAxZTMwMWVhYzhfNTk3NA_8c5dc1e4-b7be-48c0-8a2f-cf9708874d8a" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, Financial Instruments-Credit Losses: Measurement of Credit Losses on Financial Instruments (&#8220;ASU 2016-13&#8221;), which changes the impairment model for most financial assets and certain other instruments. For trade receivables and other instruments, entities will be required to use a new forward-looking expected loss model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. This guidance is effective for annual reporting periods beginning after December 15, 2019, including interim periods within those years, with early adoption permitted only as of annual reporting periods beginning after December 15, 2018. The Company adopted ASU 2016-13 as of January 1, 2020. The adoption of this standard did not have a material impact on the Company&#8217;s condensed consolidated financial statements or related financial statement disclosures.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><ix:continuation id="i8d9f1d6e2f054fdcae068fb3257bce3f"><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RleHRyZWdpb246NWMyMTcxYTdlZDg2NDYzNDkzZDY4MzAxZTMwMWVhYzhfNTk3NQ_c9e8c001-b329-49e9-b660-6a5bac9cb3fa" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss Per Share</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period. The Company uses the if-converted method for assumed conversion of the 2027 Notes to compute the weighted average shares of common stock outstanding for diluted net loss per share. Diluted net loss per share excludes the potential impact of the Company&#8217;s common stock options and unvested shares of restricted stock and the potential shares issuable upon conversion of the 2027 Notes because their effect would be anti-dilutive due to the Company&#8217;s net loss. Since the Company had a net loss in each of the periods presented, basic and diluted net loss per common share are the same.</span></div><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RleHRyZWdpb246NWMyMTcxYTdlZDg2NDYzNDkzZDY4MzAxZTMwMWVhYzhfNTk2OQ_04ad465b-97b3-46a5-8008-fffdd75b2f2d" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib505254a0d25402398cd90e47386b544_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RhYmxlOjExOGVjNzE2N2Y4ZTRkNGI4OGZhODU1MzE0NWNlMDQ0L3RhYmxlcmFuZ2U6MTE4ZWM3MTY3ZjhlNGQ0Yjg4ZmE4NTUzMTQ1Y2UwNDRfMi0xLTEtMS0w_3d1f65ab-872c-4942-880c-63c116a00a79">12,321,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i16119fa6447641b4b0438be989f83724_D20190101-20190930" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RhYmxlOjExOGVjNzE2N2Y4ZTRkNGI4OGZhODU1MzE0NWNlMDQ0L3RhYmxlcmFuZ2U6MTE4ZWM3MTY3ZjhlNGQ0Yjg4ZmE4NTUzMTQ1Y2UwNDRfMi0zLTEtMS0w_f0527ea8-df1b-43d5-9235-c17363e03692">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85914c244cbc465a8537031c3daf6f1e_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RhYmxlOjExOGVjNzE2N2Y4ZTRkNGI4OGZhODU1MzE0NWNlMDQ0L3RhYmxlcmFuZ2U6MTE4ZWM3MTY3ZjhlNGQ0Yjg4ZmE4NTUzMTQ1Y2UwNDRfMy0xLTEtMS0w_66a1bd1c-8db5-4675-8da3-64eb862cedb9">10,266,895</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5d717c27684b4376bc058963cf8edc06_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RhYmxlOjExOGVjNzE2N2Y4ZTRkNGI4OGZhODU1MzE0NWNlMDQ0L3RhYmxlcmFuZ2U6MTE4ZWM3MTY3ZjhlNGQ0Yjg4ZmE4NTUzMTQ1Y2UwNDRfMy0zLTEtMS0w_a693ec1e-9d22-463d-8055-06780e45a88c">8,099,861</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested shares under restricted stock grants</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i628ea545993847d1a0da78338212f66f_D20200101-20200930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RhYmxlOjExOGVjNzE2N2Y4ZTRkNGI4OGZhODU1MzE0NWNlMDQ0L3RhYmxlcmFuZ2U6MTE4ZWM3MTY3ZjhlNGQ0Yjg4ZmE4NTUzMTQ1Y2UwNDRfNC0xLTEtMS0w_012e73d9-28a6-46f6-9b55-386767987477">4,530,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65156772da894ffc943654c22ccecde9_D20190101-20190930" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RhYmxlOjExOGVjNzE2N2Y4ZTRkNGI4OGZhODU1MzE0NWNlMDQ0L3RhYmxlcmFuZ2U6MTE4ZWM3MTY3ZjhlNGQ0Yjg4ZmE4NTUzMTQ1Y2UwNDRfNC0zLTEtMS0w_681a1aee-9d65-4b2f-b939-802ea4be909e">5,053,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_43"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RleHRyZWdpb246MjEwYjZlNDVmNmVlNGVhOTk5MjYxODU5ZTBiYWU2OWFfMTA5OTUxMTYyODA3NQ_b54010aa-00b4-4dbd-8034-f1f26e287cfb" continuedAt="ie856e0f9951e4c0b9d411efe4d42e616" escape="true">Balance Sheet Accounts and Supplemental Disclosures</ix:nonNumeric></span></div><ix:continuation id="ie856e0f9951e4c0b9d411efe4d42e616"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RleHRyZWdpb246MjEwYjZlNDVmNmVlNGVhOTk5MjYxODU5ZTBiYWU2OWFfMjk4_e1e336dc-47a6-4930-802b-a6da4e7ac578" escape="true"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Useful Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1e067eee87aa40508462e122f6750be3_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfMS0xLTEtMS04NzEvdGV4dHJlZ2lvbjphMDJkMGU3NDM2OGI0MzNmYWEyNTQxOWMzNDQzNTYzNF8zMjk4NTM0ODgzMzM2_0b43415c-6e4f-4d94-81a9-77a8008fde51">3</ix:nonNumeric>-<ix:nonNumeric contextRef="i4a55d6d56691410aa331d57da9a540d1_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfMS0xLTEtMS04NzEvdGV4dHJlZ2lvbjphMDJkMGU3NDM2OGI0MzNmYWEyNTQxOWMzNDQzNTYzNF8zMjk4NTM0ODgzMzM5_835611fe-5e6c-4e45-9852-d9be7cf246c3">7</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8bca8bf3b2f456db5ae73401c2d37be_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfMS0zLTEtMS0w_4a9f0472-684a-47f0-906c-aa24a9d644ff">1,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76f89fa7250e4a06b29eb2156d416d96_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfMS01LTEtMS0w_45a186fd-5b7a-4323-9920-bdde399e08f3">1,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i260bc0a3e86245f2b8b08107a4dee7bd_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfMi0xLTEtMS0w_6a4948bf-dff9-4363-bd24-bea5ad5b90a5">5</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib750f63eb6b944cb98e71a7f0d4cf5f8_I20200930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfMi0zLTEtMS0w_24f38eba-9b90-4b75-8cd5-e56ae242cfe6">143</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21f9a7a1498e4ac9bff64988b80f1530_I20191231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfMi01LTEtMS0w_a8dcd310-d492-4015-acbd-5b9a06942097">124</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1b11b05347a54ecd8d3f69919983392e_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfMy0xLTEtMS0w_cbfcf1cf-e706-4e57-9e41-45f7c6b12745">3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d433a516bc643149feff09002c301ba_I20200930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfMy0zLTEtMS0w_989bf44a-6957-4bc6-9721-84a2ab7b4636">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a4aedbde574295bf88fe0261d77059_I20191231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfMy01LTEtMS0w_83bdcdde-f222-418e-9e99-893e956fbca3">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lab equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8efc8bdaf1074768864d3ed973853b90_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNC0xLTEtMS04NzkvdGV4dHJlZ2lvbjo1NmExYmJlMDViYTc0MTZiODI2MzZkOGQwMjY3ZTEyYl8zMjk4NTM0ODgzMzM2_eb61c4f3-ca80-40a7-b97e-f13295a49946">2</ix:nonNumeric>-<ix:nonNumeric contextRef="i103f71b1047849e5b84f76f80ae06494_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNC0xLTEtMS04NzkvdGV4dHJlZ2lvbjo1NmExYmJlMDViYTc0MTZiODI2MzZkOGQwMjY3ZTEyYl8zMjk4NTM0ODgzMzM5_995e01bf-c175-4585-a36b-cd5dd80f084d">5</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42449cdc53ba4b89b9cdf57fa83320b0_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNC0zLTEtMS0w_b49de5ef-f0a1-4f7a-ad27-a2b242224be7">4,025</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdf44d92b2ca4b57a02e2892703853f1_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNC01LTEtMS0w_16da0dfe-a53e-449b-976b-6a90b1a46567">3,054</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if27e640809cf45798d09eb333cf0b6da_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNS0xLTEtMS04ODUvdGV4dHJlZ2lvbjpjMTg5ZTU3MjEzZTU0MGQwOWU5ZmMzZTg4NGQwM2I1MF8zMjk4NTM0ODgzMzM2_51d40f68-dffe-4c41-8e67-021b3ad60b7a">6</ix:nonNumeric>-<ix:nonNumeric contextRef="i9d06d2274931457baab6e055385a4ed4_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNS0xLTEtMS04ODUvdGV4dHJlZ2lvbjpjMTg5ZTU3MjEzZTU0MGQwOWU5ZmMzZTg4NGQwM2I1MF8zMjk4NTM0ODgzMzM5_dd15aa0f-974d-4798-aa70-a7fc6eda5630">7</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1c26254dc044115869b6c29020aa2f9_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNS0zLTEtMS0w_a24091b9-dee0-47d8-b9c9-d4896b4a3801">2,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd07bdcfbfb94667ac7bec7ea6ef1c07_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNS01LTEtMS0w_e32f0850-acb6-4c22-a645-c22d058d21ff">2,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in process</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i611f783c934a4fb6b3f38212acc720ca_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNi0zLTEtMS0w_f5bb653c-a936-4327-9af0-ced2d39f6200">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d68ba3fe6824af092a4888b932d3991_I20191231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNi01LTEtMS0w_0f3a036d-c197-4bc8-a764-d83e031554f4">48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNy0zLTEtMS0w_3c3315e2-6ff0-4bce-974f-8ee976a458bb">7,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNy01LTEtMS0w_460ee457-8c2b-40e1-b7ba-551221210ebd">6,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfOC0zLTEtMS0w_29bc3759-4d34-46e2-b97b-ccfbf3c9fd63">2,258</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfOC01LTEtMS0w_befd6026-08c8-4e0f-95d0-f54ec9fc7127">1,214</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfOS0zLTEtMS0w_6746befb-0ae3-4de2-b5e8-7c7ef34010c5">5,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfOS01LTEtMS0w_371ebdd1-5105-437f-a30a-eb235282f068">5,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Expenses and Other Current Liabilities </span></div><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RleHRyZWdpb246MjEwYjZlNDVmNmVlNGVhOTk5MjYxODU5ZTBiYWU2OWFfMjk2_73c0d393-ea57-49d1-bf23-d7572de08852" escape="true"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consisted of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued compensation</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfMi0xLTEtMS0w_0ed895ca-8981-4beb-b6a7-9cdec6dc4f95">8,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfMi0zLTEtMS0w_dbcf0ca2-6ea3-4ed1-b89e-15131adb4461">9,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, current</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfMy0xLTEtMS0w_5b5edc41-9166-4722-bcec-df824d3d98ed">3,548</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfMy0zLTEtMS0w_3301b133-4e3f-4fa3-a00c-a9b2d887ede8">2,354</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued professional service fees</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfNC0xLTEtMS0w_245a2f96-c27a-4c18-bf0f-25ad469f61c3">2,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfNC0zLTEtMS0w_c292e012-e7b4-453b-ab1b-633f33491dcd">2,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued interest, current</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfNS0xLTEtMS0w_078cbea6-501e-4517-9882-7a4ee958d9d8">3,864</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfNS0zLTEtMS0w_3df2517e-aacf-4bdb-953b-319b8035911b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued other</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfNi0xLTEtMS0w_bc842977-5a51-4a43-b1b2-613de54dc804">612</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfNi0zLTEtMS0w_79a106ec-7cf5-45c9-897b-1a1967b13cff">1,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued in process research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" name="goss:AccruedInProcessResearchAndDevelopment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfNy0xLTEtMS0w_84cfa00e-f2da-4df3-8a15-6085d8343a86">275</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="goss:AccruedInProcessResearchAndDevelopment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfNy0zLTEtMS0w_c311a876-d1d9-4aa2-88ac-10d87e84bdf2">1,600</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accrued expenses</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfOC0xLTEtMS0w_23951540-46db-46b0-997a-2d56b5b8f249">19,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfOC0zLTEtMS0w_8796e83b-fd63-4ffa-91ac-5f402fcdf37e">16,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_49"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="goss:FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RleHRyZWdpb246YmZmOTU4ZmZhYWI0NDNhNDgxMTkyOWI5ZmM0ZDdlYjNfMTA5OTUxMTYzMzcxOQ_6ea2cc1a-71bd-4743-bdcf-b3aba07db109" continuedAt="i44376b15ced84b479a3bafa3b147fa0c" escape="true">Fair Value Measurements and Available for Sale Investments</ix:nonNumeric></span></div><ix:continuation id="i44376b15ced84b479a3bafa3b147fa0c" continuedAt="i72ca60f9bb434cee9af4dd198b444b89"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting guidance defines fair value, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the accounting guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1: Observable inputs such as quoted prices in active markets;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its cash equivalents and available-for-sale investments within Level&#160;1 or Level&#160;2. The fair value of the Company&#8217;s investment grade corporate debt securities and commercial paper is determined using proprietary valuation models and analytical tools, which utilize market pricing or prices for similar instruments that are both objective and publicly available, such as matrix pricing or reported trades, benchmark yields, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, and offers.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RleHRyZWdpb246YmZmOTU4ZmZhYWI0NDNhNDgxMTkyOWI5ZmM0ZDdlYjNfNTkzOQ_db92bfa5-768a-45b0-b2a1-3edc7ef5e73d" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for assets measured at fair value on a recurring basis as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:42.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value Measurements at End of Period Using:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total<br/>Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Quoted&#160;Market<br/>Prices for<br/>Identical&#160;Assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Significant<br/>Other&#160;Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of September 30, 2020</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i835b26655f28493fad355a6322860843_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMy0xLTEtMS0w_14e650e0-a829-471d-8fb5-62e5c23a588e">367,344</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0f0c40e6d7654a0d84a3748e61f8aac5_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMy0zLTEtMS0w_293ee798-94b7-46d0-8018-cb2adeb88184">367,344</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i17213d559ba7419fab19ce258c60725e_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMy01LTEtMS0w_aed0ccb6-bd26-4c2a-9dbb-43520b8ed04a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i26809f02394e4f7fa0669e5465e107e5_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMy03LTEtMS0w_22cbc7d1-15ed-4b86-90ce-62597089b4fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Treasury and agency securities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icf0f77fbe2fa411887f11ed7f2f99c11_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNC0xLTEtMS0w_965b7632-e063-4d8d-a443-e61b5d35f947">53,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5c3c2ed990164cdf9677553f5b066742_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNC0zLTEtMS0w_d96142c2-183d-400c-b0ba-61a9ceb67f0a">53,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i20a2c95edf9e4ccba5c6b16a8d676493_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNC01LTEtMS0w_3d80eb24-8d45-4bd3-b0e3-fbcb23bd81b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iada21370c53144b09d7b9404f3ee35ff_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNC03LTEtMS0w_e3b8bb2e-89c0-4fb9-a6cb-452c9b9f12c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibe176d3a79e745d79ba915619691251d_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNS0xLTEtMS0w_5efce40d-fe1f-42d9-b19b-c24c350da851">5,580</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bda7b8e7dd04e8caccd4a6f241affe0_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNS0zLTEtMS0w_dd7789c1-d47c-4cd5-b6e8-e3c8f7a56944">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i345c770504cf47799812979d3f5b302d_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNS01LTEtMS0w_053dc4e6-8fe9-480e-bd76-24feecd76820">5,580</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8e3869d1f23741b4a71e5a062db9b80c_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNS03LTEtMS0w_9f47c5ca-cfea-4061-9655-bd97471316f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i301f52d7e9c04c2491017b8e1843e74a_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNi0xLTEtMS0w_99dddcae-c1d2-43ee-8e5c-17ee8371aee5">53,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6e014916db25406589a2a5f00d8eb334_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNi0zLTEtMS0w_eda24ac7-9632-4acc-910a-48db6e18de62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1402b051056b4d9799e3b18f2092e6f0_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNi01LTEtMS0w_42785af6-88dd-4976-a8cb-41e4590a480b">53,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if59687e3ceb840559fdd247e955190ca_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNi03LTEtMS0w_1021d1a8-bf24-42c9-b24b-e924cc94f1c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iba100508cf4f4d92b301e065ad6ff443_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfOC0xLTEtMS0w_f98a945f-b5e7-4cda-be7e-a16f141b7dc0">82,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia7e2d34db3e44a1c82443160f196e896_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfOC0zLTEtMS0w_60f03455-4cad-41ea-8a3f-9a0c668d10ae">82,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i81256eb7c9e04561a9015aca0c513258_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfOC01LTEtMS0w_bdf53f49-d046-4552-b8e2-5c0b758466d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i42e5b4d69dd14ffea2c2f3c7b25f6034_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfOC03LTEtMS0w_d0e45457-b187-4196-9a43-f3c789df535b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Treasury and agency securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifc5f664a8d9f42fbae6150714af2998f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfOS0xLTEtMS0w_ffdf62e6-8a7d-4a22-afbb-81e71dbfed05">91,717</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0b301e21a02a4512a5e81e1b78038f75_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfOS0zLTEtMS0w_8842157f-da07-47e6-ac85-20eda9552cc0">91,717</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8e20f232351042e2a775afe12f0c8249_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfOS01LTEtMS0w_5fc30542-3671-4ac9-972b-28cba5eff8c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i977d5f93f97946efb350e31e78f7b85c_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfOS03LTEtMS0w_2476a9b8-c189-4839-b41e-5884222eb4be">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i833b6168e6d6460e8cb4fa5a0da5de2e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMTAtMS0xLTEtMA_f9bd15f9-8b25-4e5d-a249-d27b99905a89">37,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i09e8387031f142ac9019e52d736c6004_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMTAtMy0xLTEtMA_5c75a30d-aa90-4ddc-8677-71b436d3f253">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie1efadb52eb943fe9951cac243f24a01_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMTAtNS0xLTEtMA_f1be8292-c772-4184-b326-2ca15a331465">37,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i039111ce7909430b990dd8e90c1779a2_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMTAtNy0xLTEtMA_3db8d33a-05d0-4005-b55d-7d5c2500a3f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4266b95b8b344eb6960b0767413da8a3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMTEtMS0xLTEtMA_fc1a0124-0a0f-4a86-b8a2-b319f749ab35">156,277</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5c5f2803efa24a25b712849347cd1cf5_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMTEtMy0xLTEtMA_1bc43a0e-694b-4b11-891c-48ab43292a0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i686c91e5254648cea5586df68b2d908e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMTEtNS0xLTEtMA_48fc528d-63de-4d54-9e32-5a1e4fafeb50">156,277</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5083b3c67e204f679f3a2c11014f24c1_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMTEtNy0xLTEtMA_a2f1a3b4-75ee-4cd2-a96a-1536fc34385c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did <ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:FairValueEquityLevel1ToLevel2TransfersAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RleHRyZWdpb246YmZmOTU4ZmZhYWI0NDNhNDgxMTkyOWI5ZmM0ZDdlYjNfMTA5OTUxMTYzMzc0NA_0e455d48-a6da-40e8-99fc-5a9a627b28e6"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:FairValueEquityLevel1ToLevel2TransfersAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RleHRyZWdpb246YmZmOTU4ZmZhYWI0NDNhNDgxMTkyOWI5ZmM0ZDdlYjNfMTA5OTUxMTYzMzc0NA_7b4e0c4f-7cee-4c6a-a4a5-bdff79dc6484"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:FairValueEquityLevel2ToLevel1TransfersAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RleHRyZWdpb246YmZmOTU4ZmZhYWI0NDNhNDgxMTkyOWI5ZmM0ZDdlYjNfMTA5OTUxMTYzMzc0NA_bcb4b8b9-fbcf-4ff2-847e-061e741541cb"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:FairValueEquityLevel2ToLevel1TransfersAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RleHRyZWdpb246YmZmOTU4ZmZhYWI0NDNhNDgxMTkyOWI5ZmM0ZDdlYjNfMTA5OTUxMTYzMzc0NA_d2fad162-6901-4070-b630-ebd835f3f54a">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>t reclassify any investments between levels in the fair value hierarchy during the periods presented.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Other Financial Instruments</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020 and December&#160;31, 2019, the carrying amounts of the Company&#8217;s financial instruments, which include cash, interest receivable, accounts payable and accrued expenses, approximate fair values because of their short maturities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest receivable as of September&#160;30, 2020 and December&#160;31, 2019, was $<ix:nonFraction unitRef="usd" contextRef="i83bde4dee6094380821298b49ab659af_I20200930" decimals="-5" format="ixt:numdotdecimal" name="goss:InterestAndSecuritiesReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RleHRyZWdpb246YmZmOTU4ZmZhYWI0NDNhNDgxMTkyOWI5ZmM0ZDdlYjNfMjM2Mg_d8502d7f-85f9-44f4-a518-bb357277996a">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3101b95085834b9ea5a1dc9f746956db_I20191231" decimals="-5" format="ixt:numdotdecimal" name="goss:InterestAndSecuritiesReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RleHRyZWdpb246YmZmOTU4ZmZhYWI0NDNhNDgxMTkyOWI5ZmM0ZDdlYjNfMjM2OQ_e1fd1120-1dd2-4c1c-9940-de3e592b945c">1.5</ix:nonFraction> million,respectively, and is recorded as a component of prepaid expenses and other current assets on the condensed consolidated balance sheets.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that its Credit Facility bears interest at a rate that approximates prevailing market rates for instruments with similar characteristics and, accordingly, the carrying value of the Credit Facility approximates fair value.&#160;The Company estimates the fair value of long-term debt utilizing an income approach. The Company uses a present value calculation to discount principal and interest payments and the final maturity payment on these liabilities using a discounted </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><ix:continuation id="i72ca60f9bb434cee9af4dd198b444b89"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cash flow model based on observable inputs. The debt instrument is then discounted based on what the current market rates would be as of the reporting date. Based on the assumptions used to value these liabilities at fair value, the debt instrument is categorized as Level 2 in the fair value hierarchy.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020 the fair value of the Company&#8217;s 2027 Notes was $<ix:nonFraction unitRef="usd" contextRef="ice172af8d59747e98811da5f3ed0dfc7_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RleHRyZWdpb246YmZmOTU4ZmZhYWI0NDNhNDgxMTkyOWI5ZmM0ZDdlYjNfMzM1Ng_da0871b1-03a9-40b6-8aa4-32ffef3002ac">202.0</ix:nonFraction> million.&#160;&#160;The fair value was determined on the basis of market prices observable for similar instruments and is considered Level 2 in the fair value hierarchy (see Note 5).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Available for Sale Investments</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company invests its excess cash in U.S. Treasury and agency securities and debt instruments of corporations and commercial obligations, which are classified as available-for-sale investments. These investments are carried at fair value and are included in the tables below.&#160;&#160;The Company evaluates securities with unrealized losses to determine whether such losses, if any, are due to credit-related factors. Realized gains and losses are calculated using the specific identification method and recorded as interest income or expense. The Company does not generally intend to sell the investments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity. </span></div><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RleHRyZWdpb246YmZmOTU4ZmZhYWI0NDNhNDgxMTkyOWI5ZmM0ZDdlYjNfNTk0MA_515f18fb-5436-41d4-b460-592d74960f31" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value, cost basis, and gross unrealized gains and losses of available-for-sale investments by security type, classified in marketable securities and long-term investments as of September&#160;30, 2020 are as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketable securities</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Treasury and agency securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifec2d9641952468d8894861a5747a001_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfMi0xLTEtMS0w_105f07ec-e21c-43c4-88da-4a0489b72bc7">35,194</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifec2d9641952468d8894861a5747a001_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfMi0zLTEtMS0w_5467d54f-f08c-4e0d-a084-e120ad36ee88">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifec2d9641952468d8894861a5747a001_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfMi01LTEtMS0w_8b5720cb-1bad-4eca-a32d-bcc60c05040a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifec2d9641952468d8894861a5747a001_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfMi03LTEtMS0w_508f484c-4c7a-4db4-80d8-3d59bf890c14">35,194</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib8ff014a368f4ecdbeb3dedc5d6a4ec9_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfMy0xLTEtMS0w_c413e2ca-6185-42ce-82ac-1467c6aa17f6">5,580</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib8ff014a368f4ecdbeb3dedc5d6a4ec9_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfMy0zLTEtMS0w_0c3e9c0a-fbe8-4313-b9ab-0063fb9a8801">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib8ff014a368f4ecdbeb3dedc5d6a4ec9_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfMy01LTEtMS0w_0f36ce49-efa3-45bb-8bb7-145441b0cb3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib8ff014a368f4ecdbeb3dedc5d6a4ec9_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfMy03LTEtMS0w_6c20c4a6-bd79-4213-925f-57b31e119666">5,580</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia0a2dd9240654fb5a702e98d4d3f4e28_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfNC0xLTEtMS0w_c52c89a3-6602-4845-af39-48bcf08b057d">52,346</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia0a2dd9240654fb5a702e98d4d3f4e28_I20200930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfNC0zLTEtMS0w_8a768778-baeb-4e7a-9a05-f4947ab6d4a6">302</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia0a2dd9240654fb5a702e98d4d3f4e28_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfNC01LTEtMS0w_e9352e59-d401-46a7-8e73-0235670e3502">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia0a2dd9240654fb5a702e98d4d3f4e28_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfNC03LTEtMS0w_1bcdf515-e886-4bbf-8551-b3b16637ee7c">52,648</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfNS0xLTEtMS0w_d5badfa2-56be-43be-acfb-81ba6410f248">93,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfNS0zLTEtMS0w_67152160-29eb-4bb4-b080-051f16f6bc77">302</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfNS01LTEtMS0w_ae9b087b-3a05-42ad-8b86-6fb5bc5d1ea9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfNS03LTEtMS0w_33838a6e-6c40-41fe-b1fc-029497376c6b">93,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At each reporting date, the Company performs an evaluation of impairment to determine if any unrealized losses are due to credit-related factors. The Company records an allowance for credit losses when unrealized losses are due to credit-related factors. Factors considered when evaluating available-for-sale investments for impairment include the severity of the impairment, changes in underlying credit ratings, the financial condition of the issuer, the probability that the scheduled cash payments will continue to be made and the Company&#8217;s intent and ability to hold the investment until recovery of the amortized cost basis. The Company intends and has the ability to hold its investments in unrealized loss positions until their amortized cost basis has been recovered. As of September&#160;30, 2020, there were no material declines in the market value of the Company&#8217;s available-for-sale investments due to credit-related factors.</span></div><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RleHRyZWdpb246YmZmOTU4ZmZhYWI0NDNhNDgxMTkyOWI5ZmM0ZDdlYjNfNTk0MQ_6daeb2fb-5b86-44ec-8c69-e8a05ba78932" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual maturities of available-for-sale debt securities, as of September&#160;30, 2020, were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated<br/> Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due within one year</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjE2YWZkNDE3OTg3MDRlNTRhYzUxMGMxMjM3MWFmYjNhL3RhYmxlcmFuZ2U6MTZhZmQ0MTc5ODcwNGU1NGFjNTEwYzEyMzcxYWZiM2FfMS0xLTEtMS0w_38d06cf2-4342-4f45-b226-941119f1d73c">79,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One to two years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="goss:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjE2YWZkNDE3OTg3MDRlNTRhYzUxMGMxMjM3MWFmYjNhL3RhYmxlcmFuZ2U6MTZhZmQ0MTc5ODcwNGU1NGFjNTEwYzEyMzcxYWZiM2FfMi0xLTEtMS0w_3f05483d-f2b5-4540-9204-6b857a20b3e1">13,840</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjE2YWZkNDE3OTg3MDRlNTRhYzUxMGMxMjM3MWFmYjNhL3RhYmxlcmFuZ2U6MTZhZmQ0MTc5ODcwNGU1NGFjNTEwYzEyMzcxYWZiM2FfMy0xLTEtMS0w_edcecf1b-7db9-4ed5-8739-538b6487e8f4">93,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has the ability, if necessary, to liquidate any of its cash equivalents and marketable securities to meet its liquidity needs in the next 12&#160;months. Accordingly, those investments with contractual maturities greater than one year from the date of purchase are classified as current assets on the accompanying condensed consolidated balance sheets.</span></div></ix:continuation><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_55"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTA5OTUxMTYzOTgxOQ_956c362d-ff7d-45e5-82e3-3e0913602965" continuedAt="ibba4f4a1d30849aeab0a20d13521fc53" escape="true">Indebtedness</ix:nonNumeric></span></div><ix:continuation id="ibba4f4a1d30849aeab0a20d13521fc53" continuedAt="i1082df4e025b490db3432de32bf6ae3d"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facility</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 2, 2019, the Company entered into a credit, guaranty and security agreement, as amended on September 18, 2019 and July 2, 2020 (the &#8220;Credit Facility&#8221;), with MidCap Financial Trust (&#8220;MidCap&#8221;), as agent and lender, and the additional lenders party thereto from time to time (together with MidCap, the &#8220;Lenders&#8221;), pursuant to which the Lenders, including affiliates of MidCap and Silicon Valley Bank, agreed to make term loans available to the Company for working capital and </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><ix:continuation id="i1082df4e025b490db3432de32bf6ae3d" continuedAt="idbbecc281f7d44b0a81a3c0193e5d6fb"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">general business purposes, in a principal amount of up  to $<ix:nonFraction unitRef="usd" contextRef="i5422129c1c59408889a2b99ef392c162_I20190502" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNjI5_6f46344b-496f-4b68-94a0-fc2aaa6355cc">150.0</ix:nonFraction> million in term loan commitments, including a $<ix:nonFraction unitRef="usd" contextRef="i70316c2b436540a398e8730c8f3d7325_D20190502-20190502" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNjcw_a918f5e1-d1a4-4ae6-a026-352716468ded">30.0</ix:nonFraction> million term loan that was funded at the closing date, with the ability to access the remaining $<ix:nonFraction unitRef="usd" contextRef="i5422129c1c59408889a2b99ef392c162_I20190502" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNzYx_471d6265-3f50-4fb4-b552-bdd66d9a51a0">120.0</ix:nonFraction> million in <ix:nonFraction unitRef="tranche" contextRef="i5422129c1c59408889a2b99ef392c162_I20190502" decimals="INF" format="ixt-sec:numwordsen" name="goss:NumberOfAdditionalTranches" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNzY3_b7fd1871-40c1-45bd-a944-9e2660fe6a6c">two</ix:nonFraction> additional tranches (each $<ix:nonFraction unitRef="usd" contextRef="i5007e0fab37a4961ae06a859fbe77235_I20190502" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNzk0_47ffd711-98a7-4ec1-91eb-dc3dbaac4f60"><ix:nonFraction unitRef="usd" contextRef="i667382cf02644ff3a4aefdaf07b9cb60_I20190502" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNzk0_7aedb5ef-abec-4946-90c7-cb784140a0fb">60.0</ix:nonFraction></ix:nonFraction> million), subject to specified availability periods, the achievement of certain clinical development milestones, minimum cash requirements and other customary conditions. The Company, GB001, Inc., GB002, Inc., and GB004, Inc., each wholly-owned subsidiaries of the Company, are designated as co-borrowers to the Credit Facility, whereas GB003, Inc., GB005, Inc., GB006, Inc., GB007, Inc., GB008, Inc. and Gossamer Bio Services, Inc.,each wholly-owned subsidiaries of the Company, are designated as guarantors. The remaining two tranches are available no earlier than the satisfaction of the applicable funding conditions, including the applicable clinical development milestones, and no later than December 31, 2022. As of September&#160;30, 2020, no other tranches under the Credit Facility have been drawn. The Credit Facility is secured by substantially all of the Company&#8217;s and its domestic subsidiaries&#8217; personal property, including intellectual property.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each term loan under the Credit Facility bears interest at an annual rate equal to the sum of (i) one-month LIBOR (customarily defined, with a change to prime rate if LIBOR funding becomes unlawful or impractical) plus (ii) <ix:nonFraction unitRef="number" contextRef="i049d323be2aa4c3fbc15de6068f993c8_D20190502-20190502" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTkxNQ_20f93583-8883-4444-90a0-9f0a0c62992d">7.00</ix:nonFraction>%, subject to a LIBOR floor of <ix:nonFraction unitRef="number" contextRef="i2111df5e71074410b154ca22ac755a6d_I20190502" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTk0Nw_0f7957b9-a69a-4ac7-9f51-bde1ef186c72">2.00</ix:nonFraction>%.&#160;&#160;The borrower is required to make interest-only payments on the term loan for all payment dates prior to July 1, 2022.&#160;&#160;The term loans under the Credit Facility will begin amortizing on July 1, 2022, with equal monthly payments of principal plus interest being made by the Company to the Lenders in consecutive monthly installments following such interest-only period until the Credit Facility matures on January 1, 2025.&#160;&#160;Upon final repayment of the term loans, the borrower must pay an exit fee of <ix:nonFraction unitRef="number" contextRef="i5422129c1c59408889a2b99ef392c162_I20190502" decimals="INF" name="goss:PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMjU0Nw_81e6017b-24d7-4d3f-8acf-be041c08e02b">1.75</ix:nonFraction>% of the amount borrowed under the Credit Facility, less any partial exit fees previously paid.&#160;&#160;Upon partial prepayment of a portion of the term loans, the borrower must pay a partial exit fee of <ix:nonFraction unitRef="number" contextRef="i5422129c1c59408889a2b99ef392c162_I20190502" decimals="INF" name="goss:PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMjc0NQ_25543d9d-ea69-425a-8e77-f3028acc0ab8">1.75</ix:nonFraction>% of the principal being prepaid. At the borrower&#8217;s option, the borrower may prepay the outstanding principal balance of the term loan in whole or in part, subject to a prepayment fee of <ix:nonFraction unitRef="number" contextRef="i7d6528bf258548188d528464e3134189_I20190502" decimals="INF" name="goss:PercentageOfPrepaymentFee" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMjkzMw_2df72f61-d193-4392-a054-af5c8e12f269">3.00</ix:nonFraction>% of any amount prepaid if the prepayment occurs through and including the first anniversary of the second amendment effective date, <ix:nonFraction unitRef="number" contextRef="idd99beac9caf44318e4f61c224f56fa4_I20190502" decimals="INF" name="goss:PercentageOfPrepaymentFee" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMzA0Nw_12f30fa7-730a-42c8-bbe9-5cfd469791a4">2.00</ix:nonFraction>% of the amount prepaid if the prepayment occurs after the first anniversary of the second amendment effective date through and including the second anniversary of the second amendment effective date, and <ix:nonFraction unitRef="number" contextRef="i1aa9b85a36ff422abc868819f1b52110_I20190502" decimals="INF" name="goss:PercentageOfPrepaymentFee" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMzIxNQ_916aef3c-8741-4f59-acd8-8164f6461021">1.00</ix:nonFraction>% of any amount prepaid after the second anniversary of the second amendment effective date and prior to January 1, 2025.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facility includes affirmative and negative covenants applicable to the Company and certain of its subsidiaries. The affirmative covenants include, among others, covenants requiring such entities to maintain their legal existence and governmental approvals, deliver certain financial reports, maintain insurance coverage, maintain property, pay taxes, satisfy certain requirements regarding accounts and comply with laws and regulations.&#160;&#160;The negative covenants include, among others, restrictions on such entities from transferring collateral, incurring additional indebtedness, engaging in mergers or acquisitions, paying dividends or making other distributions, making investments, creating liens, amending material agreements and organizational documents, selling assets and suffering a change in control, in each case subject to certain exceptions.&#160;&#160;The Company and certain of its subsidiaries are also subject to an ongoing minimum cash financial covenant in which they must maintain unrestricted cash in an amount not less than <ix:nonFraction unitRef="number" contextRef="i70316c2b436540a398e8730c8f3d7325_D20190502-20190502" decimals="INF" name="goss:DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNDM1OQ_084a69e7-4d74-4af1-a9fd-93d2e3d57bdf">25</ix:nonFraction>% of the outstanding principal amount of the term loans. As of September&#160;30, 2020, the Company was in compliance with these covenants.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facility also includes events of default, the occurrence and continuation of which could cause interest to be charged at the rate that is otherwise applicable plus <ix:nonFraction unitRef="number" contextRef="ifd6482abdd604fa3b4920ae6543e4b2e_D20200101-20200930" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNDY1NA_c83d9264-fa67-4952-bebf-a44d34b75776">3.00</ix:nonFraction>% and would provide MidCap, as agent, with the right to exercise remedies against the Company and/or certain of its subsidiaries, and the collateral securing the Credit Facility, including foreclosure against the properties securing the credit facilities, including cash.&#160;&#160;These events of default include, among other things, failure to pay any amounts due under the Credit Facility, a breach of covenants under the Credit Facility, insolvency or the occurrence of insolvency events, the occurrence of a change in control, the occurrence of certain U.S. Food and Drug Administration (&#8220;FDA&#8221;) and regulatory events, failure to remain registered with the SEC and listed for trading on Nasdaq, the occurrence of a material adverse change, the occurrence of a default under a material agreement reasonably expected to result in a material adverse change, the occurrence of certain defaults under certain other indebtedness in an amount greater than $<ix:nonFraction unitRef="usd" contextRef="i4f195af7643b4ea094fcedba56dc2482_I20200930" decimals="-5" format="ixt:numdotdecimal" name="goss:DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMzI5ODUzNDkwMTE4OA_b4260cb3-b7f9-4f32-8a27-4ba8de5b3aad">2.5</ix:nonFraction> million and the occurrence of certain defaults under subordinated indebtedness and convertible indebtedness.</span></div><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTIwMzY_8bc29cae-132d-4dbf-b56e-fd3b2d23d1be" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt as of September&#160;30, 2020 consisted of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic984cdc9b0e0482fbb94f5d207f8e3fa_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOjE0MGMyMTY1Y2Q1MjQ1ZDY5N2U1ODYxNTY0YzgzY2RjL3RhYmxlcmFuZ2U6MTQwYzIxNjVjZDUyNDVkNjk3ZTU4NjE1NjRjODNjZGNfMS0xLTEtMS0w_34bdae01-adc0-45a3-a48b-2ac21b0c8e9d">30,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount and issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic984cdc9b0e0482fbb94f5d207f8e3fa_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOjE0MGMyMTY1Y2Q1MjQ1ZDY5N2U1ODYxNTY0YzgzY2RjL3RhYmxlcmFuZ2U6MTQwYzIxNjVjZDUyNDVkNjk3ZTU4NjE1NjRjODNjZGNfMi0xLTEtMS0w_4ed8d245-d129-4981-8948-fa9601e4eb87">1,335</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic984cdc9b0e0482fbb94f5d207f8e3fa_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOjE0MGMyMTY1Y2Q1MjQ1ZDY5N2U1ODYxNTY0YzgzY2RjL3RhYmxlcmFuZ2U6MTQwYzIxNjVjZDUyNDVkNjk3ZTU4NjE1NjRjODNjZGNfMy0xLTEtMS0w_b364328a-8302-4935-8689-508c6d956636">28,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTIwMzc_f2f35af2-f80f-40a7-90bd-6d3acec89c2b" continuedAt="idd5fdab7497a48a79ce43faf3de66664" escape="true">The scheduled future minimum principal payments are as follows (in thousands)</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><ix:continuation id="idbbecc281f7d44b0a81a3c0193e5d6fb" continuedAt="if3a726b0da8a4bbf9034372daf468332"><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="idd5fdab7497a48a79ce43faf3de66664"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 (remaining 3 months)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOjc2YTU4ZTNmNTdkYzQwNmFiNGJkMDAzMjgxZjEyYTI1L3RhYmxlcmFuZ2U6NzZhNThlM2Y1N2RjNDA2YWI0YmQwMDMyODFmMTJhMjVfMS0xLTEtMS0w_bbba65ed-dca0-4bcf-8be7-a4a2d9a0f2ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fbffc547f2d4d6c8b7ed7d9553a691e_I20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOjc2YTU4ZTNmNTdkYzQwNmFiNGJkMDAzMjgxZjEyYTI1L3RhYmxlcmFuZ2U6NzZhNThlM2Y1N2RjNDA2YWI0YmQwMDMyODFmMTJhMjVfMi0xLTEtMS0w_ae2dead5-196e-4e96-b754-e1cdd77d65ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fbffc547f2d4d6c8b7ed7d9553a691e_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOjc2YTU4ZTNmNTdkYzQwNmFiNGJkMDAzMjgxZjEyYTI1L3RhYmxlcmFuZ2U6NzZhNThlM2Y1N2RjNDA2YWI0YmQwMDMyODFmMTJhMjVfMy0xLTEtMS0w_47482a4f-0f0a-4d84-96d7-2752ddb29019">5,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fbffc547f2d4d6c8b7ed7d9553a691e_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOjc2YTU4ZTNmNTdkYzQwNmFiNGJkMDAzMjgxZjEyYTI1L3RhYmxlcmFuZ2U6NzZhNThlM2Y1N2RjNDA2YWI0YmQwMDMyODFmMTJhMjVfNC0xLTEtMS0w_fe5cbde0-9592-4e88-9333-d8fe1f679b59">11,613</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fbffc547f2d4d6c8b7ed7d9553a691e_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOjc2YTU4ZTNmNTdkYzQwNmFiNGJkMDAzMjgxZjEyYTI1L3RhYmxlcmFuZ2U6NzZhNThlM2Y1N2RjNDA2YWI0YmQwMDMyODFmMTJhMjVfNS0xLTEtMS0w_41ee6dab-e512-4d88-8da1-fe0cd245cae7">11,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fbffc547f2d4d6c8b7ed7d9553a691e_I20200930" decimals="-3" name="goss:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOjc2YTU4ZTNmNTdkYzQwNmFiNGJkMDAzMjgxZjEyYTI1L3RhYmxlcmFuZ2U6NzZhNThlM2Y1N2RjNDA2YWI0YmQwMDMyODFmMTJhMjVfNi0xLTEtMS0xODUw_b0f922ea-87f2-4b13-92dd-d5ecc810a965">968</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fbffc547f2d4d6c8b7ed7d9553a691e_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOjc2YTU4ZTNmNTdkYzQwNmFiNGJkMDAzMjgxZjEyYTI1L3RhYmxlcmFuZ2U6NzZhNThlM2Y1N2RjNDA2YWI0YmQwMDMyODFmMTJhMjVfNi0xLTEtMS0w_bee4dccd-e12c-4d1b-a844-75c3282fa4b3">30,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">5.00% Convertible Senior Notes due 2027</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 21, 2020, the Company issued $<ix:nonFraction unitRef="usd" contextRef="i5fed8506ec5c42a0b5ad8496948c43b6_D20200521-20200521" decimals="INF" format="ixt:numdotdecimal" name="goss:DebtInstrumentAggregatePrincipalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNTkyOA_a5b43fd8-7ece-471f-bfea-b8f2f76b1461">200.0</ix:nonFraction> million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="ib0fc320a9ff8434485ec70bde2f2d365_I20200521" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNTk2MQ_c7c856fd-fcc6-4c49-b445-7b40e6409185">5.00</ix:nonFraction>% convertible senior notes due 2027 in a public offering. The 2027 Notes were registered pursuant to the Company&#8217;s Shelf Registration Statement (as defined in Note 7 below). The interest rate on the 2027 Notes is fixed at <ix:nonFraction unitRef="number" contextRef="ib0fc320a9ff8434485ec70bde2f2d365_I20200521" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNjE4NA_97a5355d-5c3a-4186-90fc-b53aa2a1aa12">5.00</ix:nonFraction>% per annum. Interest is payable semi-annually in arrears on June 1 and December 1 of each year, commencing on December 1, 2020. The 2027 Notes will mature on June 1, 2027. The net proceeds from the offering, after deducting the underwriting discounts and commissions and other offering costs, were approximately $<ix:nonFraction unitRef="usd" contextRef="i5fed8506ec5c42a0b5ad8496948c43b6_D20200521-20200521" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMzI5ODUzNDkwMTE4MA_8ee535bb-7a06-4af2-a846-ec1a83c8f045">193.6</ix:nonFraction> million. The 2027 Notes may be settled in cash, shares of the Company&#8217;s common stock, or a combination thereof, solely at the Company&#8217;s election. The initial conversion rate of the 2027 Notes is&#160;61.6095&#160;shares per&#160;$1,000&#160;principal amount, which is equivalent to a conversion price of approximately&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="ib0fc320a9ff8434485ec70bde2f2d365_I20200521" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNjc4Mg_763f9f50-c7fa-4b91-9f67-8e071249569f">16.23</ix:nonFraction>&#160;per share, subject to adjustments.&#160;In addition, following certain corporate events that occur prior to the maturity date or if the Company issues a notice of redemption, the Company will increase the conversion rate for a holder who elects to convert its 2027 Notes in connection with such a corporate event during the related redemption period in certain circumstances.&#160;</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2027 Notes are senior unsecured obligations of the Company, ranking senior in right of payment to any of the Company&#8217;s indebtedness that is expressly subordinated in right of payment to the 2027 Notes, and are effectively subordinated to the Company&#8217;s existing and future secured indebtedness, to the extent of the value of the collateral securing that indebtedness, including all indebtedness under the Credit Facility.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their notes at their option only in the following circumstances: (1) during any calendar quarter (and only during such calendar quarter) commencing after the calendar quarter ending on September 30, 2020, if the last reported sale price per share of the Company&#8217;s common stock exceeds <ix:nonFraction unitRef="number" contextRef="i5fed8506ec5c42a0b5ad8496948c43b6_D20200521-20200521" decimals="INF" name="goss:DebtInstrumentConvertibleConversionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNzg4Nw_f2d6fede-345a-4b05-88bb-6758d7a51891">130</ix:nonFraction>% of the conversion price for each of at least <ix:nonFraction unitRef="day" contextRef="idda6a8263ec542759323ed492c31b7bc_D20200521-20200521" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNzkzNQ_70ec3516-1817-4949-9f6f-d4d9cf933c50">20</ix:nonFraction> trading days (whether or not consecutive) during the <ix:nonFraction unitRef="day" contextRef="i3dc17920346740a4a7c548c095f7e04c_D20200521-20200521" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNzk5MQ_02d979f8-b164-44f0-b6bb-eaa2670357cf">30</ix:nonFraction> consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (2) during the <ix:nonFraction unitRef="day" contextRef="i4f7d41d10a544ee8bd19cb9b3d404bd3_D20200521-20200521" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfODEyOA_cdbd0692-2150-4e8f-9a9a-b018d633944f">five</ix:nonFraction> consecutive business days immediately after any <ix:nonFraction unitRef="day" contextRef="iaeecc10913964395b00a41848ddfd5d3_D20200521-20200521" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfODE3OQ_aaa9beeb-8220-45ef-8f87-5ff0a7ad600f">10</ix:nonFraction> consecutive trading day period (such <ix:nonFraction unitRef="day" contextRef="iaeecc10913964395b00a41848ddfd5d3_D20200521-20200521" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfODIxOQ_d3f147ca-4384-4d50-839f-d48d9821576d">10</ix:nonFraction> consecutive trading day period, the &#8220;measurement period&#8221;) in which the trading price per $<ix:nonFraction unitRef="usd" contextRef="i5fed8506ec5c42a0b5ad8496948c43b6_D20200521-20200521" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtConversionConvertedInstrumentAmount1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfODMxMQ_a519aa2f-2636-4b8c-bfac-7b6de212fe4e">1,000</ix:nonFraction> principal amount of notes for each trading day of the measurement period was less than <ix:nonFraction unitRef="number" contextRef="i7efacb2f1f254242abcd3924f60c15be_D20200521-20200521" decimals="2" name="goss:DebtInstrumentConvertibleConversionLastReportedSalePricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfODQwMQ_05fef57e-6744-45a1-b95c-a1577d711517">98</ix:nonFraction>% of the product of the last reported sale price per share of the Company&#8217;s common stock on such trading day and the conversion rate on such trading day; (3) upon the occurrence of certain corporate events or distributions on the Company&#8217;s common stock; (4) if the Company calls such notes for redemption; and (5) at any time from, and including, March 1, 2027 until the close of business on the scheduled trading day immediately before the maturity date. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will not have the right to redeem the 2027 Notes prior to June 6, 2024. On or after June 6, 2024 and on or before the 50th scheduled trading day immediately before the maturity date, the Company may redeem the 2027 Notes, in whole or in part, if the last reported sale price of the Company&#8217;s common stock has been at least <ix:nonFraction unitRef="number" contextRef="i5fed8506ec5c42a0b5ad8496948c43b6_D20200521-20200521" decimals="INF" name="goss:DebtInstrumentConvertibleConversionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfOTE5NA_93571ad9-1bbd-47ef-8a42-b2860fc7846a">130</ix:nonFraction>% of the conversion price then in effect on (1) each of at least <ix:nonFraction unitRef="day" contextRef="idda6a8263ec542759323ed492c31b7bc_D20200521-20200521" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTA5OTUxMTYzOTgyNg_11f03f8f-0002-48c5-b952-e1281d2607ee">20</ix:nonFraction> trading days (whether or not consecutive) during the <ix:nonFraction unitRef="day" contextRef="i3dc17920346740a4a7c548c095f7e04c_D20200521-20200521" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfOTMxNA_e67901c5-f0a7-43e9-b0f2-89823b3cb8a0">30</ix:nonFraction> consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice; and (2)the trading day immediately before the date the Company sends such notice. In the case of any optional redemption, the Company will redeem the 2027 Notes at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="i5fed8506ec5c42a0b5ad8496948c43b6_D20200521-20200521" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfOTY1Mw_a617c72e-596a-46e3-8ae3-948a1b4ad0ab">100</ix:nonFraction>% of the principal amount of such Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company undergoes a fundamental change prior to the maturity date of the 2027 Notes, holders of the 2027 Notes may require the Company to repurchase for cash all or part of their 2027 Notes at a repurchase price equal to <ix:nonFraction unitRef="number" contextRef="i5fed8506ec5c42a0b5ad8496948c43b6_D20200521-20200521" decimals="INF" name="goss:PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTAwMTI_264ea3d3-2cda-4850-abdc-64bc0ec52c64">100</ix:nonFraction>% of the principal amount of the 2027 Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The indenture governing the 2027 Notes provides for customary terms and covenants, including that upon certain events of default, either the trustee or the holders of not less than <ix:nonFraction unitRef="number" contextRef="i5fed8506ec5c42a0b5ad8496948c43b6_D20200521-20200521" decimals="INF" name="goss:LongTermDebtPercentageInAggregatePrincipalAmount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTA5OTUxMTY0NjI3Mw_ccb7a7c8-788c-4a89-9e4a-304c9d328dad">25</ix:nonFraction>% in aggregate principal amount of the 2027 Notes then outstanding may declare the unpaid principal amount of the 2027 Notes and accrued and unpaid interest, if any, thereon </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><ix:continuation id="if3a726b0da8a4bbf9034372daf468332"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">immediately due and payable. As of September&#160;30, 2020, the Company was in compliance with these covenants. In the case of certain events of bankruptcy, insolvency or reorganization, the principal amount of the 2027 Notes together with accrued and unpaid interest, if any, thereon will automatically become and be immediately due and payable. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, there were no events or market conditions that would allow holders to convert the 2027 Notes.&#160;&#160;At the time the 2027 Notes become convertible within 12 months of the balance sheet date, the carrying value of the 2027 Notes will be reclassified to short-term.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accounting for the issuance of the 2027 Notes, the Company separated the 2027 Notes into liability and equity components.&#160;&#160;The carrying amount of the liability component was calculated by measuring the fair value of similar debt instruments that do not have associated convertible features. The carrying amount of the equity component representing the conversion option was $<ix:nonFraction unitRef="usd" contextRef="ib0fc320a9ff8434485ec70bde2f2d365_I20200521" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTA4MTc_0b32593f-25a2-4324-9afb-330bb8b3e45c">53.0</ix:nonFraction> million and was determined by deducting the fair value of the liability component from the par value of the 2027 Notes. The equity component is not remeasured as long as it continues to meet the conditions for equity classification. The debt discount is amortized to interest expense over the term of the 2027 Notes at an effective interest rate of <ix:nonFraction unitRef="number" contextRef="ib0fc320a9ff8434485ec70bde2f2d365_I20200521" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTExNjE_55c0a819-c1b4-4974-b514-28c71fb33a01">11.17</ix:nonFraction>% over the contractual terms of the 2027 Notes.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accounting for the debt issuance costs of&#160;$<ix:nonFraction unitRef="usd" contextRef="ib0fc320a9ff8434485ec70bde2f2d365_I20200521" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTEyNTU_891befb9-62f3-4200-9fa8-2802fbc87ed2">0.4</ix:nonFraction> million&#160;related to the 2027 Notes, the Company allocated the total amount incurred to the liability and equity components of the 2027 Notes based on their relative fair values. Issuance costs attributable to the liability component were $<ix:nonFraction unitRef="usd" contextRef="i5fed8506ec5c42a0b5ad8496948c43b6_D20200521-20200521" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTE0ODc_090bda39-a52a-4059-9591-9250621b4c57">0.3</ix:nonFraction> million and will be amortized to interest expense using the effective interest method over the contractual terms of the 2027 Notes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Issuance costs attributable to the equity component were netted with the equity component in stockholders&#8217; equity.</span></div><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="goss:ScheduleOfLiabilityComponentsOfNotesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTIwMzk_17712ded-3ae4-428f-912a-c46fdce7cfef" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net carrying amount of the liability component of the 2027 Notes was as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65ad3aed5a854b92910ae3dd0bf4a19a_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmZjZTNmNTgzNzU4ZDQ1ODNiOTU1ZDE2M2EwMWRmMzczL3RhYmxlcmFuZ2U6ZmNlM2Y1ODM3NThkNDU4M2I5NTVkMTYzYTAxZGYzNzNfMS0xLTEtMS0w_32012879-83f9-4568-8b32-c6bc99dc3881">200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bf8c1de2ef4f56b4e73b156372b2a3_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmZjZTNmNTgzNzU4ZDQ1ODNiOTU1ZDE2M2EwMWRmMzczL3RhYmxlcmFuZ2U6ZmNlM2Y1ODM3NThkNDU4M2I5NTVkMTYzYTAxZGYzNzNfMS0zLTEtMS0w_5f6e54f5-1505-4073-a6a1-bd3b8644d004">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65ad3aed5a854b92910ae3dd0bf4a19a_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmZjZTNmNTgzNzU4ZDQ1ODNiOTU1ZDE2M2EwMWRmMzczL3RhYmxlcmFuZ2U6ZmNlM2Y1ODM3NThkNDU4M2I5NTVkMTYzYTAxZGYzNzNfMi0xLTEtMS0w_6b2b16f5-5189-44d0-8b01-38a2bd9a8fd0">57,557</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bf8c1de2ef4f56b4e73b156372b2a3_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmZjZTNmNTgzNzU4ZDQ1ODNiOTU1ZDE2M2EwMWRmMzczL3RhYmxlcmFuZ2U6ZmNlM2Y1ODM3NThkNDU4M2I5NTVkMTYzYTAxZGYzNzNfMi0zLTEtMS0w_e2d0a633-bba6-4ac8-8a9c-c3c64ed098cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65ad3aed5a854b92910ae3dd0bf4a19a_I20200930" decimals="-3" name="us-gaap:DeferredFinanceCostsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmZjZTNmNTgzNzU4ZDQ1ODNiOTU1ZDE2M2EwMWRmMzczL3RhYmxlcmFuZ2U6ZmNlM2Y1ODM3NThkNDU4M2I5NTVkMTYzYTAxZGYzNzNfMy0xLTEtMS0w_47839458-80fd-4440-bfe7-15d4802c7ccb">285</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bf8c1de2ef4f56b4e73b156372b2a3_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredFinanceCostsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmZjZTNmNTgzNzU4ZDQ1ODNiOTU1ZDE2M2EwMWRmMzczL3RhYmxlcmFuZ2U6ZmNlM2Y1ODM3NThkNDU4M2I5NTVkMTYzYTAxZGYzNzNfMy0zLTEtMS0w_6ac35b97-dae6-4f07-bbd0-cd458371d522">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65ad3aed5a854b92910ae3dd0bf4a19a_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmZjZTNmNTgzNzU4ZDQ1ODNiOTU1ZDE2M2EwMWRmMzczL3RhYmxlcmFuZ2U6ZmNlM2Y1ODM3NThkNDU4M2I5NTVkMTYzYTAxZGYzNzNfNC0xLTEtMS0w_e7015026-bc5a-4ccd-a16f-35746602dfb5">142,158</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bf8c1de2ef4f56b4e73b156372b2a3_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmZjZTNmNTgzNzU4ZDQ1ODNiOTU1ZDE2M2EwMWRmMzczL3RhYmxlcmFuZ2U6ZmNlM2Y1ODM3NThkNDU4M2I5NTVkMTYzYTAxZGYzNzNfNC0zLTEtMS0w_8cb3606c-4f5a-4d1d-96ad-0fb7e5632670">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="goss:ScheduleOfEquityComponentsOfNotesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTIwNDA_a03392ea-6f6b-4f22-aabe-216a638b15b8" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net carrying amount of the equity component of the 2027 Notes was as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount related to the value of conversion option</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65ad3aed5a854b92910ae3dd0bf4a19a_I20200930" decimals="-3" format="ixt:numdotdecimal" name="goss:AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmUzMjU1OGJkZjJkNzRmNmM5MDczZWU0ZjJmZWY5NDAyL3RhYmxlcmFuZ2U6ZTMyNTU4YmRmMmQ3NGY2YzkwNzNlZTRmMmZlZjk0MDJfMS0xLTEtMS0w_e4b8b990-eb48-45c5-8ae3-c85f32a98a13">53,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bf8c1de2ef4f56b4e73b156372b2a3_I20191231" decimals="-3" format="ixt:zerodash" name="goss:AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmUzMjU1OGJkZjJkNzRmNmM5MDczZWU0ZjJmZWY5NDAyL3RhYmxlcmFuZ2U6ZTMyNTU4YmRmMmQ3NGY2YzkwNzNlZTRmMmZlZjk0MDJfMS0zLTEtMS0w_e0820b46-aab6-4b8e-abeb-1669feab7a3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65ad3aed5a854b92910ae3dd0bf4a19a_I20200930" decimals="-3" name="goss:AdjustmentsToEquityComponentOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmUzMjU1OGJkZjJkNzRmNmM5MDczZWU0ZjJmZWY5NDAyL3RhYmxlcmFuZ2U6ZTMyNTU4YmRmMmQ3NGY2YzkwNzNlZTRmMmZlZjk0MDJfMi0xLTEtMS0w_7c05ca7d-cf45-4909-8325-76372c82fa3f">109</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bf8c1de2ef4f56b4e73b156372b2a3_I20191231" decimals="-3" format="ixt:zerodash" name="goss:AdjustmentsToEquityComponentOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmUzMjU1OGJkZjJkNzRmNmM5MDczZWU0ZjJmZWY5NDAyL3RhYmxlcmFuZ2U6ZTMyNTU4YmRmMmQ3NGY2YzkwNzNlZTRmMmZlZjk0MDJfMi0zLTEtMS0w_7c6c623d-8218-4cd3-b8f7-ace002f166fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65ad3aed5a854b92910ae3dd0bf4a19a_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmUzMjU1OGJkZjJkNzRmNmM5MDczZWU0ZjJmZWY5NDAyL3RhYmxlcmFuZ2U6ZTMyNTU4YmRmMmQ3NGY2YzkwNzNlZTRmMmZlZjk0MDJfMy0xLTEtMS0w_c804a3a6-f45c-4923-8601-0eecd3433015">53,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5bf8c1de2ef4f56b4e73b156372b2a3_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmUzMjU1OGJkZjJkNzRmNmM5MDczZWU0ZjJmZWY5NDAyL3RhYmxlcmFuZ2U6ZTMyNTU4YmRmMmQ3NGY2YzkwNzNlZTRmMmZlZjk0MDJfMy0zLTEtMS0w_15c7ba4b-ca78-4520-b070-f3da868f4018">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="goss:ScheduleOfInterestExpenseRecognizedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTIwNDE_baebbd3f-2205-412c-8548-cbf044792663" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the interest expense recognized related to the 2027 Notes (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest expense</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48ce1ae69a484b2897d46eda4fe74206_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="goss:ContractualInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfMS0xLTEtMS0w_3b319bd5-6c9e-45cc-a662-459c829dec08">2,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if94daf002452491ebb4b1b5e305750ce_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="goss:ContractualInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfMS0zLTEtMS0w_3140ddd2-befa-41a6-95ea-6caa97a257f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if767ec539aa84bdf81a78eff0a4bcd22_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="goss:ContractualInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfMi01LTEtMS0yNzE0_e1245c94-718f-434d-af65-0d62dc969e55">3,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ba65eca1c4988aeda7e1649f3720f_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="goss:ContractualInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfMi03LTEtMS0yNzE0_81426ca6-3c23-4a8b-be80-bc465ff1117d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48ce1ae69a484b2897d46eda4fe74206_D20200701-20200930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfMi0xLTEtMS0w_2a47e73d-bfc2-48a9-af0a-2d0eabacfd31">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if94daf002452491ebb4b1b5e305750ce_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfMi0zLTEtMS0w_f7e1dcbf-2dda-4a9d-82ed-30c54d34297e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if767ec539aa84bdf81a78eff0a4bcd22_D20200101-20200930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfMy01LTEtMS0yNzE0_c4767a51-b929-4fda-9912-fb26484b1107">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ba65eca1c4988aeda7e1649f3720f_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfMy03LTEtMS0yNzE0_46ea99d5-e640-4a90-b64e-32876a8d37f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance cost</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48ce1ae69a484b2897d46eda4fe74206_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfMy0xLTEtMS0w_2b46ba9e-9611-47a8-8938-267980404aab">1,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if94daf002452491ebb4b1b5e305750ce_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfMy0zLTEtMS0w_60c2cbbf-7683-4065-b5d1-236fddbd278b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if767ec539aa84bdf81a78eff0a4bcd22_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfNC01LTEtMS0yNzE0_cddc2250-f564-4dc0-9e2e-85a9a06a1af6">2,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ba65eca1c4988aeda7e1649f3720f_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfNC03LTEtMS0yNzE0_aeedeacd-aef0-48d7-95b5-aa17c4ea7f15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense related to the 2027 Notes</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48ce1ae69a484b2897d46eda4fe74206_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfNC0xLTEtMS0w_5c47259e-834b-4d8f-bd7a-1311b72febb9">3,943</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if94daf002452491ebb4b1b5e305750ce_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfNC0zLTEtMS0w_f7a6f315-12db-4148-a837-427861c4f4de">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if767ec539aa84bdf81a78eff0a4bcd22_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfNS01LTEtMS0yNzE0_2ddc63f2-0c2c-4071-8dcc-e9082e949d74">5,727</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ba65eca1c4988aeda7e1649f3720f_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfNS03LTEtMS0yNzE0_da0f90fe-beb0-4e5f-bed8-620755787217">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_61"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMTA5OTUxMTYzMzI0MA_1204bc57-5bc5-4be4-996e-222d28e5f60b" continuedAt="ib9a5ee3ecaf6471ab5c4f35554c111d4" escape="true">Licenses, Asset Acquisitions and Contingent Consideration</ix:nonNumeric></span></div><ix:continuation id="ib9a5ee3ecaf6471ab5c4f35554c111d4" continuedAt="idc7ae60c9ec34da49c5f14000f7b822a"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following purchased assets were accounted for as asset acquisitions as substantially all of the fair value of the assets acquired were concentrated in a group of similar assets and/or the acquired assets were not capable of producing outputs due to the lack of employees and early stage of development. Because the assets had not yet received regulatory approval, the fair value attributable to these assets was recorded as in process research and development (&#8220;IPR&amp;D&#8221;) expenses in the Company&#8217;s condensed consolidated statement of operations for the three and nine months ended September&#160;30, 2020.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for contingent consideration payable upon achievement of certain regulatory, development or sales milestones in such asset acquisitions when the underlying contingency is met.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><ix:continuation id="idc7ae60c9ec34da49c5f14000f7b822a" continuedAt="ie06efe66d3ac49229856718b25e43d10"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">License from Pulmokine, Inc. (GB002)</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;2, 2017, the Company, entered into a license agreement with Pulmokine, Inc. under which it was granted an exclusive worldwide license and sublicense to certain intellectual property rights owned or controlled by Pulmokine to develop and commercialize GB002 and certain backup compounds for the treatment, prevention and diagnosis of any and all disease or conditions. The Company also has the right to sublicense its rights under the license agreement, subject to certain conditions. The assets acquired are in the early stages of the FDA approval process, and the Company intends to further develop the assets acquired through potential FDA approval as evidenced by the milestone arrangement in the contract. The development activities cannot be performed without significant cost and effort by the Company. The agreement will remain in effect from the effective date, unless terminated earlier, until, on a licensed product-by-licensed product and country-by-country basis, the later of <ix:nonNumeric contextRef="ia7131a2487c34cb4bd58334ee5055363_D20171002-20171002" format="ixt-sec:durwordsen" name="goss:ProductLicenseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMTg3MQ_f6e8484c-b619-4f94-b413-87b24f4fe3ea">ten years</ix:nonNumeric> from the date of first commercial sale or when there is no longer a valid patent claim covering such licensed product or specified regulatory exclusivity for the licensed product in such country. The Company is obligated to make future development and regulatory milestone payments of up to $<ix:nonFraction unitRef="usd" contextRef="i51900b7591e64e51863c94621c055cae_I20171002" decimals="INF" format="ixt:numdotdecimal" name="goss:BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMjE2NQ_44f4151d-77b6-4eee-8a60-3a383cfc60ef">63.0</ix:nonFraction> million, commercial milestone payments of up to $<ix:nonFraction unitRef="usd" contextRef="i51900b7591e64e51863c94621c055cae_I20171002" decimals="INF" format="ixt:numdotdecimal" name="goss:BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMjIwOA_5f1a5e72-0011-4718-a026-6aed34849b1b">45.0</ix:nonFraction> million, and sales milestone payments of up to $<ix:nonFraction unitRef="usd" contextRef="i51900b7591e64e51863c94621c055cae_I20171002" decimals="INF" format="ixt:numdotdecimal" name="goss:BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMjI1MA_f051c2dd-9871-4506-87e4-e7a95d15e68f">190.0</ix:nonFraction> million. The Company is also obligated to pay tiered royalties on sales for each licensed product, at percentages ranging from the mid-single digits to the high single-digits. The Company made an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="idcc05f91f85e4e60b74e1e52f826c49d_D20171001-20171031" decimals="-5" format="ixt:numdotdecimal" name="goss:UpfrontPayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMjQ2MA_f59487e3-ad14-4a41-99f4-c2155ad88b38">5.5</ix:nonFraction> million in October 2017. As of September&#160;30, 2020, <ix:nonFraction unitRef="usd" contextRef="id960de866c1840368aa1b490b1df8a76_I20200930" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMjQ5MA_d3df7c08-4b05-49b2-b79d-58cbb20dc152">no</ix:nonFraction> milestones had been accrued as the underlying contingencies had not yet been met.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">AA Biopharma Inc. Acquisition (GB001)</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;4, 2018, the Company acquired AA Biopharma Inc. pursuant to a merger agreement, and with the acquisition acquired the rights to GB001 and certain backup compounds. In connection with the merger agreement, the Company issued an aggregate of <ix:nonFraction unitRef="shares" contextRef="i48df4955276f406984e65cbd02fc2753_D20180104-20180104" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMjg2MA_b6e3a60d-a010-438a-8458-2e2efd0021e1">20,000,000</ix:nonFraction> shares of Series Seed Convertible Preferred Stock and <ix:nonFraction unitRef="shares" contextRef="ibc437c92dc4d47abbc82d156fe56b94a_D20180104-20180104" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMjkxNw_c00b0065-9be8-49df-918b-8b45999e8c03">1,101,278</ix:nonFraction> shares of Common Stock to the AA Biopharma shareholders. The Company recorded IPR&amp;D of $<ix:nonFraction unitRef="usd" contextRef="ia6763b93bb734419aa637f9886d0f8d4_D20180101-20180131" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMzAwNw_f5e563e5-1682-4b92-ac9f-4cd25d3d360a">19.3</ix:nonFraction> million in January 2018 in connection with the acquisition of AA Biopharma.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">License from Aerpio Pharmaceuticals, Inc. (GB004)</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;24, 2018, the Company entered into a license agreement with Aerpio Pharmaceuticals, Inc. (&#8220;Aerpio&#8221;) under which the Company was granted an exclusive worldwide license and sublicense to certain intellectual property rights owned or controlled by Aerpio to develop and commercialize GB004, and certain other related compounds for all applications. The Company made an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i149440b5575441f1ade1e500f96cffcd_D20180601-20180630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMzI5ODUzNDg4ODg1Mw_47a2c6fc-ad55-4a15-b56d-1b54d40da065">20.0</ix:nonFraction> million in June 2018, which represented the purchase consideration for an asset acquisition. On May 11, 2020, the Company entered into an amendment to the license agreement with Aerpio pursuant to which the Company made an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i4c1fea39e1c24a86b52512965a113dc8_D20200511-20200511" decimals="-5" format="ixt:numdotdecimal" name="goss:UpfrontPayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMzYyNw_f90acbc9-b7cc-4f21-ad3e-96a429031188">15.0</ix:nonFraction> million to Aerpio for a reduction in future milestone payments and royalties. Under the amended license agreement, the Company is obligated to make future approval milestone payments of up to $<ix:nonFraction unitRef="usd" contextRef="i34b002ec88bf4140996fb7ae42f20c25_I20200511" decimals="INF" format="ixt:numdotdecimal" name="goss:BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMzgxNA_c1c9671d-cebe-4a0f-9e5e-26b3fb40b68e">40.0</ix:nonFraction> million and a sales milestone payment of $<ix:nonFraction unitRef="usd" contextRef="i34b002ec88bf4140996fb7ae42f20c25_I20200511" decimals="INF" format="ixt:numdotdecimal" name="goss:BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMzg1MA_849194fd-f69c-42a8-964c-ff2b133f4ba3">50.0</ix:nonFraction> million. The Company also has the right to sublicense its rights under the license agreement, subject to certain conditions. The Company is also obligated to pay tiered royalties on sales for each licensed product, at percentages ranging from low- to mid-single digits, subject to certain customary reductions. Aerpio retains its twenty percent (<ix:nonFraction unitRef="number" contextRef="i058b2b9596f049bf88bf24e8ef1b88f5_D20180624-20180624" decimals="3" name="goss:ParticipationRight" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfNDE5MA_20d730ed-45fc-45f5-a8f6-69da23e18a3b">20.00</ix:nonFraction>%) participation right on a disposition of GB004. As of September&#160;30, 2020, <ix:nonFraction unitRef="usd" contextRef="i3f2d41e0946a449d9739a4055373fcb5_I20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfNDM3NQ_39156bc7-9659-4398-811f-b93b9fb079b4">no</ix:nonFraction> milestones had been accrued as the underlying contingencies had not yet been met.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adhaere Pharmaceuticals, Inc. Acquisition (GB1275) </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;21, 2018,&#160;the Company acquired Adhaere Pharmaceuticals, Inc. (&#8220;Adhaere&#8221;) pursuant to a merger agreement for an upfront payment of  $<ix:nonFraction unitRef="usd" contextRef="i8d3bd9ebc0c04c8aac7d80aadda3c812_D20180921-20180921" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfNDY1Ng_3d5663d8-2c08-4556-8961-b4086f823a8f">7.5</ix:nonFraction> million in cash, and with the acquisition acquired the rights to GB1275 and certain backup compounds. The Company is obligated to make regulatory, development and sales milestone payments of up to $<ix:nonFraction unitRef="usd" contextRef="i71ff0fe376bb4ce4a0d344274d60cda5_I20180921" decimals="INF" format="ixt:numdotdecimal" name="goss:BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfNDg0OA_6419f430-bf4c-4cf0-89c7-06392624bafd">62.0</ix:nonFraction> million and pay tiered royalties on worldwide net sales, at percentages ranging from low to mid-single digits, subject to customary reductions. In September 2018, the Company recorded IPR&amp;D of $<ix:nonFraction unitRef="usd" contextRef="i311895b288e84df99a0fe27ae04661aa_D20180901-20180930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfNTAzNg_2822f729-e9ee-42fd-99fc-6bab8b82a2c9">7.5</ix:nonFraction> million in connection with the acquisition of Adhaere. In May 2019, the Company made a milestone payment of $<ix:nonFraction unitRef="usd" contextRef="i449c34cb7fd642fc8a19b754af262018_D20190501-20190531" decimals="-5" format="ixt:numdotdecimal" name="goss:BusinessCombinationContingentConsiderationMilestonesPayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfNTEzOQ_43a27f12-ad24-4cec-9ab1-fbeb49358a6e">1.0</ix:nonFraction> million in connection with the filing of the Investigational New Drug application for the GB1275 program. As of September&#160;30, 2020, <ix:nonFraction unitRef="usd" contextRef="ib5f049d5e60d4e86a687f615be004af7_I20200930" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfNTI1MA_3e4dae1e-0203-4670-b1b3-381f8cabc7d9">no</ix:nonFraction> other milestones had been accrued as the underlying contingencies had not yet been met.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><ix:continuation id="ie06efe66d3ac49229856718b25e43d10"><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="goss:InProcessResearchAndDevelopmentExpensesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfNTQ2Mg_b0498d5a-680c-4f31-99e5-366b76603936" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded the following IPR&amp;D expense on the condensed consolidated statements of operations (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.046%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GB001</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4e0c83f4759440487e347440556bf19_D20200701-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMi0xLTEtMS0w_cb5517a3-0c5f-4856-8afa-bf1ab64d8b79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa29bc841f9e4fb0955d09333da173cf_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMi0zLTEtMS0w_e89a70d6-0f38-4785-8f14-c6f3661e3a63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0589fce7ead149e3b77ab56902cfd9da_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMi01LTEtMS0w_6436898f-fe27-4b96-93b1-8ade54e92a65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb792d6d5530491786d139e759d02ca9_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMi03LTEtMS0w_031c6777-8d86-4b08-9206-00a0a1859d15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GB002</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d36daa696204d2a993a2a5386f71366_D20200701-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMy0xLTEtMS0yNjQ1_589f69d6-0fb2-4a93-8081-78aa4c6bf934">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica43b072ffa14194a075ee24b8eefd04_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMy0zLTEtMS0yNjQ1_fa42e59b-7a7f-4132-8f82-9b80a23411e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic25495903f344f3badaca483a298b34c_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMy01LTEtMS0yNjQ1_25d9788b-bf19-4c90-bda6-957059d806c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69f21cf412842c28bbd38e5675710e9_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMy03LTEtMS0yNjQ1_679bf469-47a3-49c6-856e-400007afba2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GB004</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i785b0d7d87e64989afb260e63ffcaa75_D20200701-20200930" decimals="-3" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMy0xLTEtMS0w_4684ae8a-2f13-426d-9345-bffecc145bb3">275</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5877020a64de4daf9c2e9fc19548520c_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMy0zLTEtMS0w_99794960-c6d0-42b4-9015-520fe39614ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dcb3875d02e46f6860a02a7ae51afa3_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMy01LTEtMS0w_5fb0d1a5-d5ac-488d-a6ff-4819f6659e61">15,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc960cc1b38e453d8577212588425de5_D20190101-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMy03LTEtMS0w_3c108ef9-6cd3-4877-9405-94521ce43344">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GB1275</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e82f42dcfad490d88675b7ce2d18579_D20200701-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNC0xLTEtMS0w_5c3d530a-844a-4382-80d0-529c9eff8deb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f1eb79d41a7477e8aac7ef9621f779b_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNC0zLTEtMS0w_5d4d1f20-8977-4d59-8781-c139c6d685c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc076cf8ed8c4b60a0160f586d633a9d_D20200101-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNC01LTEtMS0w_d062c900-3280-41e0-b12e-720d9fdea218">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6dfed8a74714ce4b52a2b48f1f8bcfe_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNC03LTEtMS0w_d0ffc557-a364-48e6-8770-7a31b7e34621">1,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Programs</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29791a3aea134a31a642f180d6f252e1_D20200701-20200930" decimals="-3" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNS0xLTEtMS0w_a4a8bb42-80be-46bc-ad47-f374550e902d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28e36142d5da400cbe56fb94780d66fe_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNS0zLTEtMS0w_f80bce88-3b49-4ac4-a797-47aed9156161">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i213f70a2c4f54d029f161eb250548f2f_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNS01LTEtMS0w_ec5e2d8c-d29d-43a4-8020-46fa673faf76">2,805</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97eeb89fb4f541069f7d7bb71850f31f_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNS03LTEtMS0w_78b2752f-7dbc-462a-a25c-932604c72fe4">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total in process research and development</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-3" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNi0xLTEtMS0w_3cf662b1-7b4c-420b-a51d-f7c5e6da6500">275</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930" decimals="-3" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNi0zLTEtMS0w_68621662-4a6b-4b14-9297-491122d0eb2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNi01LTEtMS0w_86ba8b7a-9522-4aa5-9dfa-5bb32d986cfc">18,080</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNi03LTEtMS0w_c49d4d8a-2080-4692-9560-cbb401c46d52">2,000</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_67"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMTA5OTUxMTYzMTY3Ng_36dabb9b-0139-4073-a715-bd84716823a9" continuedAt="i721ad1413c574eba8f214a12a1689686" escape="true">Stockholders&#8217; Equity</ix:nonNumeric></span></div><ix:continuation id="i721ad1413c574eba8f214a12a1689686" continuedAt="i1a8507ac0e75462197482a0c265ea2ff"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s IPO, the outstanding shares of the Company&#8217;s Series Seed, Series A, and Series B Convertible Preferred Stock automatically converted into <ix:nonFraction unitRef="shares" contextRef="i4c1117486726474d966d52141c13b867_D20190101-20190331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMjAw_3a21de1a-4d93-4eba-8c07-ae190165299f">30,493,460</ix:nonFraction> shares of common stock. Each share of common stock is entitled to <ix:nonFraction unitRef="vote" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="goss:CommonStockVotingRightsNumberOfVotesPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMjY5_bdb741eb-ad17-47ac-99df-be2fd832fd10">one</ix:nonFraction> vote. Common stock owners are entitled to dividends when funds are legally available and declared by the Board.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shelf Registration Statement and Stock Offering</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 10, 2020, the Company filed a universal shelf registration statement on Form S-3, covering the offering from time to time of common stock, preferred stock, debt securities, warrants and units, which registration statement became automatically effective on April 10, 2020 (the &#8220;Shelf Registration Statement&#8221;).</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 21, 2020, the Company completed a public offering of <ix:nonFraction unitRef="shares" contextRef="i32aaefa176c1431b83d26da9efa9e0e0_D20200521-20200521" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfODEw_efb314ae-e8de-4f67-b0a5-b057c5c3ad13">9,433,963</ix:nonFraction> shares of its common stock at a public offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i4903290fc91c4b818ef0419687e6bdb2_I20200521" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfODcw_bd7eb8db-d690-49f7-b2cc-2bde202a48a9">13.25</ix:nonFraction> per share. The net proceeds from the offering, after deducting underwriting discounts and commissions and other offering costs, were approximately $<ix:nonFraction unitRef="usd" contextRef="i32aaefa176c1431b83d26da9efa9e0e0_D20200521-20200521" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMTA5OTUxMTYzMTcwOQ_fc8dd8aa-ffd5-4953-821f-d94667836e69">117.1</ix:nonFraction>&#160;million. The shares sold in the offering were registered pursuant to the Company&#8217;s Shelf Registration Statement.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Founder Shares</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;3, 2015, the Company issued <ix:nonFraction unitRef="shares" contextRef="id9231a57c1ff4550b9a94b3c726cfbfc_D20151203-20151203" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMTE4Mw_8f3a59e0-f259-4e09-98a9-e342bc74413e">9,160,888</ix:nonFraction> shares of common stock as founder shares for services rendered to the Company, valued at $<ix:nonFraction unitRef="usdPerShare" contextRef="i6f6a02fac0054f41ac0a21a7a698dd11_I20151203" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMTI3NQ_3c0d333c-c769-401b-80cd-8ed6271ee631">0.0001</ix:nonFraction> par value per share, for a total of approximately $<ix:nonFraction unitRef="usd" contextRef="id9231a57c1ff4550b9a94b3c726cfbfc_D20151203-20151203" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMTMyOA_91bf378f-b8bc-46bc-a932-81098a52f3ce">4,100</ix:nonFraction>. On January&#160;4, 2018, incremental vesting conditions were placed on the previously issued founder shares. <ix:nonFraction unitRef="number" contextRef="ia9c4125058a849188d84d6987a2aca5c_I20180104" decimals="2" format="ixt-sec:numwordsen" name="goss:CommonStockVestingPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMTQzNg_e4cdbf7d-14f0-486e-a371-16767f83e3fe">Fifty</ix:nonFraction> percent of the previously issued founder shares vested on January&#160;4, 2018, and the remaining founder shares are subject to vesting restrictions over a period of <ix:nonNumeric contextRef="i56b9c2498afd46cea09d67fffcd7f527_D20180104-20180104" format="ixt-sec:durwordsen" name="goss:CommonStockVestingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMTA5OTUxMTYzMTcyNA_a2d467fa-415a-4e7c-8a73-92a7a9aee145">five years</ix:nonNumeric>.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the employment agreements with the Company&#8217;s founders executed January 4, 2018, the Company provided for certain potential additional issuances of common stock (the &#8220;anti-dilution shares&#8221;) to each of the founders to ensure the total number of shares of common stock held by them and their affiliates (inclusive of any shares subject to equity awards granted by the Company) would represent <ix:nonFraction unitRef="number" contextRef="id747bd928ed14565962ba04db245c625_I20180104" decimals="2" name="goss:PercentageOfFullyDilutedShareCapital" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMjAxMg_963b91ca-36ac-46ba-9bbe-a6267e465d63">15</ix:nonFraction>% of the Company&#8217;s fully-diluted capitalization until such time as the Company raised $<ix:nonFraction unitRef="usd" contextRef="id747bd928ed14565962ba04db245c625_I20180104" decimals="-5" format="ixt:numdotdecimal" name="goss:IncreasedInEquityCapitalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMjA5OQ_562622dc-0880-4145-9cf8-0604e4b49309">300.0</ix:nonFraction> million in equity capital, including the capital raised in the Series&#160;A financing.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In furtherance of this obligation, on May 21, 2018, the Company issued <ix:nonFraction unitRef="shares" contextRef="ia05c65f0299b4470b9988c00f268c597_D20180521-20180521" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMjI0OA_542d65a3-16f9-4d8f-b16e-db5800d88323">251,547</ix:nonFraction> shares of common stock to the founders for services rendered to the Company, valued at $<ix:nonFraction unitRef="usdPerShare" contextRef="i44b0b9ab297245a587e455ae0fbdf7e1_I20180521" decimals="INF" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMjMzOA_2df4878b-bfe0-41b9-974f-c1c4f756170e">2.61</ix:nonFraction> per share with an additional <ix:nonFraction unitRef="shares" contextRef="ia05c65f0299b4470b9988c00f268c597_D20180521-20180521" decimals="INF" format="ixt:numdotdecimal" name="goss:IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMjM3MA_e7fb29e2-e3ae-4e90-b073-974a74f6a6e8">251,547</ix:nonFraction>&#160;shares of restricted stock subject to the same vesting restrictions and vesting period as the founder shares. In addition, on September 6, 2018, the Company issued <ix:nonFraction unitRef="shares" contextRef="i13993408590b4d4aae392dedae7f7168_D20180906-20180906" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMjUzNw_eb431826-8e85-4598-948f-fd807ccd87eb">1,795,023</ix:nonFraction> shares of common stock to the founders for services rendered to the Company, valued at $<ix:nonFraction unitRef="usdPerShare" contextRef="i4232852076fb41578223f9f35c5620ed_I20180906" decimals="INF" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMjYyNw_1e6ec274-3b87-4e81-9be3-837b8b285fa0">9.63</ix:nonFraction> per share, with an additional <ix:nonFraction unitRef="shares" contextRef="i13993408590b4d4aae392dedae7f7168_D20180906-20180906" decimals="INF" format="ixt:numdotdecimal" name="goss:IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMjY2MA_fe3704c3-4cbc-4540-9283-c017113356df">1,795,023</ix:nonFraction> shares of restricted stock subject to the same vesting restrictions and vesting period as the founder shares.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shares of Common Stock Subject to Repurchase</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2017, in connection with the issuance of the Series A Convertible Preferred Stock, certain employees entered into stock restriction agreements, whereby <ix:nonFraction unitRef="shares" contextRef="i6361b8d7044547f78137b4ca8e8367ae_D20171101-20171130" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMjk4Mg_e78ecd7d-bd77-4fea-b0e7-2b2af847af39">1,305,427</ix:nonFraction> shares are subject to forfeiture by the Company upon the stockholder&#8217;s termination of employment or service to the Company. In January 2018, the Company&#8217;s founders entered into stock restriction agreements, whereby <ix:nonFraction unitRef="shares" contextRef="id21572d412b64344adae1b7652804401_D20180101-20180131" decimals="INF" format="ixt:numdotdecimal" name="goss:StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMzIwMA_65727863-61e0-4d7e-9bf1-7754a9dd5a8e">4,580,444</ix:nonFraction> of previously unrestricted shares of common stock were subject to service vesting conditions. These shares are also subject to forfeiture by the Company upon the stockholders&#8217; termination of employment or service to the Company. Any shares subject to repurchase by the Company are not deemed, for accounting purposes, to be outstanding until those shares vest. As such, the Company recognizes the measurement date fair value of the restricted stock over the vesting period as compensation expense. As of September&#160;30, 2020 and December&#160;31, 2019, <ix:nonFraction unitRef="shares" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMzcxOA_385d456f-e25f-4cb9-b8a1-6ead493b6533">3,434,613</ix:nonFraction> </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1a8507ac0e75462197482a0c265ea2ff">and <ix:nonFraction unitRef="shares" contextRef="i565814101ba9433cabc2aba6a50774be_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMzcyNQ_c5d24c54-f29a-47f7-83c8-5fdef2e453ac">4,648,526</ix:nonFraction> shares of common stock were subject to repurchase by the Company, respectively. The unvested stock liability related to these awards is immaterial to all periods presented.</ix:continuation></span></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_73"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMTA5OTUxMTYzMzc3Ng_1531d348-a3b8-42dd-877f-30f824a2ea16" continuedAt="ie3ec802e70744388b3698e6f2808a98d" escape="true">Equity Incentive Plans</ix:nonNumeric></span></div><ix:continuation id="ie3ec802e70744388b3698e6f2808a98d" continuedAt="ie5b90b4c7d0446cc97e220c085878cb5"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019 Equity Incentive Plan </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2019, the Company&#8217;s board of directors and stockholders approved and adopted the 2019 Incentive Award Plan (the &#8220;2019 Plan&#8221;). The 2019 Plan became effective on February 6, 2019, the day prior to the effectiveness of the registration statement filed in connection with the IPO. Under the 2019 Plan, the Company may grant stock options, stock appreciation rights, restricted stock, restricted stock units, and other stock or cash-based awards to individuals who are then employees, officers, directors or consultants of the Company, and employees and consultants of the Company&#8217;s subsidiaries. A total of <ix:nonFraction unitRef="shares" contextRef="icada44f7b33b4bb69194179efb087bf7_I20190206" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNjcz_2d59ff04-d58e-4ea9-b732-92f70c7fd178">5,750,000</ix:nonFraction> shares of common stock were approved to be initially reserved for issuance under the 2019 Plan. The number of shares that remained available for issuance under the 2017 Plan (as defined below) as of the effective date of the 2019 Plan were, and shares subject to outstanding awards under the 2017 Plan as of the effective date of the 2019 Plan that are subsequently canceled, forfeited or repurchased by the Company will be, added to the shares reserved under the 2019 Plan. In addition, the number of shares of common stock available for issuance under the 2019 Plan will be automatically increased on the first day of each calendar year during the <ix:nonNumeric contextRef="i1c8bcc0cc5824acab60dce389cc0e01a_D20190206-20190206" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMTA5OTUxMTYzMzgwMA_77ff1c09-1b0c-4641-89b2-236eb1332ab2">ten-year</ix:nonNumeric> term of the 2019 Plan, beginning with January 1, 2020 and ending with January 1, 2029, by an amount equal to <ix:nonFraction unitRef="number" contextRef="i1c8bcc0cc5824acab60dce389cc0e01a_D20190206-20190206" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMTQ0NA_6d53ae0a-0510-4a4b-a5ad-215a11be167d">5</ix:nonFraction>% of the outstanding number of shares of the Company&#8217;s common stock on December 31 of the preceding calendar year or such lesser amount as determined by the Company&#8217;s board of directors. As of September&#160;30, 2020, an aggregate of <ix:nonFraction unitRef="shares" contextRef="id21248c7f8d1404dbfbcc4790900c1a8_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMTY1OA_4d182763-cb84-48aa-9822-9a568c674753">1,696,802</ix:nonFraction> shares of common stock were available for issuance under the 2019 Plan and <ix:nonFraction unitRef="shares" contextRef="id21248c7f8d1404dbfbcc4790900c1a8_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMTczNg_b9367529-ba7f-4ace-ab52-1dcdfe920a2f">7,291,966</ix:nonFraction> shares of common stock were subject to outstanding awards under the 2019 Plan.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019 Employee Stock Purchase Plan</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2019, the Company&#8217;s board of directors and stockholders approved and adopted the 2019 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;). The ESPP became effective as of February 6, 2019, the day prior to the effectiveness of the registration statement filed in connection with the IPO. The ESPP permits participants to purchase common stock through payroll deductions of up to <ix:nonFraction unitRef="number" contextRef="id682609138d74f299a22b9b828664934_D20190206-20190206" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMjIzMg_74487d0c-a427-4671-9cc9-caa193e98a25">20</ix:nonFraction>% of their eligible compensation. A total of <ix:nonFraction unitRef="shares" contextRef="i55d566fa333348f38fe0698d8122d240_I20190206" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMjI3OA_dc397cad-7274-4479-af78-542d77caf735">700,000</ix:nonFraction> shares of common stock were approved to be initially reserved for issuance under the ESPP. In addition, the number of shares of common stock available for issuance under the ESPP will be automatically increased on the first day of each calendar year during the first <ix:nonNumeric contextRef="id82f48c87413404898cd5e95a6f92456_D20190206-20190206" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMTA5OTUxMTYzMzc5OQ_4878abe2-f167-477d-adf0-0d96da185bf0">ten-years</ix:nonNumeric> of the term of the ESPP, beginning with January 1, 2020 and ending with January 1, 2029, by an amount equal to <ix:nonFraction unitRef="number" contextRef="id82f48c87413404898cd5e95a6f92456_D20190206-20190206" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMjY2OQ_82b5b28f-0023-417b-af08-d0e654ddd872">1</ix:nonFraction>% of the outstanding number of shares of the Company&#8217;s common stock on December 31 of the preceding calendar year or such lesser amount as determined by the Company&#8217;s board of directors. During the nine months ended September 30, 2020, <ix:nonFraction unitRef="shares" contextRef="icf9016d9d3c54fdcbd742124c1e00da3_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="goss:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMjg3NQ_029bd432-9348-4be2-8bb3-55ec6abdefdb">113,286</ix:nonFraction> shares were issued pursuant to the ESPP. As of September&#160;30, 2020, an aggregate of <ix:nonFraction unitRef="shares" contextRef="icf9016d9d3c54fdcbd742124c1e00da3_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMjk0NQ_0902f637-b915-43b6-b840-a195c66faf5a">1,249,554</ix:nonFraction> shares of common stock were available for issuance under the ESPP.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2017 Equity Incentive Plan</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s 2017 Equity Incentive Plan (the &#8220;2017 Plan&#8221;) permitted the granting of incentive stock options, non-statutory stock options, restricted stock, restricted stock units and other stock-based awards. Subsequent to the adoption of the 2019 Plan, no additional equity awards can be made under the 2017 Plan. As of September&#160;30, 2020, <ix:nonFraction unitRef="shares" contextRef="ib62a29f3d4bd41768f85b8c430ff8ed2_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMzM2OA_0ea53d60-61b1-4a95-80d5-456e8118d446">4,071,312</ix:nonFraction> shares of common stock were subject to outstanding options under the 2017 Plan, and <ix:nonFraction unitRef="shares" contextRef="i1bca54ddec634c619bb186716592456f_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMzQ1NQ_2e7340c4-cc93-44f0-9e89-5ad57957ea35">342,006</ix:nonFraction> shares of restricted stock awards granted under the 2017 plan were unvested.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each employee and non-employee stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. The Company, prior to the closing of its IPO on February 12, 2019, was a private company and lacked company-specific historical and implied volatility information. Therefore, it estimated its expected volatility based on the historical volatility of a publicly traded set of peer companies. Due to the lack of historical exercise history, the expected term of the Company&#8217;s stock options for employees has been determined utilizing the &#8220;simplified&#8221; method for awards. The expected term of stock options granted to non-employees is equal to the contractual term of the option award. The risk-free interest rate is determined by reference to the U.S.&#160;Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is <ix:nonFraction unitRef="number" contextRef="id60e67dc25ec478c8538a048150413cc_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNDUxMA_1bde5c27-6c5a-4098-86e4-8c5b528d92a7">zero</ix:nonFraction> based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><ix:continuation id="ie5b90b4c7d0446cc97e220c085878cb5"><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNTk5Nw_be6d6913-8fe0-483f-86bd-572eda5907e3" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity during the nine months ended September 30, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares&#160;Subject&#160;to<br/>Options&#160;Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Remaining<br/>Contractual<br/>Life<br/>(Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic&#160;Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2019</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfMy0xLTEtMS0w_d388561f-30a4-48ef-aafe-d335b588d160">8,538,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfMy0zLTEtMS0w_48152440-8cab-4ad1-a501-f435713b7b45">13.67</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i565814101ba9433cabc2aba6a50774be_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfMy01LTEtMS0w_d81acb74-5c03-403c-88f6-c6359e7d5a05">9.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfMy03LTEtMS0w_2f564b3d-a1bb-4ef6-af10-afb63000206a">35,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfNC0xLTEtMS0w_b7deb812-4bd0-4fe5-bb37-bfad4bbaff9c">2,540,122</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfNC0zLTEtMS0w_85eb92b2-e7e3-4f06-8b11-5982437bec1e">14.02</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Option exercised</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfNS0xLTEtMS0w_1d9ac4ef-4849-4af5-ba91-9230024286c8">76,275</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfNS0zLTEtMS0w_74d40704-26c2-4549-ba89-759443e22c6d">3.73</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited/cancelled</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfNi0xLTEtMS0w_d9ad65dc-907c-4357-8411-2b4a72b0b035">735,012</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfNi0zLTEtMS0w_07851c37-03dc-4d46-af42-9b0d6a4ed327">13.61</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of September 30, 2020</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfNy0xLTEtMS0w_4909ba36-a623-4ad2-a598-ae586635391c">10,266,895</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfNy0zLTEtMS0w_f4eaecc1-5d6c-4ab3-bb77-d11800378a9c">13.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfNy01LTEtMS0w_fdf12eed-5615-486a-b30a-5c4faa5ed253">8.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfNy03LTEtMS0w_63be10fc-cf6e-4831-96bc-c5b1e02f07cc">19,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and exercisable as of September 30, 2020</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfOC0xLTEtMS0w_9298c95f-05a4-4ad3-9561-5ae01b6f9f9b">3,274,782</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfOC0zLTEtMS0w_0f097bfd-a5d5-499f-929d-94e031161bf8">12.57</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfOC01LTEtMS0w_6e83b60e-2773-4a80-ba2a-d4bf09f517df">7.7</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfOC03LTEtMS0w_ddc21c04-d851-4101-8252-bf5adc5bc0ac">10,026</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value in the above table is calculated as the difference between fair value of the Company&#8217;s common stock price on September&#160;30, 2020 and the exercise price of the stock options. The aggregate intrinsic value of stock options exercised during the nine months ended September 30, 2020 was $<ix:nonFraction unitRef="usd" contextRef="id60e67dc25ec478c8538a048150413cc_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMzI5ODUzNDg4OTM1OA_92125d23-919f-483d-a475-554e0c065ac6">0.7</ix:nonFraction> million.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant date fair value per share for the stock option grants during the nine months ended September 30, 2020 was $<ix:nonFraction unitRef="usdPerShare" contextRef="id60e67dc25ec478c8538a048150413cc_D20200101-20200930" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNTA5NQ_302855f8-aefb-4bf8-9eab-b8a016fdeeaa">10.61</ix:nonFraction>.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate fair value of stock options that vested during the nine months ended September 30, 2020 was $<ix:nonFraction unitRef="usd" contextRef="id60e67dc25ec478c8538a048150413cc_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNTE3NA_13f24403-3c30-4c42-8250-5e703d1b0f17">23.1</ix:nonFraction> million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock</span></div><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNTk5OA_0324a7ea-536b-43c0-943e-62dec58a5471" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summary of the Company&#8217;s restricted stock activity is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Restricted<br/>Stock Units<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2019</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i57a7a1c92af444738a26579e9c9b97f4_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjY2YzcxZDQ4ODM0NzQxZjBiODY5OGU4OTdmZTllNjZkL3RhYmxlcmFuZ2U6NjZjNzFkNDg4MzQ3NDFmMGI4Njk4ZTg5N2ZlOWU2NmRfMS0xLTEtMS0w_ed536bf5-8fc3-4a16-98f0-2f40aaf79914">4,648,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i57a7a1c92af444738a26579e9c9b97f4_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjY2YzcxZDQ4ODM0NzQxZjBiODY5OGU4OTdmZTllNjZkL3RhYmxlcmFuZ2U6NjZjNzFkNDg4MzQ3NDFmMGI4Njk4ZTg5N2ZlOWU2NmRfMS0zLTEtMS0w_0986cc33-0991-476d-a3bf-b53346faf068">3.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id7cf20b97501468ba190ca44f798aa5c_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjY2YzcxZDQ4ODM0NzQxZjBiODY5OGU4OTdmZTllNjZkL3RhYmxlcmFuZ2U6NjZjNzFkNDg4MzQ3NDFmMGI4Njk4ZTg5N2ZlOWU2NmRfMi0xLTEtMS0w_efd7502a-5afa-4fe6-afdc-1dc8cf8747c6">1,176,340</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id7cf20b97501468ba190ca44f798aa5c_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjY2YzcxZDQ4ODM0NzQxZjBiODY5OGU4OTdmZTllNjZkL3RhYmxlcmFuZ2U6NjZjNzFkNDg4MzQ3NDFmMGI4Njk4ZTg5N2ZlOWU2NmRfMi0zLTEtMS0w_a9d6355f-c6b7-4ec7-b551-6dcdb6bde1a5">11.94</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id7cf20b97501468ba190ca44f798aa5c_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjY2YzcxZDQ4ODM0NzQxZjBiODY5OGU4OTdmZTllNjZkL3RhYmxlcmFuZ2U6NjZjNzFkNDg4MzQ3NDFmMGI4Njk4ZTg5N2ZlOWU2NmRfMy0xLTEtMS0w_ed93cd9d-fb9e-425c-b8a4-0c8ee556881d">1,213,911</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id7cf20b97501468ba190ca44f798aa5c_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjY2YzcxZDQ4ODM0NzQxZjBiODY5OGU4OTdmZTllNjZkL3RhYmxlcmFuZ2U6NjZjNzFkNDg4MzQ3NDFmMGI4Njk4ZTg5N2ZlOWU2NmRfMy0zLTEtMS0w_6a7f710c-dda6-4e45-99ac-ddeaddef21af">3.71</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id7cf20b97501468ba190ca44f798aa5c_D20200101-20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjY2YzcxZDQ4ODM0NzQxZjBiODY5OGU4OTdmZTllNjZkL3RhYmxlcmFuZ2U6NjZjNzFkNDg4MzQ3NDFmMGI4Njk4ZTg5N2ZlOWU2NmRfNC0xLTEtMS0w_750c9693-06e5-4670-b1c5-8c2d4446c3ed">79,957</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id7cf20b97501468ba190ca44f798aa5c_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjY2YzcxZDQ4ODM0NzQxZjBiODY5OGU4OTdmZTllNjZkL3RhYmxlcmFuZ2U6NjZjNzFkNDg4MzQ3NDFmMGI4Njk4ZTg5N2ZlOWU2NmRfNC0zLTEtMS0w_278d6790-a273-40e6-b6d1-23cc8fe6b949">12.95</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at September 30, 2020</span></td><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8dde91022b6f4727b6a3442ab07af3f3_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjY2YzcxZDQ4ODM0NzQxZjBiODY5OGU4OTdmZTllNjZkL3RhYmxlcmFuZ2U6NjZjNzFkNDg4MzQ3NDFmMGI4Njk4ZTg5N2ZlOWU2NmRfNS0xLTEtMS0w_ce3d0c69-d002-4cf7-a952-c35692f8d037">4,530,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjY2YzcxZDQ4ODM0NzQxZjBiODY5OGU4OTdmZTllNjZkL3RhYmxlcmFuZ2U6NjZjNzFkNDg4MzQ3NDFmMGI4Njk4ZTg5N2ZlOWU2NmRfNS0zLTEtMS0w_b578e5e9-e56c-492b-af10-d9a581fc40af">5.96</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, the total unrecognized compensation related to unvested restricted stock awards granted was $<ix:nonFraction unitRef="usd" contextRef="i8dde91022b6f4727b6a3442ab07af3f3_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNTM2Ng_68cd7555-9a60-4c23-95b3-fb48f7dadf09">20.7</ix:nonFraction> million, which the Company expects to recognize over a weighted-average period of approximately <ix:nonNumeric contextRef="id7cf20b97501468ba190ca44f798aa5c_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNTQ1Nw_74f2aa9b-b36e-4ee9-b541-61857ad513cb">2.2</ix:nonNumeric> years.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNTk5OQ_c77bff78-176d-44e2-8e3c-adfca601b9ed" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense has been reported in the Company&#8217;s condensed consolidated statements of operations as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.046%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ee46adffb174aab896b0ef706379d9e_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfMi0xLTEtMS0w_7d8c3620-d3c5-43b1-93c4-0394c979c508">4,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i383e88d1480f4707a5e280fb091f49f1_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfMi0zLTEtMS0w_f6eb5455-6613-41bf-bc25-023809d50329">2,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e99060b0b3445c2ab001b2db044619c_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfMi01LTEtMS0w_411b3a7d-53c4-4ac5-8a6b-68e9ae858cd1">14,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbd4563ff308475bb9677d83bd6901ed_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfMi03LTEtMS0w_97fb14d7-bf8f-4c97-8c60-5586c8ce7e04">6,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5234f8600a24470b93bc826f0087d51f_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfMy0xLTEtMS0w_8592dd67-3043-4ce3-95a1-acd66478b0d3">4,197</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83e749032dd647eeb7e5730f0d79e71f_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfMy0zLTEtMS0w_745baa2a-5094-49c5-b334-78ac3886b542">3,001</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9addd071f2134af4b1c59d6d7647b955_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfMy01LTEtMS0w_4857c089-8846-45f2-9eb1-16cd5ac1db3c">11,973</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44d278160054bb5935c16c50beece12_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfMy03LTEtMS0w_0876e4b9-3c26-4d8e-88f6-b1c4916f91ae">7,474</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfNC0xLTEtMS0w_12c36381-a25b-4f64-9dc6-d70a1643e035">8,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfNC0zLTEtMS0w_e7b0f267-531f-4536-9877-9b77326b62a9">5,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfNC01LTEtMS0w_0a84ae1b-f2f6-47b0-b281-bbc1ea9daf89">26,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfNC03LTEtMS0w_2f6e48c9-fc98-4cc5-9fa0-56eeaff54bdb">13,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, the total unrecognized compensation related to unvested stock option awards granted was $<ix:nonFraction unitRef="usd" contextRef="ief5753da810c4701b357b0ba9f8e7bc1_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNTczNA_6c02b597-1593-44cc-8e93-7b4834488145">61.3</ix:nonFraction> million, which the Company expects to recognize over a weighted-average period of approximately <ix:nonNumeric contextRef="ib4c2928920df49ebaed3b6aed298b48b_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNTgyNQ_b8df9036-d516-4fac-9751-5288f08d02e5">2.5</ix:nonNumeric> years.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, total unrecognized compensation expense related to the ESPP was $<ix:nonFraction unitRef="usd" contextRef="ib654ba389ce740a5b5698b7efa4bf39b_I20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNTkwMw_7cf841d9-28ae-491f-ae5b-4caa62bed4f7">1.9</ix:nonFraction> million, which the Company expects to recognize over a weighted-average period of approximately <ix:nonNumeric contextRef="ib0f9d120e4f34b0e85ac915426783ced_D20200101-20200930" format="ixt-sec:durwordsen" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNTk5NA_e21fd0df-90e8-4a32-be26-5a92a03b77d6">one year</ix:nonNumeric>.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMTA5OTUxMTYzMjg2Mw_f89ea91c-d832-4908-bdd0-67c23d527ab8" continuedAt="if67ea307354a4522aea14dd64c6efef1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="if67ea307354a4522aea14dd64c6efef1" continuedAt="i15ebeb639f4147a392910b7c9129d380"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company subleases certain office and laboratory space under a non-cancelable operating lease expiring in January 2025 for the initial leased space and December 2022 for expansion space leased pursuant to an amendment to the lease agreement entered into in August 2018. The sublease agreement included options to extend for the entire premises through October 2028. The options to extend must be exercised prior to the termination of the original lease agreement. The period covered by the options was not included in the non-cancellable lease term as it not was not determined to be reasonably certain to be executed. The lease agreement also includes a one-time termination option for the expansion space only whereby the Company can terminate the lease with advance written notice. The termination option was not determined to be reasonably certain to be executed. The lease is subject to charges for common area maintenance and other costs, and base rent is subject to an annual <ix:nonFraction unitRef="number" contextRef="i2d1e2f5620c948549f4affe56ba4eba6_D20200101-20200930" decimals="INF" name="goss:OperatingSubleaseAnnualIncreasePercentageForBaseRent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTEwMQ_2941c5c8-c513-46ad-91f6-5223c459050f">3</ix:nonFraction>% increase each subsequent year. Costs determined to be variable and not based on an index or rate were not included in the measurement of the operating lease liabilities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the Company entered into an additional non-cancelable lease agreement for certain office and laboratory space (the &#8220;permanent space&#8221;) in San Diego, California, commencing on May 1, 2020 and expiring on December 31, 2021. The lease agreement includes a lease for temporary space commencing on January 1, 2020 and expiring on the commencement date of the lease of the permanent space. The monthly base rent for the permanent and temporary space is $<ix:nonFraction unitRef="usd" contextRef="i6f160954a3ed444fa5812d76c8308a06_D20191101-20191130" decimals="0" format="ixt:numdotdecimal" name="goss:PermanentMonthlyBaseRent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMTYwOA_d08ccb9c-a240-4069-9189-9e0c3d17ccd5">63,425</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i6f160954a3ed444fa5812d76c8308a06_D20191101-20191130" decimals="0" format="ixt:numdotdecimal" name="goss:TemporaryMonthlyBaseRent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMTYxNQ_ebfde6e7-db59-4e4f-acf6-a5dfa7bb1000">28,745</ix:nonFraction>, respectively. The lease agreement included an option to extend the term of the permanent space for <ix:nonNumeric contextRef="i6f160954a3ed444fa5812d76c8308a06_D20191101-20191130" format="ixt-sec:durwordsen" name="goss:PeriodForWhichLeaseOfPermanentSpaceCanBeExtended" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMTcxOA_56a7d218-7a81-4d93-b8f0-25478dc12541">twelve months</ix:nonNumeric>. The option to extend must be exercised nine months prior to the termination of the original lease agreement. The period covered by the option was not included in the non-cancellable lease term as it not was not determined to be reasonably certain to be executed. The lease is subject to charges for common area maintenance and other costs, and base rent is subject to an annual <ix:nonFraction unitRef="number" contextRef="i6f160954a3ed444fa5812d76c8308a06_D20191101-20191130" decimals="2" name="goss:AnnualIncreasePercentageForLeaseCharges" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMjEwMA_0858d8d3-2752-4192-8f7b-466657a12f97">3</ix:nonFraction>% increase each subsequent year.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, the Company entered into a sublease agreement for the permanent space with a third party. The sublease commenced on July&#160;1, 2020 and expires on December&#160;31, 2021. The sublessee pays the monthly base rent of $<ix:nonFraction unitRef="usd" contextRef="ia55f355b0bbc4b78be1ab19f707c05ec_D20200601-20200630" decimals="0" format="ixt:numdotdecimal" name="goss:SubleaseTemporaryMonthlyBaseRent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTEwNg_916c0650-bbe2-44ef-a7b7-be17a7caa2ad">63,425</ix:nonFraction>, subject to an annual <ix:nonFraction unitRef="number" contextRef="ia55f355b0bbc4b78be1ab19f707c05ec_D20200601-20200630" decimals="2" name="goss:SubleaseAnnualIncreasePercentageForLeaseCharges" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTExMQ_2d9ec6c1-215d-466b-b381-77912ebb3b98">3</ix:nonFraction>% increase, and is obligated to pay for common area maintenance and other costs.&#160;&#160;The sublessee received a <ix:nonNumeric contextRef="ia55f355b0bbc4b78be1ab19f707c05ec_D20200601-20200630" format="ixt-sec:durmonth" name="goss:SubleasePeriodOfBaseRentAbatement" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTEyNA_932fc0a0-3ae1-487a-856f-37ce032a9f86">6</ix:nonNumeric> months base rent abatement. The Company determined that there was no impairment on the original right-of-use asset and will continue to account for the permanent space as it did before the commencement of the sublease.&#160;&#160;The Company recognized $<ix:nonFraction unitRef="usd" contextRef="i29f32f74db5543c8a8510694e76a3c8d_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTIwNQ_227fa485-ed27-4861-b6dc-cb49cae9b8aa"><ix:nonFraction unitRef="usd" contextRef="i9ac3518affc6454b9e891197f6e12355_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTIwNQ_85a89dcd-afb3-4e9f-b725-4ea9a01b65dd">0.1</ix:nonFraction></ix:nonFraction> million in sublease income for the three and nine months ended September&#160;30, 2020.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2020, the Company entered into a lease assignment agreement, whereby it became the assignee to a lease for certain office and laboratory space in Ann Arbor, Michigan. The lease term expires on December 31, 2026 and the Company has the option to extend the term of the lease by up to <ix:nonNumeric contextRef="i5ea38ec7e8c7483eb917072f4fe3f12d_I20200729" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMTA5OTUxMTYzMzYxNg_edd93e2b-8c4e-4989-bb3a-334acb231911">five years</ix:nonNumeric>. The period covered by the option was not included in the non-cancellable lease term as it was not determined to be reasonably certain to be executed. The monthly base rent for the space is $<ix:nonFraction unitRef="usd" contextRef="i0c084b288ebf4e26a9b2953bd0afde9a_D20200729-20200729" decimals="0" format="ixt:numdotdecimal" name="goss:OperatingLeasesMonthlyBaseRentExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMTA5OTUxMTYzMzYzMA_7405823c-6a94-4b25-9af4-9388aa091717">28,495</ix:nonFraction>. The lease is subject to charges for common area maintenance and other costs, and base rent is subject to an annual <ix:nonFraction unitRef="number" contextRef="i0c084b288ebf4e26a9b2953bd0afde9a_D20200729-20200729" decimals="3" name="goss:AnnualIncreasePercentageForLeaseCharges" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMTA5OTUxMTYzMzYzOQ_edbf676f-d873-4738-a8bc-5ce7aa385d84">2.5</ix:nonFraction>% increase on January 1 of each year.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Monthly rent expense is recognized on a straight-line basis over the term of the leases. The operating leases are included in the balance sheet at the present value of the lease payments at a weighted-average discount rate of <ix:nonFraction unitRef="number" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="2" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTEzNA_76669df4-4273-458e-8629-5563ee9f4e68">7</ix:nonFraction>% using the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment as the leases do not provide an implicit rate. The weighted average remaining lease term was <ix:nonNumeric contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTEyOA_0a78bf37-1350-4ffa-889b-88498b2dcb02">3.7</ix:nonNumeric> years.</span></div><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfNTA4Ng_62caef4f-5d80-4095-86e5-1fb6072cadb3" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease costs were comprised of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOmQyNDUyZjljNGU0NDQxMTFhNGI5MmU5MTJlYjk4ZjY4L3RhYmxlcmFuZ2U6ZDI0NTJmOWM0ZTQ0NDExMWE0YjkyZTkxMmViOThmNjhfMS0xLTEtMS0w_be0ec9fd-da22-467b-9d83-8352f6a869d2">1,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOmQyNDUyZjljNGU0NDQxMTFhNGI5MmU5MTJlYjk4ZjY4L3RhYmxlcmFuZ2U6ZDI0NTJmOWM0ZTQ0NDExMWE0YjkyZTkxMmViOThmNjhfMS0zLTEtMS0w_958c3687-7ac3-43ff-bbec-6922d71ad721">2,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term lease cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOmQyNDUyZjljNGU0NDQxMTFhNGI5MmU5MTJlYjk4ZjY4L3RhYmxlcmFuZ2U6ZDI0NTJmOWM0ZTQ0NDExMWE0YjkyZTkxMmViOThmNjhfMi0xLTEtMS0w_4bffe212-51cc-4c2d-a2fc-12676f1e0ed9">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOmQyNDUyZjljNGU0NDQxMTFhNGI5MmU5MTJlYjk4ZjY4L3RhYmxlcmFuZ2U6ZDI0NTJmOWM0ZTQ0NDExMWE0YjkyZTkxMmViOThmNjhfMi0zLTEtMS0w_7d542b06-c19e-4796-898d-6aa9100aaabc">54</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease cost</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOmQyNDUyZjljNGU0NDQxMTFhNGI5MmU5MTJlYjk4ZjY4L3RhYmxlcmFuZ2U6ZDI0NTJmOWM0ZTQ0NDExMWE0YjkyZTkxMmViOThmNjhfMy0xLTEtMS0w_4f052fec-d071-4941-9bae-0c7298e3051d">1,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOmQyNDUyZjljNGU0NDQxMTFhNGI5MmU5MTJlYjk4ZjY4L3RhYmxlcmFuZ2U6ZDI0NTJmOWM0ZTQ0NDExMWE0YjkyZTkxMmViOThmNjhfMy0zLTEtMS0w_2c304b78-6d6e-4652-aa93-dc113b878b50">2,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of operating lease liabilities for the three and nine months ended September 30, 2020 was $<ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTE0MA_eadc7525-ec18-4435-841f-bd9b62558c30">1.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTE0OQ_41543de5-8d84-48a2-8b30-53dc61f4dcfa">2.6</ix:nonFraction> million, respectively.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><ix:continuation id="i15ebeb639f4147a392910b7c9129d380"><ix:nonNumeric contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfNTA4NA_600fcb3d-51fc-480d-92da-4e5bbcf008db" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross future minimum annual rental commitments as of September&#160;30, 2020, were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Undiscounted&#160;Rent<br/>Payments</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ending December 31</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020 (remaining 3 months)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfMi0xLTEtMS0w_13a0df5c-9153-4859-b453-fdaca6a7534d">1,043</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfMy0xLTEtMS0w_71b8c849-4322-44b6-9c8d-518ec2886a28">4,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfNC0xLTEtMS0w_eb81bc94-cd6f-4398-90c3-3cf488f32428">3,579</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfNS0xLTEtMS0w_e40d3614-9110-4265-af72-cceec7b64f99">2,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfNi0xLTEtMS0w_05e7231b-8145-4de3-87c4-208a0f99f298">2,123</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" name="goss:LesseeOperatingLeaseLiabilityPaymentsDueYearSix" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfNy0xLTEtMS0xNTIz_a60a0a26-b413-439c-9619-1af23a9c4ab0">387</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" name="goss:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfOC0xLTEtMS0xNzk0_8e4f83b5-1c8b-4512-86a9-d259a402fe63">397</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total undiscounted rent payments</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfNy0xLTEtMS0w_df30785d-97ae-47e9-a179-c53ff5179e1d">13,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value discount</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfOS0xLTEtMS0w_bef47903-d5f8-403f-bd52-1d9efcb92f31">1,670</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfMTAtMS0xLTEtMA_90414e91-2f8e-4c1b-89e8-15a247f48c05">12,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current portion of operating lease liability (included as a component of accrued expenses)</span></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfMTEtMS0xLTEtMA_69445079-67f9-476f-b72d-28cd5ba462ae">3,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncurrent operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfMTItMS0xLTEtMA_3f7ac23f-d279-4baf-a6ba-253e11e4beb5">8,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease liability</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfMTMtMS0xLTEtMA_ca0b20a9-ef27-4bf5-81bc-4a5e3e450e91">12,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2020 the Company recorded approximately $<ix:nonFraction unitRef="usd" contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTE1Mw_d69fa2a8-2d85-44f9-ad7f-5c3d239feffc">1.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTE2MQ_bcb5686a-adf3-46a1-9477-f72754f08bc7">2.9</ix:nonFraction> million, respectively, in rent expense.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Kuhne vs. Gossamer Bio, Inc., et. al.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 3, 2020, Scott Kuhne, individually and on behalf of all others similarly situated, filed a putative class action lawsuit against the Company, certain of its executive officers and directors, and the underwriters of its IPO in the United States District Court for the Southern District of California (Case No. 3:20-cv-00649-DMS-MDD). The first amended complaint was filed on August 31, 2020. The complaint was filed on behalf of all persons who purchased or otherwise acquired the Company&#8217;s securities between February 8, 2019 and December 13, 2019. The first amended complaint alleges that the Company, certain of its executive officers and directors, and the underwriters of its IPO made false and/or misleading statements and failed to disclose material adverse facts about its business, operations and prospects in violation of Sections 11, 12(a)(2) and 15 of the Securities Act of 1933, as amended, and Sections 10(b) (and Rule 10b-5 promulgated thereunder) and 20(a) of the Securities Exchange Act of 1934, as amended. The plaintiff seeks damages, interest, costs, attorneys&#8217; fees, and other unspecified equitable relief. Following meet and confer discussions amongst the parties to the litigation, Plaintiff was granted leave to further amend his complaint by no later than November 20, 2020. Thereafter, the Company&#8217;s deadline to move to dismiss or otherwise answer that complaint is January 19, 2021. The Company intends to vigorously defend this matter. Given the uncertainty of litigation, the preliminary stage of the case, and the legal standards that must be met for, among other things, class certification and success on the merits, the Company cannot estimate the reasonably possible loss or range of loss that may result from this action.</span></div></ix:continuation><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_85"></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_91"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis and the unaudited interim condensed consolidated financial statements included in this quarterly report on Form 10-Q should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2019 and the related Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, both of which are contained in our Annual Report on Form 10-K filed with the Securities and Exchange Commission, or SEC, on March 24, 2020.</span></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_94"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This quarterly report on Form 10-Q contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. All statements other than statements of historical facts contained in this quarterly report, including statements regarding our future results of operations and financial position, business strategy, the impact of the COVID-19 pandemic, prospective products, product approvals, research and development costs, timing and likelihood of success, plans and objectives of management for future operations, clinical developments and future results of product development programs, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;intend,&#8221; &#8220;target,&#8221; &#8220;project,&#8221; &#8220;contemplates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; &#8220;potential&#8221; or &#8220;continue&#8221; or the negative of these terms or other similar expressions. The forward-looking statements in this quarterly report are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. These forward-looking statements speak only as of the date of this quarterly report and are subject to a number of risks, uncertainties and assumptions, including those described in Part II, Item 1A, &#8220;Risk Factors&#8221; of this report and Part I, Item 1A, &#8220;Risk Factors&#8221; in our most recent Annual Report on Form 10-K filed with the SEC on March 24, 2020. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.</span></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_97"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Our goal is to be an industry leader in each of these therapeutic areas and enhance and extend the lives of patients suffering from such diseases. To accomplish this goal, we have assembled a deeply experienced and highly skilled group of industry veterans, scientists, clinicians and key opinion leaders from leading biotechnology and pharmaceutical companies, as well as leading academic centers from around the world. Our collective immunology and translational discovery and development expertise serves as the foundation of our company.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are pursuing product candidates with strong scientific rationale to address indications where there is both a high unmet need and an opportunity to develop best-in-class or first-in-class programs. We currently have four clinical-stage product candidates, in addition to multiple preclinical programs. We have completed the LEDA Phase 2b clinical trial for our most advanced product candidate, GB001, in moderate-to-severe eosinophilic asthma, and in the fourth quarter of 2020, we announced topline results. GB001 did not achieve its primary endpoint of statistically significant reduction in the portion of patients experiencing asthma worsening, though consistent and meaningful numeric reductions in the odds of asthma worsening were observed across all three drug arms, as compared to placebo. GB001 did achieve statistically significant improvements in the key secondary endpoint of time to first asthma worsening in two of the three drug arms, as compared to placebo. We are engaging global regulatory authorities about the clinical development path forward for GB001 in asthma, to inform our thinking on potential partnerships or strategic alternatives. We have completed the TITAN Phase 2 for GB001 in patients with chronic rhinosinusitis, both with and without nasal polyps, and in the fourth quarter of 2020, we announced topline results. GB001 did not achieve its primary or secondary endpoints in the TITAN trial, and we will not pursue further clinical development for GB001 in chronic rhinosinusitis. We are developing GB002 for the treatment of pulmonary arterial hypertension, or PAH. We commenced enrolling patients for a Phase 1b clinical trial in PAH in the first quarter of 2020, and because we temporarily paused enrollment as a result of the ongoing COVID-19 viral pandemic, we now expect to report topline results from this trial in the fourth quarter of 2020. We have activated sites for the TORREY Phase 2 clinical trial in PAH, and we expect to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">commence the trial in the fourth quarter of 2020. We expect to report topline results of the TORREY trial in the first half of 2022, subject to developments in the ongoing COVID-19 viral pandemic.  GB002 has received orphan designation from the FDA and the European Medicines Agency, or EMA, for the treatment of PAH. We are developing GB004 for the treatment of inflammatory bowel disease, including ulcerative colitis, or UC, and Crohn&#8217;s disease. In the second quarter of 2020, we announced promising topline Phase 1b clinical trial results in mild-to-moderate UC patients with active disease symptoms and histology. We commenced the SHIFT-UC Phase 2 trial of GB004 in UC in the fourth quarter of 2020. We expect to report topline results of the SHIFT-UC trial in the first half of 2022, subject to developments in the ongoing COVID-19 viral pandemic. We are developing GB1275 for the treatment of oncology indications. In the third quarter of 2019, we initiated a Phase 1/2 clinical trial for GB1275 in solid tumor indications as a monotherapy and in combination with either pembrolizumab or chemotherapy. Initial results from this trial were presented at the American Society of Oncology Virtual Program in May of 2020, and further results were presented at the Society for Immunotherapy of Cancer meeting in November 2020. GB1275 has received orphan designation from the FDA and the EMA for the treatment of pancreatic cancer. Our expectations with respect to reporting of topline data and commencement of clinical trials are subject to risks associated with the ongoing COVID-19 pandemic discussed further below.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were incorporated in October 2015 and commenced operations in 2017. To date, we have focused primarily on organizing and staffing our company, business planning, raising capital, identifying, acquiring and in-licensing our product candidates and conducting preclinical studies and early clinical trials. We have funded our operations primarily through equity and debt financings. We raised $942.0 million from October 2017 through September&#160;30, 2020&#160;through Series A and B convertible preferred stock financings,&#160;a convertible note financing,&#160;our IPO completed in February 2019, proceeds from our Credit Facility, and proceeds from our concurrent underwritten public offerings of 2027 Notes and common stock in May 2020. In addition, we received $12.8 million in cash in connection with the January 2018 acquisition of AA Biopharma Inc., of which Pulmagen Therapeutics (Asthma) Limited is a wholly-owned subsidiary. As of September&#160;30, 2020, we had $555.4&#160;million in cash, cash equivalents and marketable securities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred significant operating losses since our inception and expect to continue to incur significant operating losses for the foreseeable future. For the three and nine months ended September&#160;30, 2020 our net loss was $57.8 million and $178.8 million, respectively. For the three and nine months ended September&#160;30, 2019 our net loss was $48.5 million and $125.6 million, respectively. As of September&#160;30, 2020, we had an accumulated deficit of $512.9 million. We expect our expenses and operating losses will increase substantially as we conduct our ongoing and planned clinical trials, continue our research and development activities and conduct preclinical studies, and seek regulatory approvals for our product candidates, as well as hire additional personnel, protect our intellectual property and incur additional costs associated with being a public company. In addition, as our product candidates progress through development and toward commercialization, we will need to make milestone payments to the licensors and other third parties from whom we have in-licensed or acquired our product candidates, including GB002, GB004 and GB1275. Our net losses may fluctuate significantly from quarter-to-quarter and year-to-year, depending in particular on the timing of our clinical trials and preclinical studies and our expenditures on other research and development activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not expect to generate any revenue from product sales unless and until we successfully complete development and obtain regulatory approval for one or more of our product candidates, which we expect will take a number of years. If we obtain regulatory approval for any of our product candidates, we expect to incur significant commercialization expenses related to product sales, marketing, manufacturing and distribution. Accordingly, until such time as we can generate substantial product revenues to support our cost structure, if ever, we expect to finance our cash needs through equity offerings, debt financings or other capital sources, including potentially collaborations, licenses and other similar arrangements. However, we may be unable to raise additional funds or enter into such other arrangements when needed on favorable terms or at all. Our failure to raise capital or enter into such other arrangements when needed could have a negative impact on our financial condition and on our ability to pursue our business plans and strategies. If we are unable to raise additional capital when needed, we could be forced to delay, limit, reduce or terminate our product candidate development or future commercialization efforts or grant rights to develop and market our product candidates even if we would otherwise prefer to develop and market such product candidates ourselves.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Pandemic</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current COVID-19 worldwide pandemic has presented substantial public health and economic challenges and is affecting our employees, patients, communities and business operations, as well as the U.S. and global economies and financial markets. International and U.S. governmental authorities in impacted regions are taking actions in an effort to slow the spread of COVID-19, including issuing varying forms of &#8220;stay-at-home&#8221; orders, and restricting business functions outside of one&#8217;s home. In response, we have implemented a work-from-home policy for certain of our employees. To date, we have been able to continue to supply our product candidates to our patients currently enrolled in our clinical trials, including for GB002, GB004 </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and GB1275, and do not currently anticipate any interruptions in supply. In addition, while we are continuing the clinical trials we have underway in sites across the globe, COVID-19 precautions have delayed, such as the previous pause in enrollment in our Phase 1b clinical trial for GB002 in PAH earlier this year, and may continue to delay completion of these and future trials and may directly or indirectly impact the timeline for data readouts, initiation of, as well as monitoring, data collection and analysis and other related activities for, some of our current and future clinical trials.   For example, our current expectations for when we will initiate our planned Phase 2 clinical trial of GB002 and how we will enroll our Phase 2 clinical trials of GB002 and GB004 are based on an assumption that clinical trial and healthcare activities begin to return to normal and clinical sites remain open or reopen during the fourth quarter of 2020 and first half of 2021 in light of the continued spread of COVID-19.  In particular with respect to GB002, some PAH clinical trial sites are currently closed as PAH patients may be at a higher risk of COVID-19 complications than the general population, and some PAH clinical trials may close again if there is a surge of COVID-19 cases in the specific geographies of such trial site locations. Therefore, our assumptions around initiation timing may prove to be incorrect, in particular if COVID-19 continues to spread. In light of recent developments relating to the COVID-19 pandemic, and consistent with the FDA&#8217;s updated industry guidance for conducting clinical trials, clinical trials may be deprioritized in favor of treating patients who have contracted the virus or to prevent the spread of the virus. This may lead to clinical trial protocol deviations or to discontinuation of treatment for patients who are currently enrolled in our trials. Any delays in the completion of our clinical trials, data analysis or readouts and any disruption in our supply chain could have a material adverse effect on our business, results of operations and financial condition. The full extent to which the COVID-19 pandemic will directly or indirectly impact our business, results of operations and financial condition, will depend on future developments that are highly uncertain, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain or treat it, as well as the economic impact on local, regional, national and international markets.</span></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_100"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Components of Results of Operations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not generated any revenue since our inception and do not expect to generate any revenue from the sale of products for the foreseeable future.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating expenses</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses have related primarily to preclinical and clinical development of our product candidates and discovery efforts. Research and development expenses are recognized as incurred and payments made prior to the receipt of goods or services to be used in research and development are capitalized until the goods or services are received.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses include or could include:</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">salaries, payroll taxes, employee benefits, and stock-based compensation charges for those individuals involved in research and development efforts;</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">external research and development expenses incurred under agreements with contract research organizations, or CROs, investigative sites and consultants to conduct our clinical trials and preclinical and non-clinical studies;</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laboratory supplies;</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs related to manufacturing our product candidates for clinical trials and preclinical studies, including fees paid to third-party manufacturers;</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs related to compliance with regulatory requirements; and</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">facilities, depreciation and other allocated expenses, which include direct and allocated expenses for rent, maintenance of facilities, insurance, equipment and other supplies.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our direct research and development expenses consist principally of external costs, such as fees paid to CROs, investigative sites and consultants in connection with our clinical trials, preclinical and non-clinical studies, and costs related to manufacturing clinical trial materials. We deploy our personnel and facility related resources across all of our research and development activities. We track external costs and personnel expense on a program-by-program basis and allocate common expenses, such as facility related resources, to each program based on the personnel resources allocated to such program. Stock-based compensation and personnel and common expenses not attributable to a specific program are considered unallocated research and development expenses.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to substantially increase our research and development expenses for the foreseeable future as we continue the development of our product candidates and conduct discovery and research activities for our preclinical programs. We cannot determine with certainty the timing of initiation, the duration or the completion costs of current or future preclinical studies and clinical trials of our product candidates due to the inherently unpredictable nature of preclinical and clinical development. Clinical and preclinical development timelines, the probability of success and development costs can differ materially from expectations. We anticipate that we will make determinations as to which product candidates to pursue and how much funding to direct to each product candidate on an ongoing basis in response to the results of ongoing and future preclinical studies and clinical trials, regulatory developments and our ongoing assessments as to each product candidate&#8217;s commercial potential. We will need to raise substantial additional capital in the future.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our clinical development costs may vary significantly based on factors such as:</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs incurred as a result of the COVID-19 pandemic, including clinical trial delays;</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">per patient trial costs;</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of trials required for approval;</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of sites included in the trials;</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the countries in which the trials are conducted;</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the length of time required to enroll eligible patients;</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of patients that participate in the trials;</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of doses that patients receive;</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the drop-out or discontinuation rates of patients;</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential additional safety monitoring requested by regulatory agencies;</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the duration of patient participation in the trials and follow-up;</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of manufacturing our product candidates;</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the phase of development of our product candidates; and</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the efficacy and safety profile of our product candidates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In process research and development</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In process research and development, or IPR&amp;D, expenses include IPR&amp;D acquired as part of an asset acquisition or in-license for which there is no alternative future use, are expensed as incurred.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPR&amp;D expenses consist of our upfront payments made to Pulmokine, Inc., in connection with the in-license of GB002, the value of our stock issued to former AA Biopharma Inc. shareholders, in connection with the acquisition of GB001, our upfront payments made to Aerpio Pharmaceuticals, Inc., or Aerpio, in connection with the in-license and subsequent amendment of the in-license of GB004, our upfront and milestone payments made to Adhaere Pharmaceuticals, Inc., or Adhaere, in connection with the acquisition of GB1275, and upfront and milestone payments made in connection with the acquisition of certain preclinical programs.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses consist primarily of salaries and employee-related costs, including stock-based compensation, for personnel in executive, finance and other administrative functions. Other significant costs include facility-related costs, legal fees relating to intellectual property and corporate matters, professional fees for accounting and consulting services and insurance costs.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our general and administrative expenses will increase for the foreseeable future to support our expanded infrastructure and increased costs of operating as a public company. These increases will likely include increased expenses related to audit, legal, regulatory and tax-related services associated with maintaining compliance with exchange listing and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SEC requirements, director and officer insurance premiums, and investor relations costs associated with operating as a public company.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income, net</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net consists of (1) interest income on our cash, cash equivalents and marketable securities, (2) sublease income, (3) interest expense related to our Credit Facility and our 5.00% 2027 Notes, and (4) other miscellaneous income (expense).</span></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_103"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management&#8217;s discussion and analysis of our financial condition and results of operations are based on our condensed consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States, or GAAP. The preparation of these financial statements requires us to make judgments and estimates that affect the reported amounts of assets, liabilities, revenues, and expenses and the disclosure of contingent assets and liabilities in our condensed consolidated financial statements. We base our estimates on historical experience, known trends and events, and various other factors that are believed to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions. On an ongoing basis, we evaluate our judgments and estimates in light of changes in circumstances, facts and experience. During the three and nine months ended September&#160;30, 2020, there have been no significant changes in our critical accounting policies as discussed in Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations &#8211; Critical Accounting Policies and Estimates&#8221; in our Annual Report on Form 10-K filed with the SEC on March 24, 2020, with the exception of policies put in place with regards to the 2027 Notes (see Note 2 &#8220;Summary of Significant Accounting Policies&#8212;Convertible Senior Notes&#8221; to the Notes to Unaudited Condensed Consolidated Financial Statements included in Part I, Item 1, of this Form 10-Q).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations &#8211; Comparison of the Three and Nine Months Ended September 30, 2020 and 2019</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our selected statements of operations data for the three months ended September&#160;30, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020&#160;vs&#160;2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41,846&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40,148&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,698&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In process research and development</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">275&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">275&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,448&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,838&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,610&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,569&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,986&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,583&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss from operations</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(53,569)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(49,986)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,583)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,243)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,486&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,729)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(57,812)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(48,500)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9,312)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our selected statements of operations data for the nine months ended September&#160;30, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:62.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020&#160;vs&#160;2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121,944&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100,807&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21,137&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In process research and development</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,080&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,000&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,080&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,851&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,544&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,307&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173,875&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130,351&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43,524&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss from operations</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(173,875)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(130,351)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(43,524)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,881)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,742&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9,623)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(178,756)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(125,609)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(53,147)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_106"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses were $41.8 million for the three months ended September&#160;30, 2020, compared to $40.1 million for the three months ended September&#160;30, 2019, for an increase of $1.7 million, which was primarily attributable to an increase of costs related to personnel.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses were $121.9 million for the nine months ended September&#160;30, 2020, compared to $100.8 million for the nine months ended September&#160;30, 2019, for an increase of $21.1 million, which was primarily attributable to an increase of $14.1 million of costs related to personnel and an increase of $4.6  million of costs associated with other preclinical studies.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows our research and development expenses by program for the three and nine months ended September&#160;30, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.046%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GB001</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,716&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,007&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,258&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,205&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GB002</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,687&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,856&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,593&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,002&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GB004</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,598&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,246&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,522&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,455&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GB1275</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,181&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,484&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,620&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,861&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Programs</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,664&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,555&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,951&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,284&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total research and development</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,846&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,148&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,944&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,807&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In process research and development</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no significant IPR&amp;D expenses for the three months ended September&#160;30, 2020 or 2019.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPR&amp;D expenses for the nine months ended September&#160;30, 2020 were $18.1 million, compared to $2.0 million for the nine months ended September&#160;30, 2019, for an increase of $16.1 million, which was primarily attributable to a $15.0 million upfront payment to Aerpio in connection with the amendment to the in-license agreement of GB004.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses were $11.4 million for the three months ended September&#160;30, 2020, compared to $9.8 million for the three months ended September&#160;30, 2019, for an increase of $1.6 million, which was primarily attributable to a $1.2 million increase in stock-based compensation costs.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses were $33.9 million for the nine months ended September&#160;30, 2020, compared to $27.5 million for the nine months ended September&#160;30, 2019, for an increase of $6.3 million, which was primarily attributable to a $4.5 million increase in stock-based compensation costs and a $1.8 million increase in personnel costs.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other income (expense), net</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net was $4.2 million for the three months ended September&#160;30, 2020, compared to other income, net of $1.5 million for the three months ended September&#160;30, 2019, for a decrease of $5.7 million, which was primarily attributable to a $4.0 million increase in interest expense and a $1.7 million decrease in investment income earned on our cash, cash equivalents and marketable securities during the period.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net was $4.9 million for the nine months ended September&#160;30, 2020, compared to other income, net of $4.7 million for the nine months ended September&#160;30, 2019, for a decrease of $9.6 million, which was primarily attributable to a $6.7 million increase in interest expense and a $3.0 million decrease in investment income earned on our cash, cash equivalents and marketable securities during the period.</span></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_109"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred substantial operating losses since our inception and expect to continue to incur significant operating losses for the foreseeable future and may never become profitable. As of September&#160;30, 2020, we had an accumulated deficit of $512.9 million.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary use of cash is to fund operating expenses, which consist primarily of research and development expenditures, and to a lesser extent, general and administrative expenditures. Cash used to fund operating expenses is impacted by the timing of when we pay these expenses, as reflected in the change in our outstanding accounts payable and accrued expenses.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From our inception through the nine months ended September&#160;30, 2020, our operations have been financed primarily by gross proceeds of $942.0 million from the sale of our convertible preferred stock, convertible promissory note, proceeds from our IPO, proceeds from our Credit Facility, and proceeds from our concurrent underwritten public offerings of 2027 Notes and common stock. As of September&#160;30, 2020 we had cash, cash equivalents and marketable securities of $555.4&#160;million. Cash in excess of immediate requirements is invested in accordance with our investment policy, primarily with a view to capital preservation and liquidity.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 12, 2019, we closed our IPO and the underwriters in the IPO purchased 19,837,500 shares, including the full exercise of their option to purchase additional shares of common stock. The net proceeds from the IPO were $291.3 million, after deducting underwriting discounts and commissions and estimated offering costs. In connection with the closing of the IPO, the outstanding shares of our convertible preferred stock were converted into shares of common stock at a ratio of 4.5-to-one.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 2, 2019, we entered into a credit, guaranty and security agreement, as amended on September 18, 2019 and July 2, 2020, pursuant to which the lenders party thereto agreed to make term loans available to us for working capital and general business purposes, in a principal amount of up to $150.0 million in term loan commitments, including a $30.0 million term loan which was funded at the closing date, with the ability to access the remaining $120.0 million in two additional tranches (each $60.0 million), subject to specified availability periods, the achievement of certain clinical development milestones, minimum cash requirements and other customary conditions, or the Credit Facility. As of September&#160;30, 2020, no other tranches under the Credit Facility have been drawn.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 10, 2020, we filed a registration statement on Form S-3, or the Shelf Registration Statement, covering the offering from time to time of common stock, preferred stock, debt securities, warrants and units, which registration statement became automatically effective on April 10, 2020.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we issued $200.0 million aggregate principal amount 5.00% convertible senior notes due 2027 in a registered public offering. The interest rate on the 2027 Notes is fixed at 5.00% per annum. Interest is payable semi-annually in arrears on June 1 and December 1 of each year commencing on December 1, 2020. The total net proceeds from the 2027 Notes, after deducting the underwriting discounts and commissions and other offering costs, were approximately $193.6 million. Concurrent with the registered underwritten public offering of the 2027 Notes, we completed an underwritten public offering of 9,433,963 shares of our common stock. We received net proceeds of $117.1 million, after deducting underwriting discounts and commissions and other offering costs. Our concurrent offerings of 2027 Notes and common stock were registered pursuant to the Shelf Registration Statement.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information about our long-term borrowings is presented in Note 5 &#8220;Indebtedness&#8221; to the Notes to Unaudited Condensed Consolidated Financial Statements included in Part I, Item 1, of this Form 10-Q, which is incorporated herein by this reference.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows a summary of our cash flows for each of the nine months ended September&#160;30, 2020 and 2019, respectively:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139,624)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100,694)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,242&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(194,077)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312,291&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,060&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash and cash equivalents</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,909&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,289&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating activities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2020, operating activities used approximately $139.6 million of cash, primarily resulting from a net loss of $178.8 million and changes in operating assets and liabilities of $10.1 million, reduced by stock-based compensation expense of $26.1 million and IPR&amp;D expense of $18.1 million. Net cash used in changes in operating assets and liabilities consisted primarily of&#160;changes&#160;in accrued research and development expenses and prepaid expenses and other current assets.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2019, operating activities used approximately $100.7 million of cash, primarily resulting from a net loss of $125.6 million, partially reduced by stock-based compensation expense of $14.0 million and changes in operating assets and liabilities of $10.5 million. Net cash provided by changes in operating assets and liabilities consisted primarily of changes in operating lease right of use assets and liabilities, other assets, accounts payable, accrued research and development expenses, and accrued compensation and benefits of $14.1 million, offset by cash used in prepaid expenses and other current assets and accrued expenses of $3.6 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing activities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2020, investing activities provided approximately $154.2 million of cash, primarily resulting from the sales and maturities of marketable securities of $282.5 million, offset by the purchases of marketable securities of $109.0 million and a $15.0 million upfront payment to Aerpio in connection with the amendment to the in-license agreement of GB004.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2019, investing activities used approximately $194.1 million of cash, primarily resulting from the purchase of marketable securities of $399.4 million, milestone payments of $2.0 million, and purchases of property and equipment of $2.4 million, offset by sales and maturities of investments of $209.8 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing activities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2020, financing activities provided $312.3 million of cash, primarily resulting from the concurrent registered underwritten public offerings of 2027 Notes and our common stock for net proceeds of $193.6 million and $117.1 million, respectively.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2019, financing activities provided $320.1 million of cash, primarily resulting from the net proceeds from our IPO of $291.3 million and proceeds from a long-term debt facility of $30 million, offset by $1.8 million of debt issuance costs.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Funding requirements</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our current operating plan, we believe that our existing cash, cash equivalents and marketable securities, and access to our Credit Facility, will be sufficient to fund our operations into the second half of 2023. However, our forecast of the period of time through which our financial resources will be adequate to support our operations is a forward-looking statement that involves risks and uncertainties, and actual results could vary materially. We have based this estimate on assumptions that may prove to be wrong, and we could use our capital resources sooner than we expect. Additionally, the process of testing product candidates in clinical trials is costly, and the timing of progress and expenses in these trials is uncertain.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future capital requirements will depend on many factors, including:</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the type, number, scope, progress, expansions, results, costs and timing of, our preclinical studies and clinical trials of our product candidates which we are pursuing or may choose to pursue in the future;</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs and timing of manufacturing for our product candidates;</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs, timing and outcome of regulatory review of our product candidates;</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of obtaining, maintaining and enforcing our patents and other intellectual property rights;</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our efforts to enhance operational systems and hire additional personnel to satisfy our obligations as a public company, including enhanced internal controls over financial reporting;</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs associated with hiring additional personnel and consultants as our preclinical and clinical activities increase;</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and amount of the milestone or other payments we must make to the licensors and other third parties from whom we have in-licensed our acquired our product candidates;</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs and timing of establishing or securing sales and marketing capabilities if any product candidate is approved;</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to achieve sufficient market acceptance, coverage and adequate reimbursement from third-party payors and adequate market share and revenue for any approved products;</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the terms and timing of establishing and maintaining collaborations, licenses and other similar arrangements;</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs associated with any products or technologies that we may in-license or acquire; and</span></div><div style="margin-top:10pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any delays and cost increases that result from the COVID-19 pandemic.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until such time as we can generate substantial product revenues to support our cost structure, if ever, we expect to finance our cash needs through equity offerings, our Credit Facility, debt financings or other capital sources, including potentially collaborations, licenses and other similar arrangements.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, we may be unable to raise additional funds or enter into such other arrangements when needed on favorable terms or at all. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interest of our stockholders will be or could be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of our common stockholders. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we raise funds through collaborations, licenses and other similar arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to us and/or may reduce the value of our common stock. Our failure to raise capital or enter into such other arrangements when needed could have a negative impact on our financial condition and on our ability to pursue our business plans and strategies. If we are unable to raise additional capital when needed, we could be forced to delay, limit, reduce or terminate our product candidate development or future commercialization efforts or grant rights to develop and market our product candidates even if we would otherwise prefer to develop and market such product candidates ourselves.</span></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_112"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations and Commitments</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our license agreements with Pulmokine and Aerpio and our merger agreement with Adhaere, as well as our other license and acquisition agreements, we have payment obligations that are contingent upon future events such as our achievement of specified development, regulatory and commercial milestones and are required to make royalty payments in connection with the sale of products developed under those agreements. As of September&#160;30, 2020, we were unable to estimate the timing or likelihood of achieving the outstanding milestones or making future product sales and, therefore, any related payments had not been accrued as the underlying contingencies had not yet been met.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into contracts in the normal course of business with clinical trial sites and clinical supply manufacturers and with vendors for preclinical studies, research supplies and other services and products for operating purposes. These contracts </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">generally provide for termination after a notice period, and, therefore, are cancelable contracts. During the three and nine months ended September&#160;30, 2020, there have been no material changes outside of the ordinary course of business in the composition of these contractual obligations or commitments from the information discussed in Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations &#8211; Contractual Obligations and Commitments&#8221; in our Annual Report on Form 10-K filed with the SEC on March 24, 2020, with the exception of the contractual obligations and commitments related to the 2027 Notes issued in May 2020.</span></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_115"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not have during the periods presented, and we do not currently have, any off-balance sheet arrangements, as defined under the rules and regulations of the SEC.</span></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_118"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">JOBS Act</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an emerging growth company under the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, we can take advantage of an extended transition period for complying with new or revised accounting standards. This allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have irrevocably elected not to avail ourselves of this exemption and, therefore, we will be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies. We intend to rely on other exemptions provided by the JOBS Act, including without limitation, not being required to comply with the auditor attestation requirements of Section 404(b) of Sarbanes-Oxley.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will remain an emerging growth company until the earliest of (i) the last day of the fiscal year following the fifth anniversary of the consummation of our IPO, (ii) the last day of the fiscal year in which we have total annual gross revenue of at least $1.07 billion, (iii) the last day of the fiscal year in which we are deemed to be a &#8220;large accelerated filer&#8221; as defined in Rule 12b-2 under the Exchange Act, which would occur if the market value of our common stock held by non-affiliates exceeded $700.0 million as of the last business day of the second fiscal quarter of such year, or (iv) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.</span></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_121"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, there have been no material changes surrounding our market risk, including interest rate risk, foreign currency exchange risk, and inflation risk, from the discussion provided in Item 7A, &#8220;Quantitative and Qualitative Disclosures About Market Risk&#8221; in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 filed with the SEC on March 24, 2020.</span></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_124"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. CONTROLS AND PROCEDURES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our periodic and current reports that we file with the SEC is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable and not absolute assurance of achieving the desired control objectives. In reaching a reasonable level of assurance, management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. In addition, the design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, control may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of the end of the period covered by this quarterly report. Based on such evaluation, our principal executive officer and principal financial officer have concluded that as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in our internal control over financial reporting during the three months ended September&#160;30, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_127"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. OTHER INFORMATION</span></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_130"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. LEGAL PROCEEDINGS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We discuss certain legal proceedings in Part I of this Quarterly Report on Form 10-Q under the caption &#8220;Item 1. Consolidated Financial Statements,&#8221; in Note 9 to our Condensed Consolidated Financial Statements, which is captioned &#8220;Commitments and Contingencies,&#8221; under the sub-caption &#8220;Litigation,&#8221; and refer you to that discussion, which is incorporated herein by reference to that Note 9, for important information concerning those legal proceedings, including the basis for such actions and, where known, the relief sought.</span></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_133"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A. RISK FACTORS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the risk factors previously disclosed by us in Part I, Item&#160;1A &#8220;Risk Factors&#8221; of our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 filed with the SEC on March 24, 2020, and in Part II, Item 1A of our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020 and June 30, 2020 filed with the SEC on May 14, 2019 and August 8, 2020, respectively, except as follows:</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The topline data from our LEDA Phase 2b clinical trial for GB001 may not be predictive of future results, are subject to audit and verification procedures that could result in material changes in the final data, or adversely affect the ability to advance GB001 into Phase 3 clinical development or establish partnerships or strategic alternatives.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">  </span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, we announced topline data for our LEDA Phase 2b and TITAN Phase 2 clinical trials for GB001, which was based on a preliminary analysis of then-available data, and the results and related findings and conclusions are subject to change following a more comprehensive review of the data. We made certain assumptions, estimations, calculations and conclusions as part of our analyses of data, and we may not have received or had the opportunity to fully and carefully evaluate all data. As a result, the topline results that we reported may differ from future results of the same studies, or different conclusions or considerations may qualify such results, once additional data have been received and fully evaluated. Topline data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, topline data should be viewed with caution until the final data are available.  We are discussing the results of the LEDA trial with global regulatory authorities and explore potential partnerships or strategic alternatives for the GB001 program. Regulatory agencies or potential partners may not accept or agree with our assumptions, estimates, calculations, conclusions or analyses or may interpret or weigh the importance of data differently, which could materially and adversely affect the feasibility of a Phase 3 development program or the approvability or commercialization of GB001 and the value of the program or our company generally. Further, we may not be successful in establishing strategic partnerships or collaborations for GB001 based on the topline data, regulatory feedback or otherwise, and may not realize the benefits of any established arrangements.  In addition, the information we publicly disclosed regarding our LEDA Phase 2b clinical trial results for GB001 included what is typically extensive information; however, others may not agree with what we determined was the material or otherwise appropriate information to include in our disclosure, and any information we determined not to disclose may ultimately be deemed significant with respect to future decisions, conclusions, views, activities or otherwise regarding the potential of GB001 or our business. If the topline data that we reported differ from actual results, or if others, including regulatory authorities or potential partners, disagree with the conclusions reached, our ability to obtain approval for, and commercialize, GB001, or partner the program, may be harmed, which could harm our business, results of operations, prospects or financial condition.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_136"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unregistered Sales of Equity Securities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Proceeds</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 7, 2019, our registration statement on Form S-1 (File No. 333-228984) was declared effective by the SEC for our initial public offering. At the closing of the offering on February 12, 2019, we sold 19,837,500 shares of common stock, which included the exercise in full by the underwriters of their option to purchase 2,587,500 additional shares, at an initial public offering price of $16.00 per share and received gross proceeds of $317.4 million, which resulted in net proceeds to us of approximately $291.3 million, after deducting underwriting discounts and commissions of approximately $22.2 million and offering-related transaction costs of approximately $3.9 million. None of the expenses associated with the initial public offering were paid to directors, officers, persons owning ten percent or more of any class of equity securities, or to their associates, or to our affiliates. Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated, SVB Leerink LLC, Barclays Capital Inc. and Evercore Group L.L.C. acted as joint book-running managers for the offering.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, we have not used any of the proceeds from our initial public offering. There has been no material change in the planned use of proceeds from our initial public offering from that described in the final prospectus filed by us with the SEC on February 8, 2019.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Repurchases of Equity Securities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_139"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. DEFAULTS UPON SENIOR SECURITIES</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_142"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. MINE SAFETY DISCLOSURES</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_145"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5. OTHER INFORMATION</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_148"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. EXHIBITS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exhibits filed or furnished as part of this Quarterly Report on Form 10-Q are set forth on the Exhibit Index, which Exhibit Index is incorporated herein by reference.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_151"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT INDEX</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.310%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.553%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.461%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filed Herewith</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 3.37pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1728117/000119312519035980/d672794dex31.htm">Amended and Restated Certificate of Incorporation.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/12/2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 3.37pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1728117/000156459020024690/goss-ex32_408.htm">Amended and Restated Bylaws.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/12/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 3.37pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1728117/000119312519014857/d690055dex41.htm">Form of Common Stock Certificate.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/23/2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 3.37pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1728117/000119312518356444/d626950dex42.htm">Amended and Restated Investors&#8217; Rights Agreement, dated July 20, 2018, by and among the Registrant and certain of its stockholders.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/21/2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 3.37pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1728117/000156459020026546/goss-ex41_10.htm">Indenture, dated as of May 21, 2020, by and between the Company and Wilmington Trust, National Association.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/21/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 3.37pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1728117/000156459020026546/goss-ex42_11.htm">First Supplemental Indenture, dated May 21, 2020, by and between the Company and Wilmington Trust, National Association.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/21/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 3.37pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1728117/000156459020026546/goss-ex42_11.htm">Form of Global Note representing 5.00% Convertible Senior Notes due 2027 (included as part of Exhibit 4.4).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/21/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1728117/000156459020031695/goss-ex101_9.htm">Second Amendment to Credit, Guaranty and Security Agreement, dated July 2, 2020, by and among the Company, GB001, Inc., GB002, Inc. and GB004, Inc., as co-borrowers, the other guarantors from time to time party thereto and MidCap Financial Trust, as Agent and as a Lender and the additional lenders from time to time party </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1728117/000156459020031695/goss-ex101_9.htm">thereto.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7/2/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="goss-20200930xxexx311.htm">Certification of Chief Executive Officer of Gossamer Bio,&#160;Inc., as required by Rule&#160;13a-14(a)&#160;or Rule&#160;15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="goss-20200930xxexx312.htm">Certification of Chief Financial Officer of Gossamer Bio,&#160;Inc., as required by Rule&#160;13a-14(a)&#160;or Rule&#160;15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="goss-20200930xxexx321.htm">Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="goss-20200930xxexx322.htm">Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 3.37pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Report Instance Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 3.37pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 3.37pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 3.37pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 3.37pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 3.37pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.468%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This certification is deemed not filed for purpose of section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i40514bbc3b4c4ca6a3766d45caf8fa76_154"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i40514bbc3b4c4ca6a3766d45caf8fa76_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.492%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GOSSAMER BIO, INC.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 10, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Sheila Gujrathi</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sheila Gujrathi</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 10, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Bryan Giraudo</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bryan Giraudo</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>goss-20200930xxexx311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i905f8602b6a44226957939a13d88f390_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PERIODIC REPORT UNDER SECTION 302 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Sheila Gujrathi, certify that&#58;</font></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">I have reviewed this quarterly report on Form 10-Q of Gossamer Bio, Inc.&#59;</font></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;10, 2020</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:37.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:59.808%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sheila Gujrathi</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sheila Gujrathi</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>goss-20200930xxexx312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="icb97b0dcdaa24aab8324d4adbd6883b8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PERIODIC REPORT UNDER SECTION 302 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Bryan Giraudo, certify that&#58;</font></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">I have reviewed this quarterly report on Form 10-Q of Gossamer Bio, Inc.&#59;</font></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;10, 2020 </font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:37.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:59.808%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Bryan Giraudo</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bryan Giraudo</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>goss-20200930xxexx321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i2876e19950684b5c84e6dd5b44d49817_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Sheila Gujrathi, President and Chief Executive Officer of Gossamer Bio, Inc. (the &#8220;Company&#8221;), do hereby certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge&#58;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the accompanying Quarterly Report on Form 10-Q of the Company for the quarter ended September&#160;30, 2020 (the &#8220;Report&#8221;), as filed with the Securities and Exchange Commission, fully complies with the requirements of Section&#160;13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;10, 2020 </font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.304%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.496%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sheila Gujrathi</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sheila Gujrathi</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>goss-20200930xxexx322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="ia2a920cd60384d85bc8465bad80a7f77_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Bryan Giraudo, Chief Financial Officer of Gossamer Bio, Inc. (the &#8220;Company&#8221;), do hereby certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge&#58;</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">the accompanying Quarterly Report on Form 10-Q of the Company for the quarter ended September&#160;30, 2020 (the &#8220;Report&#8221;), as filed with the Securities and Exchange Commission, fully complies with the requirements of Section&#160;13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:10pt;padding-left:54pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;10, 2020 </font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:37.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:59.808%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Bryan Giraudo</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bryan Giraudo</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>goss-20200930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:a28f2324-59ee-4208-be3f-ac91f14d0976,g:685f1ccc-55e8-49df-855b-4b6ee836ad79-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:goss="http://www.gossamerbio.com/20200930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.gossamerbio.com/20200930">
  <xs:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="goss-20200930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="goss-20200930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="goss-20200930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="goss-20200930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.gossamerbio.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity" roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsParenthetical" roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionoftheBusiness" roleURI="http://www.gossamerbio.com/role/DescriptionoftheBusiness">
        <link:definition>2101101 - Disclosure - Description of the Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionoftheBusinessAdditionalInformationDetail" roleURI="http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail">
        <link:definition>2402401 - Disclosure - Description of the Business - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>2103102 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>2305301 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossPerShareDetails" roleURI="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossPerShareDetails">
        <link:definition>2406402 - Disclosure - Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities not Included in Calculation of Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetAccountsandSupplementalDisclosures" roleURI="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosures">
        <link:definition>2107103 - Disclosure - Balance Sheet Accounts and Supplemental Disclosures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetAccountsandSupplementalDisclosuresTables" roleURI="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresTables">
        <link:definition>2308302 - Disclosure - Balance Sheet Accounts and Supplemental Disclosures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails" roleURI="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails">
        <link:definition>2409403 - Disclosure - Balance Sheet Accounts and Supplemental Disclosures - Schedule of Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails" roleURI="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails">
        <link:definition>2410404 - Disclosure - Balance Sheet Accounts and Supplemental Disclosures - Schedule of Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsandAvailableforSaleInvestments" roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestments">
        <link:definition>2111104 - Disclosure - Fair Value Measurements and Available for Sale Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsandAvailableforSaleInvestmentsTables" roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsTables">
        <link:definition>2312303 - Disclosure - Fair Value Measurements and Available for Sale Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails" roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails">
        <link:definition>2413405 - Disclosure - Fair Value Measurements and Available for Sale Investments - Assets Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails" roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails">
        <link:definition>2414406 - Disclosure - Fair Value Measurements and Available for Sale Investments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails" roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails">
        <link:definition>2415407 - Disclosure - Fair Value Measurements and Available for Sale Investments - Schedule of Available for sale Investments by Security Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofContractualMaturitiesofAvailableforsaleDebtSecuritiesDetails" roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofContractualMaturitiesofAvailableforsaleDebtSecuritiesDetails">
        <link:definition>2416408 - Disclosure - Fair Value Measurements and Available for Sale Investments - Schedule of Contractual Maturities of Available-for-sale Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Indebtedness" roleURI="http://www.gossamerbio.com/role/Indebtedness">
        <link:definition>2117105 - Disclosure - Indebtedness</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IndebtednessTables" roleURI="http://www.gossamerbio.com/role/IndebtednessTables">
        <link:definition>2318304 - Disclosure - Indebtedness (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IndebtednessAdditionalInformationDetails" roleURI="http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails">
        <link:definition>2419409 - Disclosure - Indebtedness - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IndebtednessScheduleofLongtermDebtDetails" roleURI="http://www.gossamerbio.com/role/IndebtednessScheduleofLongtermDebtDetails">
        <link:definition>2420410 - Disclosure - Indebtedness - Schedule of Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails" roleURI="http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails">
        <link:definition>2421411 - Disclosure - Indebtedness - Schedule of Future Minimum Principal Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails" roleURI="http://www.gossamerbio.com/role/IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails">
        <link:definition>2422412 - Disclosure - Indebtedness - Schedule of Net Carrying Amount of Liability Component (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IndebtednessScheduleofEquityComponentsDetails" roleURI="http://www.gossamerbio.com/role/IndebtednessScheduleofEquityComponentsDetails">
        <link:definition>2423413 - Disclosure - Indebtedness - Schedule of Equity Components (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IndebtednessScheduleofInterestExpenseRecognizedDetails" roleURI="http://www.gossamerbio.com/role/IndebtednessScheduleofInterestExpenseRecognizedDetails">
        <link:definition>2424414 - Disclosure - Indebtedness - Schedule of Interest Expense Recognized (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LicensesAssetAcquisitionsandContingentConsideration" roleURI="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsideration">
        <link:definition>2125106 - Disclosure - Licenses, Asset Acquisitions and Contingent Consideration</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LicensesAssetAcquisitionsandContingentConsiderationTables" roleURI="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationTables">
        <link:definition>2326305 - Disclosure - Licenses, Asset Acquisitions and Contingent Consideration (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails" roleURI="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails">
        <link:definition>2427415 - Disclosure - Licenses, Asset Acquisitions and Contingent Consideration - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails" roleURI="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails">
        <link:definition>2428416 - Disclosure - Licenses, Asset Acquisitions and Contingent Consideration - Schedule of IPR&amp;D Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.gossamerbio.com/role/StockholdersEquity">
        <link:definition>2129107 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityAdditionalInformationDetails" roleURI="http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails">
        <link:definition>2430417 - Disclosure - Stockholders' Equity - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentivePlans" roleURI="http://www.gossamerbio.com/role/EquityIncentivePlans">
        <link:definition>2131108 - Disclosure - Equity Incentive Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentivePlansTables" roleURI="http://www.gossamerbio.com/role/EquityIncentivePlansTables">
        <link:definition>2332306 - Disclosure - Equity Incentive Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentivePlansAdditionalInformationDetails" roleURI="http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails">
        <link:definition>2433418 - Disclosure - Equity Incentive Plans - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentivePlansSummaryofStockOptionActivityDetails" roleURI="http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails">
        <link:definition>2434419 - Disclosure - Equity Incentive Plans - Summary of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentivePlansSummaryofRestrictedStockActivityDetails" roleURI="http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails">
        <link:definition>2435420 - Disclosure - Equity Incentive Plans - Summary of Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityIncentivePlansStockBasedCompensationExpenseReportedinCondensedConsolidatedStatementsofOperationsDetails" roleURI="http://www.gossamerbio.com/role/EquityIncentivePlansStockBasedCompensationExpenseReportedinCondensedConsolidatedStatementsofOperationsDetails">
        <link:definition>2436421 - Disclosure - Equity Incentive Plans - Stock-Based Compensation Expense Reported in Condensed Consolidated Statements of Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.gossamerbio.com/role/CommitmentsandContingencies">
        <link:definition>2137109 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables" roleURI="http://www.gossamerbio.com/role/CommitmentsandContingenciesTables">
        <link:definition>2338307 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesAdditionalInformationDetails" roleURI="http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails">
        <link:definition>2439422 - Disclosure - Commitments and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesScheduleofLeaseCostsDetails" roleURI="http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofLeaseCostsDetails">
        <link:definition>2440423 - Disclosure - Commitments and Contingencies - Schedule of Lease Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails" roleURI="http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails">
        <link:definition>2441424 - Disclosure - Commitments and Contingencies - Schedule of Gross Future Minimum Annual Rental Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails_1" roleURI="http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails_1">
        <link:definition>2441424 - Disclosure - Commitments and Contingencies - Schedule of Gross Future Minimum Annual Rental Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="goss_LeaseContractualTermDomain" abstract="true" name="LeaseContractualTermDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_StockholdersEquityLineItems" abstract="true" name="StockholdersEquityLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="goss_LongTermConvertibleSeniorNotes" abstract="false" name="LongTermConvertibleSeniorNotes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix" abstract="false" name="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_ProductLicenseTerm" abstract="false" name="ProductLicenseTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="goss_SeriesAConvertiblePreferredStockMember" abstract="true" name="SeriesAConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes" abstract="false" name="PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="goss_LeaseContractualTermAxis" abstract="true" name="LeaseContractualTermAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="goss_BusinessCombinationContingentConsiderationMilestonesPayment" abstract="false" name="BusinessCombinationContingentConsiderationMilestonesPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan" abstract="false" name="DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="goss_InProcessResearchAndDevelopmentExpensesTableTextBlock" abstract="false" name="InProcessResearchAndDevelopmentExpensesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="goss_ScheduleOfLiabilityComponentsOfNotesTableTextBlock" abstract="false" name="ScheduleOfLiabilityComponentsOfNotesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="goss_SubleasePeriodOfBaseRentAbatement" abstract="false" name="SubleasePeriodOfBaseRentAbatement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="goss_TwoThousandNineteenEquityIncentivePlanMember" abstract="true" name="TwoThousandNineteenEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_IncreaseDecreaseInOperatingLeaseLiabilities" abstract="false" name="IncreaseDecreaseInOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_StockholdersEquityTable" abstract="true" name="StockholdersEquityTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="goss_PermanentMonthlyBaseRent" abstract="false" name="PermanentMonthlyBaseRent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_StockRestrictionAgreementsMember" abstract="true" name="StockRestrictionAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_InProcessResearchAndDevelopmentOtherProgramsMember" abstract="true" name="InProcessResearchAndDevelopmentOtherProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_AnnualIncreasePercentageForLeaseCharges" abstract="false" name="AnnualIncreasePercentageForLeaseCharges" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract" abstract="true" name="BalanceSheetsAccountsAndSupplementalDisclosuresAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="goss_PeriodForWhichLeaseOfPermanentSpaceCanBeExtended" abstract="false" name="PeriodForWhichLeaseOfPermanentSpaceCanBeExtended" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts" abstract="false" name="AdjustmentsToEquityComponentOfDebtIssuanceCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_AdhaerePharmaceuticalsIncMember" abstract="true" name="AdhaerePharmaceuticalsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_TemporaryMonthlyBaseRent" abstract="false" name="TemporaryMonthlyBaseRent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_InProcessResearchAndDevelopmentExpenses" abstract="false" name="InProcessResearchAndDevelopmentExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_OperatingLeasesMonthlyBaseRentExpense" abstract="false" name="OperatingLeasesMonthlyBaseRentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_TemporaryEquitySharesConvertedIntoCommonSharesValue" abstract="false" name="TemporaryEquitySharesConvertedIntoCommonSharesValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_ConversionOfConvertiblePreferredStockIntoCommonStockMember" abstract="true" name="ConversionOfConvertiblePreferredStockIntoCommonStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix" abstract="false" name="LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment" abstract="false" name="PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="goss_AdditionalNonCancelableLeaseAgreementInNov2019Member" abstract="true" name="AdditionalNonCancelableLeaseAgreementInNov2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption" abstract="false" name="AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_CommonStockVestingPeriod" abstract="false" name="CommonStockVestingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="goss_SubleaseTemporaryMonthlyBaseRent" abstract="false" name="SubleaseTemporaryMonthlyBaseRent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_LicenseAgreementMember" abstract="true" name="LicenseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_LesseeOperatingLeaseLiabilityPaymentsDueYearSix" abstract="false" name="LesseeOperatingLeaseLiabilityPaymentsDueYearSix" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember" abstract="true" name="InProcessResearchAndDevelopmentGBZeroZeroFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_SubleaseAnnualIncreasePercentageForLeaseCharges" abstract="false" name="SubleaseAnnualIncreasePercentageForLeaseCharges" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="goss_TwoThousandNineteenEmployeeStockPurchasePlanMember" abstract="true" name="TwoThousandNineteenEmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember" abstract="true" name="InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable" abstract="false" name="BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_LongTermDebtPercentageInAggregatePrincipalAmount" abstract="false" name="LongTermDebtPercentageInAggregatePrincipalAmount" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="goss_EquityComponentOfConvertibleNoteIssuance" abstract="false" name="EquityComponentOfConvertibleNoteIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_FounderSharesMember" abstract="true" name="FounderSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_AmortizationOfOperatingLeaseRightOfUseAssets" abstract="false" name="AmortizationOfOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember" abstract="true" name="SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_USTreasuryAndAgencySecuritiesMember" abstract="true" name="USTreasuryAndAgencySecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_AABiopharmaIncMember" abstract="true" name="AABiopharmaIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_TrancheTwoMember" abstract="true" name="TrancheTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses" abstract="false" name="IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_NumberOfAdditionalTranches" abstract="false" name="NumberOfAdditionalTranches" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="goss_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" abstract="false" name="RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment" abstract="false" name="PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="goss_FounderMember" abstract="true" name="FounderMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable" abstract="false" name="BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember" abstract="true" name="InProcessResearchAndDevelopmentGBZeroZeroTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_InterestAndSecuritiesReceivable" abstract="false" name="InterestAndSecuritiesReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_CommonStockVotingRightsNumberOfVotesPerShare" abstract="false" name="CommonStockVotingRightsNumberOfVotesPerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="goss_MidCapFinancialTrustMember" abstract="true" name="MidCapFinancialTrustMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_OperatingSubleaseAnnualIncreasePercentageForBaseRent" abstract="false" name="OperatingSubleaseAnnualIncreasePercentageForBaseRent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="goss_DebtInstrumentAggregatePrincipalAmount" abstract="false" name="DebtInstrumentAggregatePrincipalAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember" abstract="true" name="FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_SeriesBConvertiblePreferredStockMember" abstract="true" name="SeriesBConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract" abstract="true" name="FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="goss_OneHundredThirtyPercentApplicableConversionPriceMember" abstract="true" name="OneHundredThirtyPercentApplicableConversionPriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_AerpioPharmaceuticalsIncMember" abstract="true" name="AerpioPharmaceuticalsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable" abstract="false" name="BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="goss_DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt" abstract="false" name="DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_TrancheOneMember" abstract="true" name="TrancheOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions" abstract="false" name="PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_SubleaseAgreementEnteredInJune2020Member" abstract="true" name="SubleaseAgreementEnteredInJune2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_SeriesSeedConvertiblePreferredStockMember" abstract="true" name="SeriesSeedConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock" abstract="false" name="FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="goss_NinetyEightPercentApplicableConversionPriceMember" abstract="true" name="NinetyEightPercentApplicableConversionPriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_ParticipationRight" abstract="false" name="ParticipationRight" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="goss_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_NonCancelableLeaseAgreementEnteredInAugust2018Member" abstract="true" name="NonCancelableLeaseAgreementEnteredInAugust2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_DebtInstrumentConvertibleConversionPricePercentage" abstract="false" name="DebtInstrumentConvertibleConversionPricePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="goss_PulmokineIncMember" abstract="true" name="PulmokineIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_TwoThousandSeventeenEquityIncentivePlanMember" abstract="true" name="TwoThousandSeventeenEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_IncreasedInEquityCapitalAmount" abstract="false" name="IncreasedInEquityCapitalAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_DebtInstrumentConvertibleConversionLastReportedSalePricePercentage" abstract="false" name="DebtInstrumentConvertibleConversionLastReportedSalePricePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="goss_ContractualInterestExpense" abstract="false" name="ContractualInterestExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember" abstract="true" name="InProcessResearchAndDevelopmentGBZeroZeroOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_CommonStockVestingPercentage" abstract="false" name="CommonStockVestingPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="goss_ProceedsFromMaturityOfMarketableSecurities" abstract="false" name="ProceedsFromMaturityOfMarketableSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_PercentageOfPrepaymentFee" abstract="false" name="PercentageOfPrepaymentFee" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="goss_TwoThousandTwentySevenNotesMember" abstract="true" name="TwoThousandTwentySevenNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_ConvertibleSeniorNotesPolicyTextBlock" abstract="false" name="ConvertibleSeniorNotesPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="goss_NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax" abstract="false" name="NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_ScheduleOfEquityComponentsOfNotesTableTextBlock" abstract="false" name="ScheduleOfEquityComponentsOfNotesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="goss_StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares" abstract="false" name="StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="goss_ScheduleOfInterestExpenseRecognizedTableTextBlock" abstract="false" name="ScheduleOfInterestExpenseRecognizedTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock" abstract="false" name="StockIssuedDuringPeriodSharesVestingOfRestrictedStock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="goss_AccruedResearchAndDevelopmentExpenses" abstract="false" name="AccruedResearchAndDevelopmentExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_LeaseAssignmentAgreementEnteredInJuly2020Member" abstract="true" name="LeaseAssignmentAgreementEnteredInJuly2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember" abstract="true" name="PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="goss_DescriptionOfBusinessTable" abstract="true" name="DescriptionOfBusinessTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="goss_TemporaryEquitySharesConvertedIntoCommonSharesShares" abstract="false" name="TemporaryEquitySharesConvertedIntoCommonSharesShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable" abstract="false" name="BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_AccruedInProcessResearchAndDevelopment" abstract="false" name="AccruedInProcessResearchAndDevelopment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_PercentageOfFullyDilutedShareCapital" abstract="false" name="PercentageOfFullyDilutedShareCapital" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="goss_FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering" abstract="false" name="FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting" abstract="false" name="IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="goss_ProceedsFromSaleOfMarketableSecurities" abstract="false" name="ProceedsFromSaleOfMarketableSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock" abstract="false" name="NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_DescriptionOfBusinessLineItems" abstract="true" name="DescriptionOfBusinessLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="goss_UpfrontPayment" abstract="false" name="UpfrontPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="goss_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" abstract="false" name="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>goss-20200930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:a28f2324-59ee-4208-be3f-ac91f14d0976,g:685f1ccc-55e8-49df-855b-4b6ee836ad79-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.gossamerbio.com/role/Cover" xlink:type="simple" xlink:href="goss-20200930.xsd#Cover"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/Cover" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="goss-20200930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ad209fb7-631d-4cc0-9e1d-68ef6fcf05bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6c9ec961-7130-47e1-bc52-5530e3404cfa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ad209fb7-631d-4cc0-9e1d-68ef6fcf05bd" xlink:to="loc_us-gaap_AssetsCurrent_6c9ec961-7130-47e1-bc52-5530e3404cfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e76c7d72-191f-445d-bea5-973ac95778e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ad209fb7-631d-4cc0-9e1d-68ef6fcf05bd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e76c7d72-191f-445d-bea5-973ac95778e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_78b2be23-32d7-42e3-8577-437c66374ca0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ad209fb7-631d-4cc0-9e1d-68ef6fcf05bd" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_78b2be23-32d7-42e3-8577-437c66374ca0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5f4e62f1-632c-494d-9026-90623bb6d560" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ad209fb7-631d-4cc0-9e1d-68ef6fcf05bd" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5f4e62f1-632c-494d-9026-90623bb6d560" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_fce3bf95-2c14-44d6-ab0a-0e65321a54f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8940e5ed-72f2-429f-81eb-626b2afabaac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_fce3bf95-2c14-44d6-ab0a-0e65321a54f9" xlink:to="loc_us-gaap_CommonStockValue_8940e5ed-72f2-429f-81eb-626b2afabaac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_bc6565c1-0bcc-4577-9ace-aff5ad8b58b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_fce3bf95-2c14-44d6-ab0a-0e65321a54f9" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_bc6565c1-0bcc-4577-9ace-aff5ad8b58b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_65be38eb-3dba-4d1e-8a46-f0a541b904c6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_fce3bf95-2c14-44d6-ab0a-0e65321a54f9" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_65be38eb-3dba-4d1e-8a46-f0a541b904c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1954d089-ca2c-42db-81ba-2a43c41f4206" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_fce3bf95-2c14-44d6-ab0a-0e65321a54f9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1954d089-ca2c-42db-81ba-2a43c41f4206" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9c6802e2-8ed4-44b0-aebb-c09623e5277a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_f7106339-e454-4bb1-8844-cf6756d62ab1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_9c6802e2-8ed4-44b0-aebb-c09623e5277a" xlink:to="loc_us-gaap_AccountsPayableCurrent_f7106339-e454-4bb1-8844-cf6756d62ab1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AccruedResearchAndDevelopmentExpenses_dd4d77a6-8cc8-4a95-9041-4675b5e96f03" xlink:href="goss-20200930.xsd#goss_AccruedResearchAndDevelopmentExpenses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_9c6802e2-8ed4-44b0-aebb-c09623e5277a" xlink:to="loc_goss_AccruedResearchAndDevelopmentExpenses_dd4d77a6-8cc8-4a95-9041-4675b5e96f03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_01ce6d25-daca-446b-9315-fa08462042e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_9c6802e2-8ed4-44b0-aebb-c09623e5277a" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_01ce6d25-daca-446b-9315-fa08462042e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f7276c06-bae9-48dd-a7be-3c1a1a7a54c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8c0e36b8-dfbf-4a0a-9970-1d424d17ca8a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f7276c06-bae9-48dd-a7be-3c1a1a7a54c3" xlink:to="loc_us-gaap_LiabilitiesCurrent_8c0e36b8-dfbf-4a0a-9970-1d424d17ca8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LongTermConvertibleSeniorNotes_e812c512-9019-4225-9653-76fa84662d7a" xlink:href="goss-20200930.xsd#goss_LongTermConvertibleSeniorNotes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f7276c06-bae9-48dd-a7be-3c1a1a7a54c3" xlink:to="loc_goss_LongTermConvertibleSeniorNotes_e812c512-9019-4225-9653-76fa84662d7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_5b60c285-f6dd-46c2-8690-fe51872af664" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f7276c06-bae9-48dd-a7be-3c1a1a7a54c3" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_5b60c285-f6dd-46c2-8690-fe51872af664" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_00356b43-dc2d-47f4-ac86-31ded3cd2c6c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f7276c06-bae9-48dd-a7be-3c1a1a7a54c3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_00356b43-dc2d-47f4-ac86-31ded3cd2c6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0c292f6d-4a95-45a2-ab15-0c8463267a4c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_64a96aa6-27aa-4c67-a47b-4ed821674b8f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0c292f6d-4a95-45a2-ab15-0c8463267a4c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_64a96aa6-27aa-4c67-a47b-4ed821674b8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_62a43b62-e9ee-473a-85b8-db8e144cf997" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0c292f6d-4a95-45a2-ab15-0c8463267a4c" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_62a43b62-e9ee-473a-85b8-db8e144cf997" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b15c8b28-7575-443e-8738-34b4a17a5e09" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0c292f6d-4a95-45a2-ab15-0c8463267a4c" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b15c8b28-7575-443e-8738-34b4a17a5e09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_94d50f5f-ab84-4e68-823d-580de95dd146" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c90ed466-3567-49a6-a4dc-327a7aa21519" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_94d50f5f-ab84-4e68-823d-580de95dd146" xlink:to="loc_us-gaap_Liabilities_c90ed466-3567-49a6-a4dc-327a7aa21519" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_1f862347-b7c6-4c26-baf6-d11ade7112cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_94d50f5f-ab84-4e68-823d-580de95dd146" xlink:to="loc_us-gaap_CommitmentsAndContingencies_1f862347-b7c6-4c26-baf6-d11ade7112cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_22090447-84c2-4d63-88dd-d9d842d2936b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_94d50f5f-ab84-4e68-823d-580de95dd146" xlink:to="loc_us-gaap_StockholdersEquity_22090447-84c2-4d63-88dd-d9d842d2936b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="goss-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="goss-20200930.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_311e6853-c7b8-4887-b3c9-4f426c810101" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9d8ad140-0f0f-4866-b2ca-15dc348e1315" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_311e6853-c7b8-4887-b3c9-4f426c810101" xlink:to="loc_us-gaap_NetIncomeLoss_9d8ad140-0f0f-4866-b2ca-15dc348e1315" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_275a1e2a-d7b4-4efb-af98-327ce7f070c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_311e6853-c7b8-4887-b3c9-4f426c810101" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_275a1e2a-d7b4-4efb-af98-327ce7f070c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_88047d90-bbc1-400b-8972-20581e116bf9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_a7be63ef-e89c-4379-8d08-ce66dbe3b1eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_88047d90-bbc1-400b-8972-20581e116bf9" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_a7be63ef-e89c-4379-8d08-ce66dbe3b1eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_6911fea7-e658-40e4-a509-650c806ba476" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_88047d90-bbc1-400b-8972-20581e116bf9" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_6911fea7-e658-40e4-a509-650c806ba476" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_782b6605-c6fc-412f-a3c1-6c1e7ba044b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_88047d90-bbc1-400b-8972-20581e116bf9" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_782b6605-c6fc-412f-a3c1-6c1e7ba044b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7184ea84-cef5-4dcb-8365-8d7311b691cb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9badbbdc-fb82-4150-9563-7eccd773bb3d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7184ea84-cef5-4dcb-8365-8d7311b691cb" xlink:to="loc_us-gaap_OperatingIncomeLoss_9badbbdc-fb82-4150-9563-7eccd773bb3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_9aba4aef-dada-4255-ad2e-f871cce297eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7184ea84-cef5-4dcb-8365-8d7311b691cb" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_9aba4aef-dada-4255-ad2e-f871cce297eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f4e347e0-82f2-4abb-b584-4153f965d359" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_9ae23e85-89bc-43dc-9fd1-005754094c75" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f4e347e0-82f2-4abb-b584-4153f965d359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_9ae23e85-89bc-43dc-9fd1-005754094c75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_690aacea-ea8e-4eba-851c-22694cb227d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f4e347e0-82f2-4abb-b584-4153f965d359" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_690aacea-ea8e-4eba-851c-22694cb227d9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity" xlink:type="simple" xlink:href="goss-20200930.xsd#CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="goss-20200930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4e40654c-ef85-48d3-9e22-9a98e7075489" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions_897a2d97-0c09-4216-b69a-a983073c3130" xlink:href="goss-20200930.xsd#goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4e40654c-ef85-48d3-9e22-9a98e7075489" xlink:to="loc_goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions_897a2d97-0c09-4216-b69a-a983073c3130" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_147920be-e3a7-47b7-b13b-c83d702f8ab4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4e40654c-ef85-48d3-9e22-9a98e7075489" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_147920be-e3a7-47b7-b13b-c83d702f8ab4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ProceedsFromMaturityOfMarketableSecurities_4acee755-d37c-46f7-af44-2bae03a30b9e" xlink:href="goss-20200930.xsd#goss_ProceedsFromMaturityOfMarketableSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4e40654c-ef85-48d3-9e22-9a98e7075489" xlink:to="loc_goss_ProceedsFromMaturityOfMarketableSecurities_4acee755-d37c-46f7-af44-2bae03a30b9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ProceedsFromSaleOfMarketableSecurities_10695b62-9275-44f6-aa0f-7f111cccbdd9" xlink:href="goss-20200930.xsd#goss_ProceedsFromSaleOfMarketableSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4e40654c-ef85-48d3-9e22-9a98e7075489" xlink:to="loc_goss_ProceedsFromSaleOfMarketableSecurities_10695b62-9275-44f6-aa0f-7f111cccbdd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_512de07b-a4d6-41d6-846c-1047a59e73c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4e40654c-ef85-48d3-9e22-9a98e7075489" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_512de07b-a4d6-41d6-846c-1047a59e73c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_91082180-1c23-4bb9-8c1c-48be3a0f8fed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6a07755a-0459-4a0d-865b-3eff67a5b158" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_91082180-1c23-4bb9-8c1c-48be3a0f8fed" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6a07755a-0459-4a0d-865b-3eff67a5b158" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_7ecd765f-1b25-460c-af2d-b0d9ec6edd5e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_91082180-1c23-4bb9-8c1c-48be3a0f8fed" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_7ecd765f-1b25-460c-af2d-b0d9ec6edd5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_f82b7c26-e678-43c5-a48f-0aae7f4af7af" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_91082180-1c23-4bb9-8c1c-48be3a0f8fed" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_f82b7c26-e678-43c5-a48f-0aae7f4af7af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_5a8f32ee-8f8d-43fd-93de-e2a0958f679a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_91082180-1c23-4bb9-8c1c-48be3a0f8fed" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_5a8f32ee-8f8d-43fd-93de-e2a0958f679a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8480bc7f-d970-4c6d-8464-cae8cd398986" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9107da9c-5a98-4e44-8a5a-60a1d565d813" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8480bc7f-d970-4c6d-8464-cae8cd398986" xlink:to="loc_us-gaap_ProfitLoss_9107da9c-5a98-4e44-8a5a-60a1d565d813" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_e61c4356-fb24-45ed-9697-f1bbb5bcdfd5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8480bc7f-d970-4c6d-8464-cae8cd398986" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_e61c4356-fb24-45ed-9697-f1bbb5bcdfd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_10f81747-3868-4c13-b9c4-dfd192ae41ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8480bc7f-d970-4c6d-8464-cae8cd398986" xlink:to="loc_us-gaap_ShareBasedCompensation_10f81747-3868-4c13-b9c4-dfd192ae41ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentExpenses_d0197416-6866-4d10-9ed3-880f28f79827" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentExpenses"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8480bc7f-d970-4c6d-8464-cae8cd398986" xlink:to="loc_goss_InProcessResearchAndDevelopmentExpenses_d0197416-6866-4d10-9ed3-880f28f79827" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AmortizationOfOperatingLeaseRightOfUseAssets_5161966a-3aba-453a-a4ea-ac0403c13e1f" xlink:href="goss-20200930.xsd#goss_AmortizationOfOperatingLeaseRightOfUseAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8480bc7f-d970-4c6d-8464-cae8cd398986" xlink:to="loc_goss_AmortizationOfOperatingLeaseRightOfUseAssets_5161966a-3aba-453a-a4ea-ac0403c13e1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_dbeaaa64-72b1-4738-af75-a813d4737c62" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8480bc7f-d970-4c6d-8464-cae8cd398986" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_dbeaaa64-72b1-4738-af75-a813d4737c62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_b0718b3f-7a98-4a2b-90c5-09d39cad3b5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8480bc7f-d970-4c6d-8464-cae8cd398986" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_b0718b3f-7a98-4a2b-90c5-09d39cad3b5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_4d63767f-7aaa-45c0-a5d5-390a6c1ca4da" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8480bc7f-d970-4c6d-8464-cae8cd398986" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_4d63767f-7aaa-45c0-a5d5-390a6c1ca4da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_163c69cb-784e-474d-8de8-10275aa0aa49" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8480bc7f-d970-4c6d-8464-cae8cd398986" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_163c69cb-784e-474d-8de8-10275aa0aa49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1ec6b5f5-6b06-4c79-aeff-5870674ab7aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8480bc7f-d970-4c6d-8464-cae8cd398986" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1ec6b5f5-6b06-4c79-aeff-5870674ab7aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_IncreaseDecreaseInOperatingLeaseLiabilities_5056f0da-5409-4381-955e-e62594cd72b4" xlink:href="goss-20200930.xsd#goss_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8480bc7f-d970-4c6d-8464-cae8cd398986" xlink:to="loc_goss_IncreaseDecreaseInOperatingLeaseLiabilities_5056f0da-5409-4381-955e-e62594cd72b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_9473aaaa-e951-4ea7-85d4-0c693a59b32c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8480bc7f-d970-4c6d-8464-cae8cd398986" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_9473aaaa-e951-4ea7-85d4-0c693a59b32c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_4f6d6442-c05e-4878-8caa-f564094ee763" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8480bc7f-d970-4c6d-8464-cae8cd398986" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_4f6d6442-c05e-4878-8caa-f564094ee763" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses_ca34e0b0-60bd-4ef3-8b87-693d3257e8df" xlink:href="goss-20200930.xsd#goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8480bc7f-d970-4c6d-8464-cae8cd398986" xlink:to="loc_goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses_ca34e0b0-60bd-4ef3-8b87-693d3257e8df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_5c8860c3-693c-4af2-b047-655d3ec3f30e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8480bc7f-d970-4c6d-8464-cae8cd398986" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_5c8860c3-693c-4af2-b047-655d3ec3f30e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_9b11ebc1-df1c-447c-a95d-a6312622fb87" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b74576e8-af06-4ad2-9c23-77713050255e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_9b11ebc1-df1c-447c-a95d-a6312622fb87" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b74576e8-af06-4ad2-9c23-77713050255e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_861f004d-d38c-4946-80b6-56ec599588f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_9b11ebc1-df1c-447c-a95d-a6312622fb87" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_861f004d-d38c-4946-80b6-56ec599588f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a540a60d-2bf2-4846-a892-85546d4bf59e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_9b11ebc1-df1c-447c-a95d-a6312622fb87" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a540a60d-2bf2-4846-a892-85546d4bf59e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical" xlink:type="simple" xlink:href="goss-20200930.xsd#CondensedConsolidatedStatementsofCashFlowsParenthetical"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/DescriptionoftheBusiness" xlink:type="simple" xlink:href="goss-20200930.xsd#DescriptionoftheBusiness"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/DescriptionoftheBusiness" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail" xlink:type="simple" xlink:href="goss-20200930.xsd#DescriptionoftheBusinessAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="goss-20200930.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="goss-20200930.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="goss-20200930.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossPerShareDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosures" xlink:type="simple" xlink:href="goss-20200930.xsd#BalanceSheetAccountsandSupplementalDisclosures"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosures" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresTables" xlink:type="simple" xlink:href="goss-20200930.xsd#BalanceSheetAccountsandSupplementalDisclosuresTables"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9ba46658-dd82-48ea-a793-0ea45e0f67f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ad793015-f14e-4a29-b20e-1e1d01cbc10e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_9ba46658-dd82-48ea-a793-0ea45e0f67f5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ad793015-f14e-4a29-b20e-1e1d01cbc10e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_06ca6aef-21a8-4d33-82b1-801f18d17844" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_9ba46658-dd82-48ea-a793-0ea45e0f67f5" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_06ca6aef-21a8-4d33-82b1-801f18d17844" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_8c0e6384-d4a7-4304-9dc8-e485a53524aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e8700fbc-ea08-479e-b89c-cd683688ec8f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8c0e6384-d4a7-4304-9dc8-e485a53524aa" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e8700fbc-ea08-479e-b89c-cd683688ec8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_51bf6041-1451-401b-a8d0-ba72cccd2513" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8c0e6384-d4a7-4304-9dc8-e485a53524aa" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_51bf6041-1451-401b-a8d0-ba72cccd2513" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_c43e88c4-e8a9-4426-8dfe-19242f907949" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8c0e6384-d4a7-4304-9dc8-e485a53524aa" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_c43e88c4-e8a9-4426-8dfe-19242f907949" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_ae26d14e-6ae9-4f5a-8763-8cfcaeac7f80" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8c0e6384-d4a7-4304-9dc8-e485a53524aa" xlink:to="loc_us-gaap_InterestPayableCurrent_ae26d14e-6ae9-4f5a-8763-8cfcaeac7f80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_4a6d0195-f0a6-4824-987e-70741861c332" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8c0e6384-d4a7-4304-9dc8-e485a53524aa" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_4a6d0195-f0a6-4824-987e-70741861c332" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AccruedInProcessResearchAndDevelopment_7f56a561-6daa-459c-8e70-30de7a6e97af" xlink:href="goss-20200930.xsd#goss_AccruedInProcessResearchAndDevelopment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8c0e6384-d4a7-4304-9dc8-e485a53524aa" xlink:to="loc_goss_AccruedInProcessResearchAndDevelopment_7f56a561-6daa-459c-8e70-30de7a6e97af" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestments" xlink:type="simple" xlink:href="goss-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestments"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsTables" xlink:type="simple" xlink:href="goss-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsTables"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e80f745a-d22f-4bcb-9010-2ef030bc330e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0fa81970-e7b8-465a-90ad-7a31200d3675" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e80f745a-d22f-4bcb-9010-2ef030bc330e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0fa81970-e7b8-465a-90ad-7a31200d3675" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_2de82b8a-8299-4670-bb47-37011f4621e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e80f745a-d22f-4bcb-9010-2ef030bc330e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_2de82b8a-8299-4670-bb47-37011f4621e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7a3599f0-9ec3-4c09-a141-cc6147989e32" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e80f745a-d22f-4bcb-9010-2ef030bc330e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7a3599f0-9ec3-4c09-a141-cc6147989e32" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofContractualMaturitiesofAvailableforsaleDebtSecuritiesDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofContractualMaturitiesofAvailableforsaleDebtSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofContractualMaturitiesofAvailableforsaleDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_470daea6-9375-4f8b-beb9-fbbd7f455ff2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_27d1adc9-26df-45f9-82de-96c0184ab54d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_470daea6-9375-4f8b-beb9-fbbd7f455ff2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_27d1adc9-26df-45f9-82de-96c0184ab54d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_370cf146-eec0-498f-93e3-63500fc5d776" xlink:href="goss-20200930.xsd#goss_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_470daea6-9375-4f8b-beb9-fbbd7f455ff2" xlink:to="loc_goss_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_370cf146-eec0-498f-93e3-63500fc5d776" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/Indebtedness" xlink:type="simple" xlink:href="goss-20200930.xsd#Indebtedness"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/Indebtedness" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/IndebtednessTables" xlink:type="simple" xlink:href="goss-20200930.xsd#IndebtednessTables"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/IndebtednessTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#IndebtednessAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/IndebtednessScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#IndebtednessScheduleofLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/IndebtednessScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_7cbcf96d-443e-40d0-9163-75234dc78b41" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_6f345fb4-c2bc-4b34-a46b-e9b9e64ead73" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_7cbcf96d-443e-40d0-9163-75234dc78b41" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_6f345fb4-c2bc-4b34-a46b-e9b9e64ead73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_41a86be0-03b7-4f9e-938b-4bdb7b2c0197" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_7cbcf96d-443e-40d0-9163-75234dc78b41" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_41a86be0-03b7-4f9e-938b-4bdb7b2c0197" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_45bb423f-145f-4d59-9376-68cabb651b16" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_6f1b38bb-4c0b-4583-85bc-f9abbaf03616" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_45bb423f-145f-4d59-9376-68cabb651b16" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_6f1b38bb-4c0b-4583-85bc-f9abbaf03616" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3f21afcf-21c6-4a22-bda4-a1755cad6a0f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_45bb423f-145f-4d59-9376-68cabb651b16" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3f21afcf-21c6-4a22-bda4-a1755cad6a0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_04442eda-7d91-4b31-8f67-9524848be63a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_45bb423f-145f-4d59-9376-68cabb651b16" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_04442eda-7d91-4b31-8f67-9524848be63a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_84ba5c2f-2659-4e38-994e-73bae7db7e4f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_45bb423f-145f-4d59-9376-68cabb651b16" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_84ba5c2f-2659-4e38-994e-73bae7db7e4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_b73fed2a-c9d1-4fdb-a826-5148851220ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_45bb423f-145f-4d59-9376-68cabb651b16" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_b73fed2a-c9d1-4fdb-a826-5148851220ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix_d75a90e6-ae19-4898-8278-1c60c716417e" xlink:href="goss-20200930.xsd#goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_45bb423f-145f-4d59-9376-68cabb651b16" xlink:to="loc_goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix_d75a90e6-ae19-4898-8278-1c60c716417e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_89a94896-90d9-46aa-9cdb-668e2e03d053" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_1fc9ec5d-4204-46f0-9174-4bf18e13c97c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_89a94896-90d9-46aa-9cdb-668e2e03d053" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_1fc9ec5d-4204-46f0-9174-4bf18e13c97c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_3b850239-631d-42fe-9836-79e3e0e8b037" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_89a94896-90d9-46aa-9cdb-668e2e03d053" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_3b850239-631d-42fe-9836-79e3e0e8b037" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_67b2ad2f-707c-495f-a911-bc1223d1f4af" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_89a94896-90d9-46aa-9cdb-668e2e03d053" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_67b2ad2f-707c-495f-a911-bc1223d1f4af" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/IndebtednessScheduleofEquityComponentsDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#IndebtednessScheduleofEquityComponentsDetails"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/IndebtednessScheduleofEquityComponentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_69418e2d-ea50-4795-bb59-555c25a502ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption_ccaf51b3-3b29-43d3-a4d3-d93848def234" xlink:href="goss-20200930.xsd#goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_69418e2d-ea50-4795-bb59-555c25a502ab" xlink:to="loc_goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption_ccaf51b3-3b29-43d3-a4d3-d93848def234" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts_7b1ae9d1-cf07-41ad-a576-9549f9cde48d" xlink:href="goss-20200930.xsd#goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_69418e2d-ea50-4795-bb59-555c25a502ab" xlink:to="loc_goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts_7b1ae9d1-cf07-41ad-a576-9549f9cde48d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/IndebtednessScheduleofInterestExpenseRecognizedDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#IndebtednessScheduleofInterestExpenseRecognizedDetails"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/IndebtednessScheduleofInterestExpenseRecognizedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_694db3af-c075-4eef-b2f7-ea76f946d315" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ContractualInterestExpense_d892ee1c-2812-4c63-b013-9a243391fcde" xlink:href="goss-20200930.xsd#goss_ContractualInterestExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_694db3af-c075-4eef-b2f7-ea76f946d315" xlink:to="loc_goss_ContractualInterestExpense_d892ee1c-2812-4c63-b013-9a243391fcde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_e8689111-9ccb-4afb-8b11-b9988caae2fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_694db3af-c075-4eef-b2f7-ea76f946d315" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_e8689111-9ccb-4afb-8b11-b9988caae2fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_ecf5e56c-5f82-46b3-b0f8-21c341139e45" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_694db3af-c075-4eef-b2f7-ea76f946d315" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_ecf5e56c-5f82-46b3-b0f8-21c341139e45" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsideration" xlink:type="simple" xlink:href="goss-20200930.xsd#LicensesAssetAcquisitionsandContingentConsideration"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsideration" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationTables" xlink:type="simple" xlink:href="goss-20200930.xsd#LicensesAssetAcquisitionsandContingentConsiderationTables"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/StockholdersEquity" xlink:type="simple" xlink:href="goss-20200930.xsd#StockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/StockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#StockholdersEquityAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/EquityIncentivePlans" xlink:type="simple" xlink:href="goss-20200930.xsd#EquityIncentivePlans"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/EquityIncentivePlans" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/EquityIncentivePlansTables" xlink:type="simple" xlink:href="goss-20200930.xsd#EquityIncentivePlansTables"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/EquityIncentivePlansTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#EquityIncentivePlansAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#EquityIncentivePlansSummaryofStockOptionActivityDetails"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#EquityIncentivePlansSummaryofRestrictedStockActivityDetails"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/EquityIncentivePlansStockBasedCompensationExpenseReportedinCondensedConsolidatedStatementsofOperationsDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#EquityIncentivePlansStockBasedCompensationExpenseReportedinCondensedConsolidatedStatementsofOperationsDetails"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/EquityIncentivePlansStockBasedCompensationExpenseReportedinCondensedConsolidatedStatementsofOperationsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="goss-20200930.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="goss-20200930.xsd#CommitmentsandContingenciesTables"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/CommitmentsandContingenciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#CommitmentsandContingenciesAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofLeaseCostsDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#CommitmentsandContingenciesScheduleofLeaseCostsDetails"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_ea37d063-ffd2-4bfc-91f6-1863bb9db2a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_0dd6e1cb-a95e-4b89-bd88-bb8f866bd7f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ea37d063-ffd2-4bfc-91f6-1863bb9db2a6" xlink:to="loc_us-gaap_OperatingLeaseCost_0dd6e1cb-a95e-4b89-bd88-bb8f866bd7f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_4e239766-16e4-4b23-b681-c5f3fa2b9d69" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_ea37d063-ffd2-4bfc-91f6-1863bb9db2a6" xlink:to="loc_us-gaap_ShortTermLeaseCost_4e239766-16e4-4b23-b681-c5f3fa2b9d69" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_680542c3-962a-4639-b3f0-ad17e4423136" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c6909326-dff2-4d84-99cc-57bfc3d2a11b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_680542c3-962a-4639-b3f0-ad17e4423136" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c6909326-dff2-4d84-99cc-57bfc3d2a11b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e3a3209e-b299-4dff-a390-c1b0d2ff5306" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_680542c3-962a-4639-b3f0-ad17e4423136" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e3a3209e-b299-4dff-a390-c1b0d2ff5306" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f21b05e5-32c8-4a21-b9d0-cc9103d18055" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d45bf63e-e95b-4126-b4f7-2b6f2c3b4cd6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f21b05e5-32c8-4a21-b9d0-cc9103d18055" xlink:to="loc_us-gaap_OperatingLeaseLiability_d45bf63e-e95b-4126-b4f7-2b6f2c3b4cd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_380b9d33-ebfa-421d-a765-b0ebd7ead228" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f21b05e5-32c8-4a21-b9d0-cc9103d18055" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_380b9d33-ebfa-421d-a765-b0ebd7ead228" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails_1" xlink:type="simple" xlink:href="goss-20200930.xsd#CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9e0f38d1-89d5-4568-98c5-7ce38cda9dc1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_50af6bd3-c258-4ef0-8573-b4786e4acf6a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9e0f38d1-89d5-4568-98c5-7ce38cda9dc1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_50af6bd3-c258-4ef0-8573-b4786e4acf6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_34193993-8558-42d3-bda5-5f6e6f8dbce1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9e0f38d1-89d5-4568-98c5-7ce38cda9dc1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_34193993-8558-42d3-bda5-5f6e6f8dbce1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_42893e74-af3c-4aec-aa99-8df00d1d0dd9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9e0f38d1-89d5-4568-98c5-7ce38cda9dc1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_42893e74-af3c-4aec-aa99-8df00d1d0dd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a4901b36-86a4-44f0-9a4d-63b1d8758137" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9e0f38d1-89d5-4568-98c5-7ce38cda9dc1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a4901b36-86a4-44f0-9a4d-63b1d8758137" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2fc76816-0d2e-40de-88f5-e5dc98c7496e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9e0f38d1-89d5-4568-98c5-7ce38cda9dc1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2fc76816-0d2e-40de-88f5-e5dc98c7496e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LesseeOperatingLeaseLiabilityPaymentsDueYearSix_4fbec868-f040-4c4e-9ccb-b6bcf621b0f2" xlink:href="goss-20200930.xsd#goss_LesseeOperatingLeaseLiabilityPaymentsDueYearSix"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9e0f38d1-89d5-4568-98c5-7ce38cda9dc1" xlink:to="loc_goss_LesseeOperatingLeaseLiabilityPaymentsDueYearSix_4fbec868-f040-4c4e-9ccb-b6bcf621b0f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix_36436357-5ba4-496f-b833-40d46082c23c" xlink:href="goss-20200930.xsd#goss_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9e0f38d1-89d5-4568-98c5-7ce38cda9dc1" xlink:to="loc_goss_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix_36436357-5ba4-496f-b833-40d46082c23c" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>goss-20200930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:a28f2324-59ee-4208-be3f-ac91f14d0976,g:685f1ccc-55e8-49df-855b-4b6ee836ad79-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/Cover" xlink:type="simple" xlink:href="goss-20200930.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/Cover" xlink:type="extended" id="i7a039a36ef1a4eda9d01109b2f321ddd_Cover"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="goss-20200930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended" id="ic3676110928c493f93bd9f29de78f338_CondensedConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="goss-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="i961307681b984fc0860be60f8fc4b90e_CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="goss-20200930.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended" id="i7206611246174944b8c3507ef98d86aa_CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity" xlink:type="simple" xlink:href="goss-20200930.xsd#CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity" xlink:type="extended" id="i2ab86a59def841c0ad82c4431c24efb5_CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a8ff6618-1a48-459f-ac60-23fd28c9c373" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef0505ba-5a99-401b-b6ab-bd71e9b135c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a8ff6618-1a48-459f-ac60-23fd28c9c373" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef0505ba-5a99-401b-b6ab-bd71e9b135c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_3c5111bf-ede7-4f97-bbe8-371b5917016e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef0505ba-5a99-401b-b6ab-bd71e9b135c4" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_3c5111bf-ede7-4f97-bbe8-371b5917016e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_da21e8f8-01ed-430f-8693-2279eeb7c930" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef0505ba-5a99-401b-b6ab-bd71e9b135c4" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_da21e8f8-01ed-430f-8693-2279eeb7c930" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TemporaryEquitySharesConvertedIntoCommonSharesShares_1a5c54c0-0695-49fc-a311-b01dba30edd2" xlink:href="goss-20200930.xsd#goss_TemporaryEquitySharesConvertedIntoCommonSharesShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef0505ba-5a99-401b-b6ab-bd71e9b135c4" xlink:to="loc_goss_TemporaryEquitySharesConvertedIntoCommonSharesShares_1a5c54c0-0695-49fc-a311-b01dba30edd2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TemporaryEquitySharesConvertedIntoCommonSharesValue_7d2e96f3-b1a5-4210-8a38-f106e1470955" xlink:href="goss-20200930.xsd#goss_TemporaryEquitySharesConvertedIntoCommonSharesValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef0505ba-5a99-401b-b6ab-bd71e9b135c4" xlink:to="loc_goss_TemporaryEquitySharesConvertedIntoCommonSharesValue_7d2e96f3-b1a5-4210-8a38-f106e1470955" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_2c27fa07-8434-4a67-8735-9a9f635747b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_71452150-e673-49cb-b4c5-84ff4a7d0b40" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a8ff6618-1a48-459f-ac60-23fd28c9c373" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_237dc7d9-27c5-4aa4-b8cc-48f986d178ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_SharesOutstanding_237dc7d9-27c5-4aa4-b8cc-48f986d178ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9aea1120-1068-4fcf-9d21-6988e7ebf306" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_StockholdersEquity_9aea1120-1068-4fcf-9d21-6988e7ebf306" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b852d0b5-4e2e-44ad-a906-0b8469e45cda" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b852d0b5-4e2e-44ad-a906-0b8469e45cda" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c2d0cda2-b0c0-4ebe-8047-38e92e3f7468" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c2d0cda2-b0c0-4ebe-8047-38e92e3f7468" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_EquityComponentOfConvertibleNoteIssuance_1017043c-0cee-4adf-96a1-d44afb37be19" xlink:href="goss-20200930.xsd#goss_EquityComponentOfConvertibleNoteIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_goss_EquityComponentOfConvertibleNoteIssuance_1017043c-0cee-4adf-96a1-d44afb37be19" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_292868d5-3d96-4fc0-a41f-bb8766d3b854" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_292868d5-3d96-4fc0-a41f-bb8766d3b854" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock_7b975b9b-d60b-4e59-ae0c-955b84f08a4d" xlink:href="goss-20200930.xsd#goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock_7b975b9b-d60b-4e59-ae0c-955b84f08a4d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_922a10f1-55a1-461c-847d-31d3bbfb43ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_922a10f1-55a1-461c-847d-31d3bbfb43ba" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_37c2d497-e44e-4c92-8049-8efd2ff2bb07" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_37c2d497-e44e-4c92-8049-8efd2ff2bb07" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0a02ea0c-40a2-4e31-b44f-73524470c308" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0a02ea0c-40a2-4e31-b44f-73524470c308" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_576fc0c0-da82-4cc9-9758-3f870fddfde3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_576fc0c0-da82-4cc9-9758-3f870fddfde3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_af21399e-cf20-4f0e-979a-e7de1f5112ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_af21399e-cf20-4f0e-979a-e7de1f5112ec" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_35743fc0-20b4-4e5f-b0ea-58a2c618336a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_35743fc0-20b4-4e5f-b0ea-58a2c618336a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_629dc00e-c7ef-438e-9fd7-fb249a5512e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_NetIncomeLoss_629dc00e-c7ef-438e-9fd7-fb249a5512e1" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_361f6069-9dcd-46d3-ba2a-27ed2fec09b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_361f6069-9dcd-46d3-ba2a-27ed2fec09b6" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_e507f9d3-574c-4c8b-b4d5-61db2beae381" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_e507f9d3-574c-4c8b-b4d5-61db2beae381" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_aa64bd55-9121-4fa8-b274-89c193bcdcab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_aa64bd55-9121-4fa8-b274-89c193bcdcab" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_070d3c2d-ed02-4d55-ac9a-3a7882cdd21b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_070d3c2d-ed02-4d55-ac9a-3a7882cdd21b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_16ab697c-0c42-4a81-9261-4772b2d95c10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d2ef578b-c86e-456a-a036-91bd8f498220" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_55fb6844-f4cf-412b-9b84-c9543f4777d2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_a8ff6618-1a48-459f-ac60-23fd28c9c373" xlink:to="loc_us-gaap_StatementTable_55fb6844-f4cf-412b-9b84-c9543f4777d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_39cda1c8-d79e-48f6-90ad-d940dfbe430e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_55fb6844-f4cf-412b-9b84-c9543f4777d2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_39cda1c8-d79e-48f6-90ad-d940dfbe430e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_39cda1c8-d79e-48f6-90ad-d940dfbe430e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_39cda1c8-d79e-48f6-90ad-d940dfbe430e" xlink:to="loc_us-gaap_ClassOfStockDomain_39cda1c8-d79e-48f6-90ad-d940dfbe430e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e9845b9f-12ae-41d1-881a-ae83e20ff4db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_39cda1c8-d79e-48f6-90ad-d940dfbe430e" xlink:to="loc_us-gaap_ClassOfStockDomain_e9845b9f-12ae-41d1-881a-ae83e20ff4db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SeriesSeedConvertiblePreferredStockMember_0364036c-1113-40dd-ab58-b5f07afb9197" xlink:href="goss-20200930.xsd#goss_SeriesSeedConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e9845b9f-12ae-41d1-881a-ae83e20ff4db" xlink:to="loc_goss_SeriesSeedConvertiblePreferredStockMember_0364036c-1113-40dd-ab58-b5f07afb9197" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SeriesAConvertiblePreferredStockMember_669a37b0-d1e1-447c-b97b-0d7e31d93182" xlink:href="goss-20200930.xsd#goss_SeriesAConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e9845b9f-12ae-41d1-881a-ae83e20ff4db" xlink:to="loc_goss_SeriesAConvertiblePreferredStockMember_669a37b0-d1e1-447c-b97b-0d7e31d93182" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SeriesBConvertiblePreferredStockMember_4e97d051-67ed-417d-8e53-37496ab90f0a" xlink:href="goss-20200930.xsd#goss_SeriesBConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e9845b9f-12ae-41d1-881a-ae83e20ff4db" xlink:to="loc_goss_SeriesBConvertiblePreferredStockMember_4e97d051-67ed-417d-8e53-37496ab90f0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4089aa95-c1d4-44c7-aae5-8357886f8a95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_55fb6844-f4cf-412b-9b84-c9543f4777d2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4089aa95-c1d4-44c7-aae5-8357886f8a95" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4089aa95-c1d4-44c7-aae5-8357886f8a95_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4089aa95-c1d4-44c7-aae5-8357886f8a95" xlink:to="loc_us-gaap_EquityComponentDomain_4089aa95-c1d4-44c7-aae5-8357886f8a95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_47d3ded9-f338-4d36-958a-dfd84128a622" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4089aa95-c1d4-44c7-aae5-8357886f8a95" xlink:to="loc_us-gaap_EquityComponentDomain_47d3ded9-f338-4d36-958a-dfd84128a622" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e6f14a80-8d5d-49a6-b040-9ab96cfed2b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_47d3ded9-f338-4d36-958a-dfd84128a622" xlink:to="loc_us-gaap_CommonStockMember_e6f14a80-8d5d-49a6-b040-9ab96cfed2b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_6feb16c4-3291-4ce0-ba50-eae037128065" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_47d3ded9-f338-4d36-958a-dfd84128a622" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_6feb16c4-3291-4ce0-ba50-eae037128065" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_00426206-043e-4d07-acd1-0ec3e1a9b60e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_47d3ded9-f338-4d36-958a-dfd84128a622" xlink:to="loc_us-gaap_RetainedEarningsMember_00426206-043e-4d07-acd1-0ec3e1a9b60e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_130fcf50-88d5-4528-a9d6-63b21173af75" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_47d3ded9-f338-4d36-958a-dfd84128a622" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_130fcf50-88d5-4528-a9d6-63b21173af75" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="goss-20200930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended" id="ic31239a94eae4dc78b5c0df4afe47213_CondensedConsolidatedStatementsofCashFlows">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_602bb2e7-7ad9-4720-b801-1f0d5555001b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ea9c6298-0c2b-4b73-8869-922e02b368ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_602bb2e7-7ad9-4720-b801-1f0d5555001b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ea9c6298-0c2b-4b73-8869-922e02b368ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3da6ab4b-59c3-4665-8e87-0d7817171a29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ea9c6298-0c2b-4b73-8869-922e02b368ae" xlink:to="loc_us-gaap_ProfitLoss_3da6ab4b-59c3-4665-8e87-0d7817171a29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a526e6ac-a3c4-42f4-826b-8c89c459aae1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ea9c6298-0c2b-4b73-8869-922e02b368ae" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a526e6ac-a3c4-42f4-826b-8c89c459aae1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_3da67f01-8dc0-4d83-a87f-049341f287e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a526e6ac-a3c4-42f4-826b-8c89c459aae1" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_3da67f01-8dc0-4d83-a87f-049341f287e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_087084ee-467f-4788-ac3c-87a49326f79a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a526e6ac-a3c4-42f4-826b-8c89c459aae1" xlink:to="loc_us-gaap_ShareBasedCompensation_087084ee-467f-4788-ac3c-87a49326f79a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentExpenses_e8c0da14-80e3-4d72-97f1-34dcdc03862d" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a526e6ac-a3c4-42f4-826b-8c89c459aae1" xlink:to="loc_goss_InProcessResearchAndDevelopmentExpenses_e8c0da14-80e3-4d72-97f1-34dcdc03862d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AmortizationOfOperatingLeaseRightOfUseAssets_b22e4d5a-a13b-4252-ba19-da3c7ac9849f" xlink:href="goss-20200930.xsd#goss_AmortizationOfOperatingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a526e6ac-a3c4-42f4-826b-8c89c459aae1" xlink:to="loc_goss_AmortizationOfOperatingLeaseRightOfUseAssets_b22e4d5a-a13b-4252-ba19-da3c7ac9849f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_3f2de833-dc2d-43aa-9814-0da8b22fb06e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a526e6ac-a3c4-42f4-826b-8c89c459aae1" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_3f2de833-dc2d-43aa-9814-0da8b22fb06e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_a69cc960-8779-4e82-96c9-24c9e9a2df9c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a526e6ac-a3c4-42f4-826b-8c89c459aae1" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_a69cc960-8779-4e82-96c9-24c9e9a2df9c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_0232a4b9-4a70-4996-9f93-f853c2150a45" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a526e6ac-a3c4-42f4-826b-8c89c459aae1" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_0232a4b9-4a70-4996-9f93-f853c2150a45" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3571abf-e74b-405f-b66d-ff2cfd507413" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ea9c6298-0c2b-4b73-8869-922e02b368ae" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3571abf-e74b-405f-b66d-ff2cfd507413" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c4cc76f1-4027-479b-8da9-04614ef95d0b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3571abf-e74b-405f-b66d-ff2cfd507413" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c4cc76f1-4027-479b-8da9-04614ef95d0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_ff7f2d99-1f75-4b0f-90b0-2b46f838abdc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3571abf-e74b-405f-b66d-ff2cfd507413" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_ff7f2d99-1f75-4b0f-90b0-2b46f838abdc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_IncreaseDecreaseInOperatingLeaseLiabilities_cecad724-6438-4e13-b287-de8949606042" xlink:href="goss-20200930.xsd#goss_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3571abf-e74b-405f-b66d-ff2cfd507413" xlink:to="loc_goss_IncreaseDecreaseInOperatingLeaseLiabilities_cecad724-6438-4e13-b287-de8949606042" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1248af24-4f18-4a6b-8d8c-9e7ae2c12bb3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3571abf-e74b-405f-b66d-ff2cfd507413" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1248af24-4f18-4a6b-8d8c-9e7ae2c12bb3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_2e8ccee0-be26-4341-ae49-4dde42867ce4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3571abf-e74b-405f-b66d-ff2cfd507413" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_2e8ccee0-be26-4341-ae49-4dde42867ce4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses_8fd47ae2-90cd-46fa-b336-475696149246" xlink:href="goss-20200930.xsd#goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3571abf-e74b-405f-b66d-ff2cfd507413" xlink:to="loc_goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses_8fd47ae2-90cd-46fa-b336-475696149246" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_af7d6d41-0744-4b33-a46d-289400ce9def" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3571abf-e74b-405f-b66d-ff2cfd507413" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_af7d6d41-0744-4b33-a46d-289400ce9def" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_46b87b9d-b9d5-4cd6-a8df-83943948964a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ea9c6298-0c2b-4b73-8869-922e02b368ae" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_46b87b9d-b9d5-4cd6-a8df-83943948964a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_93b7ea5d-8b8f-42c4-80ff-1c12a0c2477a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_602bb2e7-7ad9-4720-b801-1f0d5555001b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_93b7ea5d-8b8f-42c4-80ff-1c12a0c2477a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions_4150f8b9-63a6-42be-90e6-bd8980357f08" xlink:href="goss-20200930.xsd#goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_93b7ea5d-8b8f-42c4-80ff-1c12a0c2477a" xlink:to="loc_goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions_4150f8b9-63a6-42be-90e6-bd8980357f08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_5269058c-18d8-4858-8d98-db2fdc20980c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_93b7ea5d-8b8f-42c4-80ff-1c12a0c2477a" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_5269058c-18d8-4858-8d98-db2fdc20980c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ProceedsFromMaturityOfMarketableSecurities_5da738cb-5da3-40ba-bd14-1e4b7afdf9f1" xlink:href="goss-20200930.xsd#goss_ProceedsFromMaturityOfMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_93b7ea5d-8b8f-42c4-80ff-1c12a0c2477a" xlink:to="loc_goss_ProceedsFromMaturityOfMarketableSecurities_5da738cb-5da3-40ba-bd14-1e4b7afdf9f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ProceedsFromSaleOfMarketableSecurities_a0f51f99-2684-4d74-b903-6e3fd4d8e3ff" xlink:href="goss-20200930.xsd#goss_ProceedsFromSaleOfMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_93b7ea5d-8b8f-42c4-80ff-1c12a0c2477a" xlink:to="loc_goss_ProceedsFromSaleOfMarketableSecurities_a0f51f99-2684-4d74-b903-6e3fd4d8e3ff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_66273fae-acea-4ff8-a971-a42baf3c683c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_93b7ea5d-8b8f-42c4-80ff-1c12a0c2477a" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_66273fae-acea-4ff8-a971-a42baf3c683c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a3d32a58-784c-4631-9f93-f7e21f14f588" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_93b7ea5d-8b8f-42c4-80ff-1c12a0c2477a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a3d32a58-784c-4631-9f93-f7e21f14f588" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d0d6dad-d600-4b22-bd2e-7fd2b425b46b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_602bb2e7-7ad9-4720-b801-1f0d5555001b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d0d6dad-d600-4b22-bd2e-7fd2b425b46b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ae769d84-9622-493b-a8f1-ae772063fc35" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d0d6dad-d600-4b22-bd2e-7fd2b425b46b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ae769d84-9622-493b-a8f1-ae772063fc35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_14d7836b-0def-4634-b878-5e31dd166869" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d0d6dad-d600-4b22-bd2e-7fd2b425b46b" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_14d7836b-0def-4634-b878-5e31dd166869" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_b598a42d-c32a-44b7-8953-af0f734ebc2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d0d6dad-d600-4b22-bd2e-7fd2b425b46b" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_b598a42d-c32a-44b7-8953-af0f734ebc2c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_2f3a5238-d651-42f0-919f-cbfc54644f54" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d0d6dad-d600-4b22-bd2e-7fd2b425b46b" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_2f3a5238-d651-42f0-919f-cbfc54644f54" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_05a35cef-f91b-41cf-a49a-7d85ee999534" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d0d6dad-d600-4b22-bd2e-7fd2b425b46b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_05a35cef-f91b-41cf-a49a-7d85ee999534" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_cdb893ee-9e27-4f4d-9506-0589bc0d5b87" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_602bb2e7-7ad9-4720-b801-1f0d5555001b" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_cdb893ee-9e27-4f4d-9506-0589bc0d5b87" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_8eeda8e5-2ac0-412e-9b1d-aecf67e0703e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_602bb2e7-7ad9-4720-b801-1f0d5555001b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_8eeda8e5-2ac0-412e-9b1d-aecf67e0703e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_78ebf260-17ca-4499-a272-97873b9ea995" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_602bb2e7-7ad9-4720-b801-1f0d5555001b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_78ebf260-17ca-4499-a272-97873b9ea995" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e828fcb1-acfe-442b-a085-6d6ac61c7e5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_73eb2f2c-a64e-4425-a738-1fd6ca6f1947" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_602bb2e7-7ad9-4720-b801-1f0d5555001b" xlink:to="loc_us-gaap_SupplementalCashFlowElementsAbstract_73eb2f2c-a64e-4425-a738-1fd6ca6f1947" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_5b935420-eb70-450d-9674-080d48dc95b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_73eb2f2c-a64e-4425-a738-1fd6ca6f1947" xlink:to="loc_us-gaap_InterestPaidNet_5b935420-eb70-450d-9674-080d48dc95b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d3c10f83-495d-44c3-944f-e603fd2ab3e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_602bb2e7-7ad9-4720-b801-1f0d5555001b" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d3c10f83-495d-44c3-944f-e603fd2ab3e7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities_37f5042f-98a9-4470-b52b-3182504c0130" xlink:href="goss-20200930.xsd#goss_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d3c10f83-495d-44c3-944f-e603fd2ab3e7" xlink:to="loc_goss_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities_37f5042f-98a9-4470-b52b-3182504c0130" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax_c483e11e-f37f-449d-b97b-38bc705df534" xlink:href="goss-20200930.xsd#goss_NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d3c10f83-495d-44c3-944f-e603fd2ab3e7" xlink:to="loc_goss_NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax_c483e11e-f37f-449d-b97b-38bc705df534" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_3d2bcef1-1146-45fa-84a1-4a359ce5ed28" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d3c10f83-495d-44c3-944f-e603fd2ab3e7" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_3d2bcef1-1146-45fa-84a1-4a359ce5ed28" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock_989df77f-41e1-4f7b-b8c4-1bb2b4b7b135" xlink:href="goss-20200930.xsd#goss_NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d3c10f83-495d-44c3-944f-e603fd2ab3e7" xlink:to="loc_goss_NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock_989df77f-41e1-4f7b-b8c4-1bb2b4b7b135" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_dd8b89be-e60c-40a8-9316-58c91a7e6c9d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_602bb2e7-7ad9-4720-b801-1f0d5555001b" xlink:to="loc_us-gaap_StatementTable_dd8b89be-e60c-40a8-9316-58c91a7e6c9d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_9b0153a4-3897-4cdf-b0e4-7787072d7ded" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_dd8b89be-e60c-40a8-9316-58c91a7e6c9d" xlink:to="loc_us-gaap_PlanNameAxis_9b0153a4-3897-4cdf-b0e4-7787072d7ded" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_9b0153a4-3897-4cdf-b0e4-7787072d7ded_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_9b0153a4-3897-4cdf-b0e4-7787072d7ded" xlink:to="loc_us-gaap_PlanNameDomain_9b0153a4-3897-4cdf-b0e4-7787072d7ded_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1504f554-5c19-4507-aad4-8f40486368f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_9b0153a4-3897-4cdf-b0e4-7787072d7ded" xlink:to="loc_us-gaap_PlanNameDomain_1504f554-5c19-4507-aad4-8f40486368f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandNineteenEmployeeStockPurchasePlanMember_21477390-86fa-4b3d-ae2b-b3064f168b65" xlink:href="goss-20200930.xsd#goss_TwoThousandNineteenEmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_1504f554-5c19-4507-aad4-8f40486368f4" xlink:to="loc_goss_TwoThousandNineteenEmployeeStockPurchasePlanMember_21477390-86fa-4b3d-ae2b-b3064f168b65" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical" xlink:type="simple" xlink:href="goss-20200930.xsd#CondensedConsolidatedStatementsofCashFlowsParenthetical"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical" xlink:type="extended" id="i09e43df4305e42bcb6c371e12f6064d4_CondensedConsolidatedStatementsofCashFlowsParenthetical"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/DescriptionoftheBusiness" xlink:type="simple" xlink:href="goss-20200930.xsd#DescriptionoftheBusiness"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/DescriptionoftheBusiness" xlink:type="extended" id="ie2bd4adf0842432a994fc1624ce66a34_DescriptionoftheBusiness"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail" xlink:type="simple" xlink:href="goss-20200930.xsd#DescriptionoftheBusinessAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail" xlink:type="extended" id="i7f0aeb980d7d4e648ee21df0f285bf0f_DescriptionoftheBusinessAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_goss_DescriptionOfBusinessLineItems_fe28ff1b-7d51-40c9-9cc8-5b0f76d18688" xlink:href="goss-20200930.xsd#goss_DescriptionOfBusinessLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b099f21d-8610-424f-8a58-a4d4bd235006" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_DescriptionOfBusinessLineItems_fe28ff1b-7d51-40c9-9cc8-5b0f76d18688" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b099f21d-8610-424f-8a58-a4d4bd235006" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_e7343610-f624-4c73-afd2-d0bf25e77c64" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_DescriptionOfBusinessLineItems_fe28ff1b-7d51-40c9-9cc8-5b0f76d18688" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_e7343610-f624-4c73-afd2-d0bf25e77c64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_5fe7af36-0f41-4461-b439-3ae1af6c95fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_DescriptionOfBusinessLineItems_fe28ff1b-7d51-40c9-9cc8-5b0f76d18688" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_5fe7af36-0f41-4461-b439-3ae1af6c95fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_019401c1-acff-463b-8c62-1dedc94c49cd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_DescriptionOfBusinessLineItems_fe28ff1b-7d51-40c9-9cc8-5b0f76d18688" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_019401c1-acff-463b-8c62-1dedc94c49cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e604e685-605f-4c78-b271-c2b88a47940d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_DescriptionOfBusinessLineItems_fe28ff1b-7d51-40c9-9cc8-5b0f76d18688" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e604e685-605f-4c78-b271-c2b88a47940d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering_aa36f2d9-82c1-425f-98d2-8d4246db4765" xlink:href="goss-20200930.xsd#goss_FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_DescriptionOfBusinessLineItems_fe28ff1b-7d51-40c9-9cc8-5b0f76d18688" xlink:to="loc_goss_FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering_aa36f2d9-82c1-425f-98d2-8d4246db4765" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e85daa42-68db-4041-b120-83d555f7e3ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_DescriptionOfBusinessLineItems_fe28ff1b-7d51-40c9-9cc8-5b0f76d18688" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e85daa42-68db-4041-b120-83d555f7e3ec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_8781e02a-f596-40d4-a23c-96195e5aa572" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_DescriptionOfBusinessLineItems_fe28ff1b-7d51-40c9-9cc8-5b0f76d18688" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_8781e02a-f596-40d4-a23c-96195e5aa572" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_DescriptionOfBusinessTable_2adfd908-6f16-4ce4-8309-ee1c08520323" xlink:href="goss-20200930.xsd#goss_DescriptionOfBusinessTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_goss_DescriptionOfBusinessLineItems_fe28ff1b-7d51-40c9-9cc8-5b0f76d18688" xlink:to="loc_goss_DescriptionOfBusinessTable_2adfd908-6f16-4ce4-8309-ee1c08520323" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_b1c20a45-a1ed-4d88-9440-91362701ed63" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_goss_DescriptionOfBusinessTable_2adfd908-6f16-4ce4-8309-ee1c08520323" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_b1c20a45-a1ed-4d88-9440-91362701ed63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b1c20a45-a1ed-4d88-9440-91362701ed63_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b1c20a45-a1ed-4d88-9440-91362701ed63" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b1c20a45-a1ed-4d88-9440-91362701ed63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cee0976a-c0ad-49f8-8915-4754b369f4f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b1c20a45-a1ed-4d88-9440-91362701ed63" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cee0976a-c0ad-49f8-8915-4754b369f4f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_61ec2ab2-2b02-40f8-8c09-ef6146f54730" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cee0976a-c0ad-49f8-8915-4754b369f4f4" xlink:to="loc_us-gaap_IPOMember_61ec2ab2-2b02-40f8-8c09-ef6146f54730" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_2bf18381-ce93-4926-a7bd-191e9f68c0b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_goss_DescriptionOfBusinessTable_2adfd908-6f16-4ce4-8309-ee1c08520323" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_2bf18381-ce93-4926-a7bd-191e9f68c0b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_2bf18381-ce93-4926-a7bd-191e9f68c0b7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_2bf18381-ce93-4926-a7bd-191e9f68c0b7" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_2bf18381-ce93-4926-a7bd-191e9f68c0b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_31db8ed3-9a49-451a-afc1-a16f4bb2be9b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_2bf18381-ce93-4926-a7bd-191e9f68c0b7" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_31db8ed3-9a49-451a-afc1-a16f4bb2be9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ConversionOfConvertiblePreferredStockIntoCommonStockMember_6c43fd4c-8090-4353-9b54-222b742d2d59" xlink:href="goss-20200930.xsd#goss_ConversionOfConvertiblePreferredStockIntoCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_31db8ed3-9a49-451a-afc1-a16f4bb2be9b" xlink:to="loc_goss_ConversionOfConvertiblePreferredStockIntoCommonStockMember_6c43fd4c-8090-4353-9b54-222b742d2d59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f46923ba-2e99-40cb-a8d1-455e51543325" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_goss_DescriptionOfBusinessTable_2adfd908-6f16-4ce4-8309-ee1c08520323" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f46923ba-2e99-40cb-a8d1-455e51543325" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f46923ba-2e99-40cb-a8d1-455e51543325_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f46923ba-2e99-40cb-a8d1-455e51543325" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f46923ba-2e99-40cb-a8d1-455e51543325_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_94a3ef33-a29b-4a58-a7e8-73ed224385e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f46923ba-2e99-40cb-a8d1-455e51543325" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_94a3ef33-a29b-4a58-a7e8-73ed224385e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandTwentySevenNotesMember_a5563e92-ec3b-4596-a7ff-63f28a1c109f" xlink:href="goss-20200930.xsd#goss_TwoThousandTwentySevenNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_94a3ef33-a29b-4a58-a7e8-73ed224385e4" xlink:to="loc_goss_TwoThousandTwentySevenNotesMember_a5563e92-ec3b-4596-a7ff-63f28a1c109f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a2f3c16d-1865-4500-931b-4e1a155f4ad3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_goss_DescriptionOfBusinessTable_2adfd908-6f16-4ce4-8309-ee1c08520323" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a2f3c16d-1865-4500-931b-4e1a155f4ad3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a2f3c16d-1865-4500-931b-4e1a155f4ad3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a2f3c16d-1865-4500-931b-4e1a155f4ad3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a2f3c16d-1865-4500-931b-4e1a155f4ad3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72bc08a0-02e0-4499-ad3c-e7b625c4d9f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a2f3c16d-1865-4500-931b-4e1a155f4ad3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72bc08a0-02e0-4499-ad3c-e7b625c4d9f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AABiopharmaIncMember_70baaae7-2e02-497e-b284-740e83214c80" xlink:href="goss-20200930.xsd#goss_AABiopharmaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72bc08a0-02e0-4499-ad3c-e7b625c4d9f0" xlink:to="loc_goss_AABiopharmaIncMember_70baaae7-2e02-497e-b284-740e83214c80" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="goss-20200930.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended" id="i7b2b13fc5a844436ab1d6b10f360eebf_SummaryofSignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="goss-20200930.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended" id="i975977c7247440b6a11488c0403cc224_SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="goss-20200930.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended" id="i3860212ee4964eba8f821e6f7579cf9f_SummaryofSignificantAccountingPoliciesTables"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossPerShareDetails" xlink:type="extended" id="i11a2f9531a5946a3b9f6992a859965d3_SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e5db39dc-47c3-43a3-9405-2deb211e4f7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8d8fd8c0-9c08-484a-b250-a9a77bec7cb6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e5db39dc-47c3-43a3-9405-2deb211e4f7f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8d8fd8c0-9c08-484a-b250-a9a77bec7cb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8d4c4b6a-71be-4a02-b863-35b0f9c80fd9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e5db39dc-47c3-43a3-9405-2deb211e4f7f" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8d4c4b6a-71be-4a02-b863-35b0f9c80fd9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5cb34180-dbff-428a-aa48-c9d092216b85" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8d4c4b6a-71be-4a02-b863-35b0f9c80fd9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5cb34180-dbff-428a-aa48-c9d092216b85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5cb34180-dbff-428a-aa48-c9d092216b85_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5cb34180-dbff-428a-aa48-c9d092216b85" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5cb34180-dbff-428a-aa48-c9d092216b85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e64b6fa-fac5-40e3-8faf-d3a199001c15" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5cb34180-dbff-428a-aa48-c9d092216b85" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e64b6fa-fac5-40e3-8faf-d3a199001c15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandTwentySevenNotesMember_4f1ab2ab-44b3-4ba3-99e0-804d56cfb9ca" xlink:href="goss-20200930.xsd#goss_TwoThousandTwentySevenNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e64b6fa-fac5-40e3-8faf-d3a199001c15" xlink:to="loc_goss_TwoThousandTwentySevenNotesMember_4f1ab2ab-44b3-4ba3-99e0-804d56cfb9ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_071768de-f5b1-4851-be51-b200f43e2324" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e64b6fa-fac5-40e3-8faf-d3a199001c15" xlink:to="loc_us-gaap_EmployeeStockOptionMember_071768de-f5b1-4851-be51-b200f43e2324" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_22c77d9c-ed26-4a22-ac84-f9e41c57bbf3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e64b6fa-fac5-40e3-8faf-d3a199001c15" xlink:to="loc_us-gaap_RestrictedStockMember_22c77d9c-ed26-4a22-ac84-f9e41c57bbf3" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosures" xlink:type="simple" xlink:href="goss-20200930.xsd#BalanceSheetAccountsandSupplementalDisclosures"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosures" xlink:type="extended" id="i8737bacbee4a45318e9a53e01b92cad7_BalanceSheetAccountsandSupplementalDisclosures"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresTables" xlink:type="simple" xlink:href="goss-20200930.xsd#BalanceSheetAccountsandSupplementalDisclosuresTables"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresTables" xlink:type="extended" id="ie0b31bf5d0754e279162198b644208c0_BalanceSheetAccountsandSupplementalDisclosuresTables"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails" xlink:type="extended" id="i064a84849d114af1bbe89b3092dda987_BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1e90347f-f845-4d59-8e39-37272e844889" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c87201ca-4e12-4b8a-bdd7-0e82cdf7d355" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1e90347f-f845-4d59-8e39-37272e844889" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c87201ca-4e12-4b8a-bdd7-0e82cdf7d355" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b7c0a42d-0c71-415a-bc12-719aaba86348" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1e90347f-f845-4d59-8e39-37272e844889" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b7c0a42d-0c71-415a-bc12-719aaba86348" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ce3e8711-0bbe-40d8-836a-a0dfc7790b10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1e90347f-f845-4d59-8e39-37272e844889" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ce3e8711-0bbe-40d8-836a-a0dfc7790b10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_3badbcd8-9e59-4050-bd3a-a9b34daf29f8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1e90347f-f845-4d59-8e39-37272e844889" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_3badbcd8-9e59-4050-bd3a-a9b34daf29f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_faa8f235-6b9b-4a8b-87f0-7e33387c464e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1e90347f-f845-4d59-8e39-37272e844889" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_faa8f235-6b9b-4a8b-87f0-7e33387c464e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_19e05e72-86ef-4375-b41b-043ada1be029" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_faa8f235-6b9b-4a8b-87f0-7e33387c464e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_19e05e72-86ef-4375-b41b-043ada1be029" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_19e05e72-86ef-4375-b41b-043ada1be029_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_19e05e72-86ef-4375-b41b-043ada1be029" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_19e05e72-86ef-4375-b41b-043ada1be029_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9c9af29f-5e2f-4590-9fc2-a5f970565ec3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_19e05e72-86ef-4375-b41b-043ada1be029" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9c9af29f-5e2f-4590-9fc2-a5f970565ec3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_7ab6a20b-80dd-4adc-a3ac-0cb78b3889ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9c9af29f-5e2f-4590-9fc2-a5f970565ec3" xlink:to="loc_us-gaap_OfficeEquipmentMember_7ab6a20b-80dd-4adc-a3ac-0cb78b3889ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_a94de200-9b03-45bd-9587-76d92812a9e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9c9af29f-5e2f-4590-9fc2-a5f970565ec3" xlink:to="loc_us-gaap_ComputerEquipmentMember_a94de200-9b03-45bd-9587-76d92812a9e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_64a15485-f6d1-4570-9c94-1adbd1e21fa1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9c9af29f-5e2f-4590-9fc2-a5f970565ec3" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_64a15485-f6d1-4570-9c94-1adbd1e21fa1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_01cfa23e-1f56-4dea-9cf0-c1e1adc64119" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9c9af29f-5e2f-4590-9fc2-a5f970565ec3" xlink:to="loc_us-gaap_EquipmentMember_01cfa23e-1f56-4dea-9cf0-c1e1adc64119" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_702d2c8b-f94f-461a-89ac-f7c0c26a46a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9c9af29f-5e2f-4590-9fc2-a5f970565ec3" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_702d2c8b-f94f-461a-89ac-f7c0c26a46a3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_8f191f7e-1603-4bc5-ba8b-f6da1bd790b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9c9af29f-5e2f-4590-9fc2-a5f970565ec3" xlink:to="loc_us-gaap_ConstructionInProgressMember_8f191f7e-1603-4bc5-ba8b-f6da1bd790b8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8c26de6c-e1b1-4a19-b7ad-b2270a6a67bc" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_faa8f235-6b9b-4a8b-87f0-7e33387c464e" xlink:to="loc_srt_RangeAxis_8c26de6c-e1b1-4a19-b7ad-b2270a6a67bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8c26de6c-e1b1-4a19-b7ad-b2270a6a67bc_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_8c26de6c-e1b1-4a19-b7ad-b2270a6a67bc" xlink:to="loc_srt_RangeMember_8c26de6c-e1b1-4a19-b7ad-b2270a6a67bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e2086660-4ba0-4dbc-87e1-c5e247f60f8d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_8c26de6c-e1b1-4a19-b7ad-b2270a6a67bc" xlink:to="loc_srt_RangeMember_e2086660-4ba0-4dbc-87e1-c5e247f60f8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f1dbaf9f-3dc2-462b-a559-eb6163523434" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e2086660-4ba0-4dbc-87e1-c5e247f60f8d" xlink:to="loc_srt_MinimumMember_f1dbaf9f-3dc2-462b-a559-eb6163523434" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a2b498a9-c0be-45a0-84ea-1deb35fcbfaf" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e2086660-4ba0-4dbc-87e1-c5e247f60f8d" xlink:to="loc_srt_MaximumMember_a2b498a9-c0be-45a0-84ea-1deb35fcbfaf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails" xlink:type="extended" id="i85029344476640a981ea803644995c74_BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestments" xlink:type="simple" xlink:href="goss-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestments"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestments" xlink:type="extended" id="i22b1a83c8f924dfd982fa8d9a06e2cab_FairValueMeasurementsandAvailableforSaleInvestments"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsTables" xlink:type="simple" xlink:href="goss-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsTables"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsTables" xlink:type="extended" id="if821e4fc109444bbb7c5c04a407909c6_FairValueMeasurementsandAvailableforSaleInvestmentsTables"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended" id="ib66fa0d01f444c90a2333d218df795da_FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f34f7c47-d88e-44f7-a203-f195325b6cc1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_9e1d18f3-4c99-47e5-bbab-bd2a01a2403e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f34f7c47-d88e-44f7-a203-f195325b6cc1" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_9e1d18f3-4c99-47e5-bbab-bd2a01a2403e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a84252a-80d6-47bf-9cd5-b78d721aabf8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f34f7c47-d88e-44f7-a203-f195325b6cc1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a84252a-80d6-47bf-9cd5-b78d721aabf8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_eee4685c-e6ab-46cf-bcc7-2bce1ccd699e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a84252a-80d6-47bf-9cd5-b78d721aabf8" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_eee4685c-e6ab-46cf-bcc7-2bce1ccd699e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_eee4685c-e6ab-46cf-bcc7-2bce1ccd699e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_eee4685c-e6ab-46cf-bcc7-2bce1ccd699e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_eee4685c-e6ab-46cf-bcc7-2bce1ccd699e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_fa0b9185-0ab8-4b86-9c86-b74bc4c74a72" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_eee4685c-e6ab-46cf-bcc7-2bce1ccd699e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_fa0b9185-0ab8-4b86-9c86-b74bc4c74a72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_ecbada11-49af-4faa-ac20-0ace00200b89" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_fa0b9185-0ab8-4b86-9c86-b74bc4c74a72" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_ecbada11-49af-4faa-ac20-0ace00200b89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6fab660e-eaef-47f3-811f-ed650b75c519" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a84252a-80d6-47bf-9cd5-b78d721aabf8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6fab660e-eaef-47f3-811f-ed650b75c519" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6fab660e-eaef-47f3-811f-ed650b75c519_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6fab660e-eaef-47f3-811f-ed650b75c519" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6fab660e-eaef-47f3-811f-ed650b75c519_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8922e9f7-8ba1-4274-bff5-3dc52e60fc48" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6fab660e-eaef-47f3-811f-ed650b75c519" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8922e9f7-8ba1-4274-bff5-3dc52e60fc48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9d8ac12e-e5bc-4335-9cdb-d65ee692f085" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8922e9f7-8ba1-4274-bff5-3dc52e60fc48" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9d8ac12e-e5bc-4335-9cdb-d65ee692f085" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b6eba561-ef1e-4d03-a48d-a8d2cac37071" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8922e9f7-8ba1-4274-bff5-3dc52e60fc48" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b6eba561-ef1e-4d03-a48d-a8d2cac37071" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_0451104a-6349-4600-9a80-abdca4f0c6f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8922e9f7-8ba1-4274-bff5-3dc52e60fc48" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_0451104a-6349-4600-9a80-abdca4f0c6f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_5374d37c-9931-4fcc-a344-0fe05f9654e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a84252a-80d6-47bf-9cd5-b78d721aabf8" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_5374d37c-9931-4fcc-a344-0fe05f9654e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_5374d37c-9931-4fcc-a344-0fe05f9654e7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_5374d37c-9931-4fcc-a344-0fe05f9654e7" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_5374d37c-9931-4fcc-a344-0fe05f9654e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a71d829f-2647-4831-b541-d10c80651a64" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_5374d37c-9931-4fcc-a344-0fe05f9654e7" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a71d829f-2647-4831-b541-d10c80651a64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_60114a7b-e524-4b5a-8288-966302a53443" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a71d829f-2647-4831-b541-d10c80651a64" xlink:to="loc_us-gaap_MoneyMarketFundsMember_60114a7b-e524-4b5a-8288-966302a53443" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_USTreasuryAndAgencySecuritiesMember_f6f32cc2-8d2f-4cb4-b965-83d5db5d8be9" xlink:href="goss-20200930.xsd#goss_USTreasuryAndAgencySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a71d829f-2647-4831-b541-d10c80651a64" xlink:to="loc_goss_USTreasuryAndAgencySecuritiesMember_f6f32cc2-8d2f-4cb4-b965-83d5db5d8be9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_29a0f17b-cc26-4207-9bd7-3b88ab4f2231" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a71d829f-2647-4831-b541-d10c80651a64" xlink:to="loc_us-gaap_CommercialPaperMember_29a0f17b-cc26-4207-9bd7-3b88ab4f2231" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_850755f4-d595-4b77-bb62-3f41ba37342d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a71d829f-2647-4831-b541-d10c80651a64" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_850755f4-d595-4b77-bb62-3f41ba37342d" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails" xlink:type="extended" id="i31e9b0eaa5f349c7bd515c4bcae4bf0b_FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_47039a80-9bf9-41ed-b08a-24348a000b15" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueEquityLevel1ToLevel2TransfersAmount_762c0ce2-0cf7-47c9-b6fd-419551cba94d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueEquityLevel1ToLevel2TransfersAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_47039a80-9bf9-41ed-b08a-24348a000b15" xlink:to="loc_us-gaap_FairValueEquityLevel1ToLevel2TransfersAmount_762c0ce2-0cf7-47c9-b6fd-419551cba94d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueEquityLevel2ToLevel1TransfersAmount_86b47f9b-1e8f-4aa9-b416-707fc00ddb65" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueEquityLevel2ToLevel1TransfersAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_47039a80-9bf9-41ed-b08a-24348a000b15" xlink:to="loc_us-gaap_FairValueEquityLevel2ToLevel1TransfersAmount_86b47f9b-1e8f-4aa9-b416-707fc00ddb65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InterestAndSecuritiesReceivable_889fedd0-2134-4e4d-a352-4b689d5a478f" xlink:href="goss-20200930.xsd#goss_InterestAndSecuritiesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_47039a80-9bf9-41ed-b08a-24348a000b15" xlink:to="loc_goss_InterestAndSecuritiesReceivable_889fedd0-2134-4e4d-a352-4b689d5a478f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_250bb0d2-6bdd-4181-b1ac-98df51fad64d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_47039a80-9bf9-41ed-b08a-24348a000b15" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_250bb0d2-6bdd-4181-b1ac-98df51fad64d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ccc098ed-65df-4fe6-9e7d-2073a53b95f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_47039a80-9bf9-41ed-b08a-24348a000b15" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ccc098ed-65df-4fe6-9e7d-2073a53b95f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f21923e1-854f-4e12-b8ee-234769e94e61" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ccc098ed-65df-4fe6-9e7d-2073a53b95f1" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f21923e1-854f-4e12-b8ee-234769e94e61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f21923e1-854f-4e12-b8ee-234769e94e61_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f21923e1-854f-4e12-b8ee-234769e94e61" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f21923e1-854f-4e12-b8ee-234769e94e61_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_96e5ad6a-d8b6-4747-8c79-e31a359ae200" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f21923e1-854f-4e12-b8ee-234769e94e61" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_96e5ad6a-d8b6-4747-8c79-e31a359ae200" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_1e099177-bc4c-4843-a836-975ccb7df1c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_96e5ad6a-d8b6-4747-8c79-e31a359ae200" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_1e099177-bc4c-4843-a836-975ccb7df1c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f03801b9-1858-47a3-bf39-599df9e10746" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ccc098ed-65df-4fe6-9e7d-2073a53b95f1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f03801b9-1858-47a3-bf39-599df9e10746" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f03801b9-1858-47a3-bf39-599df9e10746_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f03801b9-1858-47a3-bf39-599df9e10746" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f03801b9-1858-47a3-bf39-599df9e10746_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dc7ab9bd-5c2b-460b-a392-234caef73ae1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f03801b9-1858-47a3-bf39-599df9e10746" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dc7ab9bd-5c2b-460b-a392-234caef73ae1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandTwentySevenNotesMember_937c92d1-0cc4-472a-a2d2-61a6f560ea6c" xlink:href="goss-20200930.xsd#goss_TwoThousandTwentySevenNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dc7ab9bd-5c2b-460b-a392-234caef73ae1" xlink:to="loc_goss_TwoThousandTwentySevenNotesMember_937c92d1-0cc4-472a-a2d2-61a6f560ea6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_efa514d7-80bb-4b82-97f5-d513fc9ae1f8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ccc098ed-65df-4fe6-9e7d-2073a53b95f1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_efa514d7-80bb-4b82-97f5-d513fc9ae1f8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_efa514d7-80bb-4b82-97f5-d513fc9ae1f8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_efa514d7-80bb-4b82-97f5-d513fc9ae1f8" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_efa514d7-80bb-4b82-97f5-d513fc9ae1f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c0ed5cbb-e662-4523-88d2-3162bc007508" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_efa514d7-80bb-4b82-97f5-d513fc9ae1f8" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c0ed5cbb-e662-4523-88d2-3162bc007508" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f28c7853-a2cc-4b24-8dc3-40ff33d01775" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c0ed5cbb-e662-4523-88d2-3162bc007508" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f28c7853-a2cc-4b24-8dc3-40ff33d01775" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails" xlink:type="extended" id="i6709e686aeaa45d5adb81b371c68e994_FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_006800e9-aa29-4f58-b0c2-389979babef3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8073ccd6-baae-4c8b-9f95-49ef03a46cd8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_006800e9-aa29-4f58-b0c2-389979babef3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8073ccd6-baae-4c8b-9f95-49ef03a46cd8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7d5ec65a-3601-4a4b-aad4-113e9b7a9f0e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_006800e9-aa29-4f58-b0c2-389979babef3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7d5ec65a-3601-4a4b-aad4-113e9b7a9f0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4cd9e7c6-70bf-4876-9107-1e0997f55425" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_006800e9-aa29-4f58-b0c2-389979babef3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4cd9e7c6-70bf-4876-9107-1e0997f55425" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_26216f2f-ba07-4567-9a8e-6955ca88aeae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_006800e9-aa29-4f58-b0c2-389979babef3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_26216f2f-ba07-4567-9a8e-6955ca88aeae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_009b372b-e544-4d7c-8d31-ca4c703ee7d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_006800e9-aa29-4f58-b0c2-389979babef3" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_009b372b-e544-4d7c-8d31-ca4c703ee7d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_fa4d9b3e-8339-4a77-acfa-294b1c413173" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_009b372b-e544-4d7c-8d31-ca4c703ee7d7" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_fa4d9b3e-8339-4a77-acfa-294b1c413173" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fa4d9b3e-8339-4a77-acfa-294b1c413173_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_fa4d9b3e-8339-4a77-acfa-294b1c413173" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_fa4d9b3e-8339-4a77-acfa-294b1c413173_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b2670280-a87e-4e6c-b2c6-be93f554b034" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_fa4d9b3e-8339-4a77-acfa-294b1c413173" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b2670280-a87e-4e6c-b2c6-be93f554b034" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_USTreasuryAndAgencySecuritiesMember_468d5c34-65ff-4a7b-b49d-57adb0bf0056" xlink:href="goss-20200930.xsd#goss_USTreasuryAndAgencySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b2670280-a87e-4e6c-b2c6-be93f554b034" xlink:to="loc_goss_USTreasuryAndAgencySecuritiesMember_468d5c34-65ff-4a7b-b49d-57adb0bf0056" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_6d3d8336-5eab-4c0a-a107-1481ddfc00a2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b2670280-a87e-4e6c-b2c6-be93f554b034" xlink:to="loc_us-gaap_CommercialPaperMember_6d3d8336-5eab-4c0a-a107-1481ddfc00a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_f8dee858-1bfb-4c6c-94b4-9dfa2ed756e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b2670280-a87e-4e6c-b2c6-be93f554b034" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_f8dee858-1bfb-4c6c-94b4-9dfa2ed756e4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofContractualMaturitiesofAvailableforsaleDebtSecuritiesDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofContractualMaturitiesofAvailableforsaleDebtSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofContractualMaturitiesofAvailableforsaleDebtSecuritiesDetails" xlink:type="extended" id="i83fdaf08af4946989ade45f2ce44e1fd_FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofContractualMaturitiesofAvailableforsaleDebtSecuritiesDetails"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/Indebtedness" xlink:type="simple" xlink:href="goss-20200930.xsd#Indebtedness"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/Indebtedness" xlink:type="extended" id="i4d577eb5f0064a358986ec3300e896d0_Indebtedness"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/IndebtednessTables" xlink:type="simple" xlink:href="goss-20200930.xsd#IndebtednessTables"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/IndebtednessTables" xlink:type="extended" id="i2e94e38b1dd94222b1e53d47b3a54fdd_IndebtednessTables"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#IndebtednessAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails" xlink:type="extended" id="i604575a042b34158aaba83ffc42a36cc_IndebtednessAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3f39d4c2-2dfe-475f-b524-e74a87b3e40a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3f39d4c2-2dfe-475f-b524-e74a87b3e40a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_d798ed6c-e495-4418-8404-29b7fcb17228" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_d798ed6c-e495-4418-8404-29b7fcb17228" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_676f637a-79f4-4153-84a5-832870126f87" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_676f637a-79f4-4153-84a5-832870126f87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_NumberOfAdditionalTranches_4fdd5c2a-90f6-4d36-9da5-3f0f6dd88365" xlink:href="goss-20200930.xsd#goss_NumberOfAdditionalTranches"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_goss_NumberOfAdditionalTranches_4fdd5c2a-90f6-4d36-9da5-3f0f6dd88365" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7a2f0970-ec6b-4c1a-bf6c-a8182d607846" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7a2f0970-ec6b-4c1a-bf6c-a8182d607846" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b210f496-0b3c-4db1-950b-609ca42723c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b210f496-0b3c-4db1-950b-609ca42723c1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment_b31809df-8bba-44db-a7e4-15d1a0b775cb" xlink:href="goss-20200930.xsd#goss_PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_goss_PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment_b31809df-8bba-44db-a7e4-15d1a0b775cb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment_af5308ec-004c-4dfc-96ae-6a47d81a9ed3" xlink:href="goss-20200930.xsd#goss_PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_goss_PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment_af5308ec-004c-4dfc-96ae-6a47d81a9ed3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PercentageOfPrepaymentFee_8d0f3357-9e56-4238-aaca-4e76f25c75e4" xlink:href="goss-20200930.xsd#goss_PercentageOfPrepaymentFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_goss_PercentageOfPrepaymentFee_8d0f3357-9e56-4238-aaca-4e76f25c75e4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan_48e44b59-b3f8-4f1f-93c2-1d2b992aa10b" xlink:href="goss-20200930.xsd#goss_DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_goss_DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan_48e44b59-b3f8-4f1f-93c2-1d2b992aa10b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt_e2946a91-5bac-42f1-99d6-848868513783" xlink:href="goss-20200930.xsd#goss_DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_goss_DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt_e2946a91-5bac-42f1-99d6-848868513783" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_DebtInstrumentAggregatePrincipalAmount_1c544456-0952-4f9c-9cb2-cb40e81258d8" xlink:href="goss-20200930.xsd#goss_DebtInstrumentAggregatePrincipalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_goss_DebtInstrumentAggregatePrincipalAmount_1c544456-0952-4f9c-9cb2-cb40e81258d8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_a15e8429-16e3-4123-b8c6-f8eba1d2f22e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_a15e8429-16e3-4123-b8c6-f8eba1d2f22e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_5f8b9f1f-7012-4419-bd5d-bd31c4994572" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_5f8b9f1f-7012-4419-bd5d-bd31c4994572" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_745eb02f-d715-4708-9ae7-99cd7e35b368" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_745eb02f-d715-4708-9ae7-99cd7e35b368" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_DebtInstrumentConvertibleConversionPricePercentage_098441f0-c776-43ac-8976-2a81eb07182a" xlink:href="goss-20200930.xsd#goss_DebtInstrumentConvertibleConversionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_goss_DebtInstrumentConvertibleConversionPricePercentage_098441f0-c776-43ac-8976-2a81eb07182a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_8f172953-58a5-4f27-9125-adb2d1c07ddb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_8f172953-58a5-4f27-9125-adb2d1c07ddb" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_27a4cbbb-df6f-4d1a-90d8-4eec81794f0b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_27a4cbbb-df6f-4d1a-90d8-4eec81794f0b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_DebtInstrumentConvertibleConversionLastReportedSalePricePercentage_9305b49a-ce29-46e8-906a-60a904de34bc" xlink:href="goss-20200930.xsd#goss_DebtInstrumentConvertibleConversionLastReportedSalePricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_goss_DebtInstrumentConvertibleConversionLastReportedSalePricePercentage_9305b49a-ce29-46e8-906a-60a904de34bc" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_4e9399e2-be33-4f16-9b85-36ae17643b43" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_4e9399e2-be33-4f16-9b85-36ae17643b43" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes_efcf2786-de2b-4801-b67d-c077b82c47b7" xlink:href="goss-20200930.xsd#goss_PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_goss_PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes_efcf2786-de2b-4801-b67d-c077b82c47b7" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LongTermDebtPercentageInAggregatePrincipalAmount_cc755a9d-ec6b-4ba2-ab75-7c41da0fa3e1" xlink:href="goss-20200930.xsd#goss_LongTermDebtPercentageInAggregatePrincipalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_goss_LongTermDebtPercentageInAggregatePrincipalAmount_cc755a9d-ec6b-4ba2-ab75-7c41da0fa3e1" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_c7eeaf0f-d251-45bf-8f61-7f65c8b2adcb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_c7eeaf0f-d251-45bf-8f61-7f65c8b2adcb" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_83fd74de-60f1-4171-9505-510731ec91bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_83fd74de-60f1-4171-9505-510731ec91bb" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_eba6e560-f386-47d0-951c-2f38a1a95ef5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_eba6e560-f386-47d0-951c-2f38a1a95ef5" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_acb8d787-5a9a-4415-94fb-a1dc49650e49" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_acb8d787-5a9a-4415-94fb-a1dc49650e49" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f8e0837d-9d25-46f1-a5d8-5d3f1ce88d38" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_DebtInstrumentTable_f8e0837d-9d25-46f1-a5d8-5d3f1ce88d38" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_af16bbbe-df01-448e-87c3-915243b19bfb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f8e0837d-9d25-46f1-a5d8-5d3f1ce88d38" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_af16bbbe-df01-448e-87c3-915243b19bfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_af16bbbe-df01-448e-87c3-915243b19bfb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_af16bbbe-df01-448e-87c3-915243b19bfb" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_af16bbbe-df01-448e-87c3-915243b19bfb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6fd7c7be-610f-4bdf-aca3-c5417c7dbf00" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_af16bbbe-df01-448e-87c3-915243b19bfb" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6fd7c7be-610f-4bdf-aca3-c5417c7dbf00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TermLoanMember_c4877c6d-b442-4212-bb44-6ae7cc306104" xlink:href="goss-20200930.xsd#goss_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6fd7c7be-610f-4bdf-aca3-c5417c7dbf00" xlink:to="loc_goss_TermLoanMember_c4877c6d-b442-4212-bb44-6ae7cc306104" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandTwentySevenNotesMember_0f30b1e5-c701-4625-b430-b3571077a914" xlink:href="goss-20200930.xsd#goss_TwoThousandTwentySevenNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6fd7c7be-610f-4bdf-aca3-c5417c7dbf00" xlink:to="loc_goss_TwoThousandTwentySevenNotesMember_0f30b1e5-c701-4625-b430-b3571077a914" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_060a5c9f-903f-4aff-a83a-544ce5d5571b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f8e0837d-9d25-46f1-a5d8-5d3f1ce88d38" xlink:to="loc_us-gaap_VestingAxis_060a5c9f-903f-4aff-a83a-544ce5d5571b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_060a5c9f-903f-4aff-a83a-544ce5d5571b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_060a5c9f-903f-4aff-a83a-544ce5d5571b" xlink:to="loc_us-gaap_VestingDomain_060a5c9f-903f-4aff-a83a-544ce5d5571b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_123a2244-699f-40fb-8a9d-1be19d4b388b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_060a5c9f-903f-4aff-a83a-544ce5d5571b" xlink:to="loc_us-gaap_VestingDomain_123a2244-699f-40fb-8a9d-1be19d4b388b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TrancheOneMember_276eb8f7-fc48-4e1f-868b-e735d88bd541" xlink:href="goss-20200930.xsd#goss_TrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_123a2244-699f-40fb-8a9d-1be19d4b388b" xlink:to="loc_goss_TrancheOneMember_276eb8f7-fc48-4e1f-868b-e735d88bd541" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TrancheTwoMember_9a393980-03bf-4e41-9b73-9aa861467abc" xlink:href="goss-20200930.xsd#goss_TrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_123a2244-699f-40fb-8a9d-1be19d4b388b" xlink:to="loc_goss_TrancheTwoMember_9a393980-03bf-4e41-9b73-9aa861467abc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_bdb71c96-4d72-416c-ade4-2f8368826094" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f8e0837d-9d25-46f1-a5d8-5d3f1ce88d38" xlink:to="loc_us-gaap_CreditFacilityAxis_bdb71c96-4d72-416c-ade4-2f8368826094" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_bdb71c96-4d72-416c-ade4-2f8368826094_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_bdb71c96-4d72-416c-ade4-2f8368826094" xlink:to="loc_us-gaap_CreditFacilityDomain_bdb71c96-4d72-416c-ade4-2f8368826094_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_cc073529-7fb3-4756-945c-7ca2cb2b73ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_bdb71c96-4d72-416c-ade4-2f8368826094" xlink:to="loc_us-gaap_CreditFacilityDomain_cc073529-7fb3-4756-945c-7ca2cb2b73ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_7e25cef5-45d8-45dd-bfbb-8ec31d48dd3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_cc073529-7fb3-4756-945c-7ca2cb2b73ff" xlink:to="loc_us-gaap_LineOfCreditMember_7e25cef5-45d8-45dd-bfbb-8ec31d48dd3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_02dafe0d-81f4-45da-a06b-9da735ddd426" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f8e0837d-9d25-46f1-a5d8-5d3f1ce88d38" xlink:to="loc_us-gaap_VariableRateAxis_02dafe0d-81f4-45da-a06b-9da735ddd426" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_02dafe0d-81f4-45da-a06b-9da735ddd426_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_02dafe0d-81f4-45da-a06b-9da735ddd426" xlink:to="loc_us-gaap_VariableRateDomain_02dafe0d-81f4-45da-a06b-9da735ddd426_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_adb25cc6-dc34-42b1-8672-8cddb6a0a73b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_02dafe0d-81f4-45da-a06b-9da735ddd426" xlink:to="loc_us-gaap_VariableRateDomain_adb25cc6-dc34-42b1-8672-8cddb6a0a73b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_46c656cc-8e42-4359-96c2-909b550e95ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_adb25cc6-dc34-42b1-8672-8cddb6a0a73b" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_46c656cc-8e42-4359-96c2-909b550e95ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_MidCapFinancialTrustMember_8899038b-1a32-4bf3-98ce-3fc97df58b2f" xlink:href="goss-20200930.xsd#goss_MidCapFinancialTrustMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_adb25cc6-dc34-42b1-8672-8cddb6a0a73b" xlink:to="loc_goss_MidCapFinancialTrustMember_8899038b-1a32-4bf3-98ce-3fc97df58b2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_7ba1e14e-205c-486d-986d-0027da8c7c67" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f8e0837d-9d25-46f1-a5d8-5d3f1ce88d38" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_7ba1e14e-205c-486d-986d-0027da8c7c67" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_7ba1e14e-205c-486d-986d-0027da8c7c67_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_7ba1e14e-205c-486d-986d-0027da8c7c67" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_7ba1e14e-205c-486d-986d-0027da8c7c67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4b2048a7-a296-421e-9b21-3f20559ab632" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_7ba1e14e-205c-486d-986d-0027da8c7c67" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4b2048a7-a296-421e-9b21-3f20559ab632" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember_c1c8ec55-e2c4-49fa-a514-d291ccd71edd" xlink:href="goss-20200930.xsd#goss_PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4b2048a7-a296-421e-9b21-3f20559ab632" xlink:to="loc_goss_PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember_c1c8ec55-e2c4-49fa-a514-d291ccd71edd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember_abd66e58-c627-4c6f-beb5-129963634a3b" xlink:href="goss-20200930.xsd#goss_FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4b2048a7-a296-421e-9b21-3f20559ab632" xlink:to="loc_goss_FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember_abd66e58-c627-4c6f-beb5-129963634a3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember_f25f2294-4bbc-4412-9da9-f7f32d0ed13b" xlink:href="goss-20200930.xsd#goss_SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4b2048a7-a296-421e-9b21-3f20559ab632" xlink:to="loc_goss_SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember_f25f2294-4bbc-4412-9da9-f7f32d0ed13b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ecee68a0-12f8-466f-aad4-e333b4f5ff3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f8e0837d-9d25-46f1-a5d8-5d3f1ce88d38" xlink:to="loc_us-gaap_DebtInstrumentAxis_ecee68a0-12f8-466f-aad4-e333b4f5ff3f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ecee68a0-12f8-466f-aad4-e333b4f5ff3f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ecee68a0-12f8-466f-aad4-e333b4f5ff3f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ecee68a0-12f8-466f-aad4-e333b4f5ff3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bbe59c72-a1af-4e16-8985-55e04a1a30b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ecee68a0-12f8-466f-aad4-e333b4f5ff3f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bbe59c72-a1af-4e16-8985-55e04a1a30b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_OneHundredThirtyPercentApplicableConversionPriceMember_c5ef2d66-647f-411a-a2d0-02fd68208acf" xlink:href="goss-20200930.xsd#goss_OneHundredThirtyPercentApplicableConversionPriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bbe59c72-a1af-4e16-8985-55e04a1a30b4" xlink:to="loc_goss_OneHundredThirtyPercentApplicableConversionPriceMember_c5ef2d66-647f-411a-a2d0-02fd68208acf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_NinetyEightPercentApplicableConversionPriceMember_3c579a3b-8056-4351-a28f-15542e08e25c" xlink:href="goss-20200930.xsd#goss_NinetyEightPercentApplicableConversionPriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bbe59c72-a1af-4e16-8985-55e04a1a30b4" xlink:to="loc_goss_NinetyEightPercentApplicableConversionPriceMember_3c579a3b-8056-4351-a28f-15542e08e25c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1a059987-896c-43bb-a872-f431a929fd75" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f8e0837d-9d25-46f1-a5d8-5d3f1ce88d38" xlink:to="loc_srt_RangeAxis_1a059987-896c-43bb-a872-f431a929fd75" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1a059987-896c-43bb-a872-f431a929fd75_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1a059987-896c-43bb-a872-f431a929fd75" xlink:to="loc_srt_RangeMember_1a059987-896c-43bb-a872-f431a929fd75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_64862706-8478-4e36-a6bd-557132a1f18d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1a059987-896c-43bb-a872-f431a929fd75" xlink:to="loc_srt_RangeMember_64862706-8478-4e36-a6bd-557132a1f18d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e7e3fe1d-097d-45f9-8f07-217df01aa5d2" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_64862706-8478-4e36-a6bd-557132a1f18d" xlink:to="loc_srt_MinimumMember_e7e3fe1d-097d-45f9-8f07-217df01aa5d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_44025c03-0747-4cd8-9e62-5bd06df7c2dc" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_64862706-8478-4e36-a6bd-557132a1f18d" xlink:to="loc_srt_MaximumMember_44025c03-0747-4cd8-9e62-5bd06df7c2dc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/IndebtednessScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#IndebtednessScheduleofLongtermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/IndebtednessScheduleofLongtermDebtDetails" xlink:type="extended" id="i02d21f29957e46bf949a21aa7e5fd0bd_IndebtednessScheduleofLongtermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5f14370d-40de-4745-8c1d-a8847b434e56" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a76c1ebb-332b-4f0c-8ed1-595a1d8aa4b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5f14370d-40de-4745-8c1d-a8847b434e56" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a76c1ebb-332b-4f0c-8ed1-595a1d8aa4b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_eea4d7f1-33ea-44d9-a7f6-0f3d78cdd893" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5f14370d-40de-4745-8c1d-a8847b434e56" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_eea4d7f1-33ea-44d9-a7f6-0f3d78cdd893" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_badfd71e-e75b-499d-88f4-dd49eceb835e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5f14370d-40de-4745-8c1d-a8847b434e56" xlink:to="loc_us-gaap_LongTermDebt_badfd71e-e75b-499d-88f4-dd49eceb835e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_896796da-0af9-4373-8a50-2825da8dae9a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5f14370d-40de-4745-8c1d-a8847b434e56" xlink:to="loc_us-gaap_DebtInstrumentTable_896796da-0af9-4373-8a50-2825da8dae9a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_eb9a4f09-d265-49a7-ad04-0ac41600c13a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_896796da-0af9-4373-8a50-2825da8dae9a" xlink:to="loc_us-gaap_CreditFacilityAxis_eb9a4f09-d265-49a7-ad04-0ac41600c13a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_eb9a4f09-d265-49a7-ad04-0ac41600c13a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_eb9a4f09-d265-49a7-ad04-0ac41600c13a" xlink:to="loc_us-gaap_CreditFacilityDomain_eb9a4f09-d265-49a7-ad04-0ac41600c13a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f33ce8dd-2f64-4a0f-a60f-ab5e695006fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_eb9a4f09-d265-49a7-ad04-0ac41600c13a" xlink:to="loc_us-gaap_CreditFacilityDomain_f33ce8dd-2f64-4a0f-a60f-ab5e695006fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_034fc45e-a51f-4df5-81d9-8e03b9df603d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_f33ce8dd-2f64-4a0f-a60f-ab5e695006fe" xlink:to="loc_us-gaap_LineOfCreditMember_034fc45e-a51f-4df5-81d9-8e03b9df603d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails" xlink:type="extended" id="i5fd99b37a07144d8a9c9754cde5917ef_IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4f7dcd0c-506d-434f-aa0a-cb09f4dd9fb0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_64ba28a5-df19-45dc-ac3b-2b107ff7023f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4f7dcd0c-506d-434f-aa0a-cb09f4dd9fb0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_64ba28a5-df19-45dc-ac3b-2b107ff7023f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_c6fa706e-0d56-4490-b6f2-da17ed76253d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4f7dcd0c-506d-434f-aa0a-cb09f4dd9fb0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_c6fa706e-0d56-4490-b6f2-da17ed76253d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_014bb266-53df-49b3-9fc0-53886fe01062" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4f7dcd0c-506d-434f-aa0a-cb09f4dd9fb0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_014bb266-53df-49b3-9fc0-53886fe01062" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_a3ce902e-747c-461f-8cd6-12cc50bd456e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4f7dcd0c-506d-434f-aa0a-cb09f4dd9fb0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_a3ce902e-747c-461f-8cd6-12cc50bd456e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_798df0cd-8464-494c-8a61-e0e419e0490d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4f7dcd0c-506d-434f-aa0a-cb09f4dd9fb0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_798df0cd-8464-494c-8a61-e0e419e0490d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix_97c2de67-1f3d-40a3-85f3-3e32ebe973c9" xlink:href="goss-20200930.xsd#goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4f7dcd0c-506d-434f-aa0a-cb09f4dd9fb0" xlink:to="loc_goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix_97c2de67-1f3d-40a3-85f3-3e32ebe973c9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_b028a4c3-da68-4e94-82e6-95a66459443b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4f7dcd0c-506d-434f-aa0a-cb09f4dd9fb0" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_b028a4c3-da68-4e94-82e6-95a66459443b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b1f6aeaa-c9af-4b83-a387-01373dc95a29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4f7dcd0c-506d-434f-aa0a-cb09f4dd9fb0" xlink:to="loc_us-gaap_DebtInstrumentTable_b1f6aeaa-c9af-4b83-a387-01373dc95a29" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_6ca0a4b4-e85e-41ce-83a0-71e331bf39be" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b1f6aeaa-c9af-4b83-a387-01373dc95a29" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_6ca0a4b4-e85e-41ce-83a0-71e331bf39be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_6ca0a4b4-e85e-41ce-83a0-71e331bf39be_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_6ca0a4b4-e85e-41ce-83a0-71e331bf39be" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_6ca0a4b4-e85e-41ce-83a0-71e331bf39be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_e54b8599-d730-40fe-a57e-f8cce6871234" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_6ca0a4b4-e85e-41ce-83a0-71e331bf39be" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_e54b8599-d730-40fe-a57e-f8cce6871234" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_1c32d820-8b6e-496a-b09c-f9e8812a38b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_e54b8599-d730-40fe-a57e-f8cce6871234" xlink:to="loc_us-gaap_LineOfCreditMember_1c32d820-8b6e-496a-b09c-f9e8812a38b4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails" xlink:type="extended" id="i7d15971a43ab4ca5b05d320ed4f97e7a_IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_adeb0d4f-dc2a-4be7-9499-74af78df1cb0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_64673ed8-14b2-4459-bb31-fb78ecd3a84f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_adeb0d4f-dc2a-4be7-9499-74af78df1cb0" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_64673ed8-14b2-4459-bb31-fb78ecd3a84f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_06f5923c-fbba-4a3f-b66d-e5278e86faaf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_adeb0d4f-dc2a-4be7-9499-74af78df1cb0" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_06f5923c-fbba-4a3f-b66d-e5278e86faaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_7216f1f1-5171-46dd-b324-a6574bd8c663" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_adeb0d4f-dc2a-4be7-9499-74af78df1cb0" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_7216f1f1-5171-46dd-b324-a6574bd8c663" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_df12df5a-4a1a-42be-afad-fb8b4bc77969" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_adeb0d4f-dc2a-4be7-9499-74af78df1cb0" xlink:to="loc_us-gaap_LongTermDebt_df12df5a-4a1a-42be-afad-fb8b4bc77969" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_33881449-e2b0-4afc-bb12-debab0f74c57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_adeb0d4f-dc2a-4be7-9499-74af78df1cb0" xlink:to="loc_us-gaap_DebtInstrumentTable_33881449-e2b0-4afc-bb12-debab0f74c57" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_fcd10f54-0225-4e64-b535-f69f0565634d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_33881449-e2b0-4afc-bb12-debab0f74c57" xlink:to="loc_us-gaap_DebtInstrumentAxis_fcd10f54-0225-4e64-b535-f69f0565634d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fcd10f54-0225-4e64-b535-f69f0565634d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_fcd10f54-0225-4e64-b535-f69f0565634d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fcd10f54-0225-4e64-b535-f69f0565634d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1ec645b5-d18a-4f60-bdea-e249cf603656" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_fcd10f54-0225-4e64-b535-f69f0565634d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1ec645b5-d18a-4f60-bdea-e249cf603656" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandTwentySevenNotesMember_deb6481e-9cf0-4155-8bee-6e4061bac4fe" xlink:href="goss-20200930.xsd#goss_TwoThousandTwentySevenNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1ec645b5-d18a-4f60-bdea-e249cf603656" xlink:to="loc_goss_TwoThousandTwentySevenNotesMember_deb6481e-9cf0-4155-8bee-6e4061bac4fe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/IndebtednessScheduleofEquityComponentsDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#IndebtednessScheduleofEquityComponentsDetails"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/IndebtednessScheduleofEquityComponentsDetails" xlink:type="extended" id="i299d49361005439ba3c50bc69fc69685_IndebtednessScheduleofEquityComponentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_90f9953a-267b-4e9b-8f6e-c364d46299a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption_f38f0f99-a4ad-403b-885a-0842756fa748" xlink:href="goss-20200930.xsd#goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_90f9953a-267b-4e9b-8f6e-c364d46299a0" xlink:to="loc_goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption_f38f0f99-a4ad-403b-885a-0842756fa748" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts_d64a47bd-11ef-4d4e-8531-689677088968" xlink:href="goss-20200930.xsd#goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_90f9953a-267b-4e9b-8f6e-c364d46299a0" xlink:to="loc_goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts_d64a47bd-11ef-4d4e-8531-689677088968" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_fee7fd48-1d64-4550-8a4f-cb6b403c2763" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_90f9953a-267b-4e9b-8f6e-c364d46299a0" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_fee7fd48-1d64-4550-8a4f-cb6b403c2763" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7a88e758-de5c-4806-9f45-137068b1d518" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_90f9953a-267b-4e9b-8f6e-c364d46299a0" xlink:to="loc_us-gaap_DebtInstrumentTable_7a88e758-de5c-4806-9f45-137068b1d518" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_38ef91d1-7661-4be9-86f7-b86f43f24a5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7a88e758-de5c-4806-9f45-137068b1d518" xlink:to="loc_us-gaap_DebtInstrumentAxis_38ef91d1-7661-4be9-86f7-b86f43f24a5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_38ef91d1-7661-4be9-86f7-b86f43f24a5f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_38ef91d1-7661-4be9-86f7-b86f43f24a5f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_38ef91d1-7661-4be9-86f7-b86f43f24a5f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1760d757-9db9-44d6-b107-bb89d45a63ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_38ef91d1-7661-4be9-86f7-b86f43f24a5f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1760d757-9db9-44d6-b107-bb89d45a63ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandTwentySevenNotesMember_025be5dc-8e66-4dd4-b3a7-c90b2a883322" xlink:href="goss-20200930.xsd#goss_TwoThousandTwentySevenNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1760d757-9db9-44d6-b107-bb89d45a63ef" xlink:to="loc_goss_TwoThousandTwentySevenNotesMember_025be5dc-8e66-4dd4-b3a7-c90b2a883322" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/IndebtednessScheduleofInterestExpenseRecognizedDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#IndebtednessScheduleofInterestExpenseRecognizedDetails"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/IndebtednessScheduleofInterestExpenseRecognizedDetails" xlink:type="extended" id="i849b8ef367eb4b32a0e94dc3ba2403ef_IndebtednessScheduleofInterestExpenseRecognizedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_51ae69ec-b580-48ca-97ee-73d6cd04ee32" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ContractualInterestExpense_6e0cc4e0-ff83-4393-abea-6aa1cc37485f" xlink:href="goss-20200930.xsd#goss_ContractualInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_51ae69ec-b580-48ca-97ee-73d6cd04ee32" xlink:to="loc_goss_ContractualInterestExpense_6e0cc4e0-ff83-4393-abea-6aa1cc37485f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_c960cb52-85f3-49e2-a67d-92de60a5aa1e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_51ae69ec-b580-48ca-97ee-73d6cd04ee32" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_c960cb52-85f3-49e2-a67d-92de60a5aa1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_49c285d4-8bec-4f86-af53-67d0280c56dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_51ae69ec-b580-48ca-97ee-73d6cd04ee32" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_49c285d4-8bec-4f86-af53-67d0280c56dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_9858ef8e-2a9b-4bb9-a344-38152823dc0e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_51ae69ec-b580-48ca-97ee-73d6cd04ee32" xlink:to="loc_us-gaap_InterestExpenseDebt_9858ef8e-2a9b-4bb9-a344-38152823dc0e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d5c2d1fe-c2b0-47f5-9538-5029bab92549" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_51ae69ec-b580-48ca-97ee-73d6cd04ee32" xlink:to="loc_us-gaap_DebtInstrumentTable_d5c2d1fe-c2b0-47f5-9538-5029bab92549" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ec36784f-1bc0-4f84-b9c3-22ff371b66f2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d5c2d1fe-c2b0-47f5-9538-5029bab92549" xlink:to="loc_us-gaap_DebtInstrumentAxis_ec36784f-1bc0-4f84-b9c3-22ff371b66f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ec36784f-1bc0-4f84-b9c3-22ff371b66f2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ec36784f-1bc0-4f84-b9c3-22ff371b66f2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ec36784f-1bc0-4f84-b9c3-22ff371b66f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_523317bb-ef25-4a2a-8882-5d129865d219" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ec36784f-1bc0-4f84-b9c3-22ff371b66f2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_523317bb-ef25-4a2a-8882-5d129865d219" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandTwentySevenNotesMember_73aa7804-d63a-453a-bdbb-ce855c77994b" xlink:href="goss-20200930.xsd#goss_TwoThousandTwentySevenNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_523317bb-ef25-4a2a-8882-5d129865d219" xlink:to="loc_goss_TwoThousandTwentySevenNotesMember_73aa7804-d63a-453a-bdbb-ce855c77994b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsideration" xlink:type="simple" xlink:href="goss-20200930.xsd#LicensesAssetAcquisitionsandContingentConsideration"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsideration" xlink:type="extended" id="i0f29f72a85824ee7a375efbe8cd060dc_LicensesAssetAcquisitionsandContingentConsideration"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationTables" xlink:type="simple" xlink:href="goss-20200930.xsd#LicensesAssetAcquisitionsandContingentConsiderationTables"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationTables" xlink:type="extended" id="ic3fa409d0a7b4ede933302d9e3a47c2f_LicensesAssetAcquisitionsandContingentConsiderationTables"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails" xlink:type="extended" id="ie2816ed77fa6404ca37f66885d346b9e_LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ProductLicenseTerm_cb0c224a-28fd-4727-bcd2-285cc70f6dc6" xlink:href="goss-20200930.xsd#goss_ProductLicenseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_goss_ProductLicenseTerm_cb0c224a-28fd-4727-bcd2-285cc70f6dc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable_0a98b891-8b35-4146-b6b0-1183eef1e685" xlink:href="goss-20200930.xsd#goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable_0a98b891-8b35-4146-b6b0-1183eef1e685" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable_6e0f31e1-f5ac-418a-b262-d2259ede1e6c" xlink:href="goss-20200930.xsd#goss_BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_goss_BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable_6e0f31e1-f5ac-418a-b262-d2259ede1e6c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable_01d7a567-e9eb-4663-9127-bdcaf8dae561" xlink:href="goss-20200930.xsd#goss_BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_goss_BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable_01d7a567-e9eb-4663-9127-bdcaf8dae561" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_UpfrontPayment_3013ee97-a8f3-446b-9566-691cd25a73aa" xlink:href="goss-20200930.xsd#goss_UpfrontPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_goss_UpfrontPayment_3013ee97-a8f3-446b-9566-691cd25a73aa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized_0d07fef8-d9b2-45c0-a573-27f36cff338a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized_0d07fef8-d9b2-45c0-a573-27f36cff338a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c07aadee-aa69-4ef5-9819-732dc321dbf7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c07aadee-aa69-4ef5-9819-732dc321dbf7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_afa9eb9a-6189-4cb6-b25c-544c79adf4cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_afa9eb9a-6189-4cb6-b25c-544c79adf4cf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ParticipationRight_35f62285-88a6-4422-8ee6-b615b372862c" xlink:href="goss-20200930.xsd#goss_ParticipationRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_goss_ParticipationRight_35f62285-88a6-4422-8ee6-b615b372862c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_175da92d-ce8d-41e5-afb4-039a4873ebba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_175da92d-ce8d-41e5-afb4-039a4873ebba" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable_f1ca8081-e0b4-4736-ba00-e281e024afa0" xlink:href="goss-20200930.xsd#goss_BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_goss_BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable_f1ca8081-e0b4-4736-ba00-e281e024afa0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_BusinessCombinationContingentConsiderationMilestonesPayment_6a760a4c-a7d5-4ef9-81c2-eb71bfa1c07e" xlink:href="goss-20200930.xsd#goss_BusinessCombinationContingentConsiderationMilestonesPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_goss_BusinessCombinationContingentConsiderationMilestonesPayment_6a760a4c-a7d5-4ef9-81c2-eb71bfa1c07e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb769aaa-4acf-48d1-b49f-032b66fff2c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb769aaa-4acf-48d1-b49f-032b66fff2c2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4660b2a6-5a2d-4bf7-ba91-bebb3d11e906" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb769aaa-4acf-48d1-b49f-032b66fff2c2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4660b2a6-5a2d-4bf7-ba91-bebb3d11e906" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4660b2a6-5a2d-4bf7-ba91-bebb3d11e906_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4660b2a6-5a2d-4bf7-ba91-bebb3d11e906" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4660b2a6-5a2d-4bf7-ba91-bebb3d11e906_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce488eed-e2ea-4d12-9621-8cfd450255ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4660b2a6-5a2d-4bf7-ba91-bebb3d11e906" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce488eed-e2ea-4d12-9621-8cfd450255ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PulmokineIncMember_ec2e0d37-9c92-4ec2-80ac-3a7bad3f7aeb" xlink:href="goss-20200930.xsd#goss_PulmokineIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce488eed-e2ea-4d12-9621-8cfd450255ca" xlink:to="loc_goss_PulmokineIncMember_ec2e0d37-9c92-4ec2-80ac-3a7bad3f7aeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AABiopharmaIncMember_cd526678-d98e-4dbc-8965-27cd5d7a5fee" xlink:href="goss-20200930.xsd#goss_AABiopharmaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce488eed-e2ea-4d12-9621-8cfd450255ca" xlink:to="loc_goss_AABiopharmaIncMember_cd526678-d98e-4dbc-8965-27cd5d7a5fee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AerpioPharmaceuticalsIncMember_db475b62-4d5b-4e89-8278-6fdff37239e2" xlink:href="goss-20200930.xsd#goss_AerpioPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce488eed-e2ea-4d12-9621-8cfd450255ca" xlink:to="loc_goss_AerpioPharmaceuticalsIncMember_db475b62-4d5b-4e89-8278-6fdff37239e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AdhaerePharmaceuticalsIncMember_32a2483a-a211-4762-9938-e27dd42f7c84" xlink:href="goss-20200930.xsd#goss_AdhaerePharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce488eed-e2ea-4d12-9621-8cfd450255ca" xlink:to="loc_goss_AdhaerePharmaceuticalsIncMember_32a2483a-a211-4762-9938-e27dd42f7c84" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_71cb5813-fd41-467d-9bda-643d9b2ae389" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb769aaa-4acf-48d1-b49f-032b66fff2c2" xlink:to="loc_us-gaap_TypeOfArrangementAxis_71cb5813-fd41-467d-9bda-643d9b2ae389" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_71cb5813-fd41-467d-9bda-643d9b2ae389_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_71cb5813-fd41-467d-9bda-643d9b2ae389" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_71cb5813-fd41-467d-9bda-643d9b2ae389_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_efc05282-edd2-46da-887a-d7a39734e564" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_71cb5813-fd41-467d-9bda-643d9b2ae389" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_efc05282-edd2-46da-887a-d7a39734e564" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LicenseAgreementMember_22acc776-a229-4586-a392-2b34c79f6e76" xlink:href="goss-20200930.xsd#goss_LicenseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_efc05282-edd2-46da-887a-d7a39734e564" xlink:to="loc_goss_LicenseAgreementMember_22acc776-a229-4586-a392-2b34c79f6e76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6819d208-9ad5-4a7c-b843-a00c01468d61" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb769aaa-4acf-48d1-b49f-032b66fff2c2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6819d208-9ad5-4a7c-b843-a00c01468d61" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6819d208-9ad5-4a7c-b843-a00c01468d61_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6819d208-9ad5-4a7c-b843-a00c01468d61" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6819d208-9ad5-4a7c-b843-a00c01468d61_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c816441-15ba-442f-91a7-95b17bc5d9de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6819d208-9ad5-4a7c-b843-a00c01468d61" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c816441-15ba-442f-91a7-95b17bc5d9de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember_32654389-c8bc-451c-8012-3a176e2ed4b9" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c816441-15ba-442f-91a7-95b17bc5d9de" xlink:to="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember_32654389-c8bc-451c-8012-3a176e2ed4b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember_caa0caea-a9e7-436a-91f4-c5e1f60f8f2f" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c816441-15ba-442f-91a7-95b17bc5d9de" xlink:to="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember_caa0caea-a9e7-436a-91f4-c5e1f60f8f2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember_74dad604-faa6-48b3-ade9-62b323f9702d" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c816441-15ba-442f-91a7-95b17bc5d9de" xlink:to="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember_74dad604-faa6-48b3-ade9-62b323f9702d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember_6f370ae0-81f2-4a97-bae5-b5e0915b5b01" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c816441-15ba-442f-91a7-95b17bc5d9de" xlink:to="loc_goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember_6f370ae0-81f2-4a97-bae5-b5e0915b5b01" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d351a606-4f3d-4ff9-a39d-6735f7550d4d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb769aaa-4acf-48d1-b49f-032b66fff2c2" xlink:to="loc_srt_RangeAxis_d351a606-4f3d-4ff9-a39d-6735f7550d4d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d351a606-4f3d-4ff9-a39d-6735f7550d4d_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d351a606-4f3d-4ff9-a39d-6735f7550d4d" xlink:to="loc_srt_RangeMember_d351a606-4f3d-4ff9-a39d-6735f7550d4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f47eafb0-d817-466e-9f36-f01055f1629d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d351a606-4f3d-4ff9-a39d-6735f7550d4d" xlink:to="loc_srt_RangeMember_f47eafb0-d817-466e-9f36-f01055f1629d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e051c053-3c6b-4ac8-acf2-8d5cc7143ce7" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f47eafb0-d817-466e-9f36-f01055f1629d" xlink:to="loc_srt_MinimumMember_e051c053-3c6b-4ac8-acf2-8d5cc7143ce7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2164e57a-31bd-4e85-aa9c-51b3989005c2" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f47eafb0-d817-466e-9f36-f01055f1629d" xlink:to="loc_srt_MaximumMember_2164e57a-31bd-4e85-aa9c-51b3989005c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_86d4570b-455f-46a2-97e6-40e99bc47221" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb769aaa-4acf-48d1-b49f-032b66fff2c2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_86d4570b-455f-46a2-97e6-40e99bc47221" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_86d4570b-455f-46a2-97e6-40e99bc47221_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_86d4570b-455f-46a2-97e6-40e99bc47221" xlink:to="loc_us-gaap_ClassOfStockDomain_86d4570b-455f-46a2-97e6-40e99bc47221_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_183d3cee-6f1c-44a0-aee1-f9fc9093bdc6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_86d4570b-455f-46a2-97e6-40e99bc47221" xlink:to="loc_us-gaap_ClassOfStockDomain_183d3cee-6f1c-44a0-aee1-f9fc9093bdc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SeriesSeedConvertiblePreferredStockMember_b9281bf8-f84c-4de7-abff-a4d8eba3660d" xlink:href="goss-20200930.xsd#goss_SeriesSeedConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_183d3cee-6f1c-44a0-aee1-f9fc9093bdc6" xlink:to="loc_goss_SeriesSeedConvertiblePreferredStockMember_b9281bf8-f84c-4de7-abff-a4d8eba3660d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_397e3b50-9d34-48e2-acdc-19338af3089d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb769aaa-4acf-48d1-b49f-032b66fff2c2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_397e3b50-9d34-48e2-acdc-19338af3089d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_397e3b50-9d34-48e2-acdc-19338af3089d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_397e3b50-9d34-48e2-acdc-19338af3089d" xlink:to="loc_us-gaap_EquityComponentDomain_397e3b50-9d34-48e2-acdc-19338af3089d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9ce7d94f-e775-4d7f-9b9a-9ad81b70057e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_397e3b50-9d34-48e2-acdc-19338af3089d" xlink:to="loc_us-gaap_EquityComponentDomain_9ce7d94f-e775-4d7f-9b9a-9ad81b70057e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e57d6082-227c-4d0d-95ab-96b103c565cb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9ce7d94f-e775-4d7f-9b9a-9ad81b70057e" xlink:to="loc_us-gaap_CommonStockMember_e57d6082-227c-4d0d-95ab-96b103c565cb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails" xlink:type="extended" id="i2db30b73c9194da99db9e4ba00cef6fd_LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_43020ef9-7e35-4483-8cf4-c8a9b7746f69" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_7f9578e9-e712-4b04-bbdf-8c0721fad055" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_43020ef9-7e35-4483-8cf4-c8a9b7746f69" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_7f9578e9-e712-4b04-bbdf-8c0721fad055" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_66f11388-e36b-4f66-af79-54700ea8c970" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_43020ef9-7e35-4483-8cf4-c8a9b7746f69" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_66f11388-e36b-4f66-af79-54700ea8c970" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dab47d7f-f79c-417d-807e-b58b17c88344" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_66f11388-e36b-4f66-af79-54700ea8c970" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dab47d7f-f79c-417d-807e-b58b17c88344" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dab47d7f-f79c-417d-807e-b58b17c88344_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dab47d7f-f79c-417d-807e-b58b17c88344" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dab47d7f-f79c-417d-807e-b58b17c88344_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cf55e8b4-9686-4fa9-9104-660cfb7aebd1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dab47d7f-f79c-417d-807e-b58b17c88344" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cf55e8b4-9686-4fa9-9104-660cfb7aebd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember_a1595abb-ccb5-4fdf-bd85-e2f9b902a5b8" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cf55e8b4-9686-4fa9-9104-660cfb7aebd1" xlink:to="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember_a1595abb-ccb5-4fdf-bd85-e2f9b902a5b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember_40fd7cf3-5ee3-4edf-826d-a5a91095a912" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cf55e8b4-9686-4fa9-9104-660cfb7aebd1" xlink:to="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember_40fd7cf3-5ee3-4edf-826d-a5a91095a912" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember_7c0945ad-362a-4f15-bd19-7cbbe46e72e1" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cf55e8b4-9686-4fa9-9104-660cfb7aebd1" xlink:to="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember_7c0945ad-362a-4f15-bd19-7cbbe46e72e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember_e1b08b9d-a891-45bd-a8b5-d8d86aca4860" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cf55e8b4-9686-4fa9-9104-660cfb7aebd1" xlink:to="loc_goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember_e1b08b9d-a891-45bd-a8b5-d8d86aca4860" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentOtherProgramsMember_25163d5b-c4b3-4809-b381-03a2a7f7ee4e" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentOtherProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cf55e8b4-9686-4fa9-9104-660cfb7aebd1" xlink:to="loc_goss_InProcessResearchAndDevelopmentOtherProgramsMember_25163d5b-c4b3-4809-b381-03a2a7f7ee4e" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/StockholdersEquity" xlink:type="simple" xlink:href="goss-20200930.xsd#StockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/StockholdersEquity" xlink:type="extended" id="ia8b0a867e83b4c38bc9176e8c59fc931_StockholdersEquity"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#StockholdersEquityAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="extended" id="i14e54cd02596444fa1ccffa86c8ae628_StockholdersEquityAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:href="goss-20200930.xsd#goss_StockholdersEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_84663b03-17ea-44f1-977e-68ad62f43a23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_84663b03-17ea-44f1-977e-68ad62f43a23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_CommonStockVotingRightsNumberOfVotesPerShare_51ccc630-bead-43ad-b0ed-22fabef45679" xlink:href="goss-20200930.xsd#goss_CommonStockVotingRightsNumberOfVotesPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_goss_CommonStockVotingRightsNumberOfVotesPerShare_51ccc630-bead-43ad-b0ed-22fabef45679" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_50823cf6-94f1-4307-8503-8f0c79f44142" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_50823cf6-94f1-4307-8503-8f0c79f44142" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_da2e0443-65a8-4cca-9815-41326b75334e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_da2e0443-65a8-4cca-9815-41326b75334e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_5e7f33cf-c375-4743-b1b0-f0b2c7eac719" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_5e7f33cf-c375-4743-b1b0-f0b2c7eac719" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_064b890a-83a3-43cb-835f-cdc567ad9523" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_064b890a-83a3-43cb-835f-cdc567ad9523" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_fe6fc649-718b-4d9f-a97d-6ad9c6cbdc85" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_fe6fc649-718b-4d9f-a97d-6ad9c6cbdc85" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_CommonStockVestingPercentage_5db1ea37-dc7c-4c5b-839e-2095428f1152" xlink:href="goss-20200930.xsd#goss_CommonStockVestingPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_goss_CommonStockVestingPercentage_5db1ea37-dc7c-4c5b-839e-2095428f1152" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_CommonStockVestingPeriod_343c164a-0d06-443e-ba0c-15c7cb067010" xlink:href="goss-20200930.xsd#goss_CommonStockVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_goss_CommonStockVestingPeriod_343c164a-0d06-443e-ba0c-15c7cb067010" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PercentageOfFullyDilutedShareCapital_ceeea640-0d5d-40bf-b734-a85b39a89e10" xlink:href="goss-20200930.xsd#goss_PercentageOfFullyDilutedShareCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_goss_PercentageOfFullyDilutedShareCapital_ceeea640-0d5d-40bf-b734-a85b39a89e10" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_IncreasedInEquityCapitalAmount_4ce93e62-dd65-4a44-abd6-bccaf2335b02" xlink:href="goss-20200930.xsd#goss_IncreasedInEquityCapitalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_goss_IncreasedInEquityCapitalAmount_4ce93e62-dd65-4a44-abd6-bccaf2335b02" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_8ea2475e-cbc0-4bea-ad1f-0a3f6fb0dd73" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_8ea2475e-cbc0-4bea-ad1f-0a3f6fb0dd73" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting_e4165743-18fa-4628-8353-d762d4fa4899" xlink:href="goss-20200930.xsd#goss_IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_goss_IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting_e4165743-18fa-4628-8353-d762d4fa4899" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_2d106971-f6ec-4cc6-9a4a-a143c8fabee3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_2d106971-f6ec-4cc6-9a4a-a143c8fabee3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares_7f8f422f-fec5-4d25-881d-faf7e135951c" xlink:href="goss-20200930.xsd#goss_StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_goss_StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares_7f8f422f-fec5-4d25-881d-faf7e135951c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_2714c797-07be-4770-af68-4854f8b056b5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_2714c797-07be-4770-af68-4854f8b056b5" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_StockholdersEquityTable_84970e96-c8e6-49ac-b4d5-1212f7a58f1f" xlink:href="goss-20200930.xsd#goss_StockholdersEquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_goss_StockholdersEquityTable_84970e96-c8e6-49ac-b4d5-1212f7a58f1f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_00b81e36-320f-4d8f-8305-3fb981c1687c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_goss_StockholdersEquityTable_84970e96-c8e6-49ac-b4d5-1212f7a58f1f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_00b81e36-320f-4d8f-8305-3fb981c1687c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_00b81e36-320f-4d8f-8305-3fb981c1687c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_00b81e36-320f-4d8f-8305-3fb981c1687c" xlink:to="loc_us-gaap_EquityComponentDomain_00b81e36-320f-4d8f-8305-3fb981c1687c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5e77efcd-e505-401b-a893-b2109bec04d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_00b81e36-320f-4d8f-8305-3fb981c1687c" xlink:to="loc_us-gaap_EquityComponentDomain_5e77efcd-e505-401b-a893-b2109bec04d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9d9dcb5a-935d-43ef-b5db-a66558994286" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5e77efcd-e505-401b-a893-b2109bec04d4" xlink:to="loc_us-gaap_CommonStockMember_9d9dcb5a-935d-43ef-b5db-a66558994286" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_FounderSharesMember_de12e2ce-eaf5-444b-b9b4-d2d2c05765b8" xlink:href="goss-20200930.xsd#goss_FounderSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5e77efcd-e505-401b-a893-b2109bec04d4" xlink:to="loc_goss_FounderSharesMember_de12e2ce-eaf5-444b-b9b4-d2d2c05765b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_483a7fd9-98cb-489b-921e-ddb9e0047c62" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_goss_StockholdersEquityTable_84970e96-c8e6-49ac-b4d5-1212f7a58f1f" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_483a7fd9-98cb-489b-921e-ddb9e0047c62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_483a7fd9-98cb-489b-921e-ddb9e0047c62_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_483a7fd9-98cb-489b-921e-ddb9e0047c62" xlink:to="loc_us-gaap_RelatedPartyDomain_483a7fd9-98cb-489b-921e-ddb9e0047c62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_587b8ac8-9270-4b7a-ad3d-5c2563a5f78f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_483a7fd9-98cb-489b-921e-ddb9e0047c62" xlink:to="loc_us-gaap_RelatedPartyDomain_587b8ac8-9270-4b7a-ad3d-5c2563a5f78f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_FounderMember_da5176eb-7201-43b6-9cec-c33405aa62b3" xlink:href="goss-20200930.xsd#goss_FounderMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_587b8ac8-9270-4b7a-ad3d-5c2563a5f78f" xlink:to="loc_goss_FounderMember_da5176eb-7201-43b6-9cec-c33405aa62b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_8f88430f-3017-433d-a809-70f65e647ae3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_goss_StockholdersEquityTable_84970e96-c8e6-49ac-b4d5-1212f7a58f1f" xlink:to="loc_us-gaap_StatementClassOfStockAxis_8f88430f-3017-433d-a809-70f65e647ae3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8f88430f-3017-433d-a809-70f65e647ae3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_8f88430f-3017-433d-a809-70f65e647ae3" xlink:to="loc_us-gaap_ClassOfStockDomain_8f88430f-3017-433d-a809-70f65e647ae3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2c03e932-d4e8-4ada-941f-cc862f6bcbfa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_8f88430f-3017-433d-a809-70f65e647ae3" xlink:to="loc_us-gaap_ClassOfStockDomain_2c03e932-d4e8-4ada-941f-cc862f6bcbfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SeriesAConvertiblePreferredStockMember_d3a41294-8972-4797-b696-276ecf965b73" xlink:href="goss-20200930.xsd#goss_SeriesAConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_2c03e932-d4e8-4ada-941f-cc862f6bcbfa" xlink:to="loc_goss_SeriesAConvertiblePreferredStockMember_d3a41294-8972-4797-b696-276ecf965b73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_9cc28ead-2254-4ca5-83c0-35a14c73bdeb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_goss_StockholdersEquityTable_84970e96-c8e6-49ac-b4d5-1212f7a58f1f" xlink:to="loc_us-gaap_TypeOfArrangementAxis_9cc28ead-2254-4ca5-83c0-35a14c73bdeb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_9cc28ead-2254-4ca5-83c0-35a14c73bdeb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_9cc28ead-2254-4ca5-83c0-35a14c73bdeb" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_9cc28ead-2254-4ca5-83c0-35a14c73bdeb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e2368526-e75a-4b6e-916c-71a1d77d3db3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_9cc28ead-2254-4ca5-83c0-35a14c73bdeb" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e2368526-e75a-4b6e-916c-71a1d77d3db3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_StockRestrictionAgreementsMember_ee73c16c-92bf-4613-b77e-e0e7c5477be3" xlink:href="goss-20200930.xsd#goss_StockRestrictionAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e2368526-e75a-4b6e-916c-71a1d77d3db3" xlink:to="loc_goss_StockRestrictionAgreementsMember_ee73c16c-92bf-4613-b77e-e0e7c5477be3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/EquityIncentivePlans" xlink:type="simple" xlink:href="goss-20200930.xsd#EquityIncentivePlans"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/EquityIncentivePlans" xlink:type="extended" id="i0e5ade7838444d80958c14a202b97863_EquityIncentivePlans"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/EquityIncentivePlansTables" xlink:type="simple" xlink:href="goss-20200930.xsd#EquityIncentivePlansTables"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/EquityIncentivePlansTables" xlink:type="extended" id="ia08dcf55037b40a384fcab18704bf09f_EquityIncentivePlansTables"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#EquityIncentivePlansAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails" xlink:type="extended" id="i2254ff4a88d749f1a6e3aa9ddd12a8df_EquityIncentivePlansAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_21ee31e3-3e07-4be1-9b1b-df702c39f0e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_21ee31e3-3e07-4be1-9b1b-df702c39f0e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2028044e-c9b1-4490-9c3c-c1b337e6ac34" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2028044e-c9b1-4490-9c3c-c1b337e6ac34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_5caf4b40-e265-404c-9e28-96f19c15fde3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_5caf4b40-e265-404c-9e28-96f19c15fde3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2d15a840-178f-4974-9a3a-8f698184bccf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2d15a840-178f-4974-9a3a-8f698184bccf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2954149f-672e-4687-9bef-77e0a47475f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2954149f-672e-4687-9bef-77e0a47475f6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1219a306-3524-49f5-bb5c-2a6445e699aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1219a306-3524-49f5-bb5c-2a6445e699aa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued_a1576a61-af5f-460f-940b-9de5d82d32bb" xlink:href="goss-20200930.xsd#goss_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_goss_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued_a1576a61-af5f-460f-940b-9de5d82d32bb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_3d60864e-c392-4d5e-a3b5-971f0b10184c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_3d60864e-c392-4d5e-a3b5-971f0b10184c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2fce6a2f-cf32-4817-b22b-19dbe1712c32" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2fce6a2f-cf32-4817-b22b-19dbe1712c32" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1efd79ff-a248-4f2b-8090-e5dc7f64abea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1efd79ff-a248-4f2b-8090-e5dc7f64abea" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2de3acfe-f890-44ca-a446-3eed25d8f17c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2de3acfe-f890-44ca-a446-3eed25d8f17c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_3141eb07-7cd3-4000-9f10-3d68478e24fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_3141eb07-7cd3-4000-9f10-3d68478e24fc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_82b2efa0-4a31-4ff4-9754-05d2a57f6e91" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_82b2efa0-4a31-4ff4-9754-05d2a57f6e91" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_151aa70e-3257-49bc-b822-d2399330336e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_151aa70e-3257-49bc-b822-d2399330336e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_69714028-f480-4332-8a1e-95480a2f5531" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_69714028-f480-4332-8a1e-95480a2f5531" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_7a8cd0ca-4a42-4f3e-8a17-883a45ca2be5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_7a8cd0ca-4a42-4f3e-8a17-883a45ca2be5" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_11cc50ba-a2c1-4958-bebb-1e04e7d45c6c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_11cc50ba-a2c1-4958-bebb-1e04e7d45c6c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_7b892224-23ac-47f4-bd8c-195d325c37a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_11cc50ba-a2c1-4958-bebb-1e04e7d45c6c" xlink:to="loc_us-gaap_PlanNameAxis_7b892224-23ac-47f4-bd8c-195d325c37a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_7b892224-23ac-47f4-bd8c-195d325c37a1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_7b892224-23ac-47f4-bd8c-195d325c37a1" xlink:to="loc_us-gaap_PlanNameDomain_7b892224-23ac-47f4-bd8c-195d325c37a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b57058c6-fb07-47d3-a0cd-60feb0d55bb8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_7b892224-23ac-47f4-bd8c-195d325c37a1" xlink:to="loc_us-gaap_PlanNameDomain_b57058c6-fb07-47d3-a0cd-60feb0d55bb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandNineteenEquityIncentivePlanMember_f9c78227-eeef-4106-ab2d-b22f8d2bdea6" xlink:href="goss-20200930.xsd#goss_TwoThousandNineteenEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_b57058c6-fb07-47d3-a0cd-60feb0d55bb8" xlink:to="loc_goss_TwoThousandNineteenEquityIncentivePlanMember_f9c78227-eeef-4106-ab2d-b22f8d2bdea6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandNineteenEmployeeStockPurchasePlanMember_9b3a2fc2-23b1-4001-a36f-6766dd8ecc50" xlink:href="goss-20200930.xsd#goss_TwoThousandNineteenEmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_b57058c6-fb07-47d3-a0cd-60feb0d55bb8" xlink:to="loc_goss_TwoThousandNineteenEmployeeStockPurchasePlanMember_9b3a2fc2-23b1-4001-a36f-6766dd8ecc50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandSeventeenEquityIncentivePlanMember_bacee427-58b0-42bf-aafa-72d48f608399" xlink:href="goss-20200930.xsd#goss_TwoThousandSeventeenEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_b57058c6-fb07-47d3-a0cd-60feb0d55bb8" xlink:to="loc_goss_TwoThousandSeventeenEquityIncentivePlanMember_bacee427-58b0-42bf-aafa-72d48f608399" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e0d0f540-f122-434a-886e-70d653e25bfa" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_11cc50ba-a2c1-4958-bebb-1e04e7d45c6c" xlink:to="loc_srt_RangeAxis_e0d0f540-f122-434a-886e-70d653e25bfa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e0d0f540-f122-434a-886e-70d653e25bfa_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e0d0f540-f122-434a-886e-70d653e25bfa" xlink:to="loc_srt_RangeMember_e0d0f540-f122-434a-886e-70d653e25bfa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e61c4ac3-6687-4b83-b32b-c99f324dd901" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e0d0f540-f122-434a-886e-70d653e25bfa" xlink:to="loc_srt_RangeMember_e61c4ac3-6687-4b83-b32b-c99f324dd901" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7ea7836c-457c-4198-a114-d12300307982" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e61c4ac3-6687-4b83-b32b-c99f324dd901" xlink:to="loc_srt_MaximumMember_7ea7836c-457c-4198-a114-d12300307982" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7498b956-024d-4ee4-b459-51536155f8d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_11cc50ba-a2c1-4958-bebb-1e04e7d45c6c" xlink:to="loc_us-gaap_AwardTypeAxis_7498b956-024d-4ee4-b459-51536155f8d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7498b956-024d-4ee4-b459-51536155f8d4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_7498b956-024d-4ee4-b459-51536155f8d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7498b956-024d-4ee4-b459-51536155f8d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e638ada5-7d7f-41e7-9a9a-64bdd2720420" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_7498b956-024d-4ee4-b459-51536155f8d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e638ada5-7d7f-41e7-9a9a-64bdd2720420" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_e21386fd-c060-4470-b91e-71a3d060aacd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e638ada5-7d7f-41e7-9a9a-64bdd2720420" xlink:to="loc_us-gaap_RestrictedStockMember_e21386fd-c060-4470-b91e-71a3d060aacd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b0feb237-6b2a-4a5c-9d84-2425942a8a6e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e638ada5-7d7f-41e7-9a9a-64bdd2720420" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b0feb237-6b2a-4a5c-9d84-2425942a8a6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_3d9afc90-46f8-4c1f-930d-7dc7d5e6ac0e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e638ada5-7d7f-41e7-9a9a-64bdd2720420" xlink:to="loc_us-gaap_StockCompensationPlanMember_3d9afc90-46f8-4c1f-930d-7dc7d5e6ac0e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#EquityIncentivePlansSummaryofStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails" xlink:type="extended" id="i825b49215f6c41f18901caccee08190f_EquityIncentivePlansSummaryofStockOptionActivityDetails"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#EquityIncentivePlansSummaryofRestrictedStockActivityDetails"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails" xlink:type="extended" id="idf3ce6363bd64eadab06b887c1fc0f21_EquityIncentivePlansSummaryofRestrictedStockActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50527a3c-5897-4e87-895a-b0e96a854386" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fdbcc3f6-a20f-40ae-be7d-5b51604b6bf5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50527a3c-5897-4e87-895a-b0e96a854386" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fdbcc3f6-a20f-40ae-be7d-5b51604b6bf5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d7dbb089-cd3e-4f5c-b8c7-0b31c2da2a5b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fdbcc3f6-a20f-40ae-be7d-5b51604b6bf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d7dbb089-cd3e-4f5c-b8c7-0b31c2da2a5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_85bf9263-03ef-4c70-ab2f-367a8b63eb7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fdbcc3f6-a20f-40ae-be7d-5b51604b6bf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_85bf9263-03ef-4c70-ab2f-367a8b63eb7f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_eac5e009-c10d-475d-9107-4f257be62bef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fdbcc3f6-a20f-40ae-be7d-5b51604b6bf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_eac5e009-c10d-475d-9107-4f257be62bef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7c5f7d61-49b9-498e-8ffc-c92c53ab2d59" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fdbcc3f6-a20f-40ae-be7d-5b51604b6bf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7c5f7d61-49b9-498e-8ffc-c92c53ab2d59" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ae411f14-74b3-4bfd-9d19-5e53c7579281" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_145e14f8-2e1b-488f-84af-dc6be006928d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50527a3c-5897-4e87-895a-b0e96a854386" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_145e14f8-2e1b-488f-84af-dc6be006928d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9d92cf10-98e9-410d-a1ec-c9145333e517" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_145e14f8-2e1b-488f-84af-dc6be006928d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9d92cf10-98e9-410d-a1ec-c9145333e517" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ed6bfb76-01d9-4373-8547-560423bd14b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_145e14f8-2e1b-488f-84af-dc6be006928d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ed6bfb76-01d9-4373-8547-560423bd14b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2474daa6-725e-494c-9e45-b7bdcf3073db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_145e14f8-2e1b-488f-84af-dc6be006928d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2474daa6-725e-494c-9e45-b7bdcf3073db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2b67f7cb-7d2f-4c1d-ac07-9050678969b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_145e14f8-2e1b-488f-84af-dc6be006928d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2b67f7cb-7d2f-4c1d-ac07-9050678969b6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8b574682-ae71-47ad-8a5e-fc61a2f03641" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a1def98-592f-4241-aa68-da4a11b686f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50527a3c-5897-4e87-895a-b0e96a854386" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a1def98-592f-4241-aa68-da4a11b686f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_205dbcd6-56b1-4088-8a94-2e5e1b8be951" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a1def98-592f-4241-aa68-da4a11b686f1" xlink:to="loc_us-gaap_AwardTypeAxis_205dbcd6-56b1-4088-8a94-2e5e1b8be951" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_205dbcd6-56b1-4088-8a94-2e5e1b8be951_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_205dbcd6-56b1-4088-8a94-2e5e1b8be951" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_205dbcd6-56b1-4088-8a94-2e5e1b8be951_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_727c2bc6-a2fd-416a-a881-275c5d653df6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_205dbcd6-56b1-4088-8a94-2e5e1b8be951" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_727c2bc6-a2fd-416a-a881-275c5d653df6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_45833302-83ba-4de1-814b-fd62d738415d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_727c2bc6-a2fd-416a-a881-275c5d653df6" xlink:to="loc_us-gaap_RestrictedStockMember_45833302-83ba-4de1-814b-fd62d738415d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/EquityIncentivePlansStockBasedCompensationExpenseReportedinCondensedConsolidatedStatementsofOperationsDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#EquityIncentivePlansStockBasedCompensationExpenseReportedinCondensedConsolidatedStatementsofOperationsDetails"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/EquityIncentivePlansStockBasedCompensationExpenseReportedinCondensedConsolidatedStatementsofOperationsDetails" xlink:type="extended" id="i12b38c0d79f24935887ca89809d2ad3b_EquityIncentivePlansStockBasedCompensationExpenseReportedinCondensedConsolidatedStatementsofOperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f599597e-dd19-4f29-9db8-b9872ad3c955" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_347ca9ba-4366-48ca-b6ef-d5635ceeffa3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f599597e-dd19-4f29-9db8-b9872ad3c955" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_347ca9ba-4366-48ca-b6ef-d5635ceeffa3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_a4e8245a-ee02-4a9c-a8d2-08912571f241" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f599597e-dd19-4f29-9db8-b9872ad3c955" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_a4e8245a-ee02-4a9c-a8d2-08912571f241" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ebc124ee-cc3c-4d46-900c-4aae996d424e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_a4e8245a-ee02-4a9c-a8d2-08912571f241" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ebc124ee-cc3c-4d46-900c-4aae996d424e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ebc124ee-cc3c-4d46-900c-4aae996d424e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ebc124ee-cc3c-4d46-900c-4aae996d424e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ebc124ee-cc3c-4d46-900c-4aae996d424e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ef530e64-90e5-4af6-aeb1-486201731d8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ebc124ee-cc3c-4d46-900c-4aae996d424e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ef530e64-90e5-4af6-aeb1-486201731d8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_cbd084ee-cd1b-46b4-8645-525b3ee61fea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ef530e64-90e5-4af6-aeb1-486201731d8c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_cbd084ee-cd1b-46b4-8645-525b3ee61fea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_b2308d97-f356-4f33-b6c9-a6d07ab8911c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ef530e64-90e5-4af6-aeb1-486201731d8c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_b2308d97-f356-4f33-b6c9-a6d07ab8911c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="goss-20200930.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/CommitmentsandContingencies" xlink:type="extended" id="i892b2934fe5e496d9d9f6579620cba2f_CommitmentsandContingencies"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="goss-20200930.xsd#CommitmentsandContingenciesTables"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/CommitmentsandContingenciesTables" xlink:type="extended" id="i804495d8940842418d85260f30d9307b_CommitmentsandContingenciesTables"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#CommitmentsandContingenciesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="extended" id="i384ca645ac6d45da802635232e4bfac1_CommitmentsandContingenciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_OperatingSubleaseAnnualIncreasePercentageForBaseRent_fb17cb07-fb9c-4e5a-9cda-06e248f13139" xlink:href="goss-20200930.xsd#goss_OperatingSubleaseAnnualIncreasePercentageForBaseRent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_goss_OperatingSubleaseAnnualIncreasePercentageForBaseRent_fb17cb07-fb9c-4e5a-9cda-06e248f13139" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PermanentMonthlyBaseRent_82b17f4c-1189-4461-893b-22f95da54ccd" xlink:href="goss-20200930.xsd#goss_PermanentMonthlyBaseRent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_goss_PermanentMonthlyBaseRent_82b17f4c-1189-4461-893b-22f95da54ccd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TemporaryMonthlyBaseRent_360ce45f-05d2-404d-91be-bbed34b6529b" xlink:href="goss-20200930.xsd#goss_TemporaryMonthlyBaseRent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_goss_TemporaryMonthlyBaseRent_360ce45f-05d2-404d-91be-bbed34b6529b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PeriodForWhichLeaseOfPermanentSpaceCanBeExtended_b698bb4f-dcd2-49c6-a92d-526046794228" xlink:href="goss-20200930.xsd#goss_PeriodForWhichLeaseOfPermanentSpaceCanBeExtended"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_goss_PeriodForWhichLeaseOfPermanentSpaceCanBeExtended_b698bb4f-dcd2-49c6-a92d-526046794228" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AnnualIncreasePercentageForLeaseCharges_8f0bb928-07ad-4d4f-95b6-478a6468d45f" xlink:href="goss-20200930.xsd#goss_AnnualIncreasePercentageForLeaseCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_goss_AnnualIncreasePercentageForLeaseCharges_8f0bb928-07ad-4d4f-95b6-478a6468d45f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SubleaseTemporaryMonthlyBaseRent_0d70083f-4518-4b73-b417-f30dbb33f098" xlink:href="goss-20200930.xsd#goss_SubleaseTemporaryMonthlyBaseRent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_goss_SubleaseTemporaryMonthlyBaseRent_0d70083f-4518-4b73-b417-f30dbb33f098" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SubleaseAnnualIncreasePercentageForLeaseCharges_5b16096a-581e-425e-ac55-03a6d9a5aea3" xlink:href="goss-20200930.xsd#goss_SubleaseAnnualIncreasePercentageForLeaseCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_goss_SubleaseAnnualIncreasePercentageForLeaseCharges_5b16096a-581e-425e-ac55-03a6d9a5aea3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SubleasePeriodOfBaseRentAbatement_f14141af-56bc-4fed-8e1a-67f4dff60444" xlink:href="goss-20200930.xsd#goss_SubleasePeriodOfBaseRentAbatement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_goss_SubleasePeriodOfBaseRentAbatement_f14141af-56bc-4fed-8e1a-67f4dff60444" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_68cc35ff-3d83-45f8-8d02-aab764399859" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_us-gaap_SubleaseIncome_68cc35ff-3d83-45f8-8d02-aab764399859" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_6804f842-a72c-42b2-b443-32748e431833" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_6804f842-a72c-42b2-b443-32748e431833" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_OperatingLeasesMonthlyBaseRentExpense_560db317-a70c-4691-bf78-6a0a1ef8bb99" xlink:href="goss-20200930.xsd#goss_OperatingLeasesMonthlyBaseRentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_goss_OperatingLeasesMonthlyBaseRentExpense_560db317-a70c-4691-bf78-6a0a1ef8bb99" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_d1a1702c-8397-4113-9063-7a3676515ba7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_d1a1702c-8397-4113-9063-7a3676515ba7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8c9b39be-4e62-491f-b946-eb99fc466ebb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8c9b39be-4e62-491f-b946-eb99fc466ebb" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_049e51a2-41d0-4e1c-859a-ec82c53b4d43" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_us-gaap_OperatingLeasePayments_049e51a2-41d0-4e1c-859a-ec82c53b4d43" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_2a24c6d9-4d7c-4f5b-96e6-1f311b1f3413" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_us-gaap_OperatingLeaseExpense_2a24c6d9-4d7c-4f5b-96e6-1f311b1f3413" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_db5247a8-89dc-4b74-a27b-a5ccee8d99a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_db5247a8-89dc-4b74-a27b-a5ccee8d99a1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LeaseContractualTermAxis_3e518ad8-4dc3-45de-b37c-fb196d60d0d5" xlink:href="goss-20200930.xsd#goss_LeaseContractualTermAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_db5247a8-89dc-4b74-a27b-a5ccee8d99a1" xlink:to="loc_goss_LeaseContractualTermAxis_3e518ad8-4dc3-45de-b37c-fb196d60d0d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LeaseContractualTermDomain_3e518ad8-4dc3-45de-b37c-fb196d60d0d5_default" xlink:href="goss-20200930.xsd#goss_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_goss_LeaseContractualTermAxis_3e518ad8-4dc3-45de-b37c-fb196d60d0d5" xlink:to="loc_goss_LeaseContractualTermDomain_3e518ad8-4dc3-45de-b37c-fb196d60d0d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LeaseContractualTermDomain_5581c84e-009d-4c2d-9d08-937dc0b9a348" xlink:href="goss-20200930.xsd#goss_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_goss_LeaseContractualTermAxis_3e518ad8-4dc3-45de-b37c-fb196d60d0d5" xlink:to="loc_goss_LeaseContractualTermDomain_5581c84e-009d-4c2d-9d08-937dc0b9a348" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_NonCancelableLeaseAgreementEnteredInAugust2018Member_273cad39-c65c-40fe-9c06-f28d0b11f5d0" xlink:href="goss-20200930.xsd#goss_NonCancelableLeaseAgreementEnteredInAugust2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_LeaseContractualTermDomain_5581c84e-009d-4c2d-9d08-937dc0b9a348" xlink:to="loc_goss_NonCancelableLeaseAgreementEnteredInAugust2018Member_273cad39-c65c-40fe-9c06-f28d0b11f5d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AdditionalNonCancelableLeaseAgreementInNov2019Member_f5ae318b-4eef-46ac-9b93-a43edfefb7d6" xlink:href="goss-20200930.xsd#goss_AdditionalNonCancelableLeaseAgreementInNov2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_LeaseContractualTermDomain_5581c84e-009d-4c2d-9d08-937dc0b9a348" xlink:to="loc_goss_AdditionalNonCancelableLeaseAgreementInNov2019Member_f5ae318b-4eef-46ac-9b93-a43edfefb7d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SubleaseAgreementEnteredInJune2020Member_018be015-d374-4ff9-901e-98a782595638" xlink:href="goss-20200930.xsd#goss_SubleaseAgreementEnteredInJune2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_LeaseContractualTermDomain_5581c84e-009d-4c2d-9d08-937dc0b9a348" xlink:to="loc_goss_SubleaseAgreementEnteredInJune2020Member_018be015-d374-4ff9-901e-98a782595638" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LeaseAssignmentAgreementEnteredInJuly2020Member_c6fd9ba9-dcd8-4965-acb2-8f88e67a2480" xlink:href="goss-20200930.xsd#goss_LeaseAssignmentAgreementEnteredInJuly2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_goss_LeaseContractualTermDomain_5581c84e-009d-4c2d-9d08-937dc0b9a348" xlink:to="loc_goss_LeaseAssignmentAgreementEnteredInJuly2020Member_c6fd9ba9-dcd8-4965-acb2-8f88e67a2480" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofLeaseCostsDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#CommitmentsandContingenciesScheduleofLeaseCostsDetails"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofLeaseCostsDetails" xlink:type="extended" id="if54c3887d9a94729bc022450c48b1497_CommitmentsandContingenciesScheduleofLeaseCostsDetails"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails" xlink:type="extended" id="ic74cd736437b49a4876a97b67da876de_CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>goss-20200930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:a28f2324-59ee-4208-be3f-ac91f14d0976,g:685f1ccc-55e8-49df-855b-4b6ee836ad79-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_fef9ace1-f1e4-4c02-b1b1-fedfe213eb48_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_09203d70-e8c4-449c-8e81-27f87237bb0d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_a11bc235-2032-4250-858c-731b963a960c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions_077c21f5-0931-478d-88cf-0a4aa346563f_negatedLabel_en-US" xlink:label="lab_goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development asset acquisitions, net of cash acquired</link:label>
    <link:label id="lab_goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions_label_en-US" xlink:label="lab_goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Proceeds From Research And Development Asset Acquisitions</link:label>
    <link:label id="lab_goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions_documentation_en-US" xlink:label="lab_goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) research and development asset acquisitions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions" xlink:href="goss-20200930.xsd#goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions" xlink:to="lab_goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_dc9b678c-6792-44a1-ad80-a41f16447bf1_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_a1cda6d3-8198-4021-9b2c-09efab5a6386_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6a6da4ed-40f2-4927-a049-6d2a6fea8f81_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_DescriptionOfBusinessLineItems_71ff03d9-70c9-42fc-b336-15f2c16718a8_terseLabel_en-US" xlink:label="lab_goss_DescriptionOfBusinessLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description Of Business [Line Items]</link:label>
    <link:label id="lab_goss_DescriptionOfBusinessLineItems_label_en-US" xlink:label="lab_goss_DescriptionOfBusinessLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description Of Business [Line Items]</link:label>
    <link:label id="lab_goss_DescriptionOfBusinessLineItems_documentation_en-US" xlink:label="lab_goss_DescriptionOfBusinessLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_DescriptionOfBusinessLineItems" xlink:href="goss-20200930.xsd#goss_DescriptionOfBusinessLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_DescriptionOfBusinessLineItems" xlink:to="lab_goss_DescriptionOfBusinessLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_2813d1bb-bd89-488d-8bbe-5e8db250a49c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ffe35547-0bde-4422-a8ef-526cfec941ba_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_c7c4829a-b922-45f3-a0ad-e6109cbcc5dd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ce82afa7-57c8-4b4d-a0ce-b455271aa1f4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_e597bf46-d24e-487f-bd8c-a44434c032e4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2f4479cf-5023-40aa-a00b-fa27a1204384_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Restricted Stock Units Outstanding, Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_NinetyEightPercentApplicableConversionPriceMember_07c0fe0e-c576-405e-b63e-0c36aea841ae_terseLabel_en-US" xlink:label="lab_goss_NinetyEightPercentApplicableConversionPriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">98% Applicable Conversion Price</link:label>
    <link:label id="lab_goss_NinetyEightPercentApplicableConversionPriceMember_label_en-US" xlink:label="lab_goss_NinetyEightPercentApplicableConversionPriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ninety Eight Percent Applicable Conversion Price [Member]</link:label>
    <link:label id="lab_goss_NinetyEightPercentApplicableConversionPriceMember_documentation_en-US" xlink:label="lab_goss_NinetyEightPercentApplicableConversionPriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ninety Eight Percent Applicable Conversion Price [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_NinetyEightPercentApplicableConversionPriceMember" xlink:href="goss-20200930.xsd#goss_NinetyEightPercentApplicableConversionPriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_NinetyEightPercentApplicableConversionPriceMember" xlink:to="lab_goss_NinetyEightPercentApplicableConversionPriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_dc2c8d4a-e43d-4d22-bae1-d66583bdf123_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1983f636-2dc1-4e63-b940-784329ab3e86_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Restricted Stock Units Outstanding, Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_2e1a1f32-cb3a-4e7f-ba3f-367d8ef8ef75_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_11935113-251b-4022-9f87-f26d6f5b56bd_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_9170fce8-b564-4157-9e8c-0a6564b14b37_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_21e74e10-51e1-4df5-9d9b-98d8519dfacc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_LicenseAgreementMember_c235fedc-c6da-486e-bde5-1a131265eb8f_terseLabel_en-US" xlink:label="lab_goss_LicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Agreement</link:label>
    <link:label id="lab_goss_LicenseAgreementMember_label_en-US" xlink:label="lab_goss_LicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Agreement [Member]</link:label>
    <link:label id="lab_goss_LicenseAgreementMember_documentation_en-US" xlink:label="lab_goss_LicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LicenseAgreementMember" xlink:href="goss-20200930.xsd#goss_LicenseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_LicenseAgreementMember" xlink:to="lab_goss_LicenseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_6529bdbe-1b31-48f9-9bd7-0151c97066af_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs attributable to convertible feature</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_834b7c8a-133e-4c17-90ce-70b3fa054e45_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares outstanding awarded (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a644e141-1910-4287-82db-80679c4611dd_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Subject to Options Outstanding, Outstanding as of December 31, 2019 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8b85ca4b-5777-42df-9b81-05c7833de11c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Subject to Options Outstanding, Outstanding as of Sept 30,2020 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_7437c564-4f3e-4e06-8b48-be237bd0b451_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with a public offering, net of underwriting discounts, commissions, and offering costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_820b4598-13a6-4d85-a243-412479d82792_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with a public offering net of underwriting discounts, commissions and offering costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_ad843c69-dca8-416f-a22b-d0d82e41d1c1_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_98284075-9f48-4ceb-afdc-5f5caa689835_terseLabel_en-US" xlink:label="lab_goss_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One to two years</link:label>
    <link:label id="lab_goss_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_label_en-US" xlink:label="lab_goss_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Debt Maturities After One Through Two Years Fair Value</link:label>
    <link:label id="lab_goss_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_documentation_en-US" xlink:label="lab_goss_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale securities debt maturities after one through two years fair value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" xlink:href="goss-20200930.xsd#goss_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" xlink:to="lab_goss_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_00dc0c25-e4a4-4516-8fd5-f8536db54e46_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_c77b829a-8fa2-4054-bcd6-b0564d1d3221_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_d841cbf5-b2dd-451d-87f7-bf108ff023f9_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discount and issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_1de85898-00bc-435a-a402-e0202c179864_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_d425adc1-0519-4307-a015-2965ce35f238_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_75b3a0cb-2eab-42a1-99b7-c3d7363e6b6e_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of convertible senior notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_16c4a972-d073-4258-aa58-f9da969112ca_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f713b598-243b-4a2d-92e0-920f910227c0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_NonCancelableLeaseAgreementEnteredInAugust2018Member_d95db17b-ad9f-43a3-aa4d-5d2a61169575_terseLabel_en-US" xlink:label="lab_goss_NonCancelableLeaseAgreementEnteredInAugust2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cancelable Lease Agreement Entered in August 2018</link:label>
    <link:label id="lab_goss_NonCancelableLeaseAgreementEnteredInAugust2018Member_label_en-US" xlink:label="lab_goss_NonCancelableLeaseAgreementEnteredInAugust2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cancelable Lease Agreement Entered in August 2018 [Member]</link:label>
    <link:label id="lab_goss_NonCancelableLeaseAgreementEnteredInAugust2018Member_documentation_en-US" xlink:label="lab_goss_NonCancelableLeaseAgreementEnteredInAugust2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cancelable Lease Agreement Entered in August 2018</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_NonCancelableLeaseAgreementEnteredInAugust2018Member" xlink:href="goss-20200930.xsd#goss_NonCancelableLeaseAgreementEnteredInAugust2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_NonCancelableLeaseAgreementEnteredInAugust2018Member" xlink:to="lab_goss_NonCancelableLeaseAgreementEnteredInAugust2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable_32c50707-53a2-43e7-9612-5532204330c8_terseLabel_en-US" xlink:label="lab_goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and regulatory milestone payments, payable</link:label>
    <link:label id="lab_goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable_label_en-US" xlink:label="lab_goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Development And Regulatory Milestone Payments Payable</link:label>
    <link:label id="lab_goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable_documentation_en-US" xlink:label="lab_goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, contingent consideration, development and regulatory milestone payments, payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable" xlink:href="goss-20200930.xsd#goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable" xlink:to="lab_goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c5d4585f-11aa-41c5-996a-aed464d00bf0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_bd11d543-81e0-4cd1-8346-43202e463f1b_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_65faabb8-8e32-4d3e-a994-98dce44be4fd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price, Option exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_be6c050d-cece-48dd-a728-73e4445891d4_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_4a13d90a-2f58-43b8-a032-3a40145eda9e_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_1e616f8f-fa92-4ff7-9582-e370368b7f27_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_20d9026c-1667-44fc-96b0-44579f5fb99c_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_21747349-c983-47de-8e4e-9d2fae445d42_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_a362f12b-b6a6-4c2d-9811-bb3fdb1e02fe_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a1747f94-af5e-4ffd-a6c8-5d87ee9728f8_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Investments, Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_304091ef-e64b-454e-812a-b169bf0d80ad_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_4aff1472-a316-4cad-b4c7-b3049dc6cb5d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_e15b4720-534f-464b-a66b-964c4d419450_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in process</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_ConversionOfConvertiblePreferredStockIntoCommonStockMember_18af9347-92ad-4069-be69-ef2fedc75dfd_terseLabel_en-US" xlink:label="lab_goss_ConversionOfConvertiblePreferredStockIntoCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Convertible Preferred Stock into Common Stock</link:label>
    <link:label id="lab_goss_ConversionOfConvertiblePreferredStockIntoCommonStockMember_label_en-US" xlink:label="lab_goss_ConversionOfConvertiblePreferredStockIntoCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion Of Convertible Preferred Stock Into Common Stock [Member]</link:label>
    <link:label id="lab_goss_ConversionOfConvertiblePreferredStockIntoCommonStockMember_documentation_en-US" xlink:label="lab_goss_ConversionOfConvertiblePreferredStockIntoCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of convertible preferred stock into common stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ConversionOfConvertiblePreferredStockIntoCommonStockMember" xlink:href="goss-20200930.xsd#goss_ConversionOfConvertiblePreferredStockIntoCommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_ConversionOfConvertiblePreferredStockIntoCommonStockMember" xlink:to="lab_goss_ConversionOfConvertiblePreferredStockIntoCommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_911315a0-f9a7-4a86-98dd-c4be94298a71_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_2ab6e149-7b37-4885-aedf-71bb8cb2e13e_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_9a21fe7e-c206-4aed-a314-feaf09dc3640_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested shares under restricted stock grants</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_49182d81-c22d-4d53-96ab-dba86796fc3b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_8671aa3c-2184-4f41-bb17-53a5537ad07a_terseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash received in connection with acquisition</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_a54e49f6-92e2-4282-97ea-6d8c4cae35d0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_56dd5571-32c1-497c-aaef-a0017228439e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_7aca8924-81e7-4c59-83a5-a3cf60609957_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_64512d5e-5076-49de-8892-b71fd0fefea3_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_5ad3fbbd-0fa9-4fa3-914b-ff2456e95140_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_48a815ba-9dad-42a6-80e5-f66693ed1c9d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of convertible debt, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_10ce6d8a-62aa-496f-b4f9-1b01ebd67bdb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value, Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_5eb84bdf-9419-4b56-b708-bc6e1ab3a6c2_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_70975547-554c-4df1-870a-543de75b8a4f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_InProcessResearchAndDevelopmentExpensesTableTextBlock_c885c7dd-c454-4c0d-9585-d7dfd015c777_terseLabel_en-US" xlink:label="lab_goss_InProcessResearchAndDevelopmentExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of IPR&amp;D Expense</link:label>
    <link:label id="lab_goss_InProcessResearchAndDevelopmentExpensesTableTextBlock_label_en-US" xlink:label="lab_goss_InProcessResearchAndDevelopmentExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research And Development Expenses Table [Text Block]</link:label>
    <link:label id="lab_goss_InProcessResearchAndDevelopmentExpensesTableTextBlock_documentation_en-US" xlink:label="lab_goss_InProcessResearchAndDevelopmentExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In process research and development expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentExpensesTableTextBlock" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentExpensesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_InProcessResearchAndDevelopmentExpensesTableTextBlock" xlink:to="lab_goss_InProcessResearchAndDevelopmentExpensesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_b8babea3-450a-48b3-b816-c5ac99505e61_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Subject to Options Outstanding, Options forfeited/cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_7e8ab4ae-d0fb-4366-ad12-599e68212b11_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_0984d1f7-93f6-41b5-9e0c-4ac23ff72159_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_3ff608d4-cbd3-4e12-ab43-69892a4dd5f3_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_6900b714-3091-49f5-824d-8d1e7decf6ca_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_30e93bfd-935f-4fd2-bfab-25426b29418b_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_a4d332b0-2280-46cb-b1c0-08415ce746a9_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of noncash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d4815ba1-c97b-4b64-805a-5b0f38e68cd7_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5dc9cd1d-5e8e-4ff4-8b53-92afb54a54b4_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, at the end of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_e8381cd7-28d5-415d-8b61-4e774d489cdc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_8e743a57-521c-4224-8a5d-15c14d0b3763_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_caa56b21-c8fb-4d2e-a236-0ffaef85e466_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding, basic and diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_TrancheTwoMember_28442040-0c70-4bb9-8bed-7a3e4e235dcb_terseLabel_en-US" xlink:label="lab_goss_TrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche Two</link:label>
    <link:label id="lab_goss_TrancheTwoMember_label_en-US" xlink:label="lab_goss_TrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche Two [Member]</link:label>
    <link:label id="lab_goss_TrancheTwoMember_documentation_en-US" xlink:label="lab_goss_TrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche two.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TrancheTwoMember" xlink:href="goss-20200930.xsd#goss_TrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_TrancheTwoMember" xlink:to="lab_goss_TrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_LongTermConvertibleSeniorNotes_d254de13-d4fa-492a-85ef-c8f6c087170e_terseLabel_en-US" xlink:label="lab_goss_LongTermConvertibleSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term convertible senior notes</link:label>
    <link:label id="lab_goss_LongTermConvertibleSeniorNotes_label_en-US" xlink:label="lab_goss_LongTermConvertibleSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Convertible Senior Notes</link:label>
    <link:label id="lab_goss_LongTermConvertibleSeniorNotes_documentation_en-US" xlink:label="lab_goss_LongTermConvertibleSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term convertible senior notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LongTermConvertibleSeniorNotes" xlink:href="goss-20200930.xsd#goss_LongTermConvertibleSeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_LongTermConvertibleSeniorNotes" xlink:to="lab_goss_LongTermConvertibleSeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_74ca6369-aec3-4f1d-b7c6-7ee7913c466b_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_586f46f8-0a4c-4ba8-9625-3fe313fcf489_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_8f4c4733-c792-4039-bbc7-277ab2b2b4fa_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_31510898-5f75-4796-b347-19b483bb159a_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_b0cdd533-5933-4ad6-a367-4bf3dd1f802f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_InProcessResearchAndDevelopmentOtherProgramsMember_ff662c92-78db-42a7-b130-af0fcd191fac_terseLabel_en-US" xlink:label="lab_goss_InProcessResearchAndDevelopmentOtherProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Programs</link:label>
    <link:label id="lab_goss_InProcessResearchAndDevelopmentOtherProgramsMember_label_en-US" xlink:label="lab_goss_InProcessResearchAndDevelopmentOtherProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research And Development Other Programs [Member]</link:label>
    <link:label id="lab_goss_InProcessResearchAndDevelopmentOtherProgramsMember_documentation_en-US" xlink:label="lab_goss_InProcessResearchAndDevelopmentOtherProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In process research and development other programs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentOtherProgramsMember" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentOtherProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_InProcessResearchAndDevelopmentOtherProgramsMember" xlink:to="lab_goss_InProcessResearchAndDevelopmentOtherProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_64999cf6-1f45-445e-87de-f34f766c6cb3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation costs</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_fa0c3bb9-b841-4b40-83bf-b077a69d4dc2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_c1ba3632-58a4-4185-869e-6cb473fde6f1_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_460aa188-bae2-4cd7-9534-13c93e418b9e_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ab6dd8cd-1cd9-4973-946c-71ce8060e05b_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember_bb9dceeb-07de-4274-9b47-5964a672018c_terseLabel_en-US" xlink:label="lab_goss_SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Anniversary of Closing Date and Prior to Jan 1, 2025</link:label>
    <link:label id="lab_goss_SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember_label_en-US" xlink:label="lab_goss_SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Anniversary Of Closing Date And Prior To Jan First Two Thousand Twenty Five [Member]</link:label>
    <link:label id="lab_goss_SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember_documentation_en-US" xlink:label="lab_goss_SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Anniversary Of Closing Date And Prior To Jan First Two Thousand Twenty Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember" xlink:href="goss-20200930.xsd#goss_SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember" xlink:to="lab_goss_SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_USTreasuryAndAgencySecuritiesMember_e1cf8816-68ca-4084-9810-a81ffd94334a_terseLabel_en-US" xlink:label="lab_goss_USTreasuryAndAgencySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Treasury and agency securities</link:label>
    <link:label id="lab_goss_USTreasuryAndAgencySecuritiesMember_label_en-US" xlink:label="lab_goss_USTreasuryAndAgencySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U S Treasury And Agency Securities [Member]</link:label>
    <link:label id="lab_goss_USTreasuryAndAgencySecuritiesMember_documentation_en-US" xlink:label="lab_goss_USTreasuryAndAgencySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Treasury and agency securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_USTreasuryAndAgencySecuritiesMember" xlink:href="goss-20200930.xsd#goss_USTreasuryAndAgencySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_USTreasuryAndAgencySecuritiesMember" xlink:to="lab_goss_USTreasuryAndAgencySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_a32bf285-756f-45ea-8616-43da0b76b21d_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_b0752d86-e646-4194-ad74-4367de9d38ae_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value, Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c36f2bfc-2517-417a-9f0c-002038aa4268_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_6a9e6263-e550-4eaf-a2b1-6fae55791974_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_6ab7ffd2-3102-4d25-b0cd-c2e41083e29d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_69e328c5-da6c-4689-8ff8-4e64605371b9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Restricted Stock Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_09713f17-c592-480a-a200-6bb3fdc9d313_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_b24512b9-cf36-45de-8d2e-1caa94afd4af_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_TemporaryEquitySharesConvertedIntoCommonSharesValue_56485da2-7d2a-47a3-beb2-4c2ec41d1bd8_negatedTerseLabel_en-US" xlink:label="lab_goss_TemporaryEquitySharesConvertedIntoCommonSharesValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of convertible preferred stock into common stock</link:label>
    <link:label id="lab_goss_TemporaryEquitySharesConvertedIntoCommonSharesValue_label_en-US" xlink:label="lab_goss_TemporaryEquitySharesConvertedIntoCommonSharesValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Converted Into Common Shares, Value</link:label>
    <link:label id="lab_goss_TemporaryEquitySharesConvertedIntoCommonSharesValue_documentation_en-US" xlink:label="lab_goss_TemporaryEquitySharesConvertedIntoCommonSharesValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Converted Into Common Shares, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TemporaryEquitySharesConvertedIntoCommonSharesValue" xlink:href="goss-20200930.xsd#goss_TemporaryEquitySharesConvertedIntoCommonSharesValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_TemporaryEquitySharesConvertedIntoCommonSharesValue" xlink:to="lab_goss_TemporaryEquitySharesConvertedIntoCommonSharesValue" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_InterestAndSecuritiesReceivable_94470585-19b8-454e-a6c8-1f7993611a47_terseLabel_en-US" xlink:label="lab_goss_InterestAndSecuritiesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and securities receivable</link:label>
    <link:label id="lab_goss_InterestAndSecuritiesReceivable_label_en-US" xlink:label="lab_goss_InterestAndSecuritiesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest And Securities Receivable</link:label>
    <link:label id="lab_goss_InterestAndSecuritiesReceivable_documentation_en-US" xlink:label="lab_goss_InterestAndSecuritiesReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and securities receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InterestAndSecuritiesReceivable" xlink:href="goss-20200930.xsd#goss_InterestAndSecuritiesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_InterestAndSecuritiesReceivable" xlink:to="lab_goss_InterestAndSecuritiesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_CommonStockVestingPercentage_87d8b02a-81d8-4392-a5de-35c9c3af3567_terseLabel_en-US" xlink:label="lab_goss_CommonStockVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock vesting percentage</link:label>
    <link:label id="lab_goss_CommonStockVestingPercentage_label_en-US" xlink:label="lab_goss_CommonStockVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Vesting Percentage</link:label>
    <link:label id="lab_goss_CommonStockVestingPercentage_documentation_en-US" xlink:label="lab_goss_CommonStockVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock vesting percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_CommonStockVestingPercentage" xlink:href="goss-20200930.xsd#goss_CommonStockVestingPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_CommonStockVestingPercentage" xlink:to="lab_goss_CommonStockVestingPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_0b63f3af-56dd-4c56-8ef5-63c721e030a4_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption_9938a72b-8bf6-4279-b3a6-a8e4e51c4229_terseLabel_en-US" xlink:label="lab_goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discount related to the value of conversion option</link:label>
    <link:label id="lab_goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption_label_en-US" xlink:label="lab_goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Equity Component Of Debt Discount Related To Value Of Conversion Option</link:label>
    <link:label id="lab_goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption_documentation_en-US" xlink:label="lab_goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to equity component of debt discount related to value of conversion option.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption" xlink:href="goss-20200930.xsd#goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption" xlink:to="lab_goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_e176ec0c-bd3c-4077-a723-73e4582613ad_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, options vested in period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a7c3eaa8-5f83-4854-af58-ad1e72238dde_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price, Outstanding as of December 31, 2019 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4dc7e0a4-5834-4fae-b207-5eb4d8cb6178_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price, Outstanding as of September 30, 2020 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueEquityLevel2ToLevel1TransfersAmount_d0245cf8-7150-44fd-b959-1f00502bffa9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueEquityLevel2ToLevel1TransfersAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value hierarchy level 2 to level 1</link:label>
    <link:label id="lab_us-gaap_FairValueEquityLevel2ToLevel1TransfersAmount_label_en-US" xlink:label="lab_us-gaap_FairValueEquityLevel2ToLevel1TransfersAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Equity, Level 2 to Level 1 Transfers, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueEquityLevel2ToLevel1TransfersAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueEquityLevel2ToLevel1TransfersAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueEquityLevel2ToLevel1TransfersAmount" xlink:to="lab_us-gaap_FairValueEquityLevel2ToLevel1TransfersAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_SubleasePeriodOfBaseRentAbatement_d8e26edc-ec32-4108-b888-03dc403a2c8d_terseLabel_en-US" xlink:label="lab_goss_SubleasePeriodOfBaseRentAbatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease period of base rent abatement</link:label>
    <link:label id="lab_goss_SubleasePeriodOfBaseRentAbatement_label_en-US" xlink:label="lab_goss_SubleasePeriodOfBaseRentAbatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Period Of Base Rent Abatement</link:label>
    <link:label id="lab_goss_SubleasePeriodOfBaseRentAbatement_documentation_en-US" xlink:label="lab_goss_SubleasePeriodOfBaseRentAbatement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease period of base rent abatement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SubleasePeriodOfBaseRentAbatement" xlink:href="goss-20200930.xsd#goss_SubleasePeriodOfBaseRentAbatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_SubleasePeriodOfBaseRentAbatement" xlink:to="lab_goss_SubleasePeriodOfBaseRentAbatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_a5e5a9b5-c9bb-454b-8912-3bd8e6ca7131_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_e696ca59-7cf5-41a3-a3f4-094d152c9f6b_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_a6cc263e-5464-4f6e-b132-ae98a398c9cb_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2d2c21aa-4f97-44c3-b9b7-2c12d42ed338_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_6bbe976f-dd29-4613-9d99-d409c603e7a0_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_SeriesBConvertiblePreferredStockMember_7dbe74a1-61a1-49f8-847f-3ad7218fea76_terseLabel_en-US" xlink:label="lab_goss_SeriesBConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Convertible Preferred Stock</link:label>
    <link:label id="lab_goss_SeriesBConvertiblePreferredStockMember_label_en-US" xlink:label="lab_goss_SeriesBConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_goss_SeriesBConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_goss_SeriesBConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series b convertible preferred stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SeriesBConvertiblePreferredStockMember" xlink:href="goss-20200930.xsd#goss_SeriesBConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_SeriesBConvertiblePreferredStockMember" xlink:to="lab_goss_SeriesBConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_3321f685-557d-4038-b159-544c8b199b4b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_c94a1cd2-40d6-4f2b-8328-206f4e6f6500_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_99e8cfb7-5009-4e87-b97a-a14d1074dcea_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized_33dde10e-d67c-45ab-99f0-b8c2c975af5e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestones accrued</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Assets and Liabilities Arising from Contingencies, Amount Recognized, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized" xlink:to="lab_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_c86943e8-7c5a-47ec-9379-849090033f79_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_9d922a4a-8e68-483d-8854-9d695fd38d28_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Measured at Fair Value on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d16e4779-381a-44ff-aadc-3bd16ac1fe7f_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Investments, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f463a627-ccb7-4cfe-9434-63d4c8a280f1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_b6fb8936-cac0-4435-85b5-fcacc1a9410f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_fd3965fe-aea1-437c-bd8d-aab140f0dc32_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted&#160;Market Prices for Identical&#160;Assets (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_SubleaseAnnualIncreasePercentageForLeaseCharges_967fb2de-b37a-4c29-8a9f-4755c48f6a0e_terseLabel_en-US" xlink:label="lab_goss_SubleaseAnnualIncreasePercentageForLeaseCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease annual increase percentage for lease charges</link:label>
    <link:label id="lab_goss_SubleaseAnnualIncreasePercentageForLeaseCharges_label_en-US" xlink:label="lab_goss_SubleaseAnnualIncreasePercentageForLeaseCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Annual Increase Percentage For Lease Charges</link:label>
    <link:label id="lab_goss_SubleaseAnnualIncreasePercentageForLeaseCharges_documentation_en-US" xlink:label="lab_goss_SubleaseAnnualIncreasePercentageForLeaseCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease annual increase percentage for lease charges.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SubleaseAnnualIncreasePercentageForLeaseCharges" xlink:href="goss-20200930.xsd#goss_SubleaseAnnualIncreasePercentageForLeaseCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_SubleaseAnnualIncreasePercentageForLeaseCharges" xlink:to="lab_goss_SubleaseAnnualIncreasePercentageForLeaseCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_928f157f-f1f1-4357-b32b-7e96c6a8bb19_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense related to the ESPP.</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_4b4c7ffc-b864-463f-a32c-0864279c2f4a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_e0e31564-3895-4a03-b7d4-8d1902735165_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_144f5ff7-8796-45a8-bae1-dce44b8e6aad_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_a3ba72fe-2fff-40c9-90fe-acf7dd7e8424_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_e372485b-2e29-4070-ab4c-a66db186aa2a_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_2a9c9c2f-4e30-4ac5-a55d-31471bf9b12f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_8438bed4-8baa-4201-b451-95bc1b33471f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5664cbf0-40b4-42cf-bd74-efcd0e61e339_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total undiscounted rent payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_ProceedsFromMaturityOfMarketableSecurities_1379ac6b-1c50-432f-991d-826ceeaadffb_terseLabel_en-US" xlink:label="lab_goss_ProceedsFromMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of marketable securities</link:label>
    <link:label id="lab_goss_ProceedsFromMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_goss_ProceedsFromMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Maturity Of Marketable Securities</link:label>
    <link:label id="lab_goss_ProceedsFromMaturityOfMarketableSecurities_documentation_en-US" xlink:label="lab_goss_ProceedsFromMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturity of marketable securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ProceedsFromMaturityOfMarketableSecurities" xlink:href="goss-20200930.xsd#goss_ProceedsFromMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_ProceedsFromMaturityOfMarketableSecurities" xlink:to="lab_goss_ProceedsFromMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_ScheduleOfLiabilityComponentsOfNotesTableTextBlock_d5e8c024-6f77-4db2-82cf-e9c64b60bf66_terseLabel_en-US" xlink:label="lab_goss_ScheduleOfLiabilityComponentsOfNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Carrying Amount of Liability Component</link:label>
    <link:label id="lab_goss_ScheduleOfLiabilityComponentsOfNotesTableTextBlock_label_en-US" xlink:label="lab_goss_ScheduleOfLiabilityComponentsOfNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Liability Components Of Notes Table [Text Block]</link:label>
    <link:label id="lab_goss_ScheduleOfLiabilityComponentsOfNotesTableTextBlock_documentation_en-US" xlink:label="lab_goss_ScheduleOfLiabilityComponentsOfNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of liability components of notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ScheduleOfLiabilityComponentsOfNotesTableTextBlock" xlink:href="goss-20200930.xsd#goss_ScheduleOfLiabilityComponentsOfNotesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_ScheduleOfLiabilityComponentsOfNotesTableTextBlock" xlink:to="lab_goss_ScheduleOfLiabilityComponentsOfNotesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_87cfe957-e8b7-452e-b924-5aab5c353294_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_4d988144-fe58-4e1b-9ba0-3d45ee81c099_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_a7b8c8cd-a8a9-4c10-ab01-d30f48d83017_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_6655eecc-1b02-4c66-9010-4b5ba046a849_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_b471858e-5586-401e-8b27-d509eaab7413_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Options vested and exercisable as of September 30, 2020</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_8bf77563-78ea-48e0-b61a-0c1543eae524_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term lease cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4e02c0b7-d168-4948-8034-52c4ea6e4b55_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2f30fadb-b497-4e1c-90b4-ca16dad511d5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Subject to Options Outstanding, Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7df359d7-61fc-49f5-b581-2607e21b5eb4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock option (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_04ce2e07-5125-43c0-bbb4-374cb10dddf6_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Subject to Options Outstanding, Option exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_604f206c-2a3c-4648-9c4b-7a26d8aad6df_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_147e2103-e91d-4017-b50a-f173fe655ca3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_f8f92f98-7563-48a6-975f-70210bb53224_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_add3b4e9-090e-4103-bd14-dda7805ac604_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_SeriesSeedConvertiblePreferredStockMember_8a7c925b-8cd9-4095-95fe-da5294b3c157_terseLabel_en-US" xlink:label="lab_goss_SeriesSeedConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series Seed Convertible Preferred Stock</link:label>
    <link:label id="lab_goss_SeriesSeedConvertiblePreferredStockMember_label_en-US" xlink:label="lab_goss_SeriesSeedConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series Seed Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_goss_SeriesSeedConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_goss_SeriesSeedConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series seed convertible preferred stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SeriesSeedConvertiblePreferredStockMember" xlink:href="goss-20200930.xsd#goss_SeriesSeedConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_SeriesSeedConvertiblePreferredStockMember" xlink:to="lab_goss_SeriesSeedConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_06923d09-baf4-4e44-9e05-36d552ff36e2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of the equity component</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_bdda18d5-0cb1-40db-a1ea-6a2ad2253ee4_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net carrying amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Carrying Amount of Equity Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:to="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock_def30f2b-0300-4018-ac39-f910dfafa3bc_terseLabel_en-US" xlink:label="lab_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements and Available for Sale Investments</link:label>
    <link:label id="lab_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock_label_en-US" xlink:label="lab_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements And Available For Sale Investments [Text Block]</link:label>
    <link:label id="lab_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock_documentation_en-US" xlink:label="lab_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value measurements and available for sale investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock" xlink:href="goss-20200930.xsd#goss_FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock" xlink:to="lab_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_7ac58906-c969-476a-8af5-cfcf3b094082_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_fba3f132-42bf-43fc-8e71-afa9af45155a_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_56e9c561-c21c-49e1-8a76-7a76a88e075e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_SubleaseAgreementEnteredInJune2020Member_f53e745b-e677-44c7-8b26-5445cf5c162c_terseLabel_en-US" xlink:label="lab_goss_SubleaseAgreementEnteredInJune2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Agreement Entered in June 2020</link:label>
    <link:label id="lab_goss_SubleaseAgreementEnteredInJune2020Member_label_en-US" xlink:label="lab_goss_SubleaseAgreementEnteredInJune2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Agreement Entered in June 2020 [Member]</link:label>
    <link:label id="lab_goss_SubleaseAgreementEnteredInJune2020Member_documentation_en-US" xlink:label="lab_goss_SubleaseAgreementEnteredInJune2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Agreement Entered in June 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SubleaseAgreementEnteredInJune2020Member" xlink:href="goss-20200930.xsd#goss_SubleaseAgreementEnteredInJune2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_SubleaseAgreementEnteredInJune2020Member" xlink:to="lab_goss_SubleaseAgreementEnteredInJune2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_c62a9a1f-3955-474d-be91-6b2997808f05_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_975e49c4-2ddd-4a2a-bf5f-aa1b2532c28d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_f6379f02-3893-475f-b6f4-d9f9a37328ae_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_5dcc65f6-baa2-45e2-9ee6-2a65b6589911_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c8e76652-39b0-4ad8-b3c0-5a4f4281a095_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_9325472c-183e-4f1b-9e8e-6200fffd0a78_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount and issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_fb9f10d8-af09-42e6-a163-125eed22fa02_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_41289906-fa91-4719-a114-e1e0275ed076_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_aec1b3e0-8d63-4b03-8e61-af2599c72cab_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_aa2c88dd-79c4-44b3-930b-69852bba512e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_SubleaseTemporaryMonthlyBaseRent_f088768c-a9ad-4db8-aa64-e7332d2815d6_terseLabel_en-US" xlink:label="lab_goss_SubleaseTemporaryMonthlyBaseRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease monthly base rent</link:label>
    <link:label id="lab_goss_SubleaseTemporaryMonthlyBaseRent_label_en-US" xlink:label="lab_goss_SubleaseTemporaryMonthlyBaseRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Temporary Monthly Base Rent</link:label>
    <link:label id="lab_goss_SubleaseTemporaryMonthlyBaseRent_documentation_en-US" xlink:label="lab_goss_SubleaseTemporaryMonthlyBaseRent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease temporary monthly base rent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SubleaseTemporaryMonthlyBaseRent" xlink:href="goss-20200930.xsd#goss_SubleaseTemporaryMonthlyBaseRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_SubleaseTemporaryMonthlyBaseRent" xlink:to="lab_goss_SubleaseTemporaryMonthlyBaseRent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_8bb1cb23-7716-4eb2-9746-85dabca59f7f_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_cb4aa268-0bf7-46b8-a36c-1ba8b2c89079_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_30448d62-7acc-4395-884f-15ae1e0dc9e5_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_1c8cbdc5-7230-42bc-96d7-52880005f267_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_7b99754c-401b-4e28-865c-9b784f0336a0_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of convertible preferred stock into common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_dbd1af6e-fff1-4ace-99f1-21ca3fc19583_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_dbba2505-bc8e-426b-bc11-5ce94aebd988_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Accounts and Supplemental Disclosures</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_f44e8257-0075-440c-ba19-c986e2baa60e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities - long-term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_08edc425-9c56-4954-8e5f-e781c45e8d40_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_8a72e81a-9a1b-45e1-90b1-81df1355dc6f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares_bd66f369-cc67-4e02-b50d-abd4f9dc6382_verboseLabel_en-US" xlink:label="lab_goss_StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrestricted shares of common stock were subject to service vesting conditions (in shares)</link:label>
    <link:label id="lab_goss_StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares_label_en-US" xlink:label="lab_goss_StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incremental Vesting Conditions Place On Previously Issued Common Shares</link:label>
    <link:label id="lab_goss_StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares_documentation_en-US" xlink:label="lab_goss_StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock incremental vesting conditions place on previously issued common shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares" xlink:href="goss-20200930.xsd#goss_StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares" xlink:to="lab_goss_StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_9ffcacc0-c38f-440c-8e42-537779a6f0e0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock_ecc3735c-ef76-49b6-8e3f-141c3c90d972_terseLabel_en-US" xlink:label="lab_goss_NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of convertible preferred stock to common stock</link:label>
    <link:label id="lab_goss_NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock_label_en-US" xlink:label="lab_goss_NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Financing And Investing Conversions Of Convertible Preferred Stock To Common Stock</link:label>
    <link:label id="lab_goss_NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock_documentation_en-US" xlink:label="lab_goss_NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non cash financing and investing conversion of convertible preferred stock to common stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock" xlink:href="goss-20200930.xsd#goss_NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock" xlink:to="lab_goss_NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_6d441165-a629-4bf6-ae91-2f204605e45a_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_094ddae2-5000-4755-a0a8-596cdd3a3cb1_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_41b67649-4d6d-46b5-96c4-b2428f994880_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds, after deducting underwriting discounts, commissions, and offering expenses</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_8fc5a7fd-aabe-4658-ad9c-29aa7dcaf9de_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan_881ad169-568d-4e7e-b1e0-124d69db247a_terseLabel_en-US" xlink:label="lab_goss_DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt covenant minimum unrestricted cash percentage</link:label>
    <link:label id="lab_goss_DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan_label_en-US" xlink:label="lab_goss_DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Required Minimum Unrestricted Cash Percentage Of Term Loan</link:label>
    <link:label id="lab_goss_DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan_documentation_en-US" xlink:label="lab_goss_DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt covenant required minimum unrestricted cash percentage of term loan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan" xlink:href="goss-20200930.xsd#goss_DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan" xlink:to="lab_goss_DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_657b9365-5660-4903-befb-8ba7fa3deaab_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses_7d4b1634-f411-43d5-a605-33dc04c2b5db_terseLabel_en-US" xlink:label="lab_goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued research and development expenses</link:label>
    <link:label id="lab_goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses_label_en-US" xlink:label="lab_goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Accrued Research And Development Expenses</link:label>
    <link:label id="lab_goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses_documentation_en-US" xlink:label="lab_goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of increase (decrease) in accrued research and development expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses" xlink:href="goss-20200930.xsd#goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses" xlink:to="lab_goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_36cae5f0-1151-455f-99ac-287bd1bcf846_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_270a2cfd-bcf2-4a8e-8b61-1f67185ce8c4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_85920b85-daed-43fc-82c4-4ad31281e7e3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Potentially Dilutive Securities not Included in Calculation of Diluted Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_c0f0bd10-e0c4-4d57-8b89-b8f2daf514ce_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember_66551c5b-b27d-430a-b460-c1c9803470a0_terseLabel_en-US" xlink:label="lab_goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GB001</link:label>
    <link:label id="lab_goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember_label_en-US" xlink:label="lab_goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research And Development G B Zero Zero One [Member]</link:label>
    <link:label id="lab_goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember_documentation_en-US" xlink:label="lab_goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development, GB zero zero one.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember" xlink:to="lab_goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_84de3100-b1fd-4912-b642-0a9f75365710_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the issuance of long-term debt, net of issuance costs of $1,778</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_f71007e8-8bec-4004-ad56-607bd403b3b3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount funded</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_StockRestrictionAgreementsMember_228e5bbc-f94d-4741-bd52-f9b61b4c73e0_terseLabel_en-US" xlink:label="lab_goss_StockRestrictionAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Restriction Agreements</link:label>
    <link:label id="lab_goss_StockRestrictionAgreementsMember_label_en-US" xlink:label="lab_goss_StockRestrictionAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Restriction Agreements [Member]</link:label>
    <link:label id="lab_goss_StockRestrictionAgreementsMember_documentation_en-US" xlink:label="lab_goss_StockRestrictionAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock restriction agreements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_StockRestrictionAgreementsMember" xlink:href="goss-20200930.xsd#goss_StockRestrictionAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_StockRestrictionAgreementsMember" xlink:to="lab_goss_StockRestrictionAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_ContractualInterestExpense_d58bcd0f-d133-47ff-9815-07e254650df6_terseLabel_en-US" xlink:label="lab_goss_ContractualInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual interest expense</link:label>
    <link:label id="lab_goss_ContractualInterestExpense_label_en-US" xlink:label="lab_goss_ContractualInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Interest Expense</link:label>
    <link:label id="lab_goss_ContractualInterestExpense_documentation_en-US" xlink:label="lab_goss_ContractualInterestExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual interest expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ContractualInterestExpense" xlink:href="goss-20200930.xsd#goss_ContractualInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_ContractualInterestExpense" xlink:to="lab_goss_ContractualInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_bf812169-2433-4812-81b6-2e25821d124a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_d034efbf-c961-4025-ab75-a2a07987efb7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f29aea93-6fac-4a6a-bfee-1e573b13b0ae_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_827aa6c0-8195-4803-bb15-50fcde731b5c_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_6096520d-685c-4a40-83cb-a5aa831494d6_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Name</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockNameDomain" xlink:to="lab_us-gaap_ConversionOfStockNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_101198e8-59c0-4963-9f1e-3030741a6de9_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance cost</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_a361280a-1427-4d27-90ee-d9a404207c88_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid property and equipment</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_921da65f-3064-49c8-8b1f-e45a26003382_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_892337d6-ffd8-4698-8a97-011fe8c36194_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_7615f0d7-fc81-4155-b84e-78cd5362e0a2_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting_04de23c5-51b7-4b53-a18c-579161cf6330_terseLabel_en-US" xlink:label="lab_goss_IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional shares of restricted stock subject to vesting restrictions (in shares)</link:label>
    <link:label id="lab_goss_IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting_label_en-US" xlink:label="lab_goss_IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable To Restricted Stock Subject To Vesting</link:label>
    <link:label id="lab_goss_IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting_documentation_en-US" xlink:label="lab_goss_IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental common shares attributable to restricted stock subject to vesting.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting" xlink:href="goss-20200930.xsd#goss_IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting" xlink:to="lab_goss_IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_8ee55e59-3c30-4628-8590-e91093ee9119_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, estimated useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_PulmokineIncMember_254d30fd-465b-43a9-a55e-162b403a1363_terseLabel_en-US" xlink:label="lab_goss_PulmokineIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pulmokine, Inc.</link:label>
    <link:label id="lab_goss_PulmokineIncMember_label_en-US" xlink:label="lab_goss_PulmokineIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pulmokine Inc [Member]</link:label>
    <link:label id="lab_goss_PulmokineIncMember_documentation_en-US" xlink:label="lab_goss_PulmokineIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pulmokine, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PulmokineIncMember" xlink:href="goss-20200930.xsd#goss_PulmokineIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_PulmokineIncMember" xlink:to="lab_goss_PulmokineIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ba56e218-171b-41d7-852b-a87ef3a884a2_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_8a84e5a9-ae9d-4db5-a156-34dd45947eec_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt conversion, converted Instrument</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_55b97458-9a7a-41a6-a968-b41b2af87f79_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of share reserved for future issuance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_d3894e78-ee55-49b3-82b9-d9e149152615_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_07fef4ce-2b31-495b-a746-e7b94f03e15e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_edba11c4-c770-4f81-8214-c18f650aa844_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_b6effc46-ab01-43b5-9489-be21dc8d8321_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember_5d6205c4-c0fd-4318-9940-876d149389fb_terseLabel_en-US" xlink:label="lab_goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GB004</link:label>
    <link:label id="lab_goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember_label_en-US" xlink:label="lab_goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research And Development G B Zero Zero Four [Member]</link:label>
    <link:label id="lab_goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember_documentation_en-US" xlink:label="lab_goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development, GB zero zero four.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember" xlink:to="lab_goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_c752088c-3163-4cd4-bb30-0eb5d54d9b4f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_b68341eb-7392-47ef-8fbc-371cd066caf8_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Remaining Contractual Life (Years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4dfe93d3-817f-4296-8ec5-3a4d7c938989_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Investments, Total Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6a35e98e-efff-412f-bdb6-3b5612f0609f_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_97128898-092d-4f0d-bc62-11d33fdf2112_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued price per share</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_DebtInstrumentConvertibleConversionLastReportedSalePricePercentage_b9358383-7233-44d8-93cb-879dd8063b9e_terseLabel_en-US" xlink:label="lab_goss_DebtInstrumentConvertibleConversionLastReportedSalePricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, percentage of last reported sale price of common stock</link:label>
    <link:label id="lab_goss_DebtInstrumentConvertibleConversionLastReportedSalePricePercentage_label_en-US" xlink:label="lab_goss_DebtInstrumentConvertibleConversionLastReportedSalePricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Convertible Conversion Last Reported Sale Price Percentage</link:label>
    <link:label id="lab_goss_DebtInstrumentConvertibleConversionLastReportedSalePricePercentage_documentation_en-US" xlink:label="lab_goss_DebtInstrumentConvertibleConversionLastReportedSalePricePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument convertible conversion last reported sale price percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_DebtInstrumentConvertibleConversionLastReportedSalePricePercentage" xlink:href="goss-20200930.xsd#goss_DebtInstrumentConvertibleConversionLastReportedSalePricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_DebtInstrumentConvertibleConversionLastReportedSalePricePercentage" xlink:to="lab_goss_DebtInstrumentConvertibleConversionLastReportedSalePricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3e824ec8-39de-4b3a-afdd-76706bfaf4fd_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, beginning balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_a7e30e07-49d5-4046-aa66-cd7bf9d16fc2_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_e0acc02f-7415-4025-bac4-7dc354db196e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_b440b425-d807-4594-acd7-218014bfc7da_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_72329bd5-8280-4c7e-a047-5711565fdd9e_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_969d1f61-eb08-407d-8b74-63b7ba9f4a40_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on marketable securities, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_51f62071-1bf7-4615-970e-952111b3bfd0_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock awards granted (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable_6dd896a1-c4bd-42ce-a64a-b3e7856168de_terseLabel_en-US" xlink:label="lab_goss_BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial milestone payments, payable</link:label>
    <link:label id="lab_goss_BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable_label_en-US" xlink:label="lab_goss_BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Commercial Milestone Payments Payable</link:label>
    <link:label id="lab_goss_BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable_documentation_en-US" xlink:label="lab_goss_BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, contingent consideration, commercial milestone payments, payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable" xlink:href="goss-20200930.xsd#goss_BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable" xlink:to="lab_goss_BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_PercentageOfPrepaymentFee_a483ce66-daab-4194-99cd-e822fed361cd_terseLabel_en-US" xlink:label="lab_goss_PercentageOfPrepaymentFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of prepayment fee</link:label>
    <link:label id="lab_goss_PercentageOfPrepaymentFee_label_en-US" xlink:label="lab_goss_PercentageOfPrepaymentFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Prepayment Fee</link:label>
    <link:label id="lab_goss_PercentageOfPrepaymentFee_documentation_en-US" xlink:label="lab_goss_PercentageOfPrepaymentFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of prepayment fee.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PercentageOfPrepaymentFee" xlink:href="goss-20200930.xsd#goss_PercentageOfPrepaymentFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_PercentageOfPrepaymentFee" xlink:to="lab_goss_PercentageOfPrepaymentFee" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_fcb7263f-4b85-41b1-a292-db88e9e75575_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_8de626b2-fbde-4101-a33c-940d0cc50764_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_StockholdersEquityLineItems_3f846b50-97fb-4f39-9c7d-916ebeff8618_terseLabel_en-US" xlink:label="lab_goss_StockholdersEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders Equity [Line Items]</link:label>
    <link:label id="lab_goss_StockholdersEquityLineItems_label_en-US" xlink:label="lab_goss_StockholdersEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders Equity [Line Items]</link:label>
    <link:label id="lab_goss_StockholdersEquityLineItems_documentation_en-US" xlink:label="lab_goss_StockholdersEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders equity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_StockholdersEquityLineItems" xlink:href="goss-20200930.xsd#goss_StockholdersEquityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_StockholdersEquityLineItems" xlink:to="lab_goss_StockholdersEquityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_70f80e59-f56b-43f4-a537-2325b9819c86_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_c5840fc9-39a0-45e3-a8e2-618bbb1b9c92_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_6fd6b54b-f519-44ad-897e-7dae88e38d6e_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember_468cff58-ac1d-446f-a0f2-38e8c4e48c5e_terseLabel_en-US" xlink:label="lab_goss_FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Anniversary of Closing Date through Second Anniversary of Closing Date</link:label>
    <link:label id="lab_goss_FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember_label_en-US" xlink:label="lab_goss_FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Anniversary Of Closing Date Through Second Anniversary Of Closing Date [Member]</link:label>
    <link:label id="lab_goss_FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember_documentation_en-US" xlink:label="lab_goss_FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First anniversary of closing date through second anniversary of closing date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember" xlink:href="goss-20200930.xsd#goss_FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember" xlink:to="lab_goss_FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a8a68cbe-d891-4f71-b9c3-798547e0cb2e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax_033c70b7-3a0a-472d-a5b8-5d09f06eacaa_terseLabel_en-US" xlink:label="lab_goss_NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrealized gain on marketable securities, net of tax</link:label>
    <link:label id="lab_goss_NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax_label_en-US" xlink:label="lab_goss_NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing And Financing Activities Change In Unrealized Gain On Marketable Securities Net Of Tax</link:label>
    <link:label id="lab_goss_NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax_documentation_en-US" xlink:label="lab_goss_NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash investing and financing activities change in unrealized gain on marketable securities net of tax.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax" xlink:href="goss-20200930.xsd#goss_NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax" xlink:to="lab_goss_NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_77247dc6-6c80-4e15-8196-cdf231701074_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e6a1f042-2771-4321-82c1-8fff661dd806_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_a42db40d-b670-4d10-9a1d-c7c4f27e61fe_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plans</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_ScheduleOfInterestExpenseRecognizedTableTextBlock_521e5463-f562-499a-ac92-12917520fe64_terseLabel_en-US" xlink:label="lab_goss_ScheduleOfInterestExpenseRecognizedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Interest Expense Recognized</link:label>
    <link:label id="lab_goss_ScheduleOfInterestExpenseRecognizedTableTextBlock_label_en-US" xlink:label="lab_goss_ScheduleOfInterestExpenseRecognizedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Interest Expense Recognized Table [Text Block]</link:label>
    <link:label id="lab_goss_ScheduleOfInterestExpenseRecognizedTableTextBlock_documentation_en-US" xlink:label="lab_goss_ScheduleOfInterestExpenseRecognizedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of interest expense recognized.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ScheduleOfInterestExpenseRecognizedTableTextBlock" xlink:href="goss-20200930.xsd#goss_ScheduleOfInterestExpenseRecognizedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_ScheduleOfInterestExpenseRecognizedTableTextBlock" xlink:to="lab_goss_ScheduleOfInterestExpenseRecognizedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_f5bd64b1-ef40-4131-ab5d-0470e2f8e39b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_817e3b60-fcb5-42ec-8e5f-ad4a3dd2c676_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_1b4e118a-2aba-4b4c-a6a6-c991dffd0500_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional service fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_OperatingLeasesMonthlyBaseRentExpense_8d9ce7ec-6786-48ee-9bd5-1d452b458a0b_terseLabel_en-US" xlink:label="lab_goss_OperatingLeasesMonthlyBaseRentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease assignment agreement, monthly base rent expense</link:label>
    <link:label id="lab_goss_OperatingLeasesMonthlyBaseRentExpense_label_en-US" xlink:label="lab_goss_OperatingLeasesMonthlyBaseRentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Monthly Base Rent Expense</link:label>
    <link:label id="lab_goss_OperatingLeasesMonthlyBaseRentExpense_documentation_en-US" xlink:label="lab_goss_OperatingLeasesMonthlyBaseRentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Monthly Base Rent Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_OperatingLeasesMonthlyBaseRentExpense" xlink:href="goss-20200930.xsd#goss_OperatingLeasesMonthlyBaseRentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_OperatingLeasesMonthlyBaseRentExpense" xlink:to="lab_goss_OperatingLeasesMonthlyBaseRentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_3bea5583-8298-497a-9883-961f2690f6fc_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract_cfe07d6e-6c56-4925-842a-aacf1b738f51_terseLabel_en-US" xlink:label="lab_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements And Available For Sale Investments [Abstract]</link:label>
    <link:label id="lab_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract_label_en-US" xlink:label="lab_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements And Available For Sale Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract" xlink:href="goss-20200930.xsd#goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract" xlink:to="lab_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_FounderMember_b06b6a73-b674-4aaa-919d-c495867c14cc_terseLabel_en-US" xlink:label="lab_goss_FounderMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Founder</link:label>
    <link:label id="lab_goss_FounderMember_label_en-US" xlink:label="lab_goss_FounderMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Founder [Member]</link:label>
    <link:label id="lab_goss_FounderMember_documentation_en-US" xlink:label="lab_goss_FounderMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Founder.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_FounderMember" xlink:href="goss-20200930.xsd#goss_FounderMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_FounderMember" xlink:to="lab_goss_FounderMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_9946df29-31d5-404b-96da-ebfbbbc8535c_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_8228b91e-a206-4d8f-b565-cedbe27f174b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_d874fda5-5363-45c6-86db-0cb4d19a39fe_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_bf512b31-e3aa-4abf-acbb-e2aba8897ad0_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_5f1e4079-c6b8-4010-8d24-31cb7f180ad3_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock pursuant to Employee Stock Purchase Plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_2de334ba-6c36-4548-81f6-ac4ef2193015_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets measured at fair value on recurring basis</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_ad127ff0-2500-430e-99cc-1f5d1ab1fde8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock available for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_78662bdf-e405-472e-ac55-8069bda7e686_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_NumberOfAdditionalTranches_ddbb88b9-5d4f-4652-9333-4b37228264ac_terseLabel_en-US" xlink:label="lab_goss_NumberOfAdditionalTranches" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional tranches</link:label>
    <link:label id="lab_goss_NumberOfAdditionalTranches_label_en-US" xlink:label="lab_goss_NumberOfAdditionalTranches" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Additional Tranches</link:label>
    <link:label id="lab_goss_NumberOfAdditionalTranches_documentation_en-US" xlink:label="lab_goss_NumberOfAdditionalTranches" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional tranches.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_NumberOfAdditionalTranches" xlink:href="goss-20200930.xsd#goss_NumberOfAdditionalTranches"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_NumberOfAdditionalTranches" xlink:to="lab_goss_NumberOfAdditionalTranches" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_687e2692-ca48-40d0-94cf-23e2e4f3dcf3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_1f3ba528-94f4-47c1-9cea-95dd5380b8d0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gross Future Minimum Annual Rental Commitments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dce32bb9-6a0b-4f10-bd5d-216649904850_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value, Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_f8481fbb-89c7-4907-a47e-be07fe89897b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_DebtInstrumentAggregatePrincipalAmount_894e4eab-3698-4f12-9ba4-b066980c923d_terseLabel_en-US" xlink:label="lab_goss_DebtInstrumentAggregatePrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument aggregate principal amount</link:label>
    <link:label id="lab_goss_DebtInstrumentAggregatePrincipalAmount_label_en-US" xlink:label="lab_goss_DebtInstrumentAggregatePrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Aggregate Principal Amount</link:label>
    <link:label id="lab_goss_DebtInstrumentAggregatePrincipalAmount_documentation_en-US" xlink:label="lab_goss_DebtInstrumentAggregatePrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument aggregate principal amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_DebtInstrumentAggregatePrincipalAmount" xlink:href="goss-20200930.xsd#goss_DebtInstrumentAggregatePrincipalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_DebtInstrumentAggregatePrincipalAmount" xlink:to="lab_goss_DebtInstrumentAggregatePrincipalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_ee62ba66-5460-4b18-ac34-9fba74a6980a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_e957893e-11f5-4365-9daa-cb13221b3f99_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_7e5e1919-43f4-411b-8746-c739f42e6761_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_fd984669-22cb-42b9-86f8-f4ad3ec8c066_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7750f2f4-d7d2-4dba-95d9-dc0460e43f89_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Investments, Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_LeaseAssignmentAgreementEnteredInJuly2020Member_77e9f596-269d-40ef-b685-5db092bfe388_terseLabel_en-US" xlink:label="lab_goss_LeaseAssignmentAgreementEnteredInJuly2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Assignment Agreement Entered in July 2020</link:label>
    <link:label id="lab_goss_LeaseAssignmentAgreementEnteredInJuly2020Member_label_en-US" xlink:label="lab_goss_LeaseAssignmentAgreementEnteredInJuly2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Assignment Agreement Entered in July 2020 [Member]</link:label>
    <link:label id="lab_goss_LeaseAssignmentAgreementEnteredInJuly2020Member_documentation_en-US" xlink:label="lab_goss_LeaseAssignmentAgreementEnteredInJuly2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Assignment Agreement Entered in July 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LeaseAssignmentAgreementEnteredInJuly2020Member" xlink:href="goss-20200930.xsd#goss_LeaseAssignmentAgreementEnteredInJuly2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_LeaseAssignmentAgreementEnteredInJuly2020Member" xlink:to="lab_goss_LeaseAssignmentAgreementEnteredInJuly2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_e0758901-668c-4bee-90a7-237b6788cf39_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_03be4a77-bea6-4147-88b7-a78a4d02e8b0_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_01ae8593-4792-43bc-a754-485c19d8f874_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_ec8565cd-419d-4743-9f6d-0c4e35d1714e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_5cfe9c9d-2590-49fc-b472-8fb26c5b2c58_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_5bab2020-7386-4ee1-8c27-ba3982db6a20_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation Expense Reported in Condensed Consolidated Statements of Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_CommonStockVotingRightsNumberOfVotesPerShare_bb194dcc-0770-48e4-8aa8-2146b448ec67_terseLabel_en-US" xlink:label="lab_goss_CommonStockVotingRightsNumberOfVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock number of votes per share</link:label>
    <link:label id="lab_goss_CommonStockVotingRightsNumberOfVotesPerShare_label_en-US" xlink:label="lab_goss_CommonStockVotingRightsNumberOfVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number Of Votes Per Share</link:label>
    <link:label id="lab_goss_CommonStockVotingRightsNumberOfVotesPerShare_documentation_en-US" xlink:label="lab_goss_CommonStockVotingRightsNumberOfVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number Of Votes Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_CommonStockVotingRightsNumberOfVotesPerShare" xlink:href="goss-20200930.xsd#goss_CommonStockVotingRightsNumberOfVotesPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_CommonStockVotingRightsNumberOfVotesPerShare" xlink:to="lab_goss_CommonStockVotingRightsNumberOfVotesPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_AmortizationOfOperatingLeaseRightOfUseAssets_698469a4-e2b5-4d10-afb8-793a5ae37687_terseLabel_en-US" xlink:label="lab_goss_AmortizationOfOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of operating lease right-of-use assets</link:label>
    <link:label id="lab_goss_AmortizationOfOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_goss_AmortizationOfOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Operating Lease Right Of Use Assets</link:label>
    <link:label id="lab_goss_AmortizationOfOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_goss_AmortizationOfOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of operating lease right-of-use assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AmortizationOfOperatingLeaseRightOfUseAssets" xlink:href="goss-20200930.xsd#goss_AmortizationOfOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_AmortizationOfOperatingLeaseRightOfUseAssets" xlink:to="lab_goss_AmortizationOfOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8c3ae16a-bc85-4c20-acd1-70690399aad4_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_0049b69d-0e9d-4b70-b339-962e13461863_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_AdhaerePharmaceuticalsIncMember_a88e83e2-7fea-42d4-940c-a16b5a7b344e_terseLabel_en-US" xlink:label="lab_goss_AdhaerePharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adhaere Pharmaceuticals, Inc.</link:label>
    <link:label id="lab_goss_AdhaerePharmaceuticalsIncMember_label_en-US" xlink:label="lab_goss_AdhaerePharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adhaere Pharmaceuticals Inc [Member]</link:label>
    <link:label id="lab_goss_AdhaerePharmaceuticalsIncMember_documentation_en-US" xlink:label="lab_goss_AdhaerePharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adhaere Pharmaceuticals, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AdhaerePharmaceuticalsIncMember" xlink:href="goss-20200930.xsd#goss_AdhaerePharmaceuticalsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_AdhaerePharmaceuticalsIncMember" xlink:to="lab_goss_AdhaerePharmaceuticalsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_PercentageOfFullyDilutedShareCapital_d58164d4-4f3c-4fa2-8ab1-a82252a88dd9_terseLabel_en-US" xlink:label="lab_goss_PercentageOfFullyDilutedShareCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of fully diluted share capital</link:label>
    <link:label id="lab_goss_PercentageOfFullyDilutedShareCapital_label_en-US" xlink:label="lab_goss_PercentageOfFullyDilutedShareCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Fully Diluted Share Capital</link:label>
    <link:label id="lab_goss_PercentageOfFullyDilutedShareCapital_documentation_en-US" xlink:label="lab_goss_PercentageOfFullyDilutedShareCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of fully diluted share capital.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PercentageOfFullyDilutedShareCapital" xlink:href="goss-20200930.xsd#goss_PercentageOfFullyDilutedShareCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_PercentageOfFullyDilutedShareCapital" xlink:to="lab_goss_PercentageOfFullyDilutedShareCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_AABiopharmaIncMember_6e82c162-5d62-431e-942b-afb58114021f_terseLabel_en-US" xlink:label="lab_goss_AABiopharmaIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AA Biopharma Inc.</link:label>
    <link:label id="lab_goss_AABiopharmaIncMember_label_en-US" xlink:label="lab_goss_AABiopharmaIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A A Biopharma Inc [Member]</link:label>
    <link:label id="lab_goss_AABiopharmaIncMember_documentation_en-US" xlink:label="lab_goss_AABiopharmaIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AA Biopharma Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AABiopharmaIncMember" xlink:href="goss-20200930.xsd#goss_AABiopharmaIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_AABiopharmaIncMember" xlink:to="lab_goss_AABiopharmaIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_8c79021d-17b2-431c-9174-76f30cf1cdfd_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value discount</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_1254fda6-ed18-4b83-9b93-e58797b7ab08_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument conversion ratio</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_a255c6d9-6fb7-4fc7-a522-55f48a4b8e6b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_342e68a2-0980-4471-ae15-6ec7b751fd3b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share, basic and diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueEquityLevel1ToLevel2TransfersAmount_4f5c041e-0b74-4950-b446-154e57c02a1b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueEquityLevel1ToLevel2TransfersAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value hierarchy level 1 to level 2</link:label>
    <link:label id="lab_us-gaap_FairValueEquityLevel1ToLevel2TransfersAmount_label_en-US" xlink:label="lab_us-gaap_FairValueEquityLevel1ToLevel2TransfersAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Equity, Level 1 to Level 2 Transfers, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueEquityLevel1ToLevel2TransfersAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueEquityLevel1ToLevel2TransfersAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueEquityLevel1ToLevel2TransfersAmount" xlink:to="lab_us-gaap_FairValueEquityLevel1ToLevel2TransfersAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_AnnualIncreasePercentageForLeaseCharges_294e07ef-48bc-4e25-9f2b-aea02500dfe6_terseLabel_en-US" xlink:label="lab_goss_AnnualIncreasePercentageForLeaseCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual increase percentage for lease charges</link:label>
    <link:label id="lab_goss_AnnualIncreasePercentageForLeaseCharges_label_en-US" xlink:label="lab_goss_AnnualIncreasePercentageForLeaseCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Increase Percentage For Lease Charges</link:label>
    <link:label id="lab_goss_AnnualIncreasePercentageForLeaseCharges_documentation_en-US" xlink:label="lab_goss_AnnualIncreasePercentageForLeaseCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual increase percentage for lease charges.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AnnualIncreasePercentageForLeaseCharges" xlink:href="goss-20200930.xsd#goss_AnnualIncreasePercentageForLeaseCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_AnnualIncreasePercentageForLeaseCharges" xlink:to="lab_goss_AnnualIncreasePercentageForLeaseCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract_3b5febb0-d430-4931-be6f-8ac6cfe981e5_terseLabel_en-US" xlink:label="lab_goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheets Accounts And Supplemental Disclosures [Abstract]</link:label>
    <link:label id="lab_goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract_label_en-US" xlink:label="lab_goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheets Accounts And Supplemental Disclosures [Abstract]</link:label>
    <link:label id="lab_goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract_documentation_en-US" xlink:label="lab_goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance sheets accounts and supplemental disclosures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract" xlink:href="goss-20200930.xsd#goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract" xlink:to="lab_goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_7f60a75d-ed27-4329-8573-76d3bf10e625_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_37a056a2-5290-4e04-9b28-629e5aed01b9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Principal Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_TwoThousandNineteenEquityIncentivePlanMember_4a2f640c-c825-47ec-9e6e-e72f6d31792a_terseLabel_en-US" xlink:label="lab_goss_TwoThousandNineteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Equity Incentive Plan</link:label>
    <link:label id="lab_goss_TwoThousandNineteenEquityIncentivePlanMember_label_en-US" xlink:label="lab_goss_TwoThousandNineteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Nineteen Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_goss_TwoThousandNineteenEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_goss_TwoThousandNineteenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand nineteen equity incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandNineteenEquityIncentivePlanMember" xlink:href="goss-20200930.xsd#goss_TwoThousandNineteenEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_TwoThousandNineteenEquityIncentivePlanMember" xlink:to="lab_goss_TwoThousandNineteenEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember_6ca55d56-9405-4a2e-89a8-3e552e4571ea_terseLabel_en-US" xlink:label="lab_goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GB1275</link:label>
    <link:label id="lab_goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember_label_en-US" xlink:label="lab_goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research And Development G B One Two Seven Five [Member]</link:label>
    <link:label id="lab_goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember_documentation_en-US" xlink:label="lab_goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development, GB one two seven five.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember" xlink:to="lab_goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_38532205-3c19-432c-bb32-50f5b7aea5f1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_bfd17f1e-efa0-4085-8821-ede22c260b6a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_CommonStockVestingPeriod_d9c100e9-bc84-4050-8c10-af84bff6e7db_terseLabel_en-US" xlink:label="lab_goss_CommonStockVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock vesting period</link:label>
    <link:label id="lab_goss_CommonStockVestingPeriod_label_en-US" xlink:label="lab_goss_CommonStockVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Vesting Period</link:label>
    <link:label id="lab_goss_CommonStockVestingPeriod_documentation_en-US" xlink:label="lab_goss_CommonStockVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock vesting period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_CommonStockVestingPeriod" xlink:href="goss-20200930.xsd#goss_CommonStockVestingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_CommonStockVestingPeriod" xlink:to="lab_goss_CommonStockVestingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_4ef7f954-fedc-402d-a960-6c72d4e4fc3e_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_4f12b872-3055-4c81-821a-20f97e73b574_negatedLabel_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized gain on investments</link:label>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_label_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Investment Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:to="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_cd10fc9d-3e91-4436-839c-dbdd73333dbc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_34d8e7bd-d070-4a78-bad9-f5ca399afdc7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic&#160;Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7830b990-fc2b-4b35-bb7b-6024fbd8c706_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_LongTermDebtPercentageInAggregatePrincipalAmount_8a9c7dd4-7aab-4663-bcd5-536157a7d219_terseLabel_en-US" xlink:label="lab_goss_LongTermDebtPercentageInAggregatePrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage in aggregate principal amount (not less than)</link:label>
    <link:label id="lab_goss_LongTermDebtPercentageInAggregatePrincipalAmount_label_en-US" xlink:label="lab_goss_LongTermDebtPercentageInAggregatePrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Percentage In Aggregate Principal Amount</link:label>
    <link:label id="lab_goss_LongTermDebtPercentageInAggregatePrincipalAmount_documentation_en-US" xlink:label="lab_goss_LongTermDebtPercentageInAggregatePrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Percentage In Aggregate Principal Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LongTermDebtPercentageInAggregatePrincipalAmount" xlink:href="goss-20200930.xsd#goss_LongTermDebtPercentageInAggregatePrincipalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_LongTermDebtPercentageInAggregatePrincipalAmount" xlink:to="lab_goss_LongTermDebtPercentageInAggregatePrincipalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_727c782d-1c14-4ff9-8d74-e16607b44e5f_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_UpfrontPayment_bb8ef42b-b990-42c6-a1ec-6fa884045af0_terseLabel_en-US" xlink:label="lab_goss_UpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payment</link:label>
    <link:label id="lab_goss_UpfrontPayment_label_en-US" xlink:label="lab_goss_UpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront Payment</link:label>
    <link:label id="lab_goss_UpfrontPayment_documentation_en-US" xlink:label="lab_goss_UpfrontPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_UpfrontPayment" xlink:href="goss-20200930.xsd#goss_UpfrontPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_UpfrontPayment" xlink:to="lab_goss_UpfrontPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_9054d8d3-7b92-4e81-9d7f-562ded5c1189_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_e3ef5de3-43b5-40f3-aa4c-77e415bc580f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_bbf23319-4ea3-412a-8f3f-19de7e66f75c_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock, repurchase (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_2c4c781d-d243-4066-8d6c-676b6ab2af0d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, redemption percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5b52ecfe-8809-4759-a467-255a65cdc328_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_e4b1ffe5-0204-4bee-9fa3-465520ded734_terseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_IncreasedInEquityCapitalAmount_3f1012e9-5fec-4aab-a084-3fccc2ff67e3_terseLabel_en-US" xlink:label="lab_goss_IncreasedInEquityCapitalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increased in equity capital amount</link:label>
    <link:label id="lab_goss_IncreasedInEquityCapitalAmount_label_en-US" xlink:label="lab_goss_IncreasedInEquityCapitalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increased In Equity Capital Amount</link:label>
    <link:label id="lab_goss_IncreasedInEquityCapitalAmount_documentation_en-US" xlink:label="lab_goss_IncreasedInEquityCapitalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increased in equity capital amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_IncreasedInEquityCapitalAmount" xlink:href="goss-20200930.xsd#goss_IncreasedInEquityCapitalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_IncreasedInEquityCapitalAmount" xlink:to="lab_goss_IncreasedInEquityCapitalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_LeaseContractualTermDomain_fe5e5d09-6c43-4543-8b59-c004b5b15e47_terseLabel_en-US" xlink:label="lab_goss_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:label id="lab_goss_LeaseContractualTermDomain_label_en-US" xlink:label="lab_goss_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:label id="lab_goss_LeaseContractualTermDomain_documentation_en-US" xlink:label="lab_goss_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LeaseContractualTermDomain" xlink:href="goss-20200930.xsd#goss_LeaseContractualTermDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_LeaseContractualTermDomain" xlink:to="lab_goss_LeaseContractualTermDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_1566a268-7746-4f03-aed9-fc7fb0d7a83f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Subject to Options Outstanding, Options vested and exercisable as of Sept 30, 2020 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix_5f103d4a-8f57-4e09-98e5-efe94441bd43_terseLabel_en-US" xlink:label="lab_goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix_label_en-US" xlink:label="lab_goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Six</link:label>
    <link:label id="lab_goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix_documentation_en-US" xlink:label="lab_goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Six</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix" xlink:href="goss-20200930.xsd#goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix" xlink:to="lab_goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_c6dfbb27-bcb4-4385-90b4-cba5a765c917_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indebtedness</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_44714729-26fb-4da4-b201-650c82d68d11_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of share reserved for future issuance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_05828561-d000-4c85-aee4-85b158d3e082_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of the Business</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment_4c885a43-53fb-4604-be06-6b36a79b48d2_terseLabel_en-US" xlink:label="lab_goss_PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of exit fee on amount borrowed on final repayment</link:label>
    <link:label id="lab_goss_PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment_label_en-US" xlink:label="lab_goss_PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Exit Fee On Amount Borrowed On Final Repayment</link:label>
    <link:label id="lab_goss_PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment_documentation_en-US" xlink:label="lab_goss_PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of exit fee on amount borrowed on final repayment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment" xlink:href="goss-20200930.xsd#goss_PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment" xlink:to="lab_goss_PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_1f86dda3-e4cc-4b2b-864e-0cb6cfc2870b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_3488cf6a-789e-41f7-a120-cac8e63b2710_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_a2d99924-39a6-4ee9-810a-384a343355ed_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_DescriptionOfBusinessTable_be0bfcf1-0a7f-4bb2-b72f-a1041bf33c71_terseLabel_en-US" xlink:label="lab_goss_DescriptionOfBusinessTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description Of Business [Table]</link:label>
    <link:label id="lab_goss_DescriptionOfBusinessTable_label_en-US" xlink:label="lab_goss_DescriptionOfBusinessTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description Of Business [Table]</link:label>
    <link:label id="lab_goss_DescriptionOfBusinessTable_documentation_en-US" xlink:label="lab_goss_DescriptionOfBusinessTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_DescriptionOfBusinessTable" xlink:href="goss-20200930.xsd#goss_DescriptionOfBusinessTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_DescriptionOfBusinessTable" xlink:to="lab_goss_DescriptionOfBusinessTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_d6a51758-db58-44e5-aae4-1cd6703f6a73_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment_c425ca9b-4de1-4698-9528-e2bbe889f173_terseLabel_en-US" xlink:label="lab_goss_PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of exit fee on amount borrowed on partial prepayment</link:label>
    <link:label id="lab_goss_PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment_label_en-US" xlink:label="lab_goss_PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Exit Fee On Amount Borrowed On Partial Prepayment</link:label>
    <link:label id="lab_goss_PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment_documentation_en-US" xlink:label="lab_goss_PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of exit fee on amount borrowed on partial prepayment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment" xlink:href="goss-20200930.xsd#goss_PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment" xlink:to="lab_goss_PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_11c71327-920c-41c7-a61b-be13465bbe94_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Restricted Stock Units Outstanding, Nonvested at December 31, 2019 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b8a5a470-8e55-4f2a-8e92-e0c989d8a7bc_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Restricted Stock Units Outstanding, Nonvested at September 30, 2020 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_c88f3ee1-044b-40d4-9c21-0ed9ffab398a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of amount increase in outstanding shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_7b2350dc-a9e2-4955-94db-28f76ae9fc00_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_9e36938e-741f-440e-a1a6-1a89b38ebbef_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_da7501da-2e97-46c8-9d74-7adcb155ec46_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_9cf3bc6d-abb4-4489-8fed-d20b2e355b02_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_e7d1a668-e9f9-4c9a-994f-d202273a9f5f_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liability (included as a component of accrued expenses)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_cc75b09d-cd72-4d0f-a78b-3f776b88ec2c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_fac82fb0-beff-4f7c-b993-0cf9d3e2676e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_TrancheOneMember_b2c27449-3604-4318-82d5-f8d5b5b18376_terseLabel_en-US" xlink:label="lab_goss_TrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche One</link:label>
    <link:label id="lab_goss_TrancheOneMember_label_en-US" xlink:label="lab_goss_TrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche One [Member]</link:label>
    <link:label id="lab_goss_TrancheOneMember_documentation_en-US" xlink:label="lab_goss_TrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche one.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TrancheOneMember" xlink:href="goss-20200930.xsd#goss_TrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_TrancheOneMember" xlink:to="lab_goss_TrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_5a34994c-c126-4072-8f68-5377541b9e8d_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software</link:label>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember" xlink:to="lab_us-gaap_SoftwareDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_LesseeOperatingLeaseLiabilityPaymentsDueYearSix_f550b809-2150-4184-9c79-a35c5cfd8ae1_terseLabel_en-US" xlink:label="lab_goss_LesseeOperatingLeaseLiabilityPaymentsDueYearSix" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_goss_LesseeOperatingLeaseLiabilityPaymentsDueYearSix_label_en-US" xlink:label="lab_goss_LesseeOperatingLeaseLiabilityPaymentsDueYearSix" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Six</link:label>
    <link:label id="lab_goss_LesseeOperatingLeaseLiabilityPaymentsDueYearSix_documentation_en-US" xlink:label="lab_goss_LesseeOperatingLeaseLiabilityPaymentsDueYearSix" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Six</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LesseeOperatingLeaseLiabilityPaymentsDueYearSix" xlink:href="goss-20200930.xsd#goss_LesseeOperatingLeaseLiabilityPaymentsDueYearSix"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_LesseeOperatingLeaseLiabilityPaymentsDueYearSix" xlink:to="lab_goss_LesseeOperatingLeaseLiabilityPaymentsDueYearSix" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_b7ddd8f7-e6aa-4659-b331-b28b0bb63e20_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_6340cbea-584a-42c8-a02c-77242bfd7f35_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_08b2fd49-6e99-42be-bc1b-7b1cc624e757_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, aggregate number of shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_133514c0-3b43-460a-84c7-de9695b12358_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 (remaining 3 months)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_288d89b0-18ab-4a88-b081-a3fdb72bbdae_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other&#160;Observable Inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_c543db68-fced-4115-a11c-5a7f808f298c_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_296ef338-3521-4ee5-a720-b0389e4a62ba_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_bf5e6d84-4958-4012-91f0-4167764beb8d_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_DebtInstrumentConvertibleConversionPricePercentage_28ecd9b8-084e-4370-9475-9ca83a3ee63e_terseLabel_en-US" xlink:label="lab_goss_DebtInstrumentConvertibleConversionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, percentage of conversion price</link:label>
    <link:label id="lab_goss_DebtInstrumentConvertibleConversionPricePercentage_label_en-US" xlink:label="lab_goss_DebtInstrumentConvertibleConversionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Convertible Conversion Price Percentage</link:label>
    <link:label id="lab_goss_DebtInstrumentConvertibleConversionPricePercentage_documentation_en-US" xlink:label="lab_goss_DebtInstrumentConvertibleConversionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument convertible conversion price percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_DebtInstrumentConvertibleConversionPricePercentage" xlink:href="goss-20200930.xsd#goss_DebtInstrumentConvertibleConversionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_DebtInstrumentConvertibleConversionPricePercentage" xlink:to="lab_goss_DebtInstrumentConvertibleConversionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable_39ddd8a0-4809-4a30-a47b-6fd4c57b919c_terseLabel_en-US" xlink:label="lab_goss_BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory, development and sales milestone payments payable</link:label>
    <link:label id="lab_goss_BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable_label_en-US" xlink:label="lab_goss_BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Regulatory Development And Sales Milestones Payable</link:label>
    <link:label id="lab_goss_BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable_documentation_en-US" xlink:label="lab_goss_BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, contingent consideration, development and sales milestones, payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable" xlink:href="goss-20200930.xsd#goss_BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable" xlink:to="lab_goss_BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentInProcess_291e2e92-0360-49c5-9928-7ddd9b0036ac_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In process research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentInProcess_33e70f43-c7ba-4b02-84d0-172bddac7fa0_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total in process research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentInProcess_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development in Process</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentInProcess" xlink:to="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_90554f3d-2c60-49fc-b251-32317ef42efb_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES, CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS' EQUITY (DEFICIT)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_TwoThousandNineteenEmployeeStockPurchasePlanMember_83a4a1b9-5c59-42bb-9ef0-d731e387e80d_verboseLabel_en-US" xlink:label="lab_goss_TwoThousandNineteenEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_goss_TwoThousandNineteenEmployeeStockPurchasePlanMember_103c92fe-2251-4c48-a9e6-64563c0a18b3_terseLabel_en-US" xlink:label="lab_goss_TwoThousandNineteenEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Employee Stock Purchase Plan</link:label>
    <link:label id="lab_goss_TwoThousandNineteenEmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_goss_TwoThousandNineteenEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Nineteen Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_goss_TwoThousandNineteenEmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_goss_TwoThousandNineteenEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand nineteen employee stock purchase plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandNineteenEmployeeStockPurchasePlanMember" xlink:href="goss-20200930.xsd#goss_TwoThousandNineteenEmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_TwoThousandNineteenEmployeeStockPurchasePlanMember" xlink:to="lab_goss_TwoThousandNineteenEmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_da8f3506-0cd2-4ffd-b53d-8decc26561fe_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_55730895-5f29-49e7-9139-19cdc8eb2015_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_159b559d-3417-49f6-aa51-5a6022ef37db_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_d739f701-0216-4c5e-b067-00064b4462a2_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_14446bbb-7f25-4e2a-98b9-6293cae16587_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a473e91d-8eaa-4911-b21e-253954b98f2f_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_070dc854-8c9b-4b94-9a58-8dc9c4217630_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest, current</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_OneHundredThirtyPercentApplicableConversionPriceMember_cb0a0927-c520-4e0b-a24a-ee2f185261b8_terseLabel_en-US" xlink:label="lab_goss_OneHundredThirtyPercentApplicableConversionPriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">130% Applicable Conversion Price</link:label>
    <link:label id="lab_goss_OneHundredThirtyPercentApplicableConversionPriceMember_label_en-US" xlink:label="lab_goss_OneHundredThirtyPercentApplicableConversionPriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Hundred Thirty Percent Applicable Conversion Price [Member]</link:label>
    <link:label id="lab_goss_OneHundredThirtyPercentApplicableConversionPriceMember_documentation_en-US" xlink:label="lab_goss_OneHundredThirtyPercentApplicableConversionPriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">130% Applicable Conversion Price [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_OneHundredThirtyPercentApplicableConversionPriceMember" xlink:href="goss-20200930.xsd#goss_OneHundredThirtyPercentApplicableConversionPriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_OneHundredThirtyPercentApplicableConversionPriceMember" xlink:to="lab_goss_OneHundredThirtyPercentApplicableConversionPriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2a6dab81-9316-4cdc-9af9-7895eaee0f71_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockSharesIssued1_f7d68810-a5c2-49dc-bab5-37a7bd07e5d7_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued in conversion of convertible preferred stock (in shares)</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockSharesIssued1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockSharesIssued1" xlink:to="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_SeriesAConvertiblePreferredStockMember_65d7e4ec-7b82-4d82-97c7-3b505e8b6a40_terseLabel_en-US" xlink:label="lab_goss_SeriesAConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Convertible Preferred Stock</link:label>
    <link:label id="lab_goss_SeriesAConvertiblePreferredStockMember_label_en-US" xlink:label="lab_goss_SeriesAConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_goss_SeriesAConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_goss_SeriesAConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series a convertible preferred stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SeriesAConvertiblePreferredStockMember" xlink:href="goss-20200930.xsd#goss_SeriesAConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_SeriesAConvertiblePreferredStockMember" xlink:to="lab_goss_SeriesAConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_AccruedResearchAndDevelopmentExpenses_de1a31e4-8c9c-40eb-a832-1ac5cee800df_terseLabel_en-US" xlink:label="lab_goss_AccruedResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued research and development expenses</link:label>
    <link:label id="lab_goss_AccruedResearchAndDevelopmentExpenses_label_en-US" xlink:label="lab_goss_AccruedResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Research And Development Expenses</link:label>
    <link:label id="lab_goss_AccruedResearchAndDevelopmentExpenses_documentation_en-US" xlink:label="lab_goss_AccruedResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued research and development expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AccruedResearchAndDevelopmentExpenses" xlink:href="goss-20200930.xsd#goss_AccruedResearchAndDevelopmentExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_AccruedResearchAndDevelopmentExpenses" xlink:to="lab_goss_AccruedResearchAndDevelopmentExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_TwoThousandTwentySevenNotesMember_6ecbbbe4-183f-433b-8015-6a94a4b55bd7_terseLabel_en-US" xlink:label="lab_goss_TwoThousandTwentySevenNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Notes</link:label>
    <link:label id="lab_goss_TwoThousandTwentySevenNotesMember_label_en-US" xlink:label="lab_goss_TwoThousandTwentySevenNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty Seven Notes [Member]</link:label>
    <link:label id="lab_goss_TwoThousandTwentySevenNotesMember_documentation_en-US" xlink:label="lab_goss_TwoThousandTwentySevenNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Twenty Seven Notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandTwentySevenNotesMember" xlink:href="goss-20200930.xsd#goss_TwoThousandTwentySevenNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_TwoThousandTwentySevenNotesMember" xlink:to="lab_goss_TwoThousandTwentySevenNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_588038ef-f31e-40db-9e59-79f415172da9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_bac01e6e-1fd2-4c84-9bc3-2b46dbe48416_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7eec0207-6cbe-4cfe-a72b-71de70bf402d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period of cost expects to recognize</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_TemporaryMonthlyBaseRent_15c17cb0-0441-41ad-bd62-68b0df5f03cd_terseLabel_en-US" xlink:label="lab_goss_TemporaryMonthlyBaseRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly base rent for temporary space</link:label>
    <link:label id="lab_goss_TemporaryMonthlyBaseRent_label_en-US" xlink:label="lab_goss_TemporaryMonthlyBaseRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Monthly Base Rent</link:label>
    <link:label id="lab_goss_TemporaryMonthlyBaseRent_documentation_en-US" xlink:label="lab_goss_TemporaryMonthlyBaseRent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary monthly base rent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TemporaryMonthlyBaseRent" xlink:href="goss-20200930.xsd#goss_TemporaryMonthlyBaseRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_TemporaryMonthlyBaseRent" xlink:to="lab_goss_TemporaryMonthlyBaseRent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_456bc934-4b22-4370-83f1-ab2cab586af3_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_6e2b3bf5-0fa1-4873-90af-047c6159e9ce_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_ProductLicenseTerm_c222c1c9-b7d4-42ce-a585-d7f164eae73b_terseLabel_en-US" xlink:label="lab_goss_ProductLicenseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product license term</link:label>
    <link:label id="lab_goss_ProductLicenseTerm_label_en-US" xlink:label="lab_goss_ProductLicenseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product License Term</link:label>
    <link:label id="lab_goss_ProductLicenseTerm_documentation_en-US" xlink:label="lab_goss_ProductLicenseTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product license term.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ProductLicenseTerm" xlink:href="goss-20200930.xsd#goss_ProductLicenseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_ProductLicenseTerm" xlink:to="lab_goss_ProductLicenseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering_748ed786-34cc-4bd3-beee-d938c893f092_terseLabel_en-US" xlink:label="lab_goss_FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funds raised through Series A and Series B Convertible Preferred Stock, convertible note financings and completed IPO</link:label>
    <link:label id="lab_goss_FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering_label_en-US" xlink:label="lab_goss_FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funds Raised Through Preferred Equity Financing Convertible Note Financings And Completed Initial Public Offering</link:label>
    <link:label id="lab_goss_FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering_documentation_en-US" xlink:label="lab_goss_FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funds raised through preferred equity financing, convertible note financings and completed initial public offering.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering" xlink:href="goss-20200930.xsd#goss_FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering" xlink:to="lab_goss_FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_4deadb26-bce8-42e9-b5d0-b943b9e4d984_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument interest rate percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_ff24b8a0-51d7-4bd8-91ef-60b0d21f523e_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_cc18f1f8-f784-4eba-9f45-f35df58603ec_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_3ba9904f-cc9f-4498-9146-1320836aa57c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_3a52e68b-a6e3-4e29-baab-8efb622c4fa2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_1c00e285-9cc3-490d-93e7-3f31527af5d5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_bd190367-816c-4f07-bfac-7b2acf4fa4d5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_09126e29-a683-4461-b9fb-72c1269fabf2_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_a0f7499d-0d29-4536-aa97-bb04a5becf4e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of common stock through payroll deductions, percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_81ee0ccd-16a8-437e-8dfa-5ac756ebc6d9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_9cbb2860-d84e-4701-a58a-29b8c1641801_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payment, purchase consideration paid</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock_bb5bcdb0-dad5-40c4-ba4b-c2b177ab617f_terseLabel_en-US" xlink:label="lab_goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted stock (in shares)</link:label>
    <link:label id="lab_goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock_label_en-US" xlink:label="lab_goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period Shares Vesting Of Restricted Stock</link:label>
    <link:label id="lab_goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock_documentation_en-US" xlink:label="lab_goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued during period shares vesting of restricted stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock" xlink:href="goss-20200930.xsd#goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock" xlink:to="lab_goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_be31ce5b-316b-4905-8495-7432e70d7902_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_1ef9a7c7-b684-4762-8554-6f2ffffae0e4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_b05d988f-c14b-43c0-82a3-9612224e8d83_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_0a5a8e56-927a-45cf-8726-2375ae0a0574_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contractual Maturities of Available-for-sale Debt Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_81e3f303-c50d-44a0-87cc-ffad62d19b47_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of awards</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IPOMember_6195aa25-d1a0-4e9c-ac22-ab778bf539bc_terseLabel_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Public Offering ("IPO")</link:label>
    <link:label id="lab_us-gaap_IPOMember_label_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IPOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember" xlink:to="lab_us-gaap_IPOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_804dc75d-c37c-445a-a195-d3a6038434c5_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7ddc5c77-ee8a-4f98-8b6d-1f1963cb7063_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_OperatingSubleaseAnnualIncreasePercentageForBaseRent_c8885982-c818-4e4a-a761-5257a1ebaa49_terseLabel_en-US" xlink:label="lab_goss_OperatingSubleaseAnnualIncreasePercentageForBaseRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating sublease, annual increase percentage for base rent</link:label>
    <link:label id="lab_goss_OperatingSubleaseAnnualIncreasePercentageForBaseRent_label_en-US" xlink:label="lab_goss_OperatingSubleaseAnnualIncreasePercentageForBaseRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Sublease Annual Increase Percentage For Base Rent</link:label>
    <link:label id="lab_goss_OperatingSubleaseAnnualIncreasePercentageForBaseRent_documentation_en-US" xlink:label="lab_goss_OperatingSubleaseAnnualIncreasePercentageForBaseRent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating sublease, annual increase percentage for base rent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_OperatingSubleaseAnnualIncreasePercentageForBaseRent" xlink:href="goss-20200930.xsd#goss_OperatingSubleaseAnnualIncreasePercentageForBaseRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_OperatingSubleaseAnnualIncreasePercentageForBaseRent" xlink:to="lab_goss_OperatingSubleaseAnnualIncreasePercentageForBaseRent" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities_64496acc-7675-4319-a94c-919e5c423975_terseLabel_en-US" xlink:label="lab_goss_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for lease liabilities</link:label>
    <link:label id="lab_goss_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities_label_en-US" xlink:label="lab_goss_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right Of Use Assets Obtained In Exchange For Lease Liabilities</link:label>
    <link:label id="lab_goss_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities_documentation_en-US" xlink:label="lab_goss_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for lease liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" xlink:href="goss-20200930.xsd#goss_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" xlink:to="lab_goss_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued_ba614429-9355-407a-b813-dd3367b9bc13_terseLabel_en-US" xlink:label="lab_goss_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of share issued under ESPP</link:label>
    <link:label id="lab_goss_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued_label_en-US" xlink:label="lab_goss_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Issued</link:label>
    <link:label id="lab_goss_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued_documentation_en-US" xlink:label="lab_goss_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional shares issued for issuance under share-based payment arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued" xlink:href="goss-20200930.xsd#goss_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued" xlink:to="lab_goss_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_3041bd40-3c8c-4cb2-8413-d8e1e71123ad_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_TwoThousandSeventeenEquityIncentivePlanMember_0c117833-4d7c-4fc3-8df3-65e5112ff65f_terseLabel_en-US" xlink:label="lab_goss_TwoThousandSeventeenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Equity Incentive Plan</link:label>
    <link:label id="lab_goss_TwoThousandSeventeenEquityIncentivePlanMember_label_en-US" xlink:label="lab_goss_TwoThousandSeventeenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Seventeen Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_goss_TwoThousandSeventeenEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_goss_TwoThousandSeventeenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand seventeen equity incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandSeventeenEquityIncentivePlanMember" xlink:href="goss-20200930.xsd#goss_TwoThousandSeventeenEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_TwoThousandSeventeenEquityIncentivePlanMember" xlink:to="lab_goss_TwoThousandSeventeenEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_05760cf0-0f0e-48ef-a144-0175c3abe6d5_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Remainder of Fiscal Year, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember_a7d944f2-8fe1-4b56-913b-d328b578b63f_terseLabel_en-US" xlink:label="lab_goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GB002</link:label>
    <link:label id="lab_goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember_label_en-US" xlink:label="lab_goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research And Development G B Zero Zero Two [Member]</link:label>
    <link:label id="lab_goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember_documentation_en-US" xlink:label="lab_goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development, GB zero zero two.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember" xlink:to="lab_goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_e2a7c56f-8bd4-4b26-9189-c446faa76c74_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_c769d365-d8c5-46c9-9b4d-21f938f32527_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_8e8113f9-265d-4932-a882-aa3f8d340b06_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_70630a0f-0a01-41e3-893d-42439e2f0e33_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_2b884530-f798-4cf2-a314-6cc4037142d9_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_daa4aaf9-7132-423e-a768-e2d0372cc179_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_44a3fde0-640a-43b1-8b87-8ebffb374a2e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares subject to forfeiture (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_3825f9fd-5970-41a0-9427-be9e4e910efa_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_b93f62c1-0e2d-4031-991f-b490eea36c04_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_00229879-52ab-4f6d-97fe-d6f25f2c9622_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts_0c2a5fcb-dcfb-4ef3-b4f9-a4a115eaa092_negatedLabel_en-US" xlink:label="lab_goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance cost</link:label>
    <link:label id="lab_goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts_label_en-US" xlink:label="lab_goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Equity Component Of Debt Issuance Costs</link:label>
    <link:label id="lab_goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts_documentation_en-US" xlink:label="lab_goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to equity component of debt issuance costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts" xlink:href="goss-20200930.xsd#goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts" xlink:to="lab_goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_6ef2d643-4ee0-4411-9a8c-8c875881a392_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_75f80301-d68a-46e1-80d0-31f12f1102b8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_eec12195-2bc6-451c-9157-b90c69eade7a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value, Nonvested at December 31, 2019 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1a2d28aa-5dbf-4016-ba62-df765fda3e40_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value, Nonvested at September 30, 2020 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_22eb67e6-11f7-497b-9aea-9d9c18f91535_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_210bf9a8-d5c0-49dc-9108-8389ca2fd1bc_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_cdb4e1bf-fefb-437d-b937-7c9a514eb033_totalLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total interest expense related to the 2027 Notes</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_dc8a36b8-3c2a-45e1-a908-98df5271dda1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_AerpioPharmaceuticalsIncMember_021bc70e-4534-493f-8aa6-fa433425476d_terseLabel_en-US" xlink:label="lab_goss_AerpioPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aerpio Pharmaceuticals, Inc.</link:label>
    <link:label id="lab_goss_AerpioPharmaceuticalsIncMember_label_en-US" xlink:label="lab_goss_AerpioPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aerpio Pharmaceuticals Inc [Member]</link:label>
    <link:label id="lab_goss_AerpioPharmaceuticalsIncMember_documentation_en-US" xlink:label="lab_goss_AerpioPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aerpio Pharmaceuticals, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AerpioPharmaceuticalsIncMember" xlink:href="goss-20200930.xsd#goss_AerpioPharmaceuticalsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_AerpioPharmaceuticalsIncMember" xlink:to="lab_goss_AerpioPharmaceuticalsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_abd20309-1235-45b8-9ac6-816406c74330_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes_781647f7-d6d8-4e33-a053-e5c47fb3fd4e_terseLabel_en-US" xlink:label="lab_goss_PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of repurchase price is equal to principal amount of convertible notes</link:label>
    <link:label id="lab_goss_PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes_label_en-US" xlink:label="lab_goss_PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Repurchase Price Is Equal To Principal Amount Of Convertible Notes</link:label>
    <link:label id="lab_goss_PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes_documentation_en-US" xlink:label="lab_goss_PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of repurchase price is equal to principal amount of convertible notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes" xlink:href="goss-20200930.xsd#goss_PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes" xlink:to="lab_goss_PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_6758b9c7-364b-4b7f-93ea-83e2b8aa8e35_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, initial conversion price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_87f73e29-6fd7-4a28-8064-6a91ca51e89b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3602f10f-9656-4769-89c6-0386ee03e3d5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_7d69f99c-44fd-4c90-b026-96068f237dfc_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_8c65f06c-07b7-4279-a132-866b476e113a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_be2ec513-0759-428f-949e-43128c135b74_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price, Options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_07f2b03e-693b-4634-a3d3-72e1fe37542f_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_ca6237dc-7bab-4d2d-a7f3-9990c07e503d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock pursuant to Employee Stock Purchase Plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_ProceedsFromSaleOfMarketableSecurities_57ad8f24-31b6-4bd3-b995-67ac25cb5a65_terseLabel_en-US" xlink:label="lab_goss_ProceedsFromSaleOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales of marketable securities</link:label>
    <link:label id="lab_goss_ProceedsFromSaleOfMarketableSecurities_label_en-US" xlink:label="lab_goss_ProceedsFromSaleOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Marketable Securities</link:label>
    <link:label id="lab_goss_ProceedsFromSaleOfMarketableSecurities_documentation_en-US" xlink:label="lab_goss_ProceedsFromSaleOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of marketable securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ProceedsFromSaleOfMarketableSecurities" xlink:href="goss-20200930.xsd#goss_ProceedsFromSaleOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_ProceedsFromSaleOfMarketableSecurities" xlink:to="lab_goss_ProceedsFromSaleOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_9c77fce6-8940-49e1-9bf0-328cc693af19_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with a public offering, net of underwriting discounts, commissions, and offering costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_FounderSharesMember_ea5368ba-5749-468a-9fae-fae3c9e35dae_terseLabel_en-US" xlink:label="lab_goss_FounderSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Founder Shares</link:label>
    <link:label id="lab_goss_FounderSharesMember_label_en-US" xlink:label="lab_goss_FounderSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Founder Shares [Member]</link:label>
    <link:label id="lab_goss_FounderSharesMember_documentation_en-US" xlink:label="lab_goss_FounderSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Founder shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_FounderSharesMember" xlink:href="goss-20200930.xsd#goss_FounderSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_FounderSharesMember" xlink:to="lab_goss_FounderSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_TermLoanMember_f0519edb-b771-4734-a30a-e81f5490d818_terseLabel_en-US" xlink:label="lab_goss_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_goss_TermLoanMember_label_en-US" xlink:label="lab_goss_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_goss_TermLoanMember_documentation_en-US" xlink:label="lab_goss_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TermLoanMember" xlink:href="goss-20200930.xsd#goss_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_TermLoanMember" xlink:to="lab_goss_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_PeriodForWhichLeaseOfPermanentSpaceCanBeExtended_36a0b947-62b3-4974-a33a-14a00f100f65_terseLabel_en-US" xlink:label="lab_goss_PeriodForWhichLeaseOfPermanentSpaceCanBeExtended" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to extend lease term of permanent space</link:label>
    <link:label id="lab_goss_PeriodForWhichLeaseOfPermanentSpaceCanBeExtended_label_en-US" xlink:label="lab_goss_PeriodForWhichLeaseOfPermanentSpaceCanBeExtended" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period For Which Lease Of Permanent Space Can Be Extended</link:label>
    <link:label id="lab_goss_PeriodForWhichLeaseOfPermanentSpaceCanBeExtended_documentation_en-US" xlink:label="lab_goss_PeriodForWhichLeaseOfPermanentSpaceCanBeExtended" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period for which lease of permanent space can be extended.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PeriodForWhichLeaseOfPermanentSpaceCanBeExtended" xlink:href="goss-20200930.xsd#goss_PeriodForWhichLeaseOfPermanentSpaceCanBeExtended"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_PeriodForWhichLeaseOfPermanentSpaceCanBeExtended" xlink:to="lab_goss_PeriodForWhichLeaseOfPermanentSpaceCanBeExtended" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_fea0d153-8cb5-4680-83d6-00d577ff4eb5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price, Options vested and exercisable as of September 30,2020 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_BusinessCombinationContingentConsiderationMilestonesPayment_0f05f29b-f50b-424e-ad0a-ad86b01fc2f2_terseLabel_en-US" xlink:label="lab_goss_BusinessCombinationContingentConsiderationMilestonesPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestones payment</link:label>
    <link:label id="lab_goss_BusinessCombinationContingentConsiderationMilestonesPayment_label_en-US" xlink:label="lab_goss_BusinessCombinationContingentConsiderationMilestonesPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Milestones Payment</link:label>
    <link:label id="lab_goss_BusinessCombinationContingentConsiderationMilestonesPayment_documentation_en-US" xlink:label="lab_goss_BusinessCombinationContingentConsiderationMilestonesPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination contingent consideration milestones payment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_BusinessCombinationContingentConsiderationMilestonesPayment" xlink:href="goss-20200930.xsd#goss_BusinessCombinationContingentConsiderationMilestonesPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_BusinessCombinationContingentConsiderationMilestonesPayment" xlink:to="lab_goss_BusinessCombinationContingentConsiderationMilestonesPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_b57be73b-1a48-4329-bb5f-39b156be9090_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Conversion Description</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Conversion Description [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:to="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_8b89b771-f65a-4fd1-a602-e3c235c8a7d1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Remaining Contractual Life (Years), Options vested and exercisable as of September 30, 2020</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_IncreaseDecreaseInOperatingLeaseLiabilities_c40b015a-6b85-4281-819e-0adb877359f8_negatedLabel_en-US" xlink:label="lab_goss_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_goss_IncreaseDecreaseInOperatingLeaseLiabilities_label_en-US" xlink:label="lab_goss_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Operating Lease Liabilities</link:label>
    <link:label id="lab_goss_IncreaseDecreaseInOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_goss_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase decrease in operating lease liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:href="goss-20200930.xsd#goss_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="lab_goss_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_b745c298-44d7-4b0f-9449-b1c87b40a324_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1a7b6f4a-b2c3-4795-8f89-71dc0887474a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_699ca0cd-4264-45cc-9f64-69f9c679f876_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable_a2e7b3e2-26ed-4061-a475-ba4186a7aaeb_terseLabel_en-US" xlink:label="lab_goss_BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales milestone payments, payable</link:label>
    <link:label id="lab_goss_BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable_label_en-US" xlink:label="lab_goss_BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Sales Milestone Payments Payable</link:label>
    <link:label id="lab_goss_BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable_documentation_en-US" xlink:label="lab_goss_BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, contingent consideration, sales milestone payments, payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable" xlink:href="goss-20200930.xsd#goss_BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable" xlink:to="lab_goss_BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_a0961692-e76d-4a61-b263-84093aded1f2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licenses, Asset Acquisitions and Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_3602dacb-2e4f-4ffa-acc4-160aaf760bd4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.0001 par value; 700,000,000 shares authorized as of September&#160;30, 2020 and December&#160;31, 2019; 75,907,527 shares issued and 72,475,912 shares outstanding as of September&#160;30, 2020, and 66,284,003 shares issued and 61,635,477 shares outstanding as of December&#160;31, 2019</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_8ab02b4d-2129-41b7-87ff-03197cb70ff7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 (remaining 3 months)</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_f24dee4e-42ae-4109-ba45-0b24f40ab437_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_95c9ca68-a9df-4499-a67b-4080b5194254_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price, Options forfeited/cancelled (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_ScheduleOfEquityComponentsOfNotesTableTextBlock_09be48fb-dd37-4c4d-ae21-d8985e5bae32_terseLabel_en-US" xlink:label="lab_goss_ScheduleOfEquityComponentsOfNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Components</link:label>
    <link:label id="lab_goss_ScheduleOfEquityComponentsOfNotesTableTextBlock_label_en-US" xlink:label="lab_goss_ScheduleOfEquityComponentsOfNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Equity Components Of Notes Table [Text Block]</link:label>
    <link:label id="lab_goss_ScheduleOfEquityComponentsOfNotesTableTextBlock_documentation_en-US" xlink:label="lab_goss_ScheduleOfEquityComponentsOfNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of equity components of notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ScheduleOfEquityComponentsOfNotesTableTextBlock" xlink:href="goss-20200930.xsd#goss_ScheduleOfEquityComponentsOfNotesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_ScheduleOfEquityComponentsOfNotesTableTextBlock" xlink:to="lab_goss_ScheduleOfEquityComponentsOfNotesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_c468f726-d2ef-4c94-a0af-cf86090b4155_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_aec3f53c-6f5a-43e5-9489-bd09602d243c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_8b2a1aca-6c91-470e-bae7-f696b4dde156_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_3db900ff-bed0-4f19-9c76-6837b12e3509_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_3135d5ba-ab69-4b18-95fc-e3b31bf03397_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_13ed2be1-dd27-43b7-9cba-0c370618d982_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_e5ad274f-73fe-45fb-bab4-1f5fe53afb5e_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ba8a7cd6-e0f0-4f09-b57b-b254142755dd_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_982210ce-8af1-43ec-945b-a1d9245f33fb_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_InProcessResearchAndDevelopmentExpenses_d6c77310-e1af-40db-b952-e2b1175a0b29_terseLabel_en-US" xlink:label="lab_goss_InProcessResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In process research and development expenses</link:label>
    <link:label id="lab_goss_InProcessResearchAndDevelopmentExpenses_label_en-US" xlink:label="lab_goss_InProcessResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research And Development Expenses</link:label>
    <link:label id="lab_goss_InProcessResearchAndDevelopmentExpenses_documentation_en-US" xlink:label="lab_goss_InProcessResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentExpenses" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_InProcessResearchAndDevelopmentExpenses" xlink:to="lab_goss_InProcessResearchAndDevelopmentExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_587a8283-72f2-45cd-9684-fceb7ef4fc9a_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Restricted Stock Units Outstanding, Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_befc9cf0-8bd4-403b-bd6e-aeebdc978ad9_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate fair value of stock options vested during period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_5a6fcc13-3c6d-4e59-8535-e06bc8354880_negatedLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of premium on investments, net of accretion of discounts</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember_14d2187b-ab24-43a4-9069-ce3ced3b9c39_terseLabel_en-US" xlink:label="lab_goss_PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment Occurs through First Anniversary of Closing Date</link:label>
    <link:label id="lab_goss_PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember_label_en-US" xlink:label="lab_goss_PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment Occurs Through First Anniversary Of Closing Date [Member]</link:label>
    <link:label id="lab_goss_PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember_documentation_en-US" xlink:label="lab_goss_PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepayment occurs through first anniversary of closing date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember" xlink:href="goss-20200930.xsd#goss_PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember" xlink:to="lab_goss_PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_ce697e41-44e8-4a16-b7f0-1bcdaccd4d28_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Costs</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_856651e8-286a-4da3-8596-cc1db75c0810_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_5a88bcc4-0211-41c7-9b41-522e12121591_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_7581786b-c048-477f-a294-3069e0b496da_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of convertible preferred stock into common stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_1f3d97c6-1315-4458-9b0e-b2180a79b3b1_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_TemporaryEquitySharesConvertedIntoCommonSharesShares_61080bdd-dead-42f6-8b90-2f3d07dcf3af_negatedTerseLabel_en-US" xlink:label="lab_goss_TemporaryEquitySharesConvertedIntoCommonSharesShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of convertible preferred stock into common stock (in shares)</link:label>
    <link:label id="lab_goss_TemporaryEquitySharesConvertedIntoCommonSharesShares_label_en-US" xlink:label="lab_goss_TemporaryEquitySharesConvertedIntoCommonSharesShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Converted Into Common Shares, Shares</link:label>
    <link:label id="lab_goss_TemporaryEquitySharesConvertedIntoCommonSharesShares_documentation_en-US" xlink:label="lab_goss_TemporaryEquitySharesConvertedIntoCommonSharesShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Converted Into Common Shares, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TemporaryEquitySharesConvertedIntoCommonSharesShares" xlink:href="goss-20200930.xsd#goss_TemporaryEquitySharesConvertedIntoCommonSharesShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_TemporaryEquitySharesConvertedIntoCommonSharesShares" xlink:to="lab_goss_TemporaryEquitySharesConvertedIntoCommonSharesShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_dd548c99-3ef3-4829-a4d1-b6a10505995b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_AdditionalNonCancelableLeaseAgreementInNov2019Member_bfedde3b-9b20-404a-8654-cb4660670ec9_terseLabel_en-US" xlink:label="lab_goss_AdditionalNonCancelableLeaseAgreementInNov2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Non-cancelable Lease Agreement Entered in November 2019</link:label>
    <link:label id="lab_goss_AdditionalNonCancelableLeaseAgreementInNov2019Member_label_en-US" xlink:label="lab_goss_AdditionalNonCancelableLeaseAgreementInNov2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Non-cancelable Lease Agreement In Nov 2019 [Member]</link:label>
    <link:label id="lab_goss_AdditionalNonCancelableLeaseAgreementInNov2019Member_documentation_en-US" xlink:label="lab_goss_AdditionalNonCancelableLeaseAgreementInNov2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Non-cancelable Lease Agreement In Nov 2019</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AdditionalNonCancelableLeaseAgreementInNov2019Member" xlink:href="goss-20200930.xsd#goss_AdditionalNonCancelableLeaseAgreementInNov2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_AdditionalNonCancelableLeaseAgreementInNov2019Member" xlink:to="lab_goss_AdditionalNonCancelableLeaseAgreementInNov2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_6e5b4a7c-7e82-4620-bc50-814d92387840_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_40dc13ed-a027-4208-92c5-e3064db6430d_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_e1b835be-9dde-4ca3-8a53-08b40db30829_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_ConvertibleSeniorNotesPolicyTextBlock_37158616-0539-4658-af53-5497b441bf08_terseLabel_en-US" xlink:label="lab_goss_ConvertibleSeniorNotesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes</link:label>
    <link:label id="lab_goss_ConvertibleSeniorNotesPolicyTextBlock_label_en-US" xlink:label="lab_goss_ConvertibleSeniorNotesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes Policy [Text Block]</link:label>
    <link:label id="lab_goss_ConvertibleSeniorNotesPolicyTextBlock_documentation_en-US" xlink:label="lab_goss_ConvertibleSeniorNotesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ConvertibleSeniorNotesPolicyTextBlock" xlink:href="goss-20200930.xsd#goss_ConvertibleSeniorNotesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_ConvertibleSeniorNotesPolicyTextBlock" xlink:to="lab_goss_ConvertibleSeniorNotesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt_414e2f26-5b34-4d31-a57f-70188a73358d_terseLabel_en-US" xlink:label="lab_goss_DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, default trigger amount</link:label>
    <link:label id="lab_goss_DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt_label_en-US" xlink:label="lab_goss_DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Terms, Default Trigger, Default Amount Of Other Debt</link:label>
    <link:label id="lab_goss_DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt_documentation_en-US" xlink:label="lab_goss_DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant Terms, Default Trigger, Default Amount Of Other Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt" xlink:href="goss-20200930.xsd#goss_DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt" xlink:to="lab_goss_DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_c9a8d6df-c6a4-433f-9911-d21e73298513_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f915be51-4869-4dac-a151-b64a1421683e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive securities not included from calculation of diluted net loss per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_PermanentMonthlyBaseRent_323b7a91-ec51-42c0-b061-9077af5e7368_terseLabel_en-US" xlink:label="lab_goss_PermanentMonthlyBaseRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly base rent for permanent space</link:label>
    <link:label id="lab_goss_PermanentMonthlyBaseRent_label_en-US" xlink:label="lab_goss_PermanentMonthlyBaseRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Permanent Monthly Base Rent</link:label>
    <link:label id="lab_goss_PermanentMonthlyBaseRent_documentation_en-US" xlink:label="lab_goss_PermanentMonthlyBaseRent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Permanent monthly base rent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PermanentMonthlyBaseRent" xlink:href="goss-20200930.xsd#goss_PermanentMonthlyBaseRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_PermanentMonthlyBaseRent" xlink:to="lab_goss_PermanentMonthlyBaseRent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_9d052810-b8a8-49ad-9ee8-223e10899cb2_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_39149fea-038d-4a17-bc0a-fba64cda03f3_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_850d8148-a040-4e85-b18d-c56017ba0bff_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9626f7a0-ee69-4725-a4d1-5584e0ca365f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_LeaseContractualTermAxis_484df10a-7fc5-4971-ba8c-17ede4ae3fbe_terseLabel_en-US" xlink:label="lab_goss_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:label id="lab_goss_LeaseContractualTermAxis_label_en-US" xlink:label="lab_goss_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:label id="lab_goss_LeaseContractualTermAxis_documentation_en-US" xlink:label="lab_goss_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LeaseContractualTermAxis" xlink:href="goss-20200930.xsd#goss_LeaseContractualTermAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_LeaseContractualTermAxis" xlink:to="lab_goss_LeaseContractualTermAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_3c56eaeb-ae75-4ab4-9e59-52737e646eb5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available for Sale Investments by Security Type</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_d01c2433-7c51-4094-b8dd-c5b3f9a3d6f5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_StockholdersEquityTable_de14a932-07c7-4dc0-a299-23fafca2aeab_terseLabel_en-US" xlink:label="lab_goss_StockholdersEquityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders Equity [Table]</link:label>
    <link:label id="lab_goss_StockholdersEquityTable_label_en-US" xlink:label="lab_goss_StockholdersEquityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders Equity [Table]</link:label>
    <link:label id="lab_goss_StockholdersEquityTable_documentation_en-US" xlink:label="lab_goss_StockholdersEquityTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders equity .</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_StockholdersEquityTable" xlink:href="goss-20200930.xsd#goss_StockholdersEquityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_StockholdersEquityTable" xlink:to="lab_goss_StockholdersEquityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_604ba5a0-3337-4164-b2e8-3a0952ac3739_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_8f182f93-353e-43d4-b94f-81502c8ec5f4_terseLabel_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office equipment</link:label>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_label_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OfficeEquipmentMember" xlink:to="lab_us-gaap_OfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_3c6b65d2-d9db-4d67-a5b6-9818e71e42a3_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issuable upon exercise of stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_e25509be-f345-495c-a022-f4262c090218_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_ed68ee63-e5d1-4869-968d-84b475891ac8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_875cd73f-e2c3-47a2-acc5-d150e38eb077_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lab equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_361606e2-7b6a-4b76-8b44-032f5aabce24_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance cost</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_ParticipationRight_6ce9e10d-495e-4ebb-b2b4-aaf1fe7a307d_terseLabel_en-US" xlink:label="lab_goss_ParticipationRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participation rights</link:label>
    <link:label id="lab_goss_ParticipationRight_label_en-US" xlink:label="lab_goss_ParticipationRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participation Right</link:label>
    <link:label id="lab_goss_ParticipationRight_documentation_en-US" xlink:label="lab_goss_ParticipationRight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participation right .</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ParticipationRight" xlink:href="goss-20200930.xsd#goss_ParticipationRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_ParticipationRight" xlink:to="lab_goss_ParticipationRight" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_9bfda765-830d-4237-8dd9-8c4144dbda04_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_EquityComponentOfConvertibleNoteIssuance_abc1f5f2-4d3d-4a59-ae8f-72e85baca073_terseLabel_en-US" xlink:label="lab_goss_EquityComponentOfConvertibleNoteIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity component of convertible note issuance</link:label>
    <link:label id="lab_goss_EquityComponentOfConvertibleNoteIssuance_label_en-US" xlink:label="lab_goss_EquityComponentOfConvertibleNoteIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component Of Convertible Note Issuance</link:label>
    <link:label id="lab_goss_EquityComponentOfConvertibleNoteIssuance_documentation_en-US" xlink:label="lab_goss_EquityComponentOfConvertibleNoteIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity component of convertible note issuance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_EquityComponentOfConvertibleNoteIssuance" xlink:href="goss-20200930.xsd#goss_EquityComponentOfConvertibleNoteIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_EquityComponentOfConvertibleNoteIssuance" xlink:to="lab_goss_EquityComponentOfConvertibleNoteIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_MidCapFinancialTrustMember_09a924eb-3668-4cbd-b7bb-d8037deff7a3_terseLabel_en-US" xlink:label="lab_goss_MidCapFinancialTrustMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MidCap Financial Trust</link:label>
    <link:label id="lab_goss_MidCapFinancialTrustMember_label_en-US" xlink:label="lab_goss_MidCapFinancialTrustMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mid Cap Financial Trust [Member]</link:label>
    <link:label id="lab_goss_MidCapFinancialTrustMember_documentation_en-US" xlink:label="lab_goss_MidCapFinancialTrustMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MidCap financial trust.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_MidCapFinancialTrustMember" xlink:href="goss-20200930.xsd#goss_MidCapFinancialTrustMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_MidCapFinancialTrustMember" xlink:to="lab_goss_MidCapFinancialTrustMember" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix_f8889fc7-f277-446f-8706-d57901fb38c4_terseLabel_en-US" xlink:label="lab_goss_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_goss_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix_label_en-US" xlink:label="lab_goss_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due After Year Six</link:label>
    <link:label id="lab_goss_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix_documentation_en-US" xlink:label="lab_goss_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due After Year Six</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix" xlink:href="goss-20200930.xsd#goss_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix" xlink:to="lab_goss_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix" xlink:type="arc" order="1"/>
    <link:label id="lab_goss_AccruedInProcessResearchAndDevelopment_b093c97c-9926-44eb-9fcd-7dc9ee870a85_terseLabel_en-US" xlink:label="lab_goss_AccruedInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued in process research and development</link:label>
    <link:label id="lab_goss_AccruedInProcessResearchAndDevelopment_label_en-US" xlink:label="lab_goss_AccruedInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued In Process Research And Development</link:label>
    <link:label id="lab_goss_AccruedInProcessResearchAndDevelopment_documentation_en-US" xlink:label="lab_goss_AccruedInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued in process research and development.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AccruedInProcessResearchAndDevelopment" xlink:href="goss-20200930.xsd#goss_AccruedInProcessResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_goss_AccruedInProcessResearchAndDevelopment" xlink:to="lab_goss_AccruedInProcessResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_1382a096-39cc-4a40-85fc-4ff79aa38342_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_b3d06133-08a3-4bac-9061-968afd030cc5_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1dc0d11f-c627-4e2d-9b7d-37d1ba7fa795_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>goss-20200930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:a28f2324-59ee-4208-be3f-ac91f14d0976,g:685f1ccc-55e8-49df-855b-4b6ee836ad79-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.gossamerbio.com/role/Cover" xlink:type="simple" xlink:href="goss-20200930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_8d67a97d-a5d8-4f81-bed4-314097650ce7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_DocumentType_8d67a97d-a5d8-4f81-bed4-314097650ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_80cefff1-2f08-47fc-9869-ddb646f918be" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_DocumentQuarterlyReport_80cefff1-2f08-47fc-9869-ddb646f918be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_d6c435ca-e191-4099-8945-fd082c5451a6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_DocumentTransitionReport_d6c435ca-e191-4099-8945-fd082c5451a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_cbd7a12b-bc80-4fdd-aa52-47b6b5c3610f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_EntityFileNumber_cbd7a12b-bc80-4fdd-aa52-47b6b5c3610f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d6b32319-9abf-4994-83ac-6e0fe8fbc3cc" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_EntityRegistrantName_d6b32319-9abf-4994-83ac-6e0fe8fbc3cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_1bb5f71e-e996-4177-8d1e-cc366d4b15ee" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_1bb5f71e-e996-4177-8d1e-cc366d4b15ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_094cb28d-10eb-4931-abba-ad675452a306" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_EntityTaxIdentificationNumber_094cb28d-10eb-4931-abba-ad675452a306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_dbe2d4e1-15aa-41a4-8ae1-87318d4342f7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_EntityAddressAddressLine1_dbe2d4e1-15aa-41a4-8ae1-87318d4342f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_b1708be1-0cbc-470c-ace2-e44b585d6b26" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_EntityAddressCityOrTown_b1708be1-0cbc-470c-ace2-e44b585d6b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_a88f21ea-5165-4cee-b631-b3d29db5c379" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_EntityAddressStateOrProvince_a88f21ea-5165-4cee-b631-b3d29db5c379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_d1ef24e9-3137-4cff-8fd6-0a8ece19af86" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_EntityAddressPostalZipCode_d1ef24e9-3137-4cff-8fd6-0a8ece19af86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_52b15917-c5c1-4253-8d27-7ab42e181b88" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_CityAreaCode_52b15917-c5c1-4253-8d27-7ab42e181b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_172cf0c7-cd81-47a5-b286-db83517c72b5" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_LocalPhoneNumber_172cf0c7-cd81-47a5-b286-db83517c72b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_d3d3fb98-e72e-46e3-9b22-be833030bfb5" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_Security12bTitle_d3d3fb98-e72e-46e3-9b22-be833030bfb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_ef3112d0-ecf5-411d-a7bd-0dd433dd7394" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_TradingSymbol_ef3112d0-ecf5-411d-a7bd-0dd433dd7394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_7c4f866b-7dff-4d2a-99c0-b880aefc7b47" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_SecurityExchangeName_7c4f866b-7dff-4d2a-99c0-b880aefc7b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_b4e56ca8-f684-4962-a4ee-f3a887518ef8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_EntityCurrentReportingStatus_b4e56ca8-f684-4962-a4ee-f3a887518ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_35a74659-06f2-411b-a3be-6cb6b7b3d23c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_EntityInteractiveDataCurrent_35a74659-06f2-411b-a3be-6cb6b7b3d23c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_4d2c9dde-8ef8-4a8a-81fe-92841d4982df" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_EntityFilerCategory_4d2c9dde-8ef8-4a8a-81fe-92841d4982df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_20ec82f8-6aef-400d-8f91-339cf4df2900" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_EntitySmallBusiness_20ec82f8-6aef-400d-8f91-339cf4df2900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ba289869-3ea2-432f-bcba-f27d8b90e7f8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_EntityEmergingGrowthCompany_ba289869-3ea2-432f-bcba-f27d8b90e7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_32b6d628-5f78-47a4-90fc-6088c4b78b10" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_EntityExTransitionPeriod_32b6d628-5f78-47a4-90fc-6088c4b78b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_5510fc80-7268-4cf6-b70a-abc6c6d4b3bd" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_EntityShellCompany_5510fc80-7268-4cf6-b70a-abc6c6d4b3bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_5e422565-2333-47b8-bcf6-22a50f6f7b20" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_5e422565-2333-47b8-bcf6-22a50f6f7b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_2bf51529-001e-45ce-a467-81ac2e2d13ec" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_AmendmentFlag_2bf51529-001e-45ce-a467-81ac2e2d13ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_887f0d74-8c85-47bd-902d-ec8b3b3f2452" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_DocumentPeriodEndDate_887f0d74-8c85-47bd-902d-ec8b3b3f2452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_e3f7c749-0266-44eb-b8ed-0cfa37a56c3d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_DocumentFiscalYearFocus_e3f7c749-0266-44eb-b8ed-0cfa37a56c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_e5217716-c418-41de-b065-9a125f9fa725" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_DocumentFiscalPeriodFocus_e5217716-c418-41de-b065-9a125f9fa725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_819490ff-245f-4a26-a863-f423f3a54d4e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_EntityCentralIndexKey_819490ff-245f-4a26-a863-f423f3a54d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_ab793986-0311-4f8b-8f69-e2b2f4f41112" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5d216aa1-6c38-4063-bfe0-d68b769cea9e" xlink:to="loc_dei_CurrentFiscalYearEndDate_ab793986-0311-4f8b-8f69-e2b2f4f41112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="goss-20200930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0adab87a-e27f-4ea9-a33f-329f668a2736" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_5b3a6307-7777-44bc-b212-51c856365aa3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0adab87a-e27f-4ea9-a33f-329f668a2736" xlink:to="loc_us-gaap_AssetsAbstract_5b3a6307-7777-44bc-b212-51c856365aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_bc4b1de1-a2a8-4272-aaaf-32237b95c0d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5b3a6307-7777-44bc-b212-51c856365aa3" xlink:to="loc_us-gaap_AssetsCurrentAbstract_bc4b1de1-a2a8-4272-aaaf-32237b95c0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6adbd6cb-b7f7-4a51-a8e2-a98283883d30" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bc4b1de1-a2a8-4272-aaaf-32237b95c0d7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6adbd6cb-b7f7-4a51-a8e2-a98283883d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_c2192e34-ae00-47d9-a339-1911db995e91" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bc4b1de1-a2a8-4272-aaaf-32237b95c0d7" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_c2192e34-ae00-47d9-a339-1911db995e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_dc1807c4-07a3-4972-8921-bf173bcd935d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bc4b1de1-a2a8-4272-aaaf-32237b95c0d7" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_dc1807c4-07a3-4972-8921-bf173bcd935d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_622e940d-ccb7-4937-a43a-f3a0a7713dc1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_bc4b1de1-a2a8-4272-aaaf-32237b95c0d7" xlink:to="loc_us-gaap_AssetsCurrent_622e940d-ccb7-4937-a43a-f3a0a7713dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9b17a29e-fe70-4ae1-8451-f287bcb68d52" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5b3a6307-7777-44bc-b212-51c856365aa3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9b17a29e-fe70-4ae1-8451-f287bcb68d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2914cf44-b29f-47e7-a5d7-bc0c5a21aaaa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5b3a6307-7777-44bc-b212-51c856365aa3" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2914cf44-b29f-47e7-a5d7-bc0c5a21aaaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8d8a8cb6-4b6c-4ebb-a074-309ffffd9e46" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5b3a6307-7777-44bc-b212-51c856365aa3" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8d8a8cb6-4b6c-4ebb-a074-309ffffd9e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ef1db6c0-e9ad-4e77-acd9-422501798491" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5b3a6307-7777-44bc-b212-51c856365aa3" xlink:to="loc_us-gaap_Assets_ef1db6c0-e9ad-4e77-acd9-422501798491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_469f58cd-3e05-484f-8ff6-442eb5eb1ca0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0adab87a-e27f-4ea9-a33f-329f668a2736" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_469f58cd-3e05-484f-8ff6-442eb5eb1ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_d5017635-6b9c-4b74-bf09-5a012c970905" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_469f58cd-3e05-484f-8ff6-442eb5eb1ca0" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_d5017635-6b9c-4b74-bf09-5a012c970905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_af78dc60-b0a2-448b-a2ce-2f38a50316a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d5017635-6b9c-4b74-bf09-5a012c970905" xlink:to="loc_us-gaap_AccountsPayableCurrent_af78dc60-b0a2-448b-a2ce-2f38a50316a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AccruedResearchAndDevelopmentExpenses_13274bb8-e02b-4a31-a843-e0441a6446b0" xlink:href="goss-20200930.xsd#goss_AccruedResearchAndDevelopmentExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d5017635-6b9c-4b74-bf09-5a012c970905" xlink:to="loc_goss_AccruedResearchAndDevelopmentExpenses_13274bb8-e02b-4a31-a843-e0441a6446b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_8a2aed98-92e8-4c2a-99a8-787254ba965b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d5017635-6b9c-4b74-bf09-5a012c970905" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_8a2aed98-92e8-4c2a-99a8-787254ba965b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_766c0ba0-d061-45d9-80e5-32bd0c2e81bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d5017635-6b9c-4b74-bf09-5a012c970905" xlink:to="loc_us-gaap_LiabilitiesCurrent_766c0ba0-d061-45d9-80e5-32bd0c2e81bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LongTermConvertibleSeniorNotes_3c4b5dc0-6194-4c98-a98b-f3ef88ccb438" xlink:href="goss-20200930.xsd#goss_LongTermConvertibleSeniorNotes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_469f58cd-3e05-484f-8ff6-442eb5eb1ca0" xlink:to="loc_goss_LongTermConvertibleSeniorNotes_3c4b5dc0-6194-4c98-a98b-f3ef88ccb438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_4b7d6e8a-449d-4947-8c68-b364c76cc88b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_469f58cd-3e05-484f-8ff6-442eb5eb1ca0" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_4b7d6e8a-449d-4947-8c68-b364c76cc88b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5da45744-5bcc-42d8-a35d-4cefaa4d823c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_469f58cd-3e05-484f-8ff6-442eb5eb1ca0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5da45744-5bcc-42d8-a35d-4cefaa4d823c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d023246c-1cd7-43f7-b9cd-fe37d7448043" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_469f58cd-3e05-484f-8ff6-442eb5eb1ca0" xlink:to="loc_us-gaap_Liabilities_d023246c-1cd7-43f7-b9cd-fe37d7448043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_bb1459cb-fd9c-44fd-adb8-47c9b7050776" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_469f58cd-3e05-484f-8ff6-442eb5eb1ca0" xlink:to="loc_us-gaap_CommitmentsAndContingencies_bb1459cb-fd9c-44fd-adb8-47c9b7050776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_45d0f33b-481a-4725-b8b4-612c687e3bfa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0adab87a-e27f-4ea9-a33f-329f668a2736" xlink:to="loc_us-gaap_StockholdersEquityAbstract_45d0f33b-481a-4725-b8b4-612c687e3bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_0f89abf9-6683-49b4-bf64-3fa860dcf317" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_45d0f33b-481a-4725-b8b4-612c687e3bfa" xlink:to="loc_us-gaap_CommonStockValue_0f89abf9-6683-49b4-bf64-3fa860dcf317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b6287f66-a1e6-480c-ab11-f4377eccb6e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_45d0f33b-481a-4725-b8b4-612c687e3bfa" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_b6287f66-a1e6-480c-ab11-f4377eccb6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5711f502-e51b-42af-b77e-f82f2049d182" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_45d0f33b-481a-4725-b8b4-612c687e3bfa" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5711f502-e51b-42af-b77e-f82f2049d182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_80681439-8b3a-4002-89ba-cf91c31215d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_45d0f33b-481a-4725-b8b4-612c687e3bfa" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_80681439-8b3a-4002-89ba-cf91c31215d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9c52f279-7e7d-4ad3-a3d2-9a5a89b7f05b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_45d0f33b-481a-4725-b8b4-612c687e3bfa" xlink:to="loc_us-gaap_StockholdersEquity_9c52f279-7e7d-4ad3-a3d2-9a5a89b7f05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_06ff84e4-79de-4654-bea3-2ae7c423e69a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0adab87a-e27f-4ea9-a33f-329f668a2736" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_06ff84e4-79de-4654-bea3-2ae7c423e69a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="goss-20200930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_bdce2f2b-337e-46a1-ad85-a254673b20a4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_0bff895b-151d-443c-82d3-9860531cb6b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bdce2f2b-337e-46a1-ad85-a254673b20a4" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_0bff895b-151d-443c-82d3-9860531cb6b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_c97a69a0-05f3-4f59-aac5-6ac2216106b5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bdce2f2b-337e-46a1-ad85-a254673b20a4" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_c97a69a0-05f3-4f59-aac5-6ac2216106b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_d943d2be-9fe1-42c6-b6ec-3725e079e3f2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bdce2f2b-337e-46a1-ad85-a254673b20a4" xlink:to="loc_us-gaap_CommonStockSharesIssued_d943d2be-9fe1-42c6-b6ec-3725e079e3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_353fa2e7-e860-4261-8821-b95f2b756598" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bdce2f2b-337e-46a1-ad85-a254673b20a4" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_353fa2e7-e860-4261-8821-b95f2b756598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="goss-20200930.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_63117b30-4417-4db2-97d9-f3a21a427618" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_eb89b3d1-2d80-401c-97b8-cb8c8cdde142" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63117b30-4417-4db2-97d9-f3a21a427618" xlink:to="loc_us-gaap_OperatingExpensesAbstract_eb89b3d1-2d80-401c-97b8-cb8c8cdde142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3de4e026-f28b-42ce-a204-8c671ab0341f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb89b3d1-2d80-401c-97b8-cb8c8cdde142" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3de4e026-f28b-42ce-a204-8c671ab0341f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_26a44bbe-8f45-4740-bb9a-1e8c0bee61a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb89b3d1-2d80-401c-97b8-cb8c8cdde142" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_26a44bbe-8f45-4740-bb9a-1e8c0bee61a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_8123e3c2-7569-4bde-a5a0-6509c23ebc56" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb89b3d1-2d80-401c-97b8-cb8c8cdde142" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_8123e3c2-7569-4bde-a5a0-6509c23ebc56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_90f649ba-cfec-449e-a4be-e27c9790ec19" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eb89b3d1-2d80-401c-97b8-cb8c8cdde142" xlink:to="loc_us-gaap_OperatingExpenses_90f649ba-cfec-449e-a4be-e27c9790ec19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e753ba14-0a54-4c2e-aeb8-b82d302d0975" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63117b30-4417-4db2-97d9-f3a21a427618" xlink:to="loc_us-gaap_OperatingIncomeLoss_e753ba14-0a54-4c2e-aeb8-b82d302d0975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_ebb64aff-8b52-481d-8df5-c2729fba14c8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63117b30-4417-4db2-97d9-f3a21a427618" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_ebb64aff-8b52-481d-8df5-c2729fba14c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a2b5f0e0-6662-4b9b-b7c7-4b4b90d3d937" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63117b30-4417-4db2-97d9-f3a21a427618" xlink:to="loc_us-gaap_NetIncomeLoss_a2b5f0e0-6662-4b9b-b7c7-4b4b90d3d937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_6d348ff3-d73c-4a69-adf7-94f189f53074" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63117b30-4417-4db2-97d9-f3a21a427618" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_6d348ff3-d73c-4a69-adf7-94f189f53074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_98d96e27-8919-4bab-b649-48e858f8c289" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_6d348ff3-d73c-4a69-adf7-94f189f53074" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_98d96e27-8919-4bab-b649-48e858f8c289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_268b7c25-be36-4b46-8618-8841fac4e675" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_6d348ff3-d73c-4a69-adf7-94f189f53074" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_268b7c25-be36-4b46-8618-8841fac4e675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ca4d0736-081e-4782-88e2-b113fc999376" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_6d348ff3-d73c-4a69-adf7-94f189f53074" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ca4d0736-081e-4782-88e2-b113fc999376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_56885907-e9e6-44af-b15f-8143383f1f1a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63117b30-4417-4db2-97d9-f3a21a427618" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_56885907-e9e6-44af-b15f-8143383f1f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_8a908c68-28d0-4a93-8a5e-7775ab8e4553" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63117b30-4417-4db2-97d9-f3a21a427618" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_8a908c68-28d0-4a93-8a5e-7775ab8e4553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_218a4f62-7eb8-41af-8610-3c7c7a7cb656" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_63117b30-4417-4db2-97d9-f3a21a427618" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_218a4f62-7eb8-41af-8610-3c7c7a7cb656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity" xlink:type="simple" xlink:href="goss-20200930.xsd#CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_cc359585-4b20-48f5-b002-caa526ce60c8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_55fb6844-f4cf-412b-9b84-c9543f4777d2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_cc359585-4b20-48f5-b002-caa526ce60c8" xlink:to="loc_us-gaap_StatementTable_55fb6844-f4cf-412b-9b84-c9543f4777d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_39cda1c8-d79e-48f6-90ad-d940dfbe430e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_55fb6844-f4cf-412b-9b84-c9543f4777d2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_39cda1c8-d79e-48f6-90ad-d940dfbe430e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e9845b9f-12ae-41d1-881a-ae83e20ff4db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_39cda1c8-d79e-48f6-90ad-d940dfbe430e" xlink:to="loc_us-gaap_ClassOfStockDomain_e9845b9f-12ae-41d1-881a-ae83e20ff4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SeriesSeedConvertiblePreferredStockMember_0364036c-1113-40dd-ab58-b5f07afb9197" xlink:href="goss-20200930.xsd#goss_SeriesSeedConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e9845b9f-12ae-41d1-881a-ae83e20ff4db" xlink:to="loc_goss_SeriesSeedConvertiblePreferredStockMember_0364036c-1113-40dd-ab58-b5f07afb9197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SeriesAConvertiblePreferredStockMember_669a37b0-d1e1-447c-b97b-0d7e31d93182" xlink:href="goss-20200930.xsd#goss_SeriesAConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e9845b9f-12ae-41d1-881a-ae83e20ff4db" xlink:to="loc_goss_SeriesAConvertiblePreferredStockMember_669a37b0-d1e1-447c-b97b-0d7e31d93182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SeriesBConvertiblePreferredStockMember_4e97d051-67ed-417d-8e53-37496ab90f0a" xlink:href="goss-20200930.xsd#goss_SeriesBConvertiblePreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e9845b9f-12ae-41d1-881a-ae83e20ff4db" xlink:to="loc_goss_SeriesBConvertiblePreferredStockMember_4e97d051-67ed-417d-8e53-37496ab90f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4089aa95-c1d4-44c7-aae5-8357886f8a95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_55fb6844-f4cf-412b-9b84-c9543f4777d2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4089aa95-c1d4-44c7-aae5-8357886f8a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_47d3ded9-f338-4d36-958a-dfd84128a622" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4089aa95-c1d4-44c7-aae5-8357886f8a95" xlink:to="loc_us-gaap_EquityComponentDomain_47d3ded9-f338-4d36-958a-dfd84128a622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e6f14a80-8d5d-49a6-b040-9ab96cfed2b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_47d3ded9-f338-4d36-958a-dfd84128a622" xlink:to="loc_us-gaap_CommonStockMember_e6f14a80-8d5d-49a6-b040-9ab96cfed2b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_6feb16c4-3291-4ce0-ba50-eae037128065" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_47d3ded9-f338-4d36-958a-dfd84128a622" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_6feb16c4-3291-4ce0-ba50-eae037128065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_00426206-043e-4d07-acd1-0ec3e1a9b60e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_47d3ded9-f338-4d36-958a-dfd84128a622" xlink:to="loc_us-gaap_RetainedEarningsMember_00426206-043e-4d07-acd1-0ec3e1a9b60e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_130fcf50-88d5-4528-a9d6-63b21173af75" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_47d3ded9-f338-4d36-958a-dfd84128a622" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_130fcf50-88d5-4528-a9d6-63b21173af75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a8ff6618-1a48-459f-ac60-23fd28c9c373" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_55fb6844-f4cf-412b-9b84-c9543f4777d2" xlink:to="loc_us-gaap_StatementLineItems_a8ff6618-1a48-459f-ac60-23fd28c9c373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef0505ba-5a99-401b-b6ab-bd71e9b135c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a8ff6618-1a48-459f-ac60-23fd28c9c373" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef0505ba-5a99-401b-b6ab-bd71e9b135c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_3c5111bf-ede7-4f97-bbe8-371b5917016e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef0505ba-5a99-401b-b6ab-bd71e9b135c4" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_3c5111bf-ede7-4f97-bbe8-371b5917016e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_da21e8f8-01ed-430f-8693-2279eeb7c930" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef0505ba-5a99-401b-b6ab-bd71e9b135c4" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_da21e8f8-01ed-430f-8693-2279eeb7c930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TemporaryEquitySharesConvertedIntoCommonSharesShares_1a5c54c0-0695-49fc-a311-b01dba30edd2" xlink:href="goss-20200930.xsd#goss_TemporaryEquitySharesConvertedIntoCommonSharesShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef0505ba-5a99-401b-b6ab-bd71e9b135c4" xlink:to="loc_goss_TemporaryEquitySharesConvertedIntoCommonSharesShares_1a5c54c0-0695-49fc-a311-b01dba30edd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TemporaryEquitySharesConvertedIntoCommonSharesValue_7d2e96f3-b1a5-4210-8a38-f106e1470955" xlink:href="goss-20200930.xsd#goss_TemporaryEquitySharesConvertedIntoCommonSharesValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef0505ba-5a99-401b-b6ab-bd71e9b135c4" xlink:to="loc_goss_TemporaryEquitySharesConvertedIntoCommonSharesValue_7d2e96f3-b1a5-4210-8a38-f106e1470955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_2c27fa07-8434-4a67-8735-9a9f635747b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef0505ba-5a99-401b-b6ab-bd71e9b135c4" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_2c27fa07-8434-4a67-8735-9a9f635747b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_71452150-e673-49cb-b4c5-84ff4a7d0b40" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ef0505ba-5a99-401b-b6ab-bd71e9b135c4" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_71452150-e673-49cb-b4c5-84ff4a7d0b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a8ff6618-1a48-459f-ac60-23fd28c9c373" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_237dc7d9-27c5-4aa4-b8cc-48f986d178ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_SharesOutstanding_237dc7d9-27c5-4aa4-b8cc-48f986d178ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9aea1120-1068-4fcf-9d21-6988e7ebf306" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_StockholdersEquity_9aea1120-1068-4fcf-9d21-6988e7ebf306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b852d0b5-4e2e-44ad-a906-0b8469e45cda" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b852d0b5-4e2e-44ad-a906-0b8469e45cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c2d0cda2-b0c0-4ebe-8047-38e92e3f7468" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_c2d0cda2-b0c0-4ebe-8047-38e92e3f7468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_EquityComponentOfConvertibleNoteIssuance_1017043c-0cee-4adf-96a1-d44afb37be19" xlink:href="goss-20200930.xsd#goss_EquityComponentOfConvertibleNoteIssuance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_goss_EquityComponentOfConvertibleNoteIssuance_1017043c-0cee-4adf-96a1-d44afb37be19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_292868d5-3d96-4fc0-a41f-bb8766d3b854" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_292868d5-3d96-4fc0-a41f-bb8766d3b854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock_7b975b9b-d60b-4e59-ae0c-955b84f08a4d" xlink:href="goss-20200930.xsd#goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock_7b975b9b-d60b-4e59-ae0c-955b84f08a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_922a10f1-55a1-461c-847d-31d3bbfb43ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_922a10f1-55a1-461c-847d-31d3bbfb43ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_37c2d497-e44e-4c92-8049-8efd2ff2bb07" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_37c2d497-e44e-4c92-8049-8efd2ff2bb07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0a02ea0c-40a2-4e31-b44f-73524470c308" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0a02ea0c-40a2-4e31-b44f-73524470c308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_576fc0c0-da82-4cc9-9758-3f870fddfde3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_576fc0c0-da82-4cc9-9758-3f870fddfde3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_af21399e-cf20-4f0e-979a-e7de1f5112ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_af21399e-cf20-4f0e-979a-e7de1f5112ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_35743fc0-20b4-4e5f-b0ea-58a2c618336a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_35743fc0-20b4-4e5f-b0ea-58a2c618336a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_629dc00e-c7ef-438e-9fd7-fb249a5512e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_NetIncomeLoss_629dc00e-c7ef-438e-9fd7-fb249a5512e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_361f6069-9dcd-46d3-ba2a-27ed2fec09b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_361f6069-9dcd-46d3-ba2a-27ed2fec09b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_e507f9d3-574c-4c8b-b4d5-61db2beae381" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_e507f9d3-574c-4c8b-b4d5-61db2beae381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_aa64bd55-9121-4fa8-b274-89c193bcdcab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_aa64bd55-9121-4fa8-b274-89c193bcdcab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_070d3c2d-ed02-4d55-ac9a-3a7882cdd21b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_070d3c2d-ed02-4d55-ac9a-3a7882cdd21b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_16ab697c-0c42-4a81-9261-4772b2d95c10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_SharesOutstanding_16ab697c-0c42-4a81-9261-4772b2d95c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d2ef578b-c86e-456a-a036-91bd8f498220" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b5d0a4cc-0269-4b88-929c-27c1a37e073a" xlink:to="loc_us-gaap_StockholdersEquity_d2ef578b-c86e-456a-a036-91bd8f498220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="goss-20200930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_854384e7-058f-429b-8617-5f98b8fb3f1f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_dd8b89be-e60c-40a8-9316-58c91a7e6c9d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_854384e7-058f-429b-8617-5f98b8fb3f1f" xlink:to="loc_us-gaap_StatementTable_dd8b89be-e60c-40a8-9316-58c91a7e6c9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_9b0153a4-3897-4cdf-b0e4-7787072d7ded" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dd8b89be-e60c-40a8-9316-58c91a7e6c9d" xlink:to="loc_us-gaap_PlanNameAxis_9b0153a4-3897-4cdf-b0e4-7787072d7ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1504f554-5c19-4507-aad4-8f40486368f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_9b0153a4-3897-4cdf-b0e4-7787072d7ded" xlink:to="loc_us-gaap_PlanNameDomain_1504f554-5c19-4507-aad4-8f40486368f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandNineteenEmployeeStockPurchasePlanMember_21477390-86fa-4b3d-ae2b-b3064f168b65" xlink:href="goss-20200930.xsd#goss_TwoThousandNineteenEmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_1504f554-5c19-4507-aad4-8f40486368f4" xlink:to="loc_goss_TwoThousandNineteenEmployeeStockPurchasePlanMember_21477390-86fa-4b3d-ae2b-b3064f168b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_602bb2e7-7ad9-4720-b801-1f0d5555001b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_dd8b89be-e60c-40a8-9316-58c91a7e6c9d" xlink:to="loc_us-gaap_StatementLineItems_602bb2e7-7ad9-4720-b801-1f0d5555001b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ea9c6298-0c2b-4b73-8869-922e02b368ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_602bb2e7-7ad9-4720-b801-1f0d5555001b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ea9c6298-0c2b-4b73-8869-922e02b368ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3da6ab4b-59c3-4665-8e87-0d7817171a29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ea9c6298-0c2b-4b73-8869-922e02b368ae" xlink:to="loc_us-gaap_ProfitLoss_3da6ab4b-59c3-4665-8e87-0d7817171a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a526e6ac-a3c4-42f4-826b-8c89c459aae1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ea9c6298-0c2b-4b73-8869-922e02b368ae" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a526e6ac-a3c4-42f4-826b-8c89c459aae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_3da67f01-8dc0-4d83-a87f-049341f287e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a526e6ac-a3c4-42f4-826b-8c89c459aae1" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_3da67f01-8dc0-4d83-a87f-049341f287e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_087084ee-467f-4788-ac3c-87a49326f79a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a526e6ac-a3c4-42f4-826b-8c89c459aae1" xlink:to="loc_us-gaap_ShareBasedCompensation_087084ee-467f-4788-ac3c-87a49326f79a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentExpenses_e8c0da14-80e3-4d72-97f1-34dcdc03862d" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a526e6ac-a3c4-42f4-826b-8c89c459aae1" xlink:to="loc_goss_InProcessResearchAndDevelopmentExpenses_e8c0da14-80e3-4d72-97f1-34dcdc03862d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AmortizationOfOperatingLeaseRightOfUseAssets_b22e4d5a-a13b-4252-ba19-da3c7ac9849f" xlink:href="goss-20200930.xsd#goss_AmortizationOfOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a526e6ac-a3c4-42f4-826b-8c89c459aae1" xlink:to="loc_goss_AmortizationOfOperatingLeaseRightOfUseAssets_b22e4d5a-a13b-4252-ba19-da3c7ac9849f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_3f2de833-dc2d-43aa-9814-0da8b22fb06e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a526e6ac-a3c4-42f4-826b-8c89c459aae1" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_3f2de833-dc2d-43aa-9814-0da8b22fb06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_a69cc960-8779-4e82-96c9-24c9e9a2df9c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a526e6ac-a3c4-42f4-826b-8c89c459aae1" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_a69cc960-8779-4e82-96c9-24c9e9a2df9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_0232a4b9-4a70-4996-9f93-f853c2150a45" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a526e6ac-a3c4-42f4-826b-8c89c459aae1" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_0232a4b9-4a70-4996-9f93-f853c2150a45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3571abf-e74b-405f-b66d-ff2cfd507413" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ea9c6298-0c2b-4b73-8869-922e02b368ae" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3571abf-e74b-405f-b66d-ff2cfd507413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c4cc76f1-4027-479b-8da9-04614ef95d0b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3571abf-e74b-405f-b66d-ff2cfd507413" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c4cc76f1-4027-479b-8da9-04614ef95d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_ff7f2d99-1f75-4b0f-90b0-2b46f838abdc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3571abf-e74b-405f-b66d-ff2cfd507413" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_ff7f2d99-1f75-4b0f-90b0-2b46f838abdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_IncreaseDecreaseInOperatingLeaseLiabilities_cecad724-6438-4e13-b287-de8949606042" xlink:href="goss-20200930.xsd#goss_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3571abf-e74b-405f-b66d-ff2cfd507413" xlink:to="loc_goss_IncreaseDecreaseInOperatingLeaseLiabilities_cecad724-6438-4e13-b287-de8949606042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1248af24-4f18-4a6b-8d8c-9e7ae2c12bb3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3571abf-e74b-405f-b66d-ff2cfd507413" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1248af24-4f18-4a6b-8d8c-9e7ae2c12bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_2e8ccee0-be26-4341-ae49-4dde42867ce4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3571abf-e74b-405f-b66d-ff2cfd507413" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_2e8ccee0-be26-4341-ae49-4dde42867ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses_8fd47ae2-90cd-46fa-b336-475696149246" xlink:href="goss-20200930.xsd#goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3571abf-e74b-405f-b66d-ff2cfd507413" xlink:to="loc_goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses_8fd47ae2-90cd-46fa-b336-475696149246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_af7d6d41-0744-4b33-a46d-289400ce9def" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a3571abf-e74b-405f-b66d-ff2cfd507413" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_af7d6d41-0744-4b33-a46d-289400ce9def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_46b87b9d-b9d5-4cd6-a8df-83943948964a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ea9c6298-0c2b-4b73-8869-922e02b368ae" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_46b87b9d-b9d5-4cd6-a8df-83943948964a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_93b7ea5d-8b8f-42c4-80ff-1c12a0c2477a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_602bb2e7-7ad9-4720-b801-1f0d5555001b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_93b7ea5d-8b8f-42c4-80ff-1c12a0c2477a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions_4150f8b9-63a6-42be-90e6-bd8980357f08" xlink:href="goss-20200930.xsd#goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_93b7ea5d-8b8f-42c4-80ff-1c12a0c2477a" xlink:to="loc_goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions_4150f8b9-63a6-42be-90e6-bd8980357f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_5269058c-18d8-4858-8d98-db2fdc20980c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_93b7ea5d-8b8f-42c4-80ff-1c12a0c2477a" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_5269058c-18d8-4858-8d98-db2fdc20980c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ProceedsFromMaturityOfMarketableSecurities_5da738cb-5da3-40ba-bd14-1e4b7afdf9f1" xlink:href="goss-20200930.xsd#goss_ProceedsFromMaturityOfMarketableSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_93b7ea5d-8b8f-42c4-80ff-1c12a0c2477a" xlink:to="loc_goss_ProceedsFromMaturityOfMarketableSecurities_5da738cb-5da3-40ba-bd14-1e4b7afdf9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ProceedsFromSaleOfMarketableSecurities_a0f51f99-2684-4d74-b903-6e3fd4d8e3ff" xlink:href="goss-20200930.xsd#goss_ProceedsFromSaleOfMarketableSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_93b7ea5d-8b8f-42c4-80ff-1c12a0c2477a" xlink:to="loc_goss_ProceedsFromSaleOfMarketableSecurities_a0f51f99-2684-4d74-b903-6e3fd4d8e3ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_66273fae-acea-4ff8-a971-a42baf3c683c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_93b7ea5d-8b8f-42c4-80ff-1c12a0c2477a" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_66273fae-acea-4ff8-a971-a42baf3c683c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a3d32a58-784c-4631-9f93-f7e21f14f588" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_93b7ea5d-8b8f-42c4-80ff-1c12a0c2477a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a3d32a58-784c-4631-9f93-f7e21f14f588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d0d6dad-d600-4b22-bd2e-7fd2b425b46b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_602bb2e7-7ad9-4720-b801-1f0d5555001b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d0d6dad-d600-4b22-bd2e-7fd2b425b46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ae769d84-9622-493b-a8f1-ae772063fc35" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d0d6dad-d600-4b22-bd2e-7fd2b425b46b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ae769d84-9622-493b-a8f1-ae772063fc35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_14d7836b-0def-4634-b878-5e31dd166869" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d0d6dad-d600-4b22-bd2e-7fd2b425b46b" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_14d7836b-0def-4634-b878-5e31dd166869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_b598a42d-c32a-44b7-8953-af0f734ebc2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d0d6dad-d600-4b22-bd2e-7fd2b425b46b" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_b598a42d-c32a-44b7-8953-af0f734ebc2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_2f3a5238-d651-42f0-919f-cbfc54644f54" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d0d6dad-d600-4b22-bd2e-7fd2b425b46b" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_2f3a5238-d651-42f0-919f-cbfc54644f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_05a35cef-f91b-41cf-a49a-7d85ee999534" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8d0d6dad-d600-4b22-bd2e-7fd2b425b46b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_05a35cef-f91b-41cf-a49a-7d85ee999534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_cdb893ee-9e27-4f4d-9506-0589bc0d5b87" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_602bb2e7-7ad9-4720-b801-1f0d5555001b" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_cdb893ee-9e27-4f4d-9506-0589bc0d5b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_8eeda8e5-2ac0-412e-9b1d-aecf67e0703e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_602bb2e7-7ad9-4720-b801-1f0d5555001b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_8eeda8e5-2ac0-412e-9b1d-aecf67e0703e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_78ebf260-17ca-4499-a272-97873b9ea995" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_602bb2e7-7ad9-4720-b801-1f0d5555001b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_78ebf260-17ca-4499-a272-97873b9ea995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e828fcb1-acfe-442b-a085-6d6ac61c7e5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_602bb2e7-7ad9-4720-b801-1f0d5555001b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e828fcb1-acfe-442b-a085-6d6ac61c7e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_73eb2f2c-a64e-4425-a738-1fd6ca6f1947" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_602bb2e7-7ad9-4720-b801-1f0d5555001b" xlink:to="loc_us-gaap_SupplementalCashFlowElementsAbstract_73eb2f2c-a64e-4425-a738-1fd6ca6f1947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_5b935420-eb70-450d-9674-080d48dc95b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_73eb2f2c-a64e-4425-a738-1fd6ca6f1947" xlink:to="loc_us-gaap_InterestPaidNet_5b935420-eb70-450d-9674-080d48dc95b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d3c10f83-495d-44c3-944f-e603fd2ab3e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_602bb2e7-7ad9-4720-b801-1f0d5555001b" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d3c10f83-495d-44c3-944f-e603fd2ab3e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities_37f5042f-98a9-4470-b52b-3182504c0130" xlink:href="goss-20200930.xsd#goss_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d3c10f83-495d-44c3-944f-e603fd2ab3e7" xlink:to="loc_goss_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities_37f5042f-98a9-4470-b52b-3182504c0130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax_c483e11e-f37f-449d-b97b-38bc705df534" xlink:href="goss-20200930.xsd#goss_NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d3c10f83-495d-44c3-944f-e603fd2ab3e7" xlink:to="loc_goss_NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax_c483e11e-f37f-449d-b97b-38bc705df534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_3d2bcef1-1146-45fa-84a1-4a359ce5ed28" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d3c10f83-495d-44c3-944f-e603fd2ab3e7" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_3d2bcef1-1146-45fa-84a1-4a359ce5ed28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock_989df77f-41e1-4f7b-b8c4-1bb2b4b7b135" xlink:href="goss-20200930.xsd#goss_NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d3c10f83-495d-44c3-944f-e603fd2ab3e7" xlink:to="loc_goss_NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock_989df77f-41e1-4f7b-b8c4-1bb2b4b7b135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical" xlink:type="simple" xlink:href="goss-20200930.xsd#CondensedConsolidatedStatementsofCashFlowsParenthetical"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_2b05f97f-988d-45ed-aee0-f8b02c2df982" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f64ca3f5-6883-4e1e-9733-5eb2d9553125" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_2b05f97f-988d-45ed-aee0-f8b02c2df982" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f64ca3f5-6883-4e1e-9733-5eb2d9553125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/DescriptionoftheBusiness" xlink:type="simple" xlink:href="goss-20200930.xsd#DescriptionoftheBusiness"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/DescriptionoftheBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d1228360-0562-41b9-81e2-43efdbf6bbe7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_79f5b80c-5a9e-47e8-9be9-ad58c448f9fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d1228360-0562-41b9-81e2-43efdbf6bbe7" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_79f5b80c-5a9e-47e8-9be9-ad58c448f9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail" xlink:type="simple" xlink:href="goss-20200930.xsd#DescriptionoftheBusinessAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_646e4255-8c43-4157-939c-719f374e484a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_DescriptionOfBusinessTable_2adfd908-6f16-4ce4-8309-ee1c08520323" xlink:href="goss-20200930.xsd#goss_DescriptionOfBusinessTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_646e4255-8c43-4157-939c-719f374e484a" xlink:to="loc_goss_DescriptionOfBusinessTable_2adfd908-6f16-4ce4-8309-ee1c08520323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_b1c20a45-a1ed-4d88-9440-91362701ed63" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_DescriptionOfBusinessTable_2adfd908-6f16-4ce4-8309-ee1c08520323" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_b1c20a45-a1ed-4d88-9440-91362701ed63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cee0976a-c0ad-49f8-8915-4754b369f4f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b1c20a45-a1ed-4d88-9440-91362701ed63" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cee0976a-c0ad-49f8-8915-4754b369f4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_61ec2ab2-2b02-40f8-8c09-ef6146f54730" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_cee0976a-c0ad-49f8-8915-4754b369f4f4" xlink:to="loc_us-gaap_IPOMember_61ec2ab2-2b02-40f8-8c09-ef6146f54730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_2bf18381-ce93-4926-a7bd-191e9f68c0b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_DescriptionOfBusinessTable_2adfd908-6f16-4ce4-8309-ee1c08520323" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_2bf18381-ce93-4926-a7bd-191e9f68c0b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_31db8ed3-9a49-451a-afc1-a16f4bb2be9b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_2bf18381-ce93-4926-a7bd-191e9f68c0b7" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_31db8ed3-9a49-451a-afc1-a16f4bb2be9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ConversionOfConvertiblePreferredStockIntoCommonStockMember_6c43fd4c-8090-4353-9b54-222b742d2d59" xlink:href="goss-20200930.xsd#goss_ConversionOfConvertiblePreferredStockIntoCommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_31db8ed3-9a49-451a-afc1-a16f4bb2be9b" xlink:to="loc_goss_ConversionOfConvertiblePreferredStockIntoCommonStockMember_6c43fd4c-8090-4353-9b54-222b742d2d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f46923ba-2e99-40cb-a8d1-455e51543325" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_DescriptionOfBusinessTable_2adfd908-6f16-4ce4-8309-ee1c08520323" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f46923ba-2e99-40cb-a8d1-455e51543325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_94a3ef33-a29b-4a58-a7e8-73ed224385e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f46923ba-2e99-40cb-a8d1-455e51543325" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_94a3ef33-a29b-4a58-a7e8-73ed224385e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandTwentySevenNotesMember_a5563e92-ec3b-4596-a7ff-63f28a1c109f" xlink:href="goss-20200930.xsd#goss_TwoThousandTwentySevenNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_94a3ef33-a29b-4a58-a7e8-73ed224385e4" xlink:to="loc_goss_TwoThousandTwentySevenNotesMember_a5563e92-ec3b-4596-a7ff-63f28a1c109f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a2f3c16d-1865-4500-931b-4e1a155f4ad3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_DescriptionOfBusinessTable_2adfd908-6f16-4ce4-8309-ee1c08520323" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a2f3c16d-1865-4500-931b-4e1a155f4ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72bc08a0-02e0-4499-ad3c-e7b625c4d9f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a2f3c16d-1865-4500-931b-4e1a155f4ad3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72bc08a0-02e0-4499-ad3c-e7b625c4d9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AABiopharmaIncMember_70baaae7-2e02-497e-b284-740e83214c80" xlink:href="goss-20200930.xsd#goss_AABiopharmaIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72bc08a0-02e0-4499-ad3c-e7b625c4d9f0" xlink:to="loc_goss_AABiopharmaIncMember_70baaae7-2e02-497e-b284-740e83214c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_DescriptionOfBusinessLineItems_fe28ff1b-7d51-40c9-9cc8-5b0f76d18688" xlink:href="goss-20200930.xsd#goss_DescriptionOfBusinessLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_DescriptionOfBusinessTable_2adfd908-6f16-4ce4-8309-ee1c08520323" xlink:to="loc_goss_DescriptionOfBusinessLineItems_fe28ff1b-7d51-40c9-9cc8-5b0f76d18688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b099f21d-8610-424f-8a58-a4d4bd235006" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_DescriptionOfBusinessLineItems_fe28ff1b-7d51-40c9-9cc8-5b0f76d18688" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b099f21d-8610-424f-8a58-a4d4bd235006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_e7343610-f624-4c73-afd2-d0bf25e77c64" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_DescriptionOfBusinessLineItems_fe28ff1b-7d51-40c9-9cc8-5b0f76d18688" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_e7343610-f624-4c73-afd2-d0bf25e77c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_5fe7af36-0f41-4461-b439-3ae1af6c95fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_DescriptionOfBusinessLineItems_fe28ff1b-7d51-40c9-9cc8-5b0f76d18688" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_5fe7af36-0f41-4461-b439-3ae1af6c95fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_019401c1-acff-463b-8c62-1dedc94c49cd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_DescriptionOfBusinessLineItems_fe28ff1b-7d51-40c9-9cc8-5b0f76d18688" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_019401c1-acff-463b-8c62-1dedc94c49cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e604e685-605f-4c78-b271-c2b88a47940d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_DescriptionOfBusinessLineItems_fe28ff1b-7d51-40c9-9cc8-5b0f76d18688" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e604e685-605f-4c78-b271-c2b88a47940d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering_aa36f2d9-82c1-425f-98d2-8d4246db4765" xlink:href="goss-20200930.xsd#goss_FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_DescriptionOfBusinessLineItems_fe28ff1b-7d51-40c9-9cc8-5b0f76d18688" xlink:to="loc_goss_FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering_aa36f2d9-82c1-425f-98d2-8d4246db4765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e85daa42-68db-4041-b120-83d555f7e3ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_DescriptionOfBusinessLineItems_fe28ff1b-7d51-40c9-9cc8-5b0f76d18688" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e85daa42-68db-4041-b120-83d555f7e3ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_8781e02a-f596-40d4-a23c-96195e5aa572" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_DescriptionOfBusinessLineItems_fe28ff1b-7d51-40c9-9cc8-5b0f76d18688" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_8781e02a-f596-40d4-a23c-96195e5aa572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="goss-20200930.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_57c16682-18a7-41e4-8834-3addbad3ffeb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_4eb96b20-bec7-4788-a007-736b4a16f041" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_57c16682-18a7-41e4-8834-3addbad3ffeb" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_4eb96b20-bec7-4788-a007-736b4a16f041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="goss-20200930.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5347aa5d-84e2-481d-9c1c-27d0b888d0f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_dd324ba4-4c60-42e1-bbf6-d1ed6568e668" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5347aa5d-84e2-481d-9c1c-27d0b888d0f5" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_dd324ba4-4c60-42e1-bbf6-d1ed6568e668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_df9147dc-0d78-4c75-af30-5a0be6d7b017" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5347aa5d-84e2-481d-9c1c-27d0b888d0f5" xlink:to="loc_us-gaap_UseOfEstimates_df9147dc-0d78-4c75-af30-5a0be6d7b017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ConvertibleSeniorNotesPolicyTextBlock_3d058a38-9add-42af-8576-28ca7c13f7ca" xlink:href="goss-20200930.xsd#goss_ConvertibleSeniorNotesPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5347aa5d-84e2-481d-9c1c-27d0b888d0f5" xlink:to="loc_goss_ConvertibleSeniorNotesPolicyTextBlock_3d058a38-9add-42af-8576-28ca7c13f7ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3d9553d0-2506-4b47-9f4e-bcd2e3600aba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5347aa5d-84e2-481d-9c1c-27d0b888d0f5" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3d9553d0-2506-4b47-9f4e-bcd2e3600aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_9a0055e2-0284-4848-a90c-46f0a57be75f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5347aa5d-84e2-481d-9c1c-27d0b888d0f5" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_9a0055e2-0284-4848-a90c-46f0a57be75f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="goss-20200930.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b8efb146-8de2-4b03-a3d4-f310fd86ac7e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_e785a9d5-b74f-4e54-925c-e5a8cac46c56" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b8efb146-8de2-4b03-a3d4-f310fd86ac7e" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_e785a9d5-b74f-4e54-925c-e5a8cac46c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5b25cc65-22df-46ac-9c5f-862a526b4f7c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8d4c4b6a-71be-4a02-b863-35b0f9c80fd9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5b25cc65-22df-46ac-9c5f-862a526b4f7c" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8d4c4b6a-71be-4a02-b863-35b0f9c80fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5cb34180-dbff-428a-aa48-c9d092216b85" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8d4c4b6a-71be-4a02-b863-35b0f9c80fd9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5cb34180-dbff-428a-aa48-c9d092216b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e64b6fa-fac5-40e3-8faf-d3a199001c15" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5cb34180-dbff-428a-aa48-c9d092216b85" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e64b6fa-fac5-40e3-8faf-d3a199001c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandTwentySevenNotesMember_4f1ab2ab-44b3-4ba3-99e0-804d56cfb9ca" xlink:href="goss-20200930.xsd#goss_TwoThousandTwentySevenNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e64b6fa-fac5-40e3-8faf-d3a199001c15" xlink:to="loc_goss_TwoThousandTwentySevenNotesMember_4f1ab2ab-44b3-4ba3-99e0-804d56cfb9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_071768de-f5b1-4851-be51-b200f43e2324" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e64b6fa-fac5-40e3-8faf-d3a199001c15" xlink:to="loc_us-gaap_EmployeeStockOptionMember_071768de-f5b1-4851-be51-b200f43e2324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_22c77d9c-ed26-4a22-ac84-f9e41c57bbf3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9e64b6fa-fac5-40e3-8faf-d3a199001c15" xlink:to="loc_us-gaap_RestrictedStockMember_22c77d9c-ed26-4a22-ac84-f9e41c57bbf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e5db39dc-47c3-43a3-9405-2deb211e4f7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8d4c4b6a-71be-4a02-b863-35b0f9c80fd9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e5db39dc-47c3-43a3-9405-2deb211e4f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8d8fd8c0-9c08-484a-b250-a9a77bec7cb6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_e5db39dc-47c3-43a3-9405-2deb211e4f7f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8d8fd8c0-9c08-484a-b250-a9a77bec7cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosures" xlink:type="simple" xlink:href="goss-20200930.xsd#BalanceSheetAccountsandSupplementalDisclosures"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract_f64b47a0-10f9-41f8-bc41-e49522c51ed5" xlink:href="goss-20200930.xsd#goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_059d7b33-f82f-458d-ba40-aa1a365a2118" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract_f64b47a0-10f9-41f8-bc41-e49522c51ed5" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_059d7b33-f82f-458d-ba40-aa1a365a2118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresTables" xlink:type="simple" xlink:href="goss-20200930.xsd#BalanceSheetAccountsandSupplementalDisclosuresTables"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract_a08053f7-02f5-4d29-ac0e-a8e3aaa3ce7e" xlink:href="goss-20200930.xsd#goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_7705bf9b-4d48-4aa2-81b3-64c4bb4b526a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract_a08053f7-02f5-4d29-ac0e-a8e3aaa3ce7e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_7705bf9b-4d48-4aa2-81b3-64c4bb4b526a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_170d2944-65a9-4438-8c4d-2be60c0c6cff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract_a08053f7-02f5-4d29-ac0e-a8e3aaa3ce7e" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_170d2944-65a9-4438-8c4d-2be60c0c6cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b485cd87-f253-4756-963b-58109995152e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_faa8f235-6b9b-4a8b-87f0-7e33387c464e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b485cd87-f253-4756-963b-58109995152e" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_faa8f235-6b9b-4a8b-87f0-7e33387c464e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_19e05e72-86ef-4375-b41b-043ada1be029" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_faa8f235-6b9b-4a8b-87f0-7e33387c464e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_19e05e72-86ef-4375-b41b-043ada1be029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9c9af29f-5e2f-4590-9fc2-a5f970565ec3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_19e05e72-86ef-4375-b41b-043ada1be029" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9c9af29f-5e2f-4590-9fc2-a5f970565ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_7ab6a20b-80dd-4adc-a3ac-0cb78b3889ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9c9af29f-5e2f-4590-9fc2-a5f970565ec3" xlink:to="loc_us-gaap_OfficeEquipmentMember_7ab6a20b-80dd-4adc-a3ac-0cb78b3889ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_a94de200-9b03-45bd-9587-76d92812a9e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9c9af29f-5e2f-4590-9fc2-a5f970565ec3" xlink:to="loc_us-gaap_ComputerEquipmentMember_a94de200-9b03-45bd-9587-76d92812a9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_64a15485-f6d1-4570-9c94-1adbd1e21fa1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9c9af29f-5e2f-4590-9fc2-a5f970565ec3" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_64a15485-f6d1-4570-9c94-1adbd1e21fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_01cfa23e-1f56-4dea-9cf0-c1e1adc64119" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9c9af29f-5e2f-4590-9fc2-a5f970565ec3" xlink:to="loc_us-gaap_EquipmentMember_01cfa23e-1f56-4dea-9cf0-c1e1adc64119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_702d2c8b-f94f-461a-89ac-f7c0c26a46a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9c9af29f-5e2f-4590-9fc2-a5f970565ec3" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_702d2c8b-f94f-461a-89ac-f7c0c26a46a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_8f191f7e-1603-4bc5-ba8b-f6da1bd790b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9c9af29f-5e2f-4590-9fc2-a5f970565ec3" xlink:to="loc_us-gaap_ConstructionInProgressMember_8f191f7e-1603-4bc5-ba8b-f6da1bd790b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8c26de6c-e1b1-4a19-b7ad-b2270a6a67bc" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_faa8f235-6b9b-4a8b-87f0-7e33387c464e" xlink:to="loc_srt_RangeAxis_8c26de6c-e1b1-4a19-b7ad-b2270a6a67bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e2086660-4ba0-4dbc-87e1-c5e247f60f8d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_8c26de6c-e1b1-4a19-b7ad-b2270a6a67bc" xlink:to="loc_srt_RangeMember_e2086660-4ba0-4dbc-87e1-c5e247f60f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f1dbaf9f-3dc2-462b-a559-eb6163523434" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e2086660-4ba0-4dbc-87e1-c5e247f60f8d" xlink:to="loc_srt_MinimumMember_f1dbaf9f-3dc2-462b-a559-eb6163523434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a2b498a9-c0be-45a0-84ea-1deb35fcbfaf" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e2086660-4ba0-4dbc-87e1-c5e247f60f8d" xlink:to="loc_srt_MaximumMember_a2b498a9-c0be-45a0-84ea-1deb35fcbfaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1e90347f-f845-4d59-8e39-37272e844889" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_faa8f235-6b9b-4a8b-87f0-7e33387c464e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1e90347f-f845-4d59-8e39-37272e844889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c87201ca-4e12-4b8a-bdd7-0e82cdf7d355" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1e90347f-f845-4d59-8e39-37272e844889" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c87201ca-4e12-4b8a-bdd7-0e82cdf7d355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b7c0a42d-0c71-415a-bc12-719aaba86348" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1e90347f-f845-4d59-8e39-37272e844889" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b7c0a42d-0c71-415a-bc12-719aaba86348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ce3e8711-0bbe-40d8-836a-a0dfc7790b10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1e90347f-f845-4d59-8e39-37272e844889" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ce3e8711-0bbe-40d8-836a-a0dfc7790b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_3badbcd8-9e59-4050-bd3a-a9b34daf29f8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1e90347f-f845-4d59-8e39-37272e844889" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_3badbcd8-9e59-4050-bd3a-a9b34daf29f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_c73463fa-4465-4fd5-b3ac-70bc43893ff4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_cf35dcb4-2b9b-47a3-bc9a-36d1ebe9edf6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_c73463fa-4465-4fd5-b3ac-70bc43893ff4" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_cf35dcb4-2b9b-47a3-bc9a-36d1ebe9edf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_28b876b8-de1b-49b4-9866-d4c44d93ddcb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_c73463fa-4465-4fd5-b3ac-70bc43893ff4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_28b876b8-de1b-49b4-9866-d4c44d93ddcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_e5d77d11-bac3-4555-b103-d50025ddaf00" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_c73463fa-4465-4fd5-b3ac-70bc43893ff4" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_e5d77d11-bac3-4555-b103-d50025ddaf00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_b84d54dd-7f25-44fe-82fd-eb41e01712e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_c73463fa-4465-4fd5-b3ac-70bc43893ff4" xlink:to="loc_us-gaap_InterestPayableCurrent_b84d54dd-7f25-44fe-82fd-eb41e01712e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_f430088b-52e9-4f08-b9dd-7c573d3cba17" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_c73463fa-4465-4fd5-b3ac-70bc43893ff4" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_f430088b-52e9-4f08-b9dd-7c573d3cba17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AccruedInProcessResearchAndDevelopment_f7864aa8-045a-4159-80d7-fc9a44cc384c" xlink:href="goss-20200930.xsd#goss_AccruedInProcessResearchAndDevelopment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_c73463fa-4465-4fd5-b3ac-70bc43893ff4" xlink:to="loc_goss_AccruedInProcessResearchAndDevelopment_f7864aa8-045a-4159-80d7-fc9a44cc384c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_5453385c-cda1-4301-aa40-21483e319a95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_c73463fa-4465-4fd5-b3ac-70bc43893ff4" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_5453385c-cda1-4301-aa40-21483e319a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestments" xlink:type="simple" xlink:href="goss-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestments"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract_5b3c1d3e-ec6c-41e2-b380-f8f846cda041" xlink:href="goss-20200930.xsd#goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock_1bbc698f-b5c1-4519-99fc-4bab31071f5e" xlink:href="goss-20200930.xsd#goss_FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract_5b3c1d3e-ec6c-41e2-b380-f8f846cda041" xlink:to="loc_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock_1bbc698f-b5c1-4519-99fc-4bab31071f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsTables" xlink:type="simple" xlink:href="goss-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract_41a602e7-5bd1-4be5-9493-fb98ca810b60" xlink:href="goss-20200930.xsd#goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_e33d58ed-79f2-4d40-861f-d52955bed9c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract_41a602e7-5bd1-4be5-9493-fb98ca810b60" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_e33d58ed-79f2-4d40-861f-d52955bed9c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_02ecddc0-0f22-4103-b133-a0c5e13e80c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract_41a602e7-5bd1-4be5-9493-fb98ca810b60" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_02ecddc0-0f22-4103-b133-a0c5e13e80c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_0fd1f7bb-9f76-4c2a-84db-741a1dedc489" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract_41a602e7-5bd1-4be5-9493-fb98ca810b60" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_0fd1f7bb-9f76-4c2a-84db-741a1dedc489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract_27f314d3-edd2-4129-905a-fda053d983c4" xlink:href="goss-20200930.xsd#goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a84252a-80d6-47bf-9cd5-b78d721aabf8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract_27f314d3-edd2-4129-905a-fda053d983c4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a84252a-80d6-47bf-9cd5-b78d721aabf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_eee4685c-e6ab-46cf-bcc7-2bce1ccd699e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a84252a-80d6-47bf-9cd5-b78d721aabf8" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_eee4685c-e6ab-46cf-bcc7-2bce1ccd699e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_fa0b9185-0ab8-4b86-9c86-b74bc4c74a72" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_eee4685c-e6ab-46cf-bcc7-2bce1ccd699e" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_fa0b9185-0ab8-4b86-9c86-b74bc4c74a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_ecbada11-49af-4faa-ac20-0ace00200b89" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_fa0b9185-0ab8-4b86-9c86-b74bc4c74a72" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_ecbada11-49af-4faa-ac20-0ace00200b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6fab660e-eaef-47f3-811f-ed650b75c519" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a84252a-80d6-47bf-9cd5-b78d721aabf8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6fab660e-eaef-47f3-811f-ed650b75c519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8922e9f7-8ba1-4274-bff5-3dc52e60fc48" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6fab660e-eaef-47f3-811f-ed650b75c519" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8922e9f7-8ba1-4274-bff5-3dc52e60fc48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9d8ac12e-e5bc-4335-9cdb-d65ee692f085" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8922e9f7-8ba1-4274-bff5-3dc52e60fc48" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9d8ac12e-e5bc-4335-9cdb-d65ee692f085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b6eba561-ef1e-4d03-a48d-a8d2cac37071" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8922e9f7-8ba1-4274-bff5-3dc52e60fc48" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b6eba561-ef1e-4d03-a48d-a8d2cac37071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_0451104a-6349-4600-9a80-abdca4f0c6f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8922e9f7-8ba1-4274-bff5-3dc52e60fc48" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_0451104a-6349-4600-9a80-abdca4f0c6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_5374d37c-9931-4fcc-a344-0fe05f9654e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a84252a-80d6-47bf-9cd5-b78d721aabf8" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_5374d37c-9931-4fcc-a344-0fe05f9654e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a71d829f-2647-4831-b541-d10c80651a64" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_5374d37c-9931-4fcc-a344-0fe05f9654e7" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a71d829f-2647-4831-b541-d10c80651a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_60114a7b-e524-4b5a-8288-966302a53443" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a71d829f-2647-4831-b541-d10c80651a64" xlink:to="loc_us-gaap_MoneyMarketFundsMember_60114a7b-e524-4b5a-8288-966302a53443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_USTreasuryAndAgencySecuritiesMember_f6f32cc2-8d2f-4cb4-b965-83d5db5d8be9" xlink:href="goss-20200930.xsd#goss_USTreasuryAndAgencySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a71d829f-2647-4831-b541-d10c80651a64" xlink:to="loc_goss_USTreasuryAndAgencySecuritiesMember_f6f32cc2-8d2f-4cb4-b965-83d5db5d8be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_29a0f17b-cc26-4207-9bd7-3b88ab4f2231" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a71d829f-2647-4831-b541-d10c80651a64" xlink:to="loc_us-gaap_CommercialPaperMember_29a0f17b-cc26-4207-9bd7-3b88ab4f2231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_850755f4-d595-4b77-bb62-3f41ba37342d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a71d829f-2647-4831-b541-d10c80651a64" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_850755f4-d595-4b77-bb62-3f41ba37342d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f34f7c47-d88e-44f7-a203-f195325b6cc1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7a84252a-80d6-47bf-9cd5-b78d721aabf8" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f34f7c47-d88e-44f7-a203-f195325b6cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_9e1d18f3-4c99-47e5-bbab-bd2a01a2403e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f34f7c47-d88e-44f7-a203-f195325b6cc1" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_9e1d18f3-4c99-47e5-bbab-bd2a01a2403e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract_dbccbe19-c40f-43b6-ac12-515545a19602" xlink:href="goss-20200930.xsd#goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ccc098ed-65df-4fe6-9e7d-2073a53b95f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract_dbccbe19-c40f-43b6-ac12-515545a19602" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ccc098ed-65df-4fe6-9e7d-2073a53b95f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f21923e1-854f-4e12-b8ee-234769e94e61" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ccc098ed-65df-4fe6-9e7d-2073a53b95f1" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f21923e1-854f-4e12-b8ee-234769e94e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_96e5ad6a-d8b6-4747-8c79-e31a359ae200" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f21923e1-854f-4e12-b8ee-234769e94e61" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_96e5ad6a-d8b6-4747-8c79-e31a359ae200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_1e099177-bc4c-4843-a836-975ccb7df1c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_96e5ad6a-d8b6-4747-8c79-e31a359ae200" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_1e099177-bc4c-4843-a836-975ccb7df1c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f03801b9-1858-47a3-bf39-599df9e10746" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ccc098ed-65df-4fe6-9e7d-2073a53b95f1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f03801b9-1858-47a3-bf39-599df9e10746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dc7ab9bd-5c2b-460b-a392-234caef73ae1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f03801b9-1858-47a3-bf39-599df9e10746" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dc7ab9bd-5c2b-460b-a392-234caef73ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandTwentySevenNotesMember_937c92d1-0cc4-472a-a2d2-61a6f560ea6c" xlink:href="goss-20200930.xsd#goss_TwoThousandTwentySevenNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dc7ab9bd-5c2b-460b-a392-234caef73ae1" xlink:to="loc_goss_TwoThousandTwentySevenNotesMember_937c92d1-0cc4-472a-a2d2-61a6f560ea6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_efa514d7-80bb-4b82-97f5-d513fc9ae1f8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ccc098ed-65df-4fe6-9e7d-2073a53b95f1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_efa514d7-80bb-4b82-97f5-d513fc9ae1f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c0ed5cbb-e662-4523-88d2-3162bc007508" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_efa514d7-80bb-4b82-97f5-d513fc9ae1f8" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c0ed5cbb-e662-4523-88d2-3162bc007508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f28c7853-a2cc-4b24-8dc3-40ff33d01775" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c0ed5cbb-e662-4523-88d2-3162bc007508" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f28c7853-a2cc-4b24-8dc3-40ff33d01775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_47039a80-9bf9-41ed-b08a-24348a000b15" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ccc098ed-65df-4fe6-9e7d-2073a53b95f1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_47039a80-9bf9-41ed-b08a-24348a000b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueEquityLevel1ToLevel2TransfersAmount_762c0ce2-0cf7-47c9-b6fd-419551cba94d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueEquityLevel1ToLevel2TransfersAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_47039a80-9bf9-41ed-b08a-24348a000b15" xlink:to="loc_us-gaap_FairValueEquityLevel1ToLevel2TransfersAmount_762c0ce2-0cf7-47c9-b6fd-419551cba94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueEquityLevel2ToLevel1TransfersAmount_86b47f9b-1e8f-4aa9-b416-707fc00ddb65" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueEquityLevel2ToLevel1TransfersAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_47039a80-9bf9-41ed-b08a-24348a000b15" xlink:to="loc_us-gaap_FairValueEquityLevel2ToLevel1TransfersAmount_86b47f9b-1e8f-4aa9-b416-707fc00ddb65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InterestAndSecuritiesReceivable_889fedd0-2134-4e4d-a352-4b689d5a478f" xlink:href="goss-20200930.xsd#goss_InterestAndSecuritiesReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_47039a80-9bf9-41ed-b08a-24348a000b15" xlink:to="loc_goss_InterestAndSecuritiesReceivable_889fedd0-2134-4e4d-a352-4b689d5a478f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_250bb0d2-6bdd-4181-b1ac-98df51fad64d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_47039a80-9bf9-41ed-b08a-24348a000b15" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_250bb0d2-6bdd-4181-b1ac-98df51fad64d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract_d7ec8230-337a-4ca8-bd36-53d3aa797e09" xlink:href="goss-20200930.xsd#goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_009b372b-e544-4d7c-8d31-ca4c703ee7d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract_d7ec8230-337a-4ca8-bd36-53d3aa797e09" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_009b372b-e544-4d7c-8d31-ca4c703ee7d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_fa4d9b3e-8339-4a77-acfa-294b1c413173" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_009b372b-e544-4d7c-8d31-ca4c703ee7d7" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_fa4d9b3e-8339-4a77-acfa-294b1c413173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b2670280-a87e-4e6c-b2c6-be93f554b034" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_fa4d9b3e-8339-4a77-acfa-294b1c413173" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b2670280-a87e-4e6c-b2c6-be93f554b034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_USTreasuryAndAgencySecuritiesMember_468d5c34-65ff-4a7b-b49d-57adb0bf0056" xlink:href="goss-20200930.xsd#goss_USTreasuryAndAgencySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b2670280-a87e-4e6c-b2c6-be93f554b034" xlink:to="loc_goss_USTreasuryAndAgencySecuritiesMember_468d5c34-65ff-4a7b-b49d-57adb0bf0056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_6d3d8336-5eab-4c0a-a107-1481ddfc00a2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b2670280-a87e-4e6c-b2c6-be93f554b034" xlink:to="loc_us-gaap_CommercialPaperMember_6d3d8336-5eab-4c0a-a107-1481ddfc00a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_f8dee858-1bfb-4c6c-94b4-9dfa2ed756e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b2670280-a87e-4e6c-b2c6-be93f554b034" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_f8dee858-1bfb-4c6c-94b4-9dfa2ed756e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_006800e9-aa29-4f58-b0c2-389979babef3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_009b372b-e544-4d7c-8d31-ca4c703ee7d7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_006800e9-aa29-4f58-b0c2-389979babef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8073ccd6-baae-4c8b-9f95-49ef03a46cd8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_006800e9-aa29-4f58-b0c2-389979babef3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8073ccd6-baae-4c8b-9f95-49ef03a46cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7d5ec65a-3601-4a4b-aad4-113e9b7a9f0e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_006800e9-aa29-4f58-b0c2-389979babef3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7d5ec65a-3601-4a4b-aad4-113e9b7a9f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4cd9e7c6-70bf-4876-9107-1e0997f55425" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_006800e9-aa29-4f58-b0c2-389979babef3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4cd9e7c6-70bf-4876-9107-1e0997f55425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_26216f2f-ba07-4567-9a8e-6955ca88aeae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_006800e9-aa29-4f58-b0c2-389979babef3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_26216f2f-ba07-4567-9a8e-6955ca88aeae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofContractualMaturitiesofAvailableforsaleDebtSecuritiesDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofContractualMaturitiesofAvailableforsaleDebtSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofContractualMaturitiesofAvailableforsaleDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract_c9fd24b1-aa9f-45f6-a398-3eacc2c5b15c" xlink:href="goss-20200930.xsd#goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_a8847738-a124-41ec-9dbf-5b9d1bbe5578" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract_c9fd24b1-aa9f-45f6-a398-3eacc2c5b15c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_a8847738-a124-41ec-9dbf-5b9d1bbe5578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_72cdc638-a3f6-4a9e-a1d5-1e68c0a76d31" xlink:href="goss-20200930.xsd#goss_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract_c9fd24b1-aa9f-45f6-a398-3eacc2c5b15c" xlink:to="loc_goss_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_72cdc638-a3f6-4a9e-a1d5-1e68c0a76d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f5dcc093-ad02-470e-8542-5ce89021404c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract_c9fd24b1-aa9f-45f6-a398-3eacc2c5b15c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f5dcc093-ad02-470e-8542-5ce89021404c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/Indebtedness" xlink:type="simple" xlink:href="goss-20200930.xsd#Indebtedness"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/Indebtedness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_cc1262c1-ea58-4710-81ac-e8816229704e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_d4396c4a-9a61-4292-9cd2-18dc115b79b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cc1262c1-ea58-4710-81ac-e8816229704e" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_d4396c4a-9a61-4292-9cd2-18dc115b79b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/IndebtednessTables" xlink:type="simple" xlink:href="goss-20200930.xsd#IndebtednessTables"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/IndebtednessTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c448ec5f-a479-457f-98f8-cd8b9110f24f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_74bc98af-ac97-44fc-8ca5-86e360d67b47" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c448ec5f-a479-457f-98f8-cd8b9110f24f" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_74bc98af-ac97-44fc-8ca5-86e360d67b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_75eb0884-df27-41d3-a508-a8b9827f0a7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c448ec5f-a479-457f-98f8-cd8b9110f24f" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_75eb0884-df27-41d3-a508-a8b9827f0a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ScheduleOfLiabilityComponentsOfNotesTableTextBlock_2998cf4f-5725-4a22-9a59-e395299f57a9" xlink:href="goss-20200930.xsd#goss_ScheduleOfLiabilityComponentsOfNotesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c448ec5f-a479-457f-98f8-cd8b9110f24f" xlink:to="loc_goss_ScheduleOfLiabilityComponentsOfNotesTableTextBlock_2998cf4f-5725-4a22-9a59-e395299f57a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ScheduleOfEquityComponentsOfNotesTableTextBlock_01af487b-f25b-4193-a112-a99df7d2f156" xlink:href="goss-20200930.xsd#goss_ScheduleOfEquityComponentsOfNotesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c448ec5f-a479-457f-98f8-cd8b9110f24f" xlink:to="loc_goss_ScheduleOfEquityComponentsOfNotesTableTextBlock_01af487b-f25b-4193-a112-a99df7d2f156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ScheduleOfInterestExpenseRecognizedTableTextBlock_76f2b8ab-c70c-48d9-9539-34c5d5672cca" xlink:href="goss-20200930.xsd#goss_ScheduleOfInterestExpenseRecognizedTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c448ec5f-a479-457f-98f8-cd8b9110f24f" xlink:to="loc_goss_ScheduleOfInterestExpenseRecognizedTableTextBlock_76f2b8ab-c70c-48d9-9539-34c5d5672cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#IndebtednessAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d12b4f86-ff31-4940-a534-2871ea4e5751" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f8e0837d-9d25-46f1-a5d8-5d3f1ce88d38" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d12b4f86-ff31-4940-a534-2871ea4e5751" xlink:to="loc_us-gaap_DebtInstrumentTable_f8e0837d-9d25-46f1-a5d8-5d3f1ce88d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_af16bbbe-df01-448e-87c3-915243b19bfb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f8e0837d-9d25-46f1-a5d8-5d3f1ce88d38" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_af16bbbe-df01-448e-87c3-915243b19bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6fd7c7be-610f-4bdf-aca3-c5417c7dbf00" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_af16bbbe-df01-448e-87c3-915243b19bfb" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6fd7c7be-610f-4bdf-aca3-c5417c7dbf00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TermLoanMember_c4877c6d-b442-4212-bb44-6ae7cc306104" xlink:href="goss-20200930.xsd#goss_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6fd7c7be-610f-4bdf-aca3-c5417c7dbf00" xlink:to="loc_goss_TermLoanMember_c4877c6d-b442-4212-bb44-6ae7cc306104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandTwentySevenNotesMember_0f30b1e5-c701-4625-b430-b3571077a914" xlink:href="goss-20200930.xsd#goss_TwoThousandTwentySevenNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6fd7c7be-610f-4bdf-aca3-c5417c7dbf00" xlink:to="loc_goss_TwoThousandTwentySevenNotesMember_0f30b1e5-c701-4625-b430-b3571077a914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_060a5c9f-903f-4aff-a83a-544ce5d5571b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f8e0837d-9d25-46f1-a5d8-5d3f1ce88d38" xlink:to="loc_us-gaap_VestingAxis_060a5c9f-903f-4aff-a83a-544ce5d5571b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_123a2244-699f-40fb-8a9d-1be19d4b388b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_060a5c9f-903f-4aff-a83a-544ce5d5571b" xlink:to="loc_us-gaap_VestingDomain_123a2244-699f-40fb-8a9d-1be19d4b388b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TrancheOneMember_276eb8f7-fc48-4e1f-868b-e735d88bd541" xlink:href="goss-20200930.xsd#goss_TrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_123a2244-699f-40fb-8a9d-1be19d4b388b" xlink:to="loc_goss_TrancheOneMember_276eb8f7-fc48-4e1f-868b-e735d88bd541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TrancheTwoMember_9a393980-03bf-4e41-9b73-9aa861467abc" xlink:href="goss-20200930.xsd#goss_TrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_123a2244-699f-40fb-8a9d-1be19d4b388b" xlink:to="loc_goss_TrancheTwoMember_9a393980-03bf-4e41-9b73-9aa861467abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_bdb71c96-4d72-416c-ade4-2f8368826094" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f8e0837d-9d25-46f1-a5d8-5d3f1ce88d38" xlink:to="loc_us-gaap_CreditFacilityAxis_bdb71c96-4d72-416c-ade4-2f8368826094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_cc073529-7fb3-4756-945c-7ca2cb2b73ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_bdb71c96-4d72-416c-ade4-2f8368826094" xlink:to="loc_us-gaap_CreditFacilityDomain_cc073529-7fb3-4756-945c-7ca2cb2b73ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_7e25cef5-45d8-45dd-bfbb-8ec31d48dd3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_cc073529-7fb3-4756-945c-7ca2cb2b73ff" xlink:to="loc_us-gaap_LineOfCreditMember_7e25cef5-45d8-45dd-bfbb-8ec31d48dd3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_02dafe0d-81f4-45da-a06b-9da735ddd426" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f8e0837d-9d25-46f1-a5d8-5d3f1ce88d38" xlink:to="loc_us-gaap_VariableRateAxis_02dafe0d-81f4-45da-a06b-9da735ddd426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_adb25cc6-dc34-42b1-8672-8cddb6a0a73b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_02dafe0d-81f4-45da-a06b-9da735ddd426" xlink:to="loc_us-gaap_VariableRateDomain_adb25cc6-dc34-42b1-8672-8cddb6a0a73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_46c656cc-8e42-4359-96c2-909b550e95ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_adb25cc6-dc34-42b1-8672-8cddb6a0a73b" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_46c656cc-8e42-4359-96c2-909b550e95ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_MidCapFinancialTrustMember_8899038b-1a32-4bf3-98ce-3fc97df58b2f" xlink:href="goss-20200930.xsd#goss_MidCapFinancialTrustMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_adb25cc6-dc34-42b1-8672-8cddb6a0a73b" xlink:to="loc_goss_MidCapFinancialTrustMember_8899038b-1a32-4bf3-98ce-3fc97df58b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_7ba1e14e-205c-486d-986d-0027da8c7c67" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f8e0837d-9d25-46f1-a5d8-5d3f1ce88d38" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_7ba1e14e-205c-486d-986d-0027da8c7c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4b2048a7-a296-421e-9b21-3f20559ab632" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_7ba1e14e-205c-486d-986d-0027da8c7c67" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4b2048a7-a296-421e-9b21-3f20559ab632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember_c1c8ec55-e2c4-49fa-a514-d291ccd71edd" xlink:href="goss-20200930.xsd#goss_PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4b2048a7-a296-421e-9b21-3f20559ab632" xlink:to="loc_goss_PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember_c1c8ec55-e2c4-49fa-a514-d291ccd71edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember_abd66e58-c627-4c6f-beb5-129963634a3b" xlink:href="goss-20200930.xsd#goss_FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4b2048a7-a296-421e-9b21-3f20559ab632" xlink:to="loc_goss_FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember_abd66e58-c627-4c6f-beb5-129963634a3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember_f25f2294-4bbc-4412-9da9-f7f32d0ed13b" xlink:href="goss-20200930.xsd#goss_SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_4b2048a7-a296-421e-9b21-3f20559ab632" xlink:to="loc_goss_SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember_f25f2294-4bbc-4412-9da9-f7f32d0ed13b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ecee68a0-12f8-466f-aad4-e333b4f5ff3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f8e0837d-9d25-46f1-a5d8-5d3f1ce88d38" xlink:to="loc_us-gaap_DebtInstrumentAxis_ecee68a0-12f8-466f-aad4-e333b4f5ff3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bbe59c72-a1af-4e16-8985-55e04a1a30b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ecee68a0-12f8-466f-aad4-e333b4f5ff3f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bbe59c72-a1af-4e16-8985-55e04a1a30b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_OneHundredThirtyPercentApplicableConversionPriceMember_c5ef2d66-647f-411a-a2d0-02fd68208acf" xlink:href="goss-20200930.xsd#goss_OneHundredThirtyPercentApplicableConversionPriceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bbe59c72-a1af-4e16-8985-55e04a1a30b4" xlink:to="loc_goss_OneHundredThirtyPercentApplicableConversionPriceMember_c5ef2d66-647f-411a-a2d0-02fd68208acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_NinetyEightPercentApplicableConversionPriceMember_3c579a3b-8056-4351-a28f-15542e08e25c" xlink:href="goss-20200930.xsd#goss_NinetyEightPercentApplicableConversionPriceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bbe59c72-a1af-4e16-8985-55e04a1a30b4" xlink:to="loc_goss_NinetyEightPercentApplicableConversionPriceMember_3c579a3b-8056-4351-a28f-15542e08e25c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1a059987-896c-43bb-a872-f431a929fd75" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f8e0837d-9d25-46f1-a5d8-5d3f1ce88d38" xlink:to="loc_srt_RangeAxis_1a059987-896c-43bb-a872-f431a929fd75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_64862706-8478-4e36-a6bd-557132a1f18d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1a059987-896c-43bb-a872-f431a929fd75" xlink:to="loc_srt_RangeMember_64862706-8478-4e36-a6bd-557132a1f18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e7e3fe1d-097d-45f9-8f07-217df01aa5d2" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_64862706-8478-4e36-a6bd-557132a1f18d" xlink:to="loc_srt_MinimumMember_e7e3fe1d-097d-45f9-8f07-217df01aa5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_44025c03-0747-4cd8-9e62-5bd06df7c2dc" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_64862706-8478-4e36-a6bd-557132a1f18d" xlink:to="loc_srt_MaximumMember_44025c03-0747-4cd8-9e62-5bd06df7c2dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f8e0837d-9d25-46f1-a5d8-5d3f1ce88d38" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3f39d4c2-2dfe-475f-b524-e74a87b3e40a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3f39d4c2-2dfe-475f-b524-e74a87b3e40a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_d798ed6c-e495-4418-8404-29b7fcb17228" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_d798ed6c-e495-4418-8404-29b7fcb17228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_676f637a-79f4-4153-84a5-832870126f87" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_676f637a-79f4-4153-84a5-832870126f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_NumberOfAdditionalTranches_4fdd5c2a-90f6-4d36-9da5-3f0f6dd88365" xlink:href="goss-20200930.xsd#goss_NumberOfAdditionalTranches"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_goss_NumberOfAdditionalTranches_4fdd5c2a-90f6-4d36-9da5-3f0f6dd88365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7a2f0970-ec6b-4c1a-bf6c-a8182d607846" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7a2f0970-ec6b-4c1a-bf6c-a8182d607846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b210f496-0b3c-4db1-950b-609ca42723c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b210f496-0b3c-4db1-950b-609ca42723c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment_b31809df-8bba-44db-a7e4-15d1a0b775cb" xlink:href="goss-20200930.xsd#goss_PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_goss_PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment_b31809df-8bba-44db-a7e4-15d1a0b775cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment_af5308ec-004c-4dfc-96ae-6a47d81a9ed3" xlink:href="goss-20200930.xsd#goss_PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_goss_PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment_af5308ec-004c-4dfc-96ae-6a47d81a9ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PercentageOfPrepaymentFee_8d0f3357-9e56-4238-aaca-4e76f25c75e4" xlink:href="goss-20200930.xsd#goss_PercentageOfPrepaymentFee"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_goss_PercentageOfPrepaymentFee_8d0f3357-9e56-4238-aaca-4e76f25c75e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan_48e44b59-b3f8-4f1f-93c2-1d2b992aa10b" xlink:href="goss-20200930.xsd#goss_DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_goss_DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan_48e44b59-b3f8-4f1f-93c2-1d2b992aa10b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt_e2946a91-5bac-42f1-99d6-848868513783" xlink:href="goss-20200930.xsd#goss_DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_goss_DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt_e2946a91-5bac-42f1-99d6-848868513783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_DebtInstrumentAggregatePrincipalAmount_1c544456-0952-4f9c-9cb2-cb40e81258d8" xlink:href="goss-20200930.xsd#goss_DebtInstrumentAggregatePrincipalAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_goss_DebtInstrumentAggregatePrincipalAmount_1c544456-0952-4f9c-9cb2-cb40e81258d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_a15e8429-16e3-4123-b8c6-f8eba1d2f22e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_a15e8429-16e3-4123-b8c6-f8eba1d2f22e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_5f8b9f1f-7012-4419-bd5d-bd31c4994572" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_5f8b9f1f-7012-4419-bd5d-bd31c4994572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_745eb02f-d715-4708-9ae7-99cd7e35b368" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_745eb02f-d715-4708-9ae7-99cd7e35b368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_DebtInstrumentConvertibleConversionPricePercentage_098441f0-c776-43ac-8976-2a81eb07182a" xlink:href="goss-20200930.xsd#goss_DebtInstrumentConvertibleConversionPricePercentage"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_goss_DebtInstrumentConvertibleConversionPricePercentage_098441f0-c776-43ac-8976-2a81eb07182a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_8f172953-58a5-4f27-9125-adb2d1c07ddb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_8f172953-58a5-4f27-9125-adb2d1c07ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_27a4cbbb-df6f-4d1a-90d8-4eec81794f0b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_27a4cbbb-df6f-4d1a-90d8-4eec81794f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_DebtInstrumentConvertibleConversionLastReportedSalePricePercentage_9305b49a-ce29-46e8-906a-60a904de34bc" xlink:href="goss-20200930.xsd#goss_DebtInstrumentConvertibleConversionLastReportedSalePricePercentage"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_goss_DebtInstrumentConvertibleConversionLastReportedSalePricePercentage_9305b49a-ce29-46e8-906a-60a904de34bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_4e9399e2-be33-4f16-9b85-36ae17643b43" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_4e9399e2-be33-4f16-9b85-36ae17643b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes_efcf2786-de2b-4801-b67d-c077b82c47b7" xlink:href="goss-20200930.xsd#goss_PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_goss_PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes_efcf2786-de2b-4801-b67d-c077b82c47b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LongTermDebtPercentageInAggregatePrincipalAmount_cc755a9d-ec6b-4ba2-ab75-7c41da0fa3e1" xlink:href="goss-20200930.xsd#goss_LongTermDebtPercentageInAggregatePrincipalAmount"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_goss_LongTermDebtPercentageInAggregatePrincipalAmount_cc755a9d-ec6b-4ba2-ab75-7c41da0fa3e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_c7eeaf0f-d251-45bf-8f61-7f65c8b2adcb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_c7eeaf0f-d251-45bf-8f61-7f65c8b2adcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_83fd74de-60f1-4171-9505-510731ec91bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_83fd74de-60f1-4171-9505-510731ec91bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_eba6e560-f386-47d0-951c-2f38a1a95ef5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_eba6e560-f386-47d0-951c-2f38a1a95ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_acb8d787-5a9a-4415-94fb-a1dc49650e49" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a34889a3-06c3-4d34-966d-3c1cea9b55d9" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_acb8d787-5a9a-4415-94fb-a1dc49650e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/IndebtednessScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#IndebtednessScheduleofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/IndebtednessScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_30ec577f-95e4-4089-8933-115e9873805c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_896796da-0af9-4373-8a50-2825da8dae9a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_30ec577f-95e4-4089-8933-115e9873805c" xlink:to="loc_us-gaap_DebtInstrumentTable_896796da-0af9-4373-8a50-2825da8dae9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_eb9a4f09-d265-49a7-ad04-0ac41600c13a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_896796da-0af9-4373-8a50-2825da8dae9a" xlink:to="loc_us-gaap_CreditFacilityAxis_eb9a4f09-d265-49a7-ad04-0ac41600c13a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f33ce8dd-2f64-4a0f-a60f-ab5e695006fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_eb9a4f09-d265-49a7-ad04-0ac41600c13a" xlink:to="loc_us-gaap_CreditFacilityDomain_f33ce8dd-2f64-4a0f-a60f-ab5e695006fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_034fc45e-a51f-4df5-81d9-8e03b9df603d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_f33ce8dd-2f64-4a0f-a60f-ab5e695006fe" xlink:to="loc_us-gaap_LineOfCreditMember_034fc45e-a51f-4df5-81d9-8e03b9df603d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5f14370d-40de-4745-8c1d-a8847b434e56" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_896796da-0af9-4373-8a50-2825da8dae9a" xlink:to="loc_us-gaap_DebtInstrumentLineItems_5f14370d-40de-4745-8c1d-a8847b434e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a76c1ebb-332b-4f0c-8ed1-595a1d8aa4b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5f14370d-40de-4745-8c1d-a8847b434e56" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a76c1ebb-332b-4f0c-8ed1-595a1d8aa4b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_eea4d7f1-33ea-44d9-a7f6-0f3d78cdd893" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5f14370d-40de-4745-8c1d-a8847b434e56" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_eea4d7f1-33ea-44d9-a7f6-0f3d78cdd893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_badfd71e-e75b-499d-88f4-dd49eceb835e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5f14370d-40de-4745-8c1d-a8847b434e56" xlink:to="loc_us-gaap_LongTermDebt_badfd71e-e75b-499d-88f4-dd49eceb835e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1727819a-dab1-4264-ad4a-4234f5b5c666" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b1f6aeaa-c9af-4b83-a387-01373dc95a29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1727819a-dab1-4264-ad4a-4234f5b5c666" xlink:to="loc_us-gaap_DebtInstrumentTable_b1f6aeaa-c9af-4b83-a387-01373dc95a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_6ca0a4b4-e85e-41ce-83a0-71e331bf39be" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b1f6aeaa-c9af-4b83-a387-01373dc95a29" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_6ca0a4b4-e85e-41ce-83a0-71e331bf39be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_e54b8599-d730-40fe-a57e-f8cce6871234" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_6ca0a4b4-e85e-41ce-83a0-71e331bf39be" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_e54b8599-d730-40fe-a57e-f8cce6871234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_1c32d820-8b6e-496a-b09c-f9e8812a38b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_e54b8599-d730-40fe-a57e-f8cce6871234" xlink:to="loc_us-gaap_LineOfCreditMember_1c32d820-8b6e-496a-b09c-f9e8812a38b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4f7dcd0c-506d-434f-aa0a-cb09f4dd9fb0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b1f6aeaa-c9af-4b83-a387-01373dc95a29" xlink:to="loc_us-gaap_DebtInstrumentLineItems_4f7dcd0c-506d-434f-aa0a-cb09f4dd9fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_64ba28a5-df19-45dc-ac3b-2b107ff7023f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4f7dcd0c-506d-434f-aa0a-cb09f4dd9fb0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_64ba28a5-df19-45dc-ac3b-2b107ff7023f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_c6fa706e-0d56-4490-b6f2-da17ed76253d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4f7dcd0c-506d-434f-aa0a-cb09f4dd9fb0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_c6fa706e-0d56-4490-b6f2-da17ed76253d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_014bb266-53df-49b3-9fc0-53886fe01062" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4f7dcd0c-506d-434f-aa0a-cb09f4dd9fb0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_014bb266-53df-49b3-9fc0-53886fe01062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_a3ce902e-747c-461f-8cd6-12cc50bd456e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4f7dcd0c-506d-434f-aa0a-cb09f4dd9fb0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_a3ce902e-747c-461f-8cd6-12cc50bd456e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_798df0cd-8464-494c-8a61-e0e419e0490d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4f7dcd0c-506d-434f-aa0a-cb09f4dd9fb0" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_798df0cd-8464-494c-8a61-e0e419e0490d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix_97c2de67-1f3d-40a3-85f3-3e32ebe973c9" xlink:href="goss-20200930.xsd#goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4f7dcd0c-506d-434f-aa0a-cb09f4dd9fb0" xlink:to="loc_goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix_97c2de67-1f3d-40a3-85f3-3e32ebe973c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_b028a4c3-da68-4e94-82e6-95a66459443b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4f7dcd0c-506d-434f-aa0a-cb09f4dd9fb0" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_b028a4c3-da68-4e94-82e6-95a66459443b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_940d7a32-0f73-4eb8-9035-3aa2d7986fd8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_33881449-e2b0-4afc-bb12-debab0f74c57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_940d7a32-0f73-4eb8-9035-3aa2d7986fd8" xlink:to="loc_us-gaap_DebtInstrumentTable_33881449-e2b0-4afc-bb12-debab0f74c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_fcd10f54-0225-4e64-b535-f69f0565634d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_33881449-e2b0-4afc-bb12-debab0f74c57" xlink:to="loc_us-gaap_DebtInstrumentAxis_fcd10f54-0225-4e64-b535-f69f0565634d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1ec645b5-d18a-4f60-bdea-e249cf603656" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_fcd10f54-0225-4e64-b535-f69f0565634d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1ec645b5-d18a-4f60-bdea-e249cf603656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandTwentySevenNotesMember_deb6481e-9cf0-4155-8bee-6e4061bac4fe" xlink:href="goss-20200930.xsd#goss_TwoThousandTwentySevenNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1ec645b5-d18a-4f60-bdea-e249cf603656" xlink:to="loc_goss_TwoThousandTwentySevenNotesMember_deb6481e-9cf0-4155-8bee-6e4061bac4fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_adeb0d4f-dc2a-4be7-9499-74af78df1cb0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_33881449-e2b0-4afc-bb12-debab0f74c57" xlink:to="loc_us-gaap_DebtInstrumentLineItems_adeb0d4f-dc2a-4be7-9499-74af78df1cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_64673ed8-14b2-4459-bb31-fb78ecd3a84f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_adeb0d4f-dc2a-4be7-9499-74af78df1cb0" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_64673ed8-14b2-4459-bb31-fb78ecd3a84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_06f5923c-fbba-4a3f-b66d-e5278e86faaf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_adeb0d4f-dc2a-4be7-9499-74af78df1cb0" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_06f5923c-fbba-4a3f-b66d-e5278e86faaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_7216f1f1-5171-46dd-b324-a6574bd8c663" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_adeb0d4f-dc2a-4be7-9499-74af78df1cb0" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_7216f1f1-5171-46dd-b324-a6574bd8c663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_df12df5a-4a1a-42be-afad-fb8b4bc77969" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_adeb0d4f-dc2a-4be7-9499-74af78df1cb0" xlink:to="loc_us-gaap_LongTermDebt_df12df5a-4a1a-42be-afad-fb8b4bc77969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/IndebtednessScheduleofEquityComponentsDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#IndebtednessScheduleofEquityComponentsDetails"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/IndebtednessScheduleofEquityComponentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_949e8d04-69b9-4afe-a12a-f6178229c2bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7a88e758-de5c-4806-9f45-137068b1d518" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_949e8d04-69b9-4afe-a12a-f6178229c2bb" xlink:to="loc_us-gaap_DebtInstrumentTable_7a88e758-de5c-4806-9f45-137068b1d518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_38ef91d1-7661-4be9-86f7-b86f43f24a5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7a88e758-de5c-4806-9f45-137068b1d518" xlink:to="loc_us-gaap_DebtInstrumentAxis_38ef91d1-7661-4be9-86f7-b86f43f24a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1760d757-9db9-44d6-b107-bb89d45a63ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_38ef91d1-7661-4be9-86f7-b86f43f24a5f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1760d757-9db9-44d6-b107-bb89d45a63ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandTwentySevenNotesMember_025be5dc-8e66-4dd4-b3a7-c90b2a883322" xlink:href="goss-20200930.xsd#goss_TwoThousandTwentySevenNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1760d757-9db9-44d6-b107-bb89d45a63ef" xlink:to="loc_goss_TwoThousandTwentySevenNotesMember_025be5dc-8e66-4dd4-b3a7-c90b2a883322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_90f9953a-267b-4e9b-8f6e-c364d46299a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7a88e758-de5c-4806-9f45-137068b1d518" xlink:to="loc_us-gaap_DebtInstrumentLineItems_90f9953a-267b-4e9b-8f6e-c364d46299a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption_f38f0f99-a4ad-403b-885a-0842756fa748" xlink:href="goss-20200930.xsd#goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_90f9953a-267b-4e9b-8f6e-c364d46299a0" xlink:to="loc_goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption_f38f0f99-a4ad-403b-885a-0842756fa748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts_d64a47bd-11ef-4d4e-8531-689677088968" xlink:href="goss-20200930.xsd#goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_90f9953a-267b-4e9b-8f6e-c364d46299a0" xlink:to="loc_goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts_d64a47bd-11ef-4d4e-8531-689677088968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_fee7fd48-1d64-4550-8a4f-cb6b403c2763" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_90f9953a-267b-4e9b-8f6e-c364d46299a0" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_fee7fd48-1d64-4550-8a4f-cb6b403c2763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/IndebtednessScheduleofInterestExpenseRecognizedDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#IndebtednessScheduleofInterestExpenseRecognizedDetails"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/IndebtednessScheduleofInterestExpenseRecognizedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c68826a7-cffc-4b16-9e49-873d6853912c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d5c2d1fe-c2b0-47f5-9538-5029bab92549" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c68826a7-cffc-4b16-9e49-873d6853912c" xlink:to="loc_us-gaap_DebtInstrumentTable_d5c2d1fe-c2b0-47f5-9538-5029bab92549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ec36784f-1bc0-4f84-b9c3-22ff371b66f2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d5c2d1fe-c2b0-47f5-9538-5029bab92549" xlink:to="loc_us-gaap_DebtInstrumentAxis_ec36784f-1bc0-4f84-b9c3-22ff371b66f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_523317bb-ef25-4a2a-8882-5d129865d219" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ec36784f-1bc0-4f84-b9c3-22ff371b66f2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_523317bb-ef25-4a2a-8882-5d129865d219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandTwentySevenNotesMember_73aa7804-d63a-453a-bdbb-ce855c77994b" xlink:href="goss-20200930.xsd#goss_TwoThousandTwentySevenNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_523317bb-ef25-4a2a-8882-5d129865d219" xlink:to="loc_goss_TwoThousandTwentySevenNotesMember_73aa7804-d63a-453a-bdbb-ce855c77994b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_51ae69ec-b580-48ca-97ee-73d6cd04ee32" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d5c2d1fe-c2b0-47f5-9538-5029bab92549" xlink:to="loc_us-gaap_DebtInstrumentLineItems_51ae69ec-b580-48ca-97ee-73d6cd04ee32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ContractualInterestExpense_6e0cc4e0-ff83-4393-abea-6aa1cc37485f" xlink:href="goss-20200930.xsd#goss_ContractualInterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_51ae69ec-b580-48ca-97ee-73d6cd04ee32" xlink:to="loc_goss_ContractualInterestExpense_6e0cc4e0-ff83-4393-abea-6aa1cc37485f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_c960cb52-85f3-49e2-a67d-92de60a5aa1e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_51ae69ec-b580-48ca-97ee-73d6cd04ee32" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_c960cb52-85f3-49e2-a67d-92de60a5aa1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_49c285d4-8bec-4f86-af53-67d0280c56dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_51ae69ec-b580-48ca-97ee-73d6cd04ee32" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_49c285d4-8bec-4f86-af53-67d0280c56dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_9858ef8e-2a9b-4bb9-a344-38152823dc0e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_51ae69ec-b580-48ca-97ee-73d6cd04ee32" xlink:to="loc_us-gaap_InterestExpenseDebt_9858ef8e-2a9b-4bb9-a344-38152823dc0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsideration" xlink:type="simple" xlink:href="goss-20200930.xsd#LicensesAssetAcquisitionsandContingentConsideration"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsideration" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_b74a5eaf-2add-4a0b-86db-8a08cc29cec6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_167b34dc-9ad2-4020-b411-520cf224a19e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b74a5eaf-2add-4a0b-86db-8a08cc29cec6" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_167b34dc-9ad2-4020-b411-520cf224a19e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationTables" xlink:type="simple" xlink:href="goss-20200930.xsd#LicensesAssetAcquisitionsandContingentConsiderationTables"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_d1d8e875-a26a-4c08-ad6f-466c0c641584" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentExpensesTableTextBlock_02eb4fa2-5cbc-486f-b37e-84b4e93bc80f" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentExpensesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_d1d8e875-a26a-4c08-ad6f-466c0c641584" xlink:to="loc_goss_InProcessResearchAndDevelopmentExpensesTableTextBlock_02eb4fa2-5cbc-486f-b37e-84b4e93bc80f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_9865eb11-b595-4301-83f5-9db3181563c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb769aaa-4acf-48d1-b49f-032b66fff2c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_9865eb11-b595-4301-83f5-9db3181563c4" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb769aaa-4acf-48d1-b49f-032b66fff2c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4660b2a6-5a2d-4bf7-ba91-bebb3d11e906" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb769aaa-4acf-48d1-b49f-032b66fff2c2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4660b2a6-5a2d-4bf7-ba91-bebb3d11e906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce488eed-e2ea-4d12-9621-8cfd450255ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4660b2a6-5a2d-4bf7-ba91-bebb3d11e906" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce488eed-e2ea-4d12-9621-8cfd450255ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PulmokineIncMember_ec2e0d37-9c92-4ec2-80ac-3a7bad3f7aeb" xlink:href="goss-20200930.xsd#goss_PulmokineIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce488eed-e2ea-4d12-9621-8cfd450255ca" xlink:to="loc_goss_PulmokineIncMember_ec2e0d37-9c92-4ec2-80ac-3a7bad3f7aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AABiopharmaIncMember_cd526678-d98e-4dbc-8965-27cd5d7a5fee" xlink:href="goss-20200930.xsd#goss_AABiopharmaIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce488eed-e2ea-4d12-9621-8cfd450255ca" xlink:to="loc_goss_AABiopharmaIncMember_cd526678-d98e-4dbc-8965-27cd5d7a5fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AerpioPharmaceuticalsIncMember_db475b62-4d5b-4e89-8278-6fdff37239e2" xlink:href="goss-20200930.xsd#goss_AerpioPharmaceuticalsIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce488eed-e2ea-4d12-9621-8cfd450255ca" xlink:to="loc_goss_AerpioPharmaceuticalsIncMember_db475b62-4d5b-4e89-8278-6fdff37239e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AdhaerePharmaceuticalsIncMember_32a2483a-a211-4762-9938-e27dd42f7c84" xlink:href="goss-20200930.xsd#goss_AdhaerePharmaceuticalsIncMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ce488eed-e2ea-4d12-9621-8cfd450255ca" xlink:to="loc_goss_AdhaerePharmaceuticalsIncMember_32a2483a-a211-4762-9938-e27dd42f7c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_71cb5813-fd41-467d-9bda-643d9b2ae389" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb769aaa-4acf-48d1-b49f-032b66fff2c2" xlink:to="loc_us-gaap_TypeOfArrangementAxis_71cb5813-fd41-467d-9bda-643d9b2ae389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_efc05282-edd2-46da-887a-d7a39734e564" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_71cb5813-fd41-467d-9bda-643d9b2ae389" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_efc05282-edd2-46da-887a-d7a39734e564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LicenseAgreementMember_22acc776-a229-4586-a392-2b34c79f6e76" xlink:href="goss-20200930.xsd#goss_LicenseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_efc05282-edd2-46da-887a-d7a39734e564" xlink:to="loc_goss_LicenseAgreementMember_22acc776-a229-4586-a392-2b34c79f6e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6819d208-9ad5-4a7c-b843-a00c01468d61" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb769aaa-4acf-48d1-b49f-032b66fff2c2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6819d208-9ad5-4a7c-b843-a00c01468d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c816441-15ba-442f-91a7-95b17bc5d9de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6819d208-9ad5-4a7c-b843-a00c01468d61" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c816441-15ba-442f-91a7-95b17bc5d9de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember_32654389-c8bc-451c-8012-3a176e2ed4b9" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c816441-15ba-442f-91a7-95b17bc5d9de" xlink:to="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember_32654389-c8bc-451c-8012-3a176e2ed4b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember_caa0caea-a9e7-436a-91f4-c5e1f60f8f2f" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c816441-15ba-442f-91a7-95b17bc5d9de" xlink:to="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember_caa0caea-a9e7-436a-91f4-c5e1f60f8f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember_74dad604-faa6-48b3-ade9-62b323f9702d" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c816441-15ba-442f-91a7-95b17bc5d9de" xlink:to="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember_74dad604-faa6-48b3-ade9-62b323f9702d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember_6f370ae0-81f2-4a97-bae5-b5e0915b5b01" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7c816441-15ba-442f-91a7-95b17bc5d9de" xlink:to="loc_goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember_6f370ae0-81f2-4a97-bae5-b5e0915b5b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d351a606-4f3d-4ff9-a39d-6735f7550d4d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb769aaa-4acf-48d1-b49f-032b66fff2c2" xlink:to="loc_srt_RangeAxis_d351a606-4f3d-4ff9-a39d-6735f7550d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f47eafb0-d817-466e-9f36-f01055f1629d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d351a606-4f3d-4ff9-a39d-6735f7550d4d" xlink:to="loc_srt_RangeMember_f47eafb0-d817-466e-9f36-f01055f1629d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e051c053-3c6b-4ac8-acf2-8d5cc7143ce7" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f47eafb0-d817-466e-9f36-f01055f1629d" xlink:to="loc_srt_MinimumMember_e051c053-3c6b-4ac8-acf2-8d5cc7143ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2164e57a-31bd-4e85-aa9c-51b3989005c2" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f47eafb0-d817-466e-9f36-f01055f1629d" xlink:to="loc_srt_MaximumMember_2164e57a-31bd-4e85-aa9c-51b3989005c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_86d4570b-455f-46a2-97e6-40e99bc47221" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb769aaa-4acf-48d1-b49f-032b66fff2c2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_86d4570b-455f-46a2-97e6-40e99bc47221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_183d3cee-6f1c-44a0-aee1-f9fc9093bdc6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_86d4570b-455f-46a2-97e6-40e99bc47221" xlink:to="loc_us-gaap_ClassOfStockDomain_183d3cee-6f1c-44a0-aee1-f9fc9093bdc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SeriesSeedConvertiblePreferredStockMember_b9281bf8-f84c-4de7-abff-a4d8eba3660d" xlink:href="goss-20200930.xsd#goss_SeriesSeedConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_183d3cee-6f1c-44a0-aee1-f9fc9093bdc6" xlink:to="loc_goss_SeriesSeedConvertiblePreferredStockMember_b9281bf8-f84c-4de7-abff-a4d8eba3660d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_397e3b50-9d34-48e2-acdc-19338af3089d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb769aaa-4acf-48d1-b49f-032b66fff2c2" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_397e3b50-9d34-48e2-acdc-19338af3089d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9ce7d94f-e775-4d7f-9b9a-9ad81b70057e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_397e3b50-9d34-48e2-acdc-19338af3089d" xlink:to="loc_us-gaap_EquityComponentDomain_9ce7d94f-e775-4d7f-9b9a-9ad81b70057e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e57d6082-227c-4d0d-95ab-96b103c565cb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9ce7d94f-e775-4d7f-9b9a-9ad81b70057e" xlink:to="loc_us-gaap_CommonStockMember_e57d6082-227c-4d0d-95ab-96b103c565cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_eb769aaa-4acf-48d1-b49f-032b66fff2c2" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ProductLicenseTerm_cb0c224a-28fd-4727-bcd2-285cc70f6dc6" xlink:href="goss-20200930.xsd#goss_ProductLicenseTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_goss_ProductLicenseTerm_cb0c224a-28fd-4727-bcd2-285cc70f6dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable_0a98b891-8b35-4146-b6b0-1183eef1e685" xlink:href="goss-20200930.xsd#goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable_0a98b891-8b35-4146-b6b0-1183eef1e685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable_6e0f31e1-f5ac-418a-b262-d2259ede1e6c" xlink:href="goss-20200930.xsd#goss_BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_goss_BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable_6e0f31e1-f5ac-418a-b262-d2259ede1e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable_01d7a567-e9eb-4663-9127-bdcaf8dae561" xlink:href="goss-20200930.xsd#goss_BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_goss_BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable_01d7a567-e9eb-4663-9127-bdcaf8dae561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_UpfrontPayment_3013ee97-a8f3-446b-9566-691cd25a73aa" xlink:href="goss-20200930.xsd#goss_UpfrontPayment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_goss_UpfrontPayment_3013ee97-a8f3-446b-9566-691cd25a73aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized_0d07fef8-d9b2-45c0-a573-27f36cff338a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized_0d07fef8-d9b2-45c0-a573-27f36cff338a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c07aadee-aa69-4ef5-9819-732dc321dbf7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c07aadee-aa69-4ef5-9819-732dc321dbf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_afa9eb9a-6189-4cb6-b25c-544c79adf4cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_afa9eb9a-6189-4cb6-b25c-544c79adf4cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ParticipationRight_35f62285-88a6-4422-8ee6-b615b372862c" xlink:href="goss-20200930.xsd#goss_ParticipationRight"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_goss_ParticipationRight_35f62285-88a6-4422-8ee6-b615b372862c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_175da92d-ce8d-41e5-afb4-039a4873ebba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_175da92d-ce8d-41e5-afb4-039a4873ebba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable_f1ca8081-e0b4-4736-ba00-e281e024afa0" xlink:href="goss-20200930.xsd#goss_BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_goss_BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable_f1ca8081-e0b4-4736-ba00-e281e024afa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_BusinessCombinationContingentConsiderationMilestonesPayment_6a760a4c-a7d5-4ef9-81c2-eb71bfa1c07e" xlink:href="goss-20200930.xsd#goss_BusinessCombinationContingentConsiderationMilestonesPayment"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_76267853-cca2-49ed-ab0a-210a4d99e5fe" xlink:to="loc_goss_BusinessCombinationContingentConsiderationMilestonesPayment_6a760a4c-a7d5-4ef9-81c2-eb71bfa1c07e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_53451d7a-4997-4a16-aaa6-6d66c657ba6d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_66f11388-e36b-4f66-af79-54700ea8c970" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_53451d7a-4997-4a16-aaa6-6d66c657ba6d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_66f11388-e36b-4f66-af79-54700ea8c970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dab47d7f-f79c-417d-807e-b58b17c88344" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_66f11388-e36b-4f66-af79-54700ea8c970" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dab47d7f-f79c-417d-807e-b58b17c88344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cf55e8b4-9686-4fa9-9104-660cfb7aebd1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dab47d7f-f79c-417d-807e-b58b17c88344" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cf55e8b4-9686-4fa9-9104-660cfb7aebd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember_a1595abb-ccb5-4fdf-bd85-e2f9b902a5b8" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cf55e8b4-9686-4fa9-9104-660cfb7aebd1" xlink:to="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember_a1595abb-ccb5-4fdf-bd85-e2f9b902a5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember_40fd7cf3-5ee3-4edf-826d-a5a91095a912" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cf55e8b4-9686-4fa9-9104-660cfb7aebd1" xlink:to="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember_40fd7cf3-5ee3-4edf-826d-a5a91095a912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember_7c0945ad-362a-4f15-bd19-7cbbe46e72e1" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cf55e8b4-9686-4fa9-9104-660cfb7aebd1" xlink:to="loc_goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember_7c0945ad-362a-4f15-bd19-7cbbe46e72e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember_e1b08b9d-a891-45bd-a8b5-d8d86aca4860" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cf55e8b4-9686-4fa9-9104-660cfb7aebd1" xlink:to="loc_goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember_e1b08b9d-a891-45bd-a8b5-d8d86aca4860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_InProcessResearchAndDevelopmentOtherProgramsMember_25163d5b-c4b3-4809-b381-03a2a7f7ee4e" xlink:href="goss-20200930.xsd#goss_InProcessResearchAndDevelopmentOtherProgramsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cf55e8b4-9686-4fa9-9104-660cfb7aebd1" xlink:to="loc_goss_InProcessResearchAndDevelopmentOtherProgramsMember_25163d5b-c4b3-4809-b381-03a2a7f7ee4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_43020ef9-7e35-4483-8cf4-c8a9b7746f69" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable_66f11388-e36b-4f66-af79-54700ea8c970" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_43020ef9-7e35-4483-8cf4-c8a9b7746f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_7f9578e9-e712-4b04-bbdf-8c0721fad055" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_43020ef9-7e35-4483-8cf4-c8a9b7746f69" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_7f9578e9-e712-4b04-bbdf-8c0721fad055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/StockholdersEquity" xlink:type="simple" xlink:href="goss-20200930.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_6a09c29b-3543-4e95-8fac-5c0c91814600" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_bb82f432-e278-4fb2-b573-72ed4199549b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6a09c29b-3543-4e95-8fac-5c0c91814600" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_bb82f432-e278-4fb2-b573-72ed4199549b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#StockholdersEquityAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e080e94c-b33c-4dbd-a724-f867a4952aa9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_StockholdersEquityTable_84970e96-c8e6-49ac-b4d5-1212f7a58f1f" xlink:href="goss-20200930.xsd#goss_StockholdersEquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e080e94c-b33c-4dbd-a724-f867a4952aa9" xlink:to="loc_goss_StockholdersEquityTable_84970e96-c8e6-49ac-b4d5-1212f7a58f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_00b81e36-320f-4d8f-8305-3fb981c1687c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_StockholdersEquityTable_84970e96-c8e6-49ac-b4d5-1212f7a58f1f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_00b81e36-320f-4d8f-8305-3fb981c1687c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5e77efcd-e505-401b-a893-b2109bec04d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_00b81e36-320f-4d8f-8305-3fb981c1687c" xlink:to="loc_us-gaap_EquityComponentDomain_5e77efcd-e505-401b-a893-b2109bec04d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9d9dcb5a-935d-43ef-b5db-a66558994286" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5e77efcd-e505-401b-a893-b2109bec04d4" xlink:to="loc_us-gaap_CommonStockMember_9d9dcb5a-935d-43ef-b5db-a66558994286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_FounderSharesMember_de12e2ce-eaf5-444b-b9b4-d2d2c05765b8" xlink:href="goss-20200930.xsd#goss_FounderSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5e77efcd-e505-401b-a893-b2109bec04d4" xlink:to="loc_goss_FounderSharesMember_de12e2ce-eaf5-444b-b9b4-d2d2c05765b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_483a7fd9-98cb-489b-921e-ddb9e0047c62" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_StockholdersEquityTable_84970e96-c8e6-49ac-b4d5-1212f7a58f1f" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_483a7fd9-98cb-489b-921e-ddb9e0047c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_587b8ac8-9270-4b7a-ad3d-5c2563a5f78f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_483a7fd9-98cb-489b-921e-ddb9e0047c62" xlink:to="loc_us-gaap_RelatedPartyDomain_587b8ac8-9270-4b7a-ad3d-5c2563a5f78f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_FounderMember_da5176eb-7201-43b6-9cec-c33405aa62b3" xlink:href="goss-20200930.xsd#goss_FounderMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_587b8ac8-9270-4b7a-ad3d-5c2563a5f78f" xlink:to="loc_goss_FounderMember_da5176eb-7201-43b6-9cec-c33405aa62b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_8f88430f-3017-433d-a809-70f65e647ae3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_StockholdersEquityTable_84970e96-c8e6-49ac-b4d5-1212f7a58f1f" xlink:to="loc_us-gaap_StatementClassOfStockAxis_8f88430f-3017-433d-a809-70f65e647ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2c03e932-d4e8-4ada-941f-cc862f6bcbfa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_8f88430f-3017-433d-a809-70f65e647ae3" xlink:to="loc_us-gaap_ClassOfStockDomain_2c03e932-d4e8-4ada-941f-cc862f6bcbfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SeriesAConvertiblePreferredStockMember_d3a41294-8972-4797-b696-276ecf965b73" xlink:href="goss-20200930.xsd#goss_SeriesAConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_2c03e932-d4e8-4ada-941f-cc862f6bcbfa" xlink:to="loc_goss_SeriesAConvertiblePreferredStockMember_d3a41294-8972-4797-b696-276ecf965b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_9cc28ead-2254-4ca5-83c0-35a14c73bdeb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_StockholdersEquityTable_84970e96-c8e6-49ac-b4d5-1212f7a58f1f" xlink:to="loc_us-gaap_TypeOfArrangementAxis_9cc28ead-2254-4ca5-83c0-35a14c73bdeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e2368526-e75a-4b6e-916c-71a1d77d3db3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_9cc28ead-2254-4ca5-83c0-35a14c73bdeb" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e2368526-e75a-4b6e-916c-71a1d77d3db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_StockRestrictionAgreementsMember_ee73c16c-92bf-4613-b77e-e0e7c5477be3" xlink:href="goss-20200930.xsd#goss_StockRestrictionAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e2368526-e75a-4b6e-916c-71a1d77d3db3" xlink:to="loc_goss_StockRestrictionAgreementsMember_ee73c16c-92bf-4613-b77e-e0e7c5477be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:href="goss-20200930.xsd#goss_StockholdersEquityLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_StockholdersEquityTable_84970e96-c8e6-49ac-b4d5-1212f7a58f1f" xlink:to="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_84663b03-17ea-44f1-977e-68ad62f43a23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_84663b03-17ea-44f1-977e-68ad62f43a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_CommonStockVotingRightsNumberOfVotesPerShare_51ccc630-bead-43ad-b0ed-22fabef45679" xlink:href="goss-20200930.xsd#goss_CommonStockVotingRightsNumberOfVotesPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_goss_CommonStockVotingRightsNumberOfVotesPerShare_51ccc630-bead-43ad-b0ed-22fabef45679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_50823cf6-94f1-4307-8503-8f0c79f44142" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_50823cf6-94f1-4307-8503-8f0c79f44142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_da2e0443-65a8-4cca-9815-41326b75334e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_da2e0443-65a8-4cca-9815-41326b75334e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_5e7f33cf-c375-4743-b1b0-f0b2c7eac719" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_5e7f33cf-c375-4743-b1b0-f0b2c7eac719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_064b890a-83a3-43cb-835f-cdc567ad9523" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_064b890a-83a3-43cb-835f-cdc567ad9523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_fe6fc649-718b-4d9f-a97d-6ad9c6cbdc85" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_fe6fc649-718b-4d9f-a97d-6ad9c6cbdc85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_CommonStockVestingPercentage_5db1ea37-dc7c-4c5b-839e-2095428f1152" xlink:href="goss-20200930.xsd#goss_CommonStockVestingPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_goss_CommonStockVestingPercentage_5db1ea37-dc7c-4c5b-839e-2095428f1152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_CommonStockVestingPeriod_343c164a-0d06-443e-ba0c-15c7cb067010" xlink:href="goss-20200930.xsd#goss_CommonStockVestingPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_goss_CommonStockVestingPeriod_343c164a-0d06-443e-ba0c-15c7cb067010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PercentageOfFullyDilutedShareCapital_ceeea640-0d5d-40bf-b734-a85b39a89e10" xlink:href="goss-20200930.xsd#goss_PercentageOfFullyDilutedShareCapital"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_goss_PercentageOfFullyDilutedShareCapital_ceeea640-0d5d-40bf-b734-a85b39a89e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_IncreasedInEquityCapitalAmount_4ce93e62-dd65-4a44-abd6-bccaf2335b02" xlink:href="goss-20200930.xsd#goss_IncreasedInEquityCapitalAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_goss_IncreasedInEquityCapitalAmount_4ce93e62-dd65-4a44-abd6-bccaf2335b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_8ea2475e-cbc0-4bea-ad1f-0a3f6fb0dd73" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_8ea2475e-cbc0-4bea-ad1f-0a3f6fb0dd73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting_e4165743-18fa-4628-8353-d762d4fa4899" xlink:href="goss-20200930.xsd#goss_IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_goss_IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting_e4165743-18fa-4628-8353-d762d4fa4899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_2d106971-f6ec-4cc6-9a4a-a143c8fabee3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_2d106971-f6ec-4cc6-9a4a-a143c8fabee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares_7f8f422f-fec5-4d25-881d-faf7e135951c" xlink:href="goss-20200930.xsd#goss_StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_goss_StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares_7f8f422f-fec5-4d25-881d-faf7e135951c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_2714c797-07be-4770-af68-4854f8b056b5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_StockholdersEquityLineItems_72da685b-1699-42e2-ab4f-31afe3e874fb" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_2714c797-07be-4770-af68-4854f8b056b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/EquityIncentivePlans" xlink:type="simple" xlink:href="goss-20200930.xsd#EquityIncentivePlans"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/EquityIncentivePlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_513af8d5-a2b5-4216-802e-b6c9b7d1369b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ce47d551-e188-4188-818b-bd97d41fd48d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_513af8d5-a2b5-4216-802e-b6c9b7d1369b" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ce47d551-e188-4188-818b-bd97d41fd48d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/EquityIncentivePlansTables" xlink:type="simple" xlink:href="goss-20200930.xsd#EquityIncentivePlansTables"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/EquityIncentivePlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_da481c7a-77de-4d3c-88a1-ff4ae5e4e934" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_e2314cfc-c511-45d5-ab14-27c325faa8f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_da481c7a-77de-4d3c-88a1-ff4ae5e4e934" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_e2314cfc-c511-45d5-ab14-27c325faa8f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_af5f74d8-1e08-476c-b8f0-14df880a5c31" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_da481c7a-77de-4d3c-88a1-ff4ae5e4e934" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_af5f74d8-1e08-476c-b8f0-14df880a5c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_014806cb-3ee2-498e-973a-c47ce530f62b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_da481c7a-77de-4d3c-88a1-ff4ae5e4e934" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_014806cb-3ee2-498e-973a-c47ce530f62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#EquityIncentivePlansAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7f0a9515-3f3e-49b0-858e-e39e3b4422b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_11cc50ba-a2c1-4958-bebb-1e04e7d45c6c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7f0a9515-3f3e-49b0-858e-e39e3b4422b9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_11cc50ba-a2c1-4958-bebb-1e04e7d45c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_7b892224-23ac-47f4-bd8c-195d325c37a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_11cc50ba-a2c1-4958-bebb-1e04e7d45c6c" xlink:to="loc_us-gaap_PlanNameAxis_7b892224-23ac-47f4-bd8c-195d325c37a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b57058c6-fb07-47d3-a0cd-60feb0d55bb8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_7b892224-23ac-47f4-bd8c-195d325c37a1" xlink:to="loc_us-gaap_PlanNameDomain_b57058c6-fb07-47d3-a0cd-60feb0d55bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandNineteenEquityIncentivePlanMember_f9c78227-eeef-4106-ab2d-b22f8d2bdea6" xlink:href="goss-20200930.xsd#goss_TwoThousandNineteenEquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_b57058c6-fb07-47d3-a0cd-60feb0d55bb8" xlink:to="loc_goss_TwoThousandNineteenEquityIncentivePlanMember_f9c78227-eeef-4106-ab2d-b22f8d2bdea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandNineteenEmployeeStockPurchasePlanMember_9b3a2fc2-23b1-4001-a36f-6766dd8ecc50" xlink:href="goss-20200930.xsd#goss_TwoThousandNineteenEmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_b57058c6-fb07-47d3-a0cd-60feb0d55bb8" xlink:to="loc_goss_TwoThousandNineteenEmployeeStockPurchasePlanMember_9b3a2fc2-23b1-4001-a36f-6766dd8ecc50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TwoThousandSeventeenEquityIncentivePlanMember_bacee427-58b0-42bf-aafa-72d48f608399" xlink:href="goss-20200930.xsd#goss_TwoThousandSeventeenEquityIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_b57058c6-fb07-47d3-a0cd-60feb0d55bb8" xlink:to="loc_goss_TwoThousandSeventeenEquityIncentivePlanMember_bacee427-58b0-42bf-aafa-72d48f608399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e0d0f540-f122-434a-886e-70d653e25bfa" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_11cc50ba-a2c1-4958-bebb-1e04e7d45c6c" xlink:to="loc_srt_RangeAxis_e0d0f540-f122-434a-886e-70d653e25bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e61c4ac3-6687-4b83-b32b-c99f324dd901" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e0d0f540-f122-434a-886e-70d653e25bfa" xlink:to="loc_srt_RangeMember_e61c4ac3-6687-4b83-b32b-c99f324dd901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7ea7836c-457c-4198-a114-d12300307982" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e61c4ac3-6687-4b83-b32b-c99f324dd901" xlink:to="loc_srt_MaximumMember_7ea7836c-457c-4198-a114-d12300307982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7498b956-024d-4ee4-b459-51536155f8d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_11cc50ba-a2c1-4958-bebb-1e04e7d45c6c" xlink:to="loc_us-gaap_AwardTypeAxis_7498b956-024d-4ee4-b459-51536155f8d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e638ada5-7d7f-41e7-9a9a-64bdd2720420" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_7498b956-024d-4ee4-b459-51536155f8d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e638ada5-7d7f-41e7-9a9a-64bdd2720420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_e21386fd-c060-4470-b91e-71a3d060aacd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e638ada5-7d7f-41e7-9a9a-64bdd2720420" xlink:to="loc_us-gaap_RestrictedStockMember_e21386fd-c060-4470-b91e-71a3d060aacd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b0feb237-6b2a-4a5c-9d84-2425942a8a6e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e638ada5-7d7f-41e7-9a9a-64bdd2720420" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b0feb237-6b2a-4a5c-9d84-2425942a8a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_3d9afc90-46f8-4c1f-930d-7dc7d5e6ac0e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e638ada5-7d7f-41e7-9a9a-64bdd2720420" xlink:to="loc_us-gaap_StockCompensationPlanMember_3d9afc90-46f8-4c1f-930d-7dc7d5e6ac0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_11cc50ba-a2c1-4958-bebb-1e04e7d45c6c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_21ee31e3-3e07-4be1-9b1b-df702c39f0e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_21ee31e3-3e07-4be1-9b1b-df702c39f0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2028044e-c9b1-4490-9c3c-c1b337e6ac34" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2028044e-c9b1-4490-9c3c-c1b337e6ac34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_5caf4b40-e265-404c-9e28-96f19c15fde3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_5caf4b40-e265-404c-9e28-96f19c15fde3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2d15a840-178f-4974-9a3a-8f698184bccf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2d15a840-178f-4974-9a3a-8f698184bccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2954149f-672e-4687-9bef-77e0a47475f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2954149f-672e-4687-9bef-77e0a47475f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1219a306-3524-49f5-bb5c-2a6445e699aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1219a306-3524-49f5-bb5c-2a6445e699aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued_a1576a61-af5f-460f-940b-9de5d82d32bb" xlink:href="goss-20200930.xsd#goss_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_goss_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued_a1576a61-af5f-460f-940b-9de5d82d32bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_3d60864e-c392-4d5e-a3b5-971f0b10184c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_3d60864e-c392-4d5e-a3b5-971f0b10184c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2fce6a2f-cf32-4817-b22b-19dbe1712c32" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2fce6a2f-cf32-4817-b22b-19dbe1712c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1efd79ff-a248-4f2b-8090-e5dc7f64abea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1efd79ff-a248-4f2b-8090-e5dc7f64abea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2de3acfe-f890-44ca-a446-3eed25d8f17c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2de3acfe-f890-44ca-a446-3eed25d8f17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_3141eb07-7cd3-4000-9f10-3d68478e24fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_3141eb07-7cd3-4000-9f10-3d68478e24fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_82b2efa0-4a31-4ff4-9754-05d2a57f6e91" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_82b2efa0-4a31-4ff4-9754-05d2a57f6e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_151aa70e-3257-49bc-b822-d2399330336e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_151aa70e-3257-49bc-b822-d2399330336e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_69714028-f480-4332-8a1e-95480a2f5531" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_69714028-f480-4332-8a1e-95480a2f5531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_7a8cd0ca-4a42-4f3e-8a17-883a45ca2be5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5c18488e-b9f0-4ad1-8f9c-10dd6f2abdf8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_7a8cd0ca-4a42-4f3e-8a17-883a45ca2be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#EquityIncentivePlansSummaryofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c0aa7c52-94b7-4aa4-9f6e-f905d6b1c5f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d380b232-49ce-4374-8653-c35d56d80df3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c0aa7c52-94b7-4aa4-9f6e-f905d6b1c5f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d380b232-49ce-4374-8653-c35d56d80df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b66fd58d-fd84-4996-bb36-25f8d14b7ab5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d380b232-49ce-4374-8653-c35d56d80df3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b66fd58d-fd84-4996-bb36-25f8d14b7ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_5c09055a-8f53-46af-88d3-d8ea90dcb0aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d380b232-49ce-4374-8653-c35d56d80df3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_5c09055a-8f53-46af-88d3-d8ea90dcb0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_53216eaa-2fb1-48b3-8015-d5a4898410fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d380b232-49ce-4374-8653-c35d56d80df3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_53216eaa-2fb1-48b3-8015-d5a4898410fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_d7e9fa3d-04b4-4c28-a28f-70f85ce6896c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d380b232-49ce-4374-8653-c35d56d80df3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_d7e9fa3d-04b4-4c28-a28f-70f85ce6896c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6fba8f18-3104-4b3f-8bf8-35abcf2a79ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d380b232-49ce-4374-8653-c35d56d80df3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6fba8f18-3104-4b3f-8bf8-35abcf2a79ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_1e067f2b-c9b9-4b2c-8889-60034e39b036" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d380b232-49ce-4374-8653-c35d56d80df3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_1e067f2b-c9b9-4b2c-8889-60034e39b036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0614843e-5fe0-4cbe-bc83-48983c58a8e8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c0aa7c52-94b7-4aa4-9f6e-f905d6b1c5f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0614843e-5fe0-4cbe-bc83-48983c58a8e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b8ef7999-ca69-4801-95d5-e8f2bc2e9964" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0614843e-5fe0-4cbe-bc83-48983c58a8e8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b8ef7999-ca69-4801-95d5-e8f2bc2e9964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9b8cc3e9-2865-47d6-95d2-57aee3b20b7d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0614843e-5fe0-4cbe-bc83-48983c58a8e8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9b8cc3e9-2865-47d6-95d2-57aee3b20b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_009753f4-5537-4213-96fa-79ff5593f1fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0614843e-5fe0-4cbe-bc83-48983c58a8e8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_009753f4-5537-4213-96fa-79ff5593f1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_fa77eb16-789f-42f1-b812-786ee8fc53a7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0614843e-5fe0-4cbe-bc83-48983c58a8e8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_fa77eb16-789f-42f1-b812-786ee8fc53a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_45612d22-329f-4879-9c05-975705afcea1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0614843e-5fe0-4cbe-bc83-48983c58a8e8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_45612d22-329f-4879-9c05-975705afcea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_62dde57e-eda5-4cd9-8ba2-1ae3f3d086c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0614843e-5fe0-4cbe-bc83-48983c58a8e8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_62dde57e-eda5-4cd9-8ba2-1ae3f3d086c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7f3baa16-8770-4452-bf47-bd77a3389484" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c0aa7c52-94b7-4aa4-9f6e-f905d6b1c5f6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7f3baa16-8770-4452-bf47-bd77a3389484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_bf8f9c76-b9c4-4165-8eec-e862245a6027" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c0aa7c52-94b7-4aa4-9f6e-f905d6b1c5f6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_bf8f9c76-b9c4-4165-8eec-e862245a6027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_50d6a6c3-0823-4ef3-bb0e-ca7251c51994" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c0aa7c52-94b7-4aa4-9f6e-f905d6b1c5f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_50d6a6c3-0823-4ef3-bb0e-ca7251c51994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_7482dba1-1921-41b1-8dc8-8c7836ba6fdb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c0aa7c52-94b7-4aa4-9f6e-f905d6b1c5f6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_7482dba1-1921-41b1-8dc8-8c7836ba6fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#EquityIncentivePlansSummaryofRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ae24f99f-fd66-4c57-a191-f4d4e94b9af7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a1def98-592f-4241-aa68-da4a11b686f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ae24f99f-fd66-4c57-a191-f4d4e94b9af7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a1def98-592f-4241-aa68-da4a11b686f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_205dbcd6-56b1-4088-8a94-2e5e1b8be951" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a1def98-592f-4241-aa68-da4a11b686f1" xlink:to="loc_us-gaap_AwardTypeAxis_205dbcd6-56b1-4088-8a94-2e5e1b8be951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_727c2bc6-a2fd-416a-a881-275c5d653df6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_205dbcd6-56b1-4088-8a94-2e5e1b8be951" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_727c2bc6-a2fd-416a-a881-275c5d653df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_45833302-83ba-4de1-814b-fd62d738415d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_727c2bc6-a2fd-416a-a881-275c5d653df6" xlink:to="loc_us-gaap_RestrictedStockMember_45833302-83ba-4de1-814b-fd62d738415d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50527a3c-5897-4e87-895a-b0e96a854386" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a1def98-592f-4241-aa68-da4a11b686f1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50527a3c-5897-4e87-895a-b0e96a854386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fdbcc3f6-a20f-40ae-be7d-5b51604b6bf5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50527a3c-5897-4e87-895a-b0e96a854386" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fdbcc3f6-a20f-40ae-be7d-5b51604b6bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d7dbb089-cd3e-4f5c-b8c7-0b31c2da2a5b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fdbcc3f6-a20f-40ae-be7d-5b51604b6bf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d7dbb089-cd3e-4f5c-b8c7-0b31c2da2a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_85bf9263-03ef-4c70-ab2f-367a8b63eb7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fdbcc3f6-a20f-40ae-be7d-5b51604b6bf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_85bf9263-03ef-4c70-ab2f-367a8b63eb7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_eac5e009-c10d-475d-9107-4f257be62bef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fdbcc3f6-a20f-40ae-be7d-5b51604b6bf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_eac5e009-c10d-475d-9107-4f257be62bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7c5f7d61-49b9-498e-8ffc-c92c53ab2d59" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fdbcc3f6-a20f-40ae-be7d-5b51604b6bf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7c5f7d61-49b9-498e-8ffc-c92c53ab2d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ae411f14-74b3-4bfd-9d19-5e53c7579281" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fdbcc3f6-a20f-40ae-be7d-5b51604b6bf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ae411f14-74b3-4bfd-9d19-5e53c7579281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_145e14f8-2e1b-488f-84af-dc6be006928d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50527a3c-5897-4e87-895a-b0e96a854386" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_145e14f8-2e1b-488f-84af-dc6be006928d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9d92cf10-98e9-410d-a1ec-c9145333e517" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_145e14f8-2e1b-488f-84af-dc6be006928d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9d92cf10-98e9-410d-a1ec-c9145333e517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ed6bfb76-01d9-4373-8547-560423bd14b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_145e14f8-2e1b-488f-84af-dc6be006928d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ed6bfb76-01d9-4373-8547-560423bd14b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2474daa6-725e-494c-9e45-b7bdcf3073db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_145e14f8-2e1b-488f-84af-dc6be006928d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2474daa6-725e-494c-9e45-b7bdcf3073db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2b67f7cb-7d2f-4c1d-ac07-9050678969b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_145e14f8-2e1b-488f-84af-dc6be006928d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2b67f7cb-7d2f-4c1d-ac07-9050678969b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8b574682-ae71-47ad-8a5e-fc61a2f03641" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_145e14f8-2e1b-488f-84af-dc6be006928d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8b574682-ae71-47ad-8a5e-fc61a2f03641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/EquityIncentivePlansStockBasedCompensationExpenseReportedinCondensedConsolidatedStatementsofOperationsDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#EquityIncentivePlansStockBasedCompensationExpenseReportedinCondensedConsolidatedStatementsofOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/EquityIncentivePlansStockBasedCompensationExpenseReportedinCondensedConsolidatedStatementsofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2b53d0ca-3ba2-4a11-b2ae-c0f14e56fedc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_a4e8245a-ee02-4a9c-a8d2-08912571f241" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2b53d0ca-3ba2-4a11-b2ae-c0f14e56fedc" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_a4e8245a-ee02-4a9c-a8d2-08912571f241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ebc124ee-cc3c-4d46-900c-4aae996d424e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_a4e8245a-ee02-4a9c-a8d2-08912571f241" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ebc124ee-cc3c-4d46-900c-4aae996d424e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ef530e64-90e5-4af6-aeb1-486201731d8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ebc124ee-cc3c-4d46-900c-4aae996d424e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ef530e64-90e5-4af6-aeb1-486201731d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_cbd084ee-cd1b-46b4-8645-525b3ee61fea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ef530e64-90e5-4af6-aeb1-486201731d8c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_cbd084ee-cd1b-46b4-8645-525b3ee61fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_b2308d97-f356-4f33-b6c9-a6d07ab8911c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ef530e64-90e5-4af6-aeb1-486201731d8c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_b2308d97-f356-4f33-b6c9-a6d07ab8911c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f599597e-dd19-4f29-9db8-b9872ad3c955" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_a4e8245a-ee02-4a9c-a8d2-08912571f241" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f599597e-dd19-4f29-9db8-b9872ad3c955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_347ca9ba-4366-48ca-b6ef-d5635ceeffa3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f599597e-dd19-4f29-9db8-b9872ad3c955" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_347ca9ba-4366-48ca-b6ef-d5635ceeffa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="goss-20200930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f26d8935-fbaf-44b8-9512-22553e42ba01" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_05f91bb1-2f73-4d24-a577-1a43ca080038" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f26d8935-fbaf-44b8-9512-22553e42ba01" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_05f91bb1-2f73-4d24-a577-1a43ca080038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="goss-20200930.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_dc9540f5-22ee-407f-995d-21bcb555e1e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_4afc0cc9-53c6-4e75-90c0-8f8ba0c99ae7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_dc9540f5-22ee-407f-995d-21bcb555e1e0" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_4afc0cc9-53c6-4e75-90c0-8f8ba0c99ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_4bd7e597-b4b8-464c-bd58-09c60bb8d3e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_dc9540f5-22ee-407f-995d-21bcb555e1e0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_4bd7e597-b4b8-464c-bd58-09c60bb8d3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#CommitmentsandContingenciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c3b0152f-7e50-40a1-92a5-e18123140cc0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_db5247a8-89dc-4b74-a27b-a5ccee8d99a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c3b0152f-7e50-40a1-92a5-e18123140cc0" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_db5247a8-89dc-4b74-a27b-a5ccee8d99a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LeaseContractualTermAxis_3e518ad8-4dc3-45de-b37c-fb196d60d0d5" xlink:href="goss-20200930.xsd#goss_LeaseContractualTermAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_db5247a8-89dc-4b74-a27b-a5ccee8d99a1" xlink:to="loc_goss_LeaseContractualTermAxis_3e518ad8-4dc3-45de-b37c-fb196d60d0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LeaseContractualTermDomain_5581c84e-009d-4c2d-9d08-937dc0b9a348" xlink:href="goss-20200930.xsd#goss_LeaseContractualTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_LeaseContractualTermAxis_3e518ad8-4dc3-45de-b37c-fb196d60d0d5" xlink:to="loc_goss_LeaseContractualTermDomain_5581c84e-009d-4c2d-9d08-937dc0b9a348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_NonCancelableLeaseAgreementEnteredInAugust2018Member_273cad39-c65c-40fe-9c06-f28d0b11f5d0" xlink:href="goss-20200930.xsd#goss_NonCancelableLeaseAgreementEnteredInAugust2018Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_LeaseContractualTermDomain_5581c84e-009d-4c2d-9d08-937dc0b9a348" xlink:to="loc_goss_NonCancelableLeaseAgreementEnteredInAugust2018Member_273cad39-c65c-40fe-9c06-f28d0b11f5d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AdditionalNonCancelableLeaseAgreementInNov2019Member_f5ae318b-4eef-46ac-9b93-a43edfefb7d6" xlink:href="goss-20200930.xsd#goss_AdditionalNonCancelableLeaseAgreementInNov2019Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_LeaseContractualTermDomain_5581c84e-009d-4c2d-9d08-937dc0b9a348" xlink:to="loc_goss_AdditionalNonCancelableLeaseAgreementInNov2019Member_f5ae318b-4eef-46ac-9b93-a43edfefb7d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SubleaseAgreementEnteredInJune2020Member_018be015-d374-4ff9-901e-98a782595638" xlink:href="goss-20200930.xsd#goss_SubleaseAgreementEnteredInJune2020Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_LeaseContractualTermDomain_5581c84e-009d-4c2d-9d08-937dc0b9a348" xlink:to="loc_goss_SubleaseAgreementEnteredInJune2020Member_018be015-d374-4ff9-901e-98a782595638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LeaseAssignmentAgreementEnteredInJuly2020Member_c6fd9ba9-dcd8-4965-acb2-8f88e67a2480" xlink:href="goss-20200930.xsd#goss_LeaseAssignmentAgreementEnteredInJuly2020Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_goss_LeaseContractualTermDomain_5581c84e-009d-4c2d-9d08-937dc0b9a348" xlink:to="loc_goss_LeaseAssignmentAgreementEnteredInJuly2020Member_c6fd9ba9-dcd8-4965-acb2-8f88e67a2480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_db5247a8-89dc-4b74-a27b-a5ccee8d99a1" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_OperatingSubleaseAnnualIncreasePercentageForBaseRent_fb17cb07-fb9c-4e5a-9cda-06e248f13139" xlink:href="goss-20200930.xsd#goss_OperatingSubleaseAnnualIncreasePercentageForBaseRent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_goss_OperatingSubleaseAnnualIncreasePercentageForBaseRent_fb17cb07-fb9c-4e5a-9cda-06e248f13139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PermanentMonthlyBaseRent_82b17f4c-1189-4461-893b-22f95da54ccd" xlink:href="goss-20200930.xsd#goss_PermanentMonthlyBaseRent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_goss_PermanentMonthlyBaseRent_82b17f4c-1189-4461-893b-22f95da54ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_TemporaryMonthlyBaseRent_360ce45f-05d2-404d-91be-bbed34b6529b" xlink:href="goss-20200930.xsd#goss_TemporaryMonthlyBaseRent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_goss_TemporaryMonthlyBaseRent_360ce45f-05d2-404d-91be-bbed34b6529b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_PeriodForWhichLeaseOfPermanentSpaceCanBeExtended_b698bb4f-dcd2-49c6-a92d-526046794228" xlink:href="goss-20200930.xsd#goss_PeriodForWhichLeaseOfPermanentSpaceCanBeExtended"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_goss_PeriodForWhichLeaseOfPermanentSpaceCanBeExtended_b698bb4f-dcd2-49c6-a92d-526046794228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_AnnualIncreasePercentageForLeaseCharges_8f0bb928-07ad-4d4f-95b6-478a6468d45f" xlink:href="goss-20200930.xsd#goss_AnnualIncreasePercentageForLeaseCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_goss_AnnualIncreasePercentageForLeaseCharges_8f0bb928-07ad-4d4f-95b6-478a6468d45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SubleaseTemporaryMonthlyBaseRent_0d70083f-4518-4b73-b417-f30dbb33f098" xlink:href="goss-20200930.xsd#goss_SubleaseTemporaryMonthlyBaseRent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_goss_SubleaseTemporaryMonthlyBaseRent_0d70083f-4518-4b73-b417-f30dbb33f098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SubleaseAnnualIncreasePercentageForLeaseCharges_5b16096a-581e-425e-ac55-03a6d9a5aea3" xlink:href="goss-20200930.xsd#goss_SubleaseAnnualIncreasePercentageForLeaseCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_goss_SubleaseAnnualIncreasePercentageForLeaseCharges_5b16096a-581e-425e-ac55-03a6d9a5aea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_SubleasePeriodOfBaseRentAbatement_f14141af-56bc-4fed-8e1a-67f4dff60444" xlink:href="goss-20200930.xsd#goss_SubleasePeriodOfBaseRentAbatement"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_goss_SubleasePeriodOfBaseRentAbatement_f14141af-56bc-4fed-8e1a-67f4dff60444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_68cc35ff-3d83-45f8-8d02-aab764399859" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_us-gaap_SubleaseIncome_68cc35ff-3d83-45f8-8d02-aab764399859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_6804f842-a72c-42b2-b443-32748e431833" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_6804f842-a72c-42b2-b443-32748e431833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_OperatingLeasesMonthlyBaseRentExpense_560db317-a70c-4691-bf78-6a0a1ef8bb99" xlink:href="goss-20200930.xsd#goss_OperatingLeasesMonthlyBaseRentExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_goss_OperatingLeasesMonthlyBaseRentExpense_560db317-a70c-4691-bf78-6a0a1ef8bb99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_d1a1702c-8397-4113-9063-7a3676515ba7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_d1a1702c-8397-4113-9063-7a3676515ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8c9b39be-4e62-491f-b946-eb99fc466ebb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8c9b39be-4e62-491f-b946-eb99fc466ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_049e51a2-41d0-4e1c-859a-ec82c53b4d43" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_us-gaap_OperatingLeasePayments_049e51a2-41d0-4e1c-859a-ec82c53b4d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_2a24c6d9-4d7c-4f5b-96e6-1f311b1f3413" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e337dfaf-127e-41c6-8738-eaa757d2a428" xlink:to="loc_us-gaap_OperatingLeaseExpense_2a24c6d9-4d7c-4f5b-96e6-1f311b1f3413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofLeaseCostsDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#CommitmentsandContingenciesScheduleofLeaseCostsDetails"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_8ddefb90-51bd-478e-a327-f03187766118" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_79227536-0407-4eb6-a98c-7d477b79b1e8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8ddefb90-51bd-478e-a327-f03187766118" xlink:to="loc_us-gaap_OperatingLeaseCost_79227536-0407-4eb6-a98c-7d477b79b1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_3ae77878-ad0e-4bd4-b86a-05680f110314" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8ddefb90-51bd-478e-a327-f03187766118" xlink:to="loc_us-gaap_ShortTermLeaseCost_3ae77878-ad0e-4bd4-b86a-05680f110314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_61f858f4-b54a-4df5-be35-02d821b70297" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8ddefb90-51bd-478e-a327-f03187766118" xlink:to="loc_us-gaap_LeaseCost_61f858f4-b54a-4df5-be35-02d821b70297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails" xlink:type="simple" xlink:href="goss-20200930.xsd#CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_35f48cd8-df25-45ad-bead-c690cf2aaf1b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_2bdf45d3-c184-48bc-8b65-878b4a8c1185" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_35f48cd8-df25-45ad-bead-c690cf2aaf1b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_2bdf45d3-c184-48bc-8b65-878b4a8c1185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_94f649a2-59f4-471f-b1b7-6a4a88e80ac0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_35f48cd8-df25-45ad-bead-c690cf2aaf1b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_94f649a2-59f4-471f-b1b7-6a4a88e80ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4089d8a1-b5e6-49c1-a87b-bc621c22bf03" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_35f48cd8-df25-45ad-bead-c690cf2aaf1b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4089d8a1-b5e6-49c1-a87b-bc621c22bf03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_41efc1d3-8be6-45dd-ae85-1c9928970b85" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_35f48cd8-df25-45ad-bead-c690cf2aaf1b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_41efc1d3-8be6-45dd-ae85-1c9928970b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_3b4a7638-e8ba-44a6-976c-20d52e7bd8bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_35f48cd8-df25-45ad-bead-c690cf2aaf1b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_3b4a7638-e8ba-44a6-976c-20d52e7bd8bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LesseeOperatingLeaseLiabilityPaymentsDueYearSix_c87ce8ea-bc7d-4f41-8914-3a05b191b9cf" xlink:href="goss-20200930.xsd#goss_LesseeOperatingLeaseLiabilityPaymentsDueYearSix"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_35f48cd8-df25-45ad-bead-c690cf2aaf1b" xlink:to="loc_goss_LesseeOperatingLeaseLiabilityPaymentsDueYearSix_c87ce8ea-bc7d-4f41-8914-3a05b191b9cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_goss_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix_81147243-ee76-4958-b0c6-e7f881c474e7" xlink:href="goss-20200930.xsd#goss_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_35f48cd8-df25-45ad-bead-c690cf2aaf1b" xlink:to="loc_goss_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix_81147243-ee76-4958-b0c6-e7f881c474e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a5e29ffa-8e5b-43d9-a763-874b42990241" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_35f48cd8-df25-45ad-bead-c690cf2aaf1b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a5e29ffa-8e5b-43d9-a763-874b42990241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_abcf761c-10b9-4287-bc38-95821b999ce0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_35f48cd8-df25-45ad-bead-c690cf2aaf1b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_abcf761c-10b9-4287-bc38-95821b999ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_49da0ebe-9f41-42b3-a005-9455048024db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_35f48cd8-df25-45ad-bead-c690cf2aaf1b" xlink:to="loc_us-gaap_OperatingLeaseLiability_49da0ebe-9f41-42b3-a005-9455048024db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_89fb37c9-9436-4cf2-b448-752cc6a29d1b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_35f48cd8-df25-45ad-bead-c690cf2aaf1b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_89fb37c9-9436-4cf2-b448-752cc6a29d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f0a24bbe-5e45-43d6-80f2-285ca7f1b316" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_35f48cd8-df25-45ad-bead-c690cf2aaf1b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f0a24bbe-5e45-43d6-80f2-285ca7f1b316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b48837ef-5251-4611-8f67-5d8cbd9a36d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_35f48cd8-df25-45ad-bead-c690cf2aaf1b" xlink:to="loc_us-gaap_OperatingLeaseLiability_b48837ef-5251-4611-8f67-5d8cbd9a36d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails_1" xlink:type="simple" xlink:href="goss-20200930.xsd#CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails_1" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>goss-20200930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:goss="http://www.gossamerbio.com/20200930"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2019-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="goss-20200930.xsd" xlink:type="simple"/>
    <context id="i2860c58f164f428aa182ebed67f71810_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie505de77d9a8407ab07995dedcd8776a_I20201105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <instant>2020-11-05</instant>
        </period>
    </context>
    <context id="i720b6695621443f1bfacd04fd902b4fd_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9e476b4d712f41b58c1f9eec52fea678_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="icf88702e49f34f05a203c305e7218d7c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib7379eeb81da423f99c7cf5072cffbc2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie414046cc6c443539a8b1ba823193e96_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic6adcea0a3af47708c4c2ce641288ef5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9ca596cd49d2414786bbd3a11c836866_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib95b4750602f4fd8bdf1f4408e3bac46_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1caa3930a2594a799b9714a362f1b101_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i9700bbf1ee8c490ead9c97fb9c7d5dc7_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i93af83044802421987749ef31a183d52_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib7d34d11bc09445287a4c15de915761e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="idccd09399cdb4afd946bd554abecc76e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6fba8fc0709c48be89520d5a63454847_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib3af9d2e206e40adaa4e86d644948813_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic17e964b37084a94a4881db7645fa317_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i5ed5a5578fba4ebc96b685a36facf9c3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7c0263dedae046d1bf5c601e9e997bc3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i713b4ee54335442fa90cd348ffab165f_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i06c4796c101b42a492b0b4c35e73bbf4_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i179e6d0fae8d486f92313c7f72e868be_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="idc2769e3ef10494aaf33bceab6b40d73_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i480da23e7ba242298f782217cc12a7de_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="idc9220fd857749928edaccab2a419a18_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i0ff593aedcba40a79fd271254329a2e8_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i709889bc20a04f829d4afc37e00775f6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i61df284353eb4dd6bd4c5ccba7156006_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibbe555fee6524c44a457250b4e5a4021_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i31856bc57f6c47a3bf3f5b8adeeb728f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i71bc32578df241928d2449da7c53426b_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3d810e89f07c449a83b0758c44d745bf_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i78bd0f4aff6f43e499d7ce9e3c5b17bb_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i094d4c2753d9481590781ade460fad59_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7edc736569724e8b8c6e523b7a87a15c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie3312a4a7c1f41c7bb6ef94d06af70aa_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">goss:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i54d8aec85f094dd690dc3a0c548af271_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">goss:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i343a722113ce45f1bf66666c91555acd_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">goss:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i97e4156cb4c140a6a6a93b8df92d43a7_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="icb3c158457d84ea98458e3654e48a62c_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ieb107b5d59dc4b05a8e01ddcc4874d2f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iea07989a2b224869843ff82cca663a29_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i3b49cacc7d364d80be392cf7b95e4972_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i4c1117486726474d966d52141c13b867_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i5d8d3eefe0054e2c89d598ac1a177a07_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i204c4d8a4ae54157a23623329533ce14_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ib2b24c51d3c14bf39e027c08084d0df0_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">goss:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i7c6f2d65140a444f9beca064afdc4187_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">goss:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i0c30e6a7eee0456a8b8e9b7b04d7cc10_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">goss:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i88d438efdfcf48699af3cb8a4c151884_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ibef492d549a34220b9476308f889a3ad_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i8ca39df98ce8457d8d865eabaaba7f70_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">goss:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i2d60975fadce491d9047cc147f13b8af_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">goss:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i4a1343a170f74a2b85887cc27f953407_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">goss:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="iaa5a9b278e164c2da9b072055d0bc7c3_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i601fef938815423388ebc7b90b509f2c_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="if74dcc4469a54a8c98af2792cc68e327_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i6e47c631459c4f0aa8359cd24d601d03_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="id4b5355aba354232bb2a9f7d614c0e15_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i7f9261b47f7c4dedb3e011d185c7d383_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i51ad8abfdf85411b98659ee7f825d361_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i7688ecc551594d43b36f111047a7deb4_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="if3cc915869004ddaaa6c21c954b57896_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i5b9f0d0a440e443ab0d19184e46dc5b1_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i402b84a37c734fd2ada2568ef7353e2b_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i41d5abe0dfd841d695c962b1f348472c_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i5c1183f5df444d8a9dbef8a80208eb1d_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i3deb511ea20347b989c9a3668500baf2_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i04d13b8492374901b4f4bf2ad46601c5_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ibac864d50598406f8c85d4bdd4a64b15_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5e10c5e62242441296917276fcd983f2_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i76a2221bc96b477d9033dce08a133c47_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i3eb22709373e449784bf6abde9e5ef9d_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="id84abe36ab124aee9361fd90972e72a9_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i6d31ff554106438ca11cdde65438f9f1_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i2a97f2ca2b0143f8bf6974c1fc94e461_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ie52349d1207b400e8a20c808e6df36aa_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i4575faeae2514742ab2eedb009712d84_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="icf9016d9d3c54fdcbd742124c1e00da3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandNineteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iedadf32f302e470ca02b51105b2ffa9e_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandNineteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia37b4eed12f64ea0ad441fc0ad1e503d_D20190212-20190212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-12</startDate>
            <endDate>2019-02-12</endDate>
        </period>
    </context>
    <context id="i72382ce16b8b49b292e97c0ef7b75dd3_I20190212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-12</instant>
        </period>
    </context>
    <context id="i47525e97b2e2423db6a765678a6c4fec_D20190212-20190212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">goss:ConversionOfConvertiblePreferredStockIntoCommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-12</startDate>
            <endDate>2019-02-12</endDate>
        </period>
    </context>
    <context id="i9eebf838097e49fa93a3a4ab394c7e68_D20171001-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1fed2bfc69594ec7a6dbcd619a5e2bef_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5780f8c4c24046a9b2f18bb81e280495_D20180104-20180104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AABiopharmaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-04</startDate>
            <endDate>2018-01-04</endDate>
        </period>
    </context>
    <context id="ib505254a0d25402398cd90e47386b544_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i16119fa6447641b4b0438be989f83724_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i85914c244cbc465a8537031c3daf6f1e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5d717c27684b4376bc058963cf8edc06_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i628ea545993847d1a0da78338212f66f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i65156772da894ffc943654c22ccecde9_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i1e067eee87aa40508462e122f6750be3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4a55d6d56691410aa331d57da9a540d1_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if8bca8bf3b2f456db5ae73401c2d37be_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i76f89fa7250e4a06b29eb2156d416d96_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i260bc0a3e86245f2b8b08107a4dee7bd_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib750f63eb6b944cb98e71a7f0d4cf5f8_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i21f9a7a1498e4ac9bff64988b80f1530_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1b11b05347a54ecd8d3f69919983392e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0d433a516bc643149feff09002c301ba_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i51a4aedbde574295bf88fe0261d77059_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8efc8bdaf1074768864d3ed973853b90_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i103f71b1047849e5b84f76f80ae06494_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i42449cdc53ba4b89b9cdf57fa83320b0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibdf44d92b2ca4b57a02e2892703853f1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if27e640809cf45798d09eb333cf0b6da_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9d06d2274931457baab6e055385a4ed4_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic1c26254dc044115869b6c29020aa2f9_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="idd07bdcfbfb94667ac7bec7ea6ef1c07_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i611f783c934a4fb6b3f38212acc720ca_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4d68ba3fe6824af092a4888b932d3991_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i835b26655f28493fad355a6322860843_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i0f0c40e6d7654a0d84a3748e61f8aac5_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i17213d559ba7419fab19ce258c60725e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i26809f02394e4f7fa0669e5465e107e5_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icf0f77fbe2fa411887f11ed7f2f99c11_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">goss:USTreasuryAndAgencySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5c3c2ed990164cdf9677553f5b066742_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">goss:USTreasuryAndAgencySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i20a2c95edf9e4ccba5c6b16a8d676493_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">goss:USTreasuryAndAgencySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iada21370c53144b09d7b9404f3ee35ff_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">goss:USTreasuryAndAgencySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ibe176d3a79e745d79ba915619691251d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i4bda7b8e7dd04e8caccd4a6f241affe0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i345c770504cf47799812979d3f5b302d_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8e3869d1f23741b4a71e5a062db9b80c_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i301f52d7e9c04c2491017b8e1843e74a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i6e014916db25406589a2a5f00d8eb334_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1402b051056b4d9799e3b18f2092e6f0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="if59687e3ceb840559fdd247e955190ca_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="iba100508cf4f4d92b301e065ad6ff443_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia7e2d34db3e44a1c82443160f196e896_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i81256eb7c9e04561a9015aca0c513258_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i42e5b4d69dd14ffea2c2f3c7b25f6034_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifc5f664a8d9f42fbae6150714af2998f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">goss:USTreasuryAndAgencySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0b301e21a02a4512a5e81e1b78038f75_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">goss:USTreasuryAndAgencySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8e20f232351042e2a775afe12f0c8249_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">goss:USTreasuryAndAgencySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i977d5f93f97946efb350e31e78f7b85c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">goss:USTreasuryAndAgencySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i833b6168e6d6460e8cb4fa5a0da5de2e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i09e8387031f142ac9019e52d736c6004_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie1efadb52eb943fe9951cac243f24a01_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i039111ce7909430b990dd8e90c1779a2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4266b95b8b344eb6960b0767413da8a3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5c5f2803efa24a25b712849347cd1cf5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i686c91e5254648cea5586df68b2d908e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5083b3c67e204f679f3a2c11014f24c1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i83bde4dee6094380821298b49ab659af_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3101b95085834b9ea5a1dc9f746956db_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ice172af8d59747e98811da5f3ed0dfc7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ifec2d9641952468d8894861a5747a001_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">goss:USTreasuryAndAgencySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib8ff014a368f4ecdbeb3dedc5d6a4ec9_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia0a2dd9240654fb5a702e98d4d3f4e28_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5422129c1c59408889a2b99ef392c162_I20190502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-02</instant>
        </period>
    </context>
    <context id="i70316c2b436540a398e8730c8f3d7325_D20190502-20190502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-02</startDate>
            <endDate>2019-05-02</endDate>
        </period>
    </context>
    <context id="i5007e0fab37a4961ae06a859fbe77235_I20190502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">goss:TrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-02</instant>
        </period>
    </context>
    <context id="i667382cf02644ff3a4aefdaf07b9cb60_I20190502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">goss:TrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-02</instant>
        </period>
    </context>
    <context id="i049d323be2aa4c3fbc15de6068f993c8_D20190502-20190502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-02</startDate>
            <endDate>2019-05-02</endDate>
        </period>
    </context>
    <context id="i2111df5e71074410b154ca22ac755a6d_I20190502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-02</instant>
        </period>
    </context>
    <context id="i7d6528bf258548188d528464e3134189_I20190502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">goss:PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-02</instant>
        </period>
    </context>
    <context id="idd99beac9caf44318e4f61c224f56fa4_I20190502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">goss:FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-02</instant>
        </period>
    </context>
    <context id="i1aa9b85a36ff422abc868819f1b52110_I20190502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">goss:SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-02</instant>
        </period>
    </context>
    <context id="ifd6482abdd604fa3b4920ae6543e4b2e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">goss:MidCapFinancialTrustMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4f195af7643b4ea094fcedba56dc2482_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic984cdc9b0e0482fbb94f5d207f8e3fa_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7fbffc547f2d4d6c8b7ed7d9553a691e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5fed8506ec5c42a0b5ad8496948c43b6_D20200521-20200521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-21</startDate>
            <endDate>2020-05-21</endDate>
        </period>
    </context>
    <context id="ib0fc320a9ff8434485ec70bde2f2d365_I20200521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-21</instant>
        </period>
    </context>
    <context id="idda6a8263ec542759323ed492c31b7bc_D20200521-20200521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">goss:OneHundredThirtyPercentApplicableConversionPriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-21</startDate>
            <endDate>2020-05-21</endDate>
        </period>
    </context>
    <context id="i3dc17920346740a4a7c548c095f7e04c_D20200521-20200521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">goss:OneHundredThirtyPercentApplicableConversionPriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-21</startDate>
            <endDate>2020-05-21</endDate>
        </period>
    </context>
    <context id="i4f7d41d10a544ee8bd19cb9b3d404bd3_D20200521-20200521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">goss:NinetyEightPercentApplicableConversionPriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-21</startDate>
            <endDate>2020-05-21</endDate>
        </period>
    </context>
    <context id="iaeecc10913964395b00a41848ddfd5d3_D20200521-20200521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">goss:NinetyEightPercentApplicableConversionPriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-21</startDate>
            <endDate>2020-05-21</endDate>
        </period>
    </context>
    <context id="i7efacb2f1f254242abcd3924f60c15be_D20200521-20200521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-21</startDate>
            <endDate>2020-05-21</endDate>
        </period>
    </context>
    <context id="i65ad3aed5a854b92910ae3dd0bf4a19a_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ie5bf8c1de2ef4f56b4e73b156372b2a3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i48ce1ae69a484b2897d46eda4fe74206_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if94daf002452491ebb4b1b5e305750ce_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="if767ec539aa84bdf81a78eff0a4bcd22_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3f6ba65eca1c4988aeda7e1649f3720f_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">goss:TwoThousandTwentySevenNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ia7131a2487c34cb4bd58334ee5055363_D20171002-20171002">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:PulmokineIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">goss:LicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-02</startDate>
            <endDate>2017-10-02</endDate>
        </period>
    </context>
    <context id="i51900b7591e64e51863c94621c055cae_I20171002">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:PulmokineIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">goss:LicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-02</instant>
        </period>
    </context>
    <context id="idcc05f91f85e4e60b74e1e52f826c49d_D20171001-20171031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:PulmokineIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">goss:LicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2017-10-31</endDate>
        </period>
    </context>
    <context id="id960de866c1840368aa1b490b1df8a76_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:PulmokineIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">goss:LicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i48df4955276f406984e65cbd02fc2753_D20180104-20180104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AABiopharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">goss:SeriesSeedConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-04</startDate>
            <endDate>2018-01-04</endDate>
        </period>
    </context>
    <context id="ibc437c92dc4d47abbc82d156fe56b94a_D20180104-20180104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AABiopharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-04</startDate>
            <endDate>2018-01-04</endDate>
        </period>
    </context>
    <context id="ia6763b93bb734419aa637f9886d0f8d4_D20180101-20180131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AABiopharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-01-31</endDate>
        </period>
    </context>
    <context id="i149440b5575441f1ade1e500f96cffcd_D20180601-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <startDate>2018-06-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i4c1fea39e1c24a86b52512965a113dc8_D20200511-20200511">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AerpioPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">goss:LicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-11</startDate>
            <endDate>2020-05-11</endDate>
        </period>
    </context>
    <context id="i34b002ec88bf4140996fb7ae42f20c25_I20200511">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AerpioPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">goss:LicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-11</instant>
        </period>
    </context>
    <context id="i058b2b9596f049bf88bf24e8ef1b88f5_D20180624-20180624">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AerpioPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">goss:LicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-06-24</startDate>
            <endDate>2018-06-24</endDate>
        </period>
    </context>
    <context id="i3f2d41e0946a449d9739a4055373fcb5_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AerpioPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">goss:LicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8d3bd9ebc0c04c8aac7d80aadda3c812_D20180921-20180921">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AdhaerePharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-21</startDate>
            <endDate>2018-09-21</endDate>
        </period>
    </context>
    <context id="i71ff0fe376bb4ce4a0d344274d60cda5_I20180921">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AdhaerePharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-21</instant>
        </period>
    </context>
    <context id="i311895b288e84df99a0fe27ae04661aa_D20180901-20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AdhaerePharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="i449c34cb7fd642fc8a19b754af262018_D20190501-20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AdhaerePharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-01</startDate>
            <endDate>2019-05-31</endDate>
        </period>
    </context>
    <context id="ib5f049d5e60d4e86a687f615be004af7_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">goss:AdhaerePharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib4e0c83f4759440487e347440556bf19_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifa29bc841f9e4fb0955d09333da173cf_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0589fce7ead149e3b77ab56902cfd9da_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifb792d6d5530491786d139e759d02ca9_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i7d36daa696204d2a993a2a5386f71366_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ica43b072ffa14194a075ee24b8eefd04_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic25495903f344f3badaca483a298b34c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id69f21cf412842c28bbd38e5675710e9_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i785b0d7d87e64989afb260e63ffcaa75_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5877020a64de4daf9c2e9fc19548520c_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6dcb3875d02e46f6860a02a7ae51afa3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifc960cc1b38e453d8577212588425de5_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBZeroZeroFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i2e82f42dcfad490d88675b7ce2d18579_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5f1eb79d41a7477e8aac7ef9621f779b_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ifc076cf8ed8c4b60a0160f586d633a9d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id6dfed8a74714ce4b52a2b48f1f8bcfe_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i29791a3aea134a31a642f180d6f252e1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentOtherProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i28e36142d5da400cbe56fb94780d66fe_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentOtherProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i213f70a2c4f54d029f161eb250548f2f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentOtherProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i97eeb89fb4f541069f7d7bb71850f31f_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">goss:InProcessResearchAndDevelopmentOtherProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i32aaefa176c1431b83d26da9efa9e0e0_D20200521-20200521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <startDate>2020-05-21</startDate>
            <endDate>2020-05-21</endDate>
        </period>
    </context>
    <context id="i4903290fc91c4b818ef0419687e6bdb2_I20200521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <instant>2020-05-21</instant>
        </period>
    </context>
    <context id="id9231a57c1ff4550b9a94b3c726cfbfc_D20151203-20151203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">goss:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-12-03</startDate>
            <endDate>2015-12-03</endDate>
        </period>
    </context>
    <context id="i6f6a02fac0054f41ac0a21a7a698dd11_I20151203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">goss:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-12-03</instant>
        </period>
    </context>
    <context id="ia9c4125058a849188d84d6987a2aca5c_I20180104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">goss:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-04</instant>
        </period>
    </context>
    <context id="i56b9c2498afd46cea09d67fffcd7f527_D20180104-20180104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">goss:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-04</startDate>
            <endDate>2018-01-04</endDate>
        </period>
    </context>
    <context id="id747bd928ed14565962ba04db245c625_I20180104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">goss:FounderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-04</instant>
        </period>
    </context>
    <context id="ia05c65f0299b4470b9988c00f268c597_D20180521-20180521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">goss:FounderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-21</startDate>
            <endDate>2018-05-21</endDate>
        </period>
    </context>
    <context id="i44b0b9ab297245a587e455ae0fbdf7e1_I20180521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">goss:FounderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-21</instant>
        </period>
    </context>
    <context id="i13993408590b4d4aae392dedae7f7168_D20180906-20180906">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">goss:FounderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-06</startDate>
            <endDate>2018-09-06</endDate>
        </period>
    </context>
    <context id="i4232852076fb41578223f9f35c5620ed_I20180906">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">goss:FounderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-06</instant>
        </period>
    </context>
    <context id="i6361b8d7044547f78137b4ca8e8367ae_D20171101-20171130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">goss:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">goss:StockRestrictionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-11-01</startDate>
            <endDate>2017-11-30</endDate>
        </period>
    </context>
    <context id="id21572d412b64344adae1b7652804401_D20180101-20180131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">goss:StockRestrictionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-01-31</endDate>
        </period>
    </context>
    <context id="i565814101ba9433cabc2aba6a50774be_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icada44f7b33b4bb69194179efb087bf7_I20190206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-06</instant>
        </period>
    </context>
    <context id="i1c8bcc0cc5824acab60dce389cc0e01a_D20190206-20190206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-06</startDate>
            <endDate>2019-02-06</endDate>
        </period>
    </context>
    <context id="id21248c7f8d1404dbfbcc4790900c1a8_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id682609138d74f299a22b9b828664934_D20190206-20190206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandNineteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-06</startDate>
            <endDate>2019-02-06</endDate>
        </period>
    </context>
    <context id="i55d566fa333348f38fe0698d8122d240_I20190206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandNineteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-06</instant>
        </period>
    </context>
    <context id="id82f48c87413404898cd5e95a6f92456_D20190206-20190206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandNineteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-06</startDate>
            <endDate>2019-02-06</endDate>
        </period>
    </context>
    <context id="ib62a29f3d4bd41768f85b8c430ff8ed2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandSeventeenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i1bca54ddec634c619bb186716592456f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandSeventeenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id60e67dc25ec478c8538a048150413cc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i57a7a1c92af444738a26579e9c9b97f4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id7cf20b97501468ba190ca44f798aa5c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8dde91022b6f4727b6a3442ab07af3f3_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5ee46adffb174aab896b0ef706379d9e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i383e88d1480f4707a5e280fb091f49f1_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i0e99060b0b3445c2ab001b2db044619c_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibbd4563ff308475bb9677d83bd6901ed_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i5234f8600a24470b93bc826f0087d51f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i83e749032dd647eeb7e5730f0d79e71f_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i9addd071f2134af4b1c59d6d7647b955_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic44d278160054bb5935c16c50beece12_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ief5753da810c4701b357b0ba9f8e7bc1_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib4c2928920df49ebaed3b6aed298b48b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib654ba389ce740a5b5698b7efa4bf39b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandNineteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ib0f9d120e4f34b0e85ac915426783ced_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">goss:TwoThousandNineteenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2d1e2f5620c948549f4affe56ba4eba6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="goss:LeaseContractualTermAxis">goss:NonCancelableLeaseAgreementEnteredInAugust2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6f160954a3ed444fa5812d76c8308a06_D20191101-20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="goss:LeaseContractualTermAxis">goss:AdditionalNonCancelableLeaseAgreementInNov2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="ia55f355b0bbc4b78be1ab19f707c05ec_D20200601-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="goss:LeaseContractualTermAxis">goss:SubleaseAgreementEnteredInJune2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i29f32f74db5543c8a8510694e76a3c8d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="goss:LeaseContractualTermAxis">goss:SubleaseAgreementEnteredInJune2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9ac3518affc6454b9e891197f6e12355_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="goss:LeaseContractualTermAxis">goss:SubleaseAgreementEnteredInJune2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5ea38ec7e8c7483eb917072f4fe3f12d_I20200729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="goss:LeaseContractualTermAxis">goss:LeaseAssignmentAgreementEnteredInJuly2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-29</instant>
        </period>
    </context>
    <context id="i0c084b288ebf4e26a9b2953bd0afde9a_D20200729-20200729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
            <segment>
                <xbrldi:explicitMember dimension="goss:LeaseContractualTermAxis">goss:LeaseAssignmentAgreementEnteredInJuly2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-29</startDate>
            <endDate>2020-07-29</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="tranche">
        <measure>goss:Tranche</measure>
    </unit>
    <unit id="day">
        <measure>goss:day</measure>
    </unit>
    <unit id="vote">
        <measure>goss:vote</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80L2ZyYWc6OTk4NWQyNTNjZmY2NGZlNWJmYWFhOTEzYjg1ZDNlZjgvdGFibGU6M2I1OWU1YjE5NTY5NDc5ZTljOWM0ZDlhMmVhNzVlYTQvdGFibGVyYW5nZTozYjU5ZTViMTk1Njk0NzllOWM5YzRkOWEyZWE3NWVhNF80LTEtMS0xLTA_d29ce8cc-62d3-4078-b3d4-ef6b96d88f13">false</dei:AmendmentFlag>
    <dei:DocumentPeriodEndDate
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80L2ZyYWc6OTk4NWQyNTNjZmY2NGZlNWJmYWFhOTEzYjg1ZDNlZjgvdGFibGU6M2I1OWU1YjE5NTY5NDc5ZTljOWM0ZDlhMmVhNzVlYTQvdGFibGVyYW5nZTozYjU5ZTViMTk1Njk0NzllOWM5YzRkOWEyZWE3NWVhNF81LTEtMS0xLTA_c1b9b240-6ee5-4f30-9ada-46c639e7e282">2020-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80L2ZyYWc6OTk4NWQyNTNjZmY2NGZlNWJmYWFhOTEzYjg1ZDNlZjgvdGFibGU6M2I1OWU1YjE5NTY5NDc5ZTljOWM0ZDlhMmVhNzVlYTQvdGFibGVyYW5nZTozYjU5ZTViMTk1Njk0NzllOWM5YzRkOWEyZWE3NWVhNF82LTEtMS0xLTA_e6f7d086-0841-4b5a-96c5-bded20aac134">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80L2ZyYWc6OTk4NWQyNTNjZmY2NGZlNWJmYWFhOTEzYjg1ZDNlZjgvdGFibGU6M2I1OWU1YjE5NTY5NDc5ZTljOWM0ZDlhMmVhNzVlYTQvdGFibGVyYW5nZTozYjU5ZTViMTk1Njk0NzllOWM5YzRkOWEyZWE3NWVhNF83LTEtMS0xLTA_83aacf86-aa52-472d-99a4-ffa533a903e9">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80L2ZyYWc6OTk4NWQyNTNjZmY2NGZlNWJmYWFhOTEzYjg1ZDNlZjgvdGFibGU6M2I1OWU1YjE5NTY5NDc5ZTljOWM0ZDlhMmVhNzVlYTQvdGFibGVyYW5nZTozYjU5ZTViMTk1Njk0NzllOWM5YzRkOWEyZWE3NWVhNF8xMC0xLTEtMS0w_2e6b7c08-dd6c-4be6-a026-e0d20ab8b87c">0001728117</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80L2ZyYWc6OTk4NWQyNTNjZmY2NGZlNWJmYWFhOTEzYjg1ZDNlZjgvdGFibGU6M2I1OWU1YjE5NTY5NDc5ZTljOWM0ZDlhMmVhNzVlYTQvdGFibGVyYW5nZTozYjU5ZTViMTk1Njk0NzllOWM5YzRkOWEyZWE3NWVhNF8xMS0xLTEtMS0w_2e1b5a07-f506-46b7-9ce2-dd7f9584b6be">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i5fed8506ec5c42a0b5ad8496948c43b6_D20200521-20200521"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81OC9mcmFnOjlhYjI2NTI0YzAwNzQ0OWI5NDYyYjU2NzZiZjgwMDQ4L3RleHRyZWdpb246OWFiMjY1MjRjMDA3NDQ5Yjk0NjJiNTY3NmJmODAwNDhfMTA5OTUxMTYyNzkxMQ_c7a04677-351b-4ae8-adbe-c53a90c8e53e"
      unitRef="number">0.0616</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <dei:DocumentType
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGV4dHJlZ2lvbjo2N2VkMTBkOWMwZmE0YjkwYTYzMTg1OWE0MjEyMGIxZF8xMDk5NTExNjI5ODU2_54384758-a480-4fb9-ad2f-6b497f07dfc3">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6OWU5NDUyM2FhYTg1NGE1MTg1MTFjOGZkOGM4YjYyMWEvdGFibGVyYW5nZTo5ZTk0NTIzYWFhODU0YTUxODUxMWM4ZmQ4YzhiNjIxYV8wLTAtMS0xLTU4Ng_86441efe-f11f-453c-99a2-6eaf88b5aed4">true</dei:DocumentQuarterlyReport>
    <dei:DocumentTransitionReport
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6OWIxYzEyMGUxODE2NDY1N2I0ZDgyMGE1ZWU5MTc4NTcvdGFibGVyYW5nZTo5YjFjMTIwZTE4MTY0NjU3YjRkODIwYTVlZTkxNzg1N18wLTAtMS0xLTU5MA_e9404a11-ba3a-4192-a843-ecea7198a008">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGV4dHJlZ2lvbjo2N2VkMTBkOWMwZmE0YjkwYTYzMTg1OWE0MjEyMGIxZF8xMDk5NTExNjI5ODU3_fd3cfa81-f05d-4a77-823a-e0372b3d3bb9">001-38796</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGV4dHJlZ2lvbjo2N2VkMTBkOWMwZmE0YjkwYTYzMTg1OWE0MjEyMGIxZF8xMDk5NTExNjI5ODU5_2b73939b-5c6c-40a9-b3eb-fd2871209e4d">GOSSAMER BIO, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6NjRlODZhMzc2MDA2NDY2OGEyMTdiNTA2MThkZTU3MDQvdGFibGVyYW5nZTo2NGU4NmEzNzYwMDY0NjY4YTIxN2I1MDYxOGRlNTcwNF8wLTAtMS0xLTYwNw_c74fc985-237f-495f-bf33-b8c408250fa7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6NjRlODZhMzc2MDA2NDY2OGEyMTdiNTA2MThkZTU3MDQvdGFibGVyYW5nZTo2NGU4NmEzNzYwMDY0NjY4YTIxN2I1MDYxOGRlNTcwNF8wLTEtMS0xLTYxMA_56c1b161-e504-4710-abcf-76b9324db65f">47-5461709</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6NjRlODZhMzc2MDA2NDY2OGEyMTdiNTA2MThkZTU3MDQvdGFibGVyYW5nZTo2NGU4NmEzNzYwMDY0NjY4YTIxN2I1MDYxOGRlNTcwNF8zLTAtMS0xLTc3NQ_df8a262c-66e4-43e3-97da-812ed1986ae3">3013 Science Park Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6NjRlODZhMzc2MDA2NDY2OGEyMTdiNTA2MThkZTU3MDQvdGFibGVyYW5nZTo2NGU4NmEzNzYwMDY0NjY4YTIxN2I1MDYxOGRlNTcwNF8zLTEtMS0xLTc3Nw_652fddf5-fe31-4321-9091-1844da30fa91">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6NjRlODZhMzc2MDA2NDY2OGEyMTdiNTA2MThkZTU3MDQvdGFibGVyYW5nZTo2NGU4NmEzNzYwMDY0NjY4YTIxN2I1MDYxOGRlNTcwNF8zLTItMS0xLTc3OQ_668956ec-42b4-435c-87cd-1c56d874daa7">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6NjRlODZhMzc2MDA2NDY2OGEyMTdiNTA2MThkZTU3MDQvdGFibGVyYW5nZTo2NGU4NmEzNzYwMDY0NjY4YTIxN2I1MDYxOGRlNTcwNF8zLTEtMS0xLTYxOQ_d9865f8f-9c7d-4937-b034-6cd8e0bcfc0b">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGV4dHJlZ2lvbjo2N2VkMTBkOWMwZmE0YjkwYTYzMTg1OWE0MjEyMGIxZF8xMDk5NTExNjI5ODY1_28f00ad7-0b49-48b3-905f-77f446290199">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGV4dHJlZ2lvbjo2N2VkMTBkOWMwZmE0YjkwYTYzMTg1OWE0MjEyMGIxZF8xMDk5NTExNjI5ODY5_acd8a855-c84c-4f79-9610-d570f5b31374">684-1300</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6YjQ2Nzg2NTFmNjQzNDE3Zjg3NjVkNzc5MmRiNzc1NDcvdGFibGVyYW5nZTpiNDY3ODY1MWY2NDM0MTdmODc2NWQ3NzkyZGI3NzU0N18xLTAtMS0xLTYzNA_88e056a1-3975-4ba6-aa10-9b6cf9d23db2">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6YjQ2Nzg2NTFmNjQzNDE3Zjg3NjVkNzc5MmRiNzc1NDcvdGFibGVyYW5nZTpiNDY3ODY1MWY2NDM0MTdmODc2NWQ3NzkyZGI3NzU0N18xLTItMS0xLTYzNw_20c071bd-36d5-497b-a591-a83494c31836">GOSS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6YjQ2Nzg2NTFmNjQzNDE3Zjg3NjVkNzc5MmRiNzc1NDcvdGFibGVyYW5nZTpiNDY3ODY1MWY2NDM0MTdmODc2NWQ3NzkyZGI3NzU0N18xLTQtMS0xLTY0MA_314e8f2e-ecb9-4d99-a96b-1bb35b516ff8">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGV4dHJlZ2lvbjo2N2VkMTBkOWMwZmE0YjkwYTYzMTg1OWE0MjEyMGIxZF8xMDk5NTExNjI5ODcx_c21da7b7-435d-4bca-be6f-08295bdd1102">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGV4dHJlZ2lvbjo2N2VkMTBkOWMwZmE0YjkwYTYzMTg1OWE0MjEyMGIxZF8xMDk5NTExNjI5ODcy_5e3f5a07-6b5c-452f-8347-1455171dfb40">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6MDdjZDI1ZWU0M2EwNGMzMjgyNTBmNDM1MWE0OTQ0MTAvdGFibGVyYW5nZTowN2NkMjVlZTQzYTA0YzMyODI1MGY0MzUxYTQ5NDQxMF8xLTAtMS0xLTc5OA_1d653a17-de9f-4282-b540-896c0e9d95c5">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6MDdjZDI1ZWU0M2EwNGMzMjgyNTBmNDM1MWE0OTQ0MTAvdGFibGVyYW5nZTowN2NkMjVlZTQzYTA0YzMyODI1MGY0MzUxYTQ5NDQxMF8xLTQtMS0xLTY1OA_5ffa652a-e9ee-44f9-9f40-77726c6a87a0">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGFibGU6MDdjZDI1ZWU0M2EwNGMzMjgyNTBmNDM1MWE0OTQ0MTAvdGFibGVyYW5nZTowN2NkMjVlZTQzYTA0YzMyODI1MGY0MzUxYTQ5NDQxMF8yLTEtMS0xLTY1Ng_7dc8972b-fd5a-48a4-bdab-17ce047b83a8">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGV4dHJlZ2lvbjo2N2VkMTBkOWMwZmE0YjkwYTYzMTg1OWE0MjEyMGIxZF8xMDk5NTExNjI5ODkx_08ac8e3c-4dec-4a8c-a6b2-b600fb2f7ee5">true</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGV4dHJlZ2lvbjo2N2VkMTBkOWMwZmE0YjkwYTYzMTg1OWE0MjEyMGIxZF8xMDk5NTExNjI5ODc0_47b75038-6668-43bc-bd4c-2680d0ce5e77">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ie505de77d9a8407ab07995dedcd8776a_I20201105"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xL2ZyYWc6NjdlZDEwZDljMGZhNGI5MGE2MzE4NTlhNDIxMjBiMWQvdGV4dHJlZ2lvbjo2N2VkMTBkOWMwZmE0YjkwYTYzMTg1OWE0MjEyMGIxZF8xMDk5NTExNjI5ODc3_d9bdc7af-4661-48b8-81ec-8a93368d5814"
      unitRef="shares">75927877</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMy0xLTEtMS0w_6f85e7a4-760a-4639-bd45-d43763713c06"
      unitRef="usd">461956000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMy0zLTEtMS0w_05bcf82c-c4fd-4bcb-b1d0-961c0b4d97e4"
      unitRef="usd">135089000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfNC0xLTEtMS0w_c4413b81-a154-4edf-bd47-059eedaf3024"
      unitRef="usd">93422000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfNC0zLTEtMS0w_564d852a-83c4-4909-a6fa-2a23d5d8dbed"
      unitRef="usd">266740000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfNS0xLTEtMS0w_c3fa9c28-70bc-40d6-92ca-0ac67b5c001c"
      unitRef="usd">10828000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfNS0zLTEtMS0w_9d7be74c-c4fd-465d-8993-225d4c926e41"
      unitRef="usd">7488000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfNi0xLTEtMS0w_54339e31-b995-45c9-ae2d-58cbee3e8797"
      unitRef="usd">566206000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfNi0zLTEtMS0w_0c0f98e9-a560-4db7-b3ae-71ac6987aab4"
      unitRef="usd">409317000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfNy0xLTEtMS0w_18e3b731-0c7e-4749-9be0-c1422bffcf63"
      unitRef="usd">5717000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfNy0zLTEtMS0w_8c4cfb86-2889-4946-9690-dc56c69241cb"
      unitRef="usd">5425000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfOC0xLTEtMS0w_95c281fa-1f24-4cf8-89da-08be137f459c"
      unitRef="usd">11394000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfOC0zLTEtMS0w_de1e9cea-378b-463e-a6a6-de0bf23db2bc"
      unitRef="usd">10303000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfOS0xLTEtMS0w_8fa347d1-da4c-4963-ab03-f97e122836d4"
      unitRef="usd">861000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfOS0zLTEtMS0w_25d28d85-7f67-4e25-aa03-bb8ba1a3bd67"
      unitRef="usd">1559000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTAtMS0xLTEtMA_5664c3a0-86c5-409c-8e3d-f378f7f65ec7"
      unitRef="usd">584178000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTAtMy0xLTEtMA_1c531699-0af9-409e-b554-5cbdb21111d4"
      unitRef="usd">426604000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTMtMS0xLTEtMA_276fc92d-c3ef-4909-a485-89f5fbd4c8b6"
      unitRef="usd">865000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTMtMy0xLTEtMA_9bf404e3-a22f-4efe-b115-3a1d527e9ae9"
      unitRef="usd">956000</us-gaap:AccountsPayableCurrent>
    <goss:AccruedResearchAndDevelopmentExpenses
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTQtMS0xLTEtMA_dce934d8-4fee-46b4-af81-3c0fec670d35"
      unitRef="usd">12239000</goss:AccruedResearchAndDevelopmentExpenses>
    <goss:AccruedResearchAndDevelopmentExpenses
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTQtMy0xLTEtMA_6da45d92-b8b3-43c0-908c-d6e05b063ad7"
      unitRef="usd">19258000</goss:AccruedResearchAndDevelopmentExpenses>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTUtMS0xLTEtMA_a5dbb166-87fe-4409-8306-21be143abc2d"
      unitRef="usd">19503000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTUtMy0xLTEtMA_a2b7d038-19ca-4623-946f-ff51dba4476f"
      unitRef="usd">16709000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTYtMS0xLTEtMA_ecc51a02-38cb-4ea9-9b77-9c9820cfdd5e"
      unitRef="usd">32607000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTYtMy0xLTEtMA_4e7da944-7807-458a-9741-2ebf3d459a4a"
      unitRef="usd">36923000</us-gaap:LiabilitiesCurrent>
    <goss:LongTermConvertibleSeniorNotes
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTctMS0xLTEtMA_7999db25-d2a2-4c9e-b2fc-88c5e9c6a911"
      unitRef="usd">142158000</goss:LongTermConvertibleSeniorNotes>
    <goss:LongTermConvertibleSeniorNotes
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTctMy0xLTEtMA_ef9fe763-8537-48a5-afbf-25a0e7ecef22"
      unitRef="usd">0</goss:LongTermConvertibleSeniorNotes>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTgtMS0xLTEtMA_c01b8206-ee64-47aa-85dc-395132e26210"
      unitRef="usd">28665000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTgtMy0xLTEtMA_d7ba595f-4566-4694-865e-64e8ee7a0934"
      unitRef="usd">28459000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTktMS0xLTEtMA_fd9232f7-88ce-45d6-b54a-de6a54d8ba1e"
      unitRef="usd">8647000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMTktMy0xLTEtMA_d1e78a2d-7860-4c75-a70e-76459a290ff9"
      unitRef="usd">8737000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjAtMS0xLTEtMA_2efa6400-7ca0-4995-b454-194953f5187e"
      unitRef="usd">212077000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjAtMy0xLTEtMA_9b839f61-1477-40f8-9bfe-64deba979257"
      unitRef="usd">74119000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjEtMS0xLTEtMA_d0fc8837-749f-4036-b92d-56598ee7fe8a"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjEtMy0xLTEtMA_1d18c8c5-9ecb-4f57-8462-69c03bae51a8"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjMtMC0xLTEtNTIvdGV4dHJlZ2lvbjphNzQwZjJmYmVkMGM0ZTExOGYyZWNhNjdmZTM5MzJkNF8zMjk4NTM0ODgzNzQw_17fa281f-b65e-49ca-8271-7d9247d655af"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjMtMC0xLTEtNTIvdGV4dHJlZ2lvbjphNzQwZjJmYmVkMGM0ZTExOGYyZWNhNjdmZTM5MzJkNF8zMjk4NTM0ODgzNzQw_f7a7d872-5f86-4787-a4c5-f437ab927e61"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjMtMC0xLTEtNTIvdGV4dHJlZ2lvbjphNzQwZjJmYmVkMGM0ZTExOGYyZWNhNjdmZTM5MzJkNF8zMjk4NTM0ODgzNjE1_082d2be6-ab27-47f1-b5df-9bf2259fc033"
      unitRef="shares">700000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjMtMC0xLTEtNTIvdGV4dHJlZ2lvbjphNzQwZjJmYmVkMGM0ZTExOGYyZWNhNjdmZTM5MzJkNF8zMjk4NTM0ODgzNjE1_ac310e83-f7aa-4c83-8648-5a34ad578ed7"
      unitRef="shares">700000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjMtMC0xLTEtNTIvdGV4dHJlZ2lvbjphNzQwZjJmYmVkMGM0ZTExOGYyZWNhNjdmZTM5MzJkNF8zMjk4NTM0ODgzNjk1_701facbd-748f-4359-bb75-16c46f865db0"
      unitRef="shares">75907527</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjMtMC0xLTEtNTIvdGV4dHJlZ2lvbjphNzQwZjJmYmVkMGM0ZTExOGYyZWNhNjdmZTM5MzJkNF8zMjk4NTM0ODgzNzA3_a49c4714-15d6-4312-ab75-0a218fce813f"
      unitRef="shares">72475912</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjMtMC0xLTEtNTIvdGV4dHJlZ2lvbjphNzQwZjJmYmVkMGM0ZTExOGYyZWNhNjdmZTM5MzJkNF8zMjk4NTM0ODgzNzE5_80ba2185-07e2-4a54-9883-ced23b9f1806"
      unitRef="shares">66284003</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjMtMC0xLTEtNTIvdGV4dHJlZ2lvbjphNzQwZjJmYmVkMGM0ZTExOGYyZWNhNjdmZTM5MzJkNF8zMjk4NTM0ODgzNzMx_dc99d9c0-18a4-42b4-ad55-d307378bdd4e"
      unitRef="shares">61635477</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjMtMS0xLTEtMA_15219eaf-2266-4b48-885b-73803e701ad5"
      unitRef="usd">8000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjMtMy0xLTEtMA_a38c6ea7-de52-4f04-ac82-30fc7776c180"
      unitRef="usd">7000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjQtMS0xLTEtMA_c873a9a9-6a2a-4f4b-bd50-3f76504c23d2"
      unitRef="usd">884677000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjQtMy0xLTEtMA_9f63c109-f074-47ce-8321-213e8b456c26"
      unitRef="usd">686390000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjUtMS0xLTEtMA_83d7e870-b536-4dc0-bd30-1f92586f7a11"
      unitRef="usd">-512926000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjUtMy0xLTEtMA_8f5811de-3696-406c-9c1f-03652ff053e3"
      unitRef="usd">-334170000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjYtMS0xLTEtMA_74b88758-d202-4e35-9c3e-1974109e188f"
      unitRef="usd">342000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjYtMy0xLTEtMA_1aec386d-c761-411b-bb71-923dd285cac4"
      unitRef="usd">258000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjctMS0xLTEtMA_ef1dd983-f8ea-4731-a81c-d92e985fe946"
      unitRef="usd">372101000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjctMy0xLTEtMA_c3e1479b-ae48-42d6-95ae-f4062c25fe54"
      unitRef="usd">352485000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjgtMS0xLTEtMA_28735692-2897-43b9-89ce-321de0f5bccb"
      unitRef="usd">584178000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8xNi9mcmFnOjhjNjVmZmQ4ZDlmZjQxODQ5MDY2YWZiZjFjNmUxOTE4L3RhYmxlOmNlZDdiNGNjOTFjZDQ4Mjg5ZTcxN2NmM2RkZmE5NDk3L3RhYmxlcmFuZ2U6Y2VkN2I0Y2M5MWNkNDgyODllNzE3Y2YzZGRmYTk0OTdfMjgtMy0xLTEtMA_9de19def-8980-4f42-b08f-d1bedcc75e90"
      unitRef="usd">426604000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMy0xLTEtMS0w_3de6cc00-d35e-4595-acc5-c3fa0644d3f5"
      unitRef="usd">41846000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMy0zLTEtMS0w_fbc4f168-f4c5-49b6-9e98-0a096dd3272a"
      unitRef="usd">40148000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMy01LTEtMS0w_3fdf7f06-e4b9-4515-abc8-59dd1d0fb2bd"
      unitRef="usd">121944000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMy03LTEtMS0w_df6662dd-ef76-4171-bc75-dfeea996fdd2"
      unitRef="usd">100807000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNC0xLTEtMS0w_e34463ad-66e5-4f63-b194-5d00902b55d3"
      unitRef="usd">275000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNC0zLTEtMS0w_936aa098-1e03-4f47-b4c3-86a9f7f14769"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNC01LTEtMS0w_551e2c16-a6a2-4b77-b705-0e767f990128"
      unitRef="usd">18080000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNC03LTEtMS0w_9aea5878-d69a-4c78-bd67-5c916d99b304"
      unitRef="usd">2000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNS0xLTEtMS0w_6938dfbf-a25b-4caf-a7b6-5fff2ad61260"
      unitRef="usd">11448000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNS0zLTEtMS0w_12502475-7fbd-4749-90a9-70e0b2f7898b"
      unitRef="usd">9838000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNS01LTEtMS0w_b7ad0bd4-2563-4430-9248-2e8e2df2cf57"
      unitRef="usd">33851000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNS03LTEtMS0w_ca149d28-2d1c-40f1-83ba-3f63712c32ca"
      unitRef="usd">27544000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNi0xLTEtMS0w_c5147846-df1a-4cc8-af59-a28279ca9769"
      unitRef="usd">53569000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNi0zLTEtMS0w_737a9c98-f937-4d92-b4fa-04946422972a"
      unitRef="usd">49986000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNi01LTEtMS0w_cad0c176-e289-4b99-910f-f2c7599cbbcf"
      unitRef="usd">173875000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNi03LTEtMS0w_6a86f80e-e5c6-468a-b156-2bc0a85cda45"
      unitRef="usd">130351000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNy0xLTEtMS0w_85874649-0b15-4325-9e8f-86221b9781bb"
      unitRef="usd">-53569000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNy0zLTEtMS0w_1d808e20-8097-4490-a3da-7164dee7604e"
      unitRef="usd">-49986000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNy01LTEtMS0w_a0ecd173-8ba2-416b-8f59-76d6713a3397"
      unitRef="usd">-173875000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfNy03LTEtMS0w_e79a2c2a-0f00-43f5-93fc-fc5a619bcce4"
      unitRef="usd">-130351000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfOC0xLTEtMS0w_f37d737f-602b-4fa7-b25e-d46623ac5906"
      unitRef="usd">-4243000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfOC0zLTEtMS0w_32e4c744-194f-4a72-9445-d09a1db71240"
      unitRef="usd">1486000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfOC01LTEtMS0w_172660e3-6f15-479e-98b7-a1765e8a260e"
      unitRef="usd">-4881000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfOC03LTEtMS0w_ca14e983-6584-4ec1-ac87-f795ffcc52ae"
      unitRef="usd">4742000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfOS0xLTEtMS0w_54565f27-eced-4977-ae27-3b0dd4b98282"
      unitRef="usd">-57812000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfOS0zLTEtMS0w_20de74cc-67d9-4df1-ad03-10f419613aed"
      unitRef="usd">-48500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfOS01LTEtMS0w_715549d8-85cc-4f13-a19d-c2603229d106"
      unitRef="usd">-178756000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfOS03LTEtMS0w_52b5dda8-0d89-4bad-89ed-c72b52bc71b8"
      unitRef="usd">-125609000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTEtMS0xLTEtMA_0ea3042d-b13e-4033-a842-5980fd9dbd66"
      unitRef="usd">68000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTEtMy0xLTEtMA_0263841c-8f11-47a7-8064-867c1209d435"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTEtNS0xLTEtMA_cd6a60f9-3296-46eb-9291-fa7173f777eb"
      unitRef="usd">59000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTEtNy0xLTEtMA_dfb12522-59c7-4fd8-96c5-b9a9bb9933e7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTItMS0xLTEtMA_b0820b47-1dcb-4eed-9737-2d754ebd86b9"
      unitRef="usd">-293000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTItMy0xLTEtMA_5293d8a1-d150-4f46-86d3-815d7512a2a5"
      unitRef="usd">-168000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTItNS0xLTEtMA_cfcafc2b-861b-4405-b2d7-5bda1ba39d15"
      unitRef="usd">25000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTItNy0xLTEtMA_04715ab4-c00a-45a4-95bd-a4328b7e4de1"
      unitRef="usd">389000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTMtMS0xLTEtMA_7b280451-9281-4a3f-8d1f-dcc812343220"
      unitRef="usd">-225000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTMtMy0xLTEtMA_7a6af1c3-07a7-451f-bdda-6fc555c0b31a"
      unitRef="usd">-168000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTMtNS0xLTEtMA_f106fd45-a65a-43cb-b0a7-61229f2d52bb"
      unitRef="usd">84000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTMtNy0xLTEtMA_76a8075a-dbc0-441a-b345-efc1ed5dce2b"
      unitRef="usd">389000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTQtMS0xLTEtMA_4b6255af-b9ec-4754-b2f3-65867ec6a706"
      unitRef="usd">-58037000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTQtMy0xLTEtMA_28a84bc9-bf87-4146-9752-5ebb0fe23cd7"
      unitRef="usd">-48668000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTQtNS0xLTEtMA_e69014d8-3377-4c16-beb1-52850d8e2448"
      unitRef="usd">-178672000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTQtNy0xLTEtMA_8bfaa6ee-3b8e-46c4-98ff-eee155d4eae0"
      unitRef="usd">-125220000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTUtMS0xLTEtMA_5970dc42-ffc6-46cd-bfce-15fca4d68029"
      unitRef="usdPerShare">-0.80</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTUtMy0xLTEtMA_b1d62390-e671-4b8a-be60-ca959e9152ae"
      unitRef="usdPerShare">-0.80</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTUtNS0xLTEtMA_49a3fd4c-bfd9-4462-8a0e-ecc71616089b"
      unitRef="usdPerShare">-2.67</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTUtNy0xLTEtMA_8c226af6-55d4-4930-86f8-794cf4b26179"
      unitRef="usdPerShare">-2.39</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTYtMS0xLTEtMA_a59f171f-130a-49a4-bb4c-8e2d8f125952"
      unitRef="shares">72245897</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTYtMy0xLTEtMA_f10f7081-19a0-4220-9591-e378d558c8ac"
      unitRef="shares">60755872</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTYtNS0xLTEtMA_d8393ecd-fe4d-4c3b-ad2d-a688984457fc"
      unitRef="shares">66931512</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yMi9mcmFnOjM0YWI3ODExOGVjZTQzZjFiMTkxYWJiMjcwMmViZjIwL3RhYmxlOjQxNDkzNDE2MjIyOTQ5MTU5MTU0YzBmODhhNzc1YjgwL3RhYmxlcmFuZ2U6NDE0OTM0MTYyMjI5NDkxNTkxNTRjMGY4OGE3NzViODBfMTYtNy0xLTEtMA_a07e04e7-1f47-4472-9dda-ed516d510d04"
      unitRef="shares">52535569</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:SharesOutstanding
      contextRef="icf88702e49f34f05a203c305e7218d7c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMy0xNC0xLTEtMA_88846c87-8f32-46b3-bd2c-56aa561a9959"
      unitRef="shares">61635477</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="icf88702e49f34f05a203c305e7218d7c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMy0xNi0xLTEtMA_02783be0-f1a2-4e3f-8c4a-15eab3b8669b"
      unitRef="usd">7000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib7379eeb81da423f99c7cf5072cffbc2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMy0xOC0xLTEtMA_d3b4b089-2ed3-4d6d-a60c-e3b40ccfe9aa"
      unitRef="usd">686390000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie414046cc6c443539a8b1ba823193e96_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMy0yMC0xLTEtMA_35fdb9ad-1aac-4ded-87ce-65c298d5bebe"
      unitRef="usd">-334170000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic6adcea0a3af47708c4c2ce641288ef5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMy0yMi0xLTEtMA_f812bc07-d251-4bda-bd0e-e14266119d20"
      unitRef="usd">258000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMy0yNC0xLTEtMA_55911209-584c-4ed2-85c8-f5033ecc1ff4"
      unitRef="usd">352485000</us-gaap:StockholdersEquity>
    <goss:StockIssuedDuringPeriodSharesVestingOfRestrictedStock
      contextRef="i9ca596cd49d2414786bbd3a11c836866_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfNC0xNC0xLTEtMA_9885cf87-aeae-46ad-a417-4126525b4386"
      unitRef="shares">404637</goss:StockIssuedDuringPeriodSharesVestingOfRestrictedStock>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i9ca596cd49d2414786bbd3a11c836866_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfNS0xNC0xLTEtMA_e8f5f372-c4c4-4f70-a5c0-a4b97ec0bd95"
      unitRef="shares">4309</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib95b4750602f4fd8bdf1f4408e3bac46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfNS0xOC0xLTEtMA_253aead1-97a6-453a-84f8-bbd6a6b78f27"
      unitRef="usd">15000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i1caa3930a2594a799b9714a362f1b101_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfNS0yNC0xLTEtMA_cb88d393-88a6-49b9-9b91-0899fcab6136"
      unitRef="usd">15000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib95b4750602f4fd8bdf1f4408e3bac46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfNi0xOC0xLTEtMA_d7454711-f8cb-4182-aa43-01958d477a31"
      unitRef="usd">8244000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9700bbf1ee8c490ead9c97fb9c7d5dc7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfNi0yMC0xLTEtMA_1a6c2d89-48f1-4ae7-94ed-4bcbffc37621"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i1caa3930a2594a799b9714a362f1b101_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfNi0yNC0xLTEtMA_bc54e182-fb22-4d98-adab-8d2f56ef1487"
      unitRef="usd">8244000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i9ca596cd49d2414786bbd3a11c836866_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfNy0xNC0xLTEtMA_5771ee19-7ab5-449b-823a-14e159931dbf"
      unitRef="shares">49889</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ib95b4750602f4fd8bdf1f4408e3bac46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfNy0xOC0xLTEtMA_c0af3139-0aca-4914-b8c2-417fe11c6071"
      unitRef="usd">556000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i1caa3930a2594a799b9714a362f1b101_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfNy0yNC0xLTEtMA_76b21fd1-2bc8-4368-bb2a-bc59c097563a"
      unitRef="usd">556000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:NetIncomeLoss
      contextRef="i9700bbf1ee8c490ead9c97fb9c7d5dc7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfOC0yMC0xLTEtMA_d63a4439-caa6-4d86-b8f8-2fce5b6a3df4"
      unitRef="usd">-54074000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1caa3930a2594a799b9714a362f1b101_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfOC0yNC0xLTEtMA_0d103331-5234-47a1-b070-cabbac8c29af"
      unitRef="usd">-54074000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i93af83044802421987749ef31a183d52_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfOS0yMi0xLTEtMA_48a5bd7f-65e6-4f84-8206-622a2cf66b3a"
      unitRef="usd">-763000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i1caa3930a2594a799b9714a362f1b101_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfOS0yNC0xLTEtMA_0466b8e9-3d63-49c2-b20e-9b2944b5b71a"
      unitRef="usd">-763000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="ib7d34d11bc09445287a4c15de915761e_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTAtMTQtMS0xLTA_a94e1fd2-447b-4b6c-9e54-dbff9dd36948"
      unitRef="shares">62094000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ib7d34d11bc09445287a4c15de915761e_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTAtMTYtMS0xLTA_b2efca44-a83d-44a7-bfe1-7def7331ad09"
      unitRef="usd">7000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idccd09399cdb4afd946bd554abecc76e_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTAtMTgtMS0xLTA_7c610077-83e3-4ba6-9365-c3a8406f0189"
      unitRef="usd">695205000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6fba8fc0709c48be89520d5a63454847_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTAtMjAtMS0xLTA_30ccf0ec-5d8e-4e76-8ca1-566bd25d82d7"
      unitRef="usd">-388244000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib3af9d2e206e40adaa4e86d644948813_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTAtMjItMS0xLTA_9533ed5a-121e-47f0-8232-9747d3100c88"
      unitRef="usd">-505000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic17e964b37084a94a4881db7645fa317_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTAtMjQtMS0xLTA_16afbef7-0a6f-49e3-9d98-b1c30c6fca25"
      unitRef="usd">306463000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i5ed5a5578fba4ebc96b685a36facf9c3_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTEtMTQtMS0xLTA_1fac073c-a29f-4cba-b6dc-42c1153f344a"
      unitRef="shares">9433963</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i5ed5a5578fba4ebc96b685a36facf9c3_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTEtMTYtMS0xLTA_3da3e5fb-ec81-4144-ae58-02e0eaeca432"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i7c0263dedae046d1bf5c601e9e997bc3_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTEtMTgtMS0xLTA_52c20028-bacc-4cd6-b7b8-b8a071a915e9"
      unitRef="usd">117093000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i713b4ee54335442fa90cd348ffab165f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTEtMjQtMS0xLTA_3e63515b-1a31-44e4-b85e-17d01965215d"
      unitRef="usd">117094000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <goss:EquityComponentOfConvertibleNoteIssuance
      contextRef="i7c0263dedae046d1bf5c601e9e997bc3_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTItMTgtMS0xLTA_8dff300b-a43a-4c80-92a3-cf7464cb3e76"
      unitRef="usd">53635000</goss:EquityComponentOfConvertibleNoteIssuance>
    <goss:EquityComponentOfConvertibleNoteIssuance
      contextRef="i713b4ee54335442fa90cd348ffab165f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTItMjQtMS0xLTA_ac106527-8afc-4af6-b449-93d4c79a1b03"
      unitRef="usd">53635000</goss:EquityComponentOfConvertibleNoteIssuance>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="i7c0263dedae046d1bf5c601e9e997bc3_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTMtMTgtMS0xLTA_9ca72998-be9e-44a0-a05a-b1c7580a50c3"
      unitRef="usd">109000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="i713b4ee54335442fa90cd348ffab165f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTMtMjQtMS0xLTA_ad65c1b1-d441-448d-b273-c0c42f1845d1"
      unitRef="usd">109000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <goss:StockIssuedDuringPeriodSharesVestingOfRestrictedStock
      contextRef="i5ed5a5578fba4ebc96b685a36facf9c3_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTQtMTQtMS0xLTA_b384431e-5709-4491-9a87-7d629d448cdf"
      unitRef="shares">404637</goss:StockIssuedDuringPeriodSharesVestingOfRestrictedStock>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i5ed5a5578fba4ebc96b685a36facf9c3_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTUtMTQtMS0xLTA_c97e5ff1-707c-45ab-ae5b-13c236d1f4ce"
      unitRef="shares">39698</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7c0263dedae046d1bf5c601e9e997bc3_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTUtMTgtMS0xLTA_44585e5d-3599-40e3-88c1-330c3e16a502"
      unitRef="usd">139000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i713b4ee54335442fa90cd348ffab165f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTUtMjQtMS0xLTA_30de6af2-165b-4c4d-8d23-3df7a2d830dd"
      unitRef="usd">139000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i5ed5a5578fba4ebc96b685a36facf9c3_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTYtMTQtMS0xLTA_e1e4d7b2-eb77-4123-8923-3c4aed25489c"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7c0263dedae046d1bf5c601e9e997bc3_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTYtMTgtMS0xLTA_8eea3b93-392a-4294-bb45-f5da4d680e49"
      unitRef="usd">8900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i713b4ee54335442fa90cd348ffab165f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTYtMjQtMS0xLTA_446d7a41-660f-4702-89d9-4a6c266e480c"
      unitRef="usd">8900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i06c4796c101b42a492b0b4c35e73bbf4_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTctMjAtMS0xLTA_e617c70d-129b-4b5d-84e6-3497dc3fb0f7"
      unitRef="usd">-66870000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i713b4ee54335442fa90cd348ffab165f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTctMjQtMS0xLTA_3ce0c52a-e0f1-48f2-b272-149aa98f2c42"
      unitRef="usd">-66870000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i179e6d0fae8d486f92313c7f72e868be_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTgtMjItMS0xLTA_69b2ea34-5fb7-42ad-849f-c8547384c9b8"
      unitRef="usd">1072000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i713b4ee54335442fa90cd348ffab165f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTgtMjQtMS0xLTA_9adfe33b-5979-4158-996b-66e2d2e4386e"
      unitRef="usd">1072000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="idc2769e3ef10494aaf33bceab6b40d73_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTktMTQtMS0xLTA_03dcc46d-110d-47f5-8365-0acabb230b8a"
      unitRef="shares">71972610</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="idc2769e3ef10494aaf33bceab6b40d73_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTktMTYtMS0xLTA_cf576948-1c53-4581-ab2d-397b1aff2df6"
      unitRef="usd">8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i480da23e7ba242298f782217cc12a7de_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTktMTgtMS0xLTA_5eab939e-4a25-45f3-8546-342140c1a814"
      unitRef="usd">874863000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idc9220fd857749928edaccab2a419a18_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTktMjAtMS0xLTA_b79cb636-34d5-460c-86e7-e86026388ccf"
      unitRef="usd">-455114000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0ff593aedcba40a79fd271254329a2e8_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTktMjItMS0xLTA_a2b59bec-88cb-47f5-9c40-0e775e08f9d4"
      unitRef="usd">567000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i709889bc20a04f829d4afc37e00775f6_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMTktMjQtMS0xLTA_d0d5392c-9977-4ca3-b8a8-929839d06bb9"
      unitRef="usd">420324000</us-gaap:StockholdersEquity>
    <goss:StockIssuedDuringPeriodSharesVestingOfRestrictedStock
      contextRef="i61df284353eb4dd6bd4c5ccba7156006_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjAtMTQtMS0xLTEyMzM_e82d1d31-fe1c-436a-bcd2-537094872cbf"
      unitRef="shares">404637</goss:StockIssuedDuringPeriodSharesVestingOfRestrictedStock>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i61df284353eb4dd6bd4c5ccba7156006_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjEtMTQtMS0xLTEyMzM_38b12b31-0bd5-43c3-93ab-1d801c9f563a"
      unitRef="shares">32268</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ibbe555fee6524c44a457250b4e5a4021_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjEtMTgtMS0xLTEyMzM_fb42db71-bc06-486e-a1ea-791b92b91652"
      unitRef="usd">131000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjEtMjQtMS0xLTEyMzM_6caea8cc-0ae2-4270-be95-4df00a057a3e"
      unitRef="usd">131000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ibbe555fee6524c44a457250b4e5a4021_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjItMTgtMS0xLTEyMzM_31e9daf3-1ccc-4844-9b36-6c43dbe91957"
      unitRef="usd">8923000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i31856bc57f6c47a3bf3f5b8adeeb728f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjItMjAtMS0xLTEyMzM_dc21cf98-d643-444f-9e11-4c4072f54cd2"
      unitRef="usd">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjItMjQtMS0xLTEyMzM_bc6c3d01-9836-4743-bdbd-233e2733eef0"
      unitRef="usd">8923000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i61df284353eb4dd6bd4c5ccba7156006_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjMtMTQtMS0xLTEyMzM_7801e966-3764-4ada-a278-165d1d86be54"
      unitRef="shares">63397</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ibbe555fee6524c44a457250b4e5a4021_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjMtMTgtMS0xLTEyMzM_9eadb826-67b4-46a4-aef3-48cafa950c94"
      unitRef="usd">744000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjMtMjQtMS0xLTEyMzM_4ac21faa-d89b-4995-9e22-9cf1872cdcea"
      unitRef="usd">744000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="ibbe555fee6524c44a457250b4e5a4021_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjQtMTgtMS0xLTEyMzM_5658da05-520f-4a00-88ca-4fd7699515a1"
      unitRef="usd">16000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjQtMjQtMS0xLTEyMzM_7a0eb11c-8cd9-436c-99f1-9ab3d62268c1"
      unitRef="usd">16000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:NetIncomeLoss
      contextRef="i31856bc57f6c47a3bf3f5b8adeeb728f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjUtMjAtMS0xLTIwNzQ_b5ad6e4b-6963-4f2f-a87d-7d07cea40af9"
      unitRef="usd">-57812000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjUtMjQtMS0xLTIwNzQ_b6c57019-c52a-46bf-a921-a6c0e384b569"
      unitRef="usd">-57812000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i71bc32578df241928d2449da7c53426b_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjUtMjItMS0xLTEyMzM_b6853138-c623-4915-bbc7-067c2ac4ac6a"
      unitRef="usd">-225000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjUtMjQtMS0xLTEyMzM_835ba298-ef17-475c-baf5-4eaa75f1a3b9"
      unitRef="usd">-225000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i3d810e89f07c449a83b0758c44d745bf_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjYtMTQtMS0xLTEyMzM_13413b54-befb-4aed-b959-04ff4cd03301"
      unitRef="shares">72472912</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i3d810e89f07c449a83b0758c44d745bf_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjYtMTYtMS0xLTEyMzM_ac556179-682c-459f-ba39-c09928c7650a"
      unitRef="usd">8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i78bd0f4aff6f43e499d7ce9e3c5b17bb_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjYtMTgtMS0xLTEyMzM_6a5ce5f1-487a-4345-aa9c-d5af6a6c78d4"
      unitRef="usd">884677000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i094d4c2753d9481590781ade460fad59_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjYtMjAtMS0xLTEyMzM_5eb8568f-eac2-46b4-bdce-4a0aebfc5c28"
      unitRef="usd">-512926000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7edc736569724e8b8c6e523b7a87a15c_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjYtMjItMS0xLTEyMzM_298144e5-63c8-464d-864c-34d054ffee25"
      unitRef="usd">342000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjI5ZmZhYTEwMWU3ZDQ0YmViYzE5ZjZhM2FkZGVjZmY1L3RhYmxlcmFuZ2U6MjlmZmFhMTAxZTdkNDRiZWJjMTlmNmEzYWRkZWNmZjVfMjYtMjQtMS0xLTEyMzM_7826da9d-130f-4a92-8088-b81aa79c4a07"
      unitRef="usd">372101000</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ie3312a4a7c1f41c7bb6ef94d06af70aa_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy0xLTEtMS0w_dd224f7c-ba99-4857-b7ad-3adba33a533c"
      unitRef="shares">20000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ie3312a4a7c1f41c7bb6ef94d06af70aa_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy0zLTEtMS0w_3f73f210-73e8-4e22-83fb-7630ca74b260"
      unitRef="usd">29200000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i54d8aec85f094dd690dc3a0c548af271_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy01LTEtMS0w_11c445fa-7de4-4657-a443-a3fd2c23a0a8"
      unitRef="shares">45714286</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i54d8aec85f094dd690dc3a0c548af271_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy03LTEtMS0w_3eb48fc5-a5a5-4a51-9afa-913877bc2b79"
      unitRef="usd">79615000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i343a722113ce45f1bf66666c91555acd_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy05LTEtMS0w_30580628-874c-4a90-9d4e-f65ad4d082c9"
      unitRef="shares">71506513</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i343a722113ce45f1bf66666c91555acd_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy0xMS0xLTEtMA_79b2f1bb-f24e-4de4-8c85-31c970e9840f"
      unitRef="usd">229552000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i97e4156cb4c140a6a6a93b8df92d43a7_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy0xNC0xLTEtMA_171e976a-a7b0-4933-afe4-bd3ae7516e2d"
      unitRef="shares">8051418</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i97e4156cb4c140a6a6a93b8df92d43a7_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy0xNi0xLTEtMA_480aa907-72e0-4a5c-b202-3c5f4bb35cdf"
      unitRef="usd">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icb3c158457d84ea98458e3654e48a62c_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy0xOC0xLTEtMA_2b2d241a-7224-4f52-8edf-b89242cc94a9"
      unitRef="usd">33853000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieb107b5d59dc4b05a8e01ddcc4874d2f_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy0yMC0xLTEtMA_ba9ec170-f18d-4cdb-8cc5-7b2f646b07a5"
      unitRef="usd">-153863000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iea07989a2b224869843ff82cca663a29_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy0yMi0xLTEtMA_aaf0f7f4-824a-4105-8e7c-2008b74819e8"
      unitRef="usd">-61000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3b49cacc7d364d80be392cf7b95e4972_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMy0yNC0xLTEtMA_8e9291bb-4a37-4ae9-b1d4-21bacb05e23d"
      unitRef="usd">-120069000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i4c1117486726474d966d52141c13b867_D20190101-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNC0xNC0xLTEtMA_4330e180-170f-4ea2-a112-33225d86b218"
      unitRef="shares">19837500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i4c1117486726474d966d52141c13b867_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNC0xNi0xLTEtMA_d23b8828-3894-48c5-b009-778634d61ef6"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i5d8d3eefe0054e2c89d598ac1a177a07_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNC0xOC0xLTEtMA_5c9f088e-204d-4a6b-a65b-e6058e79e58f"
      unitRef="usd">291342000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i204c4d8a4ae54157a23623329533ce14_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNC0yNC0xLTEtMA_e8f4a028-2421-4973-8d08-e9f1a3954589"
      unitRef="usd">291344000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <goss:TemporaryEquitySharesConvertedIntoCommonSharesShares
      contextRef="ib2b24c51d3c14bf39e027c08084d0df0_D20190101-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNS0xLTEtMS0w_2dea3829-c181-4a73-a60b-9cf0e294ad3f"
      unitRef="shares">20000000</goss:TemporaryEquitySharesConvertedIntoCommonSharesShares>
    <goss:TemporaryEquitySharesConvertedIntoCommonSharesValue
      contextRef="ib2b24c51d3c14bf39e027c08084d0df0_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNS0zLTEtMS0w_0bb0c3ff-25b4-44ae-93d7-9b94b1fa89cd"
      unitRef="usd">29200000</goss:TemporaryEquitySharesConvertedIntoCommonSharesValue>
    <goss:TemporaryEquitySharesConvertedIntoCommonSharesShares
      contextRef="i7c6f2d65140a444f9beca064afdc4187_D20190101-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNS01LTEtMS0w_e970bf90-281f-41ec-88a2-70d02eb156a1"
      unitRef="shares">45714286</goss:TemporaryEquitySharesConvertedIntoCommonSharesShares>
    <goss:TemporaryEquitySharesConvertedIntoCommonSharesValue
      contextRef="i7c6f2d65140a444f9beca064afdc4187_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNS03LTEtMS0w_a8693af6-4d18-40ce-a47f-558fabaf6c2e"
      unitRef="usd">79615000</goss:TemporaryEquitySharesConvertedIntoCommonSharesValue>
    <goss:TemporaryEquitySharesConvertedIntoCommonSharesShares
      contextRef="i0c30e6a7eee0456a8b8e9b7b04d7cc10_D20190101-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNS05LTEtMS0w_48f87826-54cf-4ae3-9806-2d4142a45ecd"
      unitRef="shares">71506513</goss:TemporaryEquitySharesConvertedIntoCommonSharesShares>
    <goss:TemporaryEquitySharesConvertedIntoCommonSharesValue
      contextRef="i0c30e6a7eee0456a8b8e9b7b04d7cc10_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNS0xMS0xLTEtMA_d4ff62f4-e33c-4696-8b9c-00113a341d3a"
      unitRef="usd">229552000</goss:TemporaryEquitySharesConvertedIntoCommonSharesValue>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i4c1117486726474d966d52141c13b867_D20190101-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNS0xNC0xLTEtMA_ac7e6fb1-4532-4194-80fb-0763399b2cb2"
      unitRef="shares">30493460</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i4c1117486726474d966d52141c13b867_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNS0xNi0xLTEtMA_fc565d33-ee74-4ea3-8555-88e6f9cfdc84"
      unitRef="usd">3000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i5d8d3eefe0054e2c89d598ac1a177a07_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNS0xOC0xLTEtMA_a1e6ce51-5079-4559-9140-8d788bcc7f87"
      unitRef="usd">338364000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i204c4d8a4ae54157a23623329533ce14_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNS0yNC0xLTEtMA_ef7da098-941b-4f71-a758-5870fb968c55"
      unitRef="usd">338367000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <goss:StockIssuedDuringPeriodSharesVestingOfRestrictedStock
      contextRef="i4c1117486726474d966d52141c13b867_D20190101-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNi0xNC0xLTEtMA_404849c2-f044-4d93-aebc-0dfa16c022a3"
      unitRef="shares">1619592</goss:StockIssuedDuringPeriodSharesVestingOfRestrictedStock>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i4c1117486726474d966d52141c13b867_D20190101-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNy0xNC0xLTEtMA_faa18720-23a1-4103-97ce-70231b930f64"
      unitRef="shares">27500</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5d8d3eefe0054e2c89d598ac1a177a07_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNy0xOC0xLTEtMA_2663ada8-90d2-4a79-9bc0-bb7825383db6"
      unitRef="usd">3089000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i204c4d8a4ae54157a23623329533ce14_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfNy0yNC0xLTEtMA_788fe5b9-e3ae-4edf-980d-9b704cfdc785"
      unitRef="usd">3089000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i88d438efdfcf48699af3cb8a4c151884_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfOC0yMC0xLTEtMA_d88797cf-07f2-4869-a5d4-3a2b3e49b38f"
      unitRef="usd">-32611000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i204c4d8a4ae54157a23623329533ce14_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfOC0yNC0xLTEtMA_f889765f-1c6b-4e3f-9879-d3aea6b72c70"
      unitRef="usd">-32611000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ibef492d549a34220b9476308f889a3ad_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfOS0yMi0xLTEtMA_b245cc49-37d6-43f5-8f09-fab61cea5e2b"
      unitRef="usd">140000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i204c4d8a4ae54157a23623329533ce14_D20190101-20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfOS0yNC0xLTEtMA_e5ee698a-cc20-4a6b-b61f-f1d812bb07ea"
      unitRef="usd">140000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i8ca39df98ce8457d8d865eabaaba7f70_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtMS0xLTEtMA_a6eb8555-8092-4684-9d18-febd9e22e37b"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i8ca39df98ce8457d8d865eabaaba7f70_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtMy0xLTEtMA_e64aee15-a664-4789-8b95-d8fe63f53fee"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i2d60975fadce491d9047cc147f13b8af_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtNS0xLTEtMA_8bea59bb-b8dd-4d42-9ee9-a9e1d73f846e"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i2d60975fadce491d9047cc147f13b8af_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtNy0xLTEtMA_d7cc730d-7657-4950-bc67-f6dd87e1494c"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i4a1343a170f74a2b85887cc27f953407_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtOS0xLTEtMA_ec6225ae-c6a4-4a2f-9330-fc724bf40e66"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i4a1343a170f74a2b85887cc27f953407_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtMTEtMS0xLTA_29cea77e-46f9-489a-a11f-a3c72df8cdca"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="iaa5a9b278e164c2da9b072055d0bc7c3_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtMTQtMS0xLTA_39992259-ab7b-4ee9-9b43-a0972297c1fd"
      unitRef="shares">60029470</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="iaa5a9b278e164c2da9b072055d0bc7c3_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtMTYtMS0xLTA_196d76a0-4cab-4a30-a2a9-8af07d4a9dbb"
      unitRef="usd">7000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i601fef938815423388ebc7b90b509f2c_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtMTgtMS0xLTA_ee74510f-1475-4050-bbea-904e72ca97da"
      unitRef="usd">666648000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if74dcc4469a54a8c98af2792cc68e327_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtMjAtMS0xLTA_6724db7a-5945-4ca6-ac6a-d633a8218ee1"
      unitRef="usd">-186474000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6e47c631459c4f0aa8359cd24d601d03_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtMjItMS0xLTA_3aa50aa9-ee75-4180-becf-a08bf51f39c5"
      unitRef="usd">79000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id4b5355aba354232bb2a9f7d614c0e15_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTAtMjQtMS0xLTA_6b05bab2-4d52-4ac7-b1bb-a55742fee04f"
      unitRef="usd">480260000</us-gaap:StockholdersEquity>
    <goss:StockIssuedDuringPeriodSharesVestingOfRestrictedStock
      contextRef="i7f9261b47f7c4dedb3e011d185c7d383_D20190401-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTEtMTQtMS0xLTA_049d4dd2-bc46-4095-83c4-e702c941625b"
      unitRef="shares">404637</goss:StockIssuedDuringPeriodSharesVestingOfRestrictedStock>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i7f9261b47f7c4dedb3e011d185c7d383_D20190401-20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTItMTQtMS0xLTA_98238bb5-90c6-4b31-8adb-c46cde3f5f21"
      unitRef="shares">33273</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i51ad8abfdf85411b98659ee7f825d361_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTItMTgtMS0xLTA_76d7d4f6-21fd-4a4b-ae86-29a503153730"
      unitRef="usd">86000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7688ecc551594d43b36f111047a7deb4_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTItMjQtMS0xLTA_177bc8a3-42e2-4f4c-a6ad-c27804271142"
      unitRef="usd">86000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i51ad8abfdf85411b98659ee7f825d361_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTMtMTgtMS0xLTA_07447b03-960d-4f4c-a189-7a393f73b520"
      unitRef="usd">5140000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7688ecc551594d43b36f111047a7deb4_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTMtMjQtMS0xLTA_d6b61bcd-0b16-45e9-bf9f-fcabb0656d48"
      unitRef="usd">5140000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i51ad8abfdf85411b98659ee7f825d361_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTQtMTgtMS0xLTA_04520a3f-1341-4d24-8bda-42891dc480ce"
      unitRef="usd">39000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="i7688ecc551594d43b36f111047a7deb4_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTQtMjQtMS0xLTA_5bb7fec0-a610-4404-be05-e57a4d61328b"
      unitRef="usd">39000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:NetIncomeLoss
      contextRef="if3cc915869004ddaaa6c21c954b57896_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTUtMjAtMS0xLTA_0a2e3a98-4f01-495c-a804-bb649e64715c"
      unitRef="usd">-44498000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7688ecc551594d43b36f111047a7deb4_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTUtMjQtMS0xLTA_48c064b1-ba95-4633-a507-b3d47fc550cc"
      unitRef="usd">-44498000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5b9f0d0a440e443ab0d19184e46dc5b1_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTYtMjItMS0xLTA_a57c33d4-1730-4ceb-9102-2f9bb6fdbd69"
      unitRef="usd">417000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i7688ecc551594d43b36f111047a7deb4_D20190401-20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTYtMjQtMS0xLTA_ac4a4151-f786-4495-8981-e8b0d3ad0df8"
      unitRef="usd">417000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i402b84a37c734fd2ada2568ef7353e2b_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTctMTQtMS0xLTA_075c7366-1d17-489d-b37c-d3ca222529a3"
      unitRef="shares">60467380</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i402b84a37c734fd2ada2568ef7353e2b_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTctMTYtMS0xLTA_fd9f987f-8b19-4ea2-8056-c30462e51ff5"
      unitRef="usd">7000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i41d5abe0dfd841d695c962b1f348472c_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTctMTgtMS0xLTA_116084e7-1c58-449e-8481-7a8fbee16bca"
      unitRef="usd">671913000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5c1183f5df444d8a9dbef8a80208eb1d_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTctMjAtMS0xLTA_1848e57d-7622-45bf-88a6-93383acde905"
      unitRef="usd">-230972000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3deb511ea20347b989c9a3668500baf2_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTctMjItMS0xLTA_206a6314-e045-438c-ba51-b49f2ad6b845"
      unitRef="usd">496000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i04d13b8492374901b4f4bf2ad46601c5_I20190630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTctMjQtMS0xLTA_6dabddc1-c709-485a-a291-feb44313f8dd"
      unitRef="usd">441444000</us-gaap:StockholdersEquity>
    <goss:StockIssuedDuringPeriodSharesVestingOfRestrictedStock
      contextRef="ibac864d50598406f8c85d4bdd4a64b15_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTgtMTQtMS0xLTEzMDI_bd99d372-9065-48cd-a913-afe6f07816a0"
      unitRef="shares">404639</goss:StockIssuedDuringPeriodSharesVestingOfRestrictedStock>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ibac864d50598406f8c85d4bdd4a64b15_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTktMTQtMS0xLTEzMDI_fd9e3234-4557-4d38-b82d-382ac59663d6"
      unitRef="shares">112939</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i5e10c5e62242441296917276fcd983f2_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTktMTgtMS0xLTEzMDI_d19ade69-b20f-48ea-b066-6e6d20031fac"
      unitRef="usd">369000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMTktMjQtMS0xLTEzMDI_64c17183-fd1f-4e6d-95ad-7795733cf00e"
      unitRef="usd">369000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5e10c5e62242441296917276fcd983f2_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjAtMTgtMS0xLTEzMDI_aa8a9a7c-a59f-46b5-ad5c-fd5c644e383c"
      unitRef="usd">5728000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjAtMjQtMS0xLTEzMDI_050f69e5-2628-4d57-903b-d30bdce88795"
      unitRef="usd">5728000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i76a2221bc96b477d9033dce08a133c47_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjEtMjAtMS0xLTEzMDI_96a3cea1-ebbf-4b7a-a8b9-6708a38376e3"
      unitRef="usd">-48500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjEtMjQtMS0xLTEzMDI_a4407db2-e10b-429d-b3b9-a8bef445fa7d"
      unitRef="usd">-48500000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i3eb22709373e449784bf6abde9e5ef9d_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjItMjItMS0xLTEzMDI_5aed6d9e-6dcd-4cf0-a32f-a3922ec098c5"
      unitRef="usd">-168000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjItMjQtMS0xLTEzMDI_3a39fc05-712d-4e7d-99ae-d1734c68b597"
      unitRef="usd">-168000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="id84abe36ab124aee9361fd90972e72a9_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjMtMTQtMS0xLTEzMDI_9d553154-008e-48d4-85af-f85afb7a4952"
      unitRef="shares">60984958</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="id84abe36ab124aee9361fd90972e72a9_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjMtMTYtMS0xLTEzMDI_6775f3b2-85a9-4be4-9d27-3f174e023869"
      unitRef="usd">7000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6d31ff554106438ca11cdde65438f9f1_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjMtMTgtMS0xLTEzMDI_b6de1911-64d8-41e3-ae43-365f1959983a"
      unitRef="usd">678010000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2a97f2ca2b0143f8bf6974c1fc94e461_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjMtMjAtMS0xLTEzMDI_63829c30-872f-4702-97e0-1bba92d287ad"
      unitRef="usd">-279472000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie52349d1207b400e8a20c808e6df36aa_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjMtMjItMS0xLTEzMDI_e717d185-f802-45b7-9479-27fd3405bc34"
      unitRef="usd">328000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4575faeae2514742ab2eedb009712d84_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yNS9mcmFnOmQwYzFmNWJhYzM3ZDQyYTE4MzU2MTg1OWU3NDE5NWM3L3RhYmxlOjA2N2MyZTYxNGY2YTQyNWY5ZDI3MzliMDZjZTg5ZmQwL3RhYmxlcmFuZ2U6MDY3YzJlNjE0ZjZhNDI1ZjlkMjczOWIwNmNlODlmZDBfMjMtMjQtMS0xLTEzMDI_934ffefe-7225-4c8b-9ee0-8f20187e3726"
      unitRef="usd">398873000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMy0xLTEtMS0w_496e22b3-e101-4e2a-b092-1b7ec3a64a2c"
      unitRef="usd">-178756000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMy0zLTEtMS0w_931b581d-b18e-4a45-8d05-a7faf3fe4141"
      unitRef="usd">-125609000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNS0xLTEtMS0w_5ef44bde-778d-424b-9887-19b327afe3ac"
      unitRef="usd">1044000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNS0zLTEtMS0w_1ecbf891-8c0a-4fb5-9243-36c890876d69"
      unitRef="usd">625000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNi0xLTEtMS0w_0714abe2-2d34-4b0f-b8fd-1e147fb58e63"
      unitRef="usd">26067000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNi0zLTEtMS0w_6f19a247-c40d-444f-855c-f1f21f17372b"
      unitRef="usd">13957000</us-gaap:ShareBasedCompensation>
    <goss:InProcessResearchAndDevelopmentExpenses
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNy0xLTEtMS0w_700ca347-fdb9-4700-afe0-3ed9d876cac4"
      unitRef="usd">18080000</goss:InProcessResearchAndDevelopmentExpenses>
    <goss:InProcessResearchAndDevelopmentExpenses
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNy0zLTEtMS0w_ab7fc30a-7865-4ca6-afc0-12be95efe362"
      unitRef="usd">2000000</goss:InProcessResearchAndDevelopmentExpenses>
    <goss:AmortizationOfOperatingLeaseRightOfUseAssets
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfOC0xLTEtMS0w_b574296f-9dba-4e53-ad5a-89a41f25b798"
      unitRef="usd">2015000</goss:AmortizationOfOperatingLeaseRightOfUseAssets>
    <goss:AmortizationOfOperatingLeaseRightOfUseAssets
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfOC0zLTEtMS0w_92fc0edc-5fb9-437e-8fb3-cc05f58f51a6"
      unitRef="usd">1615000</goss:AmortizationOfOperatingLeaseRightOfUseAssets>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfOS0xLTEtMS0w_f0f62cb4-809c-4163-9419-09888f877aad"
      unitRef="usd">2294000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfOS0zLTEtMS0w_b2565b27-b2a7-4550-ad99-1e58a955ee63"
      unitRef="usd">148000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTAtMS0xLTEtMA_04772627-01d5-4b16-bfdd-2b75d057ca7c"
      unitRef="usd">-24000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTAtMy0xLTEtMA_61c37e4a-b7db-43c0-bac0-b68d695b677d"
      unitRef="usd">2296000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTEtMS0xLTEtMA_6d5ca413-4d4d-41a5-bdd3-b3134748c8f2"
      unitRef="usd">256000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTEtMy0xLTEtMA_ad6da169-e798-4476-8e54-9c42b48e56f5"
      unitRef="usd">1000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTMtMS0xLTEtMA_147e216e-8f04-4774-b8a7-342f00b3c8bc"
      unitRef="usd">3340000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTMtMy0xLTEtMA_d6538b41-f2aa-436a-8524-252e2464f59a"
      unitRef="usd">2807000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTQtMS0xLTEtMA_ee5de171-9196-41aa-bd80-41d824bde618"
      unitRef="usd">-698000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTQtMy0xLTEtMA_6355ec59-b22c-4525-9e78-3c990632d7a5"
      unitRef="usd">-2886000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <goss:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTUtMS0xLTEtMA_83560ae5-0e89-4b13-adc8-6531ff4bf79b"
      unitRef="usd">1294000</goss:IncreaseDecreaseInOperatingLeaseLiabilities>
    <goss:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTUtMy0xLTEtMA_efab1623-7d5d-43e1-a300-916695f825d9"
      unitRef="usd">1566000</goss:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTYtMS0xLTEtMA_86554b51-3bb8-4cec-a52b-c0393998c4a3"
      unitRef="usd">10000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTYtMy0xLTEtMA_632f557f-febe-4a6e-a4f3-ac38bdedbb4b"
      unitRef="usd">333000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTctMS0xLTEtMA_2bd877e9-ff94-4869-b8bd-ec3261a70f3f"
      unitRef="usd">2768000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTctMy0xLTEtMA_a1925df5-44d2-4cda-8b2e-8aac0f746143"
      unitRef="usd">-760000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <goss:IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTgtMS0xLTEtMA_4f35470d-6e9f-4390-bd8b-1bd0d6f8c818"
      unitRef="usd">-7019000</goss:IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses>
    <goss:IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTgtMy0xLTEtMA_99b15265-59cc-4c70-b35b-ba2dc40bb780"
      unitRef="usd">8518000</goss:IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTktMS0xLTEtMA_4454c4e5-a2e2-4d50-8a57-9ee1b5923c0f"
      unitRef="usd">-1959000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMTktMy0xLTEtMA_1a48cce9-7d08-4a0f-9b8f-c49748fe0a65"
      unitRef="usd">2263000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjAtMS0xLTEtMA_13ae6101-b63e-410f-960e-c31e77a05283"
      unitRef="usd">-139624000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjAtMy0xLTEtMA_42507090-c5cd-40fa-a187-b3053e0ce498"
      unitRef="usd">-100694000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <goss:PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjItMS0xLTEtMA_a611b42b-48cd-45b9-b82b-0aef5da079fd"
      unitRef="usd">18080000</goss:PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions>
    <goss:PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjItMy0xLTEtMA_0e2e459a-5382-4ba4-bfc2-744729780046"
      unitRef="usd">2000000</goss:PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjMtMS0xLTEtMA_67df4da8-14e4-45bf-97ec-ab2bfd37cacb"
      unitRef="usd">108969000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjMtMy0xLTEtMA_fe9c4dcb-00a3-46f2-9453-c98020fc4aad"
      unitRef="usd">399393000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <goss:ProceedsFromMaturityOfMarketableSecurities
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjQtMS0xLTEtMA_910cc16d-1243-47f3-bfbd-0e3f4164a814"
      unitRef="usd">199029000</goss:ProceedsFromMaturityOfMarketableSecurities>
    <goss:ProceedsFromMaturityOfMarketableSecurities
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjQtMy0xLTEtMA_b458d58c-7442-472b-8938-4e1f77fb3db2"
      unitRef="usd">205750000</goss:ProceedsFromMaturityOfMarketableSecurities>
    <goss:ProceedsFromSaleOfMarketableSecurities
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjUtMS0xLTEtMA_1aba67b5-556a-4c3b-b680-56b3c549ff20"
      unitRef="usd">83515000</goss:ProceedsFromSaleOfMarketableSecurities>
    <goss:ProceedsFromSaleOfMarketableSecurities
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjUtMy0xLTEtMA_f2a62b79-bd90-4a2a-8d95-74c1c177e341"
      unitRef="usd">4004000</goss:ProceedsFromSaleOfMarketableSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjYtMS0xLTEtMA_40e1dcf3-2143-4df4-b0fd-fa3cd181e40c"
      unitRef="usd">1253000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjYtMy0xLTEtMA_23c60bee-ba31-40b0-809f-bd084d8ca470"
      unitRef="usd">2438000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjctMS0xLTEtMA_c39d0490-e771-450c-8277-b287cc377361"
      unitRef="usd">154242000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjctMy0xLTEtMA_f44102ea-0b06-4c26-9f70-d84a55dffd5e"
      unitRef="usd">-194077000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjktMS0xLTEtMA_39d0a0a1-0af5-44b7-bcf4-042bdb9b0b4f"
      unitRef="usd">117110000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMjktMy0xLTEtMA_c5e73682-f75b-4285-8612-df49b8e17808"
      unitRef="usd">291311000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzAtMS0xLTEtMA_9a566b5f-7b5d-4d56-8bc2-003d4c915fa9"
      unitRef="usd">193596000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzAtMy0xLTEtMA_4a75df31-1d7c-4be8-a52a-880057c48798"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzEtMC0xLTEtMTc5L3RleHRyZWdpb246N2EzNjc0NWUwMjI2NDFkYmFmZjUxMDQwMmNlZGEyOTZfMzI5ODUzNDg4MzQxOA_e4329337-ab33-4c37-aa68-377a9f345ccd"
      unitRef="usd">1778000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzEtMS0xLTEtMA_d77697e0-a4ff-4d7f-a525-3d5b394748ec"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzEtMy0xLTEtMA_23e5adfc-6c38-421d-932a-6a8ea8798f66"
      unitRef="usd">28222000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="icf9016d9d3c54fdcbd742124c1e00da3_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzItMS0xLTEtMA_a8ee77e2-b564-4b27-a013-3c3fe75130a6"
      unitRef="usd">1300000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="iedadf32f302e470ca02b51105b2ffa9e_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzItMy0xLTEtMA_a2f80365-a25d-42c4-89cd-f10221b8ab14"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzMtMS0xLTEtMA_36ad716a-f373-4289-9ee3-7a2405e1597e"
      unitRef="usd">285000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzMtMy0xLTEtMA_bfb4a988-c075-47ca-afd1-4a6056a0301a"
      unitRef="usd">527000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzQtMS0xLTEtMA_d7c91979-506e-4b43-b304-ed3bd2dc734d"
      unitRef="usd">312291000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzQtMy0xLTEtMA_9643a941-8317-46ed-b384-a295987e5f9c"
      unitRef="usd">320060000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzUtMS0xLTEtMA_1f59aabb-2db7-43aa-aa59-797a74195ac9"
      unitRef="usd">-42000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzUtMy0xLTEtMA_867817e8-b2a3-454e-9c3e-b28c6b58c5bf"
      unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzYtMS0xLTEtMA_9ed26e77-9384-4f1b-90cb-329b4a59d65f"
      unitRef="usd">326909000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzYtMy0xLTEtMA_5ee635b7-6032-4f02-9611-73c55cd3a1a9"
      unitRef="usd">25289000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzctMS0xLTEtMA_a6452310-c7b6-478a-820c-bade75f29962"
      unitRef="usd">135089000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3b49cacc7d364d80be392cf7b95e4972_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzctMy0xLTEtMA_7a8e2af4-a9b0-4855-8db4-9a3696f051d3"
      unitRef="usd">105419000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzgtMS0xLTEtMA_3619fcbc-be1a-4333-9857-717b42ba201a"
      unitRef="usd">461956000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4575faeae2514742ab2eedb009712d84_I20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfMzgtMy0xLTEtMA_56eefad9-765f-4ce6-bb48-8e05d3a70ea9"
      unitRef="usd">130708000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNDEtMS0xLTEtMA_211b9a52-0ab3-45b6-b2f7-2f388164716e"
      unitRef="usd">1911000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNDEtMy0xLTEtMA_6689b76d-33e4-4f7f-8725-0f77840ffd45"
      unitRef="usd">854000</us-gaap:InterestPaidNet>
    <goss:RightOfUseAssetsObtainedInExchangeForLeaseLiabilities
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNDQtMS0xLTEtMA_3d6b1bc4-edda-4dcd-b926-784a31f126fa"
      unitRef="usd">3106000</goss:RightOfUseAssetsObtainedInExchangeForLeaseLiabilities>
    <goss:RightOfUseAssetsObtainedInExchangeForLeaseLiabilities
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNDQtMy0xLTEtMA_8eb68112-fb43-4b3e-928f-a6f2a027f977"
      unitRef="usd">12458000</goss:RightOfUseAssetsObtainedInExchangeForLeaseLiabilities>
    <goss:NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNDUtMS0xLTEtMA_64fb25aa-3b9c-4b00-9a15-7890dccaef92"
      unitRef="usd">25000</goss:NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax>
    <goss:NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNDUtMy0xLTEtMA_f99d28e7-29a7-4f38-a6cc-8efffbdcfa4d"
      unitRef="usd">510000</goss:NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNDYtMS0xLTEtMA_16575c1a-b6c0-49ac-ab1c-7df79692c184"
      unitRef="usd">83000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNDYtMy0xLTEtMA_1a57b58a-95e0-446c-961e-6cc2511273a7"
      unitRef="usd">127000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <goss:NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNDctMS0xLTEtMA_28df855e-226f-46c4-8bf4-7e24914c1b3e"
      unitRef="usd">0</goss:NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock>
    <goss:NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8yOC9mcmFnOmU2OGEwYTQxMmM1YzRhOTA5OThmYjcxYzA1NDhkMDkxL3RhYmxlOmI5OWZkZTg5NDVmYzQwYTZhYjlkZWRmYTQ5NTlmNmM1L3RhYmxlcmFuZ2U6Yjk5ZmRlODk0NWZjNDBhNmFiOWRlZGZhNDk1OWY2YzVfNDctMy0xLTEtMA_1bbd6956-e1be-4fd9-a1f6-7f427cf5bc34"
      unitRef="usd">338367000</goss:NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8zNy9mcmFnOjE2ZmIzNGVjY2U5NjQ3ZGM4MTg4YTUwNGZiMmI3ODYzL3RleHRyZWdpb246MTZmYjM0ZWNjZTk2NDdkYzgxODhhNTA0ZmIyYjc4NjNfMTA5OTUxMTYzMjM0Mw_b5795836-9028-4bba-ac53-b959bea79478">Description of the Business&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gossamer Bio, Inc. (including its subsidiaries, referred to as &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d;, or the &#x201c;Company&#x201d;) is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. The Company was incorporated in the state of Delaware on October&#160;25, 2015 (originally as FSG Bio, Inc.) and is based in San Diego, California.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the accounts of Gossamer Bio, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions among the consolidated entity have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Initial Public Offering in February 2019&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 12, 2019, the Company completed its initial public offering (&#x201c;IPO&#x201d;) with the sale of 19,837,500 shares of common stock, including shares of common stock issued upon the exercise in full of the underwriters&#x2019; option to purchase additional shares, at a public offering price of $16.00 per share, resulting in net proceeds of $291.3 million, after deducting underwriting discounts, commissions, and offering expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, in connection with the completion of the IPO, all of the Company&#x2019;s outstanding shares of convertible preferred stock were automatically converted into 30,493,460 shares of common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liquidity and Capital Resources&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has incurred significant operating losses since its inception. As of September&#160;30, 2020, the Company had an accumulated deficit of  $512.9 million. From the Company&#x2019;s inception through September&#160;30, 2020, the Company has funded its operations primarily through equity and debt financings. The Company raised $942.0 million from October 2017 through September&#160;30, 2020 through Series A and Series B convertible preferred stock financings, a convertible note financing, its IPO, its Credit Facility (as defined in Note 5 below), and concurrent underwritten public offerings of its 5.00% convertible senior notes due 2027 (the &#x201c;2027 Notes&#x201d;) and common stock in May 2020. See Note 5 for additional information regarding the Credit Facility and the 2027 Notes. In addition, the Company received $12.8 million in cash in connection with the January 2018 acquisition of AA Biopharma Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company expects to continue to incur significant operating losses for the foreseeable future and may never become profitable. As a result, the Company will need to raise capital through equity offerings, debt financings and other capital sources, including potential collaborations, licenses and other similar arrangements. Management believes that it has sufficient working capital on hand to fund operations through at least the next twelve months from the date these condensed consolidated financial statements were available to be issued. There can be no assurance that the Company will be successful in acquiring additional funding, that the Company&#x2019;s projections of its future working capital needs will prove accurate, or that any additional funding would be sufficient to continue operations in future years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;COVID-19 &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The COVID-19 pandemic has caused significant business disruption around the globe. The extent of the impact of COVID-19 on the Company&#x2019;s operational and financial performance will depend on certain developments, including the duration and spread of the pandemic and the impact on the Company&#x2019;s clinical trials, employees and vendors. At this point, the degree to which COVID-19 may impact the Company&#x2019;s financial condition or results of operations is uncertain.&#160;&#160;A prolonged pandemic could have a material and adverse impact on financial results and business operations of the Company, including the timing and ability of the Company to complete certain clinical trials and other efforts required to advance the development of its product candidates and raise additional capital. For example, the Company commenced enrolling patients for a Phase 1b clinical trial in pulmonary arterial hypertension ("PAH") in the first quarter of 2020, and because the Company temporarily paused enrollment as a result of the ongoing COVID-19 viral pandemic, the Company now expects to report topline results from this trial in the fourth quarter of 2020. In addition, due to the challenges of enrolling patients posed by the COVID-19 pandemic, the Company may experience delays in the commencement of its Phase 2 clinical trial of GB002 in PAH and enrollment of patients in its Phase 2 clinical trials of GB004 in ulcerative colitis and of GB002 in PAH, as well as delays in reporting data results from its ongoing trials.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ia37b4eed12f64ea0ad441fc0ad1e503d_D20190212-20190212"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8zNy9mcmFnOjE2ZmIzNGVjY2U5NjQ3ZGM4MTg4YTUwNGZiMmI3ODYzL3RleHRyZWdpb246MTZmYjM0ZWNjZTk2NDdkYzgxODhhNTA0ZmIyYjc4NjNfODQ0_eaab2579-ce09-4fa7-86f2-277ebd46cefb"
      unitRef="shares">19837500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i72382ce16b8b49b292e97c0ef7b75dd3_I20190212"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8zNy9mcmFnOjE2ZmIzNGVjY2U5NjQ3ZGM4MTg4YTUwNGZiMmI3ODYzL3RleHRyZWdpb246MTZmYjM0ZWNjZTk2NDdkYzgxODhhNTA0ZmIyYjc4NjNfMTAyNg_c1a96169-81ab-4099-ac88-132546ba0e5d"
      unitRef="usdPerShare">16.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="ia37b4eed12f64ea0ad441fc0ad1e503d_D20190212-20190212"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8zNy9mcmFnOjE2ZmIzNGVjY2U5NjQ3ZGM4MTg4YTUwNGZiMmI3ODYzL3RleHRyZWdpb246MTZmYjM0ZWNjZTk2NDdkYzgxODhhNTA0ZmIyYjc4NjNfMTA2OQ_89f74412-e896-417e-b9b0-dcdcb323a4ef"
      unitRef="usd">291300000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="i47525e97b2e2423db6a765678a6c4fec_D20190212-20190212"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8zNy9mcmFnOjE2ZmIzNGVjY2U5NjQ3ZGM4MTg4YTUwNGZiMmI3ODYzL3RleHRyZWdpb246MTZmYjM0ZWNjZTk2NDdkYzgxODhhNTA0ZmIyYjc4NjNfMTMxMw_b011d13a-3098-4fdf-aba3-2cd26f9600cf"
      unitRef="shares">30493460</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8zNy9mcmFnOjE2ZmIzNGVjY2U5NjQ3ZGM4MTg4YTUwNGZiMmI3ODYzL3RleHRyZWdpb246MTZmYjM0ZWNjZTk2NDdkYzgxODhhNTA0ZmIyYjc4NjNfMTUwMA_6a1e0401-7f7b-45ce-b20f-e25729de0394"
      unitRef="usd">-512900000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <goss:FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering
      contextRef="i9eebf838097e49fa93a3a4ab394c7e68_D20171001-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8zNy9mcmFnOjE2ZmIzNGVjY2U5NjQ3ZGM4MTg4YTUwNGZiMmI3ODYzL3RleHRyZWdpb246MTZmYjM0ZWNjZTk2NDdkYzgxODhhNTA0ZmIyYjc4NjNfMTcxOQ_39cb4779-e05c-491d-84bc-72c6a14d5000"
      unitRef="usd">942000000.0</goss:FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1fed2bfc69594ec7a6dbcd619a5e2bef_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8zNy9mcmFnOjE2ZmIzNGVjY2U5NjQ3ZGM4MTg4YTUwNGZiMmI3ODYzL3RleHRyZWdpb246MTZmYjM0ZWNjZTk2NDdkYzgxODhhNTA0ZmIyYjc4NjNfMTk2Mg_4169c611-3c99-4574-81f4-e99e58f9bce9"
      unitRef="number">0.0500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i5780f8c4c24046a9b2f18bb81e280495_D20180104-20180104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl8zNy9mcmFnOjE2ZmIzNGVjY2U5NjQ3ZGM4MTg4YTUwNGZiMmI3ODYzL3RleHRyZWdpb246MTZmYjM0ZWNjZTk2NDdkYzgxODhhNTA0ZmIyYjc4NjNfMjE3MA_3529a8ad-055c-4fc2-919c-6a6f187afee3"
      unitRef="usd">12800000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RleHRyZWdpb246NWMyMTcxYTdlZDg2NDYzNDkzZDY4MzAxZTMwMWVhYzhfMTA5OTUxMTYzMzc1Mg_b03ac649-3990-4f4c-8d60-b46a85d36706">Summary of Significant Accounting Policies&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) for interim financial information and with the instructions of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) on Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, the condensed consolidated financial statements include all adjustments necessary, which are of a normal and recurring nature, for the fair presentation of the Company&#x2019;s financial position and of the results of operations and cash flows for the periods presented. These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December&#160;31, 2019 included in the Company&#x2019;s Annual Report on Form 10-K filed with the SEC on March 24, 2020. The results of operations for the interim period shown in this report are not necessarily indicative of the results that may be expected for any other interim period or for the full year. The balance sheet at December&#160;31, 2019, has been derived from the audited financial statements at that date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting period. The most significant estimates in the Company&#x2019;s condensed consolidated financial statements relate to the allocation of the 2027 Notes into liability and equity components, accrued research and development expenses, the valuation of preferred and common stock, the valuation of stock options and the valuation allowance of deferred tax assets resulting from net operating losses. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Convertible Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accounting for the issuance of the 2027 Notes, the Company separated the 2027 Notes into liability and equity components. The carrying amount of the liability component was calculated by measuring the fair value of similar debt instruments that do not have associated convertible features. The carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the par value of the 2027 Notes. The equity component is not remeasured as long as it continues to meet the condition for equity classification. The excess of the principal amount of the liability component over its carrying amount (&#x201c;debt discount&#x201d;) is amortized to interest expense over the term of the 2027 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company allocated the issuance costs incurred to the liability and equity components of the 2027 Notes based on their relative fair values. Issuance costs attributable to the liability component were recorded as a reduction to the liability portion of the 2027 Notes and are being amortized to interest expense over the term of the 2027 Notes. Issuance costs attributable to the equity component, representing the conversion option, were netted with the equity component in stockholders' equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-13, Financial Instruments-Credit Losses: Measurement of Credit Losses on Financial Instruments (&#x201c;ASU 2016-13&#x201d;), which changes the impairment model for most financial assets and certain other instruments. For trade receivables and other instruments, entities will be required to use a new forward-looking expected loss model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. This guidance is effective for annual reporting periods beginning after December 15, 2019, including interim periods within those years, with early adoption permitted only as of annual reporting periods beginning after December 15, 2018. The Company adopted ASU 2016-13 as of January 1, 2020. The adoption of this standard did not have a material impact on the Company&#x2019;s condensed consolidated financial statements or related financial statement disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Loss Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period. The Company uses the if-converted method for assumed conversion of the 2027 Notes to compute the weighted average shares of common stock outstanding for diluted net loss per share. Diluted net loss per share excludes the potential impact of the Company&#x2019;s common stock options and unvested shares of restricted stock and the potential shares issuable upon conversion of the 2027 Notes because their effect would be anti-dilutive due to the Company&#x2019;s net loss. Since the Company had a net loss in each of the periods presented, basic and diluted net loss per common share are the same.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,321,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,266,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,099,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested shares under restricted stock grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,530,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,053,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RleHRyZWdpb246NWMyMTcxYTdlZDg2NDYzNDkzZDY4MzAxZTMwMWVhYzhfNTk3MQ_6199c054-1026-4f0b-a3be-ca450a6cbe1d">Basis of PresentationThe accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) for interim financial information and with the instructions of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) on Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, the condensed consolidated financial statements include all adjustments necessary, which are of a normal and recurring nature, for the fair presentation of the Company&#x2019;s financial position and of the results of operations and cash flows for the periods presented. These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December&#160;31, 2019 included in the Company&#x2019;s Annual Report on Form 10-K filed with the SEC on March 24, 2020. The results of operations for the interim period shown in this report are not necessarily indicative of the results that may be expected for any other interim period or for the full year. The balance sheet at December&#160;31, 2019, has been derived from the audited financial statements at that date.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RleHRyZWdpb246NWMyMTcxYTdlZDg2NDYzNDkzZDY4MzAxZTMwMWVhYzhfNTk3Mg_fce560f3-5e75-41d4-a907-719e4f91acc7">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting period. The most significant estimates in the Company&#x2019;s condensed consolidated financial statements relate to the allocation of the 2027 Notes into liability and equity components, accrued research and development expenses, the valuation of preferred and common stock, the valuation of stock options and the valuation allowance of deferred tax assets resulting from net operating losses. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <goss:ConvertibleSeniorNotesPolicyTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RleHRyZWdpb246NWMyMTcxYTdlZDg2NDYzNDkzZDY4MzAxZTMwMWVhYzhfNTk3Mw_d5ead1a7-35ae-452f-b20f-54392957524a">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Convertible Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accounting for the issuance of the 2027 Notes, the Company separated the 2027 Notes into liability and equity components. The carrying amount of the liability component was calculated by measuring the fair value of similar debt instruments that do not have associated convertible features. The carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the par value of the 2027 Notes. The equity component is not remeasured as long as it continues to meet the condition for equity classification. The excess of the principal amount of the liability component over its carrying amount (&#x201c;debt discount&#x201d;) is amortized to interest expense over the term of the 2027 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company allocated the issuance costs incurred to the liability and equity components of the 2027 Notes based on their relative fair values. Issuance costs attributable to the liability component were recorded as a reduction to the liability portion of the 2027 Notes and are being amortized to interest expense over the term of the 2027 Notes. Issuance costs attributable to the equity component, representing the conversion option, were netted with the equity component in stockholders' equity.&lt;/span&gt;&lt;/div&gt;</goss:ConvertibleSeniorNotesPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RleHRyZWdpb246NWMyMTcxYTdlZDg2NDYzNDkzZDY4MzAxZTMwMWVhYzhfNTk3NA_8c5dc1e4-b7be-48c0-8a2f-cf9708874d8a">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-13, Financial Instruments-Credit Losses: Measurement of Credit Losses on Financial Instruments (&#x201c;ASU 2016-13&#x201d;), which changes the impairment model for most financial assets and certain other instruments. For trade receivables and other instruments, entities will be required to use a new forward-looking expected loss model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. This guidance is effective for annual reporting periods beginning after December 15, 2019, including interim periods within those years, with early adoption permitted only as of annual reporting periods beginning after December 15, 2018. The Company adopted ASU 2016-13 as of January 1, 2020. The adoption of this standard did not have a material impact on the Company&#x2019;s condensed consolidated financial statements or related financial statement disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RleHRyZWdpb246NWMyMTcxYTdlZDg2NDYzNDkzZDY4MzAxZTMwMWVhYzhfNTk3NQ_c9e8c001-b329-49e9-b660-6a5bac9cb3fa">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Loss Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period. The Company uses the if-converted method for assumed conversion of the 2027 Notes to compute the weighted average shares of common stock outstanding for diluted net loss per share. Diluted net loss per share excludes the potential impact of the Company&#x2019;s common stock options and unvested shares of restricted stock and the potential shares issuable upon conversion of the 2027 Notes because their effect would be anti-dilutive due to the Company&#x2019;s net loss. Since the Company had a net loss in each of the periods presented, basic and diluted net loss per common share are the same.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,321,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,266,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,099,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested shares under restricted stock grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,530,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,053,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RleHRyZWdpb246NWMyMTcxYTdlZDg2NDYzNDkzZDY4MzAxZTMwMWVhYzhfNTk2OQ_04ad465b-97b3-46a5-8008-fffdd75b2f2d">&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,321,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,266,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,099,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-vested shares under restricted stock grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,530,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,053,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib505254a0d25402398cd90e47386b544_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RhYmxlOjExOGVjNzE2N2Y4ZTRkNGI4OGZhODU1MzE0NWNlMDQ0L3RhYmxlcmFuZ2U6MTE4ZWM3MTY3ZjhlNGQ0Yjg4ZmE4NTUzMTQ1Y2UwNDRfMi0xLTEtMS0w_3d1f65ab-872c-4942-880c-63c116a00a79"
      unitRef="shares">12321900</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i16119fa6447641b4b0438be989f83724_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RhYmxlOjExOGVjNzE2N2Y4ZTRkNGI4OGZhODU1MzE0NWNlMDQ0L3RhYmxlcmFuZ2U6MTE4ZWM3MTY3ZjhlNGQ0Yjg4ZmE4NTUzMTQ1Y2UwNDRfMi0zLTEtMS0w_f0527ea8-df1b-43d5-9235-c17363e03692"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i85914c244cbc465a8537031c3daf6f1e_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RhYmxlOjExOGVjNzE2N2Y4ZTRkNGI4OGZhODU1MzE0NWNlMDQ0L3RhYmxlcmFuZ2U6MTE4ZWM3MTY3ZjhlNGQ0Yjg4ZmE4NTUzMTQ1Y2UwNDRfMy0xLTEtMS0w_66a1bd1c-8db5-4675-8da3-64eb862cedb9"
      unitRef="shares">10266895</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5d717c27684b4376bc058963cf8edc06_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RhYmxlOjExOGVjNzE2N2Y4ZTRkNGI4OGZhODU1MzE0NWNlMDQ0L3RhYmxlcmFuZ2U6MTE4ZWM3MTY3ZjhlNGQ0Yjg4ZmE4NTUzMTQ1Y2UwNDRfMy0zLTEtMS0w_a693ec1e-9d22-463d-8055-06780e45a88c"
      unitRef="shares">8099861</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i628ea545993847d1a0da78338212f66f_D20200101-20200930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RhYmxlOjExOGVjNzE2N2Y4ZTRkNGI4OGZhODU1MzE0NWNlMDQ0L3RhYmxlcmFuZ2U6MTE4ZWM3MTY3ZjhlNGQ0Yjg4ZmE4NTUzMTQ1Y2UwNDRfNC0xLTEtMS0w_012e73d9-28a6-46f6-9b55-386767987477"
      unitRef="shares">4530998</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i65156772da894ffc943654c22ccecde9_D20190101-20190930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80MC9mcmFnOjVjMjE3MWE3ZWQ4NjQ2MzQ5M2Q2ODMwMWUzMDFlYWM4L3RhYmxlOjExOGVjNzE2N2Y4ZTRkNGI4OGZhODU1MzE0NWNlMDQ0L3RhYmxlcmFuZ2U6MTE4ZWM3MTY3ZjhlNGQ0Yjg4ZmE4NTUzMTQ1Y2UwNDRfNC0zLTEtMS0w_681a1aee-9d65-4b2f-b939-802ea4be909e"
      unitRef="shares">5053169</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RleHRyZWdpb246MjEwYjZlNDVmNmVlNGVhOTk5MjYxODU5ZTBiYWU2OWFfMTA5OTUxMTYyODA3NQ_b54010aa-00b4-4dbd-8034-f1f26e287cfb">Balance Sheet Accounts and Supplemental Disclosures&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Useful Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-7&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lab equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2-5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6-7&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued Expenses and Other Current Liabilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other current liabilities consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued professional service fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued interest, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued in process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RleHRyZWdpb246MjEwYjZlNDVmNmVlNGVhOTk5MjYxODU5ZTBiYWU2OWFfMjk4_e1e336dc-47a6-4930-802b-a6da4e7ac578">&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Useful Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-7&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lab equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2-5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6-7&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i1e067eee87aa40508462e122f6750be3_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfMS0xLTEtMS04NzEvdGV4dHJlZ2lvbjphMDJkMGU3NDM2OGI0MzNmYWEyNTQxOWMzNDQzNTYzNF8zMjk4NTM0ODgzMzM2_0b43415c-6e4f-4d94-81a9-77a8008fde51">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i4a55d6d56691410aa331d57da9a540d1_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfMS0xLTEtMS04NzEvdGV4dHJlZ2lvbjphMDJkMGU3NDM2OGI0MzNmYWEyNTQxOWMzNDQzNTYzNF8zMjk4NTM0ODgzMzM5_835611fe-5e6c-4e45-9852-d9be7cf246c3">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if8bca8bf3b2f456db5ae73401c2d37be_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfMS0zLTEtMS0w_4a9f0472-684a-47f0-906c-aa24a9d644ff"
      unitRef="usd">1153000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i76f89fa7250e4a06b29eb2156d416d96_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfMS01LTEtMS0w_45a186fd-5b7a-4323-9920-bdde399e08f3"
      unitRef="usd">1097000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i260bc0a3e86245f2b8b08107a4dee7bd_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfMi0xLTEtMS0w_6a4948bf-dff9-4363-bd24-bea5ad5b90a5">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib750f63eb6b944cb98e71a7f0d4cf5f8_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfMi0zLTEtMS0w_24f38eba-9b90-4b75-8cd5-e56ae242cfe6"
      unitRef="usd">143000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i21f9a7a1498e4ac9bff64988b80f1530_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfMi01LTEtMS0w_a8dcd310-d492-4015-acbd-5b9a06942097"
      unitRef="usd">124000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i1b11b05347a54ecd8d3f69919983392e_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfMy0xLTEtMS0w_cbfcf1cf-e706-4e57-9e41-45f7c6b12745">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0d433a516bc643149feff09002c301ba_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfMy0zLTEtMS0w_989bf44a-6957-4bc6-9721-84a2ab7b4636"
      unitRef="usd">114000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i51a4aedbde574295bf88fe0261d77059_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfMy01LTEtMS0w_83bdcdde-f222-418e-9e99-893e956fbca3"
      unitRef="usd">87000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i8efc8bdaf1074768864d3ed973853b90_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNC0xLTEtMS04NzkvdGV4dHJlZ2lvbjo1NmExYmJlMDViYTc0MTZiODI2MzZkOGQwMjY3ZTEyYl8zMjk4NTM0ODgzMzM2_eb61c4f3-ca80-40a7-b97e-f13295a49946">P2Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i103f71b1047849e5b84f76f80ae06494_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNC0xLTEtMS04NzkvdGV4dHJlZ2lvbjo1NmExYmJlMDViYTc0MTZiODI2MzZkOGQwMjY3ZTEyYl8zMjk4NTM0ODgzMzM5_995e01bf-c175-4585-a36b-cd5dd80f084d">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i42449cdc53ba4b89b9cdf57fa83320b0_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNC0zLTEtMS0w_b49de5ef-f0a1-4f7a-ad27-a2b242224be7"
      unitRef="usd">4025000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ibdf44d92b2ca4b57a02e2892703853f1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNC01LTEtMS0w_16da0dfe-a53e-449b-976b-6a90b1a46567"
      unitRef="usd">3054000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="if27e640809cf45798d09eb333cf0b6da_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNS0xLTEtMS04ODUvdGV4dHJlZ2lvbjpjMTg5ZTU3MjEzZTU0MGQwOWU5ZmMzZTg4NGQwM2I1MF8zMjk4NTM0ODgzMzM2_51d40f68-dffe-4c41-8e67-021b3ad60b7a">P6Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i9d06d2274931457baab6e055385a4ed4_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNS0xLTEtMS04ODUvdGV4dHJlZ2lvbjpjMTg5ZTU3MjEzZTU0MGQwOWU5ZmMzZTg4NGQwM2I1MF8zMjk4NTM0ODgzMzM5_dd15aa0f-974d-4798-aa70-a7fc6eda5630">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic1c26254dc044115869b6c29020aa2f9_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNS0zLTEtMS0w_a24091b9-dee0-47d8-b9c9-d4896b4a3801"
      unitRef="usd">2540000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="idd07bdcfbfb94667ac7bec7ea6ef1c07_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNS01LTEtMS0w_e32f0850-acb6-4c22-a645-c22d058d21ff"
      unitRef="usd">2229000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i611f783c934a4fb6b3f38212acc720ca_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNi0zLTEtMS0w_f5bb653c-a936-4327-9af0-ced2d39f6200"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4d68ba3fe6824af092a4888b932d3991_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNi01LTEtMS0w_0f3a036d-c197-4bc8-a764-d83e031554f4"
      unitRef="usd">48000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNy0zLTEtMS0w_3c3315e2-6ff0-4bce-974f-8ee976a458bb"
      unitRef="usd">7975000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfNy01LTEtMS0w_460ee457-8c2b-40e1-b7ba-551221210ebd"
      unitRef="usd">6639000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfOC0zLTEtMS0w_29bc3759-4d34-46e2-b97b-ccfbf3c9fd63"
      unitRef="usd">2258000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfOC01LTEtMS0w_befd6026-08c8-4e0f-95d0-f54ec9fc7127"
      unitRef="usd">1214000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfOS0zLTEtMS0w_6746befb-0ae3-4de2-b5e8-7c7ef34010c5"
      unitRef="usd">5717000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjgzNTYzNjA5OGU3ZjQzYzU5ODMwZjk1M2QyOTdkZTZjL3RhYmxlcmFuZ2U6ODM1NjM2MDk4ZTdmNDNjNTk4MzBmOTUzZDI5N2RlNmNfOS01LTEtMS0w_371ebdd1-5105-437f-a30a-eb235282f068"
      unitRef="usd">5425000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RleHRyZWdpb246MjEwYjZlNDVmNmVlNGVhOTk5MjYxODU5ZTBiYWU2OWFfMjk2_73c0d393-ea57-49d1-bf23-d7572de08852">&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other current liabilities consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued professional service fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued interest, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued in process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfMi0xLTEtMS0w_0ed895ca-8981-4beb-b6a7-9cdec6dc4f95"
      unitRef="usd">8623000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfMi0zLTEtMS0w_dbcf0ca2-6ea3-4ed1-b89e-15131adb4461"
      unitRef="usd">9282000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfMy0xLTEtMS0w_5b5edc41-9166-4722-bcec-df824d3d98ed"
      unitRef="usd">3548000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfMy0zLTEtMS0w_3301b133-4e3f-4fa3-a00c-a9b2d887ede8"
      unitRef="usd">2354000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfNC0xLTEtMS0w_245a2f96-c27a-4c18-bf0f-25ad469f61c3"
      unitRef="usd">2581000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfNC0zLTEtMS0w_c292e012-e7b4-453b-ab1b-633f33491dcd"
      unitRef="usd">2347000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfNS0xLTEtMS0w_078cbea6-501e-4517-9882-7a4ee958d9d8"
      unitRef="usd">3864000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfNS0zLTEtMS0w_3df2517e-aacf-4bdb-953b-319b8035911b"
      unitRef="usd">0</us-gaap:InterestPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfNi0xLTEtMS0w_bc842977-5a51-4a43-b1b2-613de54dc804"
      unitRef="usd">612000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfNi0zLTEtMS0w_79a106ec-7cf5-45c9-897b-1a1967b13cff"
      unitRef="usd">1126000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <goss:AccruedInProcessResearchAndDevelopment
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfNy0xLTEtMS0w_84cfa00e-f2da-4df3-8a15-6085d8343a86"
      unitRef="usd">275000</goss:AccruedInProcessResearchAndDevelopment>
    <goss:AccruedInProcessResearchAndDevelopment
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfNy0zLTEtMS0w_c311a876-d1d9-4aa2-88ac-10d87e84bdf2"
      unitRef="usd">1600000</goss:AccruedInProcessResearchAndDevelopment>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfOC0xLTEtMS0w_23951540-46db-46b0-997a-2d56b5b8f249"
      unitRef="usd">19503000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80My9mcmFnOjIxMGI2ZTQ1ZjZlZTRlYTk5OTI2MTg1OWUwYmFlNjlhL3RhYmxlOjhkYjI2NWU3Njk0ZjQ1NTc5YTcxOTNmOTEzY2ZiNjhmL3RhYmxlcmFuZ2U6OGRiMjY1ZTc2OTRmNDU1NzlhNzE5M2Y5MTNjZmI2OGZfOC0zLTEtMS0w_8796e83b-fd63-4ffa-91ac-5f402fcdf37e"
      unitRef="usd">16709000</us-gaap:AccruedLiabilitiesCurrent>
    <goss:FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RleHRyZWdpb246YmZmOTU4ZmZhYWI0NDNhNDgxMTkyOWI5ZmM0ZDdlYjNfMTA5OTUxMTYzMzcxOQ_6ea2cc1a-71bd-4743-bdcf-b3aba07db109">Fair Value Measurements and Available for Sale Investments&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accounting guidance defines fair value, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the accounting guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1: Observable inputs such as quoted prices in active markets;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies its cash equivalents and available-for-sale investments within Level&#160;1 or Level&#160;2. The fair value of the Company&#x2019;s investment grade corporate debt securities and commercial paper is determined using proprietary valuation models and analytical tools, which utilize market pricing or prices for similar instruments that are both objective and publicly available, such as matrix pricing or reported trades, benchmark yields, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, and offers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the hierarchy for assets measured at fair value on a recurring basis as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements at End of Period Using:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Quoted&#160;Market&lt;br/&gt;Prices for&lt;br/&gt;Identical&#160;Assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Significant&lt;br/&gt;Other&#160;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;As of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;367,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;367,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. Treasury and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;82,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;82,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. Treasury and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;156,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;156,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not reclassify any investments between levels in the fair value hierarchy during the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Other Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020 and December&#160;31, 2019, the carrying amounts of the Company&#x2019;s financial instruments, which include cash, interest receivable, accounts payable and accrued expenses, approximate fair values because of their short maturities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest receivable as of September&#160;30, 2020 and December&#160;31, 2019, was $0.5 million and $1.5 million,respectively, and is recorded as a component of prepaid expenses and other current assets on the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes that its Credit Facility bears interest at a rate that approximates prevailing market rates for instruments with similar characteristics and, accordingly, the carrying value of the Credit Facility approximates fair value.&#160;The Company estimates the fair value of long-term debt utilizing an income approach. The Company uses a present value calculation to discount principal and interest payments and the final maturity payment on these liabilities using a discounted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;cash flow model based on observable inputs. The debt instrument is then discounted based on what the current market rates would be as of the reporting date. Based on the assumptions used to value these liabilities at fair value, the debt instrument is categorized as Level 2 in the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020 the fair value of the Company&#x2019;s 2027 Notes was $202.0 million.&#160;&#160;The fair value was determined on the basis of market prices observable for similar instruments and is considered Level 2 in the fair value hierarchy (see Note 5).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Available for Sale Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company invests its excess cash in U.S. Treasury and agency securities and debt instruments of corporations and commercial obligations, which are classified as available-for-sale investments. These investments are carried at fair value and are included in the tables below.&#160;&#160;The Company evaluates securities with unrealized losses to determine whether such losses, if any, are due to credit-related factors. Realized gains and losses are calculated using the specific identification method and recorded as interest income or expense. The Company does not generally intend to sell the investments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate market value, cost basis, and gross unrealized gains and losses of available-for-sale investments by security type, classified in marketable securities and long-term investments as of September&#160;30, 2020 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.851%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. Treasury and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;35,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;35,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;52,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;52,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;93,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;93,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At each reporting date, the Company performs an evaluation of impairment to determine if any unrealized losses are due to credit-related factors. The Company records an allowance for credit losses when unrealized losses are due to credit-related factors. Factors considered when evaluating available-for-sale investments for impairment include the severity of the impairment, changes in underlying credit ratings, the financial condition of the issuer, the probability that the scheduled cash payments will continue to be made and the Company&#x2019;s intent and ability to hold the investment until recovery of the amortized cost basis. The Company intends and has the ability to hold its investments in unrealized loss positions until their amortized cost basis has been recovered. As of September&#160;30, 2020, there were no material declines in the market value of the Company&#x2019;s available-for-sale investments due to credit-related factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual maturities of available-for-sale debt securities, as of September&#160;30, 2020, were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Estimated&lt;br/&gt; Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;79,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;One to two years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;93,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has the ability, if necessary, to liquidate any of its cash equivalents and marketable securities to meet its liquidity needs in the next 12&#160;months. Accordingly, those investments with contractual maturities greater than one year from the date of purchase are classified as current assets on the accompanying condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</goss:FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RleHRyZWdpb246YmZmOTU4ZmZhYWI0NDNhNDgxMTkyOWI5ZmM0ZDdlYjNfNTkzOQ_db92bfa5-768a-45b0-b2a1-3edc7ef5e73d">&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the hierarchy for assets measured at fair value on a recurring basis as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements at End of Period Using:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Quoted&#160;Market&lt;br/&gt;Prices for&lt;br/&gt;Identical&#160;Assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Significant&lt;br/&gt;Other&#160;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;As of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;367,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;367,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. Treasury and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;82,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;82,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. Treasury and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;156,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;156,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i835b26655f28493fad355a6322860843_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMy0xLTEtMS0w_14e650e0-a829-471d-8fb5-62e5c23a588e"
      unitRef="usd">367344000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0f0c40e6d7654a0d84a3748e61f8aac5_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMy0zLTEtMS0w_293ee798-94b7-46d0-8018-cb2adeb88184"
      unitRef="usd">367344000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i17213d559ba7419fab19ce258c60725e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMy01LTEtMS0w_aed0ccb6-bd26-4c2a-9dbb-43520b8ed04a"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i26809f02394e4f7fa0669e5465e107e5_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMy03LTEtMS0w_22cbc7d1-15ed-4b86-90ce-62597089b4fc"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="icf0f77fbe2fa411887f11ed7f2f99c11_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNC0xLTEtMS0w_965b7632-e063-4d8d-a443-e61b5d35f947"
      unitRef="usd">53772000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5c3c2ed990164cdf9677553f5b066742_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNC0zLTEtMS0w_d96142c2-183d-400c-b0ba-61a9ceb67f0a"
      unitRef="usd">53772000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i20a2c95edf9e4ccba5c6b16a8d676493_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNC01LTEtMS0w_3d80eb24-8d45-4bd3-b0e3-fbcb23bd81b8"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iada21370c53144b09d7b9404f3ee35ff_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNC03LTEtMS0w_e3b8bb2e-89c0-4fb9-a6cb-452c9b9f12c7"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibe176d3a79e745d79ba915619691251d_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNS0xLTEtMS0w_5efce40d-fe1f-42d9-b19b-c24c350da851"
      unitRef="usd">5580000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4bda7b8e7dd04e8caccd4a6f241affe0_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNS0zLTEtMS0w_dd7789c1-d47c-4cd5-b6e8-e3c8f7a56944"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i345c770504cf47799812979d3f5b302d_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNS01LTEtMS0w_053dc4e6-8fe9-480e-bd76-24feecd76820"
      unitRef="usd">5580000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8e3869d1f23741b4a71e5a062db9b80c_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNS03LTEtMS0w_9f47c5ca-cfea-4061-9655-bd97471316f4"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i301f52d7e9c04c2491017b8e1843e74a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNi0xLTEtMS0w_99dddcae-c1d2-43ee-8e5c-17ee8371aee5"
      unitRef="usd">53897000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6e014916db25406589a2a5f00d8eb334_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNi0zLTEtMS0w_eda24ac7-9632-4acc-910a-48db6e18de62"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1402b051056b4d9799e3b18f2092e6f0_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNi01LTEtMS0w_42785af6-88dd-4976-a8cb-41e4590a480b"
      unitRef="usd">53897000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if59687e3ceb840559fdd247e955190ca_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfNi03LTEtMS0w_1021d1a8-bf24-42c9-b24b-e924cc94f1c7"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iba100508cf4f4d92b301e065ad6ff443_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfOC0xLTEtMS0w_f98a945f-b5e7-4cda-be7e-a16f141b7dc0"
      unitRef="usd">82125000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia7e2d34db3e44a1c82443160f196e896_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfOC0zLTEtMS0w_60f03455-4cad-41ea-8a3f-9a0c668d10ae"
      unitRef="usd">82125000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i81256eb7c9e04561a9015aca0c513258_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfOC01LTEtMS0w_bdf53f49-d046-4552-b8e2-5c0b758466d6"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i42e5b4d69dd14ffea2c2f3c7b25f6034_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfOC03LTEtMS0w_d0e45457-b187-4196-9a43-f3c789df535b"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ifc5f664a8d9f42fbae6150714af2998f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfOS0xLTEtMS0w_ffdf62e6-8a7d-4a22-afbb-81e71dbfed05"
      unitRef="usd">91717000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0b301e21a02a4512a5e81e1b78038f75_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfOS0zLTEtMS0w_8842157f-da07-47e6-ac85-20eda9552cc0"
      unitRef="usd">91717000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8e20f232351042e2a775afe12f0c8249_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfOS01LTEtMS0w_5fc30542-3671-4ac9-972b-28cba5eff8c3"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i977d5f93f97946efb350e31e78f7b85c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfOS03LTEtMS0w_2476a9b8-c189-4839-b41e-5884222eb4be"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i833b6168e6d6460e8cb4fa5a0da5de2e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMTAtMS0xLTEtMA_f9bd15f9-8b25-4e5d-a249-d27b99905a89"
      unitRef="usd">37411000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i09e8387031f142ac9019e52d736c6004_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMTAtMy0xLTEtMA_5c75a30d-aa90-4ddc-8677-71b436d3f253"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie1efadb52eb943fe9951cac243f24a01_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMTAtNS0xLTEtMA_f1be8292-c772-4184-b326-2ca15a331465"
      unitRef="usd">37411000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i039111ce7909430b990dd8e90c1779a2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMTAtNy0xLTEtMA_3db8d33a-05d0-4005-b55d-7d5c2500a3f4"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4266b95b8b344eb6960b0767413da8a3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMTEtMS0xLTEtMA_fc1a0124-0a0f-4a86-b8a2-b319f749ab35"
      unitRef="usd">156277000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5c5f2803efa24a25b712849347cd1cf5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMTEtMy0xLTEtMA_1bc43a0e-694b-4b11-891c-48ab43292a0e"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i686c91e5254648cea5586df68b2d908e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMTEtNS0xLTEtMA_48fc528d-63de-4d54-9e32-5a1e4fafeb50"
      unitRef="usd">156277000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5083b3c67e204f679f3a2c11014f24c1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjcwNzU0NjRiMDE5NjQ5YWU5MjI3NWRlODQ4NWI5NjMxL3RhYmxlcmFuZ2U6NzA3NTQ2NGIwMTk2NDlhZTkyMjc1ZGU4NDg1Yjk2MzFfMTEtNy0xLTEtMA_a2f1a3b4-75ee-4cd2-a96a-1536fc34385c"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FairValueEquityLevel1ToLevel2TransfersAmount
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RleHRyZWdpb246YmZmOTU4ZmZhYWI0NDNhNDgxMTkyOWI5ZmM0ZDdlYjNfMTA5OTUxMTYzMzc0NA_0e455d48-a6da-40e8-99fc-5a9a627b28e6"
      unitRef="usd">0</us-gaap:FairValueEquityLevel1ToLevel2TransfersAmount>
    <us-gaap:FairValueEquityLevel1ToLevel2TransfersAmount
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RleHRyZWdpb246YmZmOTU4ZmZhYWI0NDNhNDgxMTkyOWI5ZmM0ZDdlYjNfMTA5OTUxMTYzMzc0NA_7b4e0c4f-7cee-4c6a-a4a5-bdff79dc6484"
      unitRef="usd">0</us-gaap:FairValueEquityLevel1ToLevel2TransfersAmount>
    <us-gaap:FairValueEquityLevel2ToLevel1TransfersAmount
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RleHRyZWdpb246YmZmOTU4ZmZhYWI0NDNhNDgxMTkyOWI5ZmM0ZDdlYjNfMTA5OTUxMTYzMzc0NA_bcb4b8b9-fbcf-4ff2-847e-061e741541cb"
      unitRef="usd">0</us-gaap:FairValueEquityLevel2ToLevel1TransfersAmount>
    <us-gaap:FairValueEquityLevel2ToLevel1TransfersAmount
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RleHRyZWdpb246YmZmOTU4ZmZhYWI0NDNhNDgxMTkyOWI5ZmM0ZDdlYjNfMTA5OTUxMTYzMzc0NA_d2fad162-6901-4070-b630-ebd835f3f54a"
      unitRef="usd">0</us-gaap:FairValueEquityLevel2ToLevel1TransfersAmount>
    <goss:InterestAndSecuritiesReceivable
      contextRef="i83bde4dee6094380821298b49ab659af_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RleHRyZWdpb246YmZmOTU4ZmZhYWI0NDNhNDgxMTkyOWI5ZmM0ZDdlYjNfMjM2Mg_d8502d7f-85f9-44f4-a518-bb357277996a"
      unitRef="usd">500000</goss:InterestAndSecuritiesReceivable>
    <goss:InterestAndSecuritiesReceivable
      contextRef="i3101b95085834b9ea5a1dc9f746956db_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RleHRyZWdpb246YmZmOTU4ZmZhYWI0NDNhNDgxMTkyOWI5ZmM0ZDdlYjNfMjM2OQ_e1fd1120-1dd2-4c1c-9940-de3e592b945c"
      unitRef="usd">1500000</goss:InterestAndSecuritiesReceivable>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="ice172af8d59747e98811da5f3ed0dfc7_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RleHRyZWdpb246YmZmOTU4ZmZhYWI0NDNhNDgxMTkyOWI5ZmM0ZDdlYjNfMzM1Ng_da0871b1-03a9-40b6-8aa4-32ffef3002ac"
      unitRef="usd">202000000.0</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RleHRyZWdpb246YmZmOTU4ZmZhYWI0NDNhNDgxMTkyOWI5ZmM0ZDdlYjNfNTk0MA_515f18fb-5436-41d4-b460-592d74960f31">&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate market value, cost basis, and gross unrealized gains and losses of available-for-sale investments by security type, classified in marketable securities and long-term investments as of September&#160;30, 2020 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.851%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. Treasury and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;35,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;35,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;52,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;52,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;93,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;93,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ifec2d9641952468d8894861a5747a001_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfMi0xLTEtMS0w_105f07ec-e21c-43c4-88da-4a0489b72bc7"
      unitRef="usd">35194000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ifec2d9641952468d8894861a5747a001_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfMi0zLTEtMS0w_5467d54f-f08c-4e0d-a084-e120ad36ee88"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ifec2d9641952468d8894861a5747a001_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfMi01LTEtMS0w_8b5720cb-1bad-4eca-a32d-bcc60c05040a"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifec2d9641952468d8894861a5747a001_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfMi03LTEtMS0w_508f484c-4c7a-4db4-80d8-3d59bf890c14"
      unitRef="usd">35194000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib8ff014a368f4ecdbeb3dedc5d6a4ec9_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfMy0xLTEtMS0w_c413e2ca-6185-42ce-82ac-1467c6aa17f6"
      unitRef="usd">5580000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib8ff014a368f4ecdbeb3dedc5d6a4ec9_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfMy0zLTEtMS0w_0c3e9c0a-fbe8-4313-b9ab-0063fb9a8801"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib8ff014a368f4ecdbeb3dedc5d6a4ec9_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfMy01LTEtMS0w_0f36ce49-efa3-45bb-8bb7-145441b0cb3f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib8ff014a368f4ecdbeb3dedc5d6a4ec9_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfMy03LTEtMS0w_6c20c4a6-bd79-4213-925f-57b31e119666"
      unitRef="usd">5580000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia0a2dd9240654fb5a702e98d4d3f4e28_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfNC0xLTEtMS0w_c52c89a3-6602-4845-af39-48bcf08b057d"
      unitRef="usd">52346000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia0a2dd9240654fb5a702e98d4d3f4e28_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfNC0zLTEtMS0w_8a768778-baeb-4e7a-9a05-f4947ab6d4a6"
      unitRef="usd">302000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia0a2dd9240654fb5a702e98d4d3f4e28_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfNC01LTEtMS0w_e9352e59-d401-46a7-8e73-0235670e3502"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia0a2dd9240654fb5a702e98d4d3f4e28_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfNC03LTEtMS0w_1bcdf515-e886-4bbf-8551-b3b16637ee7c"
      unitRef="usd">52648000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfNS0xLTEtMS0w_d5badfa2-56be-43be-acfb-81ba6410f248"
      unitRef="usd">93120000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfNS0zLTEtMS0w_67152160-29eb-4bb4-b080-051f16f6bc77"
      unitRef="usd">302000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfNS01LTEtMS0w_ae9b087b-3a05-42ad-8b86-6fb5bc5d1ea9"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjg3MTliZTg1NzQxNDRkN2JhMTZmMjQxODdkNTkxNjU3L3RhYmxlcmFuZ2U6ODcxOWJlODU3NDE0NGQ3YmExNmYyNDE4N2Q1OTE2NTdfNS03LTEtMS0w_33838a6e-6c40-41fe-b1fc-029497376c6b"
      unitRef="usd">93422000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RleHRyZWdpb246YmZmOTU4ZmZhYWI0NDNhNDgxMTkyOWI5ZmM0ZDdlYjNfNTk0MQ_6daeb2fb-5b86-44ec-8c69-e8a05ba78932">&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual maturities of available-for-sale debt securities, as of September&#160;30, 2020, were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Estimated&lt;br/&gt; Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;79,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;One to two years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;93,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjE2YWZkNDE3OTg3MDRlNTRhYzUxMGMxMjM3MWFmYjNhL3RhYmxlcmFuZ2U6MTZhZmQ0MTc5ODcwNGU1NGFjNTEwYzEyMzcxYWZiM2FfMS0xLTEtMS0w_38d06cf2-4342-4f45-b226-941119f1d73c"
      unitRef="usd">79582000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue>
    <goss:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjE2YWZkNDE3OTg3MDRlNTRhYzUxMGMxMjM3MWFmYjNhL3RhYmxlcmFuZ2U6MTZhZmQ0MTc5ODcwNGU1NGFjNTEwYzEyMzcxYWZiM2FfMi0xLTEtMS0w_3f05483d-f2b5-4540-9204-6b857a20b3e1"
      unitRef="usd">13840000</goss:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl80OS9mcmFnOmJmZjk1OGZmYWFiNDQzYTQ4MTE5MjliOWZjNGQ3ZWIzL3RhYmxlOjE2YWZkNDE3OTg3MDRlNTRhYzUxMGMxMjM3MWFmYjNhL3RhYmxlcmFuZ2U6MTZhZmQ0MTc5ODcwNGU1NGFjNTEwYzEyMzcxYWZiM2FfMy0xLTEtMS0w_edcecf1b-7db9-4ed5-8739-538b6487e8f4"
      unitRef="usd">93422000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTA5OTUxMTYzOTgxOQ_956c362d-ff7d-45e5-82e3-3e0913602965">Indebtedness&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 2, 2019, the Company entered into a credit, guaranty and security agreement, as amended on September 18, 2019 and July 2, 2020 (the &#x201c;Credit Facility&#x201d;), with MidCap Financial Trust (&#x201c;MidCap&#x201d;), as agent and lender, and the additional lenders party thereto from time to time (together with MidCap, the &#x201c;Lenders&#x201d;), pursuant to which the Lenders, including affiliates of MidCap and Silicon Valley Bank, agreed to make term loans available to the Company for working capital and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;general business purposes, in a principal amount of up  to $150.0 million in term loan commitments, including a $30.0 million term loan that was funded at the closing date, with the ability to access the remaining $120.0 million in two additional tranches (each $60.0 million), subject to specified availability periods, the achievement of certain clinical development milestones, minimum cash requirements and other customary conditions. The Company, GB001, Inc., GB002, Inc., and GB004, Inc., each wholly-owned subsidiaries of the Company, are designated as co-borrowers to the Credit Facility, whereas GB003, Inc., GB005, Inc., GB006, Inc., GB007, Inc., GB008, Inc. and Gossamer Bio Services, Inc.,each wholly-owned subsidiaries of the Company, are designated as guarantors. The remaining two tranches are available no earlier than the satisfaction of the applicable funding conditions, including the applicable clinical development milestones, and no later than December 31, 2022. As of September&#160;30, 2020, no other tranches under the Credit Facility have been drawn. The Credit Facility is secured by substantially all of the Company&#x2019;s and its domestic subsidiaries&#x2019; personal property, including intellectual property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each term loan under the Credit Facility bears interest at an annual rate equal to the sum of (i) one-month LIBOR (customarily defined, with a change to prime rate if LIBOR funding becomes unlawful or impractical) plus (ii) 7.00%, subject to a LIBOR floor of 2.00%.&#160;&#160;The borrower is required to make interest-only payments on the term loan for all payment dates prior to July 1, 2022.&#160;&#160;The term loans under the Credit Facility will begin amortizing on July 1, 2022, with equal monthly payments of principal plus interest being made by the Company to the Lenders in consecutive monthly installments following such interest-only period until the Credit Facility matures on January 1, 2025.&#160;&#160;Upon final repayment of the term loans, the borrower must pay an exit fee of 1.75% of the amount borrowed under the Credit Facility, less any partial exit fees previously paid.&#160;&#160;Upon partial prepayment of a portion of the term loans, the borrower must pay a partial exit fee of 1.75% of the principal being prepaid. At the borrower&#x2019;s option, the borrower may prepay the outstanding principal balance of the term loan in whole or in part, subject to a prepayment fee of 3.00% of any amount prepaid if the prepayment occurs through and including the first anniversary of the second amendment effective date, 2.00% of the amount prepaid if the prepayment occurs after the first anniversary of the second amendment effective date through and including the second anniversary of the second amendment effective date, and 1.00% of any amount prepaid after the second anniversary of the second amendment effective date and prior to January 1, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Facility includes affirmative and negative covenants applicable to the Company and certain of its subsidiaries. The affirmative covenants include, among others, covenants requiring such entities to maintain their legal existence and governmental approvals, deliver certain financial reports, maintain insurance coverage, maintain property, pay taxes, satisfy certain requirements regarding accounts and comply with laws and regulations.&#160;&#160;The negative covenants include, among others, restrictions on such entities from transferring collateral, incurring additional indebtedness, engaging in mergers or acquisitions, paying dividends or making other distributions, making investments, creating liens, amending material agreements and organizational documents, selling assets and suffering a change in control, in each case subject to certain exceptions.&#160;&#160;The Company and certain of its subsidiaries are also subject to an ongoing minimum cash financial covenant in which they must maintain unrestricted cash in an amount not less than 25% of the outstanding principal amount of the term loans. As of September&#160;30, 2020, the Company was in compliance with these covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Facility also includes events of default, the occurrence and continuation of which could cause interest to be charged at the rate that is otherwise applicable plus 3.00% and would provide MidCap, as agent, with the right to exercise remedies against the Company and/or certain of its subsidiaries, and the collateral securing the Credit Facility, including foreclosure against the properties securing the credit facilities, including cash.&#160;&#160;These events of default include, among other things, failure to pay any amounts due under the Credit Facility, a breach of covenants under the Credit Facility, insolvency or the occurrence of insolvency events, the occurrence of a change in control, the occurrence of certain U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) and regulatory events, failure to remain registered with the SEC and listed for trading on Nasdaq, the occurrence of a material adverse change, the occurrence of a default under a material agreement reasonably expected to result in a material adverse change, the occurrence of certain defaults under certain other indebtedness in an amount greater than $2.5 million and the occurrence of certain defaults under subordinated indebtedness and convertible indebtedness.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt as of September&#160;30, 2020 consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt discount and issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,335)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The scheduled future minimum principal payments are as follows (in thousands)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 (remaining 3 months)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;5.00% Convertible Senior Notes due 2027&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 21, 2020, the Company issued $200.0 million aggregate principal amount of 5.00% convertible senior notes due 2027 in a public offering. The 2027 Notes were registered pursuant to the Company&#x2019;s Shelf Registration Statement (as defined in Note 7 below). The interest rate on the 2027 Notes is fixed at 5.00% per annum. Interest is payable semi-annually in arrears on June 1 and December 1 of each year, commencing on December 1, 2020. The 2027 Notes will mature on June 1, 2027. The net proceeds from the offering, after deducting the underwriting discounts and commissions and other offering costs, were approximately $193.6 million. The 2027 Notes may be settled in cash, shares of the Company&#x2019;s common stock, or a combination thereof, solely at the Company&#x2019;s election. The initial conversion rate of the 2027 Notes is&#160;61.6095&#160;shares per&#160;$1,000&#160;principal amount, which is equivalent to a conversion price of approximately&#160;$16.23&#160;per share, subject to adjustments.&#160;In addition, following certain corporate events that occur prior to the maturity date or if the Company issues a notice of redemption, the Company will increase the conversion rate for a holder who elects to convert its 2027 Notes in connection with such a corporate event during the related redemption period in certain circumstances.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2027 Notes are senior unsecured obligations of the Company, ranking senior in right of payment to any of the Company&#x2019;s indebtedness that is expressly subordinated in right of payment to the 2027 Notes, and are effectively subordinated to the Company&#x2019;s existing and future secured indebtedness, to the extent of the value of the collateral securing that indebtedness, including all indebtedness under the Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders may convert their notes at their option only in the following circumstances: (1) during any calendar quarter (and only during such calendar quarter) commencing after the calendar quarter ending on September 30, 2020, if the last reported sale price per share of the Company&#x2019;s common stock exceeds 130% of the conversion price for each of at least 20 trading days (whether or not consecutive) during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (2) during the five consecutive business days immediately after any 10 consecutive trading day period (such 10 consecutive trading day period, the &#x201c;measurement period&#x201d;) in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of the Company&#x2019;s common stock on such trading day and the conversion rate on such trading day; (3) upon the occurrence of certain corporate events or distributions on the Company&#x2019;s common stock; (4) if the Company calls such notes for redemption; and (5) at any time from, and including, March 1, 2027 until the close of business on the scheduled trading day immediately before the maturity date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company will not have the right to redeem the 2027 Notes prior to June 6, 2024. On or after June 6, 2024 and on or before the 50th scheduled trading day immediately before the maturity date, the Company may redeem the 2027 Notes, in whole or in part, if the last reported sale price of the Company&#x2019;s common stock has been at least 130% of the conversion price then in effect on (1) each of at least 20 trading days (whether or not consecutive) during the 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice; and (2)the trading day immediately before the date the Company sends such notice. In the case of any optional redemption, the Company will redeem the 2027 Notes at a redemption price equal to 100% of the principal amount of such Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the Company undergoes a fundamental change prior to the maturity date of the 2027 Notes, holders of the 2027 Notes may require the Company to repurchase for cash all or part of their 2027 Notes at a repurchase price equal to 100% of the principal amount of the 2027 Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The indenture governing the 2027 Notes provides for customary terms and covenants, including that upon certain events of default, either the trustee or the holders of not less than 25% in aggregate principal amount of the 2027 Notes then outstanding may declare the unpaid principal amount of the 2027 Notes and accrued and unpaid interest, if any, thereon &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;immediately due and payable. As of September&#160;30, 2020, the Company was in compliance with these covenants. In the case of certain events of bankruptcy, insolvency or reorganization, the principal amount of the 2027 Notes together with accrued and unpaid interest, if any, thereon will automatically become and be immediately due and payable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020, there were no events or market conditions that would allow holders to convert the 2027 Notes.&#160;&#160;At the time the 2027 Notes become convertible within 12 months of the balance sheet date, the carrying value of the 2027 Notes will be reclassified to short-term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accounting for the issuance of the 2027 Notes, the Company separated the 2027 Notes into liability and equity components.&#160;&#160;The carrying amount of the liability component was calculated by measuring the fair value of similar debt instruments that do not have associated convertible features. The carrying amount of the equity component representing the conversion option was $53.0 million and was determined by deducting the fair value of the liability component from the par value of the 2027 Notes. The equity component is not remeasured as long as it continues to meet the conditions for equity classification. The debt discount is amortized to interest expense over the term of the 2027 Notes at an effective interest rate of 11.17% over the contractual terms of the 2027 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accounting for the debt issuance costs of&#160;$0.4 million&#160;related to the 2027 Notes, the Company allocated the total amount incurred to the liability and equity components of the 2027 Notes based on their relative fair values. Issuance costs attributable to the liability component were $0.3 million and will be amortized to interest expense using the effective interest method over the contractual terms of the 2027 Notes.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Issuance costs attributable to the equity component were netted with the equity component in stockholders&#x2019; equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net carrying amount of the liability component of the 2027 Notes was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,557)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net carrying amount of the equity component of the 2027 Notes was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt discount related to the value of conversion option&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the interest expense recognized related to the 2027 Notes (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest expense related to the 2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i5422129c1c59408889a2b99ef392c162_I20190502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNjI5_6f46344b-496f-4b68-94a0-fc2aaa6355cc"
      unitRef="usd">150000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i70316c2b436540a398e8730c8f3d7325_D20190502-20190502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNjcw_a918f5e1-d1a4-4ae6-a026-352716468ded"
      unitRef="usd">30000000.0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i5422129c1c59408889a2b99ef392c162_I20190502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNzYx_471d6265-3f50-4fb4-b552-bdd66d9a51a0"
      unitRef="usd">120000000.0</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <goss:NumberOfAdditionalTranches
      contextRef="i5422129c1c59408889a2b99ef392c162_I20190502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNzY3_b7fd1871-40c1-45bd-a944-9e2660fe6a6c"
      unitRef="tranche">2</goss:NumberOfAdditionalTranches>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i5007e0fab37a4961ae06a859fbe77235_I20190502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNzk0_47ffd711-98a7-4ec1-91eb-dc3dbaac4f60"
      unitRef="usd">60000000.0</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i667382cf02644ff3a4aefdaf07b9cb60_I20190502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNzk0_7aedb5ef-abec-4946-90c7-cb784140a0fb"
      unitRef="usd">60000000.0</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i049d323be2aa4c3fbc15de6068f993c8_D20190502-20190502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTkxNQ_20f93583-8883-4444-90a0-9f0a0c62992d"
      unitRef="number">0.0700</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2111df5e71074410b154ca22ac755a6d_I20190502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTk0Nw_0f7957b9-a69a-4ac7-9f51-bde1ef186c72"
      unitRef="number">0.0200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <goss:PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment
      contextRef="i5422129c1c59408889a2b99ef392c162_I20190502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMjU0Nw_81e6017b-24d7-4d3f-8acf-be041c08e02b"
      unitRef="number">0.0175</goss:PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment>
    <goss:PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment
      contextRef="i5422129c1c59408889a2b99ef392c162_I20190502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMjc0NQ_25543d9d-ea69-425a-8e77-f3028acc0ab8"
      unitRef="number">0.0175</goss:PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment>
    <goss:PercentageOfPrepaymentFee
      contextRef="i7d6528bf258548188d528464e3134189_I20190502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMjkzMw_2df72f61-d193-4392-a054-af5c8e12f269"
      unitRef="number">0.0300</goss:PercentageOfPrepaymentFee>
    <goss:PercentageOfPrepaymentFee
      contextRef="idd99beac9caf44318e4f61c224f56fa4_I20190502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMzA0Nw_12f30fa7-730a-42c8-bbe9-5cfd469791a4"
      unitRef="number">0.0200</goss:PercentageOfPrepaymentFee>
    <goss:PercentageOfPrepaymentFee
      contextRef="i1aa9b85a36ff422abc868819f1b52110_I20190502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMzIxNQ_916aef3c-8741-4f59-acd8-8164f6461021"
      unitRef="number">0.0100</goss:PercentageOfPrepaymentFee>
    <goss:DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan
      contextRef="i70316c2b436540a398e8730c8f3d7325_D20190502-20190502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNDM1OQ_084a69e7-4d74-4af1-a9fd-93d2e3d57bdf"
      unitRef="number">0.25</goss:DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ifd6482abdd604fa3b4920ae6543e4b2e_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNDY1NA_c83d9264-fa67-4952-bebf-a44d34b75776"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <goss:DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt
      contextRef="i4f195af7643b4ea094fcedba56dc2482_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMzI5ODUzNDkwMTE4OA_b4260cb3-b7f9-4f32-8a27-4ba8de5b3aad"
      unitRef="usd">2500000</goss:DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTIwMzY_8bc29cae-132d-4dbf-b56e-fd3b2d23d1be">&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt as of September&#160;30, 2020 consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt discount and issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,335)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic984cdc9b0e0482fbb94f5d207f8e3fa_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOjE0MGMyMTY1Y2Q1MjQ1ZDY5N2U1ODYxNTY0YzgzY2RjL3RhYmxlcmFuZ2U6MTQwYzIxNjVjZDUyNDVkNjk3ZTU4NjE1NjRjODNjZGNfMS0xLTEtMS0w_34bdae01-adc0-45a3-a48b-2ac21b0c8e9d"
      unitRef="usd">30000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="ic984cdc9b0e0482fbb94f5d207f8e3fa_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOjE0MGMyMTY1Y2Q1MjQ1ZDY5N2U1ODYxNTY0YzgzY2RjL3RhYmxlcmFuZ2U6MTQwYzIxNjVjZDUyNDVkNjk3ZTU4NjE1NjRjODNjZGNfMi0xLTEtMS0w_4ed8d245-d129-4981-8948-fa9601e4eb87"
      unitRef="usd">1335000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="ic984cdc9b0e0482fbb94f5d207f8e3fa_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOjE0MGMyMTY1Y2Q1MjQ1ZDY5N2U1ODYxNTY0YzgzY2RjL3RhYmxlcmFuZ2U6MTQwYzIxNjVjZDUyNDVkNjk3ZTU4NjE1NjRjODNjZGNfMy0xLTEtMS0w_b364328a-8302-4935-8689-508c6d956636"
      unitRef="usd">28665000</us-gaap:LongTermDebt>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTIwMzc_f2f35af2-f80f-40a7-90bd-6d3acec89c2b">The scheduled future minimum principal payments are as follows (in thousands)&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 (remaining 3 months)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOjc2YTU4ZTNmNTdkYzQwNmFiNGJkMDAzMjgxZjEyYTI1L3RhYmxlcmFuZ2U6NzZhNThlM2Y1N2RjNDA2YWI0YmQwMDMyODFmMTJhMjVfMS0xLTEtMS0w_bbba65ed-dca0-4bcf-8be7-a4a2d9a0f2ad"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i7fbffc547f2d4d6c8b7ed7d9553a691e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOjc2YTU4ZTNmNTdkYzQwNmFiNGJkMDAzMjgxZjEyYTI1L3RhYmxlcmFuZ2U6NzZhNThlM2Y1N2RjNDA2YWI0YmQwMDMyODFmMTJhMjVfMi0xLTEtMS0w_ae2dead5-196e-4e96-b754-e1cdd77d65ad"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i7fbffc547f2d4d6c8b7ed7d9553a691e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOjc2YTU4ZTNmNTdkYzQwNmFiNGJkMDAzMjgxZjEyYTI1L3RhYmxlcmFuZ2U6NzZhNThlM2Y1N2RjNDA2YWI0YmQwMDMyODFmMTJhMjVfMy0xLTEtMS0w_47482a4f-0f0a-4d84-96d7-2752ddb29019"
      unitRef="usd">5806000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i7fbffc547f2d4d6c8b7ed7d9553a691e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOjc2YTU4ZTNmNTdkYzQwNmFiNGJkMDAzMjgxZjEyYTI1L3RhYmxlcmFuZ2U6NzZhNThlM2Y1N2RjNDA2YWI0YmQwMDMyODFmMTJhMjVfNC0xLTEtMS0w_fe5cbde0-9592-4e88-9333-d8fe1f679b59"
      unitRef="usd">11613000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i7fbffc547f2d4d6c8b7ed7d9553a691e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOjc2YTU4ZTNmNTdkYzQwNmFiNGJkMDAzMjgxZjEyYTI1L3RhYmxlcmFuZ2U6NzZhNThlM2Y1N2RjNDA2YWI0YmQwMDMyODFmMTJhMjVfNS0xLTEtMS0w_41ee6dab-e512-4d88-8da1-fe0cd245cae7"
      unitRef="usd">11613000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <goss:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix
      contextRef="i7fbffc547f2d4d6c8b7ed7d9553a691e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOjc2YTU4ZTNmNTdkYzQwNmFiNGJkMDAzMjgxZjEyYTI1L3RhYmxlcmFuZ2U6NzZhNThlM2Y1N2RjNDA2YWI0YmQwMDMyODFmMTJhMjVfNi0xLTEtMS0xODUw_b0f922ea-87f2-4b13-92dd-d5ecc810a965"
      unitRef="usd">968000</goss:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7fbffc547f2d4d6c8b7ed7d9553a691e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOjc2YTU4ZTNmNTdkYzQwNmFiNGJkMDAzMjgxZjEyYTI1L3RhYmxlcmFuZ2U6NzZhNThlM2Y1N2RjNDA2YWI0YmQwMDMyODFmMTJhMjVfNi0xLTEtMS0w_bee4dccd-e12c-4d1b-a844-75c3282fa4b3"
      unitRef="usd">30000000</us-gaap:DebtInstrumentCarryingAmount>
    <goss:DebtInstrumentAggregatePrincipalAmount
      contextRef="i5fed8506ec5c42a0b5ad8496948c43b6_D20200521-20200521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNTkyOA_a5b43fd8-7ece-471f-bfea-b8f2f76b1461"
      unitRef="usd">200000000.0</goss:DebtInstrumentAggregatePrincipalAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib0fc320a9ff8434485ec70bde2f2d365_I20200521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNTk2MQ_c7c856fd-fcc6-4c49-b445-7b40e6409185"
      unitRef="number">0.0500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib0fc320a9ff8434485ec70bde2f2d365_I20200521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNjE4NA_97a5355d-5c3a-4186-90fc-b53aa2a1aa12"
      unitRef="number">0.0500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i5fed8506ec5c42a0b5ad8496948c43b6_D20200521-20200521"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMzI5ODUzNDkwMTE4MA_8ee535bb-7a06-4af2-a846-ec1a83c8f045"
      unitRef="usd">193600000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="ib0fc320a9ff8434485ec70bde2f2d365_I20200521"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNjc4Mg_763f9f50-c7fa-4b91-9f67-8e071249569f"
      unitRef="usdPerShare">16.23</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <goss:DebtInstrumentConvertibleConversionPricePercentage
      contextRef="i5fed8506ec5c42a0b5ad8496948c43b6_D20200521-20200521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNzg4Nw_f2d6fede-345a-4b05-88bb-6758d7a51891"
      unitRef="number">1.30</goss:DebtInstrumentConvertibleConversionPricePercentage>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="idda6a8263ec542759323ed492c31b7bc_D20200521-20200521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNzkzNQ_70ec3516-1817-4949-9f6f-d4d9cf933c50"
      unitRef="day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i3dc17920346740a4a7c548c095f7e04c_D20200521-20200521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfNzk5MQ_02d979f8-b164-44f0-b6bb-eaa2670357cf"
      unitRef="day">30</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i4f7d41d10a544ee8bd19cb9b3d404bd3_D20200521-20200521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfODEyOA_cdbd0692-2150-4e8f-9a9a-b018d633944f"
      unitRef="day">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="iaeecc10913964395b00a41848ddfd5d3_D20200521-20200521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfODE3OQ_aaa9beeb-8220-45ef-8f87-5ff0a7ad600f"
      unitRef="day">10</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="iaeecc10913964395b00a41848ddfd5d3_D20200521-20200521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfODIxOQ_d3f147ca-4384-4d50-839f-d48d9821576d"
      unitRef="day">10</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="i5fed8506ec5c42a0b5ad8496948c43b6_D20200521-20200521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfODMxMQ_a519aa2f-2636-4b8c-bfac-7b6de212fe4e"
      unitRef="usd">1000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <goss:DebtInstrumentConvertibleConversionLastReportedSalePricePercentage
      contextRef="i7efacb2f1f254242abcd3924f60c15be_D20200521-20200521"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfODQwMQ_05fef57e-6744-45a1-b95c-a1577d711517"
      unitRef="number">0.98</goss:DebtInstrumentConvertibleConversionLastReportedSalePricePercentage>
    <goss:DebtInstrumentConvertibleConversionPricePercentage
      contextRef="i5fed8506ec5c42a0b5ad8496948c43b6_D20200521-20200521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfOTE5NA_93571ad9-1bbd-47ef-8a42-b2860fc7846a"
      unitRef="number">1.30</goss:DebtInstrumentConvertibleConversionPricePercentage>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="idda6a8263ec542759323ed492c31b7bc_D20200521-20200521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTA5OTUxMTYzOTgyNg_11f03f8f-0002-48c5-b952-e1281d2607ee"
      unitRef="day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i3dc17920346740a4a7c548c095f7e04c_D20200521-20200521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfOTMxNA_e67901c5-f0a7-43e9-b0f2-89823b3cb8a0"
      unitRef="day">30</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i5fed8506ec5c42a0b5ad8496948c43b6_D20200521-20200521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfOTY1Mw_a617c72e-596a-46e3-8ae3-948a1b4ad0ab"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <goss:PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes
      contextRef="i5fed8506ec5c42a0b5ad8496948c43b6_D20200521-20200521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTAwMTI_264ea3d3-2cda-4850-abdc-64bc0ec52c64"
      unitRef="number">1</goss:PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes>
    <goss:LongTermDebtPercentageInAggregatePrincipalAmount
      contextRef="i5fed8506ec5c42a0b5ad8496948c43b6_D20200521-20200521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTA5OTUxMTY0NjI3Mw_ccb7a7c8-788c-4a89-9e4a-304c9d328dad"
      unitRef="number">0.25</goss:LongTermDebtPercentageInAggregatePrincipalAmount>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="ib0fc320a9ff8434485ec70bde2f2d365_I20200521"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTA4MTc_0b32593f-25a2-4324-9afb-330bb8b3e45c"
      unitRef="usd">53000000.0</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ib0fc320a9ff8434485ec70bde2f2d365_I20200521"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTExNjE_55c0a819-c1b4-4974-b514-28c71fb33a01"
      unitRef="number">0.1117</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ib0fc320a9ff8434485ec70bde2f2d365_I20200521"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTEyNTU_891befb9-62f3-4200-9fa8-2802fbc87ed2"
      unitRef="usd">400000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i5fed8506ec5c42a0b5ad8496948c43b6_D20200521-20200521"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTE0ODc_090bda39-a52a-4059-9591-9250621b4c57"
      unitRef="usd">300000</us-gaap:AmortizationOfFinancingCosts>
    <goss:ScheduleOfLiabilityComponentsOfNotesTableTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTIwMzk_17712ded-3ae4-428f-912a-c46fdce7cfef">&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net carrying amount of the liability component of the 2027 Notes was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,557)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</goss:ScheduleOfLiabilityComponentsOfNotesTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i65ad3aed5a854b92910ae3dd0bf4a19a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmZjZTNmNTgzNzU4ZDQ1ODNiOTU1ZDE2M2EwMWRmMzczL3RhYmxlcmFuZ2U6ZmNlM2Y1ODM3NThkNDU4M2I5NTVkMTYzYTAxZGYzNzNfMS0xLTEtMS0w_32012879-83f9-4568-8b32-c6bc99dc3881"
      unitRef="usd">200000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie5bf8c1de2ef4f56b4e73b156372b2a3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmZjZTNmNTgzNzU4ZDQ1ODNiOTU1ZDE2M2EwMWRmMzczL3RhYmxlcmFuZ2U6ZmNlM2Y1ODM3NThkNDU4M2I5NTVkMTYzYTAxZGYzNzNfMS0zLTEtMS0w_5f6e54f5-1505-4073-a6a1-bd3b8644d004"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i65ad3aed5a854b92910ae3dd0bf4a19a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmZjZTNmNTgzNzU4ZDQ1ODNiOTU1ZDE2M2EwMWRmMzczL3RhYmxlcmFuZ2U6ZmNlM2Y1ODM3NThkNDU4M2I5NTVkMTYzYTAxZGYzNzNfMi0xLTEtMS0w_6b2b16f5-5189-44d0-8b01-38a2bd9a8fd0"
      unitRef="usd">57557000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ie5bf8c1de2ef4f56b4e73b156372b2a3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmZjZTNmNTgzNzU4ZDQ1ODNiOTU1ZDE2M2EwMWRmMzczL3RhYmxlcmFuZ2U6ZmNlM2Y1ODM3NThkNDU4M2I5NTVkMTYzYTAxZGYzNzNfMi0zLTEtMS0w_e2d0a633-bba6-4ac8-8a9c-c3c64ed098cf"
      unitRef="usd">0</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i65ad3aed5a854b92910ae3dd0bf4a19a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmZjZTNmNTgzNzU4ZDQ1ODNiOTU1ZDE2M2EwMWRmMzczL3RhYmxlcmFuZ2U6ZmNlM2Y1ODM3NThkNDU4M2I5NTVkMTYzYTAxZGYzNzNfMy0xLTEtMS0w_47839458-80fd-4440-bfe7-15d4802c7ccb"
      unitRef="usd">285000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="ie5bf8c1de2ef4f56b4e73b156372b2a3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmZjZTNmNTgzNzU4ZDQ1ODNiOTU1ZDE2M2EwMWRmMzczL3RhYmxlcmFuZ2U6ZmNlM2Y1ODM3NThkNDU4M2I5NTVkMTYzYTAxZGYzNzNfMy0zLTEtMS0w_6ac35b97-dae6-4f07-bbd0-cd458371d522"
      unitRef="usd">0</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:LongTermDebt
      contextRef="i65ad3aed5a854b92910ae3dd0bf4a19a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmZjZTNmNTgzNzU4ZDQ1ODNiOTU1ZDE2M2EwMWRmMzczL3RhYmxlcmFuZ2U6ZmNlM2Y1ODM3NThkNDU4M2I5NTVkMTYzYTAxZGYzNzNfNC0xLTEtMS0w_e7015026-bc5a-4ccd-a16f-35746602dfb5"
      unitRef="usd">142158000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie5bf8c1de2ef4f56b4e73b156372b2a3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmZjZTNmNTgzNzU4ZDQ1ODNiOTU1ZDE2M2EwMWRmMzczL3RhYmxlcmFuZ2U6ZmNlM2Y1ODM3NThkNDU4M2I5NTVkMTYzYTAxZGYzNzNfNC0zLTEtMS0w_8cb3606c-4f5a-4d1d-96ad-0fb7e5632670"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <goss:ScheduleOfEquityComponentsOfNotesTableTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTIwNDA_a03392ea-6f6b-4f22-aabe-216a638b15b8">&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net carrying amount of the equity component of the 2027 Notes was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt discount related to the value of conversion option&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</goss:ScheduleOfEquityComponentsOfNotesTableTextBlock>
    <goss:AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption
      contextRef="i65ad3aed5a854b92910ae3dd0bf4a19a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmUzMjU1OGJkZjJkNzRmNmM5MDczZWU0ZjJmZWY5NDAyL3RhYmxlcmFuZ2U6ZTMyNTU4YmRmMmQ3NGY2YzkwNzNlZTRmMmZlZjk0MDJfMS0xLTEtMS0w_e4b8b990-eb48-45c5-8ae3-c85f32a98a13"
      unitRef="usd">53635000</goss:AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption>
    <goss:AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption
      contextRef="ie5bf8c1de2ef4f56b4e73b156372b2a3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmUzMjU1OGJkZjJkNzRmNmM5MDczZWU0ZjJmZWY5NDAyL3RhYmxlcmFuZ2U6ZTMyNTU4YmRmMmQ3NGY2YzkwNzNlZTRmMmZlZjk0MDJfMS0zLTEtMS0w_e0820b46-aab6-4b8e-abeb-1669feab7a3c"
      unitRef="usd">0</goss:AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption>
    <goss:AdjustmentsToEquityComponentOfDebtIssuanceCosts
      contextRef="i65ad3aed5a854b92910ae3dd0bf4a19a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmUzMjU1OGJkZjJkNzRmNmM5MDczZWU0ZjJmZWY5NDAyL3RhYmxlcmFuZ2U6ZTMyNTU4YmRmMmQ3NGY2YzkwNzNlZTRmMmZlZjk0MDJfMi0xLTEtMS0w_7c05ca7d-cf45-4909-8325-76372c82fa3f"
      unitRef="usd">109000</goss:AdjustmentsToEquityComponentOfDebtIssuanceCosts>
    <goss:AdjustmentsToEquityComponentOfDebtIssuanceCosts
      contextRef="ie5bf8c1de2ef4f56b4e73b156372b2a3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmUzMjU1OGJkZjJkNzRmNmM5MDczZWU0ZjJmZWY5NDAyL3RhYmxlcmFuZ2U6ZTMyNTU4YmRmMmQ3NGY2YzkwNzNlZTRmMmZlZjk0MDJfMi0zLTEtMS0w_7c6c623d-8218-4cd3-b8f7-ace002f166fa"
      unitRef="usd">0</goss:AdjustmentsToEquityComponentOfDebtIssuanceCosts>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="i65ad3aed5a854b92910ae3dd0bf4a19a_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmUzMjU1OGJkZjJkNzRmNmM5MDczZWU0ZjJmZWY5NDAyL3RhYmxlcmFuZ2U6ZTMyNTU4YmRmMmQ3NGY2YzkwNzNlZTRmMmZlZjk0MDJfMy0xLTEtMS0w_c804a3a6-f45c-4923-8601-0eecd3433015"
      unitRef="usd">53526000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="ie5bf8c1de2ef4f56b4e73b156372b2a3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmUzMjU1OGJkZjJkNzRmNmM5MDczZWU0ZjJmZWY5NDAyL3RhYmxlcmFuZ2U6ZTMyNTU4YmRmMmQ3NGY2YzkwNzNlZTRmMmZlZjk0MDJfMy0zLTEtMS0w_15c7ba4b-ca78-4520-b070-f3da868f4018"
      unitRef="usd">0</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <goss:ScheduleOfInterestExpenseRecognizedTableTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RleHRyZWdpb246MGZkYjZlNWY2YzBkNDgzN2IyMjUzMjc2ODBhMmQzODlfMTIwNDE_baebbd3f-2205-412c-8548-cbf044792663">&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the interest expense recognized related to the 2027 Notes (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contractual interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest expense related to the 2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</goss:ScheduleOfInterestExpenseRecognizedTableTextBlock>
    <goss:ContractualInterestExpense
      contextRef="i48ce1ae69a484b2897d46eda4fe74206_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfMS0xLTEtMS0w_3b319bd5-6c9e-45cc-a662-459c829dec08"
      unitRef="usd">2500000</goss:ContractualInterestExpense>
    <goss:ContractualInterestExpense
      contextRef="if94daf002452491ebb4b1b5e305750ce_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfMS0zLTEtMS0w_3140ddd2-befa-41a6-95ea-6caa97a257f5"
      unitRef="usd">0</goss:ContractualInterestExpense>
    <goss:ContractualInterestExpense
      contextRef="if767ec539aa84bdf81a78eff0a4bcd22_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfMi01LTEtMS0yNzE0_e1245c94-718f-434d-af65-0d62dc969e55"
      unitRef="usd">3639000</goss:ContractualInterestExpense>
    <goss:ContractualInterestExpense
      contextRef="i3f6ba65eca1c4988aeda7e1649f3720f_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfMi03LTEtMS0yNzE0_81426ca6-3c23-4a8b-be80-bc465ff1117d"
      unitRef="usd">0</goss:ContractualInterestExpense>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i48ce1ae69a484b2897d46eda4fe74206_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfMi0xLTEtMS0w_2a47e73d-bfc2-48a9-af0a-2d0eabacfd31"
      unitRef="usd">7000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="if94daf002452491ebb4b1b5e305750ce_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfMi0zLTEtMS0w_f7e1dcbf-2dda-4a9d-82ed-30c54d34297e"
      unitRef="usd">0</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="if767ec539aa84bdf81a78eff0a4bcd22_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfMy01LTEtMS0yNzE0_c4767a51-b929-4fda-9912-fb26484b1107"
      unitRef="usd">10000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i3f6ba65eca1c4988aeda7e1649f3720f_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfMy03LTEtMS0yNzE0_46ea99d5-e640-4a90-b64e-32876a8d37f0"
      unitRef="usd">0</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i48ce1ae69a484b2897d46eda4fe74206_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfMy0xLTEtMS0w_2b46ba9e-9611-47a8-8938-267980404aab"
      unitRef="usd">1436000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="if94daf002452491ebb4b1b5e305750ce_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfMy0zLTEtMS0w_60c2cbbf-7683-4065-b5d1-236fddbd278b"
      unitRef="usd">0</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="if767ec539aa84bdf81a78eff0a4bcd22_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfNC01LTEtMS0yNzE0_cddc2250-f564-4dc0-9e2e-85a9a06a1af6"
      unitRef="usd">2078000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i3f6ba65eca1c4988aeda7e1649f3720f_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfNC03LTEtMS0yNzE0_aeedeacd-aef0-48d7-95b5-aa17c4ea7f15"
      unitRef="usd">0</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:InterestExpenseDebt
      contextRef="i48ce1ae69a484b2897d46eda4fe74206_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfNC0xLTEtMS0w_5c47259e-834b-4d8f-bd7a-1311b72febb9"
      unitRef="usd">3943000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="if94daf002452491ebb4b1b5e305750ce_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfNC0zLTEtMS0w_f7a6f315-12db-4148-a837-427861c4f4de"
      unitRef="usd">0</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="if767ec539aa84bdf81a78eff0a4bcd22_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfNS01LTEtMS0yNzE0_2ddc63f2-0c2c-4071-8dcc-e9082e949d74"
      unitRef="usd">5727000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i3f6ba65eca1c4988aeda7e1649f3720f_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl81NS9mcmFnOjBmZGI2ZTVmNmMwZDQ4MzdiMjI1MzI3NjgwYTJkMzg5L3RhYmxlOmQyZjc4ZmE2ZTJjMDQ3ZGE5YjMxNjU5ZmUzNWIxYmYxL3RhYmxlcmFuZ2U6ZDJmNzhmYTZlMmMwNDdkYTliMzE2NTlmZTM1YjFiZjFfNS03LTEtMS0yNzE0_da0f90fe-beb0-4e5f-bed8-620755787217"
      unitRef="usd">0</us-gaap:InterestExpenseDebt>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMTA5OTUxMTYzMzI0MA_1204bc57-5bc5-4be4-996e-222d28e5f60b">Licenses, Asset Acquisitions and Contingent Consideration&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following purchased assets were accounted for as asset acquisitions as substantially all of the fair value of the assets acquired were concentrated in a group of similar assets and/or the acquired assets were not capable of producing outputs due to the lack of employees and early stage of development. Because the assets had not yet received regulatory approval, the fair value attributable to these assets was recorded as in process research and development (&#x201c;IPR&amp;amp;D&#x201d;) expenses in the Company&#x2019;s condensed consolidated statement of operations for the three and nine months ended September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for contingent consideration payable upon achievement of certain regulatory, development or sales milestones in such asset acquisitions when the underlying contingency is met.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;License from Pulmokine, Inc. (GB002)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October&#160;2, 2017, the Company, entered into a license agreement with Pulmokine, Inc. under which it was granted an exclusive worldwide license and sublicense to certain intellectual property rights owned or controlled by Pulmokine to develop and commercialize GB002 and certain backup compounds for the treatment, prevention and diagnosis of any and all disease or conditions. The Company also has the right to sublicense its rights under the license agreement, subject to certain conditions. The assets acquired are in the early stages of the FDA approval process, and the Company intends to further develop the assets acquired through potential FDA approval as evidenced by the milestone arrangement in the contract. The development activities cannot be performed without significant cost and effort by the Company. The agreement will remain in effect from the effective date, unless terminated earlier, until, on a licensed product-by-licensed product and country-by-country basis, the later of ten years from the date of first commercial sale or when there is no longer a valid patent claim covering such licensed product or specified regulatory exclusivity for the licensed product in such country. The Company is obligated to make future development and regulatory milestone payments of up to $63.0 million, commercial milestone payments of up to $45.0 million, and sales milestone payments of up to $190.0 million. The Company is also obligated to pay tiered royalties on sales for each licensed product, at percentages ranging from the mid-single digits to the high single-digits. The Company made an upfront payment of $5.5 million in October 2017. As of September&#160;30, 2020, no milestones had been accrued as the underlying contingencies had not yet been met.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;AA Biopharma Inc. Acquisition (GB001)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January&#160;4, 2018, the Company acquired AA Biopharma Inc. pursuant to a merger agreement, and with the acquisition acquired the rights to GB001 and certain backup compounds. In connection with the merger agreement, the Company issued an aggregate of 20,000,000 shares of Series Seed Convertible Preferred Stock and 1,101,278 shares of Common Stock to the AA Biopharma shareholders. The Company recorded IPR&amp;amp;D of $19.3 million in January 2018 in connection with the acquisition of AA Biopharma.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;License from Aerpio Pharmaceuticals, Inc. (GB004)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June&#160;24, 2018, the Company entered into a license agreement with Aerpio Pharmaceuticals, Inc. (&#x201c;Aerpio&#x201d;) under which the Company was granted an exclusive worldwide license and sublicense to certain intellectual property rights owned or controlled by Aerpio to develop and commercialize GB004, and certain other related compounds for all applications. The Company made an upfront payment of $20.0 million in June 2018, which represented the purchase consideration for an asset acquisition. On May 11, 2020, the Company entered into an amendment to the license agreement with Aerpio pursuant to which the Company made an upfront payment of $15.0 million to Aerpio for a reduction in future milestone payments and royalties. Under the amended license agreement, the Company is obligated to make future approval milestone payments of up to $40.0 million and a sales milestone payment of $50.0 million. The Company also has the right to sublicense its rights under the license agreement, subject to certain conditions. The Company is also obligated to pay tiered royalties on sales for each licensed product, at percentages ranging from low- to mid-single digits, subject to certain customary reductions. Aerpio retains its twenty percent (20.00%) participation right on a disposition of GB004. As of September&#160;30, 2020, no milestones had been accrued as the underlying contingencies had not yet been met.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Adhaere Pharmaceuticals, Inc. Acquisition (GB1275) &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September&#160;21, 2018,&#160;the Company acquired Adhaere Pharmaceuticals, Inc. (&#x201c;Adhaere&#x201d;) pursuant to a merger agreement for an upfront payment of  $7.5 million in cash, and with the acquisition acquired the rights to GB1275 and certain backup compounds. The Company is obligated to make regulatory, development and sales milestone payments of up to $62.0 million and pay tiered royalties on worldwide net sales, at percentages ranging from low to mid-single digits, subject to customary reductions. In September 2018, the Company recorded IPR&amp;amp;D of $7.5 million in connection with the acquisition of Adhaere. In May 2019, the Company made a milestone payment of $1.0 million in connection with the filing of the Investigational New Drug application for the GB1275 program. As of September&#160;30, 2020, no other milestones had been accrued as the underlying contingencies had not yet been met.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded the following IPR&amp;amp;D expense on the condensed consolidated statements of operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GB001&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GB002&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GB004&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GB1275&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total in process research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <goss:ProductLicenseTerm
      contextRef="ia7131a2487c34cb4bd58334ee5055363_D20171002-20171002"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMTg3MQ_f6e8484c-b619-4f94-b413-87b24f4fe3ea">P10Y</goss:ProductLicenseTerm>
    <goss:BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable
      contextRef="i51900b7591e64e51863c94621c055cae_I20171002"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMjE2NQ_44f4151d-77b6-4eee-8a60-3a383cfc60ef"
      unitRef="usd">63000000.0</goss:BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable>
    <goss:BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable
      contextRef="i51900b7591e64e51863c94621c055cae_I20171002"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMjIwOA_5f1a5e72-0011-4718-a026-6aed34849b1b"
      unitRef="usd">45000000.0</goss:BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable>
    <goss:BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable
      contextRef="i51900b7591e64e51863c94621c055cae_I20171002"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMjI1MA_f051c2dd-9871-4506-87e4-e7a95d15e68f"
      unitRef="usd">190000000.0</goss:BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable>
    <goss:UpfrontPayment
      contextRef="idcc05f91f85e4e60b74e1e52f826c49d_D20171001-20171031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMjQ2MA_f59487e3-ad14-4a41-99f4-c2155ad88b38"
      unitRef="usd">5500000</goss:UpfrontPayment>
    <us-gaap:BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized
      contextRef="id960de866c1840368aa1b490b1df8a76_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMjQ5MA_d3df7c08-4b05-49b2-b79d-58cbb20dc152"
      unitRef="usd">0</us-gaap:BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i48df4955276f406984e65cbd02fc2753_D20180104-20180104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMjg2MA_b6e3a60d-a010-438a-8458-2e2efd0021e1"
      unitRef="shares">20000000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="ibc437c92dc4d47abbc82d156fe56b94a_D20180104-20180104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMjkxNw_c00b0065-9be8-49df-918b-8b45999e8c03"
      unitRef="shares">1101278</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="ia6763b93bb734419aa637f9886d0f8d4_D20180101-20180131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMzAwNw_f5e563e5-1682-4b92-ac9f-4cd25d3d360a"
      unitRef="usd">19300000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i149440b5575441f1ade1e500f96cffcd_D20180601-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMzI5ODUzNDg4ODg1Mw_47a2c6fc-ad55-4a15-b56d-1b54d40da065"
      unitRef="usd">20000000.0</us-gaap:ResearchAndDevelopmentInProcess>
    <goss:UpfrontPayment
      contextRef="i4c1fea39e1c24a86b52512965a113dc8_D20200511-20200511"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMzYyNw_f90acbc9-b7cc-4f21-ad3e-96a429031188"
      unitRef="usd">15000000.0</goss:UpfrontPayment>
    <goss:BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable
      contextRef="i34b002ec88bf4140996fb7ae42f20c25_I20200511"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMzgxNA_c1c9671d-cebe-4a0f-9e5e-26b3fb40b68e"
      unitRef="usd">40000000.0</goss:BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable>
    <goss:BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable
      contextRef="i34b002ec88bf4140996fb7ae42f20c25_I20200511"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfMzg1MA_849194fd-f69c-42a8-964c-ff2b133f4ba3"
      unitRef="usd">50000000.0</goss:BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable>
    <goss:ParticipationRight
      contextRef="i058b2b9596f049bf88bf24e8ef1b88f5_D20180624-20180624"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfNDE5MA_20d730ed-45fc-45f5-a8f6-69da23e18a3b"
      unitRef="number">0.2000</goss:ParticipationRight>
    <us-gaap:BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized
      contextRef="i3f2d41e0946a449d9739a4055373fcb5_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfNDM3NQ_39156bc7-9659-4398-811f-b93b9fb079b4"
      unitRef="usd">0</us-gaap:BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i8d3bd9ebc0c04c8aac7d80aadda3c812_D20180921-20180921"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfNDY1Ng_3d5663d8-2c08-4556-8961-b4086f823a8f"
      unitRef="usd">7500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <goss:BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable
      contextRef="i71ff0fe376bb4ce4a0d344274d60cda5_I20180921"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfNDg0OA_6419f430-bf4c-4cf0-89c7-06392624bafd"
      unitRef="usd">62000000.0</goss:BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i311895b288e84df99a0fe27ae04661aa_D20180901-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfNTAzNg_2822f729-e9ee-42fd-99fc-6bab8b82a2c9"
      unitRef="usd">7500000</us-gaap:ResearchAndDevelopmentInProcess>
    <goss:BusinessCombinationContingentConsiderationMilestonesPayment
      contextRef="i449c34cb7fd642fc8a19b754af262018_D20190501-20190531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfNTEzOQ_43a27f12-ad24-4cec-9ab1-fbeb49358a6e"
      unitRef="usd">1000000.0</goss:BusinessCombinationContingentConsiderationMilestonesPayment>
    <us-gaap:BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized
      contextRef="ib5f049d5e60d4e86a687f615be004af7_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfNTI1MA_3e4dae1e-0203-4670-b1b3-381f8cabc7d9"
      unitRef="usd">0</us-gaap:BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized>
    <goss:InProcessResearchAndDevelopmentExpensesTableTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RleHRyZWdpb246MzdiMmIxNzNjYWFlNDdhNTliZGEzYThlNWIyZWI3Y2ZfNTQ2Mg_b0498d5a-680c-4f31-99e5-366b76603936">&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded the following IPR&amp;amp;D expense on the condensed consolidated statements of operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GB001&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GB002&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GB004&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GB1275&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Programs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total in process research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</goss:InProcessResearchAndDevelopmentExpensesTableTextBlock>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="ib4e0c83f4759440487e347440556bf19_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMi0xLTEtMS0w_cb5517a3-0c5f-4856-8afa-bf1ab64d8b79"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="ifa29bc841f9e4fb0955d09333da173cf_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMi0zLTEtMS0w_e89a70d6-0f38-4785-8f14-c6f3661e3a63"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i0589fce7ead149e3b77ab56902cfd9da_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMi01LTEtMS0w_6436898f-fe27-4b96-93b1-8ade54e92a65"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="ifb792d6d5530491786d139e759d02ca9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMi03LTEtMS0w_031c6777-8d86-4b08-9206-00a0a1859d15"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i7d36daa696204d2a993a2a5386f71366_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMy0xLTEtMS0yNjQ1_589f69d6-0fb2-4a93-8081-78aa4c6bf934"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="ica43b072ffa14194a075ee24b8eefd04_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMy0zLTEtMS0yNjQ1_fa42e59b-7a7f-4132-8f82-9b80a23411e3"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="ic25495903f344f3badaca483a298b34c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMy01LTEtMS0yNjQ1_25d9788b-bf19-4c90-bda6-957059d806c0"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="id69f21cf412842c28bbd38e5675710e9_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMy03LTEtMS0yNjQ1_679bf469-47a3-49c6-856e-400007afba2c"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i785b0d7d87e64989afb260e63ffcaa75_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMy0xLTEtMS0w_4684ae8a-2f13-426d-9345-bffecc145bb3"
      unitRef="usd">275000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i5877020a64de4daf9c2e9fc19548520c_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMy0zLTEtMS0w_99794960-c6d0-42b4-9015-520fe39614ed"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i6dcb3875d02e46f6860a02a7ae51afa3_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMy01LTEtMS0w_5fb0d1a5-d5ac-488d-a6ff-4819f6659e61"
      unitRef="usd">15275000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="ifc960cc1b38e453d8577212588425de5_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfMy03LTEtMS0w_3c108ef9-6cd3-4877-9405-94521ce43344"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i2e82f42dcfad490d88675b7ce2d18579_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNC0xLTEtMS0w_5c3d530a-844a-4382-80d0-529c9eff8deb"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i5f1eb79d41a7477e8aac7ef9621f779b_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNC0zLTEtMS0w_5d4d1f20-8977-4d59-8781-c139c6d685c9"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="ifc076cf8ed8c4b60a0160f586d633a9d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNC01LTEtMS0w_d062c900-3280-41e0-b12e-720d9fdea218"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="id6dfed8a74714ce4b52a2b48f1f8bcfe_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNC03LTEtMS0w_d0ffc557-a364-48e6-8770-7a31b7e34621"
      unitRef="usd">1000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i29791a3aea134a31a642f180d6f252e1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNS0xLTEtMS0w_a4a8bb42-80be-46bc-ad47-f374550e902d"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i28e36142d5da400cbe56fb94780d66fe_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNS0zLTEtMS0w_f80bce88-3b49-4ac4-a797-47aed9156161"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i213f70a2c4f54d029f161eb250548f2f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNS01LTEtMS0w_ec5e2d8c-d29d-43a4-8020-46fa673faf76"
      unitRef="usd">2805000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i97eeb89fb4f541069f7d7bb71850f31f_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNS03LTEtMS0w_78b2752f-7dbc-462a-a25c-932604c72fe4"
      unitRef="usd">1000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNi0xLTEtMS0w_3cf662b1-7b4c-420b-a51d-f7c5e6da6500"
      unitRef="usd">275000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNi0zLTEtMS0w_68621662-4a6b-4b14-9297-491122d0eb2a"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNi01LTEtMS0w_86ba8b7a-9522-4aa5-9dfa-5bb32d986cfc"
      unitRef="usd">18080000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82MS9mcmFnOjM3YjJiMTczY2FhZTQ3YTU5YmRhM2E4ZTViMmViN2NmL3RhYmxlOjlmMGYwMWUyNzNjNTRjMDFiN2VmMjE2YzZkN2NlZTExL3RhYmxlcmFuZ2U6OWYwZjAxZTI3M2M1NGMwMWI3ZWYyMTZjNmQ3Y2VlMTFfNi03LTEtMS0w_c49d4d8a-2080-4692-9560-cbb401c46d52"
      unitRef="usd">2000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMTA5OTUxMTYzMTY3Ng_36dabb9b-0139-4073-a715-bd84716823a9">Stockholders&#x2019; Equity&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Company&#x2019;s IPO, the outstanding shares of the Company&#x2019;s Series Seed, Series A, and Series B Convertible Preferred Stock automatically converted into 30,493,460 shares of common stock. Each share of common stock is entitled to one vote. Common stock owners are entitled to dividends when funds are legally available and declared by the Board.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shelf Registration Statement and Stock Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 10, 2020, the Company filed a universal shelf registration statement on Form S-3, covering the offering from time to time of common stock, preferred stock, debt securities, warrants and units, which registration statement became automatically effective on April 10, 2020 (the &#x201c;Shelf Registration Statement&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 21, 2020, the Company completed a public offering of 9,433,963 shares of its common stock at a public offering price of $13.25 per share. The net proceeds from the offering, after deducting underwriting discounts and commissions and other offering costs, were approximately $117.1&#160;million. The shares sold in the offering were registered pursuant to the Company&#x2019;s Shelf Registration Statement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Founder Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December&#160;3, 2015, the Company issued 9,160,888 shares of common stock as founder shares for services rendered to the Company, valued at $0.0001 par value per share, for a total of approximately $4,100. On January&#160;4, 2018, incremental vesting conditions were placed on the previously issued founder shares. Fifty percent of the previously issued founder shares vested on January&#160;4, 2018, and the remaining founder shares are subject to vesting restrictions over a period of five years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the employment agreements with the Company&#x2019;s founders executed January 4, 2018, the Company provided for certain potential additional issuances of common stock (the &#x201c;anti-dilution shares&#x201d;) to each of the founders to ensure the total number of shares of common stock held by them and their affiliates (inclusive of any shares subject to equity awards granted by the Company) would represent 15% of the Company&#x2019;s fully-diluted capitalization until such time as the Company raised $300.0 million in equity capital, including the capital raised in the Series&#160;A financing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In furtherance of this obligation, on May 21, 2018, the Company issued 251,547 shares of common stock to the founders for services rendered to the Company, valued at $2.61 per share with an additional 251,547&#160;shares of restricted stock subject to the same vesting restrictions and vesting period as the founder shares. In addition, on September 6, 2018, the Company issued 1,795,023 shares of common stock to the founders for services rendered to the Company, valued at $9.63 per share, with an additional 1,795,023 shares of restricted stock subject to the same vesting restrictions and vesting period as the founder shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shares of Common Stock Subject to Repurchase&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2017, in connection with the issuance of the Series A Convertible Preferred Stock, certain employees entered into stock restriction agreements, whereby 1,305,427 shares are subject to forfeiture by the Company upon the stockholder&#x2019;s termination of employment or service to the Company. In January 2018, the Company&#x2019;s founders entered into stock restriction agreements, whereby 4,580,444 of previously unrestricted shares of common stock were subject to service vesting conditions. These shares are also subject to forfeiture by the Company upon the stockholders&#x2019; termination of employment or service to the Company. Any shares subject to repurchase by the Company are not deemed, for accounting purposes, to be outstanding until those shares vest. As such, the Company recognizes the measurement date fair value of the restricted stock over the vesting period as compensation expense. As of September&#160;30, 2020 and December&#160;31, 2019, 3,434,613 &lt;/span&gt;&lt;/div&gt;and 4,648,526 shares of common stock were subject to repurchase by the Company, respectively. The unvested stock liability related to these awards is immaterial to all periods presented.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i4c1117486726474d966d52141c13b867_D20190101-20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMjAw_3a21de1a-4d93-4eba-8c07-ae190165299f"
      unitRef="shares">30493460</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <goss:CommonStockVotingRightsNumberOfVotesPerShare
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMjY5_bdb741eb-ad17-47ac-99df-be2fd832fd10"
      unitRef="vote">1</goss:CommonStockVotingRightsNumberOfVotesPerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i32aaefa176c1431b83d26da9efa9e0e0_D20200521-20200521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfODEw_efb314ae-e8de-4f67-b0a5-b057c5c3ad13"
      unitRef="shares">9433963</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i4903290fc91c4b818ef0419687e6bdb2_I20200521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfODcw_bd7eb8db-d690-49f7-b2cc-2bde202a48a9"
      unitRef="usdPerShare">13.25</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i32aaefa176c1431b83d26da9efa9e0e0_D20200521-20200521"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMTA5OTUxMTYzMTcwOQ_fc8dd8aa-ffd5-4953-821f-d94667836e69"
      unitRef="usd">117100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="id9231a57c1ff4550b9a94b3c726cfbfc_D20151203-20151203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMTE4Mw_8f3a59e0-f259-4e09-98a9-e342bc74413e"
      unitRef="shares">9160888</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6f6a02fac0054f41ac0a21a7a698dd11_I20151203"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMTI3NQ_3c0d333c-c769-401b-80cd-8ed6271ee631"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="id9231a57c1ff4550b9a94b3c726cfbfc_D20151203-20151203"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMTMyOA_91bf378f-b8bc-46bc-a932-81098a52f3ce"
      unitRef="usd">4100</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <goss:CommonStockVestingPercentage
      contextRef="ia9c4125058a849188d84d6987a2aca5c_I20180104"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMTQzNg_e4cdbf7d-14f0-486e-a371-16767f83e3fe"
      unitRef="number">0.50</goss:CommonStockVestingPercentage>
    <goss:CommonStockVestingPeriod
      contextRef="i56b9c2498afd46cea09d67fffcd7f527_D20180104-20180104"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMTA5OTUxMTYzMTcyNA_a2d467fa-415a-4e7c-8a73-92a7a9aee145">P5Y</goss:CommonStockVestingPeriod>
    <goss:PercentageOfFullyDilutedShareCapital
      contextRef="id747bd928ed14565962ba04db245c625_I20180104"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMjAxMg_963b91ca-36ac-46ba-9bbe-a6267e465d63"
      unitRef="number">0.15</goss:PercentageOfFullyDilutedShareCapital>
    <goss:IncreasedInEquityCapitalAmount
      contextRef="id747bd928ed14565962ba04db245c625_I20180104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMjA5OQ_562622dc-0880-4145-9cf8-0604e4b49309"
      unitRef="usd">300000000.0</goss:IncreasedInEquityCapitalAmount>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ia05c65f0299b4470b9988c00f268c597_D20180521-20180521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMjI0OA_542d65a3-16f9-4d8f-b16e-db5800d88323"
      unitRef="shares">251547</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i44b0b9ab297245a587e455ae0fbdf7e1_I20180521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMjMzOA_2df4878b-bfe0-41b9-974f-c1c4f756170e"
      unitRef="usdPerShare">2.61</us-gaap:SharesIssuedPricePerShare>
    <goss:IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting
      contextRef="ia05c65f0299b4470b9988c00f268c597_D20180521-20180521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMjM3MA_e7fb29e2-e3ae-4e90-b073-974a74f6a6e8"
      unitRef="shares">251547</goss:IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i13993408590b4d4aae392dedae7f7168_D20180906-20180906"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMjUzNw_eb431826-8e85-4598-948f-fd807ccd87eb"
      unitRef="shares">1795023</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i4232852076fb41578223f9f35c5620ed_I20180906"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMjYyNw_1e6ec274-3b87-4e81-9be3-837b8b285fa0"
      unitRef="usdPerShare">9.63</us-gaap:SharesIssuedPricePerShare>
    <goss:IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting
      contextRef="i13993408590b4d4aae392dedae7f7168_D20180906-20180906"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMjY2MA_fe3704c3-4cbc-4540-9283-c017113356df"
      unitRef="shares">1795023</goss:IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="i6361b8d7044547f78137b4ca8e8367ae_D20171101-20171130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMjk4Mg_e78ecd7d-bd77-4fea-b0e7-2b2af847af39"
      unitRef="shares">1305427</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <goss:StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares
      contextRef="id21572d412b64344adae1b7652804401_D20180101-20180131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMzIwMA_65727863-61e0-4d7e-9bf1-7754a9dd5a8e"
      unitRef="shares">4580444</goss:StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMzcxOA_385d456f-e25f-4cb9-b8a1-6ead493b6533"
      unitRef="shares">3434613</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i565814101ba9433cabc2aba6a50774be_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl82Ny9mcmFnOmQxZjJmYzM4NWJmYzQ0OGE5YmM2MmNiYTM0YjVjMDkxL3RleHRyZWdpb246ZDFmMmZjMzg1YmZjNDQ4YTliYzYyY2JhMzRiNWMwOTFfMzcyNQ_c5d24c54-f29a-47f7-83c8-5fdef2e453ac"
      unitRef="shares">4648526</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMTA5OTUxMTYzMzc3Ng_1531d348-a3b8-42dd-877f-30f824a2ea16">Equity Incentive Plans&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2019 Equity Incentive Plan &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2019, the Company&#x2019;s board of directors and stockholders approved and adopted the 2019 Incentive Award Plan (the &#x201c;2019 Plan&#x201d;). The 2019 Plan became effective on February 6, 2019, the day prior to the effectiveness of the registration statement filed in connection with the IPO. Under the 2019 Plan, the Company may grant stock options, stock appreciation rights, restricted stock, restricted stock units, and other stock or cash-based awards to individuals who are then employees, officers, directors or consultants of the Company, and employees and consultants of the Company&#x2019;s subsidiaries. A total of 5,750,000 shares of common stock were approved to be initially reserved for issuance under the 2019 Plan. The number of shares that remained available for issuance under the 2017 Plan (as defined below) as of the effective date of the 2019 Plan were, and shares subject to outstanding awards under the 2017 Plan as of the effective date of the 2019 Plan that are subsequently canceled, forfeited or repurchased by the Company will be, added to the shares reserved under the 2019 Plan. In addition, the number of shares of common stock available for issuance under the 2019 Plan will be automatically increased on the first day of each calendar year during the ten-year term of the 2019 Plan, beginning with January 1, 2020 and ending with January 1, 2029, by an amount equal to 5% of the outstanding number of shares of the Company&#x2019;s common stock on December 31 of the preceding calendar year or such lesser amount as determined by the Company&#x2019;s board of directors. As of September&#160;30, 2020, an aggregate of 1,696,802 shares of common stock were available for issuance under the 2019 Plan and 7,291,966 shares of common stock were subject to outstanding awards under the 2019 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2019 Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2019, the Company&#x2019;s board of directors and stockholders approved and adopted the 2019 Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;). The ESPP became effective as of February 6, 2019, the day prior to the effectiveness of the registration statement filed in connection with the IPO. The ESPP permits participants to purchase common stock through payroll deductions of up to 20% of their eligible compensation. A total of 700,000 shares of common stock were approved to be initially reserved for issuance under the ESPP. In addition, the number of shares of common stock available for issuance under the ESPP will be automatically increased on the first day of each calendar year during the first ten-years of the term of the ESPP, beginning with January 1, 2020 and ending with January 1, 2029, by an amount equal to 1% of the outstanding number of shares of the Company&#x2019;s common stock on December 31 of the preceding calendar year or such lesser amount as determined by the Company&#x2019;s board of directors. During the nine months ended September 30, 2020, 113,286 shares were issued pursuant to the ESPP. As of September&#160;30, 2020, an aggregate of 1,249,554 shares of common stock were available for issuance under the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2017 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s 2017 Equity Incentive Plan (the &#x201c;2017 Plan&#x201d;) permitted the granting of incentive stock options, non-statutory stock options, restricted stock, restricted stock units and other stock-based awards. Subsequent to the adoption of the 2019 Plan, no additional equity awards can be made under the 2017 Plan. As of September&#160;30, 2020, 4,071,312 shares of common stock were subject to outstanding options under the 2017 Plan, and 342,006 shares of restricted stock awards granted under the 2017 plan were unvested.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each employee and non-employee stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. The Company, prior to the closing of its IPO on February 12, 2019, was a private company and lacked company-specific historical and implied volatility information. Therefore, it estimated its expected volatility based on the historical volatility of a publicly traded set of peer companies. Due to the lack of historical exercise history, the expected term of the Company&#x2019;s stock options for employees has been determined utilizing the &#x201c;simplified&#x201d; method for awards. The expected term of stock options granted to non-employees is equal to the contractual term of the option award. The risk-free interest rate is determined by reference to the U.S.&#160;Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is zero based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock option activity during the nine months ended September 30, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.851%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&#160;Subject&#160;to&lt;br/&gt;Options&#160;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,538,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,540,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Option exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,275)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options forfeited/cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(735,012)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,266,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and exercisable as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,274,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate intrinsic value in the above table is calculated as the difference between fair value of the Company&#x2019;s common stock price on September&#160;30, 2020 and the exercise price of the stock options. The aggregate intrinsic value of stock options exercised during the nine months ended September 30, 2020 was $0.7 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average grant date fair value per share for the stock option grants during the nine months ended September 30, 2020 was $10.61.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate fair value of stock options that vested during the nine months ended September 30, 2020 was $23.1 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The summary of the Company&#x2019;s restricted stock activity is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Restricted&lt;br/&gt;Stock Units&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,648,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,176,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,213,911)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,530,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2020, the total unrecognized compensation related to unvested restricted stock awards granted was $20.7 million, which the Company expects to recognize over a weighted-average period of approximately 2.2 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense has been reported in the Company&#x2019;s condensed consolidated statements of operations as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2020, the total unrecognized compensation related to unvested stock option awards granted was $61.3 million, which the Company expects to recognize over a weighted-average period of approximately 2.5 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2020, total unrecognized compensation expense related to the ESPP was $1.9 million, which the Company expects to recognize over a weighted-average period of approximately one year.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="icada44f7b33b4bb69194179efb087bf7_I20190206"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNjcz_2d59ff04-d58e-4ea9-b732-92f70c7fd178"
      unitRef="shares">5750000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i1c8bcc0cc5824acab60dce389cc0e01a_D20190206-20190206"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMTA5OTUxMTYzMzgwMA_77ff1c09-1b0c-4641-89b2-236eb1332ab2">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="i1c8bcc0cc5824acab60dce389cc0e01a_D20190206-20190206"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMTQ0NA_6d53ae0a-0510-4a4b-a5ad-215a11be167d"
      unitRef="number">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="id21248c7f8d1404dbfbcc4790900c1a8_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMTY1OA_4d182763-cb84-48aa-9822-9a568c674753"
      unitRef="shares">1696802</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="id21248c7f8d1404dbfbcc4790900c1a8_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMTczNg_b9367529-ba7f-4ace-ab52-1dcdfe920a2f"
      unitRef="shares">7291966</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="id682609138d74f299a22b9b828664934_D20190206-20190206"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMjIzMg_74487d0c-a427-4671-9cc9-caa193e98a25"
      unitRef="number">0.20</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i55d566fa333348f38fe0698d8122d240_I20190206"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMjI3OA_dc397cad-7274-4479-af78-542d77caf735"
      unitRef="shares">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="id82f48c87413404898cd5e95a6f92456_D20190206-20190206"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMTA5OTUxMTYzMzc5OQ_4878abe2-f167-477d-adf0-0d96da185bf0">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="id82f48c87413404898cd5e95a6f92456_D20190206-20190206"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMjY2OQ_82b5b28f-0023-417b-af08-d0e654ddd872"
      unitRef="number">0.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <goss:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued
      contextRef="icf9016d9d3c54fdcbd742124c1e00da3_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMjg3NQ_029bd432-9348-4be2-8bb3-55ec6abdefdb"
      unitRef="shares">113286</goss:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="icf9016d9d3c54fdcbd742124c1e00da3_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMjk0NQ_0902f637-b915-43b6-b840-a195c66faf5a"
      unitRef="shares">1249554</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ib62a29f3d4bd41768f85b8c430ff8ed2_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMzM2OA_0ea53d60-61b1-4a95-80d5-456e8118d446"
      unitRef="shares">4071312</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="i1bca54ddec634c619bb186716592456f_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMzQ1NQ_2e7340c4-cc93-44f0-9e89-5ad57957ea35"
      unitRef="shares">342006</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="id60e67dc25ec478c8538a048150413cc_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNDUxMA_1bde5c27-6c5a-4098-86e4-8c5b528d92a7"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNTk5Nw_be6d6913-8fe0-483f-86bd-572eda5907e3">&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock option activity during the nine months ended September 30, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.851%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.613%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&#160;Subject&#160;to&lt;br/&gt;Options&#160;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,538,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,540,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Option exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,275)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options forfeited/cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(735,012)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,266,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and exercisable as of September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,274,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfMy0xLTEtMS0w_d388561f-30a4-48ef-aafe-d335b588d160"
      unitRef="shares">8538060</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfMy0zLTEtMS0w_48152440-8cab-4ad1-a501-f435713b7b45"
      unitRef="usdPerShare">13.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i565814101ba9433cabc2aba6a50774be_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfMy01LTEtMS0w_d81acb74-5c03-403c-88f6-c6359e7d5a05">P9Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i9e476b4d712f41b58c1f9eec52fea678_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfMy03LTEtMS0w_2f564b3d-a1bb-4ef6-af10-afb63000206a"
      unitRef="usd">35385000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfNC0xLTEtMS0w_b7deb812-4bd0-4fe5-bb37-bfad4bbaff9c"
      unitRef="shares">2540122</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfNC0zLTEtMS0w_85eb92b2-e7e3-4f06-8b11-5982437bec1e"
      unitRef="usdPerShare">14.02</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfNS0xLTEtMS0w_1d9ac4ef-4849-4af5-ba91-9230024286c8"
      unitRef="shares">76275</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfNS0zLTEtMS0w_74d40704-26c2-4549-ba89-759443e22c6d"
      unitRef="usdPerShare">3.73</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfNi0xLTEtMS0w_d9ad65dc-907c-4357-8411-2b4a72b0b035"
      unitRef="shares">735012</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfNi0zLTEtMS0w_07851c37-03dc-4d46-af42-9b0d6a4ed327"
      unitRef="usdPerShare">13.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfNy0xLTEtMS0w_4909ba36-a623-4ad2-a598-ae586635391c"
      unitRef="shares">10266895</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfNy0zLTEtMS0w_f4eaecc1-5d6c-4ab3-bb77-d11800378a9c"
      unitRef="usdPerShare">13.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfNy01LTEtMS0w_fdf12eed-5615-486a-b30a-5c4faa5ed253">P8Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfNy03LTEtMS0w_63be10fc-cf6e-4831-96bc-c5b1e02f07cc"
      unitRef="usd">19221000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfOC0xLTEtMS0w_9298c95f-05a4-4ad3-9561-5ae01b6f9f9b"
      unitRef="shares">3274782</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfOC0zLTEtMS0w_0f097bfd-a5d5-499f-929d-94e031161bf8"
      unitRef="usdPerShare">12.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfOC01LTEtMS0w_6e83b60e-2773-4a80-ba2a-d4bf09f517df">P7Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjc1YWU5ODI3NGYzZTQ1NTY4YzVlYjUxNTcyZjliOTAxL3RhYmxlcmFuZ2U6NzVhZTk4Mjc0ZjNlNDU1NjhjNWViNTE1NzJmOWI5MDFfOC03LTEtMS0w_ddc21c04-d851-4101-8252-bf5adc5bc0ac"
      unitRef="usd">10026000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="id60e67dc25ec478c8538a048150413cc_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfMzI5ODUzNDg4OTM1OA_92125d23-919f-483d-a475-554e0c065ac6"
      unitRef="usd">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="id60e67dc25ec478c8538a048150413cc_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNTA5NQ_302855f8-aefb-4bf8-9eab-b8a016fdeeaa"
      unitRef="usdPerShare">10.61</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="id60e67dc25ec478c8538a048150413cc_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNTE3NA_13f24403-3c30-4c42-8250-5e703d1b0f17"
      unitRef="usd">23100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNTk5OA_0324a7ea-536b-43c0-943e-62dec58a5471">&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The summary of the Company&#x2019;s restricted stock activity is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Restricted&lt;br/&gt;Stock Units&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,648,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,176,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,213,911)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,530,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i57a7a1c92af444738a26579e9c9b97f4_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjY2YzcxZDQ4ODM0NzQxZjBiODY5OGU4OTdmZTllNjZkL3RhYmxlcmFuZ2U6NjZjNzFkNDg4MzQ3NDFmMGI4Njk4ZTg5N2ZlOWU2NmRfMS0xLTEtMS0w_ed536bf5-8fc3-4a16-98f0-2f40aaf79914"
      unitRef="shares">4648526</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i57a7a1c92af444738a26579e9c9b97f4_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjY2YzcxZDQ4ODM0NzQxZjBiODY5OGU4OTdmZTllNjZkL3RhYmxlcmFuZ2U6NjZjNzFkNDg4MzQ3NDFmMGI4Njk4ZTg5N2ZlOWU2NmRfMS0zLTEtMS0w_0986cc33-0991-476d-a3bf-b53346faf068"
      unitRef="usdPerShare">3.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="id7cf20b97501468ba190ca44f798aa5c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjY2YzcxZDQ4ODM0NzQxZjBiODY5OGU4OTdmZTllNjZkL3RhYmxlcmFuZ2U6NjZjNzFkNDg4MzQ3NDFmMGI4Njk4ZTg5N2ZlOWU2NmRfMi0xLTEtMS0w_efd7502a-5afa-4fe6-afdc-1dc8cf8747c6"
      unitRef="shares">1176340</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="id7cf20b97501468ba190ca44f798aa5c_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjY2YzcxZDQ4ODM0NzQxZjBiODY5OGU4OTdmZTllNjZkL3RhYmxlcmFuZ2U6NjZjNzFkNDg4MzQ3NDFmMGI4Njk4ZTg5N2ZlOWU2NmRfMi0zLTEtMS0w_a9d6355f-c6b7-4ec7-b551-6dcdb6bde1a5"
      unitRef="usdPerShare">11.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="id7cf20b97501468ba190ca44f798aa5c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjY2YzcxZDQ4ODM0NzQxZjBiODY5OGU4OTdmZTllNjZkL3RhYmxlcmFuZ2U6NjZjNzFkNDg4MzQ3NDFmMGI4Njk4ZTg5N2ZlOWU2NmRfMy0xLTEtMS0w_ed93cd9d-fb9e-425c-b8a4-0c8ee556881d"
      unitRef="shares">1213911</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="id7cf20b97501468ba190ca44f798aa5c_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjY2YzcxZDQ4ODM0NzQxZjBiODY5OGU4OTdmZTllNjZkL3RhYmxlcmFuZ2U6NjZjNzFkNDg4MzQ3NDFmMGI4Njk4ZTg5N2ZlOWU2NmRfMy0zLTEtMS0w_6a7f710c-dda6-4e45-99ac-ddeaddef21af"
      unitRef="usdPerShare">3.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="id7cf20b97501468ba190ca44f798aa5c_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjY2YzcxZDQ4ODM0NzQxZjBiODY5OGU4OTdmZTllNjZkL3RhYmxlcmFuZ2U6NjZjNzFkNDg4MzQ3NDFmMGI4Njk4ZTg5N2ZlOWU2NmRfNC0xLTEtMS0w_750c9693-06e5-4670-b1c5-8c2d4446c3ed"
      unitRef="shares">79957</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="id7cf20b97501468ba190ca44f798aa5c_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjY2YzcxZDQ4ODM0NzQxZjBiODY5OGU4OTdmZTllNjZkL3RhYmxlcmFuZ2U6NjZjNzFkNDg4MzQ3NDFmMGI4Njk4ZTg5N2ZlOWU2NmRfNC0zLTEtMS0w_278d6790-a273-40e6-b6d1-23cc8fe6b949"
      unitRef="usdPerShare">12.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i8dde91022b6f4727b6a3442ab07af3f3_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjY2YzcxZDQ4ODM0NzQxZjBiODY5OGU4OTdmZTllNjZkL3RhYmxlcmFuZ2U6NjZjNzFkNDg4MzQ3NDFmMGI4Njk4ZTg5N2ZlOWU2NmRfNS0xLTEtMS0w_ce3d0c69-d002-4cf7-a952-c35692f8d037"
      unitRef="shares">4530998</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjY2YzcxZDQ4ODM0NzQxZjBiODY5OGU4OTdmZTllNjZkL3RhYmxlcmFuZ2U6NjZjNzFkNDg4MzQ3NDFmMGI4Njk4ZTg5N2ZlOWU2NmRfNS0zLTEtMS0w_b578e5e9-e56c-492b-af10-d9a581fc40af"
      unitRef="usdPerShare">5.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i8dde91022b6f4727b6a3442ab07af3f3_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNTM2Ng_68cd7555-9a60-4c23-95b3-fb48f7dadf09"
      unitRef="usd">20700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="id7cf20b97501468ba190ca44f798aa5c_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNTQ1Nw_74f2aa9b-b36e-4ee9-b541-61857ad513cb">P2Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNTk5OQ_c77bff78-176d-44e2-8e3c-adfca601b9ed">&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense has been reported in the Company&#x2019;s condensed consolidated statements of operations as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.046%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5ee46adffb174aab896b0ef706379d9e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfMi0xLTEtMS0w_7d8c3620-d3c5-43b1-93c4-0394c979c508"
      unitRef="usd">4726000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i383e88d1480f4707a5e280fb091f49f1_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfMi0zLTEtMS0w_f6eb5455-6613-41bf-bc25-023809d50329"
      unitRef="usd">2727000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0e99060b0b3445c2ab001b2db044619c_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfMi01LTEtMS0w_411b3a7d-53c4-4ac5-8a6b-68e9ae858cd1"
      unitRef="usd">14094000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibbd4563ff308475bb9677d83bd6901ed_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfMi03LTEtMS0w_97fb14d7-bf8f-4c97-8c60-5586c8ce7e04"
      unitRef="usd">6483000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5234f8600a24470b93bc826f0087d51f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfMy0xLTEtMS0w_8592dd67-3043-4ce3-95a1-acd66478b0d3"
      unitRef="usd">4197000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i83e749032dd647eeb7e5730f0d79e71f_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfMy0zLTEtMS0w_745baa2a-5094-49c5-b334-78ac3886b542"
      unitRef="usd">3001000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9addd071f2134af4b1c59d6d7647b955_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfMy01LTEtMS0w_4857c089-8846-45f2-9eb1-16cd5ac1db3c"
      unitRef="usd">11973000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic44d278160054bb5935c16c50beece12_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfMy03LTEtMS0w_0876e4b9-3c26-4d8e-88f6-b1c4916f91ae"
      unitRef="usd">7474000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfNC0xLTEtMS0w_12c36381-a25b-4f64-9dc6-d70a1643e035"
      unitRef="usd">8923000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icea7115411d64a9fa1d75b7e90bb5dec_D20190701-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfNC0zLTEtMS0w_e7b0f267-531f-4536-9877-9b77326b62a9"
      unitRef="usd">5728000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfNC01LTEtMS0w_0a84ae1b-f2f6-47b0-b281-bbc1ea9daf89"
      unitRef="usd">26067000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icd0c15e7ce4f422b82e6633b76fa06eb_D20190101-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RhYmxlOjBmZDA4NGJkYzcyNzRiOWNhNDkxMzAyNTUwYTcwZmY4L3RhYmxlcmFuZ2U6MGZkMDg0YmRjNzI3NGI5Y2E0OTEzMDI1NTBhNzBmZjhfNC03LTEtMS0w_2f6e48c9-fc98-4cc5-9fa0-56eeaff54bdb"
      unitRef="usd">13957000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="ief5753da810c4701b357b0ba9f8e7bc1_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNTczNA_6c02b597-1593-44cc-8e93-7b4834488145"
      unitRef="usd">61300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ib4c2928920df49ebaed3b6aed298b48b_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNTgyNQ_b8df9036-d516-4fac-9751-5288f08d02e5">P2Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="ib654ba389ce740a5b5698b7efa4bf39b_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNTkwMw_7cf841d9-28ae-491f-ae5b-4caa62bed4f7"
      unitRef="usd">1900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ib0f9d120e4f34b0e85ac915426783ced_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83My9mcmFnOjkwNTIzODllNGE5ZjQwOTRiNzk4MTk1NjY4MDBjZjZkL3RleHRyZWdpb246OTA1MjM4OWU0YTlmNDA5NGI3OTgxOTU2NjgwMGNmNmRfNTk5NA_e21fd0df-90e8-4a32-be26-5a92a03b77d6">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMTA5OTUxMTYzMjg2Mw_f89ea91c-d832-4908-bdd0-67c23d527ab8">Commitments and Contingencies&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company subleases certain office and laboratory space under a non-cancelable operating lease expiring in January 2025 for the initial leased space and December 2022 for expansion space leased pursuant to an amendment to the lease agreement entered into in August 2018. The sublease agreement included options to extend for the entire premises through October 2028. The options to extend must be exercised prior to the termination of the original lease agreement. The period covered by the options was not included in the non-cancellable lease term as it not was not determined to be reasonably certain to be executed. The lease agreement also includes a one-time termination option for the expansion space only whereby the Company can terminate the lease with advance written notice. The termination option was not determined to be reasonably certain to be executed. The lease is subject to charges for common area maintenance and other costs, and base rent is subject to an annual 3% increase each subsequent year. Costs determined to be variable and not based on an index or rate were not included in the measurement of the operating lease liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2019, the Company entered into an additional non-cancelable lease agreement for certain office and laboratory space (the &#x201c;permanent space&#x201d;) in San Diego, California, commencing on May 1, 2020 and expiring on December 31, 2021. The lease agreement includes a lease for temporary space commencing on January 1, 2020 and expiring on the commencement date of the lease of the permanent space. The monthly base rent for the permanent and temporary space is $63,425 and $28,745, respectively. The lease agreement included an option to extend the term of the permanent space for twelve months. The option to extend must be exercised nine months prior to the termination of the original lease agreement. The period covered by the option was not included in the non-cancellable lease term as it not was not determined to be reasonably certain to be executed. The lease is subject to charges for common area maintenance and other costs, and base rent is subject to an annual 3% increase each subsequent year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2020, the Company entered into a sublease agreement for the permanent space with a third party. The sublease commenced on July&#160;1, 2020 and expires on December&#160;31, 2021. The sublessee pays the monthly base rent of $63,425, subject to an annual 3% increase, and is obligated to pay for common area maintenance and other costs.&#160;&#160;The sublessee received a 6 months base rent abatement. The Company determined that there was no impairment on the original right-of-use asset and will continue to account for the permanent space as it did before the commencement of the sublease.&#160;&#160;The Company recognized $0.1 million in sublease income for the three and nine months ended September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 29, 2020, the Company entered into a lease assignment agreement, whereby it became the assignee to a lease for certain office and laboratory space in Ann Arbor, Michigan. The lease term expires on December 31, 2026 and the Company has the option to extend the term of the lease by up to five years. The period covered by the option was not included in the non-cancellable lease term as it was not determined to be reasonably certain to be executed. The monthly base rent for the space is $28,495. The lease is subject to charges for common area maintenance and other costs, and base rent is subject to an annual 2.5% increase on January 1 of each year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Monthly rent expense is recognized on a straight-line basis over the term of the leases. The operating leases are included in the balance sheet at the present value of the lease payments at a weighted-average discount rate of 7% using the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment as the leases do not provide an implicit rate. The weighted average remaining lease term was 3.7 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease costs were comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nine months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in the measurement of operating lease liabilities for the three and nine months ended September 30, 2020 was $1.0 million and $2.6 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gross future minimum annual rental commitments as of September&#160;30, 2020, were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Undiscounted&#160;Rent&lt;br/&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ending December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2020 (remaining 3 months)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total undiscounted rent payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Present value discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,670)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Present value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current portion of operating lease liability (included as a component of accrued expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncurrent operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and nine months ended September 30, 2020 the Company recorded approximately $1.0 million and $2.9 million, respectively, in rent expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Kuhne vs. Gossamer Bio, Inc., et. al.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 3, 2020, Scott Kuhne, individually and on behalf of all others similarly situated, filed a putative class action lawsuit against the Company, certain of its executive officers and directors, and the underwriters of its IPO in the United States District Court for the Southern District of California (Case No. 3:20-cv-00649-DMS-MDD). The first amended complaint was filed on August 31, 2020. The complaint was filed on behalf of all persons who purchased or otherwise acquired the Company&#x2019;s securities between February 8, 2019 and December 13, 2019. The first amended complaint alleges that the Company, certain of its executive officers and directors, and the underwriters of its IPO made false and/or misleading statements and failed to disclose material adverse facts about its business, operations and prospects in violation of Sections 11, 12(a)(2) and 15 of the Securities Act of 1933, as amended, and Sections 10(b) (and Rule 10b-5 promulgated thereunder) and 20(a) of the Securities Exchange Act of 1934, as amended. The plaintiff seeks damages, interest, costs, attorneys&#x2019; fees, and other unspecified equitable relief. Following meet and confer discussions amongst the parties to the litigation, Plaintiff was granted leave to further amend his complaint by no later than November 20, 2020. Thereafter, the Company&#x2019;s deadline to move to dismiss or otherwise answer that complaint is January 19, 2021. The Company intends to vigorously defend this matter. Given the uncertainty of litigation, the preliminary stage of the case, and the legal standards that must be met for, among other things, class certification and success on the merits, the Company cannot estimate the reasonably possible loss or range of loss that may result from this action.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <goss:OperatingSubleaseAnnualIncreasePercentageForBaseRent
      contextRef="i2d1e2f5620c948549f4affe56ba4eba6_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTEwMQ_2941c5c8-c513-46ad-91f6-5223c459050f"
      unitRef="number">0.03</goss:OperatingSubleaseAnnualIncreasePercentageForBaseRent>
    <goss:PermanentMonthlyBaseRent
      contextRef="i6f160954a3ed444fa5812d76c8308a06_D20191101-20191130"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMTYwOA_d08ccb9c-a240-4069-9189-9e0c3d17ccd5"
      unitRef="usd">63425</goss:PermanentMonthlyBaseRent>
    <goss:TemporaryMonthlyBaseRent
      contextRef="i6f160954a3ed444fa5812d76c8308a06_D20191101-20191130"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMTYxNQ_ebfde6e7-db59-4e4f-acf6-a5dfa7bb1000"
      unitRef="usd">28745</goss:TemporaryMonthlyBaseRent>
    <goss:PeriodForWhichLeaseOfPermanentSpaceCanBeExtended
      contextRef="i6f160954a3ed444fa5812d76c8308a06_D20191101-20191130"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMTcxOA_56a7d218-7a81-4d93-b8f0-25478dc12541">P12M</goss:PeriodForWhichLeaseOfPermanentSpaceCanBeExtended>
    <goss:AnnualIncreasePercentageForLeaseCharges
      contextRef="i6f160954a3ed444fa5812d76c8308a06_D20191101-20191130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMjEwMA_0858d8d3-2752-4192-8f7b-466657a12f97"
      unitRef="number">0.03</goss:AnnualIncreasePercentageForLeaseCharges>
    <goss:SubleaseTemporaryMonthlyBaseRent
      contextRef="ia55f355b0bbc4b78be1ab19f707c05ec_D20200601-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTEwNg_916c0650-bbe2-44ef-a7b7-be17a7caa2ad"
      unitRef="usd">63425</goss:SubleaseTemporaryMonthlyBaseRent>
    <goss:SubleaseAnnualIncreasePercentageForLeaseCharges
      contextRef="ia55f355b0bbc4b78be1ab19f707c05ec_D20200601-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTExMQ_2d9ec6c1-215d-466b-b381-77912ebb3b98"
      unitRef="number">0.03</goss:SubleaseAnnualIncreasePercentageForLeaseCharges>
    <goss:SubleasePeriodOfBaseRentAbatement
      contextRef="ia55f355b0bbc4b78be1ab19f707c05ec_D20200601-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTEyNA_932fc0a0-3ae1-487a-856f-37ce032a9f86">P6M</goss:SubleasePeriodOfBaseRentAbatement>
    <us-gaap:SubleaseIncome
      contextRef="i29f32f74db5543c8a8510694e76a3c8d_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTIwNQ_227fa485-ed27-4861-b6dc-cb49cae9b8aa"
      unitRef="usd">100000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="i9ac3518affc6454b9e891197f6e12355_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTIwNQ_85a89dcd-afb3-4e9f-b725-4ea9a01b65dd"
      unitRef="usd">100000</us-gaap:SubleaseIncome>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i5ea38ec7e8c7483eb917072f4fe3f12d_I20200729"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMTA5OTUxMTYzMzYxNg_edd93e2b-8c4e-4989-bb3a-334acb231911">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <goss:OperatingLeasesMonthlyBaseRentExpense
      contextRef="i0c084b288ebf4e26a9b2953bd0afde9a_D20200729-20200729"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMTA5OTUxMTYzMzYzMA_7405823c-6a94-4b25-9af4-9388aa091717"
      unitRef="usd">28495</goss:OperatingLeasesMonthlyBaseRentExpense>
    <goss:AnnualIncreasePercentageForLeaseCharges
      contextRef="i0c084b288ebf4e26a9b2953bd0afde9a_D20200729-20200729"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMTA5OTUxMTYzMzYzOQ_edbf676f-d873-4738-a8bc-5ce7aa385d84"
      unitRef="number">0.025</goss:AnnualIncreasePercentageForLeaseCharges>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTEzNA_76669df4-4273-458e-8629-5563ee9f4e68"
      unitRef="number">0.07</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTEyOA_0a78bf37-1350-4ffa-889b-88498b2dcb02">P3Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfNTA4Ng_62caef4f-5d80-4095-86e5-1fb6072cadb3">&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease costs were comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nine months ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOmQyNDUyZjljNGU0NDQxMTFhNGI5MmU5MTJlYjk4ZjY4L3RhYmxlcmFuZ2U6ZDI0NTJmOWM0ZTQ0NDExMWE0YjkyZTkxMmViOThmNjhfMS0xLTEtMS0w_be0ec9fd-da22-467b-9d83-8352f6a869d2"
      unitRef="usd">1007000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOmQyNDUyZjljNGU0NDQxMTFhNGI5MmU5MTJlYjk4ZjY4L3RhYmxlcmFuZ2U6ZDI0NTJmOWM0ZTQ0NDExMWE0YjkyZTkxMmViOThmNjhfMS0zLTEtMS0w_958c3687-7ac3-43ff-bbec-6922d71ad721"
      unitRef="usd">2577000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOmQyNDUyZjljNGU0NDQxMTFhNGI5MmU5MTJlYjk4ZjY4L3RhYmxlcmFuZ2U6ZDI0NTJmOWM0ZTQ0NDExMWE0YjkyZTkxMmViOThmNjhfMi0xLTEtMS0w_4bffe212-51cc-4c2d-a2fc-12676f1e0ed9"
      unitRef="usd">16000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOmQyNDUyZjljNGU0NDQxMTFhNGI5MmU5MTJlYjk4ZjY4L3RhYmxlcmFuZ2U6ZDI0NTJmOWM0ZTQ0NDExMWE0YjkyZTkxMmViOThmNjhfMi0zLTEtMS0w_7d542b06-c19e-4796-898d-6aa9100aaabc"
      unitRef="usd">54000</us-gaap:ShortTermLeaseCost>
    <us-gaap:LeaseCost
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOmQyNDUyZjljNGU0NDQxMTFhNGI5MmU5MTJlYjk4ZjY4L3RhYmxlcmFuZ2U6ZDI0NTJmOWM0ZTQ0NDExMWE0YjkyZTkxMmViOThmNjhfMy0xLTEtMS0w_4f052fec-d071-4941-9bae-0c7298e3051d"
      unitRef="usd">1023000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOmQyNDUyZjljNGU0NDQxMTFhNGI5MmU5MTJlYjk4ZjY4L3RhYmxlcmFuZ2U6ZDI0NTJmOWM0ZTQ0NDExMWE0YjkyZTkxMmViOThmNjhfMy0zLTEtMS0w_2c304b78-6d6e-4652-aa93-dc113b878b50"
      unitRef="usd">2631000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTE0MA_eadc7525-ec18-4435-841f-bd9b62558c30"
      unitRef="usd">1000000.0</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTE0OQ_41543de5-8d84-48a2-8b30-53dc61f4dcfa"
      unitRef="usd">2600000</us-gaap:OperatingLeasePayments>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfNTA4NA_600fcb3d-51fc-480d-92da-4e5bbcf008db">&lt;div style="margin-top:10pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gross future minimum annual rental commitments as of September&#160;30, 2020, were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Undiscounted&#160;Rent&lt;br/&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Year ending December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2020 (remaining 3 months)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total undiscounted rent payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Present value discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,670)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Present value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current portion of operating lease liability (included as a component of accrued expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncurrent operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfMi0xLTEtMS0w_13a0df5c-9153-4859-b453-fdaca6a7534d"
      unitRef="usd">1043000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfMy0xLTEtMS0w_71b8c849-4322-44b6-9c8d-518ec2886a28"
      unitRef="usd">4273000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfNC0xLTEtMS0w_eb81bc94-cd6f-4398-90c3-3cf488f32428"
      unitRef="usd">3579000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfNS0xLTEtMS0w_e40d3614-9110-4265-af72-cceec7b64f99"
      unitRef="usd">2063000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfNi0xLTEtMS0w_05e7231b-8145-4de3-87c4-208a0f99f298"
      unitRef="usd">2123000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <goss:LesseeOperatingLeaseLiabilityPaymentsDueYearSix
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfNy0xLTEtMS0xNTIz_a60a0a26-b413-439c-9619-1af23a9c4ab0"
      unitRef="usd">387000</goss:LesseeOperatingLeaseLiabilityPaymentsDueYearSix>
    <goss:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfOC0xLTEtMS0xNzk0_8e4f83b5-1c8b-4512-86a9-d259a402fe63"
      unitRef="usd">397000</goss:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfNy0xLTEtMS0w_df30785d-97ae-47e9-a179-c53ff5179e1d"
      unitRef="usd">13865000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfOS0xLTEtMS0w_bef47903-d5f8-403f-bd52-1d9efcb92f31"
      unitRef="usd">1670000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfMTAtMS0xLTEtMA_90414e91-2f8e-4c1b-89e8-15a247f48c05"
      unitRef="usd">12195000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfMTEtMS0xLTEtMA_69445079-67f9-476f-b72d-28cd5ba462ae"
      unitRef="usd">3548000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfMTItMS0xLTEtMA_3f7ac23f-d279-4baf-a6ba-253e11e4beb5"
      unitRef="usd">8647000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i720b6695621443f1bfacd04fd902b4fd_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RhYmxlOjI4MDcwYTdlMmJmNDQ3MmE4ZGU0NWVhMzhhOWI4MGQyL3RhYmxlcmFuZ2U6MjgwNzBhN2UyYmY0NDcyYThkZTQ1ZWEzOGE5YjgwZDJfMTMtMS0xLTEtMA_ca0b20a9-ef27-4bf5-81bc-4a5e3e450e91"
      unitRef="usd">12195000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseExpense
      contextRef="i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTE1Mw_d69fa2a8-2d85-44f9-ad7f-5c3d239feffc"
      unitRef="usd">1000000.0</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i2860c58f164f428aa182ebed67f71810_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQwNTE0YmJjM2I0YzRjYTZhMzc2NmQ0NWNhZjhmYTc2L3NlYzo0MDUxNGJiYzNiNGM0Y2E2YTM3NjZkNDVjYWY4ZmE3Nl83OS9mcmFnOjY5MTU3MWUxOGRhNjQ2MDZhYmE5NmE5OGU4NjhmMmFhL3RleHRyZWdpb246NjkxNTcxZTE4ZGE2NDYwNmFiYTk2YTk4ZTg2OGYyYWFfMzI5ODUzNDg4OTE2MQ_bcb5686a-adf3-46a1-9477-f72754f08bc7"
      unitRef="usd">2900000</us-gaap:OperatingLeaseExpense>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503258358104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Nov. 05, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GOSSAMER BIO, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-5461709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3013 Science Park Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">684-1300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GOSS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,927,877<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001728117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 13<br> -Subsection a-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503183956728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 461,956<span></span>
</td>
<td class="nump">$ 135,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">93,422<span></span>
</td>
<td class="nump">266,740<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">10,828<span></span>
</td>
<td class="nump">7,488<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">566,206<span></span>
</td>
<td class="nump">409,317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">5,717<span></span>
</td>
<td class="nump">5,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">11,394<span></span>
</td>
<td class="nump">10,303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">861<span></span>
</td>
<td class="nump">1,559<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">584,178<span></span>
</td>
<td class="nump">426,604<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">865<span></span>
</td>
<td class="nump">956<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_AccruedResearchAndDevelopmentExpenses', window );">Accrued research and development expenses</a></td>
<td class="nump">12,239<span></span>
</td>
<td class="nump">19,258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">19,503<span></span>
</td>
<td class="nump">16,709<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">32,607<span></span>
</td>
<td class="nump">36,923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_LongTermConvertibleSeniorNotes', window );">Long-term convertible senior notes</a></td>
<td class="nump">142,158<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">28,665<span></span>
</td>
<td class="nump">28,459<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities - long-term</a></td>
<td class="nump">8,647<span></span>
</td>
<td class="nump">8,737<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">212,077<span></span>
</td>
<td class="nump">74,119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 700,000,000 shares authorized as of September&#160;30, 2020 and December&#160;31, 2019; 75,907,527 shares issued and 72,475,912 shares outstanding as of September&#160;30, 2020, and 66,284,003 shares issued and 61,635,477 shares outstanding as of December&#160;31, 2019</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">884,677<span></span>
</td>
<td class="nump">686,390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(512,926)<span></span>
</td>
<td class="num">(334,170)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">342<span></span>
</td>
<td class="nump">258<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">372,101<span></span>
</td>
<td class="nump">352,485<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 584,178<span></span>
</td>
<td class="nump">$ 426,604<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_AccruedResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued research and development expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_AccruedResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_LongTermConvertibleSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term convertible senior notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_LongTermConvertibleSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503181565928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">700,000,000<span></span>
</td>
<td class="nump">700,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">75,907,527<span></span>
</td>
<td class="nump">66,284,003<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">72,475,912<span></span>
</td>
<td class="nump">61,635,477<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503184365880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="nump">$ 41,846<span></span>
</td>
<td class="nump">$ 40,148<span></span>
</td>
<td class="nump">$ 121,944<span></span>
</td>
<td class="nump">$ 100,807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In process research and development</a></td>
<td class="nump">275<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">18,080<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">11,448<span></span>
</td>
<td class="nump">9,838<span></span>
</td>
<td class="nump">33,851<span></span>
</td>
<td class="nump">27,544<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">53,569<span></span>
</td>
<td class="nump">49,986<span></span>
</td>
<td class="nump">173,875<span></span>
</td>
<td class="nump">130,351<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(53,569)<span></span>
</td>
<td class="num">(49,986)<span></span>
</td>
<td class="num">(173,875)<span></span>
</td>
<td class="num">(130,351)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(4,243)<span></span>
</td>
<td class="nump">1,486<span></span>
</td>
<td class="num">(4,881)<span></span>
</td>
<td class="nump">4,742<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(57,812)<span></span>
</td>
<td class="num">(48,500)<span></span>
</td>
<td class="num">(178,756)<span></span>
</td>
<td class="num">(125,609)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation, net of tax</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss) on marketable securities, net of tax</a></td>
<td class="num">(293)<span></span>
</td>
<td class="num">(168)<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">389<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(225)<span></span>
</td>
<td class="num">(168)<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="nump">389<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (58,037)<span></span>
</td>
<td class="num">$ (48,668)<span></span>
</td>
<td class="num">$ (178,672)<span></span>
</td>
<td class="num">$ (125,220)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share, basic and diluted (in dollars per share)</a></td>
<td class="num">$ (0.80)<span></span>
</td>
<td class="num">$ (0.80)<span></span>
</td>
<td class="num">$ (2.67)<span></span>
</td>
<td class="num">$ (2.39)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average common shares outstanding, basic and diluted (in shares)</a></td>
<td class="nump">72,245,897<span></span>
</td>
<td class="nump">60,755,872<span></span>
</td>
<td class="nump">66,931,512<span></span>
</td>
<td class="nump">52,535,569<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e557-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b,c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503180042728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common stock</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Accumulated deficit</div></th>
<th class="th"><div>Accumulated other comprehensive income (loss)</div></th>
<th class="th"><div>Series Seed Convertible Preferred Stock</div></th>
<th class="th"><div>Series A Convertible Preferred Stock</div></th>
<th class="th"><div>Series B Convertible Preferred Stock</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, beginning balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">45,714,286<span></span>
</td>
<td class="nump">71,506,513<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock, beginning balance at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,200<span></span>
</td>
<td class="nump">$ 79,615<span></span>
</td>
<td class="nump">$ 229,552<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_TemporaryEquitySharesConvertedIntoCommonSharesShares', window );">Conversion of convertible preferred stock into common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,000,000)<span></span>
</td>
<td class="num">(45,714,286)<span></span>
</td>
<td class="num">(71,506,513)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_TemporaryEquitySharesConvertedIntoCommonSharesValue', window );">Conversion of convertible preferred stock into common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (29,200)<span></span>
</td>
<td class="num">$ (79,615)<span></span>
</td>
<td class="num">$ (229,552)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, ending balance (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock, ending balance at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,051,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2018</a></td>
<td class="num">$ (120,069)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 33,853<span></span>
</td>
<td class="num">$ (153,863)<span></span>
</td>
<td class="num">$ (61)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with a public offering, net of underwriting discounts, commissions, and offering costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,837,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with a public offering, net of underwriting discounts, commissions, and offering costs</a></td>
<td class="nump">291,344<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">291,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock', window );">Vesting of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,619,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">3,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(32,611)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,611)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible preferred stock into common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,493,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of convertible preferred stock into common stock</a></td>
<td class="nump">338,367<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">338,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,029,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2019</a></td>
<td class="nump">480,260<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">666,648<span></span>
</td>
<td class="num">(186,474)<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, beginning balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">45,714,286<span></span>
</td>
<td class="nump">71,506,513<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock, beginning balance at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,200<span></span>
</td>
<td class="nump">$ 79,615<span></span>
</td>
<td class="nump">$ 229,552<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,051,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2018</a></td>
<td class="num">(120,069)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">33,853<span></span>
</td>
<td class="num">(153,863)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(125,609)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,984,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2019</a></td>
<td class="nump">398,873<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">678,010<span></span>
</td>
<td class="num">(279,472)<span></span>
</td>
<td class="nump">328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Convertible preferred stock, beginning balance (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock, beginning balance at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,029,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2019</a></td>
<td class="nump">480,260<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">666,648<span></span>
</td>
<td class="num">(186,474)<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock', window );">Vesting of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">404,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock option (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">5,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(44,498)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44,498)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Other additional paid-in capital</a></td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,467,380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2019</a></td>
<td class="nump">441,444<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">671,913<span></span>
</td>
<td class="num">(230,972)<span></span>
</td>
<td class="nump">496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock', window );">Vesting of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">404,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock option (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">5,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(48,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(48,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="num">(168)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(168)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,984,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2019</a></td>
<td class="nump">398,873<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">678,010<span></span>
</td>
<td class="num">(279,472)<span></span>
</td>
<td class="nump">328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,635,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">352,485<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">686,390<span></span>
</td>
<td class="num">(334,170)<span></span>
</td>
<td class="nump">258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock', window );">Vesting of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">404,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock option (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">8,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,244<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock pursuant to Employee Stock Purchase Plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock pursuant to Employee Stock Purchase Plan</a></td>
<td class="nump">556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(54,074)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54,074)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="num">(763)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(763)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,094,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2020</a></td>
<td class="nump">306,463<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">695,205<span></span>
</td>
<td class="num">(388,244)<span></span>
</td>
<td class="num">(505)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,635,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">$ 352,485<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">686,390<span></span>
</td>
<td class="num">(334,170)<span></span>
</td>
<td class="nump">258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock option (in shares)</a></td>
<td class="nump">76,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (178,756)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,472,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="nump">372,101<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">884,677<span></span>
</td>
<td class="num">(512,926)<span></span>
</td>
<td class="nump">342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,094,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2020</a></td>
<td class="nump">306,463<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">695,205<span></span>
</td>
<td class="num">(388,244)<span></span>
</td>
<td class="num">(505)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with a public offering, net of underwriting discounts, commissions, and offering costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,433,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with a public offering, net of underwriting discounts, commissions, and offering costs</a></td>
<td class="nump">117,094<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">117,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_EquityComponentOfConvertibleNoteIssuance', window );">Equity component of convertible note issuance</a></td>
<td class="nump">53,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Debt issuance costs attributable to convertible feature</a></td>
<td class="num">(109)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(109)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock', window );">Vesting of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">404,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock option (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">8,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(66,870)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(66,870)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">1,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,972,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2020</a></td>
<td class="nump">420,324<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">874,863<span></span>
</td>
<td class="num">(455,114)<span></span>
</td>
<td class="nump">567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock', window );">Vesting of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">404,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock option (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">8,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,923<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock pursuant to Employee Stock Purchase Plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock pursuant to Employee Stock Purchase Plan</a></td>
<td class="nump">744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(57,812)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57,812)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="num">(225)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(225)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Other additional paid-in capital</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,472,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="nump">$ 372,101<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 884,677<span></span>
</td>
<td class="num">$ (512,926)<span></span>
</td>
<td class="nump">$ 342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_EquityComponentOfConvertibleNoteIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity component of convertible note issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_EquityComponentOfConvertibleNoteIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares vesting of restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_TemporaryEquitySharesConvertedIntoCommonSharesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Shares Converted Into Common Shares, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_TemporaryEquitySharesConvertedIntoCommonSharesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_TemporaryEquitySharesConvertedIntoCommonSharesValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Shares Converted Into Common Shares, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_TemporaryEquitySharesConvertedIntoCommonSharesValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118258462&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118258462&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116855982&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503185166952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (178,756)<span></span>
</td>
<td class="num">$ (125,609)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,044<span></span>
</td>
<td class="nump">625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">26,067<span></span>
</td>
<td class="nump">13,957<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_InProcessResearchAndDevelopmentExpenses', window );">In process research and development expenses</a></td>
<td class="nump">18,080<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_AmortizationOfOperatingLeaseRightOfUseAssets', window );">Amortization of operating lease right-of-use assets</a></td>
<td class="nump">2,015<span></span>
</td>
<td class="nump">1,615<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance costs</a></td>
<td class="nump">2,294<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of premium on investments, net of accretion of discounts</a></td>
<td class="nump">24<span></span>
</td>
<td class="num">(2,296)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Net realized gain on investments</a></td>
<td class="num">(256)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(3,340)<span></span>
</td>
<td class="num">(2,807)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">698<span></span>
</td>
<td class="nump">2,886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(1,294)<span></span>
</td>
<td class="num">(1,566)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">2,768<span></span>
</td>
<td class="num">(760)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses', window );">Accrued research and development expenses</a></td>
<td class="num">(7,019)<span></span>
</td>
<td class="nump">8,518<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation and benefits</a></td>
<td class="num">(1,959)<span></span>
</td>
<td class="nump">2,263<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(139,624)<span></span>
</td>
<td class="num">(100,694)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions', window );">Research and development asset acquisitions, net of cash acquired</a></td>
<td class="num">(18,080)<span></span>
</td>
<td class="num">(2,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable securities</a></td>
<td class="num">(108,969)<span></span>
</td>
<td class="num">(399,393)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_ProceedsFromMaturityOfMarketableSecurities', window );">Maturities of marketable securities</a></td>
<td class="nump">199,029<span></span>
</td>
<td class="nump">205,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_ProceedsFromSaleOfMarketableSecurities', window );">Sales of marketable securities</a></td>
<td class="nump">83,515<span></span>
</td>
<td class="nump">4,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(1,253)<span></span>
</td>
<td class="num">(2,438)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">154,242<span></span>
</td>
<td class="num">(194,077)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">117,110<span></span>
</td>
<td class="nump">291,311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible debt, net</a></td>
<td class="nump">193,596<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from the issuance of long-term debt, net of issuance costs of $1,778</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">28,222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from the exercise of stock options</a></td>
<td class="nump">285<span></span>
</td>
<td class="nump">527<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">312,291<span></span>
</td>
<td class="nump">320,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(42)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">326,909<span></span>
</td>
<td class="nump">25,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, at the beginning of the period</a></td>
<td class="nump">135,089<span></span>
</td>
<td class="nump">105,419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, at the end of the period</a></td>
<td class="nump">461,956<span></span>
</td>
<td class="nump">130,708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">1,911<span></span>
</td>
<td class="nump">854<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of noncash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities', window );">Right-of-use assets obtained in exchange for lease liabilities</a></td>
<td class="nump">3,106<span></span>
</td>
<td class="nump">12,458<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax', window );">Change in unrealized gain on marketable securities, net of tax</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Unpaid property and equipment</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock', window );">Conversion of convertible preferred stock to common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">338,367<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=goss_TwoThousandNineteenEmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_AmortizationOfOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization of operating lease right-of-use assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_AmortizationOfOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_InProcessResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_InProcessResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued research and development expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non cash financing and investing conversion of convertible preferred stock to common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncash investing and financing activities change in unrealized gain on marketable securities net of tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for (Proceeds from) research and development asset acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_ProceedsFromMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from maturity of marketable securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_ProceedsFromMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_ProceedsFromSaleOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of marketable securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_ProceedsFromSaleOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right-of-use assets obtained in exchange for lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net realized gains or losses on investments during the period, not including gains or losses on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.3(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=goss_TwoThousandNineteenEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=goss_TwoThousandNineteenEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503181710584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Parenthetical)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Statement of Cash Flows [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="nump">$ 1,778<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503183232040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of the Business<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Description of the Business</a></td>
<td class="text">Description of the Business<div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gossamer Bio, Inc. (including its subsidiaries, referred to as &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221;, or the &#8220;Company&#8221;) is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. The Company was incorporated in the state of Delaware on October&#160;25, 2015 (originally as FSG Bio, Inc.) and is based in San Diego, California.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of Gossamer Bio, Inc. and its wholly owned subsidiaries. All intercompany balances and transactions among the consolidated entity have been eliminated in consolidation.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Initial Public Offering in February 2019</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 12, 2019, the Company completed its initial public offering (&#8220;IPO&#8221;) with the sale of 19,837,500 shares of common stock, including shares of common stock issued upon the exercise in full of the underwriters&#8217; option to purchase additional shares, at a public offering price of $16.00 per share, resulting in net proceeds of $291.3 million, after deducting underwriting discounts, commissions, and offering expenses.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in connection with the completion of the IPO, all of the Company&#8217;s outstanding shares of convertible preferred stock were automatically converted into 30,493,460 shares of common stock.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has incurred significant operating losses since its inception. As of September&#160;30, 2020, the Company had an accumulated deficit of  $512.9 million. From the Company&#8217;s inception through September&#160;30, 2020, the Company has funded its operations primarily through equity and debt financings. The Company raised $942.0 million from October 2017 through September&#160;30, 2020 through Series A and Series B convertible preferred stock financings, a convertible note financing, its IPO, its Credit Facility (as defined in Note 5 below), and concurrent underwritten public offerings of its 5.00% convertible senior notes due 2027 (the &#8220;2027 Notes&#8221;) and common stock in May 2020. See Note 5 for additional information regarding the Credit Facility and the 2027 Notes. In addition, the Company received $12.8 million in cash in connection with the January 2018 acquisition of AA Biopharma Inc.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects to continue to incur significant operating losses for the foreseeable future and may never become profitable. As a result, the Company will need to raise capital through equity offerings, debt financings and other capital sources, including potential collaborations, licenses and other similar arrangements. Management believes that it has sufficient working capital on hand to fund operations through at least the next twelve months from the date these condensed consolidated financial statements were available to be issued. There can be no assurance that the Company will be successful in acquiring additional funding, that the Company&#8217;s projections of its future working capital needs will prove accurate, or that any additional funding would be sufficient to continue operations in future years.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has caused significant business disruption around the globe. The extent of the impact of COVID-19 on the Company&#8217;s operational and financial performance will depend on certain developments, including the duration and spread of the pandemic and the impact on the Company&#8217;s clinical trials, employees and vendors. At this point, the degree to which COVID-19 may impact the Company&#8217;s financial condition or results of operations is uncertain.&#160;&#160;A prolonged pandemic could have a material and adverse impact on financial results and business operations of the Company, including the timing and ability of the Company to complete certain clinical trials and other efforts required to advance the development of its product candidates and raise additional capital. For example, the Company commenced enrolling patients for a Phase 1b clinical trial in pulmonary arterial hypertension ("PAH") in the first quarter of 2020, and because the Company temporarily paused enrollment as a result of the ongoing COVID-19 viral pandemic, the Company now expects to report topline results from this trial in the fourth quarter of 2020. In addition, due to the challenges of enrolling patients posed by the COVID-19 pandemic, the Company may experience delays in the commencement of its Phase 2 clinical trial of GB002 in PAH and enrollment of patients in its Phase 2 clinical trials of GB004 in ulcerative colitis and of GB002 in PAH, as well as delays in reporting data results from its ongoing trials.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503181749032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) for interim financial information and with the instructions of the Securities and Exchange Commission (&#8220;SEC&#8221;) on Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, the condensed consolidated financial statements include all adjustments necessary, which are of a normal and recurring nature, for the fair presentation of the Company&#8217;s financial position and of the results of operations and cash flows for the periods presented. These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December&#160;31, 2019 included in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March 24, 2020. The results of operations for the interim period shown in this report are not necessarily indicative of the results that may be expected for any other interim period or for the full year. The balance sheet at December&#160;31, 2019, has been derived from the audited financial statements at that date. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting period. The most significant estimates in the Company&#8217;s condensed consolidated financial statements relate to the allocation of the 2027 Notes into liability and equity components, accrued research and development expenses, the valuation of preferred and common stock, the valuation of stock options and the valuation allowance of deferred tax assets resulting from net operating losses. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results could differ from those estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accounting for the issuance of the 2027 Notes, the Company separated the 2027 Notes into liability and equity components. The carrying amount of the liability component was calculated by measuring the fair value of similar debt instruments that do not have associated convertible features. The carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the par value of the 2027 Notes. The equity component is not remeasured as long as it continues to meet the condition for equity classification. The excess of the principal amount of the liability component over its carrying amount (&#8220;debt discount&#8221;) is amortized to interest expense over the term of the 2027 Notes.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocated the issuance costs incurred to the liability and equity components of the 2027 Notes based on their relative fair values. Issuance costs attributable to the liability component were recorded as a reduction to the liability portion of the 2027 Notes and are being amortized to interest expense over the term of the 2027 Notes. Issuance costs attributable to the equity component, representing the conversion option, were netted with the equity component in stockholders' equity.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, Financial Instruments-Credit Losses: Measurement of Credit Losses on Financial Instruments (&#8220;ASU 2016-13&#8221;), which changes the impairment model for most financial assets and certain other instruments. For trade receivables and other instruments, entities will be required to use a new forward-looking expected loss model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. This guidance is effective for annual reporting periods beginning after December 15, 2019, including interim periods within those years, with early adoption permitted only as of annual reporting periods beginning after December 15, 2018. The Company adopted ASU 2016-13 as of January 1, 2020. The adoption of this standard did not have a material impact on the Company&#8217;s condensed consolidated financial statements or related financial statement disclosures.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss Per Share</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period. The Company uses the if-converted method for assumed conversion of the 2027 Notes to compute the weighted average shares of common stock outstanding for diluted net loss per share. Diluted net loss per share excludes the potential impact of the Company&#8217;s common stock options and unvested shares of restricted stock and the potential shares issuable upon conversion of the 2027 Notes because their effect would be anti-dilutive due to the Company&#8217;s net loss. Since the Company had a net loss in each of the periods presented, basic and diluted net loss per common share are the same.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,321,900&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,266,895&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,099,861&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested shares under restricted stock grants</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,530,998&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,053,169&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503183254504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Accounts and Supplemental Disclosures<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract', window );"><strong>Balance Sheets Accounts And Supplemental Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Accounts and Supplemental Disclosures</a></td>
<td class="text">Balance Sheet Accounts and Supplemental Disclosures<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Useful Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-7</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,153&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,097&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lab equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-5</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,025&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,054&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6-7</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,540&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,229&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in process</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,975&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,639&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,258&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,717&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,425&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Expenses and Other Current Liabilities </span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consisted of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued compensation</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,623&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,282&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, current</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,548&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,354&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued professional service fees</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,581&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,347&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued interest, current</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,864&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued other</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">612&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,126&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued in process research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">275&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accrued expenses</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,503&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,709&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Balance sheets accounts and supplemental disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503183823064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements and Available for Sale Investments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract', window );"><strong>Fair Value Measurements And Available For Sale Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock', window );">Fair Value Measurements and Available for Sale Investments</a></td>
<td class="text">Fair Value Measurements and Available for Sale Investments<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting guidance defines fair value, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the accounting guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1: Observable inputs such as quoted prices in active markets;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its cash equivalents and available-for-sale investments within Level&#160;1 or Level&#160;2. The fair value of the Company&#8217;s investment grade corporate debt securities and commercial paper is determined using proprietary valuation models and analytical tools, which utilize market pricing or prices for similar instruments that are both objective and publicly available, such as matrix pricing or reported trades, benchmark yields, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, and offers.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for assets measured at fair value on a recurring basis as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:42.155%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value Measurements at End of Period Using:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total<br/>Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Quoted&#160;Market<br/>Prices for<br/>Identical&#160;Assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Significant<br/>Other&#160;Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of September 30, 2020</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">367,344&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">367,344&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Treasury and agency securities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,772&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,772&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,580&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,580&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,897&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,897&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82,125&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82,125&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Treasury and agency securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91,717&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91,717&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,411&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,411&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">156,277&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">156,277&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not reclassify any investments between levels in the fair value hierarchy during the periods presented.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Other Financial Instruments</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020 and December&#160;31, 2019, the carrying amounts of the Company&#8217;s financial instruments, which include cash, interest receivable, accounts payable and accrued expenses, approximate fair values because of their short maturities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest receivable as of September&#160;30, 2020 and December&#160;31, 2019, was $0.5 million and $1.5 million,respectively, and is recorded as a component of prepaid expenses and other current assets on the condensed consolidated balance sheets.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that its Credit Facility bears interest at a rate that approximates prevailing market rates for instruments with similar characteristics and, accordingly, the carrying value of the Credit Facility approximates fair value.&#160;The Company estimates the fair value of long-term debt utilizing an income approach. The Company uses a present value calculation to discount principal and interest payments and the final maturity payment on these liabilities using a discounted </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cash flow model based on observable inputs. The debt instrument is then discounted based on what the current market rates would be as of the reporting date. Based on the assumptions used to value these liabilities at fair value, the debt instrument is categorized as Level 2 in the fair value hierarchy.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020 the fair value of the Company&#8217;s 2027 Notes was $202.0 million.&#160;&#160;The fair value was determined on the basis of market prices observable for similar instruments and is considered Level 2 in the fair value hierarchy (see Note 5).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Available for Sale Investments</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company invests its excess cash in U.S. Treasury and agency securities and debt instruments of corporations and commercial obligations, which are classified as available-for-sale investments. These investments are carried at fair value and are included in the tables below.&#160;&#160;The Company evaluates securities with unrealized losses to determine whether such losses, if any, are due to credit-related factors. Realized gains and losses are calculated using the specific identification method and recorded as interest income or expense. The Company does not generally intend to sell the investments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value, cost basis, and gross unrealized gains and losses of available-for-sale investments by security type, classified in marketable securities and long-term investments as of September&#160;30, 2020 are as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:49.851%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketable securities</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Treasury and agency securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35,194&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35,194&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,580&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,580&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52,346&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">302&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52,648&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93,120&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">302&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93,422&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At each reporting date, the Company performs an evaluation of impairment to determine if any unrealized losses are due to credit-related factors. The Company records an allowance for credit losses when unrealized losses are due to credit-related factors. Factors considered when evaluating available-for-sale investments for impairment include the severity of the impairment, changes in underlying credit ratings, the financial condition of the issuer, the probability that the scheduled cash payments will continue to be made and the Company&#8217;s intent and ability to hold the investment until recovery of the amortized cost basis. The Company intends and has the ability to hold its investments in unrealized loss positions until their amortized cost basis has been recovered. As of September&#160;30, 2020, there were no material declines in the market value of the Company&#8217;s available-for-sale investments due to credit-related factors.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual maturities of available-for-sale debt securities, as of September&#160;30, 2020, were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated<br/> Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due within one year</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79,582&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One to two years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,840&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93,422&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has the ability, if necessary, to liquidate any of its cash equivalents and marketable securities to meet its liquidity needs in the next 12&#160;months. Accordingly, those investments with contractual maturities greater than one year from the date of purchase are classified as current assets on the accompanying condensed consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value measurements and available for sale investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503183011192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Indebtedness<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Indebtedness</a></td>
<td class="text">Indebtedness<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facility</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 2, 2019, the Company entered into a credit, guaranty and security agreement, as amended on September 18, 2019 and July 2, 2020 (the &#8220;Credit Facility&#8221;), with MidCap Financial Trust (&#8220;MidCap&#8221;), as agent and lender, and the additional lenders party thereto from time to time (together with MidCap, the &#8220;Lenders&#8221;), pursuant to which the Lenders, including affiliates of MidCap and Silicon Valley Bank, agreed to make term loans available to the Company for working capital and </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">general business purposes, in a principal amount of up  to $150.0 million in term loan commitments, including a $30.0 million term loan that was funded at the closing date, with the ability to access the remaining $120.0 million in two additional tranches (each $60.0 million), subject to specified availability periods, the achievement of certain clinical development milestones, minimum cash requirements and other customary conditions. The Company, GB001, Inc., GB002, Inc., and GB004, Inc., each wholly-owned subsidiaries of the Company, are designated as co-borrowers to the Credit Facility, whereas GB003, Inc., GB005, Inc., GB006, Inc., GB007, Inc., GB008, Inc. and Gossamer Bio Services, Inc.,each wholly-owned subsidiaries of the Company, are designated as guarantors. The remaining two tranches are available no earlier than the satisfaction of the applicable funding conditions, including the applicable clinical development milestones, and no later than December 31, 2022. As of September&#160;30, 2020, no other tranches under the Credit Facility have been drawn. The Credit Facility is secured by substantially all of the Company&#8217;s and its domestic subsidiaries&#8217; personal property, including intellectual property.</span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each term loan under the Credit Facility bears interest at an annual rate equal to the sum of (i) one-month LIBOR (customarily defined, with a change to prime rate if LIBOR funding becomes unlawful or impractical) plus (ii) 7.00%, subject to a LIBOR floor of 2.00%.&#160;&#160;The borrower is required to make interest-only payments on the term loan for all payment dates prior to July 1, 2022.&#160;&#160;The term loans under the Credit Facility will begin amortizing on July 1, 2022, with equal monthly payments of principal plus interest being made by the Company to the Lenders in consecutive monthly installments following such interest-only period until the Credit Facility matures on January 1, 2025.&#160;&#160;Upon final repayment of the term loans, the borrower must pay an exit fee of 1.75% of the amount borrowed under the Credit Facility, less any partial exit fees previously paid.&#160;&#160;Upon partial prepayment of a portion of the term loans, the borrower must pay a partial exit fee of 1.75% of the principal being prepaid. At the borrower&#8217;s option, the borrower may prepay the outstanding principal balance of the term loan in whole or in part, subject to a prepayment fee of 3.00% of any amount prepaid if the prepayment occurs through and including the first anniversary of the second amendment effective date, 2.00% of the amount prepaid if the prepayment occurs after the first anniversary of the second amendment effective date through and including the second anniversary of the second amendment effective date, and 1.00% of any amount prepaid after the second anniversary of the second amendment effective date and prior to January 1, 2025.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facility includes affirmative and negative covenants applicable to the Company and certain of its subsidiaries. The affirmative covenants include, among others, covenants requiring such entities to maintain their legal existence and governmental approvals, deliver certain financial reports, maintain insurance coverage, maintain property, pay taxes, satisfy certain requirements regarding accounts and comply with laws and regulations.&#160;&#160;The negative covenants include, among others, restrictions on such entities from transferring collateral, incurring additional indebtedness, engaging in mergers or acquisitions, paying dividends or making other distributions, making investments, creating liens, amending material agreements and organizational documents, selling assets and suffering a change in control, in each case subject to certain exceptions.&#160;&#160;The Company and certain of its subsidiaries are also subject to an ongoing minimum cash financial covenant in which they must maintain unrestricted cash in an amount not less than 25% of the outstanding principal amount of the term loans. As of September&#160;30, 2020, the Company was in compliance with these covenants.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Facility also includes events of default, the occurrence and continuation of which could cause interest to be charged at the rate that is otherwise applicable plus 3.00% and would provide MidCap, as agent, with the right to exercise remedies against the Company and/or certain of its subsidiaries, and the collateral securing the Credit Facility, including foreclosure against the properties securing the credit facilities, including cash.&#160;&#160;These events of default include, among other things, failure to pay any amounts due under the Credit Facility, a breach of covenants under the Credit Facility, insolvency or the occurrence of insolvency events, the occurrence of a change in control, the occurrence of certain U.S. Food and Drug Administration (&#8220;FDA&#8221;) and regulatory events, failure to remain registered with the SEC and listed for trading on Nasdaq, the occurrence of a material adverse change, the occurrence of a default under a material agreement reasonably expected to result in a material adverse change, the occurrence of certain defaults under certain other indebtedness in an amount greater than $2.5 million and the occurrence of certain defaults under subordinated indebtedness and convertible indebtedness.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt as of September&#160;30, 2020 consisted of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount and issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,335)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,665&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled future minimum principal payments are as follows (in thousands)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 (remaining 3 months)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,806&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,613&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,613&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">5.00% Convertible Senior Notes due 2027</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 21, 2020, the Company issued $200.0 million aggregate principal amount of 5.00% convertible senior notes due 2027 in a public offering. The 2027 Notes were registered pursuant to the Company&#8217;s Shelf Registration Statement (as defined in Note 7 below). The interest rate on the 2027 Notes is fixed at 5.00% per annum. Interest is payable semi-annually in arrears on June 1 and December 1 of each year, commencing on December 1, 2020. The 2027 Notes will mature on June 1, 2027. The net proceeds from the offering, after deducting the underwriting discounts and commissions and other offering costs, were approximately $193.6 million. The 2027 Notes may be settled in cash, shares of the Company&#8217;s common stock, or a combination thereof, solely at the Company&#8217;s election. The initial conversion rate of the 2027 Notes is&#160;61.6095&#160;shares per&#160;$1,000&#160;principal amount, which is equivalent to a conversion price of approximately&#160;$16.23&#160;per share, subject to adjustments.&#160;In addition, following certain corporate events that occur prior to the maturity date or if the Company issues a notice of redemption, the Company will increase the conversion rate for a holder who elects to convert its 2027 Notes in connection with such a corporate event during the related redemption period in certain circumstances.&#160;</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2027 Notes are senior unsecured obligations of the Company, ranking senior in right of payment to any of the Company&#8217;s indebtedness that is expressly subordinated in right of payment to the 2027 Notes, and are effectively subordinated to the Company&#8217;s existing and future secured indebtedness, to the extent of the value of the collateral securing that indebtedness, including all indebtedness under the Credit Facility.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders may convert their notes at their option only in the following circumstances: (1) during any calendar quarter (and only during such calendar quarter) commencing after the calendar quarter ending on September 30, 2020, if the last reported sale price per share of the Company&#8217;s common stock exceeds 130% of the conversion price for each of at least 20 trading days (whether or not consecutive) during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (2) during the five consecutive business days immediately after any 10 consecutive trading day period (such 10 consecutive trading day period, the &#8220;measurement period&#8221;) in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of the Company&#8217;s common stock on such trading day and the conversion rate on such trading day; (3) upon the occurrence of certain corporate events or distributions on the Company&#8217;s common stock; (4) if the Company calls such notes for redemption; and (5) at any time from, and including, March 1, 2027 until the close of business on the scheduled trading day immediately before the maturity date. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will not have the right to redeem the 2027 Notes prior to June 6, 2024. On or after June 6, 2024 and on or before the 50th scheduled trading day immediately before the maturity date, the Company may redeem the 2027 Notes, in whole or in part, if the last reported sale price of the Company&#8217;s common stock has been at least 130% of the conversion price then in effect on (1) each of at least 20 trading days (whether or not consecutive) during the 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice; and (2)the trading day immediately before the date the Company sends such notice. In the case of any optional redemption, the Company will redeem the 2027 Notes at a redemption price equal to 100% of the principal amount of such Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company undergoes a fundamental change prior to the maturity date of the 2027 Notes, holders of the 2027 Notes may require the Company to repurchase for cash all or part of their 2027 Notes at a repurchase price equal to 100% of the principal amount of the 2027 Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The indenture governing the 2027 Notes provides for customary terms and covenants, including that upon certain events of default, either the trustee or the holders of not less than 25% in aggregate principal amount of the 2027 Notes then outstanding may declare the unpaid principal amount of the 2027 Notes and accrued and unpaid interest, if any, thereon </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">immediately due and payable. As of September&#160;30, 2020, the Company was in compliance with these covenants. In the case of certain events of bankruptcy, insolvency or reorganization, the principal amount of the 2027 Notes together with accrued and unpaid interest, if any, thereon will automatically become and be immediately due and payable. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, there were no events or market conditions that would allow holders to convert the 2027 Notes.&#160;&#160;At the time the 2027 Notes become convertible within 12 months of the balance sheet date, the carrying value of the 2027 Notes will be reclassified to short-term.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accounting for the issuance of the 2027 Notes, the Company separated the 2027 Notes into liability and equity components.&#160;&#160;The carrying amount of the liability component was calculated by measuring the fair value of similar debt instruments that do not have associated convertible features. The carrying amount of the equity component representing the conversion option was $53.0 million and was determined by deducting the fair value of the liability component from the par value of the 2027 Notes. The equity component is not remeasured as long as it continues to meet the conditions for equity classification. The debt discount is amortized to interest expense over the term of the 2027 Notes at an effective interest rate of 11.17% over the contractual terms of the 2027 Notes.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accounting for the debt issuance costs of&#160;$0.4 million&#160;related to the 2027 Notes, the Company allocated the total amount incurred to the liability and equity components of the 2027 Notes based on their relative fair values. Issuance costs attributable to the liability component were $0.3 million and will be amortized to interest expense using the effective interest method over the contractual terms of the 2027 Notes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Issuance costs attributable to the equity component were netted with the equity component in stockholders&#8217; equity.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net carrying amount of the liability component of the 2027 Notes was as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,557)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,158&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net carrying amount of the equity component of the 2027 Notes was as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount related to the value of conversion option</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,635&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,526&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the interest expense recognized related to the 2027 Notes (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest expense</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,500&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,639&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance cost</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,436&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,078&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense related to the 2027 Notes</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,943&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,727&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503183073096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Licenses, Asset Acquisitions and Contingent Consideration<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Licenses, Asset Acquisitions and Contingent Consideration</a></td>
<td class="text">Licenses, Asset Acquisitions and Contingent Consideration<div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following purchased assets were accounted for as asset acquisitions as substantially all of the fair value of the assets acquired were concentrated in a group of similar assets and/or the acquired assets were not capable of producing outputs due to the lack of employees and early stage of development. Because the assets had not yet received regulatory approval, the fair value attributable to these assets was recorded as in process research and development (&#8220;IPR&amp;D&#8221;) expenses in the Company&#8217;s condensed consolidated statement of operations for the three and nine months ended September&#160;30, 2020.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for contingent consideration payable upon achievement of certain regulatory, development or sales milestones in such asset acquisitions when the underlying contingency is met.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">License from Pulmokine, Inc. (GB002)</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;2, 2017, the Company, entered into a license agreement with Pulmokine, Inc. under which it was granted an exclusive worldwide license and sublicense to certain intellectual property rights owned or controlled by Pulmokine to develop and commercialize GB002 and certain backup compounds for the treatment, prevention and diagnosis of any and all disease or conditions. The Company also has the right to sublicense its rights under the license agreement, subject to certain conditions. The assets acquired are in the early stages of the FDA approval process, and the Company intends to further develop the assets acquired through potential FDA approval as evidenced by the milestone arrangement in the contract. The development activities cannot be performed without significant cost and effort by the Company. The agreement will remain in effect from the effective date, unless terminated earlier, until, on a licensed product-by-licensed product and country-by-country basis, the later of ten years from the date of first commercial sale or when there is no longer a valid patent claim covering such licensed product or specified regulatory exclusivity for the licensed product in such country. The Company is obligated to make future development and regulatory milestone payments of up to $63.0 million, commercial milestone payments of up to $45.0 million, and sales milestone payments of up to $190.0 million. The Company is also obligated to pay tiered royalties on sales for each licensed product, at percentages ranging from the mid-single digits to the high single-digits. The Company made an upfront payment of $5.5 million in October 2017. As of September&#160;30, 2020, no milestones had been accrued as the underlying contingencies had not yet been met.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">AA Biopharma Inc. Acquisition (GB001)</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;4, 2018, the Company acquired AA Biopharma Inc. pursuant to a merger agreement, and with the acquisition acquired the rights to GB001 and certain backup compounds. In connection with the merger agreement, the Company issued an aggregate of 20,000,000 shares of Series Seed Convertible Preferred Stock and 1,101,278 shares of Common Stock to the AA Biopharma shareholders. The Company recorded IPR&amp;D of $19.3 million in January 2018 in connection with the acquisition of AA Biopharma.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">License from Aerpio Pharmaceuticals, Inc. (GB004)</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;24, 2018, the Company entered into a license agreement with Aerpio Pharmaceuticals, Inc. (&#8220;Aerpio&#8221;) under which the Company was granted an exclusive worldwide license and sublicense to certain intellectual property rights owned or controlled by Aerpio to develop and commercialize GB004, and certain other related compounds for all applications. The Company made an upfront payment of $20.0 million in June 2018, which represented the purchase consideration for an asset acquisition. On May 11, 2020, the Company entered into an amendment to the license agreement with Aerpio pursuant to which the Company made an upfront payment of $15.0 million to Aerpio for a reduction in future milestone payments and royalties. Under the amended license agreement, the Company is obligated to make future approval milestone payments of up to $40.0 million and a sales milestone payment of $50.0 million. The Company also has the right to sublicense its rights under the license agreement, subject to certain conditions. The Company is also obligated to pay tiered royalties on sales for each licensed product, at percentages ranging from low- to mid-single digits, subject to certain customary reductions. Aerpio retains its twenty percent (20.00%) participation right on a disposition of GB004. As of September&#160;30, 2020, no milestones had been accrued as the underlying contingencies had not yet been met.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adhaere Pharmaceuticals, Inc. Acquisition (GB1275) </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;21, 2018,&#160;the Company acquired Adhaere Pharmaceuticals, Inc. (&#8220;Adhaere&#8221;) pursuant to a merger agreement for an upfront payment of  $7.5 million in cash, and with the acquisition acquired the rights to GB1275 and certain backup compounds. The Company is obligated to make regulatory, development and sales milestone payments of up to $62.0 million and pay tiered royalties on worldwide net sales, at percentages ranging from low to mid-single digits, subject to customary reductions. In September 2018, the Company recorded IPR&amp;D of $7.5 million in connection with the acquisition of Adhaere. In May 2019, the Company made a milestone payment of $1.0 million in connection with the filing of the Investigational New Drug application for the GB1275 program. As of September&#160;30, 2020, no other milestones had been accrued as the underlying contingencies had not yet been met.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded the following IPR&amp;D expense on the condensed consolidated statements of operations (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.046%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GB001</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GB002</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GB004</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,275&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GB1275</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Programs</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,805&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total in process research and development</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,080&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503183204824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders&#8217; Equity<div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s IPO, the outstanding shares of the Company&#8217;s Series Seed, Series A, and Series B Convertible Preferred Stock automatically converted into 30,493,460 shares of common stock. Each share of common stock is entitled to one vote. Common stock owners are entitled to dividends when funds are legally available and declared by the Board.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shelf Registration Statement and Stock Offering</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 10, 2020, the Company filed a universal shelf registration statement on Form S-3, covering the offering from time to time of common stock, preferred stock, debt securities, warrants and units, which registration statement became automatically effective on April 10, 2020 (the &#8220;Shelf Registration Statement&#8221;).</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 21, 2020, the Company completed a public offering of 9,433,963 shares of its common stock at a public offering price of $13.25 per share. The net proceeds from the offering, after deducting underwriting discounts and commissions and other offering costs, were approximately $117.1&#160;million. The shares sold in the offering were registered pursuant to the Company&#8217;s Shelf Registration Statement.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Founder Shares</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;3, 2015, the Company issued 9,160,888 shares of common stock as founder shares for services rendered to the Company, valued at $0.0001 par value per share, for a total of approximately $4,100. On January&#160;4, 2018, incremental vesting conditions were placed on the previously issued founder shares. Fifty percent of the previously issued founder shares vested on January&#160;4, 2018, and the remaining founder shares are subject to vesting restrictions over a period of five years.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the employment agreements with the Company&#8217;s founders executed January 4, 2018, the Company provided for certain potential additional issuances of common stock (the &#8220;anti-dilution shares&#8221;) to each of the founders to ensure the total number of shares of common stock held by them and their affiliates (inclusive of any shares subject to equity awards granted by the Company) would represent 15% of the Company&#8217;s fully-diluted capitalization until such time as the Company raised $300.0 million in equity capital, including the capital raised in the Series&#160;A financing.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In furtherance of this obligation, on May 21, 2018, the Company issued 251,547 shares of common stock to the founders for services rendered to the Company, valued at $2.61 per share with an additional 251,547&#160;shares of restricted stock subject to the same vesting restrictions and vesting period as the founder shares. In addition, on September 6, 2018, the Company issued 1,795,023 shares of common stock to the founders for services rendered to the Company, valued at $9.63 per share, with an additional 1,795,023 shares of restricted stock subject to the same vesting restrictions and vesting period as the founder shares.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shares of Common Stock Subject to Repurchase</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2017, in connection with the issuance of the Series A Convertible Preferred Stock, certain employees entered into stock restriction agreements, whereby 1,305,427 shares are subject to forfeiture by the Company upon the stockholder&#8217;s termination of employment or service to the Company. In January 2018, the Company&#8217;s founders entered into stock restriction agreements, whereby 4,580,444 of previously unrestricted shares of common stock were subject to service vesting conditions. These shares are also subject to forfeiture by the Company upon the stockholders&#8217; termination of employment or service to the Company. Any shares subject to repurchase by the Company are not deemed, for accounting purposes, to be outstanding until those shares vest. As such, the Company recognizes the measurement date fair value of the restricted stock over the vesting period as compensation expense. As of September&#160;30, 2020 and December&#160;31, 2019, 3,434,613 </span></div>and 4,648,526 shares of common stock were subject to repurchase by the Company, respectively. The unvested stock liability related to these awards is immaterial to all periods presented.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503261688936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Equity Incentive Plans</a></td>
<td class="text">Equity Incentive Plans<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019 Equity Incentive Plan </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2019, the Company&#8217;s board of directors and stockholders approved and adopted the 2019 Incentive Award Plan (the &#8220;2019 Plan&#8221;). The 2019 Plan became effective on February 6, 2019, the day prior to the effectiveness of the registration statement filed in connection with the IPO. Under the 2019 Plan, the Company may grant stock options, stock appreciation rights, restricted stock, restricted stock units, and other stock or cash-based awards to individuals who are then employees, officers, directors or consultants of the Company, and employees and consultants of the Company&#8217;s subsidiaries. A total of 5,750,000 shares of common stock were approved to be initially reserved for issuance under the 2019 Plan. The number of shares that remained available for issuance under the 2017 Plan (as defined below) as of the effective date of the 2019 Plan were, and shares subject to outstanding awards under the 2017 Plan as of the effective date of the 2019 Plan that are subsequently canceled, forfeited or repurchased by the Company will be, added to the shares reserved under the 2019 Plan. In addition, the number of shares of common stock available for issuance under the 2019 Plan will be automatically increased on the first day of each calendar year during the ten-year term of the 2019 Plan, beginning with January 1, 2020 and ending with January 1, 2029, by an amount equal to 5% of the outstanding number of shares of the Company&#8217;s common stock on December 31 of the preceding calendar year or such lesser amount as determined by the Company&#8217;s board of directors. As of September&#160;30, 2020, an aggregate of 1,696,802 shares of common stock were available for issuance under the 2019 Plan and 7,291,966 shares of common stock were subject to outstanding awards under the 2019 Plan.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019 Employee Stock Purchase Plan</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2019, the Company&#8217;s board of directors and stockholders approved and adopted the 2019 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;). The ESPP became effective as of February 6, 2019, the day prior to the effectiveness of the registration statement filed in connection with the IPO. The ESPP permits participants to purchase common stock through payroll deductions of up to 20% of their eligible compensation. A total of 700,000 shares of common stock were approved to be initially reserved for issuance under the ESPP. In addition, the number of shares of common stock available for issuance under the ESPP will be automatically increased on the first day of each calendar year during the first ten-years of the term of the ESPP, beginning with January 1, 2020 and ending with January 1, 2029, by an amount equal to 1% of the outstanding number of shares of the Company&#8217;s common stock on December 31 of the preceding calendar year or such lesser amount as determined by the Company&#8217;s board of directors. During the nine months ended September 30, 2020, 113,286 shares were issued pursuant to the ESPP. As of September&#160;30, 2020, an aggregate of 1,249,554 shares of common stock were available for issuance under the ESPP.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2017 Equity Incentive Plan</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s 2017 Equity Incentive Plan (the &#8220;2017 Plan&#8221;) permitted the granting of incentive stock options, non-statutory stock options, restricted stock, restricted stock units and other stock-based awards. Subsequent to the adoption of the 2019 Plan, no additional equity awards can be made under the 2017 Plan. As of September&#160;30, 2020, 4,071,312 shares of common stock were subject to outstanding options under the 2017 Plan, and 342,006 shares of restricted stock awards granted under the 2017 plan were unvested.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each employee and non-employee stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. The Company, prior to the closing of its IPO on February 12, 2019, was a private company and lacked company-specific historical and implied volatility information. Therefore, it estimated its expected volatility based on the historical volatility of a publicly traded set of peer companies. Due to the lack of historical exercise history, the expected term of the Company&#8217;s stock options for employees has been determined utilizing the &#8220;simplified&#8221; method for awards. The expected term of stock options granted to non-employees is equal to the contractual term of the option award. The risk-free interest rate is determined by reference to the U.S.&#160;Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is zero based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity during the nine months ended September 30, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:49.851%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares&#160;Subject&#160;to<br/>Options&#160;Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Remaining<br/>Contractual<br/>Life<br/>(Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic&#160;Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2019</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,538,060&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.67&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,385&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,540,122&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Option exercised</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,275)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.73&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited/cancelled</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(735,012)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.61&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of September 30, 2020</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,266,895&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.83&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,221&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and exercisable as of September 30, 2020</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,274,782&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,026&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value in the above table is calculated as the difference between fair value of the Company&#8217;s common stock price on September&#160;30, 2020 and the exercise price of the stock options. The aggregate intrinsic value of stock options exercised during the nine months ended September 30, 2020 was $0.7 million.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant date fair value per share for the stock option grants during the nine months ended September 30, 2020 was $10.61.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate fair value of stock options that vested during the nine months ended September 30, 2020 was $23.1 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summary of the Company&#8217;s restricted stock activity is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Restricted<br/>Stock Units<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2019</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,648,526&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.98&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176,340&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.94&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,213,911)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.71&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,957)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.95&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at September 30, 2020</span></td><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,530,998&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.96&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, the total unrecognized compensation related to unvested restricted stock awards granted was $20.7 million, which the Company expects to recognize over a weighted-average period of approximately 2.2 years.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense has been reported in the Company&#8217;s condensed consolidated statements of operations as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.046%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,726&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,727&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,094&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,483&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,197&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,001&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,973&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,474&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,923&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,728&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,067&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,957&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2020, the total unrecognized compensation related to unvested stock option awards granted was $61.3 million, which the Company expects to recognize over a weighted-average period of approximately 2.5 years.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2020, total unrecognized compensation expense related to the ESPP was $1.9 million, which the Company expects to recognize over a weighted-average period of approximately one year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503183158648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company subleases certain office and laboratory space under a non-cancelable operating lease expiring in January 2025 for the initial leased space and December 2022 for expansion space leased pursuant to an amendment to the lease agreement entered into in August 2018. The sublease agreement included options to extend for the entire premises through October 2028. The options to extend must be exercised prior to the termination of the original lease agreement. The period covered by the options was not included in the non-cancellable lease term as it not was not determined to be reasonably certain to be executed. The lease agreement also includes a one-time termination option for the expansion space only whereby the Company can terminate the lease with advance written notice. The termination option was not determined to be reasonably certain to be executed. The lease is subject to charges for common area maintenance and other costs, and base rent is subject to an annual 3% increase each subsequent year. Costs determined to be variable and not based on an index or rate were not included in the measurement of the operating lease liabilities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the Company entered into an additional non-cancelable lease agreement for certain office and laboratory space (the &#8220;permanent space&#8221;) in San Diego, California, commencing on May 1, 2020 and expiring on December 31, 2021. The lease agreement includes a lease for temporary space commencing on January 1, 2020 and expiring on the commencement date of the lease of the permanent space. The monthly base rent for the permanent and temporary space is $63,425 and $28,745, respectively. The lease agreement included an option to extend the term of the permanent space for twelve months. The option to extend must be exercised nine months prior to the termination of the original lease agreement. The period covered by the option was not included in the non-cancellable lease term as it not was not determined to be reasonably certain to be executed. The lease is subject to charges for common area maintenance and other costs, and base rent is subject to an annual 3% increase each subsequent year.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, the Company entered into a sublease agreement for the permanent space with a third party. The sublease commenced on July&#160;1, 2020 and expires on December&#160;31, 2021. The sublessee pays the monthly base rent of $63,425, subject to an annual 3% increase, and is obligated to pay for common area maintenance and other costs.&#160;&#160;The sublessee received a 6 months base rent abatement. The Company determined that there was no impairment on the original right-of-use asset and will continue to account for the permanent space as it did before the commencement of the sublease.&#160;&#160;The Company recognized $0.1 million in sublease income for the three and nine months ended September&#160;30, 2020.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2020, the Company entered into a lease assignment agreement, whereby it became the assignee to a lease for certain office and laboratory space in Ann Arbor, Michigan. The lease term expires on December 31, 2026 and the Company has the option to extend the term of the lease by up to five years. The period covered by the option was not included in the non-cancellable lease term as it was not determined to be reasonably certain to be executed. The monthly base rent for the space is $28,495. The lease is subject to charges for common area maintenance and other costs, and base rent is subject to an annual 2.5% increase on January 1 of each year.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Monthly rent expense is recognized on a straight-line basis over the term of the leases. The operating leases are included in the balance sheet at the present value of the lease payments at a weighted-average discount rate of 7% using the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment as the leases do not provide an implicit rate. The weighted average remaining lease term was 3.7 years.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease costs were comprised of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,007&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,577&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term lease cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease cost</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,023&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,631&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of operating lease liabilities for the three and nine months ended September 30, 2020 was $1.0 million and $2.6 million, respectively.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross future minimum annual rental commitments as of September&#160;30, 2020, were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Undiscounted&#160;Rent<br/>Payments</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ending December 31</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020 (remaining 3 months)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,043&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,273&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,579&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,063&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,123&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">387&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">397&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total undiscounted rent payments</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,865&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value discount</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,670)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,195&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current portion of operating lease liability (included as a component of accrued expenses)</span></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,548&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncurrent operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease liability</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,195&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2020 the Company recorded approximately $1.0 million and $2.9 million, respectively, in rent expense.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Kuhne vs. Gossamer Bio, Inc., et. al.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 3, 2020, Scott Kuhne, individually and on behalf of all others similarly situated, filed a putative class action lawsuit against the Company, certain of its executive officers and directors, and the underwriters of its IPO in the United States District Court for the Southern District of California (Case No. 3:20-cv-00649-DMS-MDD). The first amended complaint was filed on August 31, 2020. The complaint was filed on behalf of all persons who purchased or otherwise acquired the Company&#8217;s securities between February 8, 2019 and December 13, 2019. The first amended complaint alleges that the Company, certain of its executive officers and directors, and the underwriters of its IPO made false and/or misleading statements and failed to disclose material adverse facts about its business, operations and prospects in violation of Sections 11, 12(a)(2) and 15 of the Securities Act of 1933, as amended, and Sections 10(b) (and Rule 10b-5 promulgated thereunder) and 20(a) of the Securities Exchange Act of 1934, as amended. The plaintiff seeks damages, interest, costs, attorneys&#8217; fees, and other unspecified equitable relief. Following meet and confer discussions amongst the parties to the litigation, Plaintiff was granted leave to further amend his complaint by no later than November 20, 2020. Thereafter, the Company&#8217;s deadline to move to dismiss or otherwise answer that complaint is January 19, 2021. The Company intends to vigorously defend this matter. Given the uncertainty of litigation, the preliminary stage of the case, and the legal standards that must be met for, among other things, class certification and success on the merits, the Company cannot estimate the reasonably possible loss or range of loss that may result from this action.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503183679480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of PresentationThe accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) for interim financial information and with the instructions of the Securities and Exchange Commission (&#8220;SEC&#8221;) on Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. In the opinion of management, the condensed consolidated financial statements include all adjustments necessary, which are of a normal and recurring nature, for the fair presentation of the Company&#8217;s financial position and of the results of operations and cash flows for the periods presented. These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December&#160;31, 2019 included in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March 24, 2020. The results of operations for the interim period shown in this report are not necessarily indicative of the results that may be expected for any other interim period or for the full year. The balance sheet at December&#160;31, 2019, has been derived from the audited financial statements at that date.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting period. The most significant estimates in the Company&#8217;s condensed consolidated financial statements relate to the allocation of the 2027 Notes into liability and equity components, accrued research and development expenses, the valuation of preferred and common stock, the valuation of stock options and the valuation allowance of deferred tax assets resulting from net operating losses. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results could differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_ConvertibleSeniorNotesPolicyTextBlock', window );">Convertible Senior Notes</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accounting for the issuance of the 2027 Notes, the Company separated the 2027 Notes into liability and equity components. The carrying amount of the liability component was calculated by measuring the fair value of similar debt instruments that do not have associated convertible features. The carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the par value of the 2027 Notes. The equity component is not remeasured as long as it continues to meet the condition for equity classification. The excess of the principal amount of the liability component over its carrying amount (&#8220;debt discount&#8221;) is amortized to interest expense over the term of the 2027 Notes.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allocated the issuance costs incurred to the liability and equity components of the 2027 Notes based on their relative fair values. Issuance costs attributable to the liability component were recorded as a reduction to the liability portion of the 2027 Notes and are being amortized to interest expense over the term of the 2027 Notes. Issuance costs attributable to the equity component, representing the conversion option, were netted with the equity component in stockholders' equity.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2016-13, Financial Instruments-Credit Losses: Measurement of Credit Losses on Financial Instruments (&#8220;ASU 2016-13&#8221;), which changes the impairment model for most financial assets and certain other instruments. For trade receivables and other instruments, entities will be required to use a new forward-looking expected loss model that generally will result in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, the losses will be recognized as allowances rather than as reductions in the amortized cost of the securities. This guidance is effective for annual reporting periods beginning after December 15, 2019, including interim periods within those years, with early adoption permitted only as of annual reporting periods beginning after December 15, 2018. The Company adopted ASU 2016-13 as of January 1, 2020. The adoption of this standard did not have a material impact on the Company&#8217;s condensed consolidated financial statements or related financial statement disclosures.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss Per Share</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period. The Company uses the if-converted method for assumed conversion of the 2027 Notes to compute the weighted average shares of common stock outstanding for diluted net loss per share. Diluted net loss per share excludes the potential impact of the Company&#8217;s common stock options and unvested shares of restricted stock and the potential shares issuable upon conversion of the 2027 Notes because their effect would be anti-dilutive due to the Company&#8217;s net loss. Since the Company had a net loss in each of the periods presented, basic and diluted net loss per common share are the same.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,321,900&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,266,895&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,099,861&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested shares under restricted stock grants</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,530,998&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,053,169&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_ConvertibleSeniorNotesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible senior notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_ConvertibleSeniorNotesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503181831000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Potentially Dilutive Securities not Included in Calculation of Diluted Net Loss Per Share</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,321,900&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,266,895&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,099,861&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested shares under restricted stock grants</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,530,998&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,053,169&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503181736648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Accounts and Supplemental Disclosures (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract', window );"><strong>Balance Sheets Accounts And Supplemental Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, Net</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Useful Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-7</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,153&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,097&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lab equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-5</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,025&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,054&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6-7</span></div></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,540&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,229&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in process</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,975&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,639&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,258&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,717&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,425&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consisted of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued compensation</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,623&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,282&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, current</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,548&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,354&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued professional service fees</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,581&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,347&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued interest, current</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,864&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued other</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">612&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,126&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued in process research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">275&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accrued expenses</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,503&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,709&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Balance sheets accounts and supplemental disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503183221704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements and Available for Sale Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract', window );"><strong>Fair Value Measurements And Available For Sale Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Assets Measured at Fair Value on Recurring Basis</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for assets measured at fair value on a recurring basis as of September&#160;30, 2020 and December&#160;31, 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:42.155%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value Measurements at End of Period Using:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total<br/>Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Quoted&#160;Market<br/>Prices for<br/>Identical&#160;Assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Significant<br/>Other&#160;Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of September 30, 2020</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">367,344&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">367,344&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Treasury and agency securities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,772&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,772&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,580&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,580&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,897&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53,897&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Money market funds</span></td><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82,125&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82,125&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Treasury and agency securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91,717&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91,717&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,411&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,411&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">156,277&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">156,277&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of Available for Sale Investments by Security Type</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value, cost basis, and gross unrealized gains and losses of available-for-sale investments by security type, classified in marketable securities and long-term investments as of September&#160;30, 2020 are as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:49.851%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketable securities</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Treasury and agency securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35,194&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35,194&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,580&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,580&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52,346&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">302&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52,648&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93,120&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">302&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93,422&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Contractual Maturities of Available-for-sale Debt Securities</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual maturities of available-for-sale debt securities, as of September&#160;30, 2020, were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated<br/> Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due within one year</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79,582&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One to two years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,840&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93,422&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503183226440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Indebtedness (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Long-Term Debt</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt as of September&#160;30, 2020 consisted of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount and issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,335)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,665&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Future Minimum Principal Payments</a></td>
<td class="text">The scheduled future minimum principal payments are as follows (in thousands)<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 (remaining 3 months)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,806&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,613&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,613&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_ScheduleOfLiabilityComponentsOfNotesTableTextBlock', window );">Schedule of Net Carrying Amount of Liability Component</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net carrying amount of the liability component of the 2027 Notes was as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,557)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,158&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_ScheduleOfEquityComponentsOfNotesTableTextBlock', window );">Schedule of Equity Components</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net carrying amount of the equity component of the 2027 Notes was as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount related to the value of conversion option</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,635&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,526&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_ScheduleOfInterestExpenseRecognizedTableTextBlock', window );">Schedule of Interest Expense Recognized</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the interest expense recognized related to the 2027 Notes (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.526%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual interest expense</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,500&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,639&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance cost</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,436&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,078&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense related to the 2027 Notes</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,943&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,727&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_ScheduleOfEquityComponentsOfNotesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of equity components of notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_ScheduleOfEquityComponentsOfNotesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_ScheduleOfInterestExpenseRecognizedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of interest expense recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_ScheduleOfInterestExpenseRecognizedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_ScheduleOfLiabilityComponentsOfNotesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of liability components of notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_ScheduleOfLiabilityComponentsOfNotesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503183164264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Licenses, Asset Acquisitions and Contingent Consideration (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_InProcessResearchAndDevelopmentExpensesTableTextBlock', window );">Schedule of IPR&amp;D Expense</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded the following IPR&amp;D expense on the condensed consolidated statements of operations (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.046%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GB001</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GB002</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GB004</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,275&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GB1275</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Programs</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,805&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total in process research and development</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,080&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_InProcessResearchAndDevelopmentExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In process research and development expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_InProcessResearchAndDevelopmentExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503183929048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Summary of Stock Option Activity</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock option activity during the nine months ended September 30, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:49.851%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares&#160;Subject&#160;to<br/>Options&#160;Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Remaining<br/>Contractual<br/>Life<br/>(Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic&#160;Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2019</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,538,060&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.67&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,385&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,540,122&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.02&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Option exercised</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,275)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.73&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited/cancelled</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(735,012)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.61&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of September 30, 2020</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,266,895&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.83&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,221&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and exercisable as of September 30, 2020</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,274,782&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,026&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Summary of Restricted Stock Activity</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summary of the Company&#8217;s restricted stock activity is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Restricted<br/>Stock Units<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2019</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,648,526&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.98&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176,340&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.94&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,213,911)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.71&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 11.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,957)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.95&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at September 30, 2020</span></td><td colspan="2" style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,530,998&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.96&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Stock-Based Compensation Expense Reported in Condensed Consolidated Statements of Operations</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense has been reported in the Company&#8217;s condensed consolidated statements of operations as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.046%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,726&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,727&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,094&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,483&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,197&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,001&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,973&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,474&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,923&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,728&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,067&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,957&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503181543096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Costs</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease costs were comprised of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended September 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine months ended September 30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,007&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,577&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term lease cost</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease cost</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,023&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,631&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Gross Future Minimum Annual Rental Commitments</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross future minimum annual rental commitments as of September&#160;30, 2020, were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Undiscounted&#160;Rent<br/>Payments</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year ending December 31</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020 (remaining 3 months)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,043&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,273&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,579&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,063&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,123&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">387&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">397&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total undiscounted rent payments</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,865&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value discount</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,670)</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,195&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current portion of operating lease liability (included as a component of accrued expenses)</span></td><td colspan="2" style="background-color:#cff0fc;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,548&#160;</span></td><td style="background-color:#cff0fc;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncurrent operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease liability</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,195&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503185092280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of the Business - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">36 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 21, 2020</div></th>
<th class="th"><div>Feb. 12, 2019</div></th>
<th class="th"><div>Jan. 04, 2018</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_DescriptionOfBusinessLineItems', window );"><strong>Description Of Business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with a public offering, net of underwriting discounts, commissions, and offering costs (in shares)</a></td>
<td class="nump">9,433,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Offering price (in dollars per share)</a></td>
<td class="nump">$ 13.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (512,926)<span></span>
</td>
<td class="num">$ (334,170)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering', window );">Funds raised through Series A and Series B Convertible Preferred Stock, convertible note financings and completed IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 942,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=goss_AABiopharmaIncMember', window );">AA Biopharma Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_DescriptionOfBusinessLineItems', window );"><strong>Description Of Business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash received in connection with acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=goss_TwoThousandTwentySevenNotesMember', window );">2027 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_DescriptionOfBusinessLineItems', window );"><strong>Description Of Business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument interest rate percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Initial Public Offering ("IPO")</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_DescriptionOfBusinessLineItems', window );"><strong>Description Of Business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with a public offering, net of underwriting discounts, commissions, and offering costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,837,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Offering price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds, after deducting underwriting discounts, commissions, and offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 291,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Initial Public Offering ("IPO") | Conversion of Convertible Preferred Stock into Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_DescriptionOfBusinessLineItems', window );"><strong>Description Of Business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Common stock issued in conversion of convertible preferred stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,493,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_DescriptionOfBusinessLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_DescriptionOfBusinessLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Funds raised through preferred equity financing, convertible note financings and completed initial public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=goss_AABiopharmaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=goss_AABiopharmaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=goss_TwoThousandTwentySevenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=goss_TwoThousandTwentySevenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=goss_ConversionOfConvertiblePreferredStockIntoCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=goss_ConversionOfConvertiblePreferredStockIntoCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503183641368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities not Included in Calculation of Diluted Net Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=goss_TwoThousandTwentySevenNotesMember', window );">2027 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities not included from calculation of diluted net loss per share (in shares)</a></td>
<td class="nump">12,321,900<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Shares issuable upon exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities not included from calculation of diluted net loss per share (in shares)</a></td>
<td class="nump">10,266,895<span></span>
</td>
<td class="nump">8,099,861<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Non-vested shares under restricted stock grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities not included from calculation of diluted net loss per share (in shares)</a></td>
<td class="nump">4,530,998<span></span>
</td>
<td class="nump">5,053,169<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=goss_TwoThousandTwentySevenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=goss_TwoThousandTwentySevenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503184369896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Accounts and Supplemental Disclosures - Schedule of Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 7,975<span></span>
</td>
<td class="nump">$ 6,639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="nump">2,258<span></span>
</td>
<td class="nump">1,214<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">5,717<span></span>
</td>
<td class="nump">5,425<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 1,153<span></span>
</td>
<td class="nump">1,097<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 143<span></span>
</td>
<td class="nump">124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 114<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Lab equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 4,025<span></span>
</td>
<td class="nump">3,054<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Lab equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful life</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Lab equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 2,540<span></span>
</td>
<td class="nump">2,229<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in process</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 48<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503183498824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Accounts and Supplemental Disclosures - Schedule of Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">$ 8,623<span></span>
</td>
<td class="nump">$ 9,282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">3,548<span></span>
</td>
<td class="nump">2,354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional service fees</a></td>
<td class="nump">2,581<span></span>
</td>
<td class="nump">2,347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest, current</a></td>
<td class="nump">3,864<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued other</a></td>
<td class="nump">612<span></span>
</td>
<td class="nump">1,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_AccruedInProcessResearchAndDevelopment', window );">Accrued in process research and development</a></td>
<td class="nump">275<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses</a></td>
<td class="nump">$ 19,503<span></span>
</td>
<td class="nump">$ 16,709<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_AccruedInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued in process research and development.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_AccruedInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e7018-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503184583688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements and Available for Sale Investments - Assets Measured at Fair Value on Recurring Basis (Details) - Recurring Basis - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value on recurring basis</a></td>
<td class="nump">$ 367,344<span></span>
</td>
<td class="nump">$ 82,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">U.S. Treasury and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value on recurring basis</a></td>
<td class="nump">53,772<span></span>
</td>
<td class="nump">91,717<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value on recurring basis</a></td>
<td class="nump">5,580<span></span>
</td>
<td class="nump">37,411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value on recurring basis</a></td>
<td class="nump">53,897<span></span>
</td>
<td class="nump">156,277<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Quoted&#160;Market Prices for Identical&#160;Assets (Level 1) | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value on recurring basis</a></td>
<td class="nump">367,344<span></span>
</td>
<td class="nump">82,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Quoted&#160;Market Prices for Identical&#160;Assets (Level 1) | U.S. Treasury and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value on recurring basis</a></td>
<td class="nump">53,772<span></span>
</td>
<td class="nump">91,717<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Quoted&#160;Market Prices for Identical&#160;Assets (Level 1) | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value on recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Quoted&#160;Market Prices for Identical&#160;Assets (Level 1) | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value on recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant Other&#160;Observable Inputs (Level 2) | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value on recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant Other&#160;Observable Inputs (Level 2) | U.S. Treasury and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value on recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant Other&#160;Observable Inputs (Level 2) | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value on recurring basis</a></td>
<td class="nump">5,580<span></span>
</td>
<td class="nump">37,411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant Other&#160;Observable Inputs (Level 2) | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value on recurring basis</a></td>
<td class="nump">53,897<span></span>
</td>
<td class="nump">156,277<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant Unobservable Inputs (Level 3) | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value on recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant Unobservable Inputs (Level 3) | U.S. Treasury and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value on recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant Unobservable Inputs (Level 3) | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value on recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant Unobservable Inputs (Level 3) | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets measured at fair value on recurring basis</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=goss_USTreasuryAndAgencySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=goss_USTreasuryAndAgencySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503189148136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements and Available for Sale Investments - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueEquityLevel1ToLevel2TransfersAmount', window );">Fair value hierarchy level 1 to level 2</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueEquityLevel2ToLevel1TransfersAmount', window );">Fair value hierarchy level 2 to level 1</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=goss_TwoThousandTwentySevenNotesMember', window );">2027 Notes | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value of convertible senior notes</a></td>
<td class="nump">202,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaid Expenses and Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_InterestAndSecuritiesReceivable', window );">Interest and securities receivable</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_InterestAndSecuritiesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest and securities receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_InterestAndSecuritiesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueEquityLevel1ToLevel2TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instruments classified in shareholders' equity measured on a recurring basis out of level 1 of the fair value hierarchy into level 2.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueEquityLevel1ToLevel2TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueEquityLevel2ToLevel1TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instruments classified in shareholders' equity measured on a recurring basis out of level 2 of the fair value hierarchy into level 1.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueEquityLevel2ToLevel1TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=goss_TwoThousandTwentySevenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=goss_TwoThousandTwentySevenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503184372552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements and Available for Sale Investments - Schedule of Available for sale Investments by Security Type (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale Investments, Amortized Cost</a></td>
<td class="nump">$ 93,120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale Investments, Gross Unrealized Gains</a></td>
<td class="nump">302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale Investments, Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Investments, Total Fair Value</a></td>
<td class="nump">93,422<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=goss_USTreasuryAndAgencySecuritiesMember', window );">U.S. Treasury and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale Investments, Amortized Cost</a></td>
<td class="nump">35,194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale Investments, Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale Investments, Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Investments, Total Fair Value</a></td>
<td class="nump">35,194<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale Investments, Amortized Cost</a></td>
<td class="nump">5,580<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale Investments, Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale Investments, Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Investments, Total Fair Value</a></td>
<td class="nump">5,580<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale Investments, Amortized Cost</a></td>
<td class="nump">52,346<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale Investments, Gross Unrealized Gains</a></td>
<td class="nump">302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale Investments, Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Investments, Total Fair Value</a></td>
<td class="nump">$ 52,648<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942338&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942338&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26610-111562<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=goss_USTreasuryAndAgencySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=goss_USTreasuryAndAgencySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503183123592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements and Available for Sale Investments - Schedule of Contractual Maturities of Available-for-sale Debt Securities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract', window );"><strong>Fair Value Measurements And Available For Sale Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue', window );">Due within one year</a></td>
<td class="nump">$ 79,582<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue', window );">One to two years</a></td>
<td class="nump">13,840<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">$ 93,422<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Available for sale securities debt maturities after one through two years fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in remainder of fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942338&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26610-111562<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503260583448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Indebtedness - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 21, 2020 </div>
<div>USD ($) </div>
<div>day </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>May 02, 2019 </div>
<div>USD ($) </div>
<div>Tranche</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Amount funded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 28,222,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible debt, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193,596,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=goss_TermLoanMember', window );">Term Loan | Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Amount funded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Remaining borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_NumberOfAdditionalTranches', window );">Number of additional tranches | Tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment', window );">Percentage of exit fee on amount borrowed on final repayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment', window );">Percentage of exit fee on amount borrowed on partial prepayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan', window );">Debt covenant minimum unrestricted cash percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt', window );">Debt instrument, default trigger amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=goss_TermLoanMember', window );">Term Loan | Credit Facility | Prepayment Occurs through First Anniversary of Closing Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_PercentageOfPrepaymentFee', window );">Percentage of prepayment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=goss_TermLoanMember', window );">Term Loan | Credit Facility | First Anniversary of Closing Date through Second Anniversary of Closing Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_PercentageOfPrepaymentFee', window );">Percentage of prepayment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=goss_TermLoanMember', window );">Term Loan | Credit Facility | Second Anniversary of Closing Date and Prior to Jan 1, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_PercentageOfPrepaymentFee', window );">Percentage of prepayment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=goss_TermLoanMember', window );">Term Loan | Credit Facility | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=goss_TermLoanMember', window );">Term Loan | Credit Facility | MidCap Financial Trust</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=goss_TermLoanMember', window );">Term Loan | Tranche One | Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Remaining borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=goss_TermLoanMember', window );">Term Loan | Tranche Two | Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Remaining borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=goss_TwoThousandTwentySevenNotesMember', window );">2027 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_DebtInstrumentAggregatePrincipalAmount', window );">Debt instrument aggregate principal amount</a></td>
<td class="nump">$ 200,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible debt, net</a></td>
<td class="nump">$ 193,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Convertible notes, initial conversion price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 16.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Debt instrument conversion ratio</a></td>
<td class="nump">0.0616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_DebtInstrumentConvertibleConversionPricePercentage', window );">Convertible notes, percentage of conversion price</a></td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion, converted Instrument</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Convertible notes, redemption percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes', window );">Percentage of repurchase price is equal to principal amount of convertible notes</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_LongTermDebtPercentageInAggregatePrincipalAmount', window );">Percentage in aggregate principal amount (not less than)</a></td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Carrying amount of the equity component</a></td>
<td class="nump">$ 53,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Convertible notes, effective interest rate</a></td>
<td class="nump">11.17%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance cost</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=goss_TwoThousandTwentySevenNotesMember', window );">2027 Notes | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_DebtInstrumentConvertibleConversionLastReportedSalePricePercentage', window );">Convertible notes, percentage of last reported sale price of common stock</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=goss_TwoThousandTwentySevenNotesMember', window );">2027 Notes | 130% Applicable Conversion Price | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Convertible notes, consecutive trading days | day</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=goss_TwoThousandTwentySevenNotesMember', window );">2027 Notes | 130% Applicable Conversion Price | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Convertible notes, consecutive trading days | day</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=goss_TwoThousandTwentySevenNotesMember', window );">2027 Notes | 98% Applicable Conversion Price | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Convertible notes, consecutive trading days | day</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=goss_TwoThousandTwentySevenNotesMember', window );">2027 Notes | 98% Applicable Conversion Price | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Convertible notes, consecutive trading days | day</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt covenant required minimum unrestricted cash percentage of term loan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_DebtInstrumentAggregatePrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument aggregate principal amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_DebtInstrumentAggregatePrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_DebtInstrumentConvertibleConversionLastReportedSalePricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument convertible conversion last reported sale price percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_DebtInstrumentConvertibleConversionLastReportedSalePricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_DebtInstrumentConvertibleConversionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument convertible conversion price percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_DebtInstrumentConvertibleConversionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant Terms, Default Trigger, Default Amount Of Other Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_LongTermDebtPercentageInAggregatePrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Percentage In Aggregate Principal Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_LongTermDebtPercentageInAggregatePrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_NumberOfAdditionalTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional tranches.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_NumberOfAdditionalTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of exit fee on amount borrowed on final repayment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of exit fee on amount borrowed on partial prepayment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_PercentageOfPrepaymentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of prepayment fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_PercentageOfPrepaymentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of repurchase price is equal to principal amount of convertible notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=goss_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=goss_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=goss_PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=goss_PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=goss_FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=goss_FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=goss_SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=goss_SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=goss_MidCapFinancialTrustMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=goss_MidCapFinancialTrustMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=goss_TrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=goss_TrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=goss_TrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=goss_TrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=goss_TwoThousandTwentySevenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=goss_TwoThousandTwentySevenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=goss_OneHundredThirtyPercentApplicableConversionPriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=goss_OneHundredThirtyPercentApplicableConversionPriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=goss_NinetyEightPercentApplicableConversionPriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=goss_NinetyEightPercentApplicableConversionPriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503183847496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Indebtedness - Schedule of Long-term Debt (Details) - Credit Facility<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Term loan</a></td>
<td class="nump">$ 30,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Debt discount and issuance costs</a></td>
<td class="num">(1,335)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 28,665<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503183255704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Indebtedness - Schedule of Future Minimum Principal Payments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2020 (remaining 3 months)</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2022</a></td>
<td class="nump">5,806<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2023</a></td>
<td class="nump">11,613<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2024</a></td>
<td class="nump">11,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix', window );">2025</a></td>
<td class="nump">968<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="nump">$ 30,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Maturities, Repayments of Principal in Year Six</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503181576024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Indebtedness - Schedule of Net Carrying Amount of Liability Component (Details) - 2027 Notes - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal amount</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized debt discount</a></td>
<td class="num">(57,557)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Unamortized debt issuance cost</a></td>
<td class="num">(285)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 142,158<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=goss_TwoThousandTwentySevenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=goss_TwoThousandTwentySevenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503178931592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Indebtedness - Schedule of Equity Components (Details) - 2027 Notes - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption', window );">Debt discount related to the value of conversion option</a></td>
<td class="nump">$ 53,635<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts', window );">Debt issuance cost</a></td>
<td class="num">(109)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Net carrying amount</a></td>
<td class="nump">$ 53,526<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to equity component of debt discount related to value of conversion option.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to equity component of debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=goss_TwoThousandTwentySevenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=goss_TwoThousandTwentySevenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503286453304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Indebtedness - Schedule of Interest Expense Recognized (Details) - 2027 Notes - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_ContractualInterestExpense', window );">Contractual interest expense</a></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,639<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance cost</a></td>
<td class="nump">1,436<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,078<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total interest expense related to the 2027 Notes</a></td>
<td class="nump">$ 3,943<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5,727<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_ContractualInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_ContractualInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=goss_TwoThousandTwentySevenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=goss_TwoThousandTwentySevenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503179418264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Licenses, Asset Acquisitions and Contingent Consideration - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 11, 2020</div></th>
<th class="th"><div>Sep. 21, 2018</div></th>
<th class="th"><div>Jun. 24, 2018</div></th>
<th class="th"><div>Jan. 04, 2018</div></th>
<th class="th"><div>Oct. 02, 2017</div></th>
<th class="th"><div>May 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jan. 31, 2018</div></th>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 275,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 18,080,000<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember', window );">GB002</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember', window );">GB001</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember', window );">GB004</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,275,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember', window );">GB1275</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=goss_PulmokineIncMember', window );">Pulmokine, Inc. | License Agreement | GB002</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_ProductLicenseTerm', window );">Product license term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_UpfrontPayment', window );">Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized', window );">Milestones accrued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=goss_PulmokineIncMember', window );">Pulmokine, Inc. | License Agreement | GB002 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable', window );">Development and regulatory milestone payments, payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable', window );">Commercial milestone payments, payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable', window );">Sales milestone payments, payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 190,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=goss_AABiopharmaIncMember', window );">AA Biopharma Inc. | GB001</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=goss_AABiopharmaIncMember', window );">AA Biopharma Inc. | GB001 | Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition, aggregate number of shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,101,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=goss_AABiopharmaIncMember', window );">AA Biopharma Inc. | GB001 | Series Seed Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition, aggregate number of shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=goss_AerpioPharmaceuticalsIncMember', window );">Aerpio Pharmaceuticals, Inc. | License Agreement | GB004</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_UpfrontPayment', window );">Upfront payment</a></td>
<td class="nump">$ 15,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized', window );">Milestones accrued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_ParticipationRight', window );">Participation rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=goss_AerpioPharmaceuticalsIncMember', window );">Aerpio Pharmaceuticals, Inc. | License Agreement | GB004 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable', window );">Development and regulatory milestone payments, payable</a></td>
<td class="nump">40,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable', window );">Sales milestone payments, payable</a></td>
<td class="nump">$ 50,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=goss_AdhaerePharmaceuticalsIncMember', window );">Adhaere Pharmaceuticals, Inc. | GB1275</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized', window );">Milestones accrued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Upfront payment, purchase consideration paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_BusinessCombinationContingentConsiderationMilestonesPayment', window );">Milestones payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=goss_AdhaerePharmaceuticalsIncMember', window );">Adhaere Pharmaceuticals, Inc. | GB1275 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable', window );">Regulatory, development and sales milestone payments payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination, contingent consideration, commercial milestone payments, payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination, contingent consideration, development and regulatory milestone payments, payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_BusinessCombinationContingentConsiderationMilestonesPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination contingent consideration milestones payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_BusinessCombinationContingentConsiderationMilestonesPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination, contingent consideration, development and sales milestones, payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business combination, contingent consideration, sales milestone payments, payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_ParticipationRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Participation right .</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_ParticipationRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_ProductLicenseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product license term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_ProductLicenseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_UpfrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Upfront payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_UpfrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount, measured at acquisition-date fair value, of all the assets acquired and liabilities assumed that arise from contingencies and were recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=goss_PulmokineIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=goss_PulmokineIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=goss_LicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=goss_LicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=goss_AABiopharmaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=goss_AABiopharmaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=goss_SeriesSeedConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=goss_SeriesSeedConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=goss_AerpioPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=goss_AerpioPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=goss_AdhaerePharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=goss_AdhaerePharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503185288920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Licenses, Asset Acquisitions and Contingent Consideration - Schedule of IPR&amp;D Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">Total in process research and development</a></td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="nump">$ 275<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 18,080<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember', window );">GB001</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">Total in process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember', window );">GB002</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">Total in process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember', window );">GB004</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">Total in process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,275<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember', window );">GB1275</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">Total in process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentOtherProgramsMember', window );">Other Programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">Total in process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,805<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentOtherProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=goss_InProcessResearchAndDevelopmentOtherProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503258527688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 21, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 06, 2018 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 21, 2018 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 04, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 03, 2015 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 31, 2018 </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2017 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_StockholdersEquityLineItems', window );"><strong>Stockholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_CommonStockVotingRightsNumberOfVotesPerShare', window );">Common stock number of votes per share | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with a public offering, net of underwriting discounts, commissions, and offering costs (in shares)</a></td>
<td class="nump">9,433,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Offering price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 13.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock | $</a></td>
<td class="nump">$ 117,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117,110,000<span></span>
</td>
<td class="nump">$ 291,311,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with a public offering net of underwriting discounts, commissions and offering costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117,094,000<span></span>
</td>
<td class="nump">$ 291,344,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares of common stock, repurchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,434,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,648,526<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=goss_SeriesAConvertiblePreferredStockMember', window );">Series A Convertible Preferred Stock | Stock Restriction Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_StockholdersEquityLineItems', window );"><strong>Stockholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Shares subject to forfeiture (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,305,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=goss_FounderMember', window );">Founder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_StockholdersEquityLineItems', window );"><strong>Stockholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with a public offering, net of underwriting discounts, commissions, and offering costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,795,023<span></span>
</td>
<td class="nump">251,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_PercentageOfFullyDilutedShareCapital', window );">Percentage of fully diluted share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_IncreasedInEquityCapitalAmount', window );">Increased in equity capital amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Common stock issued price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.63<span></span>
</td>
<td class="nump">$ 2.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting', window );">Additional shares of restricted stock subject to vesting restrictions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,795,023<span></span>
</td>
<td class="nump">251,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_StockholdersEquityLineItems', window );"><strong>Stockholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible preferred stock into common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,493,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with a public offering, net of underwriting discounts, commissions, and offering costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,433,963<span></span>
</td>
<td class="nump">19,837,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with a public offering net of underwriting discounts, commissions and offering costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common stock | Stock Restriction Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_StockholdersEquityLineItems', window );"><strong>Stockholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares', window );">Unrestricted shares of common stock were subject to service vesting conditions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,580,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=goss_FounderSharesMember', window );">Founder Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_StockholdersEquityLineItems', window );"><strong>Stockholders Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with a public offering, net of underwriting discounts, commissions, and offering costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,160,888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with a public offering net of underwriting discounts, commissions and offering costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_CommonStockVestingPercentage', window );">Common Stock vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_CommonStockVestingPeriod', window );">Common stock vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_CommonStockVestingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock vesting percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_CommonStockVestingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_CommonStockVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock vesting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_CommonStockVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_CommonStockVotingRightsNumberOfVotesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Voting Rights, Number Of Votes Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_CommonStockVotingRightsNumberOfVotesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_IncreasedInEquityCapitalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increased in equity capital amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_IncreasedInEquityCapitalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Incremental common shares attributable to restricted stock subject to vesting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_PercentageOfFullyDilutedShareCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of fully diluted share capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_PercentageOfFullyDilutedShareCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock incremental vesting conditions place on previously issued common shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_StockholdersEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stockholders equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_StockholdersEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=goss_SeriesAConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=goss_SeriesAConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=goss_StockRestrictionAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=goss_StockRestrictionAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=goss_FounderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=goss_FounderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=goss_FounderSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=goss_FounderSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503258440584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 06, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares outstanding awarded (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,266,895<span></span>
</td>
<td class="nump">8,538,060<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period of cost expects to recognize</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value, options vested in period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Aggregate fair value of stock options vested during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember', window );">Stock-Based Compensation Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period of cost expects to recognize</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense related to the ESPP.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=goss_TwoThousandNineteenEquityIncentivePlanMember', window );">2019 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of share reserved for future issuance</a></td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Term of awards</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Percentage of amount increase in outstanding shares</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock available for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,696,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares outstanding awarded (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,291,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=goss_TwoThousandNineteenEmployeeStockPurchasePlanMember', window );">2019 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of share reserved for future issuance</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Term of awards</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Percentage of amount increase in outstanding shares</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued', window );">Number of share issued under ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of share reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,249,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=goss_TwoThousandNineteenEmployeeStockPurchasePlanMember', window );">2019 Employee Stock Purchase Plan | Stock-Based Compensation Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period of cost expects to recognize</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense related to the ESPP.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=goss_TwoThousandNineteenEmployeeStockPurchasePlanMember', window );">2019 Employee Stock Purchase Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase of common stock through payroll deductions, percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=goss_TwoThousandSeventeenEquityIncentivePlanMember', window );">2017 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares outstanding awarded (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,071,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=goss_TwoThousandSeventeenEquityIncentivePlanMember', window );">2017 Equity Incentive Plan | Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Stock awards granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">342,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares issued for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=goss_TwoThousandNineteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=goss_TwoThousandNineteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=goss_TwoThousandNineteenEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=goss_TwoThousandNineteenEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=goss_TwoThousandSeventeenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=goss_TwoThousandSeventeenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503185172248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans - Summary of Stock Option Activity (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares Subject to Options Outstanding, Outstanding as of December 31, 2019 (in shares) | shares</a></td>
<td class="nump">8,538,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares Subject to Options Outstanding, Options granted (in shares) | shares</a></td>
<td class="nump">2,540,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares Subject to Options Outstanding, Option exercised (in shares) | shares</a></td>
<td class="num">(76,275)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Shares Subject to Options Outstanding, Options forfeited/cancelled (in shares) | shares</a></td>
<td class="num">(735,012)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares Subject to Options Outstanding, Outstanding as of Sept 30,2020 (in shares) | shares</a></td>
<td class="nump">10,266,895<span></span>
</td>
<td class="nump">8,538,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Shares Subject to Options Outstanding, Options vested and exercisable as of Sept 30, 2020 (in shares) | shares</a></td>
<td class="nump">3,274,782<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Outstanding as of December 31, 2019 (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 13.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Options granted (in dollars per share) | $ / shares</a></td>
<td class="nump">14.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Option exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">3.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Options forfeited/cancelled (in dollars per share) | $ / shares</a></td>
<td class="nump">13.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Outstanding as of September 30, 2020 (in dollars per share) | $ / shares</a></td>
<td class="nump">13.83<span></span>
</td>
<td class="nump">$ 13.67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Options vested and exercisable as of September 30,2020 (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 12.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-Average Remaining Contractual Life (Years)</a></td>
<td class="text">8 years 4 months 24 days<span></span>
</td>
<td class="text">9 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted-Average Remaining Contractual Life (Years), Options vested and exercisable as of September 30, 2020</a></td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic&#160;Value | $</a></td>
<td class="nump">$ 19,221<span></span>
</td>
<td class="nump">$ 35,385<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Options vested and exercisable as of September 30, 2020 | $</a></td>
<td class="nump">$ 10,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503282242088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans - Summary of Restricted Stock Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted-Average Grant Date Fair Value, Nonvested at September 30, 2020 (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 5.96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of Restricted Stock Units Outstanding, Nonvested at December 31, 2019 (in shares) | shares</a></td>
<td class="nump">4,648,526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of Restricted Stock Units Outstanding, Granted (in shares) | shares</a></td>
<td class="nump">1,176,340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Number of Restricted Stock Units Outstanding, Vested (in shares) | shares</a></td>
<td class="num">(1,213,911)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number of Restricted Stock Units Outstanding, Forfeited (in shares) | shares</a></td>
<td class="num">(79,957)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of Restricted Stock Units Outstanding, Nonvested at September 30, 2020 (in shares) | shares</a></td>
<td class="nump">4,530,998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted-Average Grant Date Fair Value, Nonvested at December 31, 2019 (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 3.98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-Average Grant Date Fair Value, Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">11.94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-Average Grant Date Fair Value, Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">3.71<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted-Average Grant Date Fair Value, Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 12.95<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503188939608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans - Stock-Based Compensation Expense Reported in Condensed Consolidated Statements of Operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 8,923<span></span>
</td>
<td class="nump">$ 5,728<span></span>
</td>
<td class="nump">$ 26,067<span></span>
</td>
<td class="nump">$ 13,957<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">4,726<span></span>
</td>
<td class="nump">2,727<span></span>
</td>
<td class="nump">14,094<span></span>
</td>
<td class="nump">6,483<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 4,197<span></span>
</td>
<td class="nump">$ 3,001<span></span>
</td>
<td class="nump">$ 11,973<span></span>
</td>
<td class="nump">$ 7,474<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503185414792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 29, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Nov. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating lease, weighted average discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="nump">$ 2,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_LeaseContractualTermAxis=goss_NonCancelableLeaseAgreementEnteredInAugust2018Member', window );">Non-cancelable Lease Agreement Entered in August 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_OperatingSubleaseAnnualIncreasePercentageForBaseRent', window );">Operating sublease, annual increase percentage for base rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_LeaseContractualTermAxis=goss_AdditionalNonCancelableLeaseAgreementInNov2019Member', window );">Additional Non-cancelable Lease Agreement Entered in November 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_PermanentMonthlyBaseRent', window );">Monthly base rent for permanent space</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_TemporaryMonthlyBaseRent', window );">Monthly base rent for temporary space</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_PeriodForWhichLeaseOfPermanentSpaceCanBeExtended', window );">Option to extend lease term of permanent space</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_AnnualIncreasePercentageForLeaseCharges', window );">Annual increase percentage for lease charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_LeaseContractualTermAxis=goss_SubleaseAgreementEnteredInJune2020Member', window );">Sublease Agreement Entered in June 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_SubleaseTemporaryMonthlyBaseRent', window );">Sublease monthly base rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_SubleaseAnnualIncreasePercentageForLeaseCharges', window );">Sublease annual increase percentage for lease charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_SubleasePeriodOfBaseRentAbatement', window );">Sublease period of base rent abatement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_LeaseContractualTermAxis=goss_LeaseAssignmentAgreementEnteredInJuly2020Member', window );">Lease Assignment Agreement Entered in July 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_AnnualIncreasePercentageForLeaseCharges', window );">Annual increase percentage for lease charges</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease, renewal term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_OperatingLeasesMonthlyBaseRentExpense', window );">Lease assignment agreement, monthly base rent expense</a></td>
<td class="nump">$ 28,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_AnnualIncreasePercentageForLeaseCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual increase percentage for lease charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_AnnualIncreasePercentageForLeaseCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_OperatingLeasesMonthlyBaseRentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Leases, Monthly Base Rent Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_OperatingLeasesMonthlyBaseRentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_OperatingSubleaseAnnualIncreasePercentageForBaseRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating sublease, annual increase percentage for base rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_OperatingSubleaseAnnualIncreasePercentageForBaseRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_PeriodForWhichLeaseOfPermanentSpaceCanBeExtended">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period for which lease of permanent space can be extended.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_PeriodForWhichLeaseOfPermanentSpaceCanBeExtended</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_PermanentMonthlyBaseRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Permanent monthly base rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_PermanentMonthlyBaseRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_SubleaseAnnualIncreasePercentageForLeaseCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sublease annual increase percentage for lease charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_SubleaseAnnualIncreasePercentageForLeaseCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_SubleasePeriodOfBaseRentAbatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sublease period of base rent abatement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_SubleasePeriodOfBaseRentAbatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_SubleaseTemporaryMonthlyBaseRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sublease temporary monthly base rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_SubleaseTemporaryMonthlyBaseRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_TemporaryMonthlyBaseRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary monthly base rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_TemporaryMonthlyBaseRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_LeaseContractualTermAxis=goss_NonCancelableLeaseAgreementEnteredInAugust2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_LeaseContractualTermAxis=goss_NonCancelableLeaseAgreementEnteredInAugust2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_LeaseContractualTermAxis=goss_AdditionalNonCancelableLeaseAgreementInNov2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_LeaseContractualTermAxis=goss_AdditionalNonCancelableLeaseAgreementInNov2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_LeaseContractualTermAxis=goss_SubleaseAgreementEnteredInJune2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_LeaseContractualTermAxis=goss_SubleaseAgreementEnteredInJune2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_LeaseContractualTermAxis=goss_LeaseAssignmentAgreementEnteredInJuly2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_LeaseContractualTermAxis=goss_LeaseAssignmentAgreementEnteredInJuly2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503178792184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Lease Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 1,007<span></span>
</td>
<td class="nump">$ 2,577<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 1,023<span></span>
</td>
<td class="nump">$ 2,631<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=77888399&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140503189531896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Gross Future Minimum Annual Rental Commitments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2020 (remaining 3 months)</a></td>
<td class="nump">$ 1,043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2021</a></td>
<td class="nump">4,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2022</a></td>
<td class="nump">3,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2023</a></td>
<td class="nump">2,063<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2024</a></td>
<td class="nump">2,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_LesseeOperatingLeaseLiabilityPaymentsDueYearSix', window );">2025</a></td>
<td class="nump">387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_goss_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix', window );">Thereafter</a></td>
<td class="nump">397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted rent payments</a></td>
<td class="nump">13,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Present value discount</a></td>
<td class="num">(1,670)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value</a></td>
<td class="nump">12,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liability (included as a component of accrued expenses)</a></td>
<td class="nump">3,548<span></span>
</td>
<td class="nump">$ 2,354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Noncurrent operating lease liabilities</a></td>
<td class="nump">8,647<span></span>
</td>
<td class="nump">$ 8,737<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liability</a></td>
<td class="nump">$ 12,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, Payments, Due After Year Six</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_goss_LesseeOperatingLeaseLiabilityPaymentsDueYearSix">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, Payments, Due Year Six</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">goss_LesseeOperatingLeaseLiabilityPaymentsDueYearSix</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>goss_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease having an initial or remaining lease term in excess of one year due in remainder of fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>60
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?K*"-0C=3[WK*=8)T:HHT%9%898I9?J/HNG(TP6&D=5VQ0V*WS[VTN_)JF)
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MWHYB<7+792\:/S'U(&H-W+T!17R=0 !4=W?7#8S<M==?:VF,K-K'+6< VPK
M]XV$4U,_L#=JQQO4U;]02P,$%     @ ,H-J4<_3:3:4 @  Q08  !@   !X
M;"]W;W)K<VAE971S+W-H965T,RYX;6R5E5UOFS 4AO^*A7;12ETP$*"MDDAM
MJFJ[F!0UVG8Q[<*!DV#5V,QVDFZ_?L>&HC0?_<A%L,UY7S_G8 ZCK=*/I@*P
MY*D6THR#RMKF.@Q-44'-S$ U(/'.4NF:69SJ56@:#:STHEJ$,:596#,N@\G(
MK\WT9*365G ),TW,NJZ9_GL+0FW'010\+SSP567=0C@9-6P%<[#?FYG&6=B[
ME+P&:;B21,-R'-Q$U]/,Q?N 'QRV9F=,7"8+I1[=Y&LY#J@# @&%=0X,+QN8
M@A#."#'^=)Y!OZ43[HZ?W>]][IC+@AF8*O&3E[8:!Y<!*6')UL(^J.T7Z/))
MG5^AA/'_9-O&9GE BK6QJN[$2%!SV5[94U>''4$T/"&(.T'\7D'2"1*?:$OF
MT[ICEDU&6FV)=M'HY@:^-EZ-V7#IGN+<:KS+46<G4R5+?"90$AP9)7C)+$YN
MF6"R #)WQH:<S9@&:2NPO&#BG'PFGTA(3(6K9A1:Y'!N8='M>=ON&9_8<P[-
M@"3T@L0TID?DT]?E=U"@/'+RZ.JE/,3L^Q+$?0EB[Y><PK&8,AY,2]22W'.)
MB7,FR$P9[D_:KYN%L1K/V^]7-DOZS1*_V?!DO>L:/?&Y%H\7I&&:;)A8 SGC
MDI1*"*8-:4"WM3T_5MO6/_?^[AW=3.B 4AJ-PLUN#=\,>X$_[/&''\!G:ULI
MS?_A@7'\[7DX"MVZICLT.>U^>]SOB7R!GO;HZ0?0N3'KM['30YCTBN9IG.]1
M'P9F67PYI#0Y#IWUT-D'H+$+&\MDR>7J+?+LD#P>(GP4[Y$?!F91EJ3#/-\C
M#W>:C&OPWYA><6F(@"5*Z2!'#]TVS79B5>/[SD)9[&)^6.%W!K0+P/M+I>SS
MQ+6R_LLU^0]02P,$%     @ ,H-J4<['(\ -!0  (1,  !@   !X;"]W;W)K
M<VAE971S+W-H965T-"YX;6REF&UOVS80Q[\*8?1%"K0123T'CH'&]K8"[5HT
M[?I:L6A;J"1Z).VD^_0[4HILD[26;6]B2?G?D;_CD3QR^LC%#[EE3*&GIF[E
M[62KU.XF".1JRYI"7O,=:^$_:RZ:0L&KV 1R)UA1&J.F#BC&2= 453N93<VW
MSV(VY7M55RW[+)#<-TTA?MZQFC_>3LCD^<.7:K-5^D,PF^Z*#;MGZMONLX"W
M8/!25@UK9<5;)-CZ=O*.W"Q)J@V,XH^*/<J39Z11'CC_H5_>E[<3K'O$:K92
MVD4!/P<V9W6M/4$__NR=3H8VM>'I\[/W7PP\P#P4DLUY_;TJU?9VDDU0R=;%
MOE9?^.-OK >*M;\5KZ7YBQY[+9Z@U5XJWO3&T(.F:KO?XJD/Q(D!^/$;T-Z
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MN/Y'I76K [H)DIP*BU!7@%!X%BML>(U?-%,P.F4"(-.3,W&5OJ2)JPS'K]B
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MXGN/I"EE>V-?785(\%8K[2911=0\Q+$K*JR%NS8-:C[9&%L+8M-N8]=8%&4
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M<VAE970X+GAM;*U8VW(;N1']%13CI.0J+F^2;&DMJXJ2U[M.Q;'*3C8/J3R
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M,M%M+80.T3(12V,@,2+6.2(K:: 3U4*;42TV2&95/-BXE(E#(V&4CCM1RWM
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M[5/%+5.S;S+]U&XCT2>CLWY'\OLMJ9T\P,_(W+]Q]7TM/L3$YKX!+MEYRF/
MH4.Z<AMYC?QFD(L#L8^I@7S1CF64-E=%+)C4=6T[IDY%S$"L$MYH.OA6[H"F
M$A&<S#EXE5Y1;,1-SQ;W!04%E]6U1JO/]3[-P8BF&A&)*5.M29DU0#TIK.42
MWDX2U*$DA;D4;%\Z\(&QJC8M(EHQ]!:.DPJ=9),O;8\4NX2FZ2$[Y$JB[L"
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M8I)+8:%*O3<.6%:'. $N@#'N689H5=MDRA/+9'114 :F3.5KNJYJ:9(I-J;
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M7MO.)55=ZK-+A;.0PX3>'>A1@L9PI9OESCP'!5';?N&3W#%"N7E%'%^.L;'
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MVFSY<J-P-+*T .]7QM3M#2GH_BSBV7\!4$L#!!0    ( #*#:E%),-I$5PL
M -P?   9    >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;,U9:7,;N1']*RC%
MFY*J1A1/';ZJ;&F]L;.R5=8ZJ50J'\ 9D$1V!J !#"GEU^=U S,<4H<=[[JR
M'VR1,T"?KU\WP.=KZW[U"Z6"N*E*XU_L+4)8/CTZ\OE"5=+W[%(9O)E95\F
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;(U5;6_;. S^*X0'#'>
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MP"8(V0;QGO0]@=\K^KR6B,T]"6@:C2Z1[RGF'VYJ'I0!N]$UV9B.H*+Z_E?
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M_^?6M6RX'_8N&LV"Z?CHR>J4F Y+\;]M7TOZ7#OIY B;3CCIL')^PC 62L8
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MW%'[A]H%T/N-HAUO!VZ!KJ%<_ -02P,$%     @ ,H-J40";4EC-!   =1D
M !D   !X;"]W;W)K<VAE971S+W-H965T,C<N>&ULO9G?;Z,X$,?_%2O:AUVI
M5[ -^5&ED=IT3[=2>Q=M=N\>3O?@PJ2Q%C"+3=-*]\>?(023A)CFVN8E 3+S
M]7@\?#"3\4ID/^020*&G.$KD96^I5'KA.#)80LSDN4@AT;\L1!8SI4^S!T>F
M&;"P=(HCA[ANWXD93WJ3<7EMEDW&(E<13V"6(9G',<N>KR$2J\L>[FTN?.4/
M2U5<<";CE#W '-3W=);I,Z=6"7D,B>0B01DL+GM7^&+J>85#:?$GAY5L'*-B
M*O="_"A.OH27/;>(""((5"'!]-<C3"&*"B4=Q\]*M%>/63@VCS?JOY:3UY.Y
M9Q*F(OJ+AVIYV1OV4 @+ED?JJUC]!M6$_$(O$)$L/]&JLG5[*,BE$G'EK".(
M>;+^9D]5(AH.6J?=@50.9-?!.^! *P=:3G0=63FM&Z;89)R)%<H*:ZU6')2Y
M*;WU;'A2+.-<9?I7KOW4Y)I%+ D S<N:N0H"D2=*(I:$:)ZG:01ZR12+T V7
M021DGH%$OZ"YKJ8PCP")!9IENJ8R]5SZ?/Z9\[1P.4._:[V/-Z 8C^0G[?-]
M?H,^?OB$/B">H&]+D4OM(,>.TK,H8G&"*N+K=<3D0,0C="<2M93H<Q)"N.WO
MZ-G7*2";%%P3J^ <TG-$W3-$7.*VQ#.UN]] H-UQX8Y'EG!HO2*TU*,']#;Y
M/$,SO31J.ZWH[UMMCKXHB.4_EL&\>C"O',P[,-@W42QNVEQ"V(S5MC1KM7ZI
M5A#B<3(8#?RQ\]C,U[Y1OT]'M=%6H'X=J&\-]!:DO- W?9#'><04A/I>U=P*
M."MHT!;J6L]O1$&(/]P)==\($^RUA]JO0^U;0YVU9O,,)=":TOY>"/X #W;B
M;#'RB-\>YZ".<V"-\X_%@NL[_\!Z;TD.:\GA^]?NJ!YL]*:U.]HK2XQ]NI/H
MT7Y!N*-!>Z*Q:R#K'I5J]"^ZXPF/\]B2!]Q@.'[_M&-BAB/_J\!!*AZ7]V8N
M89%'*.(+: 6\79^B9V"9M,5J8(KIT9EG3UV9-_C$W@DR;R"([11\?>;M^H/N
MS!L*8CL&IR).<P79BP"##;3PX 09-T##PS>%3"6W11EO%S*5T?9CY\!3!QL<
M8CL/7U\<=GV_LSB( 2*Q W$N%FK%,K")&?R1$^"/&/P1.YZ.+8E*;OO!X^V4
M1&74+(GA@<<.,? C=OB]NB(Z]+M!30Q)B7TG>LON7T0*8F!)_!.4A>$=L?/N
MZ++H[Y6%YY+=O339W_E1US_ "F(H2NQ[OZULOV@W0@PRR0DV@<1@C[PS]CKT
M26>14X,]:L?>7MH[MR+44)">@(+44)"^\R:P0[_[:4,;;]1V3MT"D[ 448AX
MK&_0Q[*I894VV*(GV !2PS1JWZ ="YE*K@D9XGON#F1HV[LR.?#&3@T1J9V(
M[6E_$6VH(1D]P7Z0&KA1^W[P]65OU^]WE[TA([63ZW#^.['C&:1Y[@G:589R
M'G[?_'?H=[\!>0:1GAUA4Y%(E>7K?C5/BMLV &G5-DCS3M$E;+0)W[A/N-\#
MW(5.BXDWW$&.TVALQY ]E/U^B<HF];K'75^M_U.X*COICC%?_R%QQ[('GD@4
MP4*[NN<#3;MLW>-?GRB1EFWR>Z&4B,O#); 0LL) _[X00FU.B@'J?UHF_P%0
M2P,$%     @ ,H-J4;*3&BL0 P  G0@  !D   !X;"]W;W)K<VAE971S+W-H
M965T,C@N>&ULC99=;]HP%(;_BA7MHI6ZYHN$4 %26S9M%]-0:;>+:1<F.1"K
M3IS9#K3_?L<F1)0$Q W8\7F/'[\^CC/>"OFJ<@!-W@I>JHF3:UW=N:Y*<RBH
MNA45E#BR$K*@&KMR[:I* LVLJ.!NX'FQ6U!6.M.Q?3:7T[&H-6<ES"51=5%0
M^?X 7&PGCN_L'SRQ=:[- W<ZKN@:%J!?JKG$GMMFR5@!I6*B)!)6$^?>OWL<
MF7@;\(O!5AVTB5G)4HA7T_F>31S/  &'5)L,%/\V\ B<FT2(\:_)Z;13&N%A
M>Y_]JUT[KF5)%3P*_IME.I\XB4,R6-&:ZR>Q_0;->B*3+Q5<V5^R;6(]AZ2U
MTJ)HQ$A0L'+W3]\:'PX$_N"$(&@$P:6"L!&$=J$[,KNL&=5T.I9B2Z2)QFRF
M8;VQ:EP-*\TN+K3$488Z/7V@G)8ID(4MF?LT%76I%:%E1A9U57' '=.4DQE3
M*1>JEJ#(9[+ 8LIJ#D2LC$;6D)$O;UA9"H>O9J IX^H: U\6,W+UZ9I\(JPD
MS[FH%6968U<CN@%PTP;S88<9G,!<0'5+0N^&!%[@]<@?S\MGD*+<-W)_]%'N
MHF&M:T'K6F#SA2?RS>D[77+8^60-H%R1/_=+I246YM\S4X3M%*&=8G!BBKVM
MJ2B,K]04?9]ONRRQS6*.[&::Q$$X=C>'[G2#1D$2M$$?  <MX. LX,\*)%*5
M:\(!SQ'AC"X99YJ!NL'*E1(+IP]XES4Z8 FC07($W T*,*H?.&J!HXL<K:18
M@3*O(:QK!7+#L/Y7 +UE&75!HL0_HNT)"@?#?MJXI8TOHF6E!CQT^JRG<=?3
M)!X<47:#O'[$88LXO A1Z!QD']:P,V/L!T=4W1C?#^)^L*0%2R[TSFQVBIN-
M%XX"*M/<GM@,-GA]5<4)-Y/N=@ZC(^QNC!][)_P<M=BCL]C/PKQI:0,/S?NT
MCW#4.<_^*/*.3WU/5#ST1D>0[L'E82[N'U2N6:GP5*]0Y]T.<9%R=QGN.EI4
M]CY9"HVWDVWF^/T T@3@^$H(O>^8*ZK](IG^!U!+ P04    "  R@VI1.L]2
MS!(%   *(@  &0   'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6S-FEMOXC@4
MQ[^*Q8Y6'6FFB2\0F*5(O6BTE=J=;IG./JSVP8 I5I.8M0U,I?WPZUP:)Y"Z
M32E27MJ$G'-\CO^)?_B0X4;(![5@3(.?41BKD\Y"Z^47SU/3!8NH.A9+%ILK
M<R$CJLVIO/?44C(Z2YVBT$.^W_,BRN/.:)A^=B-'0['2(8_9C01J%454/IZQ
M4&Q..K#S],$MOU_HY -O-%S2>S9F^FYY(\V95T29\8C%BHL82#8_Z9S"+^=D
MD#BD%C\XVZC2,4A*F0CQD)Q<SDXZ?I(1"]E4)R&H^;=FYRP,DT@FCW_SH)UB
MS,2Q?/P4_6M:O"EF0A4[%^%??*87)YU^!\S8G*Y"?2LVO[.\H&X2;RI"E?X%
MF]S6[X#I2FD1Y<XF@XC'V7_Z,Y^(D@,DSSB@W &]U@'G#C@M-,LL+>N":CH:
M2K$!,K$VT9*#=&Y2;U,-CQ,9QUJ:J]SXZ=%7RB7X0<,5 ]>,JI5D1B.M (UG
MX'1->4@G(0/F=@%C:@XNXS53.C/Y#$Z58N8@=YP!JD$IGA'IEDU74O+X'IQ1
MQ14XNF#:Q%0?C?/VM<_@;GP!CCY\!!\ C\'WA5@IDX4:>MK4F63K3?.:SK*:
MT#,UC=GR&&#_$T ^\FO<S]WN%VQJW&'B#@=5=\_,;C'%J)ABE,8CS\2[%C%[
M-)K)!_-4SE<[)56"XB(H3H/B%W7[]"1#(MD5IQ,><LU929:*$(G5'R*66[/_
M]Y49 %QJ%JE_'.F1(CWBK#E/*2K=&?,DX_73G6''GR3CUXF<C=!+1TA6H_4(
M]P),R-!;E\7<->LCB+J%527_;I%_UYG_W?'X&'R7:?J/Z9R9-2V>/@*5Y)W.
MKV.6>L4HO3:*&!3I!0<7,1NA6U*GBX, ;6FX:S6  0SJ->P7Z?>=Z9^+*&)R
MRFD(EG3)I&-&!D7(01L%@[Y=S?V#2Y8/4=&LV_>W)*NQP@&!L%XS6.(1?$$U
MN122:F9@/-&O>]Z@78HA:J6 =EF'^/ "XIJ'KC\(MA7<-8/='@J>>>R@7?NA
M>_'_<R4TF_WZ"^SYOUUGV+N1?&KF-OD><3DSWQ[XE(:905[PT15;LQ# C^ _
MT B8T"[IL-M*[2T-8._PVO=V'\LZ:M;8.; )+3*@FQG[:K\?>*%E ^RW\F:P
MI(&#P]\,@U?1M\;,@5]D883<,-KW7F@ <&3Y@F ;A4>EW8)[N_ >PN=#E!7=
MYK?3I)JZA1=RPVM_P9NS'UDL(=)*Y2V@D'O3\2[*=U]6WF523=VB"[G1->;W
M,9\;<6,-OND%DYG&WR:*R77:0KB,ERLK-VK,>601A()6ZFS9@]P;DW?1N?^R
MSBZ3:NJ62LA-I3?IO!_3L>4-]MLH/+;LP>Z]S7L(GP_A$MYI4DW=4@F[J?0F
MX1L ')<:7ZWL?&'+&7SXWE<^Q M[\!HKQQX<6Q!A-XC>*'9S>&,+&-S*5AFV
MU,&';Y;ANF[9[L:]QLRU<<<63-@-IK+N=[%X3F[<&-[8 @:WLL-&+&3(X3ML
M9+=WMOUH.TVJJ5O\$#=^FLB['[.)Y0II94..6-R0PS?DR&ZG;4=OETDU]=)O
M,&X0-=&[ :J)Y0AI9<>-6*J0PW?<R&XG;4=<ETDU=<L;XN9-,W&;HYE8:I!6
MMM*(90HY?"LM'Z+G4MEEDJ7NE7ZH3]Z2N*;RGL<*A&QN?/SCP-PB,GOQ(#O1
M8IG^=C\16HLH/5PP.F,R,3#7YT+HIY/D=8#B]8_1_U!+ P04    "  R@VI1
M7<M1D_("  #<"   &0   'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6S-5M]/
MVS 0_E>L: \@,?*COP"UE4H[M$JP552PAVD/;G)M+!P[L]T4I/WQ.SLAM")D
M:$_TH;&=^\[??6??9;B3ZD&G (8\9ESHD9<:DU_XOHY3R*@^E3D(?+.6*J,&
MIVKCZUP!31PHXWX4!'T_HTQXXZ%;6ZCQ4&X-9P(6BNAMEE'U= E<[D9>Z#TO
MW+)-:NR"/Q[F= -+,'?Y0N',K[TD+ .AF11$P7KD3<*+:1A8@+.X9[#3>V-B
M0UE)^6 G\V3D!981<(B-=4'Q4< 4.+>>D,?ORJE7[VF!^^-G[U<N> QF135,
M)?_!$I..O#./)+"F6VYNY>XK5 'UK+]8<NW^R:ZR#3P2;[61605&!AD3Y9,^
M5D+L <+N&X"H D3O!70J0,<%6C)S8<VHH>.ADCNBK#5ZLP.GC4-C-$S8-"Z-
MPK<,<69\19DB]Y1O@=P U5L%F".C"14)F124<;KB0/"XD"7%P5P4H$UI\IE,
MDH399%".+\HC95-S- .#2'V,)G?+&3GZ=#ST#9*U6_IQ1>RR)!:]06P)^2GI
M!"<D"J*@ 3YMA\\@1GAHX>'Y(=Q'B6J=HEJGR/GK_%.G$S+1&BJ)KAE=,8XB
M@'[6+R$HP2W$6Z68V#BK;U*H>N&2:J;)SVO<@,P-9/I7"[U.3:_CZ'7;Z!4N
MC2D#156</A$.!7 2$B.K8=24AM)QWSFVE[X8H]S%OM)M%@=LNS7;[O^RC5[8
MADUL2\>]%K9M%@=L>S7;7BM;/( #3*'!%/\AUTU"'KCMUV[['_%$#6IZ@_?F
M2*Y)+/'B*\-L,= @&-8#815I2M'@50+L%7:_YD2<U93.6BDM%.24)>3+(S8Q
M#:5>WTT*BDQ1"BQ*E9 MX9_7>YU_Q.R$P4O=#EK%F L#"FNQVU#;W4I6N#&P
MPE;MQIH;O+K+O</,5,7UM5W8:TJAO]=Z;-^_H6K#A,8KO$9D<#K <Z#*5EI.
MC,Q=-UI)@[W-#5/\_ !E#?#]6N*YJB:VP=4?-.._4$L#!!0    ( #*#:E%J
MFQ$)IP,  *X0   9    >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;,U8WV_:
M.A3^5ZQH#YNTDM@D%"9 :JFV6ZF;JM)N#U?WP9 #6$OB7-N!<?_Z>^*D"85
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M:&5E=#,V+GAM;)6576_:,!2&_XH5]:*5UB8$ ET5D%K0-*2N0F7=+J9=F.0
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M"52:8/$>W JA$ODV^)T10734!4 T!#-&):%;3*4>"A)BCDQ.? !KE>9A%F/
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MC%3+I0'J^88QN9]H ^4?$)-_ 5!+ P04    "  R@VI1'F<NKFX&  "!'@
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MAR;+>C(\8>FGFT3L.2^;?#3/9;@V^3U" &+Q38(S(8"E,G%3^8<),#I,B><
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M 5@?/O)4+27<IB$+:^3'[?(6:5%@H)5*4Y&=J:Y)J\8I6W7!-B^ F,2\G][
MV;OSBGK^6X>S7>L-"U"KI;5:_:.T/@-OEWZVLV7L)O!:T:4.^!#&/,$J(&GN
M3R%HNF"8F0IF6]B?-Z';;'BTH2*\* ( 7?MIK:1"KT;I K[>\3@&S"@]YZ\6
MH+T2:"\#VFL#*C'\9G]CIH/BNW7WEWV.@4H=I6A(ELR8*(T)9QB!N0'/X1]H
M=-!U#LC) .FR]SCT'=LW77-@/-8P<4HFSILP*087Z >%5C\6M7. FC@]TR*D
M'K5;HG;?#C6P)R:"2+X"MGL ^])SB>?4H_9*U-Y;VAJWOSF+T-I&0+'RQ?$K
M"'@U!&P'#5_/P"\9^/]-W&-94KHLZ:IT- G_@(1E$M?U^Y4?\N)U.+$U-_HE
MV_Y;^NN129T:.+R+.#J+V0L#P*LLT#\@9A.OY_D-;K3,:D,U_X]*>P%?LI8$
M9X\>F< 6"VZ+Y(.)B (&7T<SJ03V16UEV-IK#*Q6%^V6NZQ?[O@2'.(.086$
M%7[(_*$=4VUQM:U!#LW?CT^[ZWH-OB$5)_*#G&J*\2GX<Q@Z4BH"O:[9%%S5
M+F[9;T'@15T^A8%]R,#N>G8#@6IWM]JW]Z,]T%2B3^'2J_$&AI/50*;:X*WV
M'?Z$%-'%JLB1_8IU"BNGEI5OOZC@Q;QC<ZGJ$ZSV1N%H3WZW>)?V^"%SN(<T
M2==IHEDU%E9[9W% \X[IT['VZ!C/%[K>KFD,OT=S!F=_,D1]7@NO?14?MEH4
M>I#DAQ;2@Y!N:\\3WU'5SU6U[0%53V*U-R4GD#_%[UD>U%JM'9Y76,W?60T/
M?8=6>\Z]ZE"L]A9EM%@(MJ"*X>%8B2B54?#S3Y9K_O*9QFNFX[$6<:[4W0_#
M/B'6RZ0\G&9C7]70!9.J^2#F:T%#AO=DMS01+8 \(VIB#_F"@;%W-9$PL<AN
M;"0$?)VJ_):B'"UOA4;978A13<^OE#Y2L4!&$+,YBII=#PN;R&]I\A?%5]E%
MQXPKQ9/L<<EHR(2>@-_GG*O=BUZ@O"L;_@M02P,$%     @ ,H-J47W5T=/
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MO:C4?5GHID=T_[E)NH2.SPCUJ=\ G[7!19>$_E'XW W_+!]?X,&X 7[EAC]
MYM1^_<MP#T-8Q9%6<:2YO/"(O%O0&N",W *6V1F9@XX4S_)8?;_%M>3&0*K_
M=F@**TUAKJEW1-.7#!2S.4*20M<VKUZ("7O$-RL@,=>1W A#<!TT[:Q;P;#K
M^[\W[>A/P_;\ZU7^]9QROKUV1X%EZ,IA8D"E35ZYQ8;D&9C29$12++&U)@$E
M,7O638[^'Y+V?.]7OO>=HF=,KTG&>$RPU(G<CS1).%OP!.D FJR^*D0/<M&V
MH3U. S__FWB/N]X=KJ.#_75[M@\JVP=.V^^1PP@\8<O5C4E7H/NMY@T.S1L[
MS!M6Y@V=YGV6XD/$1 0)6R10U"FY6"D 2[[D2F!:8=)Q02XV*^1]2TLC1TA'
ME=[1&Q/#N-(T/I$8]&91<@,38H.M@XM(Y0[CD@C=M65E,\S.!%A?PC15@5M;
MV%+N@5]W0-\I::?%G1XD[!Z0+D U=(]],W8:<?#&@0KJ9A%0I\N?+'$DS_7^
MY]' X*1,V#N=L:BIB.:EW-WJ&(0]VF^NC:#N*8&;O)L-0H<SJ7#@=1@4'I;K
M:-@[9E#=! (WR7XI=MY(I!0#.!C5W$_D\J2M<BM TB[HVQ70FK<#-W%?N.NL
M,#Y:,[5JY.YYB_C68JM).G"S]$-)#<U5A2,=M$U$0<VXP?"M*ZIFV6!TFE_I
MZTQN'&Q'/U5&-0,';E*LK&CAW;9\F+7H:<L'6I,O=9-O93%:R&5L:ZOF +;
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M@A:3*OL"/-]+:=X&MHD9F];U?U!+ P04    "  R@VI1'\E8;50"  !D#
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M$BX1H+V6IK[R(GWL5NFKP[1<MNZ,>0MMG^R%D\W^)?K^#P"O?P)02P,$%
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M>COJ[<_4.^73+J9;SW6-[W\FU?G\;+R]_K*\;J*$PPO. ?YKOO\"4$L#!!0
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M5:'(JE!D52BR*A19U7_*^F[,\J__P+7WM-9E<\AGW6_.Z2=02P$"% ,4
M"  R@VI1!T%-8H$   "Q    $               @ $     9&]C4')O<',O
M87!P+GAM;%!+ 0(4 Q0    ( #*#:E$ 7;RH[@   "L"   1
M  "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( #*#:E&97)PC
M$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL
M4$L! A0#%     @ ,H-J40&"_#]*!0  ]A4  !@              ("!#0@
M 'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( #*#:E'$?0R[
MH04  $T5   8              " @8T-  !X;"]W;W)K<VAE971S+W-H965T
M,BYX;6Q02P$"% ,4    "  R@VI1S]-I-I0"  #%!@  &
M@(%D$P  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ ,H-J
M4<['(\ -!0  (1,  !@              ("!+A8  'AL+W=O<FMS:&5E=',O
M<VAE970T+GAM;%!+ 0(4 Q0    ( #*#:E&*>9#A;@P  (]2   8
M      " @7$;  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M"  R@VI1.AKP!"D(   $(P  &               @($5*   >&PO=V]R:W-H
M965T<R]S:&5E=#8N>&UL4$L! A0#%     @ ,H-J474%'_HD @  ?@0  !@
M             ("!=#   'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4
M Q0    ( #*#:E'!Y#034PD  -<6   8              " @<XR  !X;"]W
M;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    "  R@VI1/H>U(Y@*   =
M'0  &               @(%7/   >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL
M4$L! A0#%     @ ,H-J4=T6N@RV P  ?P@  !D              ("!)4<
M 'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    "  R@VI1Q\KZ
M$&L+  !S(   &0              @($22P  >&PO=V]R:W-H965T<R]S:&5E
M=#$Q+GAM;%!+ 0(4 Q0    ( #*#:E$,4;O_!A,  !0[   9
M  " @;16  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @
M,H-J4:8$0$Q&"0  E!P  !D              ("!\6D  'AL+W=O<FMS:&5E
M=',O<VAE970Q,RYX;6Q02P$"% ,4    "  R@VI1>0.5U5L'  "R$P  &0
M            @(%N<P  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4
M Q0    ( #*#:E$$C^;CI@H  "(A   9              " @0![  !X;"]W
M;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ ,H-J44DPVD17"P
MW!\  !D              ("!W84  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX
M;6Q02P$"% ,4    "  R@VI1)4L/2^4*   E'P  &0              @(%K
MD0  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( #*#:E'[
M"69[  ,  #0&   9              " @8><  !X;"]W;W)K<VAE971S+W-H
M965T,3@N>&UL4$L! A0#%     @ ,H-J4>5I,B/- P  J @  !D
M     ("!OI\  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #*#:E%5X X3A ,  $,(   9              "
M@>*T  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ ,H-J
M44Q/BVR9!   &1   !D              ("!G;@  'AL+W=O<FMS:&5E=',O
M<VAE970R-2YX;6Q02P$"% ,4    "  R@VI1&;04JD4#  !<"@  &0
M        @(%MO0  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0
M   ( #*#:E$ FU)8S00  '49   9              " @>G   !X;"]W;W)K
M<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ ,H-J4;*3&BL0 P  G0@
M !D              ("![<4  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q0
M2P$"% ,4    "  R@VI1.L]2S!(%   *(@  &0              @($TR0
M>&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( #*#:E%=RU&3
M\@(  -P(   9              " @7W.  !X;"]W;W)K<VAE971S+W-H965T
M,S N>&UL4$L! A0#%     @ ,H-J46J;$0FG P  KA   !D
M ("!IM$  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    "  R
M@VI1&KQVR5P"  !-!0  &0              @(&$U0  >&PO=V]R:W-H965T
M<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( #*#:E%GD9-.L0<  )0G   9
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M970S-RYX;6Q02P$"% ,4    "  R@VI1EX^T2QD#  "8"0  &0
M    @(&TZ@  >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    (
M #*#:E'ERXFH<@8  /0C   9              " @03N  !X;"]W;W)K<VAE
M971S+W-H965T,SDN>&UL4$L! A0#%     @ ,H-J49O!\M.] P  C!   !D
M             ("!K?0  'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"
M% ,4    "  R@VI1'F<NKFX&  "!'@  &0              @(&A^   >&PO
M=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( #*#:E$H+/3K^P4
M &X<   9              " @4;_  !X;"]W;W)K<VAE971S+W-H965T-#(N
M>&UL4$L! A0#%     @ ,H-J4100(/2Z!   -Q,  !D              ("!
M> 4! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    "  R@VI1
M?=71T\ #  !%#@  &0              @(%I"@$ >&PO=V]R:W-H965T<R]S
M:&5E=#0T+GAM;%!+ 0(4 Q0    ( #*#:E'WASIF8P,  /8*   9
M      " @6 . 0!X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%
M  @ ,H-J454\A+>C!   CA,  !D              ("!^A$! 'AL+W=O<FMS
M:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    "  R@VI1!ARSWWT"  "#!@
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M+G)E;'-02P$"% ,4    "  R@VI1B)_7ON #  "$(   #P
M@ &9( $ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ ,H-J49(LH):X 0
MYQP  !H              ( !IB0! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @ ,H-J48Q/ZH^Z 0  [AP  !,              ( !
MEB8! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     #@ .  _#P  @2@!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>262</ContextCount>
  <ElementCount>373</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>68</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Description of the Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/DescriptionoftheBusiness</Role>
      <ShortName>Description of the Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2107103 - Disclosure - Balance Sheet Accounts and Supplemental Disclosures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosures</Role>
      <ShortName>Balance Sheet Accounts and Supplemental Disclosures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2111104 - Disclosure - Fair Value Measurements and Available for Sale Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestments</Role>
      <ShortName>Fair Value Measurements and Available for Sale Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2117105 - Disclosure - Indebtedness</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/Indebtedness</Role>
      <ShortName>Indebtedness</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2125106 - Disclosure - Licenses, Asset Acquisitions and Contingent Consideration</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsideration</Role>
      <ShortName>Licenses, Asset Acquisitions and Contingent Consideration</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2129107 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2131108 - Disclosure - Equity Incentive Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/EquityIncentivePlans</Role>
      <ShortName>Equity Incentive Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2137109 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.gossamerbio.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gossamerbio.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2308302 - Disclosure - Balance Sheet Accounts and Supplemental Disclosures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresTables</Role>
      <ShortName>Balance Sheet Accounts and Supplemental Disclosures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosures</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2312303 - Disclosure - Fair Value Measurements and Available for Sale Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsTables</Role>
      <ShortName>Fair Value Measurements and Available for Sale Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestments</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2318304 - Disclosure - Indebtedness (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/IndebtednessTables</Role>
      <ShortName>Indebtedness (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gossamerbio.com/role/Indebtedness</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2326305 - Disclosure - Licenses, Asset Acquisitions and Contingent Consideration (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationTables</Role>
      <ShortName>Licenses, Asset Acquisitions and Contingent Consideration (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsideration</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2332306 - Disclosure - Equity Incentive Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/EquityIncentivePlansTables</Role>
      <ShortName>Equity Incentive Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gossamerbio.com/role/EquityIncentivePlans</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2338307 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/CommitmentsandContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.gossamerbio.com/role/CommitmentsandContingencies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - Description of the Business - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail</Role>
      <ShortName>Description of the Business - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities not Included in Calculation of Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossPerShareDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities not Included in Calculation of Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2409403 - Disclosure - Balance Sheet Accounts and Supplemental Disclosures - Schedule of Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails</Role>
      <ShortName>Balance Sheet Accounts and Supplemental Disclosures - Schedule of Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Balance Sheet Accounts and Supplemental Disclosures - Schedule of Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails</Role>
      <ShortName>Balance Sheet Accounts and Supplemental Disclosures - Schedule of Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2413405 - Disclosure - Fair Value Measurements and Available for Sale Investments - Assets Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements and Available for Sale Investments - Assets Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2414406 - Disclosure - Fair Value Measurements and Available for Sale Investments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails</Role>
      <ShortName>Fair Value Measurements and Available for Sale Investments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2415407 - Disclosure - Fair Value Measurements and Available for Sale Investments - Schedule of Available for sale Investments by Security Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails</Role>
      <ShortName>Fair Value Measurements and Available for Sale Investments - Schedule of Available for sale Investments by Security Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2416408 - Disclosure - Fair Value Measurements and Available for Sale Investments - Schedule of Contractual Maturities of Available-for-sale Debt Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofContractualMaturitiesofAvailableforsaleDebtSecuritiesDetails</Role>
      <ShortName>Fair Value Measurements and Available for Sale Investments - Schedule of Contractual Maturities of Available-for-sale Debt Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2419409 - Disclosure - Indebtedness - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails</Role>
      <ShortName>Indebtedness - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2420410 - Disclosure - Indebtedness - Schedule of Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/IndebtednessScheduleofLongtermDebtDetails</Role>
      <ShortName>Indebtedness - Schedule of Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2421411 - Disclosure - Indebtedness - Schedule of Future Minimum Principal Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails</Role>
      <ShortName>Indebtedness - Schedule of Future Minimum Principal Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2422412 - Disclosure - Indebtedness - Schedule of Net Carrying Amount of Liability Component (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails</Role>
      <ShortName>Indebtedness - Schedule of Net Carrying Amount of Liability Component (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2423413 - Disclosure - Indebtedness - Schedule of Equity Components (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/IndebtednessScheduleofEquityComponentsDetails</Role>
      <ShortName>Indebtedness - Schedule of Equity Components (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2424414 - Disclosure - Indebtedness - Schedule of Interest Expense Recognized (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/IndebtednessScheduleofInterestExpenseRecognizedDetails</Role>
      <ShortName>Indebtedness - Schedule of Interest Expense Recognized (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2427415 - Disclosure - Licenses, Asset Acquisitions and Contingent Consideration - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails</Role>
      <ShortName>Licenses, Asset Acquisitions and Contingent Consideration - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2428416 - Disclosure - Licenses, Asset Acquisitions and Contingent Consideration - Schedule of IPR&amp;D Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails</Role>
      <ShortName>Licenses, Asset Acquisitions and Contingent Consideration - Schedule of IPR&amp;D Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2430417 - Disclosure - Stockholders' Equity - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails</Role>
      <ShortName>Stockholders' Equity - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2433418 - Disclosure - Equity Incentive Plans - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails</Role>
      <ShortName>Equity Incentive Plans - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2434419 - Disclosure - Equity Incentive Plans - Summary of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails</Role>
      <ShortName>Equity Incentive Plans - Summary of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2435420 - Disclosure - Equity Incentive Plans - Summary of Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails</Role>
      <ShortName>Equity Incentive Plans - Summary of Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2436421 - Disclosure - Equity Incentive Plans - Stock-Based Compensation Expense Reported in Condensed Consolidated Statements of Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/EquityIncentivePlansStockBasedCompensationExpenseReportedinCondensedConsolidatedStatementsofOperationsDetails</Role>
      <ShortName>Equity Incentive Plans - Stock-Based Compensation Expense Reported in Condensed Consolidated Statements of Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2439422 - Disclosure - Commitments and Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2440423 - Disclosure - Commitments and Contingencies - Schedule of Lease Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofLeaseCostsDetails</Role>
      <ShortName>Commitments and Contingencies - Schedule of Lease Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="goss-20200930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2441424 - Disclosure - Commitments and Contingencies - Schedule of Gross Future Minimum Annual Rental Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails</Role>
      <ShortName>Commitments and Contingencies - Schedule of Gross Future Minimum Annual Rental Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="goss-20200930.htm">goss-20200930.htm</File>
    <File>goss-20200930.xsd</File>
    <File>goss-20200930_cal.xml</File>
    <File>goss-20200930_def.xml</File>
    <File>goss-20200930_lab.xml</File>
    <File>goss-20200930_pre.xml</File>
    <File>goss-20200930xxexx311.htm</File>
    <File>goss-20200930xxexx312.htm</File>
    <File>goss-20200930xxexx321.htm</File>
    <File>goss-20200930xxexx322.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>66
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "goss-20200930.htm": {
   "axisCustom": 1,
   "axisStandard": 25,
   "contextCount": 262,
   "dts": {
    "calculationLink": {
     "local": [
      "goss-20200930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "goss-20200930_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "goss-20200930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "goss-20200930_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "goss-20200930_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "goss-20200930.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 484,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2019-01-31": 1,
    "http://xbrl.sec.gov/dei/2019-01-31": 6,
    "total": 7
   },
   "keyCustom": 68,
   "keyStandard": 305,
   "memberCustom": 35,
   "memberStandard": 28,
   "nsprefix": "goss",
   "nsuri": "http://www.gossamerbio.com/20200930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.gossamerbio.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2107103 - Disclosure - Balance Sheet Accounts and Supplemental Disclosures",
     "role": "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosures",
     "shortName": "Balance Sheet Accounts and Supplemental Disclosures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "goss:FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111104 - Disclosure - Fair Value Measurements and Available for Sale Investments",
     "role": "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestments",
     "shortName": "Fair Value Measurements and Available for Sale Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "goss:FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117105 - Disclosure - Indebtedness",
     "role": "http://www.gossamerbio.com/role/Indebtedness",
     "shortName": "Indebtedness",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2125106 - Disclosure - Licenses, Asset Acquisitions and Contingent Consideration",
     "role": "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsideration",
     "shortName": "Licenses, Asset Acquisitions and Contingent Consideration",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129107 - Disclosure - Stockholders' Equity",
     "role": "http://www.gossamerbio.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2131108 - Disclosure - Equity Incentive Plans",
     "role": "http://www.gossamerbio.com/role/EquityIncentivePlans",
     "shortName": "Equity Incentive Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137109 - Disclosure - Commitments and Contingencies",
     "role": "http://www.gossamerbio.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2308302 - Disclosure - Balance Sheet Accounts and Supplemental Disclosures (Tables)",
     "role": "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresTables",
     "shortName": "Balance Sheet Accounts and Supplemental Disclosures (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i720b6695621443f1bfacd04fd902b4fd_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i720b6695621443f1bfacd04fd902b4fd_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312303 - Disclosure - Fair Value Measurements and Available for Sale Investments (Tables)",
     "role": "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsTables",
     "shortName": "Fair Value Measurements and Available for Sale Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318304 - Disclosure - Indebtedness (Tables)",
     "role": "http://www.gossamerbio.com/role/IndebtednessTables",
     "shortName": "Indebtedness (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "goss:InProcessResearchAndDevelopmentExpensesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2326305 - Disclosure - Licenses, Asset Acquisitions and Contingent Consideration (Tables)",
     "role": "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationTables",
     "shortName": "Licenses, Asset Acquisitions and Contingent Consideration (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "goss:InProcessResearchAndDevelopmentExpensesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2332306 - Disclosure - Equity Incentive Plans (Tables)",
     "role": "http://www.gossamerbio.com/role/EquityIncentivePlansTables",
     "shortName": "Equity Incentive Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2338307 - Disclosure - Commitments and Contingencies (Tables)",
     "role": "http://www.gossamerbio.com/role/CommitmentsandContingenciesTables",
     "shortName": "Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i32aaefa176c1431b83d26da9efa9e0e0_D20200521-20200521",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - Description of the Business - Additional Information (Detail)",
     "role": "http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail",
     "shortName": "Description of the Business - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i9eebf838097e49fa93a3a4ab394c7e68_D20171001-20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "goss:FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "ib505254a0d25402398cd90e47386b544_D20200101-20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities not Included in Calculation of Diluted Net Loss Per Share (Details)",
     "role": "http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossPerShareDetails",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities not Included in Calculation of Diluted Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "ib505254a0d25402398cd90e47386b544_D20200101-20200930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i720b6695621443f1bfacd04fd902b4fd_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409403 - Disclosure - Balance Sheet Accounts and Supplemental Disclosures - Schedule of Property and Equipment, Net (Details)",
     "role": "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails",
     "shortName": "Balance Sheet Accounts and Supplemental Disclosures - Schedule of Property and Equipment, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i720b6695621443f1bfacd04fd902b4fd_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i720b6695621443f1bfacd04fd902b4fd_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Balance Sheet Accounts and Supplemental Disclosures - Schedule of Accrued Expenses (Details)",
     "role": "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails",
     "shortName": "Balance Sheet Accounts and Supplemental Disclosures - Schedule of Accrued Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i720b6695621443f1bfacd04fd902b4fd_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i835b26655f28493fad355a6322860843_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413405 - Disclosure - Fair Value Measurements and Available for Sale Investments - Assets Measured at Fair Value on Recurring Basis (Details)",
     "role": "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails",
     "shortName": "Fair Value Measurements and Available for Sale Investments - Assets Measured at Fair Value on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i835b26655f28493fad355a6322860843_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i720b6695621443f1bfacd04fd902b4fd_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i720b6695621443f1bfacd04fd902b4fd_I20200930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueEquityLevel1ToLevel2TransfersAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i720b6695621443f1bfacd04fd902b4fd_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueEquityLevel1ToLevel2TransfersAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414406 - Disclosure - Fair Value Measurements and Available for Sale Investments - Additional Information (Details)",
     "role": "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails",
     "shortName": "Fair Value Measurements and Available for Sale Investments - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueEquityLevel1ToLevel2TransfersAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i720b6695621443f1bfacd04fd902b4fd_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueEquityLevel1ToLevel2TransfersAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i720b6695621443f1bfacd04fd902b4fd_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415407 - Disclosure - Fair Value Measurements and Available for Sale Investments - Schedule of Available for sale Investments by Security Type (Details)",
     "role": "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails",
     "shortName": "Fair Value Measurements and Available for Sale Investments - Schedule of Available for sale Investments by Security Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i720b6695621443f1bfacd04fd902b4fd_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i720b6695621443f1bfacd04fd902b4fd_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416408 - Disclosure - Fair Value Measurements and Available for Sale Investments - Schedule of Contractual Maturities of Available-for-sale Debt Securities (Details)",
     "role": "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofContractualMaturitiesofAvailableforsaleDebtSecuritiesDetails",
     "shortName": "Fair Value Measurements and Available for Sale Investments - Schedule of Contractual Maturities of Available-for-sale Debt Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i720b6695621443f1bfacd04fd902b4fd_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromLongTermLinesOfCredit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419409 - Disclosure - Indebtedness - Additional Information (Details)",
     "role": "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails",
     "shortName": "Indebtedness - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i5422129c1c59408889a2b99ef392c162_I20190502",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "ic984cdc9b0e0482fbb94f5d207f8e3fa_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420410 - Disclosure - Indebtedness - Schedule of Long-term Debt (Details)",
     "role": "http://www.gossamerbio.com/role/IndebtednessScheduleofLongtermDebtDetails",
     "shortName": "Indebtedness - Schedule of Long-term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "ic984cdc9b0e0482fbb94f5d207f8e3fa_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i720b6695621443f1bfacd04fd902b4fd_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421411 - Disclosure - Indebtedness - Schedule of Future Minimum Principal Payments (Details)",
     "role": "http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails",
     "shortName": "Indebtedness - Schedule of Future Minimum Principal Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i720b6695621443f1bfacd04fd902b4fd_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "goss:ScheduleOfLiabilityComponentsOfNotesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i65ad3aed5a854b92910ae3dd0bf4a19a_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422412 - Disclosure - Indebtedness - Schedule of Net Carrying Amount of Liability Component (Details)",
     "role": "http://www.gossamerbio.com/role/IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails",
     "shortName": "Indebtedness - Schedule of Net Carrying Amount of Liability Component (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "goss:ScheduleOfLiabilityComponentsOfNotesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i65ad3aed5a854b92910ae3dd0bf4a19a_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "goss:ScheduleOfEquityComponentsOfNotesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i65ad3aed5a854b92910ae3dd0bf4a19a_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "goss:AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423413 - Disclosure - Indebtedness - Schedule of Equity Components (Details)",
     "role": "http://www.gossamerbio.com/role/IndebtednessScheduleofEquityComponentsDetails",
     "shortName": "Indebtedness - Schedule of Equity Components (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "goss:ScheduleOfEquityComponentsOfNotesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i65ad3aed5a854b92910ae3dd0bf4a19a_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "goss:AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "goss:ScheduleOfInterestExpenseRecognizedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i48ce1ae69a484b2897d46eda4fe74206_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "goss:ContractualInterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424414 - Disclosure - Indebtedness - Schedule of Interest Expense Recognized (Details)",
     "role": "http://www.gossamerbio.com/role/IndebtednessScheduleofInterestExpenseRecognizedDetails",
     "shortName": "Indebtedness - Schedule of Interest Expense Recognized (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "goss:ScheduleOfInterestExpenseRecognizedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i48ce1ae69a484b2897d46eda4fe74206_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "goss:ContractualInterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i149440b5575441f1ade1e500f96cffcd_D20180601-20180630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentInProcess",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427415 - Disclosure - Licenses, Asset Acquisitions and Contingent Consideration - Additional Information (Details)",
     "role": "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails",
     "shortName": "Licenses, Asset Acquisitions and Contingent Consideration - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "ia7131a2487c34cb4bd58334ee5055363_D20171002-20171002",
      "decimals": null,
      "lang": "en-US",
      "name": "goss:ProductLicenseTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss",
     "role": "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
     "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i149440b5575441f1ade1e500f96cffcd_D20180601-20180630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentInProcess",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428416 - Disclosure - Licenses, Asset Acquisitions and Contingent Consideration - Schedule of IPR&D Expense (Details)",
     "role": "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails",
     "shortName": "Licenses, Asset Acquisitions and Contingent Consideration - Schedule of IPR&D Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "goss:InProcessResearchAndDevelopmentExpensesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i29791a3aea134a31a642f180d6f252e1_D20200701-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentInProcess",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "goss:CommonStockVotingRightsNumberOfVotesPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430417 - Disclosure - Stockholders' Equity - Additional Information (Details)",
     "role": "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails",
     "shortName": "Stockholders' Equity - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "goss:CommonStockVotingRightsNumberOfVotesPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i720b6695621443f1bfacd04fd902b4fd_I20200930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433418 - Disclosure - Equity Incentive Plans - Additional Information (Details)",
     "role": "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails",
     "shortName": "Equity Incentive Plans - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i8dde91022b6f4727b6a3442ab07af3f3_I20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i9e476b4d712f41b58c1f9eec52fea678_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434419 - Disclosure - Equity Incentive Plans - Summary of Stock Option Activity (Details)",
     "role": "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails",
     "shortName": "Equity Incentive Plans - Summary of Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i720b6695621443f1bfacd04fd902b4fd_I20200930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435420 - Disclosure - Equity Incentive Plans - Summary of Restricted Stock Activity (Details)",
     "role": "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails",
     "shortName": "Equity Incentive Plans - Summary of Restricted Stock Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i720b6695621443f1bfacd04fd902b4fd_I20200930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436421 - Disclosure - Equity Incentive Plans - Stock-Based Compensation Expense Reported in Condensed Consolidated Statements of Operations (Details)",
     "role": "http://www.gossamerbio.com/role/EquityIncentivePlansStockBasedCompensationExpenseReportedinCondensedConsolidatedStatementsofOperationsDetails",
     "shortName": "Equity Incentive Plans - Stock-Based Compensation Expense Reported in Condensed Consolidated Statements of Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i720b6695621443f1bfacd04fd902b4fd_I20200930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439422 - Disclosure - Commitments and Contingencies - Additional Information (Details)",
     "role": "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails",
     "shortName": "Commitments and Contingencies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440423 - Disclosure - Commitments and Contingencies - Schedule of Lease Costs (Details)",
     "role": "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofLeaseCostsDetails",
     "shortName": "Commitments and Contingencies - Schedule of Lease Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i5efc190b28804925a02c31f4bc1bb791_D20200701-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i720b6695621443f1bfacd04fd902b4fd_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441424 - Disclosure - Commitments and Contingencies - Schedule of Gross Future Minimum Annual Rental Commitments (Details)",
     "role": "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails",
     "shortName": "Commitments and Contingencies - Schedule of Gross Future Minimum Annual Rental Commitments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i720b6695621443f1bfacd04fd902b4fd_I20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "ie3312a4a7c1f41c7bb6ef94d06af70aa_I20181231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity",
     "role": "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity",
     "shortName": "Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "ib2b24c51d3c14bf39e027c08084d0df0_D20190101-20190331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "goss:TemporaryEquitySharesConvertedIntoCommonSharesShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsOfDebtIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical)",
     "role": "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsOfDebtIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Description of the Business",
     "role": "http://www.gossamerbio.com/role/DescriptionoftheBusiness",
     "shortName": "Description of the Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.gossamerbio.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20200930.htm",
      "contextRef": "i2860c58f164f428aa182ebed67f71810_D20200101-20200930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 68,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "goss_AABiopharmaIncMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "AA Biopharma Inc.",
        "label": "A A Biopharma Inc [Member]",
        "terseLabel": "AA Biopharma Inc."
       }
      }
     },
     "localname": "AABiopharmaIncMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail",
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_AccruedInProcessResearchAndDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accrued in process research and development.",
        "label": "Accrued In Process Research And Development",
        "terseLabel": "Accrued in process research and development"
       }
      }
     },
     "localname": "AccruedInProcessResearchAndDevelopment",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_AccruedResearchAndDevelopmentExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accrued research and development expenses.",
        "label": "Accrued Research And Development Expenses",
        "terseLabel": "Accrued research and development expenses"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopmentExpenses",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_AdditionalNonCancelableLeaseAgreementInNov2019Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional Non-cancelable Lease Agreement In Nov 2019",
        "label": "Additional Non-cancelable Lease Agreement In Nov 2019 [Member]",
        "terseLabel": "Additional Non-cancelable Lease Agreement Entered in November 2019"
       }
      }
     },
     "localname": "AdditionalNonCancelableLeaseAgreementInNov2019Member",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_AdhaerePharmaceuticalsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Adhaere Pharmaceuticals, Inc.",
        "label": "Adhaere Pharmaceuticals Inc [Member]",
        "terseLabel": "Adhaere Pharmaceuticals, Inc."
       }
      }
     },
     "localname": "AdhaerePharmaceuticalsIncMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption": {
     "auth_ref": [],
     "calculation": {
      "http://www.gossamerbio.com/role/IndebtednessScheduleofEquityComponentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Adjustments to equity component of debt discount related to value of conversion option.",
        "label": "Adjustments To Equity Component Of Debt Discount Related To Value Of Conversion Option",
        "terseLabel": "Debt discount related to the value of conversion option"
       }
      }
     },
     "localname": "AdjustmentsToEquityComponentOfDebtDiscountRelatedToValueOfConversionOption",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessScheduleofEquityComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_AdjustmentsToEquityComponentOfDebtIssuanceCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.gossamerbio.com/role/IndebtednessScheduleofEquityComponentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Adjustments to equity component of debt issuance costs.",
        "label": "Adjustments To Equity Component Of Debt Issuance Costs",
        "negatedLabel": "Debt issuance cost"
       }
      }
     },
     "localname": "AdjustmentsToEquityComponentOfDebtIssuanceCosts",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessScheduleofEquityComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_AerpioPharmaceuticalsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aerpio Pharmaceuticals, Inc.",
        "label": "Aerpio Pharmaceuticals Inc [Member]",
        "terseLabel": "Aerpio Pharmaceuticals, Inc."
       }
      }
     },
     "localname": "AerpioPharmaceuticalsIncMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_AmortizationOfOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortization of operating lease right-of-use assets.",
        "label": "Amortization Of Operating Lease Right Of Use Assets",
        "terseLabel": "Amortization of operating lease right-of-use assets"
       }
      }
     },
     "localname": "AmortizationOfOperatingLeaseRightOfUseAssets",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_AnnualIncreasePercentageForLeaseCharges": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Annual increase percentage for lease charges.",
        "label": "Annual Increase Percentage For Lease Charges",
        "terseLabel": "Annual increase percentage for lease charges"
       }
      }
     },
     "localname": "AnnualIncreasePercentageForLeaseCharges",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "goss_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofContractualMaturitiesofAvailableforsaleDebtSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Available for sale securities debt maturities after one through two years fair value.",
        "label": "Available For Sale Securities Debt Maturities After One Through Two Years Fair Value",
        "terseLabel": "One to two years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofContractualMaturitiesofAvailableforsaleDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_BalanceSheetsAccountsAndSupplementalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Balance sheets accounts and supplemental disclosures.",
        "label": "Balance Sheets Accounts And Supplemental Disclosures [Abstract]",
        "terseLabel": "Balance Sheets Accounts And Supplemental Disclosures [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetsAccountsAndSupplementalDisclosuresAbstract",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "xbrltype": "stringItemType"
    },
    "goss_BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business combination, contingent consideration, commercial milestone payments, payable.",
        "label": "Business Combination Contingent Consideration Commercial Milestone Payments Payable",
        "terseLabel": "Commercial milestone payments, payable"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationCommercialMilestonePaymentsPayable",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business combination, contingent consideration, development and regulatory milestone payments, payable.",
        "label": "Business Combination Contingent Consideration Development And Regulatory Milestone Payments Payable",
        "terseLabel": "Development and regulatory milestone payments, payable"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationDevelopmentAndRegulatoryMilestonePaymentsPayable",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_BusinessCombinationContingentConsiderationMilestonesPayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business combination contingent consideration milestones payment.",
        "label": "Business Combination Contingent Consideration Milestones Payment",
        "terseLabel": "Milestones payment"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationMilestonesPayment",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business combination, contingent consideration, development and sales milestones, payable.",
        "label": "Business Combination Contingent Consideration Regulatory Development And Sales Milestones Payable",
        "terseLabel": "Regulatory, development and sales milestone payments payable"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationRegulatoryDevelopmentAndSalesMilestonesPayable",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business combination, contingent consideration, sales milestone payments, payable.",
        "label": "Business Combination Contingent Consideration Sales Milestone Payments Payable",
        "terseLabel": "Sales milestone payments, payable"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationSalesMilestonePaymentsPayable",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_CommonStockVestingPercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Common stock vesting percentage.",
        "label": "Common Stock Vesting Percentage",
        "terseLabel": "Common Stock vesting percentage"
       }
      }
     },
     "localname": "CommonStockVestingPercentage",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "goss_CommonStockVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Common stock vesting period.",
        "label": "Common Stock Vesting Period",
        "terseLabel": "Common stock vesting period"
       }
      }
     },
     "localname": "CommonStockVestingPeriod",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "goss_CommonStockVotingRightsNumberOfVotesPerShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Common Stock, Voting Rights, Number Of Votes Per Share",
        "label": "Common Stock, Voting Rights, Number Of Votes Per Share",
        "terseLabel": "Common stock number of votes per share"
       }
      }
     },
     "localname": "CommonStockVotingRightsNumberOfVotesPerShare",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "goss_ContractualInterestExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.gossamerbio.com/role/IndebtednessScheduleofInterestExpenseRecognizedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest expense.",
        "label": "Contractual Interest Expense",
        "terseLabel": "Contractual interest expense"
       }
      }
     },
     "localname": "ContractualInterestExpense",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessScheduleofInterestExpenseRecognizedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_ConversionOfConvertiblePreferredStockIntoCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Conversion of convertible preferred stock into common stock.",
        "label": "Conversion Of Convertible Preferred Stock Into Common Stock [Member]",
        "terseLabel": "Conversion of Convertible Preferred Stock into Common Stock"
       }
      }
     },
     "localname": "ConversionOfConvertiblePreferredStockIntoCommonStockMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_ConvertibleSeniorNotesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Convertible senior notes.",
        "label": "Convertible Senior Notes Policy [Text Block]",
        "terseLabel": "Convertible Senior Notes"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesPolicyTextBlock",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "goss_DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt covenant required minimum unrestricted cash percentage of term loan.",
        "label": "Debt Covenant Required Minimum Unrestricted Cash Percentage Of Term Loan",
        "terseLabel": "Debt covenant minimum unrestricted cash percentage"
       }
      }
     },
     "localname": "DebtCovenantRequiredMinimumUnrestrictedCashPercentageOfTermLoan",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "goss_DebtInstrumentAggregatePrincipalAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt instrument aggregate principal amount",
        "label": "Debt Instrument Aggregate Principal Amount",
        "terseLabel": "Debt instrument aggregate principal amount"
       }
      }
     },
     "localname": "DebtInstrumentAggregatePrincipalAmount",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_DebtInstrumentConvertibleConversionLastReportedSalePricePercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt instrument convertible conversion last reported sale price percentage.",
        "label": "Debt Instrument Convertible Conversion Last Reported Sale Price Percentage",
        "terseLabel": "Convertible notes, percentage of last reported sale price of common stock"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionLastReportedSalePricePercentage",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "goss_DebtInstrumentConvertibleConversionPricePercentage": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt instrument convertible conversion price percentage.",
        "label": "Debt Instrument Convertible Conversion Price Percentage",
        "terseLabel": "Convertible notes, percentage of conversion price"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPricePercentage",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "goss_DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt Instrument, Covenant Terms, Default Trigger, Default Amount Of Other Debt",
        "label": "Debt Instrument, Covenant Terms, Default Trigger, Default Amount Of Other Debt",
        "terseLabel": "Debt instrument, default trigger amount"
       }
      }
     },
     "localname": "DebtInstrumentCovenantTermsDefaultTriggerDefaultAmountOfOtherDebt",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_DescriptionOfBusinessLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of business.",
        "label": "Description Of Business [Line Items]",
        "terseLabel": "Description Of Business [Line Items]"
       }
      }
     },
     "localname": "DescriptionOfBusinessLineItems",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "goss_DescriptionOfBusinessTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of business.",
        "label": "Description Of Business [Table]",
        "terseLabel": "Description Of Business [Table]"
       }
      }
     },
     "localname": "DescriptionOfBusinessTable",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "goss_EquityComponentOfConvertibleNoteIssuance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity component of convertible note issuance.",
        "label": "Equity Component Of Convertible Note Issuance",
        "terseLabel": "Equity component of convertible note issuance"
       }
      }
     },
     "localname": "EquityComponentOfConvertibleNoteIssuance",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Measurements And Available For Sale Investments [Abstract]",
        "terseLabel": "Fair Value Measurements And Available For Sale Investments [Abstract]"
       }
      }
     },
     "localname": "FairValueMeasurementsAndAvailableForSaleInvestmentsAbstract",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "xbrltype": "stringItemType"
    },
    "goss_FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value measurements and available for sale investments.",
        "label": "Fair Value Measurements And Available For Sale Investments [Text Block]",
        "terseLabel": "Fair Value Measurements and Available for Sale Investments"
       }
      }
     },
     "localname": "FairValueMeasurementsAndAvailableForSaleInvestmentsTextBlock",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "goss_FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "First anniversary of closing date through second anniversary of closing date.",
        "label": "First Anniversary Of Closing Date Through Second Anniversary Of Closing Date [Member]",
        "terseLabel": "First Anniversary of Closing Date through Second Anniversary of Closing Date"
       }
      }
     },
     "localname": "FirstAnniversaryOfClosingDateThroughSecondAnniversaryOfClosingDateMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_FounderMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Founder.",
        "label": "Founder [Member]",
        "terseLabel": "Founder"
       }
      }
     },
     "localname": "FounderMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_FounderSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Founder shares.",
        "label": "Founder Shares [Member]",
        "terseLabel": "Founder Shares"
       }
      }
     },
     "localname": "FounderSharesMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Funds raised through preferred equity financing, convertible note financings and completed initial public offering.",
        "label": "Funds Raised Through Preferred Equity Financing Convertible Note Financings And Completed Initial Public Offering",
        "terseLabel": "Funds raised through Series A and Series B Convertible Preferred Stock, convertible note financings and completed IPO"
       }
      }
     },
     "localname": "FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_InProcessResearchAndDevelopmentExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.",
        "label": "In Process Research And Development Expenses",
        "terseLabel": "In process research and development expenses"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentExpenses",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_InProcessResearchAndDevelopmentExpensesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "In process research and development expenses.",
        "label": "In Process Research And Development Expenses Table [Text Block]",
        "terseLabel": "Schedule of IPR&amp;D Expense"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentExpensesTableTextBlock",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "goss_InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "In Process Research and Development, GB one two seven five.",
        "label": "In Process Research And Development G B One Two Seven Five [Member]",
        "terseLabel": "GB1275"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentGBOneTwoSevenFiveMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_InProcessResearchAndDevelopmentGBZeroZeroFourMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "In Process Research and Development, GB zero zero four.",
        "label": "In Process Research And Development G B Zero Zero Four [Member]",
        "terseLabel": "GB004"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentGBZeroZeroFourMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_InProcessResearchAndDevelopmentGBZeroZeroOneMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "In Process Research and Development, GB zero zero one.",
        "label": "In Process Research And Development G B Zero Zero One [Member]",
        "terseLabel": "GB001"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentGBZeroZeroOneMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_InProcessResearchAndDevelopmentGBZeroZeroTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "In Process Research and Development, GB zero zero two.",
        "label": "In Process Research And Development G B Zero Zero Two [Member]",
        "terseLabel": "GB002"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentGBZeroZeroTwoMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_InProcessResearchAndDevelopmentOtherProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "In process research and development other programs.",
        "label": "In Process Research And Development Other Programs [Member]",
        "terseLabel": "Other Programs"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentOtherProgramsMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in accrued research and development expenses.",
        "label": "Increase Decrease In Accrued Research And Development Expenses",
        "terseLabel": "Accrued research and development expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Increase decrease in operating lease liabilities.",
        "label": "Increase Decrease In Operating Lease Liabilities",
        "negatedLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_IncreasedInEquityCapitalAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Increased in equity capital amount.",
        "label": "Increased In Equity Capital Amount",
        "terseLabel": "Increased in equity capital amount"
       }
      }
     },
     "localname": "IncreasedInEquityCapitalAmount",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Incremental common shares attributable to restricted stock subject to vesting.",
        "label": "Incremental Common Shares Attributable To Restricted Stock Subject To Vesting",
        "terseLabel": "Additional shares of restricted stock subject to vesting restrictions (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToRestrictedStockSubjectToVesting",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "goss_InterestAndSecuritiesReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest and securities receivable.",
        "label": "Interest And Securities Receivable",
        "terseLabel": "Interest and securities receivable"
       }
      }
     },
     "localname": "InterestAndSecuritiesReceivable",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_LeaseAssignmentAgreementEnteredInJuly2020Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lease Assignment Agreement Entered in July 2020",
        "label": "Lease Assignment Agreement Entered in July 2020 [Member]",
        "terseLabel": "Lease Assignment Agreement Entered in July 2020"
       }
      }
     },
     "localname": "LeaseAssignmentAgreementEnteredInJuly2020Member",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_LeaseContractualTermAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lease Contractual Term",
        "label": "Lease Contractual Term [Axis]",
        "terseLabel": "Lease Contractual Term [Axis]"
       }
      }
     },
     "localname": "LeaseContractualTermAxis",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "goss_LeaseContractualTermDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lease Contractual Term",
        "label": "Lease Contractual Term [Domain]",
        "terseLabel": "Lease Contractual Term [Domain]"
       }
      }
     },
     "localname": "LeaseContractualTermDomain",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix": {
     "auth_ref": [],
     "calculation": {
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails_1": {
       "order": 7.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, Payments, Due After Year Six",
        "label": "Lessee, Operating Lease, Liability, Payments, Due After Year Six",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_LesseeOperatingLeaseLiabilityPaymentsDueYearSix": {
     "auth_ref": [],
     "calculation": {
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, Payments, Due Year Six",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Six",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearSix",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_LicenseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "License agreement.",
        "label": "License Agreement [Member]",
        "terseLabel": "License Agreement"
       }
      }
     },
     "localname": "LicenseAgreementMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_LongTermConvertibleSeniorNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long-term convertible senior notes.",
        "label": "Long Term Convertible Senior Notes",
        "terseLabel": "Long-term convertible senior notes"
       }
      }
     },
     "localname": "LongTermConvertibleSeniorNotes",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix": {
     "auth_ref": [],
     "calculation": {
      "http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long-term Debt, Maturities, Repayments of Principal in Year Six",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Six",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_LongTermDebtPercentageInAggregatePrincipalAmount": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long-term Debt, Percentage In Aggregate Principal Amount",
        "label": "Long-term Debt, Percentage In Aggregate Principal Amount",
        "terseLabel": "Percentage in aggregate principal amount (not less than)"
       }
      }
     },
     "localname": "LongTermDebtPercentageInAggregatePrincipalAmount",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "goss_MidCapFinancialTrustMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "MidCap financial trust.",
        "label": "Mid Cap Financial Trust [Member]",
        "terseLabel": "MidCap Financial Trust"
       }
      }
     },
     "localname": "MidCapFinancialTrustMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_NinetyEightPercentApplicableConversionPriceMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ninety Eight Percent Applicable Conversion Price [Member].",
        "label": "Ninety Eight Percent Applicable Conversion Price [Member]",
        "terseLabel": "98% Applicable Conversion Price"
       }
      }
     },
     "localname": "NinetyEightPercentApplicableConversionPriceMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_NonCancelableLeaseAgreementEnteredInAugust2018Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Non-cancelable Lease Agreement Entered in August 2018",
        "label": "Non-cancelable Lease Agreement Entered in August 2018 [Member]",
        "terseLabel": "Non-cancelable Lease Agreement Entered in August 2018"
       }
      }
     },
     "localname": "NonCancelableLeaseAgreementEnteredInAugust2018Member",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Non cash financing and investing conversion of convertible preferred stock to common stock.",
        "label": "Noncash Financing And Investing Conversions Of Convertible Preferred Stock To Common Stock",
        "terseLabel": "Conversion of convertible preferred stock to common stock"
       }
      }
     },
     "localname": "NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Noncash investing and financing activities change in unrealized gain on marketable securities net of tax.",
        "label": "Noncash Investing And Financing Activities Change In Unrealized Gain On Marketable Securities Net Of Tax",
        "terseLabel": "Change in unrealized gain on marketable securities, net of tax"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_NumberOfAdditionalTranches": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of additional tranches.",
        "label": "Number Of Additional Tranches",
        "terseLabel": "Number of additional tranches"
       }
      }
     },
     "localname": "NumberOfAdditionalTranches",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "goss_OneHundredThirtyPercentApplicableConversionPriceMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "130% Applicable Conversion Price [Member]",
        "label": "One Hundred Thirty Percent Applicable Conversion Price [Member]",
        "terseLabel": "130% Applicable Conversion Price"
       }
      }
     },
     "localname": "OneHundredThirtyPercentApplicableConversionPriceMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_OperatingLeasesMonthlyBaseRentExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating Leases, Monthly Base Rent Expense",
        "label": "Operating Leases, Monthly Base Rent Expense",
        "terseLabel": "Lease assignment agreement, monthly base rent expense"
       }
      }
     },
     "localname": "OperatingLeasesMonthlyBaseRentExpense",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_OperatingSubleaseAnnualIncreasePercentageForBaseRent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Operating sublease, annual increase percentage for base rent.",
        "label": "Operating Sublease Annual Increase Percentage For Base Rent",
        "terseLabel": "Operating sublease, annual increase percentage for base rent"
       }
      }
     },
     "localname": "OperatingSubleaseAnnualIncreasePercentageForBaseRent",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "goss_ParticipationRight": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Participation right .",
        "label": "Participation Right",
        "terseLabel": "Participation rights"
       }
      }
     },
     "localname": "ParticipationRight",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "goss_PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions": {
     "auth_ref": [],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Payments for (Proceeds from) research and development asset acquisitions.",
        "label": "Payments For Proceeds From Research And Development Asset Acquisitions",
        "negatedLabel": "Research and development asset acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of exit fee on amount borrowed on final repayment.",
        "label": "Percentage Of Exit Fee On Amount Borrowed On Final Repayment",
        "terseLabel": "Percentage of exit fee on amount borrowed on final repayment"
       }
      }
     },
     "localname": "PercentageOfExitFeeOnAmountBorrowedOnFinalRepayment",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "goss_PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of exit fee on amount borrowed on partial prepayment.",
        "label": "Percentage Of Exit Fee On Amount Borrowed On Partial Prepayment",
        "terseLabel": "Percentage of exit fee on amount borrowed on partial prepayment"
       }
      }
     },
     "localname": "PercentageOfExitFeeOnAmountBorrowedOnPartialPrepayment",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "goss_PercentageOfFullyDilutedShareCapital": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of fully diluted share capital.",
        "label": "Percentage Of Fully Diluted Share Capital",
        "terseLabel": "Percentage of fully diluted share capital"
       }
      }
     },
     "localname": "PercentageOfFullyDilutedShareCapital",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "goss_PercentageOfPrepaymentFee": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of prepayment fee.",
        "label": "Percentage Of Prepayment Fee",
        "terseLabel": "Percentage of prepayment fee"
       }
      }
     },
     "localname": "PercentageOfPrepaymentFee",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "goss_PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of repurchase price is equal to principal amount of convertible notes",
        "label": "Percentage Of Repurchase Price Is Equal To Principal Amount Of Convertible Notes",
        "terseLabel": "Percentage of repurchase price is equal to principal amount of convertible notes"
       }
      }
     },
     "localname": "PercentageOfRepurchasePriceIsEqualToPrincipalAmountOfConvertibleNotes",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "goss_PeriodForWhichLeaseOfPermanentSpaceCanBeExtended": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period for which lease of permanent space can be extended.",
        "label": "Period For Which Lease Of Permanent Space Can Be Extended",
        "terseLabel": "Option to extend lease term of permanent space"
       }
      }
     },
     "localname": "PeriodForWhichLeaseOfPermanentSpaceCanBeExtended",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "goss_PermanentMonthlyBaseRent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Permanent monthly base rent.",
        "label": "Permanent Monthly Base Rent",
        "terseLabel": "Monthly base rent for permanent space"
       }
      }
     },
     "localname": "PermanentMonthlyBaseRent",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Prepayment occurs through first anniversary of closing date.",
        "label": "Prepayment Occurs Through First Anniversary Of Closing Date [Member]",
        "terseLabel": "Prepayment Occurs through First Anniversary of Closing Date"
       }
      }
     },
     "localname": "PrepaymentOccursThroughFirstAnniversaryOfClosingDateMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_ProceedsFromMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Proceeds from maturity of marketable securities.",
        "label": "Proceeds From Maturity Of Marketable Securities",
        "terseLabel": "Maturities of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromMaturityOfMarketableSecurities",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_ProceedsFromSaleOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Proceeds from sale of marketable securities.",
        "label": "Proceeds From Sale Of Marketable Securities",
        "terseLabel": "Sales of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfMarketableSecurities",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_ProductLicenseTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product license term.",
        "label": "Product License Term",
        "terseLabel": "Product license term"
       }
      }
     },
     "localname": "ProductLicenseTerm",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "goss_PulmokineIncMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pulmokine, Inc.",
        "label": "Pulmokine Inc [Member]",
        "terseLabel": "Pulmokine, Inc."
       }
      }
     },
     "localname": "PulmokineIncMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Right-of-use assets obtained in exchange for lease liabilities.",
        "label": "Right Of Use Assets Obtained In Exchange For Lease Liabilities",
        "terseLabel": "Right-of-use assets obtained in exchange for lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetsObtainedInExchangeForLeaseLiabilities",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_ScheduleOfEquityComponentsOfNotesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of equity components of notes.",
        "label": "Schedule Of Equity Components Of Notes Table [Text Block]",
        "terseLabel": "Schedule of Equity Components"
       }
      }
     },
     "localname": "ScheduleOfEquityComponentsOfNotesTableTextBlock",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "goss_ScheduleOfInterestExpenseRecognizedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of interest expense recognized.",
        "label": "Schedule Of Interest Expense Recognized Table [Text Block]",
        "terseLabel": "Schedule of Interest Expense Recognized"
       }
      }
     },
     "localname": "ScheduleOfInterestExpenseRecognizedTableTextBlock",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "goss_ScheduleOfLiabilityComponentsOfNotesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of liability components of notes.",
        "label": "Schedule Of Liability Components Of Notes Table [Text Block]",
        "terseLabel": "Schedule of Net Carrying Amount of Liability Component"
       }
      }
     },
     "localname": "ScheduleOfLiabilityComponentsOfNotesTableTextBlock",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "goss_SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Second Anniversary Of Closing Date And Prior To Jan First Two Thousand Twenty Five",
        "label": "Second Anniversary Of Closing Date And Prior To Jan First Two Thousand Twenty Five [Member]",
        "terseLabel": "Second Anniversary of Closing Date and Prior to Jan 1, 2025"
       }
      }
     },
     "localname": "SecondAnniversaryOfClosingDateAndPriorToJanFirstTwoThousandTwentyFiveMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_SeriesAConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Series a convertible preferred stock.",
        "label": "Series A Convertible Preferred Stock [Member]",
        "terseLabel": "Series A Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesAConvertiblePreferredStockMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity",
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_SeriesBConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Series b convertible preferred stock.",
        "label": "Series B Convertible Preferred Stock [Member]",
        "terseLabel": "Series B Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesBConvertiblePreferredStockMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_SeriesSeedConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Series seed convertible preferred stock.",
        "label": "Series Seed Convertible Preferred Stock [Member]",
        "terseLabel": "Series Seed Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesSeedConvertiblePreferredStockMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity",
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of additional shares issued for issuance under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Issued",
        "terseLabel": "Number of share issued under ESPP"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesIssued",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "goss_StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock incremental vesting conditions place on previously issued common shares.",
        "label": "Stock Incremental Vesting Conditions Place On Previously Issued Common Shares",
        "verboseLabel": "Unrestricted shares of common stock were subject to service vesting conditions (in shares)"
       }
      }
     },
     "localname": "StockIncrementalVestingConditionsPlaceOnPreviouslyIssuedCommonShares",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "goss_StockIssuedDuringPeriodSharesVestingOfRestrictedStock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock issued during period shares vesting of restricted stock.",
        "label": "Stock Issued During Period Shares Vesting Of Restricted Stock",
        "terseLabel": "Vesting of restricted stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesVestingOfRestrictedStock",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "goss_StockRestrictionAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock restriction agreements.",
        "label": "Stock Restriction Agreements [Member]",
        "terseLabel": "Stock Restriction Agreements"
       }
      }
     },
     "localname": "StockRestrictionAgreementsMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_StockholdersEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stockholders equity.",
        "label": "Stockholders Equity [Line Items]",
        "terseLabel": "Stockholders Equity [Line Items]"
       }
      }
     },
     "localname": "StockholdersEquityLineItems",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "goss_StockholdersEquityTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stockholders equity .",
        "label": "Stockholders Equity [Table]",
        "terseLabel": "Stockholders Equity [Table]"
       }
      }
     },
     "localname": "StockholdersEquityTable",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "goss_SubleaseAgreementEnteredInJune2020Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sublease Agreement Entered in June 2020",
        "label": "Sublease Agreement Entered in June 2020 [Member]",
        "terseLabel": "Sublease Agreement Entered in June 2020"
       }
      }
     },
     "localname": "SubleaseAgreementEnteredInJune2020Member",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_SubleaseAnnualIncreasePercentageForLeaseCharges": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sublease annual increase percentage for lease charges.",
        "label": "Sublease Annual Increase Percentage For Lease Charges",
        "terseLabel": "Sublease annual increase percentage for lease charges"
       }
      }
     },
     "localname": "SubleaseAnnualIncreasePercentageForLeaseCharges",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "goss_SubleasePeriodOfBaseRentAbatement": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sublease period of base rent abatement.",
        "label": "Sublease Period Of Base Rent Abatement",
        "terseLabel": "Sublease period of base rent abatement"
       }
      }
     },
     "localname": "SubleasePeriodOfBaseRentAbatement",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "goss_SubleaseTemporaryMonthlyBaseRent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sublease temporary monthly base rent.",
        "label": "Sublease Temporary Monthly Base Rent",
        "terseLabel": "Sublease monthly base rent"
       }
      }
     },
     "localname": "SubleaseTemporaryMonthlyBaseRent",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_TemporaryEquitySharesConvertedIntoCommonSharesShares": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Temporary Equity, Shares Converted Into Common Shares, Shares",
        "label": "Temporary Equity, Shares Converted Into Common Shares, Shares",
        "negatedTerseLabel": "Conversion of convertible preferred stock into common stock (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesConvertedIntoCommonSharesShares",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "goss_TemporaryEquitySharesConvertedIntoCommonSharesValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Temporary Equity, Shares Converted Into Common Shares, Value",
        "label": "Temporary Equity, Shares Converted Into Common Shares, Value",
        "negatedTerseLabel": "Conversion of convertible preferred stock into common stock"
       }
      }
     },
     "localname": "TemporaryEquitySharesConvertedIntoCommonSharesValue",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_TemporaryMonthlyBaseRent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Temporary monthly base rent.",
        "label": "Temporary Monthly Base Rent",
        "terseLabel": "Monthly base rent for temporary space"
       }
      }
     },
     "localname": "TemporaryMonthlyBaseRent",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "goss_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term loan.",
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_TrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tranche one.",
        "label": "Tranche One [Member]",
        "terseLabel": "Tranche One"
       }
      }
     },
     "localname": "TrancheOneMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_TrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tranche two.",
        "label": "Tranche Two [Member]",
        "terseLabel": "Tranche Two"
       }
      }
     },
     "localname": "TrancheTwoMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_TwoThousandNineteenEmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two thousand nineteen employee stock purchase plan.",
        "label": "Two Thousand Nineteen Employee Stock Purchase Plan [Member]",
        "terseLabel": "2019 Employee Stock Purchase Plan",
        "verboseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "TwoThousandNineteenEmployeeStockPurchasePlanMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_TwoThousandNineteenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two thousand nineteen equity incentive plan.",
        "label": "Two Thousand Nineteen Equity Incentive Plan [Member]",
        "terseLabel": "2019 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandNineteenEquityIncentivePlanMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_TwoThousandSeventeenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two thousand seventeen equity incentive plan.",
        "label": "Two Thousand Seventeen Equity Incentive Plan [Member]",
        "terseLabel": "2017 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandSeventeenEquityIncentivePlanMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_TwoThousandTwentySevenNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two Thousand Twenty Seven Notes.",
        "label": "Two Thousand Twenty Seven Notes [Member]",
        "terseLabel": "2027 Notes"
       }
      }
     },
     "localname": "TwoThousandTwentySevenNotesMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail",
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofEquityComponentsDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofInterestExpenseRecognizedDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails",
      "http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_USTreasuryAndAgencySecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "U.S. Treasury and agency securities [Member]",
        "label": "U S Treasury And Agency Securities [Member]",
        "terseLabel": "U.S. Treasury and agency securities"
       }
      }
     },
     "localname": "USTreasuryAndAgencySecuritiesMember",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails",
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "goss_UpfrontPayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Upfront payment.",
        "label": "Upfront Payment",
        "terseLabel": "Upfront payment"
       }
      }
     },
     "localname": "UpfrontPayment",
     "nsuri": "http://www.gossamerbio.com/20200930",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails",
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails",
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails",
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails",
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Amortization of premium on investments, net of accretion of discounts"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses and other current liabilities",
        "totalLabel": "Total accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails",
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r32"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional service fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r26",
      "r115"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less: accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r46",
      "r47",
      "r48"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r45",
      "r48",
      "r49",
      "r192"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
        "label": "Adjustments to Additional Paid in Capital, Other",
        "terseLabel": "Other additional paid-in capital"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r144",
      "r146",
      "r176",
      "r177"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "auth_ref": [
      "r132",
      "r138"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "negatedLabel": "Debt issuance costs attributable to convertible feature"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r146",
      "r171",
      "r175"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansStockBasedCompensationExpenseReportedinCondensedConsolidatedStatementsofOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r61",
      "r74",
      "r208"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/IndebtednessScheduleofInterestExpenseRecognizedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Amortization of debt discount"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessScheduleofInterestExpenseRecognizedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r58",
      "r74",
      "r210"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/IndebtednessScheduleofInterestExpenseRecognizedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of debt issuance cost"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofInterestExpenseRecognizedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r74",
      "r210"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt discount and issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive securities not included from calculation of diluted net loss per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r99",
      "r247",
      "r256"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r3",
      "r4",
      "r41"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r197"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Assets measured at fair value on recurring basis"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Available-for-sale Investments, Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Available-for-sale Investments, Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r104",
      "r108"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Available-for-sale Investments, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofContractualMaturitiesofAvailableforsaleDebtSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in remainder of fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Remainder of Fiscal Year, Fair Value",
        "terseLabel": "Due within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofContractualMaturitiesofAvailableforsaleDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r102",
      "r105",
      "r108"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      },
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofContractualMaturitiesofAvailableforsaleDebtSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Available-for-sale Investments, Total Fair Value",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails",
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofContractualMaturitiesofAvailableforsaleDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r147",
      "r173"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r195",
      "r196"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail",
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r180",
      "r181"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail",
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Business acquisition, aggregate number of shares issued (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized": {
     "auth_ref": [
      "r182"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net amount, measured at acquisition-date fair value, of all the assets acquired and liabilities assumed that arise from contingencies and were recognized by the entity.",
        "label": "Business Combination, Assets and Liabilities Arising from Contingencies, Amount Recognized, Net",
        "terseLabel": "Milestones accrued"
       }
      }
     },
     "localname": "BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Licenses, Asset Acquisitions and Contingent Consideration"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsideration"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r0",
      "r85",
      "r97"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "Description of the Business"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/DescriptionoftheBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r78",
      "r79",
      "r80"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Unpaid property and equipment"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r62"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "terseLabel": "Cash received in connection with acquisition"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r1",
      "r24",
      "r76"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r70",
      "r76",
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, at the end of the period",
        "periodStartLabel": "Cash and cash equivalents, at the beginning of the period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r70",
      "r206"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity",
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails",
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r37",
      "r119",
      "r251",
      "r261"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r118",
      "r120"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common stock available for issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity",
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r16",
      "r132"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.0001 par value; 700,000,000 shares authorized as of September\u00a030, 2020 and December\u00a031, 2019; 75,907,527 shares issued and 72,475,912 shares outstanding as of September\u00a030, 2020, and 66,284,003 shares issued and 61,635,477 shares outstanding as of December\u00a031, 2019"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r52",
      "r54",
      "r55"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer equipment"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in process"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConversionOfStockByUniqueDescriptionAxis": {
     "auth_ref": [
      "r78",
      "r79",
      "r80"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by description of stock conversions.",
        "label": "Stock Conversion Description [Axis]",
        "terseLabel": "Stock Conversion Description"
       }
      }
     },
     "localname": "ConversionOfStockByUniqueDescriptionAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConversionOfStockNameDomain": {
     "auth_ref": [
      "r78",
      "r79",
      "r80"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The unique name of a noncash or part noncash stock conversion.",
        "label": "Conversion of Stock, Name [Domain]",
        "terseLabel": "Conversion of Stock, Name"
       }
      }
     },
     "localname": "ConversionOfStockNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConversionOfStockSharesIssued1": {
     "auth_ref": [
      "r78",
      "r79",
      "r80"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Issued",
        "terseLabel": "Common stock issued in conversion of convertible preferred stock (in shares)"
       }
      }
     },
     "localname": "ConversionOfStockSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt, Fair Value Disclosures",
        "terseLabel": "Fair value of convertible senior notes"
       }
      }
     },
     "localname": "ConvertibleDebtFairValueDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r140",
      "r143",
      "r264"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails",
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "auth_ref": [
      "r78",
      "r80"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Amount",
        "terseLabel": "Debt conversion, converted Instrument"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Indebtedness"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Indebtedness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r10",
      "r11",
      "r12",
      "r248",
      "r249",
      "r255"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofEquityComponentsDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofInterestExpenseRecognizedDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r12",
      "r125",
      "r249",
      "r255"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.gossamerbio.com/role/IndebtednessScheduleofLongtermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.gossamerbio.com/role/IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Term loan",
        "totalLabel": "Total",
        "verboseLabel": "Principal amount"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofLongtermDebtDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/IndebtednessScheduleofEquityComponentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.",
        "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component",
        "terseLabel": "Carrying amount of the equity component",
        "totalLabel": "Net carrying amount"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofEquityComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Convertible notes, initial conversion price (in dollars per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r35",
      "r133",
      "r134",
      "r136"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Debt instrument conversion ratio"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Convertible notes, consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r34",
      "r129",
      "r209"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Convertible notes, effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument interest rate percentage",
        "verboseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail",
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofEquityComponentsDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofInterestExpenseRecognizedDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofLongtermDebtDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofEquityComponentsDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofInterestExpenseRecognizedDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r253"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Convertible notes, redemption percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r36",
      "r83",
      "r133",
      "r135",
      "r136",
      "r137",
      "r208",
      "r209",
      "r211",
      "r254"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofEquityComponentsDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofInterestExpenseRecognizedDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofLongtermDebtDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r208",
      "r211"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedLabel": "Unamortized debt discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r126",
      "r210"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/IndebtednessScheduleofLongtermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedLabel": "Debt discount and issuance costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r210"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "negatedLabel": "Unamortized debt issuance cost"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r27",
      "r210"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r74",
      "r98"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Equity Incentive Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic and Diluted",
        "terseLabel": "Net loss per share, basic and diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r82",
      "r87",
      "r88",
      "r89"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r206"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansStockBasedCompensationExpenseReportedinCondensedConsolidatedStatementsofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period of cost expects to recognize"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r172"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation costs"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r172"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense related to the ESPP."
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options",
        "verboseLabel": "Shares issuable upon exercise of stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Lab equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity",
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails",
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r197",
      "r198",
      "r199",
      "r204"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails",
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r197",
      "r198"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Assets Measured at Fair Value on Recurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails",
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r197",
      "r204"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails",
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsScheduleofAvailableforsaleInvestmentsbySecurityTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r140",
      "r141",
      "r143",
      "r198",
      "r230"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r197",
      "r198",
      "r200",
      "r201",
      "r205"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueEquityLevel1ToLevel2TransfersAmount": {
     "auth_ref": [
      "r199"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of transfers of financial instruments classified in shareholders' equity measured on a recurring basis out of level 1 of the fair value hierarchy into level 2.",
        "label": "Fair Value, Equity, Level 1 to Level 2 Transfers, Amount",
        "terseLabel": "Fair value hierarchy level 1 to level 2"
       }
      }
     },
     "localname": "FairValueEquityLevel1ToLevel2TransfersAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueEquityLevel2ToLevel1TransfersAmount": {
     "auth_ref": [
      "r199"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of transfers of financial instruments classified in shareholders' equity measured on a recurring basis out of level 2 of the fair value hierarchy into level 1.",
        "label": "Fair Value, Equity, Level 2 to Level 1 Transfers, Amount",
        "terseLabel": "Fair value hierarchy level 2 to level 1"
       }
      }
     },
     "localname": "FairValueEquityLevel2ToLevel1TransfersAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r140",
      "r141",
      "r143",
      "r198",
      "r231"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted\u00a0Market Prices for Identical\u00a0Assets (Level 1)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r140",
      "r141",
      "r143",
      "r198",
      "r232"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other\u00a0Observable Inputs (Level 2)",
        "verboseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r140",
      "r141",
      "r143",
      "r198",
      "r233"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant Unobservable Inputs (Level 3)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r203",
      "r205"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring Basis"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table containing detailed characteristics of finite-lived intangible assets acquired during a business combination. Finite-lived intangible assets are assets that have no physical form, but have expected future economic benefit, and are expected to be used over a defined period. Acquired finite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the Entity) and in total. Additionally, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period are also disclosed.",
        "label": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]",
        "terseLabel": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r109",
      "r110",
      "r112",
      "r113",
      "r234"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r109",
      "r111"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansStockBasedCompensationExpenseReportedinCondensedConsolidatedStatementsofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "Initial Public Offering (\"IPO\")"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansStockBasedCompensationExpenseReportedinCondensedConsolidatedStatementsofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansStockBasedCompensationExpenseReportedinCondensedConsolidatedStatementsofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r61",
      "r130"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/IndebtednessScheduleofInterestExpenseRecognizedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "totalLabel": "Total interest expense related to the 2027 Notes"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessScheduleofInterestExpenseRecognizedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r68",
      "r71",
      "r77"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r32"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued interest, current"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Schedule of Contractual Maturities of Available-for-sale Debt Securities"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r224",
      "r226"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofLeaseCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Lease Costs"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Gross Future Minimum Annual Rental Commitments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r225"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due",
        "totalLabel": "Total undiscounted rent payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r225"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r225"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r225"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r225"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r225"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease having an initial or remaining lease term in excess of one year due in remainder of fiscal year following latest fiscal year.",
        "label": "Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year",
        "terseLabel": "2020 (remaining 3 months)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r225"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Present value discount"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Operating lease, renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r21",
      "r250",
      "r259"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES, CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS' EQUITY (DEFICIT)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r29",
      "r83"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r29"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r29"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Remaining borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Credit Facility"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofLongtermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r12",
      "r127",
      "r249",
      "r257"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/IndebtednessScheduleofLongtermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.gossamerbio.com/role/IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessScheduleofLongtermDebtDetails",
      "http://www.gossamerbio.com/role/IndebtednessScheduleofNetCarryingAmountofLiabilityComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r84",
      "r122"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r84",
      "r122"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r84",
      "r122"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r84",
      "r122"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal in Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year",
        "terseLabel": "2020 (remaining 3 months)"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessScheduleofFutureMinimumPrincipalPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail",
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r36",
      "r123"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail",
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r2",
      "r31"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r70",
      "r72",
      "r75"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r50",
      "r53",
      "r56",
      "r75",
      "r88",
      "r252",
      "r262"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity",
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental disclosure of noncash investing and financing activities:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.",
        "label": "Office Equipment [Member]",
        "terseLabel": "Office equipment"
       }
      }
     },
     "localname": "OfficeEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r218",
      "r226"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofLeaseCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r214"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Rent expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r213"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Total operating lease liability",
        "verboseLabel": "Present value"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r213"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities, current",
        "verboseLabel": "Current portion of operating lease liability (included as a component of accrued expenses)"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails",
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r213"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities - long-term",
        "verboseLabel": "Noncurrent operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofGrossFutureMinimumAnnualRentalCommitmentsDetails",
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r215",
      "r221"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Cash paid for operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r212"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r223",
      "r226"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating lease, weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r222",
      "r226"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r7",
      "r32"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Accrued other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r43",
      "r207"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r51",
      "r54",
      "r187",
      "r188",
      "r191"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Other comprehensive income (loss)",
        "verboseLabel": "Other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity",
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r44",
      "r46"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax",
        "terseLabel": "Unrealized gain (loss) on marketable securities, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Payables and Accruals [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r67"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r63",
      "r183"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Upfront payment, purchase consideration paid"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchase of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r147",
      "r173"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r3",
      "r22",
      "r23"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from issuance of convertible debt, net"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-term Lines of Credit",
        "terseLabel": "Amount funded",
        "verboseLabel": "Proceeds from the issuance of long-term debt, net of issuance costs of $1,778"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r65",
      "r174"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from the exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r50",
      "r53",
      "r69",
      "r99",
      "r100",
      "r187",
      "r189",
      "r190",
      "r193",
      "r194"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r26",
      "r116"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Property, Plant and Equipment, Type [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r25",
      "r114"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Total property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r8",
      "r9",
      "r116",
      "r260"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails",
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r8",
      "r116"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r8",
      "r114"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Property, Plant and Equipment, Type [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property and equipment, estimated useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "auth_ref": [
      "r263"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net realized gains or losses on investments during the period, not including gains or losses on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity.",
        "label": "Realized Investment Gains (Losses)",
        "negatedLabel": "Net realized gain on investments"
       }
      }
     },
     "localname": "RealizedInvestmentGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r142",
      "r227",
      "r228",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r179"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansStockBasedCompensationExpenseReportedinCondensedConsolidatedStatementsofOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentInProcess": {
     "auth_ref": [],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.",
        "label": "Research and Development in Process",
        "terseLabel": "In process research and development",
        "verboseLabel": "Total in process research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentInProcess",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationScheduleofIPRDExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock",
        "verboseLabel": "Non-vested shares under restricted stock grants"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails",
      "http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r18",
      "r138",
      "r258"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Net proceeds, after deducting underwriting discounts, commissions, and offering expenses"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Offering price (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail",
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Potentially Dilutive Securities not Included in Calculation of Diluted Net Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Available for Sale Investments by Security Type"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/FairValueMeasurementsandAvailableforSaleInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r180",
      "r181"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Stock-Based Compensation Expense Reported in Condensed Consolidated Statements of Operations"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r146",
      "r170",
      "r175"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansStockBasedCompensationExpenseReportedinCondensedConsolidatedStatementsofOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Principal Payments"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r26",
      "r116"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r158",
      "r163",
      "r165"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r147",
      "r173"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of Restricted Stock Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Number of Restricted Stock Units Outstanding, Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-Average Grant Date Fair Value, Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Number of Restricted Stock Units Outstanding, Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-Average Grant Date Fair Value, Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Number of Restricted Stock Units Outstanding, Nonvested at September 30, 2020 (in shares)",
        "periodStartLabel": "Number of Restricted Stock Units Outstanding, Nonvested at December 31, 2019 (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Weighted-Average Grant Date Fair Value, Nonvested at September 30, 2020 (in dollars per share)",
        "periodStartLabel": "Weighted-Average Grant Date Fair Value, Nonvested at December 31, 2019 (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Number of Restricted Stock Units Outstanding, Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-Average Grant Date Fair Value, Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Number of share reserved for future issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of share reserved for future issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r164"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, options vested in period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Shares Subject to Options Outstanding, Options forfeited/cancelled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-Average Exercise Price, Options forfeited/cancelled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Shares Subject to Options Outstanding, Options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r173"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic\u00a0Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r154",
      "r173"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Shares Subject to Options Outstanding, Outstanding as of Sept 30,2020 (in shares)",
        "periodStartLabel": "Shares Subject to Options Outstanding, Outstanding as of December 31, 2019 (in shares)",
        "verboseLabel": "Shares outstanding awarded (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted-Average Exercise Price, Outstanding as of September 30, 2020 (in dollars per share)",
        "periodStartLabel": "Weighted-Average Exercise Price, Outstanding as of December 31, 2019 (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r167"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Options vested and exercisable as of September 30, 2020"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "terseLabel": "Shares Subject to Options Outstanding, Options vested and exercisable as of Sept 30, 2020 (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted-Average Exercise Price, Options vested and exercisable as of September 30,2020 (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum",
        "terseLabel": "Percentage of amount increase in outstanding shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r145",
      "r150"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-Average Exercise Price, Option exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-Average Exercise Price, Options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Term of awards"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of non-vested options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares",
        "verboseLabel": "Stock awards granted (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-Average Remaining Contractual Life (Years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-Average Remaining Contractual Life (Years), Options vested and exercisable as of September 30, 2020"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r151"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Aggregate fair value of stock options vested during period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average grant-date fair value of options vested.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted-average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase of common stock through payroll deductions, percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Common stock issued price per share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r219",
      "r226"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofLeaseCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-term Lease, Cost",
        "terseLabel": "Short-term lease cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesScheduleofLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Internally developed software for sale, licensing or long-term internal use.",
        "label": "Software Development [Member]",
        "terseLabel": "Software"
       }
      }
     },
     "localname": "SoftwareDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosuresScheduleofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r132"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity",
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r40",
      "r132"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity",
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-based Payment Arrangement [Member]",
        "terseLabel": "Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/EquityIncentivePlansAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r39",
      "r132",
      "r133",
      "r138"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Conversion of convertible preferred stock into common stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity",
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r15",
      "r16",
      "r132",
      "r138"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock pursuant to Employee Stock Purchase Plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r15",
      "r16",
      "r132",
      "r138"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock in connection with a public offering, net of underwriting discounts, commissions, and offering costs (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity",
      "http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail",
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r15",
      "r16",
      "r132",
      "r138"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock-based compensation (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares (or other type of equity) forfeited during the period.",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, Forfeited",
        "terseLabel": "Shares subject to forfeiture (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r15",
      "r16",
      "r132",
      "r138",
      "r155"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Shares Subject to Options Outstanding, Option exercised (in shares)",
        "terseLabel": "Exercise of stock option (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity",
      "http://www.gossamerbio.com/role/EquityIncentivePlansSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r40",
      "r132",
      "r138"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Conversion of convertible preferred stock into common stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r15",
      "r16",
      "r132",
      "r138"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock pursuant to Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r15",
      "r16",
      "r132",
      "r138"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock in connection with a public offering, net of underwriting discounts, commissions, and offering costs",
        "verboseLabel": "Issuance of common stock in connection with a public offering net of underwriting discounts, commissions and offering costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity",
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r40",
      "r132",
      "r138"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r15",
      "r16",
      "r132",
      "r138"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Shares of common stock, repurchase (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r16",
      "r19",
      "r20",
      "r101"
     ],
     "calculation": {
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r220",
      "r226"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "terseLabel": "Sublease income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CommitmentsandContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/DescriptionoftheBusinessAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Balance Sheet Accounts and Supplemental Disclosures"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/BalanceSheetAccountsandSupplementalDisclosures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodEndLabel": "Convertible preferred stock, ending balance",
        "periodStartLabel": "Convertible preferred stock, beginning balance"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "periodEndLabel": "Convertible preferred stock, ending balance (in shares)",
        "periodStartLabel": "Convertible preferred stock, beginning balance (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockandStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/LicensesAssetAcquisitionsandContingentConsiderationAdditionalInformationDetails",
      "http://www.gossamerbio.com/role/StockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r90",
      "r91",
      "r92",
      "r93",
      "r94",
      "r95",
      "r96"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/IndebtednessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "terseLabel": "Weighted average common shares outstanding, basic and diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26610-111562"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26853-111562"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118942338&loc=SL82898722-210454"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031898-161870"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6036836-161870"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6036836-161870"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116855982&loc=d3e4534-113899"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=SL79508275-113901"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11149-113907"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11178-113907"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b,c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918638-209977"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918643-209977"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.3(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117420044&loc=d3e19393-158473"
  },
  "r265": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r266": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r267": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  },
  "r268": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r269": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r271": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6911-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6935-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e7018-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>67
<FILENAME>0001728117-20-000009-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001728117-20-000009-xbrl.zip
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MG&>(CT=5AAX8,*) $!>=$V!45$)880SE*X//@CWG&4(6J :KA.>:&.'0',]
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M\B!%BL%'7 ;4T($"(='QZ\WFEIAZW[1=M^$Z<"GVL/FYUSSNC0:N&QLH488
MW>W.:;MW#E JZ#>C?CAV \@_??@*>??H,#<CHPNB0]G#$L_]V34)CK"\34>D
M9RDY"POH:;^2Z-XS(']&Z#JN<^L3U#A)B=R?.@J!U@#^I2 )G_I.R,[%],6R
MHKL_\H-6;+G^^;YKPY4@XNF0G3>[#P\B*RB[(XB7A_[,M@;CA@6@RALOK&>6
M@=6!0-)>RQBG47=K[+ZC#R_#\3,6@99,(@)H"##!>/3*:265-DX%D2#\:CQU
MY[N-X_OS9Y,[/3]_UVW]9P1;, C]UFGVNR[)[LO#;TT-V.D.>W/=LIX_^UL
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M4\TR4<W:W+R!A&GN5DTD)5)Y$='0M, ]-8D1RT"EM:?T:YB;59;"25IE-/
MW@@BI4TQ,H&J7$IJ*Q%@NJ(D/%^SL\HD[!TEN20=NORI3$M#>Q30H'!1I20$
M7_ZXV^4FX66(RYAAZ*_3P"(7T><NJHX&PY!&J"*)6@6F"K6K?@ER61V#<Y9A
MZY1)!5X'"T1(19TE5+K@2)"4,VG6M/L+&)P5E;N"@40O2=D8J4@)' LL\:#1
M_4^*<+&FW5_ TJPH[:: -*J$,]$FP9)WH*@DF@J7F+4FK6EWE2(O9D@XI'1&
M&'6$.2$I<Q(,!>JU(=PD+=>$LV2$LS8[;S([@9'$...2$E3CS&DM70+*$LGN
M4P7*LBTW%2^UV;DRLMAJ'66R/%EMA8+DN23 *6@4Q-[(L*;B%39 5X:*#>=>
M465 1244 1.\2$[FMCTR H,U%5<^-&.6]J<%PTUN_Y:H8"Y8O#CD6 VN@B)D
M[70O!;6LC<X;2!<H)!>]9."MX FLE32XP/ U$XY4H)S*<I/N4AN=%9>ZW%)*
M VA+D'2)MY;$:,"20+6VCJU)=X4MS6J3KF!*>2N]\5P(\,HJXHE66E >G7'K
MP_35"<&8(=7(D MI$8X:&W4SDU[3LJZ6T"'2D-;;G$M%-6MS\P825D8%2]$W
MDD()$\!):51,RG@6+3%KO_K7,#<K+86)X9X'I8$1D92VB3L6*"54H,L4UA[3
MKV%V5IF$D8 CY/Z$*GM.AN1:M]9X89U7TKH*U%MX[MJN&V#_&&#XNA?*QM)7
M$7K3AU/7BMMGI_A;&&QVX^[P&/HOD&[Q5B6N50F]Y2A;T%L@1AHNO$6EZ6@,
M-FFA;.[=NOP29_GAFB%W!< 5=,E$:76.\3>XFM')Q"&2F()>?NY:*H/B=:][
M-(1^)TO:K_61RY.FYN=>\[@W&KAN;'[&1SS?QSMW&[UA9:+J$P0T?)6@5C*A
M3#3&"J.HDT@YCI!JE:];KM/ 6>8^F)30O'-<F90;5WKP/$(,,BJ'[RO0=6&Y
M=M)F63J*.!:C93FW520OG28,16X4D2-4K (=>I?3VIQEI47!LGT9:)!6$&-R
M"K*W%A*WZ#>IR3X]D80M*T3_I(+PX]<]UYV5MGO1A]@:OG2AU<85N-9BH]6%
MW30>\<"V$)$%83/ /I^)J\"\X,B>Q'%KP&A.@DD\:LYD;G4TQKY8$\$2$,'E
M#D?7R> ?.AQ='WJ_#D>C;FM,+L,^>@G'<$$!G?&6PV21QU].KS'];OH^7^26
M_1JB@23GN7;"HFT%1#DC;?*@->-R+7XNW>IO& Q;W:/+=Q@O.YK:U:?N!Q%Q
M2FEN6$B$*2%2XKFW<HHN$>UM\(JLZ6OVV/\\/>]VH2+T182-G'$/S#D1>/*!
MR@B*H"]B+0]FK4)O!-[U6\ZW80_5T#4RZW5C[J6$$_&N^W$W)4"2R^->[SS?
MW5LR2J^*#K]:E9I2&I,$G?N6"TH\E2(XQES0N?]37(O$-:4^G,L1E63&)R:-
M%(8:$_&M4 (XY8(:NR:^!>KC_$@[94>[O"9[$*%SF@\#WI3X7GK0\CS@/ _:
M#6'4'S2/^[W1T?'+5G\PW.QV6Y^@/W#]<YQ?NS= #9]%544(-$9K/;A@@\N%
M4Z@!D10-C(DD57)B3: _0C#_2!D3ZMD'!"+^(/G\JO*4.F>]D8[G.C^HPWTP
MRAAJ$_42%?W:O_DA<OUG4MSLQC?X@WZS]Y?KEI3]S5'72_SAFF)O/E2+2A@D
MU!@5$<EQ+RPC#I04'(1G4*'^Z@NU0\O;U%OQA3M]V>JBV]QR[69_-)B9-; <
M/M)B.KF+1*UT22N!] F.6)$"1.^DBH$A^2[_P57US-1E.1$+UH@0@_4$"$*=
MO$?T961$)P,\5: <Y(H!HI-/*4BA$XLBJF"\AJBCE9([96D%NK=>7O25@44F
MB$82!4$&P1SQTD4CK++"!!2;:J+(T0PMIB^6%I\EB6*ZKOADP>ZJ^"X/_0G%
MYTD*'.TQFY(17 @C(6CB(S!D/JZFW6;76-Z3YR[#<S^>NSA_C>[\YK-7_.+>
MYZXQ.N4,4QRY5S M+6<<(IKB@5.O?:@ \P[ZPZ=[KGLT03B_K;>ZK<ZH\S#^
MXB5"VNW"OT?=B-*Z>=SJ#\_1@0QYQ&F^8C;37_2ZV7/,OF6_%6;F"BX+;2]>
M3O$8J$;'D0NE!7'"::1C$XB52:/95@7Z_;6H[(?8V9W=@9TK2;\BZ2AHI,1)
M(0",C]0&;SV/@@@?^2K0;P-MVN'Y=NOH>/C0I/OPNF M>B^">@%"H,12;I7@
M5GJ"\I<:86),4:Y)=YD(;"UUK^XD0'+!LT030ZM7Y..2R"T329% I8<*D>Z:
M7!Z>7'+_#.X@2F>D\)995-? 8R0^"4=M!78";Q5PU4_. NF3"337^TOY;-X+
MT-Q3J;AFGE6A2LNR@3/+$CHF '6@K!-&>&8L6KL*HA,)M&!DNC>H*W#(MQPH
M71>&>NY'8LF*'#=-F)"YO25X+SSU$CB16I( DTC7,:3X8@WI/2#-Y^MWA#0/
MG16D6FD(DEOGD$MC,M1I RFA/8^&$6,5.HI?/D@7<W#-D_).20B.!F&-0>O%
M::!*V(1ZD:0)E](UE_X@E]X1TAERJ=.44\>$T8&+@%(W2L.Y )!$2JY*?YMJ
M2L8I!N6+987T^6B CO5@L!G^,VH-6E\+38RC2D?M3N\C#MCIAEEYU=DUVDV;
M_7YV6J[1T6OTWKL#V#SJ0_G5K.[YLM5M#>%UZQ/$G2Y:4$<MWX9QD8SGYW5W
MTNM?3\/?Z;[I]P(NS!X,(-=QV$1RR74:>J=Y8J^>'T*_E__W_42OGR5Q75!R
MQY2$:T-_@L1SGTWBM42S0@F0U"@>K%",!B3QX,:%Q]:4_6M3]G=G.<_-B4M>
MTS4V^)G8\X#TGBQ-1H( A1PA()?C2X8IU.;Q0M+3B:1?7M]VS0\5D?1W,F;*
MH7P66VK1*A+!*!6H$80KXQSUPA)/T?UP6BW_EMJ:LI>1LA]DBU&8F(25DFF5
M!%'6H%"6P4?"4F!:CBUO@\Z4**8OJDFUFYO/6[W38]?ON!G2[?X0A42>9TDJ
MNVE_V L?KV19]%LPV >(XR.U8::Q-WU(T.]#+$=7@)P?)%?]BJ VI=<I[B*H
MKPW]F4# (+@.EL4@HM#.^V!8I%(ED,I;X=:T?S?:W\9[#L]?]#JGO2Z^O:&L
M5Z^[)O6%DKI36G%ON?>:"T&M<XKK9(U1D203Q06ITPFI5]7L?AA27P&"NY,1
M7 Z=B1%,A16">"FU1'I+U,7LYA&2K HIA3@A.#4E./7PUO /K)NZ^[JI&65E
M!9K <0LT,.&,\I))RJR2CE(>Q\56<M0&G89OT*5EU$78]-\1#M _;?7>E-(A
MP&C8"JX]J(:8>-D;/4!%S&_C3^C=XT_H3(*<A2>$03#&)T$%L58EKQT(EA@)
M["(98TWF:S)?ZCW2ZSSQ,P6WI/',6XFL0(3U*?,&$V @46],DE/=R29^";Y8
M,\>:.69D*ZJ"W=4YN3STIP[T6104B!7*"6&CU=PZD4]^-4_!R^7?,%V3^=*3
M^8/LGIK(?;3@ PE$!.-<T-$0YV)T/!C*)I+:LHF78Y<WV/H! $77MOFY5T:N
MS+)8S'<(/QX[Z,.]*7\&DM/>+7K[^M"?"?:G*9$$7"OO10#A2.1","VB(B&Z
M<6GA-=DMQIRL'D%?.O&_1J,_U3R(&BL],P:,B,E:AQ3+T,4C0BGJIKOL=KH3
MM,1J?OF)=>E(ZEL9>><=M5G5.1*V#"K4N2H72ZBEJ?5:"I>8RC>Z*%\\"1>5
MR[OUO::_GZ._<86WN\:VRMGLA'N9O?@H09&(3KQRRNBD<BH>(4B$5>C&M2:[
MI? VO  2#$]"RWRX(HP&+K3(GK+RB=H*91Q5^4!M0;E)CED?C*#)@DB>6"DC
M(LQY=%3SD"J4FU1E\!>3Q42DL2F !A>IL,"]ULY+90D+*=KH*I3%5&7P%Y/O
ME+RV+*HH)4=#@FJC(N464 E$Q-_9"N4[51G\Q61&Z<A5=$Y9]%5$9,Y:[IB3
MW*BD*5=5RC*N6KSMXG5^<()[HEE*C@IJA2-: C#A#4"*1*QU_GS2"!:B\P.3
MPDI+>.)").Y==$@/!MG?&L\ORK_]XCI_+IP_?YT?E4V,AB0H,X(%9KR/W(!4
M6FI*8*WSY\?Y"]#Y1GH2=43_7@EKK$N>*0**IQ2<TW*M\^<7$3=_I2^-UG@]
MIT2$7([$!@;H_%$KA9&,A+72GU,LS$*TOHK!<Z,ENG8@5%)&$4>8TPXD=<GQ
MM=:?'^\OP-4/5I$0*)( ",FCD5HSRJ1!(T!&D&NU/S_>G[_>9V!8$BR&Y**P
M)!J#YI[7 5BD2 F_^/[^_8Z,JJGZ$P6O;134::$UE %ED*QB-&EM_:^M^N=*
M  NJ5A:(5B$9B"8(GU4_521)HZ+BW(VK8_RZVG_N$F 1?G_,+6<R^],<T.<E
M<\P+DV@R/B3XM0V N4N !=@ 5EOJN -'N7"<NARS1 V)*C')@/[*-L#N\!CZ
M..*H[SHK67^4&>"*H@4HHQ.$! ]2)6^%SOBK5*7ZHU4&?S&ZGU&>-'$LB"0%
MNO\V487F()-$HOQGZ5?6_7/F_/GK?:L!O+')9_ I43;IJ+W7Z/>1Q&F5:II6
M&?RYZ?R+CF>?>D.XN>59_F;ZZSOW/./,.4B.HA=!!:?>\,A4=!8_LT" +*#[
MPP_PWP)Z%5G"F24I6(J.EZ$&$A'4JGP$XZ-G\^L)>(?EFE7;O6M5ZQA:FU('
MFI*0DGCKK/ \:(8.J4_C8P=)&>'%],6R2J#O%"8JN>ME;]2-T-\_=OT'+ZDL
M<\\!PN\B5*X-_9F#A*0<8<D%I%J1!,47CE&GG;(F1DK+U+ UC'?EM.O(_ 2G
M.1L$S6:=<498:DPT(B(JVC$7G R3I+TEKC:V7,A<JY+U,^U^E;>!"6M<BD*%
MW!0]*IURO2*=)-,5*@BW!! MONI9U$)[5&P&(A522:N8=T2@/A<R*":7G]/V
MH(W/'M_@:ITW^ZX[<"$GM: E??F;;S&M",,Y@CC(A,ZN]4)H-#JL,:BQ$E,F
M2#ME.#G-GU_B9F7+@]1UOKNC-7U]Z$^E7/IL/WIF-7*:DVA%HTGI@"0?DP8Z
MX;LUFO?FNQD9^Y1;RP4QTA(OHD"?D5L6(3K025-E+G*R53%]L4;JOGQG"Z+N
MR'>7A_X,WS'.<HR85LD+*K5AC">;N Q2,0)Q6@YBC>9]^>XR0#_!=XHKZDW4
M1 @ID-4,Y=J+X P8KK2#2?<#.NU^0)=WF^]NE:\W'[SL]3^57BIOM >#8;]5
MDM%%#::'MG9U0>^ZC5@.G<W9,4.6SY6TF%>""^%0G%.OE60&Z8W0"M7X75QI
MZ:4DIX54\$5_R5"!U.*=%9P'YP-SWBDGB=;"7P]%F$<7T@?=S;_2%_2GDK:B
M$R)IS[D7WBM+K:#:0O+$:#^N]X#KQI97";]INV[#=6[IMUSV#0?HCEESIYL[
MA[<^0?[1@VIA!)/-1@O38'P() 1IF'!(V(K$ -Q8_! (=1/*9F/K=PW5CYVC
ML3N:O]>&_IP"9,($G4RD(F_S)(19:(L&+PG4F>6OM+)$<#Y(!9.H#%/$4HXV
ML$C,6L>8M]XPHY1 CW3U.*]SVNZ= Y2FPYM1/QR[P5T ^^XT%M6E?C&<+664
M2B7'\3]A$C<)<J^B:"ACD0FR,CKU!\EE631KS D,)A@M*,\%BJP)48*53B7+
MA%1K_JXR%WK%'+.)1^'1R]3*)".]"8*3E$/66=7U:QE87&T%2WUP4L0(07$1
M%+7>4Z,T5;+DO[3\$&U^=OV8O?"KKO[4[9[Q[M'*$T3,B>,Z!B8!36$4S9(;
MAY*92H(R.E2IBL0ME'%%!.^>YHV958P0E=II1X-E+@DA-*+(E-06;+#>ZB3&
M)M \=F$6RMD_:^E<V>7Y&;[2(3&"*R\)%<IXA]9,*/=]K'$YB*?R?/7@N"R>
MIPPJ2DL)^J J"<VT5RZ73W>>:)=XXK^(MEP6724!A'(Q)4^U<,X;JSR!I(GB
MVD8+%<I]0E.AUX&+8XS7O>"^%J.]A-(-X>[;9Z>Y7\@JYC=QP\'DS3E#D-^0
MR20P?.F)I4G81"N4W[3L "^H3BE82Q3QQ*,<E?F\"!??L^B)$.B,5$DK+CO
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M_<$H'YL.>S4<46Y;4?:;_U>6_SE29S,,GR[_V>-/I )R_9A9\4/'>?_\G7R
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M( U<J@9./7$A-9=@-;,E) 86//,</;,\5VXMUGD7-C9]URE2P+8IX$,ZSZ2
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M56:>S-<I+JH*( U.PF%>U>/*N<ZYYWO@Y>ZOBYPK$R $" %"@! @! @!LLJ
MJ,N +*'/QSHANUAVF1&I2 =*JQP@)1,21!UC0"NTJ?[E69FE_59FZ6^39O9Q
M,!I]?]3RF;F]5]Z<&]N3SU,>VB(>:7,J<)Z']NK+SM>=#]G)))(2K&01&2B#
M+,0DF5:6>W!6QM"<#G#H&K5HK*V5]+"F6KVZ?$V $" $" %"@! @R^J;L)(A
MY5=_Y&'LC7(34YX$DCN#X\;*&LT34%Z?9OPT,H%0(I0()4*)4"*4"*4GCA(-
M"UV7*/>%O*J; MV3-_=.[?YO#D&B*/="4>Y75Z+<R@4A@Q*,AR8'7D7%O,+
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M1H"UC@IK$7,F#Z7#&!E+!&C#!@?O;4R&YK*VZW<\WK$J?'WADPJ'CP,.KRV
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MB3.'+V@.?;]TQL^S4IJ\^BEYYMW*1TVY8+_71(! F@>Y;"L?W.7@:I(9Y\&
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M1_Y4,CWQ5%+!@\><$R*T-$YZ:D *K:7)5,-NS:1TH5DGY=@09U"($8-4!8W
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M ;T; 9TK)BZ""&(J$=9>(QYSVH4(&*5<D6Z2!^;GA@AMNFJ%9O757$X@?S!
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MN'6RBW8C^?LGNWC<>"*YUMXJ;[R0,GEM-?6TTI5D(CKCVIL#ZP,J+Y9\\<"
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ML=%)$;,IOVP:!+T/DYXK #4>=&)W5-@!/ 5M=8^!9119GLXO<(9ZDO"OI6_
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MO@A>:+_\<3SE+=.WG #@(5,9IO],NL-T>>,^96P01P(6Z'0>>'5'2&S.2D0
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M)(A(U#*A*;=:/9OM'<8M-+'>.U@(QZ*@1EJ7G*? PR,3BK,<E%C=['C5Q[V
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M=W_FJ<(<SN]TP/O*.^OT3#WH<F'@HW%"=H2].L"43'U<;3P)=GP\''P&9=T
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M8#COS<)<U>=B\"$DZB57[E3D_G[Q>WW-#3^)9<,.WA6;7;1=-XKN/Q>/;,X
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M2D3B<^!$&F>!1E%'>*3) 5#D*-BSY^=+#WSW"PSM%:+[#-"TFO>=-&\>JLG
MQ&+P&50M.C#P%J\2875>&I2,0G);I7N\0-3JW_>.'[2:]ATU[70E7! D+)A3
MC. E'2(SJ)RUC)/LN4:6PABM\)YLJVAKIFC?V8=MU>\[J=^R-PO\WUD;%4E:
M4C1VX,AJF8C@IM+.1%'EVZ9'7:/;L@_/9WW*E7?6[.#'Q4A45_R F7U,U_5_
M& @M^+E>@AVQB5C-&)&5,\1880C7E3544NF<!_N_(<5=W>=<HTV!5I'OU6UN
M=?A;='BA9 \-/'CPF"MM!)%4*^)5A)42.L?H(Z^,7\>2/:T6KY_SW9KC'ZW*
MN[^ONN0Q!LX5)5EI260,E-C$$S'*64>U8RYK/)!)JYN6@&F5^0$I\[TX^*T>
M?XL>+_OV+J68')9P2AE\>Q,K8I57Q#E6!9E<E=F=GSEL*^E=IGG[@_$%EULN
MOZ?=EMEKZU&M<31DY4S1(RI2]</0>AX$44%67%F@6$)Z8%PF$Q\K1YA@S%<\
M@SML\<RDE>*AE:AJB^ZU(/<0(T4MOGTSOBT>J7 Z"Z8(XQ'PC4E#G!$5D;PR
M&KR++.-MCU0\1H1[&H?![V(&'@^J_<#(60MMWPAM?Z\$S'B,08O,"<;!B:05
M(R:&0)*EAB<K;:SDL^=JH^(W/*]Y%SK2PEH+:X\]AM@BVC<CVG+H,#J:+<V)
M^.0ID4F!0YJB(9K32JG*5)Q5WX.P_8B;+E?G^,3?482[_4D)2=<I$8L$2:J8
M]#X(+X,,3CM1:1VE"BZ;["K]0;-GE^=1O"+EY'?7XW.9ADJ&2;W9^4XI3:=Z
M^=MD!&\=C7X?'/ENO\PGGM[K#4:3X;JD,N4[,P7=$>\^_MG=V0]G[_C+P_?[
MK\6[_;?JW=&;PQW^0H+B=G>._J^["V\]E\H4%?GHU9?=LUUH^V4/E.T0E*P+
MRGKV;O^P!TH*S[X2[_C[O+._I?;VWW[!LN6@^'1GZP.L!] \51$%_Q+IDR36
MZD0XYY$;T#Y-?8VL()8I;B$<>NM42@*@-6M9,><5^%%"*24#8RS*U2RH_^X&
MQ,;11F=K-$KCSE;XSZ0[ZN*:C#JN'SN_E^8/L#(S_#CJ@AZZNG[HJHHL)@Q=
M49=Z*;_>M^6QQ%"Y!-)F4Q#@W4L;5&9@?&BNO.'</8X<KL>383ATHQ0[;E0R
MN9Z T>JX4$ZSPE_!TG5* 6Q<'K>T/*/.:.)'8P>3YGJ]TP[\,RV?G5UW.*_^
MBG]I6B\M#*'=\AJ8<,QU-BR;#=U^QW5P_^88OS/JPM#=</:]?OP7]*2T-&UB
ML</] 9;T."ZI7^';QV"2)[ACUQE,QL<3>"I"5YKMC)X+G_"A='3<&YRF5$M:
M<D,8 PSG(-4''C^GWN 8,WQO=GX#H9F,TN) #ETL+SU-6/4VI.[GDM_V8-)S
MX\$0)N,8^@ SL+$Z'VX\'G;]I,Y26_=H-&L5:XUCOMQA+./#.8%F J 5_'D$
M70R'I;,+O>O\A!:/TU]?_?7F_W-'Q[]NE]_9KS]/MW-*,]@+3$/N^J?%0E:_
MCG#Z(SZ I+I?K%I9")B#<3IJBJ$/CAN-*SE^2S/CDE$3N]&_/'=D;6ZG"20W
MOY;0]X'H33.#4_VHYR3,,2HL8E3GV)V659X<PR\N''9AU:;S&H 2.%B7N<AL
M+*TJM#L"JCCJP$B 1 [Z]3*.)B@!YY7QY##5:SR!>0)!1M&?]2N<=KK04!JO
M+,/%M**9UF;L$K<PCP?U>WXI&X,@ZO.TR/^S#(,-@Z+SKS@/DC497_Z5<XD/
M[VE]6;4R.PO_'@[GON8!$-!A<I^(R]#97USOQ)V.GOUK6:I!I!<G<'7LEXXP
MY^\VPEJ/(J)+6>U?:E&!IZ!/;FWZT@%T :;W7U]GMD#V]Z> CSP!RYC][[_<
M\XN6\4)&\%4+O\(($M4I)^B$<. X<FZ-TL Z/5=)BLCH31G!]Q/TTN(OW3&\
M+ER#=#<TK).'@Z/.7Y/>T> 3/+/1>=4/FYV?_OB-4O[S(T#PO7YG+XP',^O$
MT3BQ:F/1.&YT"@85/@+6V75ZS=RX [!Z!9I/NN/#<[-4!!A@N OXW!T70WXP
M=(5"P4#3E] #M^-SZIP,AKT(<)#F#8,A!2(U_15>.K4->"ZCUTMU!E+@ 6"*
MQZ>=XE*..H.3/K3=F)\A\#GXS9_.^X4--0:EO"(,CH J!Z!J,&.=LJ;UWYN7
MX>D9H%X!2Y7 8!;,/8!=J1&X 7V !OM%@0H+Z;J#/N#\"#6PF$7X([+ V 6N
M F.I>Q=K&[796;*@O=$ 2-2HO*(,"3N\, ]=&&,SU'IN"W5;78P-_,I'F*+%
M>5M]YRKW=,,TI40+K&\TI:HOM[=F]&U*OS;*V!;DI"P.3A.\-T^&\,EP-MT7
M\5T@38/)P6'G>( X!:NP_!J8B/09I +X<%E&;&)F^:'#($H'M?0U'0]-)I5Z
MA(O, >,=GV'X,*#@^LA1?>J Z&#,"HEW%^LLC(%@'_2[N0N/C,M]GIH$9RSD
M,.U ,]1F$A?D'Y9XF(YJ$<7OX/P7["A36GY'64<ZN0&KUT/^"DIUA.YVJJEV
M-PWQHW$7&#**TW1I8\/=Q\2?DM6_-8(,7QN>XN?-CR"[((0;#;F'%^%*7A5%
M<!43S'%I*@#^X*6/R@@A4U)4*:%%B0!68*XYF?ZP%/,#  J_Q,D0E#F.4G\I
MQ<U?=5<;2-V'43^Y4,*!V'G](>MDI)&!>,WP#JV5Q$LFB*F@P2PS>.+@0H,R
M@ OEAJ-5AWXN3RA%N*"Y.QR-%V"L\&.$F"GW1:T>@5/6Z0U 6<!U1(^K"\+C
MQH6;]USW"+[_&=H'=ER8]#D!0]I]G (HQK([-P7P+@#P%!C/?7G*SQNQ7 8\
M1$D MX/IP;HC]PD,[F0\&:ZH;W_IQ7,0 &^B5&K%N0"@AB;^^P9!;\4LI;Y2
MEB4MDV)&BV"EYBR R >72DFL1M+GL>Y7NR^OF[KN@K#:/'BS%+O9GH]VJQ_?
MS,:Z,QWJ7\U(_ZK]IUG47#\U3?KX@N^^_B!!79ABD505UH5/*1'C-"7""2-"
M#IJF_.RY%IOG[Z.C^/3@AXU%O7F$(O7[;'2M$)T3HE<G>UL?P+-Q*E6<4%JN
M-#)#'.6::)>B )RVGOEGSZ6Z4H@*55V.2CP>&?H;!]:*SWGQ83M;'S(XXX''
M2*RI0'P4U6#(DR2I<E9%II(V6#G>TBODYYP]+#[ DE$$8>H <T7"/!R<NEYA
ML2!!M="AX4WN K,-DCE&BHOQH\+DD2ZCD9^1B*-N!%>Q?P",(78/T+=H@L&'
MX&)TZD](_<ER-X]<1!<-1!O: O/<B#M*^TWD/ 80Z&Q9-BK)I$'D96))\6RX
M#M+&&>-D#>-<*4VIKBOO;^M^-N+[A,7V-4>Q519(?A+$12:)=)(1:[,D@3.E
M7#3&"_/LN=I4EPHMDKHF:%""!9N=K0)UEP2Z-SHW$0JK:4Q&Z\",I$+C=J:7
MEGH6L\$(UW7J01=?!.1AQ1>Y8K>S;+6-@'K]N^M\MU=<Q:UA%Y7@)>C+#!X#
M_KV4,IW7>YP)%'UZ J5 H**(N0K4$.FQU*/UG/C*1J),\)[3&)CBSY[W!Q?*
MTS2.CWM'/B7<$PC#2;W3<VGLOIN6-YO*%\_'\A]FX'%KJ_-;=W!\Z$"<ZSC:
MP@YP'7EDCR3R^*?K3]SPM(8+62*/9BGR.(\5G9^5X\D04Z^4*)>#U1\6_W8>
M!$-B5L*2LPW29@H7XD]I&DZ#-LK$7AG^VX07HQ3V4PUCL];/OWPI*C8:3>J0
MISN )PX:W_U24!S!(-/HW)6AF*55BE<Z2ZJM 8NI@H^4Y\ K58=G#&54DND/
M-V>'JP"Y('AUT>;I^:W1JS*FO2'^'[G@[@1Q?R__7?I>?_J$<?'_9^]=F]I(
MLK71OZ+P^^X3W1%*)N^7GGV(H!N[PW,&8;?Q=-A?B+R";"$QNACC7W]69I5N
M(##B8@NH'7O<@$I569EK/?FLE>MRE#=:)R,#FS2 44$PXDQ;I+G0B.86W 'H
M.XDDMQ%K@Y[E_UW&QTH2JJUUF$'O78PE_F/:7;OU9AA3'&9A?C<>^,]%?-<3
M+.<Y4][0X'G@RCKG-07R*E,4TAEN&\':),'Z_+5S=NC!/,2Y>(=Q$79=$Q(R
M1#ND'1?&F*@]9KD4#\&D35?D_B_(5782@(A4PE/3_R6H+9<>#WJP"U^P F8Q
M&;,@BW4- "N59,XPYQ3CG!AK)5/):"T#3CKPF>B16O1N80!,)>^O.E0$*-Z"
MK^UU_TUUEO%\C8)O.V<@4DF NK,H$)&: I$S%%EO$N(^4 $$CTELLRV[=3FO
M<=$JJ#?TLI&WNJLWR\6M& 1F4=J>!'];.CC>B</3[J#UIKR>CY,2\CI:/$7F
M3X7+3?JQ/D)>R>1N=H1\_7S545W51;.0KL5CYL4G_K3SYOHEOGO8S-M+='-0
M#DRG=0:6#YWS";(]/84!VA4'Q_?DD"'<<(Z=$$H '"<"=R518)R,]"GY4..Q
MG.*QO&"$-WA\'WC\6NSOOO_6V3WB^[M'9._L$%@9]3)Y9(, ^]J27+5+!D2<
M ,J&@P4JD'GD-6[&@LV@H+5>5KHRC*<Y@++H1]:;:=CKA8B](G[]RP%V6RW0
M^CU[WB)DZN>Y6M_A^["^H4CE-.3T6@18M.XNJ_8]"3SW)$7+3"2><JNE$U00
M:J2PA+#@=1TY+T@=.0\_-![(.PGWA_-,-@RVWGF#G/(>\40)B#;+E24MIP8S
M0K0&LG'=N4L6BUI2BGR",&>G=RWJ]1'RB@.9<I(\]:)OM=[/HFB*>(*XKHBF
M&=_PQ'H6N')?!T&, \VGT6OM$B<<&R.34S9RFBCV5-2^T M2V9Q/_UP1/_K:
MV3GTQ!NI2$ ^N@B8C<%$BR(B*AU+#C99J>.+;7XM9I?(L:O.%M>%N@V2I>90
M\0K!R8>*FAMB> HH20/82*T&6.0>I40=82QQ9\&V%S<_4_R1084__ARS-SA#
M!8<OGF6N'B]836#L#,_GVP6,O-Y'AC%?,RKS,3Z#IYU/']OZY4I%ZQ?WU 5=
MPT([ZHP %</<N)1UCO*H8R).ZR2F/)K6+C7X85'IV'+LG,UYDMW3HCI_Y76:
MJ0BBSTQ'.KLO\X$3Q4$Q' /B E@Q_".0U4DB:8*E+!)MF:L(\64E^9]?01 7
M9K16B1)N&;JC:8I&AM=BHMWGV29+-' 2L>% =+@)1C%C>0ZO5"QY)U:?;5[$
MX.9P\P?)&HSC[2$S1$CG%:"P,(@SHY$F)*'LMC3)864<;PXW;WZX&8YM#DI=
M[>"Y<-!)J!*_MIZ&>^P"?E!2^\BJ7U<?>5X[5S-G6'75S!MV_;'HU)I?83BO
M12=U8"Z8Z#SVF'MMK5=!8VM#L,QK0NLMSM#:500_W-I5-&6(!X.=:FJF$!='
M?PX'S]A7U-G]0#I'ARP(*5G0B)8@#"$DTD82!&:&EDE39G,<FOI.0(^WH^/;
M')IG)?W.J?EW0[ZO2OB\_]A*17+YV\B4=([["(998)Q3Q8/$/MBR!5\6UP<Q
M@^9&]+)QO6P>/7N[J+-[A/=W#B4G)G&&$9BOP/E\PB#DL"UCR0P% NUL"B^V
M)?V>07V5%3(_$^C#GEN$[KN6QPT,CY4&Q^N%[6#%2<G=#U:S!\T(1[6.FH=D
MC 69IV#M8RXEL=,S?3-UY%^,IFL<^?<@MP<[WP"<*6S+25&#HHD1['FP[(T!
MJT4ZZ[33U%)O;@#.-SA'K7A D:[LE<]EFMHKG.9W=R6!Z5)2Q%0*$EX(=G]B
MG!+<)E!$$*>Z5I28UHH2MXW;O3F6+L'ELW:QP[M\VW][R)FE*A&*;* <X#)Z
M9*PC*+GHN&%"6QE?;)/O'!FM$KL$!F2N(5+EA;[N?X&)S]LY7&1[A3#O#B='
MBX>5L^2PFBR<#@='0WMRGY:U$]G3$D24./"HI95:)4F$BV#"VZ2:J.%-DM"2
M/<$B#S:2B&!A&.)2P=9.'$-,DZ2]!9,[F-6&=75._L#F=5,'9*D.B&[J@&S
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M</Y:$;M?9$)B#6!Z4\_+*YB6#$*V[V.VI&;<>":&\IF)X;)3QI_MOSU,7H<
M1@E**0@02L$0V.8)!<.E5)K)*+-0$K5%KG""PH[9@]\JN:SQ:C3H92-\F:(4
M$:J(1,PLY'0RS(LS+HQEE7/@&G[P)&CQJT%1RU:U93X-IK,;?<S69B4;+%,>
M(I8I3[=PAC6I33"4$0N[)DDI9\0Y8PUWS"LJ?7*IBI81, R&IC\TU.;!8.0E
MWSL[U(E9 >B-$A4&\8@-,K"%H<@X=5YQ3EC,Y 8$H:VUOJD?IF5A1ZLUH[X"
M%@[LE.$7H!(Y<#A_5%G8"V+5;GVQO2Q7P(MN0WYDDA;39#UL/CQQ C]82JRR
MT@!"$I+)SQ5RM2P\"QO-&SO<'Q;,"O_)@WOV/&COX#7KO#UD'@?&F$=>Y1+N
MF#BDL0](QR"I(C%*1EYLXRU J\N[3NO4#JNUGI.B=A$1"R*1H\Q!H&[/5.X(
M-(C>'6>*K#0PLW>P=[Z_<VB(2TSIA)PN>1LY-=KDGC<$ ]P(FI@'F.%MLN*8
M=JL%6]*_;']BA^?5CL3+CJ3;P$[\L% )$)@O<32NN&X_=,>%"1>R<MJS'A!E
M4!&9TV'\TAU,1KW9%K8,4UM7;VG]XH&](&G6>$YR/J"VFANB== <3 .M++7>
M"E\01V."^:* T5MY@ZL7!/'R^8V/Y@B4Y?692=7;;YVCP\A]<$D%1'@"8TS+
MB"Q3!!&II$J:199 JEYUT_SD<,D8\\4OEVXD&$6^*CE:+8O9[,HW H&TW7YQ
MYRW?(#N-1Q/W*?K"EJ?R"A^-P;ZN)#:[!;-'H$#(@N]HY<FWD,YXRD&!4N#2
M1XM-/I!(R0>5!*U.NXKLH;D07I2[,!G>6.Y@3,].T):,K?/.SJ&E,-DJ6<2)
M@'^B\DA;Q9#)):J-C9%P\6([9=?I>;3#T<4SZZ?@#7USP>J+)Z>]P7EU$G T
MC 621U<?,M>*,6K%K]%/LE;5*M6::=.BK0$L()_!A,(/?!R.;4Y!&XSS,0T
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M?A7T4TO.SDEV=SY?M]\GV(G>'@H0$TJ#1UB78H)<(..31EAB'KGCAF&3 R?
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M^MBF:4S7)2ZU9[[HROT=8\DO*?M7R5VJ!'%!V!:<XSDF&ZYTYVL"G&22.!U
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MGGZFW(0GF,"\X"EX![0W.R8\B1@'R^XE-+K*M+@?TE*E7SQCPG*4*[("&+K
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MA&^M*#2Z87#S<R^]IZ.WQ\3:9AE5-Z%M3^G,[9=-)G37=KW.'^Y/4X3JQ6O
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M@8R5.>\Y5_00CJ'DN$XJV) PF+KTND(>[=;9<=<?+R9@MF(I1#7*8CF3W-8
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MDU""!0L$S'.P:QT3L)L[L'TU&%">;'3QN#P/3:$X_ZVS<R@]IDX8A8@P#'%
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M5=_Q/W2.#@V1'DN!D7.1YHYZP+&44PC61EGE<RV?<"6C;M\'<-]1*NC*I6\
M?#U1^)I=4<%$+SU,,Q$A0WAN)PK$22E#:'2..:.O!_-J9X?]?.  DJ?A40 @
MZ]"#K0J.JG^7H6@(@ 5T'OCZM<S[5A*U@GD7P%LI7A7_WD]31-EQ=3/%YRU%
MYYV=0\-H\MABQ&P$TJV515K(A)CR$3.:(Y4E ,JE^,*:.\\W%SN=TVI#FNZ>
MB^3UV([SSC2,-;5M=>&:[K!R3/:7N78):D>#A"9YJP5QJAQ"9]U>;W:866#,
M^\'DFCVXHM.A"PPVPC7QLN>J9OG33?F2/$_?9"'"<)U=E)H$4ZPX&,6",Z^M
M%@1+PZ.2%GY=';5UR^C!J;P#D Y.XL:$^?U<,7]]U@&PI"I9K@6*@2H0<TF0
MD\$C[[CQ-AJGK5VS^IIG@FB;DI=<<&>B!B/%J"0CH6Q6?>W*.B'-LM['LFIA
MM0D^()L<0SR:A)RB GZRQF+BI A A_#6Y>J%5X9V9A-]1M"[9<9GX#(N;3#+
M4<S571^7(Y2?@FVT7QDG+6K:W[>/:N-H-((7J0Z2IW92>W84W,W>&&]/*C2N
MKHT5G"^<4-SDI"6'"?3A?T/X>[NUU_7'0&3ZB_Z/XE19845-STQD=="P\$*Y
M5?-XE1OIHHNQ>@"\S^0T7W4=QQ'1,AV]BMHKKEETA@"]H8FGR!*AH0X=5]2L
M$[+[[\*S9H>ZA2H#OXEGMG< XWQN^+ 8S/7MPU<PEV((AD7JD/8\1WIK X83
MLX@Q;KVC+#N67FPG(*E5PL1J?^+#N/CNZMZ[^@SM5F=EV&/-<]FKZ!*/5%KC
MJ!',!6Q3B,9.-S1JT%Q4;V'M+TOKZ(*M?S&]]=F9_,LR_&UOYU!Q+#1E'L&2
M< 1+))"QB2/#-) 6#$!"5#E6X>:RR?\(/,%W%#S6>(+O(F#[;P$D79(*;+Z@
M%9 HQ32RVGDD?%06MBT1-%]*,EOE%UZ,&<C[8_$3/Q7G< U2E=1/,\I ^A=,
MPJP^K=RKH=BM^1994;)O)6< K60.H^EIU5(LSBBKX:7=Q-E>T<C1<<R6\+BR
M=8'2Y!%]L;W)A>"+4WM>AQ>/5Z4?A>ZH,IN'==C&>BJK*'92&B$IX1SXBTO6
M!\Q3,)@Z^,_J1#AZD;XL;P5_UX/<J<:X6P_Q+QAAK<?/6&N7'3<Y)5E)6($
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M_%Q(F<(NJ]_80/U0C2>(X)F2Z L( E".P+(EST3LW] 1PY1?"ZR;WE'TX1<
MOV+,))'! M?L,%XI9DI-$LW$"/2[FZ%B5S=6BX@'%(-&L$X",(L23A4@7;#"
M+T![(MUV%HUL__7]#:V#AS2T6FUOT'I,0^L,4/$Z4C<[H,. \$$>ZAO=>(^]
M_?TH'0]]0(5 %93X1?$(1K>@R#GH2-71  O .E<"BO2GZ,Q:C\?!2RI#81']
MASDM$/"8ULTU]<-2E%'KHR.? GFC49$ $*XH16(0^Z-1&21(DX"^:CAGP("N
M4MA>I#5;U,"2$*"<33'"$Z(.#6P"^)8EY,L=R!MQ594,2<.EOW],E(YQ: ,#
M]*6(A56!C V/0IR#=#@Y ,JZ%"NO,'H3Y4.6";A#(FP2]"" U*C/X>]0J3$0
M-DKO#!8/\$.*05T-,5S^'90_^ @S_L8$%7VR:P5,U4<)E@>XJ8B,)[[$2-M'
MWQ6H"7 -%%$G4.2\8QT(A5N>J&#(<&:M8=&E1Q2X ^-9 9.#_^K'_< G\\]A
M[[TL[E-Z(H'N)LWBD"\)1UN)?5A>+7ND\!P<)D733'!J.F<@$HPFR/4 U_%*
M_%P$![S.1%E))V)4O:.-L3'$."ZRO$#X:AL4K(J0W('LOT#;' -J<O,#N(!,
MP$<2S ]#U%4I/R,0C? &!0!["Y%4R#GG$YJ!D,) 7:($]>#8Z1@U#DQ)FU*H
MDB\!B"M'*.UQZ Y-;(SSEY]H\YA46M%+ 8D)YP=T+U4>,W\\RH;"A%2Z38R6
M@GR*QC'%(XWU7GD/K4[4IB3:[7PZ^7#D?,6<!Z?5+XW^"07T48(;1<L/KWVB
MN;FMN,YO[YM-CS8T2D/2. !?X&:O$80J!448.&04(P?))\.1+SJ#5F8PI*QU
M5L1+/5@.A]*E!;T4T(^BPJ(U-?B50 'DW-6:%J4;C#.PA( F@">-TXC+.U'.
M ]GCV2BSYBJA2&J"^B,>AN8U\G:L4E+#Q S+(4JF(R"]YBHA'H[C[@ YT!<-
M+T'ZP^.)SVQ0Q*AITW!'\S+#R],P)'XYNRB/U4O[1+ZH,]+,/E2<.,$VS K8
M239B9D-$G'%>!BA"@>JG-H0T=)9#(1JAT\FVR11QQ%RAR3(+3:W^2>[*[-;Q
M^9M4&R9K[U<H6B57_A4N<Q6G?=*3KPK@>"ERN0(@K5W;9*91"&"!IPJO;JBU
M/<)CA@:2C& @O)HU.$)Q]'221@@W;TQC2I-(@%D/HS$1L3CZ$(]CP-6$[.&E
MM'5Y>GGT11-7=1,&LXA'!4/@48@>L DDE@(]C#HL0+] ?,(_\,R)GY,;,IZ.
M\R<A)#SX'!X8-.%3$L/@W<#KT _#6CFR9V621A9>504PBT%AD,/2EO"15CFT
M'#23B9YR/B[B44KI& 0)O,GA% 6B2DSXX^O1[\Q[4>$BR*@D [E+LD3?#DU6
MEQOTYM@C6KU'OQOH$S', 1\ATE?L?KQ!EPGZ*/TL0L^&3\HAOY?V/F-I$(-(
MKE+<D_$C@^5&F*F]R;!HDMZ(3P.Q6HSJF8NV<C?,[I<C38G2F.AQ31$PN EK
M2OSEV?GYR?\8[%X(&H,/Y>;J1 J32-%9GDA1YT3L3D[$C/[\3-BFV9PPR_48
MP*T\17B4\(+JLL0.=:(MCG5R;>]C):JD=:'5K*[A",\?DE,H4!&[UL88)@P5
MJC-LV0BG4\Y'T&UU'/^DR-(Q:&3.9_1!H6?6.;H"B$Q)&IQ\/G(7RQ(M)Q9(
MG\[B)XP%CBI+/P5#4!N\M@NUB -R^9+6$+.\A]6^'3/3/,[285(F1?+S#>>4
M(<7B^!9)CXFM44Y.!+FV98),7R?J[U$<HNZN]7C8T(RRXK-AJIT0^70T!A:<
MBRF>3\394!&MY'?]_?3CY1XLIT4&OQOVSK"$E\.7#X>4YGV/CI:+L,-K'707
MHX?VQ]@FI[E8D,_9S+UB&NL->G !1T@.&X7D[9S8956*WATE4KDX*488;+3L
M6](R0$%*V;4SU3HDW%<_$AJBJU81:6UC->J#BA+]IQCY?4328*A&^F'<>C2Q
ML6A6T2!+9LRMTW#[K+4?D44$]'B1@FG.B;5G&C3_BC+RD7]EZQ4W]]F?5I4J
MK5/JURY^C5X=(7-*OA1]:"I%0)\S)4V+W6(E+".Z"2SOQW ^'RW13N&M^&_T
M!=$&V.E3"4H1^*7VJ41UR<#0" ^VMU\Z#6$E_88J5N2SD1^*]J!G#6!#&&5B
M(W.HKI%<YX:I$NY]0/:;70A-_Z$8=X WP]VBAL"!EK-@DC(J>-T*F$,[.01^
M"#\X(%<F.T.TZU([?]F,BB0,F5WY";MV*8-[X@\&.@DET!4>)K$$@QKL8LA\
M9N6!/\;L/M=$SJO^9"'EO3@*T-:1A1?XQJ1&@-P1Y#TK74;Y!"24_$11)=(,
M/I7&P:"@[#E\AP62\L!@^Y-GA$H6M)>R/]$1T>2*U\+#P3*O>IU6HVEJ/XFJ
MK$LX,,N9.F(N_];%Q/RO\D<9E8;06]_C8:DNN\\.LH'*T/\ XBKX;FW'Y37\
MRL\Q>[#\C?P$SXS%,Z7)'UF%/\RV >Z!4J&P1'SB&"-@$XQG4M\ 5T>?9WX6
ME(U]3-$.Z)L2W,)"'W*IY\(1#X!OE9<Z M8N!Q.^R<SLM'07$I(:CO;*:S4.
M#=A1$/CY4#(N$S63<*FK*^"$AXQW;'CA5HZ.L+:/W>)2X&>2&K^"30ZV3$(%
M(":B\?J(O#%OG$_1B#-+43;=#,$@GNZE-QB- \:51V$$[VPX1SEGH"V\?J$\
M.$^WVVUT^,N94[E\-L3':S\VT5Y U^^*:VK*<JX=X6U$J!'C4UAQ^ED=6E)@
M[5A[2$E+!:H+&'W5(:12Y=*I(>P]PXCVR@6U_(/_@EQ6!&".E&+1TAT:!E1O
MFK:8J D7J6"9TJON@87"5#7N'1R6'U4+B7_BY2 3YU_>.6QT9U[>ZC;VE[U\
M/2P&9/&#H!@5G'\<*@!R1.+]51<(MJ=7MY7B5/0([&#(P;_9&R'/7$0*2$Y*
M <:F)YQQ0%$K+168J8L^0%P*91&&M*O"P"UQ I]8FK)(9D.9E:S?LD#P,%/$
MDKF*[U>G19JHQ**0B!5X TU:&8;GZSK/1,7$ER<:7)BO1=&V@J,EZ";4&C%E
M;)0K4-;EG-[45P0AS9MU/*W*;C%.NU@04X!&4:T5RZT*T%"73,F';0>&?</#
MV=&JV),^\K\KQ H%S#]19CQ'6>2'.H%.MS 59K"VK@8D^0/,=V1T&*-*<!*+
M*81=!O_2OB53W17;#E_(NC3KNII\)+5D$!<!U3K;W$2GP(@QA$:IMHMP.4S>
MQ\_POQA%!Z0/18FGXP0%IJ))99PDRNJ0YZQZ3#)XL0)D* IN$M@6U=JEVNZX
M#=-W1()(ADTI!4",LW. N[9<*Z1^NBR-$SD(UQQTEQ@QF[-[)A&:@CHU>5 @
MQ]'*TQS2IWTJ<5Y _TS^"27V@&&K]*4NPD;6/$K_,U'+!*G$3GY##$(+?$ )
M4ZM?C =>]4+;/3$O'^=HN&36NLR$LJ0L&+JBFY":#Y=98,I4853]D KK^P45
M8SI' 3;0@>^P5P9#G/(M*%XGW!TPR%R?Q?[-6^4ZB6ODQ9C3Z4@ES2<8_T)*
MS="3-<!DIVSFS*PELR@@32LAQ7;&#C#ZJSMK#I3)I&+H.#DL%519BXG/$0;%
ML=]/3=JZ<"N;Q^FT5#^CXE9)D_L]O3'[1Q[4I_JF/F<%D$%BLWXT=&AS%#%
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MQ WTV <FVLH,(0I$P87%:2Y9_!S;O2*7!BU&O[/6,XVFU[\)RO[NZX*.\D0
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M/1A'58;O2EFEL?1?4"L'T0]F>?QBX"UPOTDQ0K$O#T>EX96K4;2'W]-=XAX
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MM#THR#HN"0V2QP)=S1^,B]+E(328TNF2W4OI>NAITH# *5TLEU19,^KGY9"
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M#$,]9'ZZA<+Y%*M\,PPL"D]^:=K3NJ9<;_MR!-H-Y\/)QZ-OGRXOG&]?S[X
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MXJ@0'@5!6G!'W.6:R?/';C8F3'.X/$SSMI^&4_C/<#**__;_ 5!+ P04
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M#)8@RUK?$\MUR!M^Q8;+B4AC4^8\4L-R36P2>A<-C\UD6VR^8$?D$D:8OR[
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M9RLW?.VBX?F%KUA>WEK>L<R%H/;!EG $LP^0[X>T"4?)9<'.^JM(?.SG799
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MZ>S+!#_7#?8KOJ7/ZTV#&SRRH4:W7?CR/B>YI==0:BN<#EI'GY3A#DOPV5N
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MXZYST>I5Y;K9EA_'-U,F@@^YN/H^S">;%GH?HD^:";(ZHHXNBN5TEOOWN;Z
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M@.WY<&5+?30HE+V^0%P+]N)JL #X(I5A-LZ+Q7QDWA7.'"JEO$O::FS!FZX
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M8=^78N],)FFBE08!JK?CT2?R5<^J,W$UE*5PY>L,<B:\\;1T4"P6%9@)(9>
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M\7ITP=C23NP"\C"68]\*WH@_.VAG[QO. JN.DFL/CH&LP1,ID(4H2>&%P)L
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M9Z(C"'INI)+-@IZ;R'-O0<^WPU1MV.F+Z11G+]*_SH?3^<?6==38"#DV%PD
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M$S?.IC:7PPDUNNI/YELUL]J&]P=K6M2%J+=F5MM*KU/WHEU8?S!<:+062\J
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M/N:S%\\;9-FOF\+1@:)7/O9D&YEU&'NR \,/,_:$/!2)7@K("AVHD,D/5;Q
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M I5D5<I6&B5M5#XH9TWP-AJ; _TU8S>H[,*NY751OT0"VG_^Q_\#4$L#!!0
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MVU%'BW)CJ+Y;EMK5V3"J2=/T27PS_U)-,A1GS-QY2FTEBB"%F"(,J="EZ'E
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M#G]E R:U[&4,!\UXZ5>#<:7#[&5TG'-E]B-%UT)@7Q[%;*8E)<7+A(J4!4G
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MZ[GG@WCBT7[V?)L2G29]W&_%=%$9P^*ZKAG_8@R,>_%]\4;I],<DS44<899
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M"R7NZM ?.^ZE7%K)#(S0BOLVV@%2:<OYG6 F_A+$)AUXF+]N(B;';PAQEHF
M()C@&$$DB>+\*,A@(BCBF-$TS'#S#;TO^)_\"UII,*KOYXLBW.8#"DP^^>!/
M]0$-8V3U\$G\B>RLEO8'4FQM?V+CL;<<QVQ,)I>MZ'\JJ\MQ/'P;7J[=7QC,
M5I]S?-17#M']W/PWO%>R5E+MG^M*PQ,>1"AA$L,LU"E-D.20YDD.0QD$21!1
M*8E3\+)+YV/;\IOL?/5QX.-4#4O)'E_ 3$L.(GU26/\8=@QXLQD-NY6D+XQ[
M7@[:^3I7'LP?-^C6/X9@K8#_:MA=@.LE2LZF_]<)EW- YFC<G$L;74I#+>E,
M*(:M]ZZW4K/M9\VTM GCF7 LHE1P!@6+(ZCSM$"*,89!S!D*8A(Q;'7^:=?=
MV&AL)7!S*JD-;&U; 9-=FZRD=BGS<Q9PB[M$KS#V;;BN$&RJK=Y*H,4%GXUE
MV@N"+N6/?"(Y5%$CJV_2UX6;-4*GZP^=;67 JD*V&FW7"K)^JYNE^9Z4A;)E
M*]6^L7OOYK,I>]DD4B&)2$A.$\AR2G6$"84X#R,84\70*2-9&%O5M;;L;VQ$
MK"MIFF1:2MYZD^MF.IZ#U\Y:] A:S[2[DG2#EZY JJ4%OS?_[26EC"5"/BW!
M<UT.:OQ9ZK]K[]F^UCD#YV[9T57)T8E(<\4>:I>:,9DH^X[$D,02P2!'/$PB
MELN4NI3#/M&7$Z<,4.IZNW2O+F[MG(_S**QV?.()K)ZYQ+K$<=^EC2W@\IS'
M\VAW0V?S/*?W@9R>9U_I6 A+?1N?U-=R_7U:34C*6)3& B8HU?<]J8 T5/M$
M(G),XARSG%&G4E>MQL=F@FC9@!;.L5A5&R\[6NB*0L\\L 8 _*XE\UE.ZH#"
M7@M&M=L?MB34 <WVBCX=>N;2?)S7Q6+*I[/E0LW_39AF[2$O^ <EJ*:(9;U9
MO96[!DB=D3_B$8M"0M3,SC.($(LAS6D&(Q9&'$6"QW''0@P^Q!L;0;2S^+?U
M:X=VKS2LDP*W=-0O[1OMEY9D\/(56-[)OMK8]GV"]0K#>D$J3Y_H]Y/)TXN$
MKY3(TR>ZQ_-X>NVEVTIR_30O%]-_-#VTO;KO2O$T73Y-4DI%GJ42<A[E$*5A
M#'.>YY"C(&=I$(N,!"Z+P]D>Q\;W;8'WPB+<&/L\VG8D[!7#GGEU%[[M2*$?
M&X$]AG%:@^.3]LYW.BB366.P2T[V+W:YAA2EXK<W;S?IZ.Y6V>A,D'Q3ZB3C
M5&2(A# -U1\HEQABE$D8$YY%(9:"9*G]7:15GV/CG%IJ\ :TY 9KP>N4%RZ7
M:7; V]Q)>H>S;[/. LGS56@Z0^IR2>D=VJ%N*FN(Z:D\D][N*9U .GU9:=?4
M@#>63KIM7UNZO7KQJ0-CY5+PCU-"IS-CM.[4@XCC*)0I3F"29!RB(,:0ADD.
M$X08INJ+HLCIP-"^Z]$Q>7M;6<N^+N7>>;M_#G[GK;Q'4(?<IC=XMN0>J)"&
M+6 ][:S/]?Y:NV9+5$[LB&U;N#"+_*TTM/@XGZF7J]K[[II6BY*PQ83EROAD
M/%*\Q5.(I$[B$4=8C4LJD4AEF@1..UZK7D?'6^N,ZCK:I"7V?UOE?_A])7K7
M#/0G!\&2PGQ#VS=[^4"U>_9Z&Y1Z26A_LN/7R7%O@\71M/=6+[MQ%!=3M?L6
M!3?%,V;D89+G C-),ZCX)H=(X S2/".0A(B'088X$\2&A_9:'AO7K(4#6CH[
M-MF'ZS1C7 1"[T=D5OI;S_NCNF[F=K6:W)5@?WF8?_U9O5//:_7#[G3>;V^0
M*7M4C=6T//Y -_/@S;*:%B:-V!.=%G6D4E6)175=M$V2ZW*JGGNHS^<+G=91
M%$S__JG.AL+F#\7T'X*K71#G(@P$Y&G&($H(A7DN T@QBUB>)40FPL60\"S?
MV&C@U^E,5(NYTA"0V@YT,RQ\#Y^="?**@](S+:TT RW5KD"MG$G9V-YW-?JM
M;D9;&JZ"DL!&2>-/YL^^Z6D(?%I"OD4<U&;J"=]=ZZJO;D:=C^/S?#:3\U*_
M.&$XS5$L,,Q8HFL:"0;S.,LA1GF0JW&+9>96%G=P%<:VI+Q6/'WWS?'P7YWE
M3GO4WU+?V_81?T9CS=!P8"3_A,D:VEK\9\S;<&"47BF%PR%)+LSF4%L/34U2
M?EM\UCY6I9)#B3JM-M<E.<^CB" "L4@Q1#CF$.N\6#E/\T3R&//(R?_558"Q
MK9J-B;^2&Y %V&0B (KVUGH HTC'] ZVPV.W0/4)>L_+2SO-PR[V^VCW>L75
M%<5><C[8RO Z>1\<$3J:^\&UG8Z.GE_)=*:_FP_S\@N9">W:M?$Y;=R^-,57
M"]/OA(>I0)G:?<0X)#K-C82$<*8CD<.4L%"*3+I$#+H*X$2* X01KN6':I6"
ME=( W!0ZGZU)D6P..6H-3%D*1[]0U\&QH\0^(>^9$HV7Z$96!>\>_-:0NWN0
M=L3-JT.IJPS#^I=V1&C/W;1K.]U(\*9@I<[N\$[4_[TI;I^5):K/D-Z2YZDB
MD?7]LT1I3-(H@XS1#"(F!<Q1C& :<\0PB7 @G1(QV'<]-FOP[:,V]$VVYOE*
M9$ VI\"SS='<7]UHSV$X[ BO'Y![IKJ5T.#'E=@_::S7DH-&]%X. ]P1\TER
M#KT/2F_NJ.P26X<6.B=]6-68JXL@M[;;$YI*BO,XA8PPG:HP3B!.: *E^CL+
M28["0+J0V*G.1D=;K>*&5V#>RJ"K$^6:Y+B58W;<DUC;,90O!'OFI'9IS:MU
M7?26K%ZS/9Q%Q'.ZA^/]#9WOX:SF!Q(^G'_GPF.SF^)9-5HG(6S"&"2/\S11
M-A 1.B0GSG2A%,S5CI"&*) !9W'4Z81LOZ^Q\<C_6LX7@O_7?PK3X+__2LH_
MQ*(^FZ^ VHB &ZYV?U-&9O4#S>G-CTUF3D=^.34"CH=@E^$ZX'E7+>C5.I?I
MV5"<[D=:QS'IY?3J0'>O<U!U7.^C9U(G7KD@_>AU42QUU8S:)-K4PE6;OX_Z
M-VJG4:J=QB1/,TDC+B"-,Z+V7E$.,<DE1%F2,(1E2@(KOZDNG8^-?M9I((F1
M7^T,FMW"IDZS(:+Z(58KT2'/INW8G.:AOA'O^YYW!78M.EAOS3;" R4],.*#
MM[V#W2'%:0^@#YWPU.5+]YW_U!$^JVRHMFT.GQO54=N#F5)=V^B8-_7I>39_
M$>*+*+\JX^OPG?2G>5$7F#/7SY6IT=3^=WV,^&F^^'?1\A(SIG1S4SW)(RS#
M))-0AE*;N4FFEJ"(PDSD*4L)IC1T<L :1.JQK5B_%>5:3E-0=.TM(YJRWCME
M?M]_N;L[/H]?\7.PL[E'-\A]+Y*'G)PVWB!78*WKMN_3E;FE4?^Z "]BVQO8
M=]6"08?$:Y+;000?-E7ND&.QEW!WT,XO#$I].R-5U426F322B"*62<D@Q3KM
M9AI+2.*(P4#]-<IR%DED%0!VMJ>Q+2%&OG6(9,?PTCTX[>C<"TA]'\]NX>,]
M3^=9"'J)$=WK['7B0H_I?#06].@+7>E@-[!4<8_069AF<^TAM/&+$X&(PT0Q
M0XSS!"(2Q)!F'$',PSR(LC@)T\2-'BQ['AM=' JD=B4-6]!M2:0'*/NVZPZ%
MHVNQP49N\'L_B35<X?)+0+:=#TQ(CICL$Y1K Y=E"G\W?R+38A(B)!,I,XBS
M/-5!KUCM%40(.1,(42Q20JPJ21UN?FS4<V&V\ 8S.U+ICD3/S-'*&%[+UD/.
M\&VE^\@:WO3P*GG#M[4[ECE\YZENT_6W2MS*]]5B^J3LEVI"8DJR2 H822DA
M"E@.\T!?]#*9<9X)C"+D,EVWFQ_;=%72F53-*_G<9NT.=':SMCL@/<_:72R&
MJ1QT& Z?\WFGAT'G\V'M=N?SD:?<\\5\5'#/[A[GA?BT-%X"(LXBA!,*(Z&3
M-0=9  E%#)(TY33$:NV-K%/&[#8^MKELY -&0%!+:)\Y9@^XTW/Y4CAZGLD.
M2#CED#FF\@5I9/::'"R3S#%EVLEDCC[3T3(NM</TXD6OWXOK@FLK_%D?&7R<
M%N)F(9ZJ241RI@_R(!)QH/;P+($D2;B"#&4AE3D-(R</S?-=CFT:KR16RX^6
MV;B4KZ4&OVNY@1'<,9+> GQ+L]LKI'V;XI>CZ6ZB6P/DU6P_W^NPIKPU"GOF
MO?V;OL)>]O-L3C"*,17Z^)#J2D *=4A1$L(\H2RD<:SXR(F);#H=&Q>M$LJ*
M3@EZK6"VXQS?X/7,.D="6 [DY^TS<N4X1/W&K!SH]Y6C58XC<3Y.Y<2[W=CG
MHZ@J(=;A+\8I:-7Z2^- 4+U;BDF2IHA1J<R@@"+%0$Q"RC,$A60\$&DHXCAW
MB3BV[=B)A0:(-#87T&!9K&K,J!EDBGX_-R*[L9(U_';,U >H?6^/C,A7K8@Z
M(_75FI>TM=1(?@64[/Y(RA4MGT1EW?>@9.6*R"YA.;_?P5]=&61,"%[I%'._
MDH6.1GZYE77PAPY6WD0H3\(XRPE+*0Q9HH@K5CNY/ \YQ%&JFB"$2VE5Z,"Q
MW[$93HVT.A'D7(*GM<2@6HOLX";M@/]ITNH1U?[W<49HH*4&*['!K00;P5OY
M$?H!U\']O!^0!_(\7X-MDI<^K< ^]B7[\CEWQ^RDN[E#<\-YFKOKN.5DWN'U
M+O%)Z_H3ZY5$^__-"[V6W$I];;Y;884G K,@0C"56081IY&B?&6PBIREB*8!
ME:E#C3+G_L?&_^VJ++I4_%M2EB_:TFI2_ZI?KU4#:]U<(F?<A\AB:>@7^)Z7
MB#7FMP?!K?3OC0:@SA=FY;KC9W(XA"WU.@)#12ZUOO[9>B389B34[PNMB;=H
MI<ZHG0Y8<F]VP)BESCIOARUU;\;S)=!FON",29$G&118YQI*(@%IKM:6A!":
ML#B)H]S)!^-\EV->/U;2;]]=G$X9WQ7Y"V^ QK@LG+D!ZC%WI#U,@]P#O9+?
MICT*UO= OJAH^]2DJ4(X03S'.$0(2I%@B$1(84Y) &..$B%PR(+<*>CQ8"]C
M(YS/>C(TUSQNK'(81#LBN1B:GKEC[X3T_1F$G#GB) (^:>%P1X,RP4E==R?_
MZ8<]FQ[KM'HDHYAAQB'!)(>(A=I?3(')XT BS'$<A)D7RV.LR0W/K)8=JSB<
M!_Y"PV.$:0PO1M*?O=%GRL+SG8[#VCB7H-#^Q6[<\VE>K+.%WA1J+[Q>*M,T
M478%8S"D0:0X)TUA'BCB03119@=*"49.]L;1GL;&-;>+1U'JM"9*1/!C8WS\
M= 4*UXW-<6SM:,4+8CW325M&<--@UHAY/*V:,X><A<(G=QSO;%#..*OS+E><
M?^%U2FS]K8[:5^2EQ&'JQ_NY_E535D1O=*\?'DKQ0!;BIEB4TZ*:,I/>;$)1
M%N($"Y@D.(4H" 7$-,H@3X)<$$(S%,9#5MKJK,G8.&XM)EC+N<KTUZ@*FMP@
MVCX0&_T J0/:U?=K\LV!.+@"^HARV/I9W3\I.^K]4WPH?5]<>*RF];?-Q[1"
M1*<5TK^^ BU4KL#1+W,\E;4N'MPQ%=CJKLR?JL[6Q6/FN]S6Y0)U7<SGY>)>
ME$]UUK=YM9A@*K,L26.884$@PB* - T)#%B8H%@0D;C%ENYW,;;EST@(54]/
MJS2%SK5@#N!HN[1<@D[OG+\&ICE:]%NRY;CR?CEQKY>!R>J8EOLL<O3)KF>)
MXIE,>6/X*WHQN]DZW_7;9:D=E"=(!!$+J#*C0UU'+T<8XB!&,(D8$B05:H?O
ME)#&HL^Q$4 C\CJ"Q%@F<[/Q9[7$3>D4UP/%\^C;'BEZQ;3W0\4:SD9<@V9]
MC%)+K&BDEMGGJ:(U0'[/%<]W._#)HC4.^V>+]J^^SLG!+^K!1753W(ER.N>_
ME-HS)))Q( FGD*(\T_>@#.8Z$(61,.6$)V'(W=)I^9=Q;&Q7EZ  7Y;T[\K4
MU!NOU29_J\KQZI</6B.U0>M<@*6/81]FWW[A8/Z)=N2UICK\K]95_T9I.YY=
M]HFA&-/^^9"8?ZJ=\0F<?>]Y3W5U01;&FZI:"OYNJ8NQUDW7A-=._KJJ8<TG
M&9=QDO,,IJ%DROJ5":0)#F&4!IF(0IH(ZK;;=19A;,O#NIC]7-9UN,#<2'S!
M N ^+ %B(A)!!I,P2B"*60 I5<MZG"%&PX!S+M-)8<Y#^*L.3%X/3%N4D:S<
MJW/ZBY9N]Y&S7)E[G29_HH5WI5]K[?6<H;,3RMY3=;I),7S.SDXH'4S>V:VE
M;@N>KKQ[4U2+T@1,M')3I@&249 R&)%8+6LIPC!GB,*,1"G'A/"4.^4%.=;1
MV!8O4X%Z(^A5ARR?1S&U8S8?2/7,7P=!ZB$+Z#DH?)+,T;X&I9)S&N\2QMGG
M_27O^"P*\8W,].GR)$3:M@UB*'34.PK"3!F] 8$RS&(ITB1AQ,F1XDQ_8R.)
MC</TK+[5*&M9@;[IN#Q/1QMI.\[PB%_/U'$T*T<C+K@_!:&73!P'@.D[ 4>[
MRU?/NW% ?YMT&X=>Z\8NVQ<8$LL\DCF&YLX889+"/$LDS +%,)0F<:2OB^WS
M_W2_*!HLR<\E=T)=;G_&>L_3VVU.[_<VKWA#8W47X^/61:=&?5\L=*ALW<YG
M\3PO-1_H(BC+:D(XCRD2"I\\$!!I>X#R$$'.28:#A#"UB;!-.WRJH[$M_[6L
MJZ\6K*4%M;CV^8A/HGMZ:OO$K.=9WA4NIZ3%-EA<D,#X9/.#)3.V4;*=V-CJ
M^2Z94T0Y%=47H0_NBZ]"M4IGXDZA*U1/=9&TIGXY)AG+HX1"S+C.3)XG,-<%
MY3E)HAS1F(6)5:296[=C(XQ:<* E!RW1P5IVEXIGCB-PFD;ZP[7O(U0[2,\7
MEK\$6Y>,)WU@/%2BDQKK2IC*KANLG]=8FVL>;VE.7*$ZG=W$NK4!DYJX:KB=
MR\3Y;1]GPZV^5FF>ZBQ/M_+^4=25IM8I529!FD<Q#W)(B400"81@+H($QBE/
MDDC*.!51]^-C)UG&MABLDV21=9(L70Y9U)77F%N6+!]C196]'F*>P(#14*W1
MG$(2"@)3$A$>14DLA-,&?*BQ&F"[KI.:L>WQ&FY<NEP7](;VT#<*+46N#N65
M:PH5GD\J=^&E0R= ^[N7<!/G%:\N.N%V^G:C6Y,=MC<?R+0TL3&_"J)+)IKD
MPM<%O_Y*IC,=2O-A7GXA,W%C"DB;?VUEP1/:H32B,(@#G=,\Q)"P.(<R#P,N
MB20Q9=8[GDLD&=NZIW6I0^] 6QOCW+W6!\AY";1&H*62@^U^T=!9;)6&&I">
MZ?;86%QOC<6' V/1-9_D97/*?I\UU  -M/4R _75#-33[J0A6Y.FT@,UW6CE
M:S?F ]"3&[2+.AANS^8#AZUMG)<&.V9I$8LZH<-'+4A&6(+S((4L3W.(LI1
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M.OQ8=Q>JZ6(5]/16F5"*%80RY$6E#7AE@RY+L:E83R*&,><PTRX9"-$8YG%
M89KC)**4)&'D=$'KU/O8)GU+>+-IW1(?;.3O?,/K-C9V5D!OB/=,)S[![N3W
MY0R:;Y\P>P$&]Q=SQN:0+YE[(Q<$ ]R+I^=Y2<J77U5?C[.7-W5FU<5$!AAG
M*6:0Y(1#Q"F&A*1J2Y+%<<0C'";<:DMBU=O8&&WM0?U4RPGT708X&537 >+3
M1.4=N+XOAU:8K64%C;! 2ZL3*GM%KX,OOP\4A_;A7ZS1W/L6O24XLX3'RG/_
M:"/#>^R?T^>@I_[9E[KN"S],9Z)\2Q;B85Z^3#"E(:-1#+,L3"$2-()YAE*(
M$TXH(TDN,ZMZ%D?:'QNA-IL@(R-8">FZ+]Q&T'9?V!F78?:%EI!TV!<>5/SB
M?>%VJP/O"P^JM+\O//Q8Q]-:4S24L7(I^,<IH=/9=*&LL57"<T:1V@NF& 94
M9A"EVDR*4P9#2C!5>\0\R'*GD]N3W8UM6C>"UJ6%'8]O3^-J>93K#:V^CW7K
M:L$-7"U1>T@V;P>*U_/>TST.>_9KI?W>.;#=6QV]3V9FT 0_[ ?3%"B>Q %"
MF*<1S AC$,5Y C%&$H8)T?= G.7"R6/0KMNQ44I=D<*$\34>9*PEM*.?B1WP
M=ESC'\Z^-V2'O/ V/E=7JW+F'EU+G"#RZEABU_.P;B5.:.PYE;B]W3'L:$-U
MUT6=JOEQ/E/O5W7ZRDG(,*.<)3"+XD#GEV(P3WD&DPCC( @2&:692RZN<QTZ
ML=%@]7%F&ZG-F6O5DON_-9F2'6.6S@%OQTD^X>R9C3[N8/C^-&KNP4V64'@-
M=SK7Y[ !4)8([(5$V;[70PWK.H=N91SG6OETOPBF'M4233*:YUF"F$Y=2R$2
M$88X310-T4P91T$<IR3P5L_ZK#ACLY8V FLOTA/%$,"T6,RU*;5.DM!3$>7S
M(VI';<.-4]]FF &[U@34JC1UD:_J0(EJE5U\-8SM^B$;E0:JHFP-[6 5E<]+
M-)[JRM;H.55:MF^UZ^'T->>JG^JM^O&VO)]_*R:<\I#(5$ I90B1^K9AGJN?
MHI"16+(P3[!52=43?8R-3)L3V49.-2OUW^8ET+*ZGE7O VI[7GT13,.<6;LA
MU.'H^B@&%Q]?[[<\\!'V4=7VC[&//]K1$EL^/\_,WI_,WI"9#C7Y\BC$8N-9
MT,YQ3BF)DB"!E&&A=GXI53^%(4R8R!$1E.?8*1+*I?.Q$4,C+S "ZU-<$\YA
MMC%MM5K>-X[Q"DXC8VD_]81WW]92&\]MW%N2VV7]=S>,.F#FU0QRZ7]8HZ<#
M,GLF3I<V?(18K#:X+SHV9E7E&2&!HR2#09 E$*& 04K4H+ <IR*BA*2!DP/G
MV1['QFF[ 1CM,RX(9O/B ;I7CS^/>X %9RA*H,YP#5&>((A%(J'(<,A0(C!'
MP409N'3^*LBW>^X/^XUL8'Y\&'Q#;WFEZA/.OF]5=X-EUN)>@8W ?47/G,"F
MOV":0YV^8FS-"0Q.A]J<>O%"SF^N1C89P3#)(H%# G.BCQ 3$<(\H"'$(9=A
MG"2<I5:^5F=[&B_'BT;2OW8DE3U,'<GD$J0&(Y&5D+VXSI^%HA?.V.OL=;CB
MF,Y'.>+H"UU<W<W16L'*QO;\FZ@6)CR_X%.37?]NIKZ,V^*N%%^G\V4U>ZG/
MX9J\KN8$;D)YFLHX508B2S.(1!!!F@0<$LJ1S!6#Q#BRLUN\R30^N^:W0H>:
MEU.VT-<.1LCZ6J)UZ_!-E )42_IWP18Z7KT2Y=>IVN-]K1'0=Q@-!.X7%/Z&
M^S2]O<H0#G--L=$'- J!C4; J 1N"[!1:G6SL<HX;?0:>KA<8@$&'K:AX@6:
M2[[-\!V84,]F^-0H/6^&;UH/WVJ.&OV\!19XQ/IT\(&/C@8,4/"(RW80@\^&
M?>1$O==I22:YE(PP%D 68UD?MF"!(IC$69;E))6!<+K#/]#'V$SO+^Q1\.7,
M%*SZN#I, 3N)0?4YIA;>,1SV$,1V]OB%P/6]!/G![,)TJENH])=/M>[F%1.J
M;NEY.J/J]J,=3'"]R2?5XSHUUG7!ZS*B-3DUE]O5UNWVW<J!Q9#:_;Q59F$B
M&(NS.&%0R$R?(M)4$4HL88A"%K,\X'EFE?^J#^'&QD3V+D([#D(.1ISO\;4P
MOU]QU'JFP48SL%;-E,%>*]=R%JK [;:WT%K!IO++_7QME[_RB#I8Z*\XL@,9
MZTI#8(98KH?8I-0L6C9[MSGKRW+O:0Q.&O&^^QS.GN\)K2W3OJ\^+G#J;<<C
MJ(U%T53/2CE"89@FD*11#A&5*22Z]%@DHP"E02*06SGJ$WV-;:TUHL(W^PFR
MSX7:.(-LZ03B![J^[?[3@4H]U"^SP,6[>^N1[H;W73VM]T''U#.O=,VX5>I,
M"PNA-QL;7];F P]RQ#D1$4R"(- ED!2?! 3#)$\9YS&)&74JI'*RM['QR%K8
M.O%V==X)O /"=A3B#;>>260#F3DPV$C:2_E#"TS\IKTZU>' ::XL=-]/:V7S
M4D=3A,S$K6QHJJBFW%PASHO/@HGI5\%OBWNUE%2$F9T'"FF:I4C9)3SE.E]#
M A6A($@C%&&9YPACMW BE]['1C,ZP?1S4W+\"A"I^E2$PY?,;$*6A5+FFQXI
M]9=5[G_UG-YO3"MC;5Z9?<M<*BNS[67@:.8X#:"EX=/7L/1M"I'Z^--(;N*"
M-K*#E?#Z!J<EOD>SJ MJ7@TE)P&&-9VZ8+-G3'5JY((MVE8@Y\8A2K*$9))#
MHMY4))A@2'C.8)03DG%&9,Z=G%^/=S4VQFM+VBUR^P2L#GNRB\$:PAM@C5,M
MYEZI@3O26_'9\R!YWY\=[FWX[=E)K0_NSDZ_T>&Z1EMI;^=?14&*Q6<]24K!
M?YT6TZ?E4]O%YRVI'N^$^N**!7E0O'8ORJ>/<U),, X)#],<)BE61I;(U.X^
M% $,(V5UY5S96IG5"9 /8<;&0&9WPAI]P%.MB+*U6IY3YFCX>:V+PZG]I0-G
M<>\RX'#TS'%F)%:J@)4NH%$&;#FS:77 1A]][Z(U EJE <?'X19EP'$:Z-9D
M>^:4J_&RF4+:I#;.!#.EFJ\[$D\(G[P3N;2/X>Y /*&Q=>?AJTWWJ/AWS2?]
M06U[R>S?!2D_J-]4DS3):!ZGB5K9T@"B/(@A%9)"3)4]36(NB'TYCR-]C&[!
M:L0$M9Q "PJ,I/8Q\<?@/+W>> *I[V7$'1^GB/@S"%P0$7^LY<$BXL^HUHZ(
M/_=H!RO7^$F22KP3]7]OBB8!Y&=1J?;9HZ[=)[Z*V?Q9][P*29AD'-$PC1&4
M* PABKF^Z0P2&,><!8A%-.%6''")$&,CB55FT[*1VIP+\HW<CD>#%XV/A1$[
M .H]L\Y* [!2 =P4Z_RR*RV,XU!+CW6$TP"CX&"J#C : YFHUT^F/JZR-J>K
M\?F1-UK]I'X'B.T\\66D7HCM2>.T:]O#&:47:K]EC%[:5L=3W,8G^E9J8]@X
MXFXR@<0I(R*1 0S#1*U$22)AGA,&(YQ1'E(F,7(J&WFJL[&M.'O.XO<K9W''
M\]Q3 %N>Z'J"K>\SW19B9B]=.]*#?E*I6&#B]0CW5'_#'N)::+YWC&OS3C<"
M^4"FY=_(;"E^5:2UK .#JL_Z"EY?V3:N(%$6D(A)#A5G1! 1+-2.-@UA*-,L
MQ D3F"$7(K'I=&R$LA9/ERN:.MYA6Z%LQR:^L>N95;2XP,A[!380^O>Y<8'%
M)[%8]3LHP;@@L4LT3N]>:K%<%XLIG\Z6B^G75J[*]]]U"7/!/RC%M%_ALC;*
M;^5[4A9*B.I.E,8C=+,,XR2/ HH3R(G@:L<M&<21KKM)>!Q&.!29L,I%V9^(
M8R.S]EI_-U^H49Z2V>P%O&MT;?O'%?-%4U=>Z!@$\);,V')6NYQH4T&_HOY%
M.POIZN?Z&J0.\^YJ:'G[+ES-L]<8[0&-NK9Z[0%>*0@TEX"6BOJEE9*;81W(
M+O0]&/U8D]ZD?"4;U#?*QRU7[SUU++;SC93\7KU[_7U:35@@ [45#J (]'K!
MDTP9MCB'%,N($YF$B#EY.FVU/C;2-\(!+9UCF9PMR.Q(M3,0/?/A!@/PNQ;-
M(W4=5-EK$9NM#H:M57-(M[V2- <?ZG3S<J>]CJOJ\-'9+V_^CRCG^G^WA5@%
ME:5)$K*$0AIEV@0,"*0H#2 +68Z#&*D-K)7?=L?^QS;5?WD3!*'3*;XSXE;7
M*'WBV/L-"FBD/WY?\@MX [3\]1]*B_,;6R_8.UV>]#D& ]V;'!H+LCT65^"7
M-^ ?>AC,'_-"^+LBZ8K@F=L1YV:'O!CIJO/.G4CG9KI9=W=-M(HV)_6IOW'U
MF19"QSV7@D\7$XRXB,,@@#24:J'(PPC2%$4P(+G,DCA-LM QP?#9/ETFU#")
M^%8BUSN^Q:,P:;Y,+G6UY5LG=S;1A5>@$/65Y>H1-J\6)G'?_QM>91EV,R;/
MCY!4(Q!D BM+7.BR3@&"A"<I3(.,<A3$5/V?BTWN=7P&L=/K6V*I ZRX;W3M
MS'>OF/6\4&]_S)O$4$9>4R_)2.S/T+<&QZ?Q?[[303<$UACL;A+L7^R:RO5S
MX_BI+)+KAU+49]BKBZP(BX12!F6.%/MG*(24)Y'Z*TU#BE@6VV6:L^IM;+Q2
MY_QI"0PV$KMFY#P%LL7.P"=T?9^@GD"MB[E_%C[79*6>8!PT$>G_I>Y-FQO'
MN331OX*8B3M3%6',< %)<.:3<ZOVG:RT)]/U=G34!P566]VRY*LEJ]R__@)<
M)&JC  B@^=:'RDQ; LYY0#XX.#C+L@,GV0KMM:ZH 2R7:X;V#3)P/5 #?8YK
M?9I\R8%G/R[F51+9ALSNYHJZU"QMLVR>8<IX)"&/TU0QK)2PQ'$&E4679"C/
M(BZ-8HXNS#,V;NU(JEMI5J*VP7H6Y- #K &K^H$K,)]VD6JEM*M_=/$1-"=0
M/X@-1)U]SY@OZKP,2"]I]GQ].+J\K,,>41I\W/&JB:G'0M^4"WZOSMA+?;^U
M%,]JY.E/<3=GBQ>A+\R_B?6]?"1_3ZC$<:+38A.DJ5/] ^*8YC!1S(F3F,<)
MLBJ,9CG_V"BU(SY8:/EU99&= CJ$6FE@>95EN22&EUWA@ Y]'=;!N!(=[,D.
M:N'!+UK\7V^J& ]UH%8Z>+PV<P//Z\6:I0C#7KVYX7-T.><XC(\&>TW1OM6$
M1RD2DDK(RCR&*$HR2&BA_I>0J"AQH7Y7N'?5:Z<9&Y%5R>&O9,J!7"Q#=73;
M8FQ&6=<C%YB9CGJWM3*&:M=VB$&X'FW;F=ZQ,=NAMOW=V(X^?6WHY\-2OP;K
M-UTL<GT[Y[HVR>NN6X%,2B)(F<)<$@81R0FD4@@8BZQ(:9S2B-@5(#*<>&S,
MT4I[ RIYJSO/K<1NS2&,U\",1T(@&_Z^X I0KXAH-$,H3)SBA;G?*?K0#)'S
M,86&WW=CJ^]B3:9SP=M(Q,8]BY."D)Q%ZFQ69NJ4IDL\T#B#6209%T4:TXS9
M<-/I:<;&1-V# A=RRGHNU&S0-&.9ZS$*S"FM@+MP:?\9+OT@^*2-,S,-2A+]
MVAY2PH5/NQ:@;LOF-S49OZDGX-/B1<TTR:,RSY*(PQQGVD)!B@]21B')",%I
MC$K$K5)K>^8:&Q7L-XQI*I%J<6V+3Y]'UXP5/&$6WM]]&B[P9RVKU\+3%Q'Q
M6W;Z_'0#%YV^J/=QR>G+7W%T^[XLENOI?S9Y#-N&'!]UU-0DCN*XQ$+7J6>Z
M0%2>PE+& J91&A4H)CD7I96/MV>RL1%'5U;]+E2UZ_>BRBR=N7U &WIN/<$7
MVDU[@%S=\ZY%KI+6HT/6 !.OWM>^^89UM1IH?N17-?F.H_U!7J=K,JLNH_AT
MO5%/U-U<I^(*_F&S_K98_YM8/Y IGY TCQ,<$1BCI("(J_^5D1"0E\HN04E4
M,(RMC!'#B<=&,'_,*R_K:W,JK$[VHCT26EHGIM@;FBH!$ UMM]0B@Z[,H!4:
MT,T:*+'!FU@#+;A'&\82*J\&C>G<PUHWEH@<F3JVWW>OA_D@EM,%_SSGG\A:
M3,HDYB3/I+)N<J2,':9CNF,)=8>O)%=(I-BH#>?9&<9&0-M:C[64X+/.45%R
MVE?"W >RGV2\P!.83:R1<:J!>5)[#Q4P]\<=O/[E2;5.5;\\_4'7_A!JC-UU
M "Z3-"UX#J7D&**\5.\R*0L%6"P%9LH"*:U* .T//[87>2N=XR7+/G:&5RG.
MB 1^=\W!<.CC<$IGO[T;]F88N%_#*>V.>S2<_)3])OQYOIZNW[Z+IZEN\3!?
M:X_&I,CC3$:\@)+A&*(XRR#%2, ",YZE>2(B8KP'GYI@;&]N+2/8"6GAFCP+
MXN7]]UIH K_"EJA8;;Y]JE^Q]YX<=K"MMT^I[L[;^SG7HM-5+/&LZ<:KBY^L
MNJUU'A??MZ7M*\_ECPW]=\'6CXM_U.U^)Q'B(DE9!K.8%A#1+(4DQ@QF11GG
M,9-YFMH40[A>HK&1Q"U7YZ#I8JZ.MZM*&^U4Z[2'J'MGKVHM="NCMO%V)V]E
M!7Z9SINO_VI;,/G:%>XGI'=9M\ ,UE%GV[.^7KJ]ME./"[#3J>ERWVBE?]?H
M-?1RV1:['G#9!JO@L%N^MB%]O7SDH&N8P6OHM?BU)ZPO5\*^=J*!RV)[PN6X
M1K:O@9TK1)P.&?IC)>1F]G4JU5E7B"P360E3ED;JK)NHLVY61E"4L5I7H?Z(
MK2[I#.8<VP[Y<-*'?@/T&KQ444";2G8P4\);URBXN )F)V;/N ;>P7KC#F]
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M.L>'N5CK^[$U^=O.0 JV\F9FU1C6,S!K5BJ"/1U!K23X16OTZTU/_)+VT-^
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M(232@6GF*$/O*$MA*W_]"?#8A[JUO>$*G4]SQ%J&0:T55X0.C1GG<5PSF=5
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M^2[@)L/8]H/?/L1)D5FPDB/T!KM >$ #[P=W<]!H %H5*H]K1PGP&_@ E!Y
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M;+%RN,3J1>+JJZS3HP]\H=6KXO&U5O_'!VJK\V7Z4TQ*D>9EB@4L4"PA0I&
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M/+=_D26_?]4?7/U#K-:"_ZN8/CVK/V_5H9X\B=_4M]>?R%IL \@GE+ H%KF
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MD_$ZU =R_M_V:,0U'CH#,X@$#ZD((.=A"G%$4^6W*6P1BU*4!!G/LW#Y;(Z
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MO]CJ4'RS.],(K?M*%7NY%V M-LW&2*NV_H%WRKHM* /GT&ZY&'%>IED,=@J
M/QVJ\&=#M=MI8?:S.CT6X$ 3?S;^/B1]6O"!DDQJG^]#Z]3ZWGFW 6<PZG8M
MH^,#8]NJ_OI8E=MOC^^*JMZ\6J^+[\JC)=6/!_EZ5=::.4[9IK;7:8!Y&&0I
MA82&RH&/"(8Y2G+(1,0$CVC.(OMCF>%RS,T_WVL"&E7 IM$%&&7 @3;ZW6[U
M,8GO#H<,=\R;Q5G.-+,QLD4]GXBO5R?BX7@B;K>T]3HC#B=!T\S,1(=#!S-4
M'K\JTLP0.7Y56#M#7.GDZWCF?CQ[3VSNN/UTASCW8W!TKN/A=@/9VW7)]^NR
MWIRP,C&1Y*G  <189!"3(($TE0@&E''EV'*UCF5.I.R7QYG;0G3(SV1$!EIF
MUU:35S"U\\H](#7R(M%R.&@9P:\-5]@H?6]N(.&5O_S*4-/2DO?K>\8V?N/C
MPPS"&Z'"6E8TG7'$\ZIQK=?\T+M>9G&2Q($R#&&6$(@YB6 6YPED+. TC1G*
M N1B'6P&G9NI.)2YR9DX$-;-8%AA;F<]?",YLBDY%'<!=@(;/%_9X.EL5%P
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MN:-R:L,&W&%NC4H_ENNF'=CG<K5Z5U;ZHF6>A(E,"8)"Z%.'-(R;HN\XSK!
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MRW^0)QF'&:8XC;,\(,S)3%P99VY&HB'MTA99\S4S+:5K>YG+>-H9"@\HC1V
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MS0\X?)D^J._^\U^ZWZ@ONG[[/__E_P-02P,$%     @ ,X-J45=N\O/WAP
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M,?V>?G%K=\76A$NGA9*H6)59L8 >'/<)9>65UR52YL-=GCU.0S^@-)_#'$#
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M4.HBNIYJW>^F,K'E(U)Q+<W+3FH5S71EN@]K_@^IA(&.E?O;Y];1\;A7@I+
M6"QU6"Z@HR,Q]%+,2::\P+#K$(YA>T=*]RK!1!&$5PXT]0F$(PR\41QXN=>T
MP:#!LVT?)^-WV1L$>_4.DJWUW$"XMR?/;R\>_X#NZ9X,G@MJ"$1?*C.9<> <
MQBC!1F(9H\J;.E</]7@:N2O7B%!=M(F;9K?01C\8FQ2*.3O(+D@0)'$PV66(
MW%%K22E>/N ^:*554S,(ZH7L'=4Y]K7$R_T91*;.,^=!",\Q!G,<K$T$#!%1
MJI"][7DET7CGBV'5NET/C&UDW(!!^Q6CM<5%2MUCBZ.N4.^*$:*I5ABL0Y:>
M@C"2@D_E#R0C"YX89U5>\CU)T<C7H#4P-:P6=H;3=PQH%X.]>;D>0[W9LHRQ
MH'6T 5)D"MT/QL %(R#;)&B0VOM<I:7*H]2,?%=:$TC[2[\)$.WI+WR\*3!.
M,GIN8P"A UIC7JRQ(!@[QN09I0F#Q2HW6$,Q,*[-^_/$(+LAHH'S>4^^WYR6
M+"1*WN1H @$;B"F7APX/$$G 6:=U*34-OLK]QB#4M^A+U@;>L.C? 04-WWF\
M=;,R5^SKMY2NT^S%']^<7?_+=!5FBU49$KK+[<26*PQUC[ /8WMF_+O@9G/]
MU34!;YXDX"8CFU6I='$$*)IQ$#0;\$%02,)*=#TD3;'?^] ="=A_9,GMQV^2
ML+'4[<4AD39JSSEDPS((:2)X)W 3.>JXD@ZW<I52XVV('+&3SB$P]'#J227]
M_6F,X.[U-#NM,XY!K%!?LQ>D'3%$\JR!L(QQ7&06HRZ2P)G$G7,\I/N5-VV9
MQ<_+Q5E:KB\^S\I]]KQ[:WY65ML8D:>)]+FTD8T"/0KG&!CJ.:CBZ'OA)5-5
MJE-?)NT5FL!M\/)@].JPNFH@\-F(/4-8GN/Z4^>GL\[Q[7;Z+6=4$Q26$(#F
M&\\.P<M<&1&!^:1(($&%7"7([T_BB%W(QD!C)=W]:8[CC5*@JWWK-K;L)_1<
M=J^LJD3).$?Z;H(:J/KI29MZ6],HC S1:,A,\C(,2X$M/:FDH<1:*ZED56IK
M7Z1L../[],'2I?2R<R8S+D'YKIF\\6!T)J 3Y]SH()2H(H&^!(Z;.QH604];
MV0&5U,#)_R0W;R]NAEQ0FXA,&ET8E3"*XUJ"%]0#$=Q%1WTBK$J%70_:6BD;
M&A(4?;W-'374,N@V)V<$ZS*S&63J4@>6@,V!@9/9HG.M9 I5+C%[T-:HG=L5
M#[VCF]V4TP#>CG*>AG3#R'5;>N>58P2W(BFO65T,X+@+0(+7QG-CK*MRG#Y*
M3:.8VE7GBZ$5T "*+F]]TO(^&\Z*F%@9GU'>V0CI(UB)7H96T3)#F;.IBJ5Z
M@IYQ;[%K(VD()32 I:^+O/ZC>U#R/<T6FXPHX:A$1Q6RZN:(Z7*#: 50%WVD
MB='LZK2+>HJB<0MX:N-I&$4T@*C[&X+0D!WC"6C&. <WAT/RT>4,-"$'00E*
MJSCMNUBC:JT*:J-G'Z$W@)F/R:W2M\4L?C@]6RZ^7S9;N!G:PR(+&*AD6]YL
M*NH S^, 60<2F')"N2JGVC,TC=N*H#:6AE)& [@J4PO6R_-N/L&'.0KN!'5U
MS8O)U-*L<8^H<E+[@+%)"8C1S&)D$K4EOLJ=_G-$C=/'^G ^TT#J&!%:J^5Z
M\L7-3R[C6X.@CTD%2+04:CM4N-<N@F=,$Z><TK[/DUC\T W\X-_N8^?.JJV4
MAU;(->TNW18@<85D=/^-4J7QG7?X1_0!&4\4 FX9H;,BV?29[M ?%&-&[GMH
M[+[.=Q#?R%K_;3J?GIZ?7A&>:?0NHVGD$0VB4,RC5906DE=4<<FXX'W>SO32
M^YV51];\+GI;#"'$L;7O?FP0[I@7UC@+@90Z=XDR, +];AJ3YS('GUV?>H1^
MVM]<>9SC8##M[RS$!OS+)T_ CS<%X#19PE$ D(TH%14(99/*5"S--$M&"&,.
M>V?U<:M7)M7R*>->6>VFGY81]]=EJ?L)1B,>@BO#DTN_)>/ QZB!),-"S#IR
M6>4A^O-D-7JGL",(^F)L>XTT@*\[D[&0B##M](1?SU*GL'E\<[I8KJ?_U7W_
M2>8G7@?B!(M @D9/D$KD.Z $-+7.86"GN*@270_%0*.W%\-@=A0M-X#N)QGY
ME-:3D'@RFE(@OO@>)!HP7#EP).:@2_Z!DH/:3B2JT3N/RI9S6VWLCJS%VLWJ
M(NOW5<KGLX_3G";<.W2+D1&;4$R"2()' 4>6K.<B=EFU*B:Q!VV-WHY4QMF.
MNOD35B1?56S_^N,LS5=I-4(E\A,4C%V!W$<P0U4>NXON+5,Y?,NJ;G9;EQ\T
M%XIG5\8J(_QS:6%:*E0T\4%P8WG.5=JR/$/34#UHOJ3.#]EX+/#N?%FLQB1D
M+F/P E@7^6G'T;FP#KB*-/ED4\Q5WJ^_2-G(\<Q .'FJ'<TP"FG VSLZZ^:5
MST^Z&\UK?BZNN6'&&ZV\@9@H<F.1+VN4@M*O0D3+([):I>SN6;)&CCLJ86M
M530 K*M# ?V*G%9E;+F;O4^WVR3)J'5$U]6[TO-!2A04)1RB)(3)B-X$J1)(
M/$_6R*%$)6 -J(H&@'4]+O=*6M=<>(,.KX@1=&8H()$3&)8C)"]H(E13EJH
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M37V@OG '_X_O_B^NEO7_'_Y<W@9"1BOR/R"Y>@&O>0+'*,R2@5M#45=6<=@
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M NXS]5ZV1&8?2O*D2*;4=GJ\@)<L$[^2S1I-2*Q-*\.G]S2Q6]D;#,>27@]
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MK)X)<5-*B9KWU;%B1.)??5ZWG?9T: GV@O+?+B?\,OLPDW,6K2%ES;YVLY5
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M:430BX<X)4PZT))KRC _3OBU!9A)95/PM<N(K(W*'$64T6"!K(W4";&4(%N
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MZ*ACS)P=:$9E<"]H&:H).G+#O F@'2>NU=YK(6D-3 :3?= !=RLF7DHLCFB
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MZX4C]8E<^\1JF5(\<S6777B$O%*X]2Y?^"JK_ W?B/FOU4[_#5!+ P04
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MT@0NKT_?C_I0L1SG8ZWO.(-P .?A7^^A;KL>A))D!5=<9"1QG.%%!2ISI?+
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MV<RLG?*B0)Y5(5XD"%2C3[3>UE:RKPLNF9X."HWY 84/R1$@\O57\!J'M(1
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M/NMG>05E+L-._@%02P$"% ,4    "  S@VI1F^(MC?W8 0!HK!4 $0
M        @ $     9V]S<RTR,#(P,#DS,"YH=&U02P$"% ,4    "  S@VI1
M%T%F;8 4  ",V@  $0              @ $LV0$ 9V]S<RTR,#(P,#DS,"YX
M<V102P$"% ,4    "  S@VI10?_->3H?  #M10$ %0              @ ';
M[0$ 9V]S<RTR,#(P,#DS,%]C86PN>&UL4$L! A0#%     @ ,X-J4>("X4^L
M:   9W\$ !4              ( !2 T" &=O<W,M,C R,# Y,S!?9&5F+GAM
M;%!+ 0(4 Q0    ( #.#:E'0A3L=^NX   _E"0 5              "  2=V
M @!G;W-S+3(P,C P.3,P7VQA8BYX;6Q02P$"% ,4    "  S@VI15V[R\_>'
M  !S.P8 %0              @ %490, 9V]S<RTR,#(P,#DS,%]P<F4N>&UL
M4$L! A0#%     @ ,X-J43 L5^TA"   #"<  !D              ( !?NT#
M &=O<W,M,C R,# Y,S!X>&5X>#,Q,2YH=&U02P$"% ,4    "  S@VI1E*-D
MI18(   ()P  &0              @ '6]0, 9V]S<RTR,#(P,#DS,'AX97AX
M,S$R+FAT;5!+ 0(4 Q0    ( #.#:E&JBP[B[@0  'H3   9
M  "  2/^ P!G;W-S+3(P,C P.3,P>'AE>'@S,C$N:'1M4$L! A0#%     @
M,X-J49K^!ICI!   9Q,  !D              ( !2 ,$ &=O<W,M,C R,# Y
D,S!X>&5X>#,R,BYH=&U02P4&      H "@"F @  : @$

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
